var textForPages = ["aaaa                                                     a                                                      fFk (lexz)                              Fkk;jkW;M xz                              Fkk;jkW;M xzfFk (lexz)                              Fkk;jkW;M xzfFk (lexz)                              Fkk;jkW;M xz                                                     a                              Fkk;jkW;M xzfFk (lexz)                              Fkk;jkW;M xzfFk (lexz)                                                      fFk (lexz)                                     Dykl:e ls Dyhfud rd                                         (f}rh; laLdj.k)                                        ys[kd ,oa ysf[kdk                                      MkW- iadt dqekj vxzoky                                     ,e Mh (esfMflu)] Mh ,e (,aMksØkbuksykWth)                                 gkWeksZu ds;j ,oa fjlpZ ls.Vj] xkft;kckn (m-ç-)                                 laLFkkid] esfMdy dkWUlsIV~l bu fganh (MCH)                                              MkW- izKk vxzoky                                             ,e Mh (fQft;ksyksth)                                     lgk;d vkpk;kZ] fQft;ksykWth foHkkx]                                       jkek esfMdy dkWyst] gkiqM+ (m-ç-)                                iwoZ vkpk;kZ ,oa foHkkxk/;{kk] fQft;ksyksth foHkkx]                                     ckads fcgkjh MsaVy dkWyst] gkiqM+ (m-ç-)                                                                      R                                                  MCH çdk'ku      R                                       fpfdRlk f'k{kk] vc fganh esa","9599334581                   mchprakashan@gmail.com                              lokZf/kdkj lqjf{kr % MCH izdk”ku  MkW- iadt dqekj vxzoky            bl iqLrd dk dksbZ Hkh Hkkx] çdk'kd@ys[kdksa dh fyf[kr vuqefr ds fcuk bysDVªkWfud] fçafVax] QksVksdkWihbax vFkok fjdkWfMaZx ds :i esa dgha            çdkf'kr@eqfær@ laxzfgr@çsf\"kr ugha fd;k tk ldrk gSA            bl iqLrd ds lHkh Hkkx dsoy nksuksa ys[kdksa }kjk gh fy[ks x, gSaA            bl iqLrd ds ys[ku esa lEcaf/kr fo\"k;ksa dh çekf.kd iqLrdksa ,oa vR;k/kqfud 'kks/k i=ksa dk v/;;u rks vo'; fd;k x;k gS ijUrq bldk dksbZ Hkh            Hkkx fdlh vU; iqLrd ls mlh :i esa vFkok vuqokn ds ckn çdkf'kr ugha fd;k x;k gSA            fpfdRlk foKku ds vusd rF; foKku dh çxfr ds lkFk ifjofrZr gksrs jgrs gSaA iqLrd esa of.kZr rF;ksa dk mYys[k djus ls iwoZ mldh rkRdkfyd            leh{kk vo'; dj ysaA fdlh Hkh fookn dh fLFkfr ds fy, ys[kd] ysf[kdk vFkok çdk'kd ftEesnkj ugha gksaxsaA            Dyhfudy lkbal ,oa çSfDVl fujarj çxfr'khy jgrh gSA bl iqLrd ds ys[ku esa ;FkklaHko uohure tkudkfj;ksa dk mYys[k fd;k x;k gS ijUrq            fdlh Hkh la'k; dh fLFkfr esa fpfdRld dks vR;k/kqfud funsZ'kksa dk v/;;u iqu% dj ysuk pkfg,A             Dyhfudy lkbal esa n'kkZ;h x;h fdlh Hkh Mk;Xuksfll vFkok mipkj dh fof/k dks vusd ckj ;Fkk:i O;ogkj esa yk ikuk laHko ugha            gksrkA fpfdRldksa dks lykg nh tkrh gS fd iqLrd esa of.kZr rF;ksa dks O;ogkj esa ykrs le; fLFkfr dh Dyhfudy leh{kk vo'; dj            ysaA iqLrd esa of.kZr rF;ksa ds vuqfpr ç;ksx ls mRiUu gksus okyh fdlh Hkh fLFkfr ds fy, ys[kd] ysf[kdk vFkok çdk'kd ftEesnkj            ugha gksaxsaA             iqLrd ds çdk'ku ds iwoZ ç'kklfud funsZ'kksa dk ikyu djus dk ;FkklaHko ç;Ru fd;k x;k gSA ;fn blds ckn Hkh dksbZ =qfV jg tkrh            gS rc mls ekuoh; Hkwy gh ekuk tkuk pkfg,A               f}rh; laLdj.k % 2023            ISBN : 978-81-962274-1-8            eqæd : MCH izdk”ku  R            MRP : ` 500/-                                                         II","fFk (lexz)                                 Fkk;jkW;M xzfFk (lexz)                                 Fkk;jkW;M x         a z z fFk (lexz)                                 Fkk;jkW;M xaaaa                                 Fkk;jkW;M x                                 Fkk;jkW;M xzfFk (lexz)                                 Fkk;jkW;M xazfFk (lexz)zfFk (lexz)                                     Dykl:e ls Dyhfud rd                                             f}rh; laLdj.k           Fkk;jkW;M lexz ds çFke laLdj.k dks leFkZu nsus ds fy, ge ys[kd\&ysf[kdk] lHkh leh{kdksa ,oa ikBdksa ds vkHkkjh           gSaA ek= ,d gtkj dh lhfer la[;k esa eqfær ;g laLdj.k de ls de vius ikBdksa dks ;g fo'okl fnykus esa           lQy jgk fd vk/kqfud fpfdRlk f'k{kk dks viuh ekr`Hkk\"kk esa i<+k tk ikuk Hkh laHko gSA vusd yksxksa us ;g           fo'okl trk;k fd ;g dsoy mUgha Nk=ksa ds fy, ugha gS ftudk gkFk bafXy'k esa tjk rax gS cfYd bafXy'k esa ikjaxr           fo|kfFkZ;ksa dks Hkh bldh 'kSyh ljyrk ls le> esa vkus okyh ,oa jkspd yxhA bu cgqewY; çfrfØ;kvksa ds fy, ge           QSdYVh tu ,oa ikBdksa ds vkHkkjh gSaA           fganh esa fy[kh x;h iqLrd dks fdlh çfrf\"Br çdk'kd }kjk çdkf'kr u fd;s tkus ij gesa bldks vius gh Lrj ij           çdkf'kr djuk iM+kA ;g ,d Jelk/; dk;Z FkkA gekjh igq¡p lh/ks esfMdy dkWyst ds fo|kfFkZ;ksa rd u gks ikus ds           dkj.k vHkh gesa muds vuqHkoksa dk ykHk ugha fey ldk gSA blds foijhr] jsthMsaV~l ,oa çSDVh'kulZ }kjk gesa           vusd cgqewY; lq>ko feysA buds vk/kkj ij gh iqLrd ds f}rh; laLdj.k dh :ijs[kk cuhA vaMjxzstq,V dkslZ ds           Fkk;jkW;M lEcaf/kr lHkh fo\"k;ksa dks lfEefyr djus ds lkFk\&lkFk bl laLdj.k esa Dyhfudy dkS'ky ds v/;k; Hkh           tksM+s x;sa gSa ftuesa Fkk;jkW;M lEcaf/kr jksxksa dh Mk;Xuksfll ,oa muds mipkj dh dyk dk foLrkj esa o.kZu fd;k           x;k gSA ;g bl iqLrd dk fof'k\"V y{k.k gS D;ksafd çpfyr ikBî\&iqLrdksa esa bu rF;ksa dks dsoy fl)kar :i esa gh           fy[kk tkrk gS] O;kogkfjd :i esa buds dk;kZUo;u dh fof/k ds :i esa ughaA vius Vªsfuax çksxzkEl esa ge] iqLrd esa           fy[ks bUgha fl)karksa dks Dyhfud esa fdl çdkj ç;ksx esa yk,a] blh dyk dks lh[kus\&fl[kkus dk ç;ksx vusd o\"kksaZ ls           djrs vk jgs gSa ijUrq fyf[kr :i esa bUgsa igyh ckj çLrqr dj jgs gSaA vk'kk gS] jsthMsaV~l ,oa çSDVh'kulZ dks ;g           vkSj Hkh jkspd yxsxkA           bl dk;Z dks vaMjxzstq,V fo|kfFkZ;ksa rd igq¡pk ldus ds ç;kl esa ge bl iqLrd dk bZ\&laLdj.k Hkh yk jgs gSaA           bPNqd fo|kFkhZ] cM+h ljyrk ls bldk ykHk MCH dh osclkbV ls mBk ldrs gSaA ;gk¡ ge ;g dg nsuk mfpr           le>rs gSa fd ,d xSj\&O;olkf;d] mís';ijd laLFkk gksus ds dkj.k MCH ds varxZr çdkf'kr lHkh iqLrdsa           [Fkk;jkW;M lexz] jä ,oa fyEQ foKku ¼áweu fQft;ksykWth½] tuZy vkWQ esfMdy dkWUlsIV~l bu fganh ¼JMCH]           iquuZok½ ds lHkh vad] blesa ek= ,d lkS #i;s ds jftLVªs'ku ij miyC/k gSaA gekjh vkxkeh iqLrdsa [çSfDVdy           Mk;fcVksykWth] iYeksujh foKku ¼lexz½ ,oa xk;fud vkWUdksykWth ¼lexz½] Hkh bl osclkbV esa blh jftLVªs'ku ds           varxZr gh miyC/k jgsaxhaA bl iquhr dk;Z dks vf/kdkf/kd fo|kfFkZ;ksa rd igqapkus ds fy, ge vkids vkHkkjh gksaxsaA            bl fe'ku esa lg;ksx djus okys çR;sd O;fä dk ;Fkk;ksX; vfHkuUnuA                                                                                   LokUr% lq[kk;                                                                          MkW0 iadt dqekj vxzoky           gkWeksZu ds;j ,oa fjlpZ lsaVj]           SB-5] 'kkL=h uxj] xkft;kckn \& 201002 ¼m-ç-½                     Mh-,e- ¼baMksØkbuksykth½            drpankaj.endo@gmail.com  |      9810125568                           MkW0 çKk vxzoky           fnukad : 15 ebZ] 2023                                            ,e-Mh- ¼fQft;ksyksth½                                                      III","Fkk;jkW;M xaaaa                                 Fkk;jkW;M x                                 Fkk;jkW;M x                                 Fkk;jkW;M xzfFk (lexz)                                                      fFk (lexz)                                                     a                                                     z                                                      fFk (lexz)                                                     z                                 Fkk;jkW;M xazfFk (lexz)zfFk (lexz)                                 Fkk;jkW;M xzfFk (lexz)                                              izFke laLdj.k                                     ;g iqLrd] fganh esa D;ksa\\            fdlh Hkh Kku foKku dks le>us ds fy, lokZf/kd vko';d igyw gS çHkkoh laoknA Hkk\"kk rks bl laokn dk dsoy            ,d ek/;e ek= gSA laokn dh Hkk\"kk] gekjh le>us okyh Hkk\"kk ds ftruk lehi gksxh] og mruk gh çHkkoh gks            ldsxhA ;gh f'k{kk esa ekr`Hkk\"kk ds ç;ksx dh ewy vo/kkj.kk gSA fpfdRlk f'k{kk esa fganh ds ç;ksx ds vkykspd dsoy            mldh nq:g Hkk\"kk ,oa fDy\"V 'kSyh dks ysdj gh vk'kafdr gSaA lokZf/kd vk'kadk;sa fpfdRldh; ukekoyh ds fganh            :ikarj.k ds fo\"k; esa gh mBrh gSaA blhfy, o\"kksaZ ls pyh vk jgh i)fr dks ,dk,d cny nsus dh mRlqdrk dks            NksM+dj geus mUgsa ;Fkk:i çpfyr 'kCnkoyh esa gh fy[kk gS ftlls fo|kFkhZ dh ÅtkZ 'kCnksa dks le>us esa gh O;;            u gks tk;s ,oa bldk lnqi;ksx fo\"k; dks vkRelkr djus esa gh gksA iqLrd ys[ku esa geus lokZf/kd tksj blh fo\"k;            ij fn;k x;k gS fd og vf/kdkf/kd ljy ,oa iBuh; gks ftlls fuR;çfr fganh dk ç;ksx u djus okys Hkh bls            ljyrk ls le> ldsa ,oa bldk ykHk mBk ldsaA             çLrqr iqLrd esa geus Hkk\"kk dks gh ugha oju lEiw.kZ çLrqrhdj.k dks Hkh cnyus dh ps\"Vk Hkh dh gSA bls geus            vf/kdkf/kd laoknkRed 'kSyh esa çLrqr fd;k gSA iqLrd ys[ku dh vkSipkfjdrk dks NksM+dj geusa blesa fo\"k; dks            fofHkUu çpfyr mnkgj.kksa }kjk le>kus ij vf/kd /;ku fn;k gS tks fo|kfFkZ;ksa dks dFkkoLrq ds lkFk tksM+us esa            vf/kd lgk;d gksxkA laHkor%] QSdYVh dh deh ls tw> jgs esfMdy d‚ystksa ds fo|kfFkZ;ksa ds fy, ;g iqLrd]            bl deh dks Hkh fdlh lhek rd nwj djus esa lgk;d gks ldsxhA             fdlh Hkh uoksUes\"k dks rhu pj.kksa ls gksdj xqtjuk iM+rk gSA loZçFke migkl] rRi'pkr fojks/k ,oa var esa            Lohdk;ZrkA vHkh vusd fo}rtu fpfdRlk foKku dh fganh esa fy[kh tk jgh iqLrdksa dh vkykspuk dj jgs gSaA            muls gekjk vkxzg gS fd og fpafrr u gksaA u rks ;g ç;kl çpfyr vaxzsth ek/;e dk fojks/k gS vkSj u gh mldks            LFkkukP;qr djds mlij fganh dks Fkksius dh dqps\"VkA ;g rks mlds lekukarj ,d oSdfYid O;oLFkk gSA ;g vR;ar            LokHkkfod gS fd fganh esa fd;k x;k vHkh dk ;g vkjafHkd dk;Z] vusd n'kdksa ls laof/kZr ,oa laikfnr vaxzsth            lkfgR; dh cjkcjh u dj ldsA /kS;Z j[ksa] ;g 'kh?kz gh ifjiDork dks çkIr dj ysxkA             ,d vU; vkykspuk mPp f'k{kk ,oa 'kks/k dk;ksaZ esa vk ldus okys O;o/kku dks ysdj gSA vusd fo}kuksa dk ekuuk            gS fd fganh esa i<+us okys Nk= bu dk;ksaZ ds fy, vuqi;qä jgsaxsaA ijUrq okLrfodrk rks blds Bhd foijhr yxrh            gSA vkt vesfjdk esa mPp f'k{kk ,oa 'kks/k dk;ksaZ esa jr fons'kh Nk=ksa esa lokZf/kd la[;k rks phuh Nk=ksa dh gS ftUgksaus            lHkh dqN dsoy phuh Hkk\"kk esa gh i<+k gS] vaxzsth esa dqN Hkh ughaA gekjh f'k{kk O;oLFkk rks iwjh rkSj ij vaxzsth esa gS            ftlesa dsoy ek/;e dks gh fganh esa djus dk ç;kl fd;k tk jgk gS] rduhdh 'kCnksa dks ughaA ,sls esa tc phuh            Nk= mPp f'k{kk ,oa 'kks/k dk;ksaZ ds fy, lokZf/kd mi;qä gks ldrs gSa rc Hkkjrh; D;ksa blls oafpr jg tk;saxsa] ;g            ckr rks le> ls ijs gSA                                                          IV",";gk¡ ,d rF; ij vkSj Hkh xkSj djus dh vko';drk gSA gekjs ns'k esa çfro\"kZ 91000 ls dqN vf/kd Nk= esfMdy            f'k{kk çkIr djus gsrq p;fur gksrs gSaA ijUrq iksLVxzstq,V lhV de gksus ds dkj.k yxHkx 49000 gh vkxs tk ikrs            gSaA yxHkx 42000 Nk=ksa dks dsoy ,e-ch-ch-,l- ls gh larq\"V jg tkuk iM+rk gSA vkt bruh cM+h la[;k esa            dsoy Lukrd f'k{kk rd lhfer jg tkus okys Nk=ksa ds fy, vkokt mBkus dh vko';drk gS ftudh leLr Vªsfuax            vis{kk—r de ifjiDo vk;q ds bUgha vkjafHkd ikap o\"kksaZ esa gh gksuh gSA çfro\"kZ yxHkx 5000 MkWDVj] fons'k dk            #[k djrs gSa ,oa mPp f'k{kk ,oa 'kks/k dk;ksaZ dk p;u rks 2500 ls Hkh de MkWDVj djrs gSaA ;g og oxZ gS tks bu            vkjafHkd pj.kksa ls xqtjrs gq, vk;q] vuqHko ,oa ekufldrk esa vf/kd ifjiDo gksrs gSaA vr% Hkk\"kk;h lg;ksx dh            lokZf/kd vko';drk rks ,e-ch-ch-,l- ds Nk=ksa dks gh gS tks muds mTtoy Hkfo\"; dh –< vk/kkjf'kyk dk            fuekZ.k djus esa lgk;d gksxhA             vr%] fpfdRlk f'k{kk esa fganh ds vkxzgh egkuqHkkoksa ls gekjk ;gh vuqjks/k gS fd og vkjafHkd migkl ls            grksRlkfgr u gksrs gq, iw.kZ euks;ksx ls bl Kku ;K esa vius iq#\"kkFkZ dks vfiZr djrs jgsaA vaxzsth Hkk\"kk ds            va/kfojks/k ,oa lc dqN fganh esa cny nsus dh mRdaBk ls cprs gq, f'k{kk ds ljyhdj.k ,oa O;ogkfjdrk ij viuk            /;ku dsafær djsaA gesa iw.kZ fo'okl gS fd ekr`Hkk\"kk esa of.kZr ;g fpfdRlk foKku] vkus okys le; dk vaR;ksn;            lkfgR; cusxk tks lektksUeq[kh –f\"Vdks.k ds dkj.k fujarj yksdfç; gksrk tk;sxkA vkSj ,slk Hkh ugha gS fd fganh esa            fy[kh iqLrd] vaxzsth ek/;e ls i<+s ;qod ;qofr;ksa ds fy;s O;FkZ gksxhA ;fn os vHkh Hkh lius fganh esa ns[krs gSa] rc            og bls Hkh vius vf/kd lehi ik;saxsa o 'kh?kz gh bls vaxzsth esa fy[kh iqLrd ij ojh;rk nsus yxsaxsaA gesa cl vius            dk;Z dh xq.koÙkk cuk;s j[kuh gSA            nks o\"kksaZ ds ifjJe ls rS;kj ;g iqLrd] gekjs O;fäxr ç;kl ds :i esa Hkh çdkf'kr gks ldrh FkhA ijUrq blesa            vU; fo}rtuksa dks leh{kd ds :i esa lfEefyr djus dk mís'; bldh Lohdk;Zrk dks c<+kus dk ç;kl gksus ds            lkFk\&lkFk bls ,d o`gn Lo#i nsuk Hkh gSA vkt ds Hkkjr esa fo'o dks cnyus dh {kerk gSA ,d O;fäxr ps\"Vk ds            foijhr ge lcdk lfEefyr ç;kl] vo'; gh bls ,d vkanksyu ,oa lkekftd ifjorZu ds :i esa çfrf\"Br            djsxkA            var esa] lHkh fo}rtuksa ls bl Kku;K esa lfEefyr gksus dk vuqjks/k djrs gq, ge muls ;g vkxzg djrs gSa fd            og viuh\&viuh {kerkuqlkj blesa ;ksxnku vo'; nsaA ftl çdkj cw¡n\&cw¡n feydj lkxj dk fuekZ.k djrh gS            mlh çdkj vkidk ,d NksVk lk ç;kl Hkh vkus okys le; esa Hkkjr dks iqu% fpfdRlk {ks= ds 'kh\"kZ ij çfrf\"Br            djus esa lgk;d gksxkA ge lHkh fo}rtuksa dk vkºoku djrs gSa fd og bl iqLrd ds fdlh Hkh v/;k; vFkok            [kaM dks csgrj cukus ds fy, vius buiqV j[ksaA gesa mudks iqLrd ds vkxkeh vad esa lEcaf/kr Hkkx dk leh{kd            cukus esa çlUurk gksxhA            bl dk;Z dh dYiuk dk cht cksus ls ysdj bldks ewrZ:i esa <kyus rd ds dk;Z esa lgk;d çR;sd O;fä dk            ;Fkk;ksX; vfHkuUnuA                                                            AA Ronh;a oLrq xksfoUne] rqH;eso leiZ;s AA             gkWeksZu ds;j ,oa fjlpZ lsaVj]                                  MkW0 iadt dqekj vxzoky           SB-5] 'kkL=h uxj] xkft;kckn \& 201002 ¼m-ç-½                     Mh-,e- ¼baMksØkbuksykth½           drpankaj.endo@gmail.com  |      9810125568                            MkW0 çKk vxzoky           fnukad : 05 uoEcj] 2022                                           ,e-Mh- ¼fQft;ksyksth½                                                     V","Fkk;jkW;M xazfFk (lexz)                                             vuqØef.kdk  (Index)                                            vuqØef.kdk                                                      (Index)                                            vuqØef.kdk (Index)                                    [kaM ,d \& Fkk;jkW;M xzafFk dh lajpuk                            (Section One - Basic Anatomy of The Thyroid Gland)                           (Section One - Basic Anatomy of The Thyroid Gland)               1.  Fkk;jkW;M xzafFk dh lajpuk  (Basic Anatomy of The Thyroid Gland)      2-11                                     [kaM nks \& Fkk;jkW;M xzafFk dh fØ;k iz.kkyh                             (Section Two - Physiology of The Thyroid Gland)                             (Section Two - Physiology of The Thyroid Gland)               2.  Fkk;jkW;M gkWeksZUl dk mRiknu (Synthesis of thyroid hormone)        13-21               3.  Fkk;jkW;M gkWeksZUl dk jä esa ifjlapj.k ,oa buds flØh'ku dk fu;a=.k   22-28                  (Transport and regulation of Secretion of Thyroid Hormones - TH)               4.  Fkk;jkW;M gkWeksZUl dh dk;Ziz.kkyh (Physiology of Thyroid Hormone Actions)   29-40                                  [kaM rhu  \& Fkk;jkW;M xzafFk ds fodkj \& esfMdy                         (Section Three - Medical Disorders of The Thyroid Gland)                5.  Fkk;jkW;M xzafFk dh fofHkUu tkapsa                                  42-46                  Fkk;jkW;M QaD”ku VsLV~l dh foospuk dh dyk ¼Dyhfudy dkS”ky½              6.                                                                      47-51                  (The Art of Interpretation of Thyroid Function Tests – TFTs - Clinical Skill)               7.  gkbiksFkk;jkW;fMTe (Hhypothyroidism)                                52-60                  gkbiksFkk;jkW;fMTe ds mipkj dh dyk ¼Dyhfudy dkS”ky½              8.                                                                      61-65                  (The Art of Managing  Hypothyroidism - Clinical Skill)               9.  Fkk;jksVkWfDldksfll (Thyrotoxicosis)                                66-76              10.  gkbiksFkk;jkW;fMTe ds mipkj dh dyk ¼Dyhfudy dkS”ky½                 77-79                  (The Art of Managing Hypothyroidism - Clinical Skill)              11.  jsfM;ks,fDVo vk;ksMhu (Radioactive Iodine)                          80-84             12.  vR;f/kd xaHkhj Fkk;jksVkWfDldksfll (Thyrotoxicosis Crisis)          85-86              13.  xzsOl vkWIFkSYeksiSFkh (Graves' Ophthalmopathy)                     87-89                                                          VI","[kaM pkj \& xHkkZoLFkk ,oa ckY;koLFkk esa Fkk;jkW;M xzafFk ds fodkj                       (Section Four - Thyroid Disorders in Pregnancy and Chidhood)               14.   xHkkZoLFkk ,oa Fkk;jkW;M xzafFk ds fodkj (Thyroid Disorders in Pregnancy)  91-100                   uotkr f”k”kqvksa] ckY;koLFkk ,oa ;qokoLFkk esa gksus okyh gkbiksFkk;jkW;fMTe             15.                                                                   101-104                   (Hypothyroidism in Newborns, Childhood and Adolescence)              16.   xHkkZoLFkk ,oa uotkr f'k'kqvksa esa Fkk;jkW;M fodkjksa ds mipkj dh dyk   105-112                   ¼Dyhfudy dkS'ky½                   (The Art of Managing Hypothyroidism in Pregnancy and Newborns - Clinical Skill)                                  [kaM ikap \& Fkk;jkW;M xzafFk ds fodkj \& lftZdy                           (Section Five - Surgical Disorders of The Thyroid Gland)              17.   Fkk;jkW;M xzafFk dk vkdkj esa c<+kuk \& xkW;Vj                   114-123                   (Enlargement of The Thyroid Gland – Goiter)              18.   Fkk;jkW;M ukWMîwYl ,oa flLV~l (Thyroid Nodules and Cysts)       124-128             19.   Fkk;jkW;M dSalj (Thyroid Carcinomas)                            129-140                   Fkk;jkW;M xzafFk dh ltZjh             20.   Fkk;jkW;M xzafFk dh ltZjh  (Thyroidectomy)                      141-145                   Fkk;jkW;M xzafFk dh ltZjh (Thyroidectomy)                                    [kaM Ng \& Fkk;jkW;M xzafFk ds vU; fodkj                            (Section Six - Other Disorders of The Thyroid Gland)              21.   Fkk;jkW;MkbfVl (Thyroiditis)                                    147-154              22.   “kkjhfjd jksxksa dk Fkk;jkW;M gkWeksZUl ij izHkko               155-157                   (Nonthyroidal Illness Syndrome - NTIS)                                                                       VII","izFke laLdj.k ds izLrkod                                      izFke laLdj.k ds izLrkod                                      izFke laLdj.k ds izLrkod                                      izFke laLdj.k ds izLrkod                                      izFke laLdj.k ds izLrkod                                      izFke laLdj.k ds izLrkod            1.  MkW0 vkj-lh- xqIrk] Mhu ,oa çkpk;Z] ykyk yktir jk; Lekjd fpfdRlk egkfo|ky;] esjBA            2.  MkW0 ds-ds- ikjhd] iwoZ v/;{k] ,lksfl,'ku vkWQ fQthf'k;Ul vkWQ bafM;k] iwoZ Mhu] bafM;u dkWyst                 vkWQ fQthf'k;u] dksVk] jktLFkkuA            3.  MkW0 uohu dqekj lksuh] fQthf'k;u ,oa foHkkxk/;{k] ;FkkFkZ lqijLis'kfyVh gkWfLiVy] xzsVj uks;MkA            4.  MkW0 equh'oj xqIrk] ns'k esa fganh dh çFke Fkhfll ds jfp;rk] jsfM;ksykWftLV] vkxjkA                                        izFke laLdj.k ds leh{kd                                       izFke laLdj.k ds leh{kd                                       izFke laLdj.k ds leh{kd                                       izFke laLdj.k ds leh{kd                                       izFke laLdj.k ds leh{kd                                       izFke laLdj.k ds leh{kd            1.   MkW0 fou; dqekj] vkpk;Z ,oa foHkkxk/;{k] ,ukVkWeh] esfMdy dkWyst] lgkjuiqjA            2.   MkW0 vafrek xks;y] vkpk;kZ] ,ukVkWeh] yk-yk- jk- Lek- esfMdy dkWyst] esjB            3.   MkW0 jketh flag iaokj] iwoZ vkpk;Z ,oa foHkkxk/;{k] ,ukVkWeh] esfMdy dkWyst] xksj[kiqjA            4.   MkW0 lkSjHk xks;y] vkpk;Z] ltZjh] ljLorh esfMdy dkWyst] gkiqM+A            5.   MkW0 vfuy vxzoky] iwoZ vkpk;Z ,oa foHkkxk/;{k] iSFkksykWth] esfMdy dkWyst] esjBA            6.   MkW0 T;ksfr pksiM+k] vkpk;kZ] ,ukVkWeh] fdax tkWtZ esfMdy fo-fo-] y[kuÅA            7.   MkW0 ujflag oekZ]  vkpk;Z ,oa foHkkxk/;{k] fQft;ksykWth] fdax tkWtZ esfMdy fo-fo-] y[kuÅA            8.   MkW0 fuf[ky xqIrk] lg vkpk;Z] esfMflu] MkW0 jke euksgj yksfg;k vkbZ-,e-,l-] y[kuÅA            9.   MkW0 ohjsaæ oekZ] lgk;d vkpk;Z] esfMflu] jktf\"kZ n'kjFk esfMdy dkWyst] v;ks/;kA            10.  MkW0 'kksfHkr 'kkD;] lgk;d vkpk;Z] esfMflu] MkW0 jke euksgj yksfg;k vkbZ-,e-,l-] y[kuÅA            11.  MkW0 lhek tSu] vkpk;kZ] fçosafVo ,oa lks'ky esfMflu] yk-yk- jk-Lek- esfMdy dkWyst] esjBA            12.  MkW0 vpZuk uFkkuh] vkpk;kZ] fQft;ksykWth] fdax tkWtZ esfMdy fo-fo-] y[kuÅA            13.  MkW0 fdj.k flag] vkpk;kZ ,oa foHkkxk/;{kk] fQft;ksykWth] lqHkkjrh esfMdy d‚yst] esjBA            14.  MkW0 lanhi Hkêkpk;Z] vkpk;Z] fQft;ksykWth] fdax tkWtZ esfMdy fo-fo-] y[kuÅA            15.  MkW0 lq/kka'kq vxzoky] vkpk;Z ,oa foHkkxk/;{k] fQft;ksykWth] ,u-lh-vkj-vkbZ-,e-,l-] esjBA            16.  MkW0 euh\"kk xqIrk] vkpk;kZ ,oa foHkkxk/;{kk] fQft;ksykWth] larks\"k esfMdy dkWyst] xkft;kcknA            17.  MkW0 yfyrk pkS/kjh] vkpk;kZ ,oa foHkkxk/;{kk] fQft;ksykWth] yk-yk- jk- esfMdy dkWyst] esjBA            18.  MkW0 fou; vxzoky] vkpk;Z ,oa foHkkxk/;{k] fQft;ksykWth] ljLorh vkbZ-,e-,l-] gkiqM+A            19.  MkW0 lq/kk vxzoky] iwoZ vkpk;kZ ,oa foHkkxk/;{kk] fQft;ksykWth] yk-yk-jk- esfMdy dkWyst] esjBA            20.  MkW0 eqds'k dqekj] vkpk;Z ,oa foHkkxk/;{k] fQft;ksykWth] jktdh; esfMdy dkWyst] lksuhirA            21.  MkW0 ,e-ds- xxZ] vkpk;Z ,oa foHkkxk/;{k] esfMflu ,oa ,aMksØkbuksykWth] ,El] tks/kiqjA            22.  MkW0 fufgr [ksdjoky] lgk;d vkpk;Z] esfMflu] fdax tkWtZ esfMdy fo-fo-] y[kuÅA            23.  MkW0 fot; dqekj] vkpk;Z ,oa foHkkxk/;{k] cky jksx] yk-yk- jk- esfMdy dkWyst] esjBA            24.  MkW0 jkenkl f'kans] fQthf'k;u] iq.ksA            25.  MkW0 jktfd'kksj 'kekZ] vkpk;Z] esfMflu] ckck jk?konkl esfMdy dkWyst] xksj[kiqjA            26.  MkW0 dkSlj mLeku] vkpk;Z] esfMflu] fdax tkWtZ esfMdy fo-fo-] y[kuÅA            27.  MkW0 vtks; frokjh] funs'kd] t; Mk;fcVht ds;j lsaVj] y[kuÅA            28.  MkW ,u-ih- flag] Mhu] fjlpZ ,oa vkpk;Z] esfMflu] ,l-th-Vh- esfMdy dkWyst] xq:xzkeA                                                     VIII","29.  MkW0 uohu dqekj lksuh] fQthf'k;u ,oa foHkkxk/;{k] ;FkkFkZ lqijLis'kfyVh gkWfLiVy] xzsVj uks;MkA            30.  MkW0 iadt uUn pkS/kjh] fQthf'k;u] eSDl lqijLis'kfyVh gkWfLiVy] xkft;kcknA            31.  MkW0 vfer xqIrk] funs'kd] lsaVj QkWj Mk;fcVht ds;j] xzsVj uks;MkA            32.  MkW0 vuqt ekgs'ojh] vkpk;Z ,oa foHkkxk/;{k] esfMflu] fgUn esfMdy dkWyst] y[kuÅA            33.  MkW0 lkSjHk JhokLro] vkpk;Z ,oa foHkkxk/;{k] esfMflu] jktdh; vkbZ-,e-,l-] xzsVj uks;MkA            34.  MkW0 Lusgyrk] lg vkpk;kZ] esfMflu] yk-yk- jk- esfMdy dkWyst] esjBA            35.  MkW vkHkk xqIrk] vkpk;kZ ,oa foHkkxk/;{kk] esfMflu] yk-yk- jk-Lek- esfMdy dkWyst] esjBA            36.  MkW0 la/;k xkSre] vkpk;kZ] esfMflu] yk-yk- jk-Lek- esfMdy dkWyst] esjBA            37.  MkW0 'osrk 'kekZ] lg vkpk;kZ] esfMflu] yk-yk- jk-Lek- esfMdy dkWyst] esjBA            38.  MkW0 Mh-ds- dfV;kj] vkpk;Z] QkekZdksykWth] fdax tkWtZ esfMdy fo-fo-] y[kuÅA            39.  MkW0 v'kksd dqekj] vkpk;Z] esfMflu] larks\"k esfMdy dkWyst] xkft;kcknA            40.  MkW0 'kqHk y{eh ekxsZdj] vkpk;kZ] esfMlu] ysMh gkfMaZx esfMdy dkWyst] ubZ fnYyhA            41.  MkW0 ik;y tSu] vkpk;kZ] esfMflu] jktdh; bafLVVîwV vkWQ esfMdy lkbalst] xzsVj uks;MkA            42.  MkW0 euqt 'kekZ] lg vkpk;Z ,oa ,aMksØkbuksykWftLV] esfMflu] xk¡/kh esfMdy dkWyst] HkksikyA            43.  MkW0 çHkkr vxzoky] vkpk;Z] esfMflu] ljksftuh uk;Mw esfMdy dkWyst] vkxjkA            44.  MkW0 vk'kh\"k xkSre] vkpk;Z] esfMflu] ljksftuh uk;Mw esfMdy dkWyst] vkxjkA            45.  MkW0 vkj-lh- xqIrk] Mhu ,oa çkpk;Z] yk-yk- jk- Lek- esfMdy dkWyst] esjBA            46.  MkW0 mn; Fkkusokyk] v/;{k] esfMdy fMlkWMZlZ bu çsxusalh] eqacbZA            47.  MkW0 vuqHkk JhokLro] vkpk;kZ] esfMflu foHkkx] eksrhyky usg: esfMdy dkWyst] ç;kxjktA            48.  MkW0 lqHkk\"k ;kno] vkpk;Z] ,aMksØkbuksykWth] lat; xka/kh vk;qfoZKku laLFkku] y[kuÅA            49.  MkW0 #fpdk xxZ] vkpk;kZ] L=h ,oa çlwfr jksx] ljksftuh uk;Mw esfMdy dkWyst] vkxjkA            50.  MkW0 e/kqdj feÙky] vkpk;Z] ,aMksØkbuksykWth] ,El] tks/kiqjA            51.  MkW0 jfodkar] vkpk;Z] esfMflu] ,El] _f\"kds'kA            52.  MkW0 ehuk{kh HkV] vkpk;Z ,oa foHkkxk/;{kk] esfMflu] ,El] _f\"kds'kA            53.  MkW0 Vh-lh- xks;y] iwoZ vkpk;Z ,oa foHkkxk/;{k] ltZjh] fdax tkWtZ esfMdy fo-fo-] y[kuÅA            54.  MkW0 lat; HkV] vkpk;Z] ltZjh] MkW0 jke euksgj yksfg;k bafLVVîwV vkWQ esfMdy lkbalst] y[kuÅA            55.  MkW0 'kf'k HkkLdj 'kekZ] vkpk;Z] ltZjh foHkkx] esfMdy dkWyst] vxzksgkA            56.  MkW0 viqy xks;y] vkpk;Z ,oa foHkkxk/;{k] ;wjksykWth foHkkx] fdax tkWtZ esfMdy fo-fo-] y[kuÅA            57.  MkW0 lqf/k vxzoky] ,aMksØkbu ltZu] U;wfVek vLirky] esjBA            58-  MkW0 lq/khj jkBh] vkpk;Z ,oa foHkkxk/;{k] ltZjh] yk-yk- jk-Lek- esfMdy dkWyst] esjBA            59.   MkW0 lrh'k dqekj xqIrk] lgk;d vkpk;Z] esfMflu] th-,l- esfMdy dkWyst] gkiqM+A            60.  MkW0 ,-th- mUuh—\".ku] laiknd] bafM;u tuZy vkWQ ,aMksØkbuksykWth ,aM esVkcksfyTe] iq.ksA            61.  MkW0 uohu xxZ] vkpk;Z] ân; jksx] lat; xka/kh vk;qfoZKku laLFkku] y[kuÅA            62.   MkW0 jkts'k [kMxkor] vkpk;Z] ,aMksØkbuksykWth] ,El] ubZ fnYyhA            63.   MkW0 lat; dkyjk] iwoZ v/;{k] ,aMksØkbu lkslk;Vh vkWQ bafM;k] djukyA                                                        IX","Fkk;jkW;M bfrgkl ds >jks[ks ls                                  Fkk;jkW;M bfrgkl ds >jks[ks lsFkk;jkW;M bfrgkl ds >jks[ks ls             ys[kd% MkW- vkyksd dqekj xqIrk] v/;{k] m-ç- Mk;fcVht ,lksfl,'ku] m-ç-             ys[kd% MkW- vkyksd dqekj xqIrk] v/;{k] m-ç- Mk;fcVht ,lksfl,'ku] m-ç-             ys[kd% MkW- vkyksd dqekj xqIrk] v/;{k] m-ç- Mk;fcVht ,lksfl,'ku] m-ç-           Fkk;jkW;M xzafFk ds bfrgkl dks nks –f\"Vdks.kksa ls ns[kus dk   l{ke ugha gksrkA           ç;kl djrs gSaA ,d ik'pkR; ,oa nwljk Hkkjrh;A   1802 AD: Pope Pius VII ds O;fäxr fpfdRld           ik'pkR; –f\"V ls lc ls lqxe gksxk fd ge bl xzafFk ls   Giuseppe Flajani us xkW;Vj dk lEcU/k ckgj mHkjh           tqMh lHkh ladfyr tkudkfj;ksa dks ,d Vkbe ykbu ds   gqbZ vk¡[k (bulging eyes) vkSj fny dh rst /kM+du           ek/;e ls ns[ksaA                           (palpitation) ls tksM+kA           2700 B C: phuh 'kkld 'ksu uqax (Shen Nung) dks   1811  AD:  ;g ,d egRoiw.kZ o\"kZ FkkA lfn;ksa ls           fy[ks x, çsfLØI'ku esa 1596 esa çdkf'kr Pen Tsao   seawood ij ç;ksx xkW;Vj dh fpfdRlk ds fy, fd;k           ¼gcZy esfMflu dk buDyksihfM;k½ esa seaweed dk   tk jgk FkkA 1811 esa Bernard Courtois us tys gq,           mYys[k xkW;Vj dh fpfdRlk ds fy, feyrk gSA   seawood dks lY¶;wfjd ,flM ls fØ;k djkdj ,d           300 BC: vk;qosZn esa xyxaM jksx ¼xkW;Vj½ dk mYys[k   cSaxuh jax dh Hkki dks çkIr fd;kA Gay Lussac us bl           feyrk gSA Hkkjrh; bfrgkl dh ge vkxs vkSj foLr`r   Hkki esa mifLFkr rRo dks cSaxuh ds fy, xzhd 'kCn           ppkZ djsaxsaA                              vk;ksMhu dk uke fn;kA            40 BC: Pliny, Vitruvius vkSj Juvenal us vkYIl   1820  AD:  Jean  Francois  Coindet us dgk fd           ioZr ds ikl xkW;Vj dh çpqjrk dk o.kZu fd;k vkSj   xkW;Vj vk;ksfMu dh deh ls gksrk gS vkSj blds fy,           bldh fpfdRlk ds fy, burnt seaweed ds ç;ksx dk   vk;ksfMu dk loZçFke ç;ksx djuk çkjEHk fd;kA           mYys[k fd;kA                               1825 AD: Boussingault us ,aMht ioZr dh [knku ls            961AD; diknksfl;k ds [kyhQk vy gkfru r`rh; ds   çkIr ued esa vk;ksMhu dk irk yxk;k vkSj xkW;Vj ds           gdhe vy dkfle us igyh ckj thyroidectomy dk   cpko ds fy, vk;ksMhu ;qä ued ds ç;ksx dh lykg           o.kZu fd;kA                                nhA            1500 AD: Leonardo da Vinci us 'The Madona of   1829 AD: ftl Lugol's iodine dk ç;ksx ge o\"kksaZ ls           the Carnation' isafVax esa Fkk;jkW;M dkA   djrs vk jgs gS mldk fuekZ.k vkSj ç;ksx loZçFke JGA            1563AD: Bartholomeus Eustachius us Fkk;j‚;M   Lugol us  scrofula ¼xyxaM@xkW;Vj½ esa fd;k FkkA           xzafFk ds nks Hkkxksa dks tksM+us okys fgLls dks isthmus dk   1849 AD: JL Prevast us Hkkstu dks vk;ksMhu ;qä           uke fn;kA                                  djus dh lykg nhA           1656AD: Thomas Whartan us bl xzafFk dk uke   1862 AD: A Trousseau esa Grave's disease uke           Fkk;jkW;M (Thyroid) j[kk tks çkphu xzhd ;ks)kvksa dh   dk ç;ksx fd;kA           <ky (thyreos) dh vk—fr ls lekurk ij vk/kkfjr   1882 AD: William Ord us cretinoid features okyh           FkkA                                       v/ksM+ efgykvksa esa igyh ckj myxedema 'kCn dk           1754 AD: Cretin 'kCn dk ç;ksx fd;k x;kA ;g ySfVu   ç;ksx fd;kA           'kCn 'Christianus' ls fy;k x;k FkkA tSls ØkbLV esa   1891 AD: GR Murray us thyroid extract dk ç;ksx           vkLFkk j[kus okyk (christianus) vijk/k ugha dj   myxedema dh fpfdRlk esa djuk çkjEHk fd;kA           ldrk oSls gh cretin Hkh fdlh vijk/k dks djus esa                                                     X","1896  AD:  Eugen  Baumann us irk yxk;k fd   Lemarchand  Beraud  ,oa  Vannotti  us           vk;ksMhu] Fkk;jkW;M xzafFk dk ,d vfHkUu ?kVd gS vkSj   radioimmune assay dk ç;ksx fd;kA           bl ?kVd dk uke mUgksaus iodothyrin j[kkA                                                      1970 AD: A Schally vkSj R Guillemin us TRH           1905 AD: Robert Abbe us Graves' disease dh   (Thyrotropin  Releasing  Hormone)  dks  iFk`d           fpfdRlk ds fy, xkW;Vj esa jsfM;e dk jksi.k fd;kA   djus esa lQyrk ik;h vkSj blds fy, mUgsa la;qä :i                                                      ls ukscy iqjLdkj fn;k x;kA           1910 A  D:  Charles  H  Mayo us  exophthalmic           adenomatous  goiter/  toxic  nodule  ds  fy,   1993-1994  AD:  Thyroid  PeroÛidase           hyperthyroidism 'kCnkoyh dk ç;ksx fd;kA    Autoantibody genes dh Dyksfuax dh x;h            1912 AD: Kocher us fpfdRlk ds nkSjku vk;ksfMu dh   1998 AD: ;g irk pyk fd thyroid follicular cells                                                      dks mRiUu djus ds fy, Pax gene dh vko';drk           vksojMkst ds QyLo:i gksus okys nq\"ifj.kke dks Jad           Basedaw effect dk uke fn;kA                iM+rh gSA           1914 AD:  EC  Kendall us Fkk;jkW;M xzafFk ls ,d   1998 AD: blh o\"kZ vesfjdk esa recombinant TSH           crystalline  rRo  dks  vyx  fd;k  vkSj  mldks   ds Dyhfudy ç;ksx dh vueqfr feyhA           thyroxine uke fn;kA                        2003 AD: ;g irk yxk fd MCT8 Fkk;jkW;M gkWeksu           1917 AD: vesfjdk esa 350 MkWyj çfr xzke ds nj ij   ds VªkaliksVsZ'ku esa fof'k\"V Hkwfedk fuHkkrk gSA           thyroxine O;kolkf;d :i ls miyC/k gqvkA     2004 AD: MCT8 gene mutation Fkk;jkW;M vkSj                                                      neurological abnormalities mRiUu djkrk gSA           1927 AD: Sir Charles Haringtan vkSj George           Barger us thyroxine dh ljapuk dk irk yxk;k vkSj   2012 AD: oSKkfudksa dks embryonic stem cells ls           i'kq vk/kkfjr lzksr ls bldks cukus dk ekxZ ç'kLr    functional thyroid follicular cells dks l`ftr djus esa           fd;kA                                      ,d cM+h lQyrk feyhA            1936-1943 AD: Saul Hertz vkSj Arthur Roberts   bl iwjs Vkbe ykbu esa Hkkjr ds lUnHkZ esa flQZ ,d           us radioactive iodine dk ç;ksx Fkk;jkW;M dh fpfdRlk   pyrk gqvk lk lUnHkZ ns[kus dks feyrk gS fd 300 BC                                                                              ^^ek?kofunkua**                                                      esa xkW;Vj dk mYys[k gSA ;gk¡           vkSj funku esa çkjEHk fd;kA                esa xkW;Vj dk mYys[k gSA ;gk¡ ^^ek?kofunkua** uked ^^ek?kofunkua**  uked           1947 AD: FDA us hyperthyroidism dh fpfdRlk ds   vk;qosZfnd xzUFk dh ppkZ vR;ar lkekf;d gksxhA bl                                                      xzUFk dk ewy uke                                                                    ^^jksxfofu'p;**           fy, PTU (propylthiouracil) ds mi;ksx dh vueqfr   xzUFk dk ewy uke ^^jksxfofu'p;** gSA ;g ek/kkodj ^^jksxfofu'p;**  gSA ;g ek/kkodj           nhA                                        }kjk ç.khr gS tks vkpk;Z bUnqdj ds iq= Fks vkSj lkroha                                                      'krkCnh esa iSnk gq, FksA bl xzUFk dh egÙkk dk o.kZu           1949 AD: Methimazole dh [kkst gqbZA        ijorhZ vkpk;ksaZ us ^^funkus ek/ko% Js\"B%** ¼funku esa            1951 AD: Lawson A, Rimingtan C, Searle CE us   ek/ko Js\"B gSa½ ;g dgdj fn;k rFkk y?kq=;h ds vUrxZr           Carbimazole dk la'ys\"k.k fd;kA             bls LFkku fn;kA ek/kodj us bl xzUFk ds vUr esa fy[kk           1953  AD:  J  Grass  us  T3  dks i`Fkd djus vkSj   gS fd fofu'p; ds fy, vU; xzUFkksa ,oa rRdkyhu           la'ysf\"kr djus esa lQyrk ik;hA             fpfdRlk\&txr  esa  çpfyr  loZJs\"B  uSnkfud                                                      fo\"k;\&lkexzh dks bl xzUFk esa ladfyr fd;k x;k gSA           1956 AD: Adams vkSj Purves us LATS (Long           Acting Thyroid Stimulators) dh [kkst dhA   bl xzUFk esa Fkk;jkW;M dks pqfYydk xzafFk dk uke fn;k                                                      x;k gS- bls voVq Hkh dgk x;k gS] vkSj mRiUu gksus okys           1965  AD:  TSH  assessment  djus  ds  fy,    fofHkUu jksx ds symptoms/sings dk vR;ar foLr`r                                                      XI","cfgusZ= xyx.Mfunkue~                                                                 cfgusZ= xyx.Mfunkue~           o.kZu  fd;k  x;k  gS  ftlesa  myxoedema               cfgusZ= xyx.Mfunkue~           thyrotoxicosis, cretenism bR;kfn dk foLr`r o.kZu   fpUrk'kksdØks/kHkhfrçd\"kkZnq\".kçk;s\"oso ns'ks\"olkS L;kr~ A           'kkfey gSaA xHkZ ds le; xHkZ dk okrkoj.k Hkh Fkk;jkW;M   Hkwezk r=krho lH;s\"kq pkSoa çk;% iqalks·is{k;k L=h\"kq jksx%           lEcaf/kr fodkj mRiUu dj ldrk gS] bl dk Hkh fooj.k   AA4AA           bl xzUFk esa gSA                           vki¥~pn'k'kjn~Hk;ks foa'kfro\"kkZ.;fHkO;kI;A            Thyroid ;k pqfYydk xzafFk ds 'kjhj jpuk ;k ,ukVkWeh   tk;sr fg cfgusZ=xyx.Mk[;ks fo'ks\"ks.k AA           dk fooj.k ek/ko funkua esa fuEuor fd;k x;k gSA  HkkokFkZ \& fpUrk] 'kksd] Øks/k rFkk Hk; dh vf/kdrk ls                    vFk pqfYydkxzfUFkjksxfunkue~                    vFk pqfYydkxzfUFkjksxfunkue~                    vFk pqfYydkxzfUFkjksxfunkue~      m\".kçk; ns'kksa esa ;g jksx vf/kdrj lH; yksxksa esa 14                          vL; ifjp;%                          vL; ifjp;%                          vL; ifjp;%                  o\"kZ dh voLFkk ls ysdj 20 o\"kZ dh voLFkk rd           xzhok;ka Loj;U=lafuf/kHkoks ;'kpqfYydkukedks  fo'ks\"kr% mRiUu gksrk gS] muesa Hkh iq#\"kksa dh vis{kk           xzfUFk% L;kr~ fdy rRleqfRFkrjlks nsgs·frykHkçn%A  fL=;ksa esa fo'ks\"k :i ls gksrk gS AA4\&5AA           rL; }kS xfnrkS xnkS xnjgL;KkfufHk% dksfonS\&  vkxs ppkZ esa fy[kk x;k gS fd thyrotoxicosis dh e`nq           Lr=k|ks jlo`f)gsrqtxn% ladhfrZr% loZFkk AA1AA  ¼ekbYM½ voLFkk gksus ij ,d o\"kZ esa jksx Bhd gks tkrk           vI;U;ks jlgkfugsrqtxnks·xzs o.kZ~;rs iw.kZr\&  gSA vk/kqfud fpfdRlk lUnHkksaZ esa Hkh of.kZr gS fd 80%           Lr=knkS jlo`f)gsrqtxnks uwua cfgusZ=;qXA   jksfx;ksa esa ;g jksx 12-18 ekg esa lkekU; gks tkrk gSA           vk[;krks xyx.Muked bgSd% 'ySf\"edknZzkfUor%             vL; lk/;klk/;Roe~                                                                  vL; lk/;klk/;Roe~                                                                  vL; lk/;klk/;Roe~           'kksFkks okeurk rFkk p xyx.Mks·U;L; HksnkL=;% AA 2AA           rs\"oU;s xyx.Mukedxns lokZf/kdk NqfYydk\&    n'kk;ka  e`nkS  pkL;  jksxL;  uwua  HkosRLoLFkrk·CnkRija           xzUFkso`Zf)jos{;rs·Fk ldykuka o.kZua —RLu'k% A  loZnSo A           vI;LekfHkfjg Øes.k fof/koRlaik|rs lkaçra\&  rFkk rhozrkekfLFkrk;ka rq o\"kZ};knso i¥~pRoesrhg jksxh           rr~ çhR;k jlo`f)gkfutxnkuka Roa lekd.kZ; AA 3AA  AA 10 AA            HkkokFkZ \& xzhok esa Loj;U= ds lehi jgus okyh tks   HkkokFkZ \& bl jksx dh e`nq voLFkk gksus ij 1 o\"kZ ds ckn           pqfYydk uke dh çfUFk gksrh gS mlls tks jl fudyrk   jksxh LoLFk gks tkrk gS vkSj jksx dh rhoz voLFkk gksus           jgrk gS og 'kjhj ds fy;s vR;Ur ykHkçn gksrk gSA jksx   ij nks o\"kZ ds ckn ej tkrk gS AA 10 AA           ds jgL;osÙkk yksx mä xzafFk lacU/kh nks jksxksa dk o.kZu   vkb;s vc myxedema dh ppkZ djrs gSaA ek/ko funkua           djrs gSaA mlesa jl dh o`f) ds dkj.k gksus okyk igyk   esa bl dk vR;ar lVhd ukedj.k fd;k x;k gS \&           jksx ^cfgusZ= xyx.M* uked gksrk gS vkSj nwljk jl dh   'ySf\"edknZza 'kksFkA           deh ls gksus okyk jksx rhu çdkj dk gksrk gS\& 1-                                                                  'ySf\"edknZza'kksFkfunkue~                                                                  'ySf\"edknZza'kksFkfunkue~           'ySf\"edknZz'kksFk]2- okeurk ¼ckSukiu½ vkSj 3- xyx.M*   'ySf\"edknZza'kksFkfunkue~                                                                     rL; ifjp;%                                                                     rL; ifjp;%           buesa vfUre tks ^xyx.M* jksx gS mlesa lcls vf/kd          rL; ifjp;%           pqfYydkxzfUFk dh o`f) fn[kkbZ iM+rh gS AA1\&3॥  xns 'ySf\"edknZzk[;'kksFks fo'ks\"kkn~ HkosPpqfYydkxzfUFktkrL;                                                      uwueA ~           Exopthalmic goiter dk cgqr gh lVhd ukedj.k bl           xzUFk esa fd;k x;k gS] ^cfgusZ= xyx.M* vFkkZr ,d ,slk   jlL;kf/kdk ghurk·Fkks Ropk;ka rFkk 'ys\"eyk;ka dyk;ka           xyxaM ¼xkW;Vj½ ftlesa us= ckgj fudy vkrs gSaA bldk   ujs\"kq AA 12 AA           funku dSls dj ldrs gSa mldk fooj.k bl çdkj fn;k   vfi LFkwyrk xkSjoa psUæyqIrksn~Hkoks ekulL;kfi dk;L;           x;k gS %                                   'kh?kze~ A                                                      XII","; y                                                                      rL; y{k.ke                                                                             e           HkkokFkZ \& 'ySf\"edknZza 'kksFk  (myxoedema) jksx esa       r r L L ; y { { k k . . k k e ~ ~ ~           pqfYydk xzfUFk ds jl dh vf/kd gkfu gksrh gS vkSj Ropk   xnkjEHkdkys lnSokolknks Hk`'ka ekuls Hkz\"Vrk·fi Le`rs'p           rFkk 'ys\"ey dyk esa LFkwyrk rFkk xkSjo gksrk gS ,oa   A           bUæyqIr  dh  mRifÙk  rFkk  'kkjhfjd  vkSj  ekufld   rr%  loZ'kk[kklq  ihMks)oks·Fkks  Hkosn~  xkSjoa  orZ~euks           fØ;kvksa  esa  vR;Ur  eUnrk  mRiUu  gks  tkrh  gS   e.Mys·fi AA 17 AA           AA12\&13AA                                  Ropk LFkwyHkkoa xrk pkfr'kq\"dk [kjLi'kZ;qäk ç–';rs                          rL; p dkj.ke~                         rL; p dkj.ke~                uwue~ A                         rL; p dkj.ke~           Hkosr~ dkj.ka 'ySf\"edknZzk[;'kksFkke;L;ksn~Hkos –';ekua   fo—R;k·fUork% LFkkSY;ekIrk fo'kq\"dk% ifjHkzaf'ku'pkfi           fo'ks\"kkr~A                                ds'kk Hkos;q% AA18 AA           ija pqfYydkxzfUFkfu\"dklua oS Lo;a uk'k ,okFkok·L;k   rrks·frço`)s xns jksfxnsgs xq#Roa p ew<RoeqRi|rs·)k A           vdLekn~ AA14 A                             eq[ka pk;ra LFkwyrk nh?kZrk·fi çtk;sr nUrPNn}U}e/;s           rFkk  iq#\"kkis{k;k  L=h\"kq  lIrxq.kkf/kD;on~  –';rs   AA 19 AA           jksxtUeA                                   rFkk  x.M;ks  jfäek  d.kZikY;ka  xq#Roa  p  jksE.kka           fHk\"kfXHk'p dSf'pUerks·;a dqyksRFkLrFkSfr çdk'ka Hk`'ka   ifj{kh.krk·fi A           çkS<rk;ke~ AA 15 AA                        vFk  LFkwyrk  gLr;ks%  ikn;ks'p  f}tkuka  rq  ikrks                                                      erseZUnrk L;kr~ AA 20 AA           HkkokFkZ \& 'ySpqfYydk xzfUFk dk ,d ne fudky nsuk ;k   HkosfnfUæ;k.kka ân% {kh.krk·fi çtkrs Hk`'ka nk#.ks·fLeu~           Lo;a mldk vdLekr~ u\"V gks tkuk 'ySf\"edknZz 'kksFk   xns rq A           uked jksx ds fo'ks\"k dkj.k gSA ;g jksx iq#\"kksa dh vis{kk   ruqLFkkf;rkiL; ekuL; r}r~ {kq/kks eUnHkkoks·fi Hkwezk           fL=;ksa esa 7 xquk vf/kd gksrk gSA AA14\&15 AA  focU/k% AA21 A           ;gk¡ /;ku nsus ;ksX; rF; ;g gS fd myxedema jksx   HkkokFkZ \& jksx dh çkjEHkkoLFkk esa eu esa volkn vkSj           fL=;ksa esa iq#\"kksa dh rqyuk esa gksus dh laHkkouk 5-7 xquk   Le`fr dk Hkza'k gks tkrk gSA blds ckn lHkh 'kk[kkvksa           vf/kd gksrh gSA vk/kqfud 'kks/kksa esa Hkh ;gh lEHkkouk   ¼gkFk\&iSjksa½ esa ihM+k gksus yxrh gS vkSj iydksa esa Hkkjhiu           feyrh gSA vkxs bldks vkSj Hkh foLr`r :i ls le>k;k   gks tkrk gSA Ropk eksVh gksdj vR;Ur 'kq\"d rFkk [kj           x;k gSA                                    Li'kZ ;qä fn[kkbZ iM+us yxrh gSA ds'k fo—r] LFkwy]                        rL; laçkIrsjorkj%             'kq\"d vkSj iru'khy gks tkrs gSaA jksx ds vf/kd c<+ tkus                        rL; laçkIrsjorkj%                        rL; laçkIrsjorkj%                                                      ij 'kjhj esa xq#rk vkSj ew<rk mRiUu gks tkrh gS ,oa           vUr%LFkk jldkjdk% çdfFkrk ;s pqfYydk;k /#oa                                                      jksxh dk eq[k pkSM+k vkSj vksB eksVs rFkk cM+s gks tkrs gSaA           Hkkxk xzfUFkHkokLr ,o fg xns xPNfUr p {kh.krke~ A  diksyksa ij jfäek] d.kZikyh esa xq#rk] jkseksa dh {kh.krk]           'ys\"ek ;LRox/k: fLFkrks·fi p Hkosr~ lks·R;Uro`f)a   gkFk\&iSjksa dh LFkwyrk] nk¡rksa dk fxjuk] cqf) dh eUnrk           fRo;kr~                                    vkSj bfUæ;ksa rFkk ân; dh {kh.krk gksrh gSA bl jksx dh                                                      nk#.k voLFkk gksus ij 'kjhj dk LFkk;h rkieku rFkk           rLekÙod~ çfoyksD;rs ç—frr% LFkwyk dyk 'ys\"eyk           AA16 AA                                    Hkw[k nksuksa eUn gks tkrs gS vkSj focU/k ¼c)dks\"Brk½ gks                                                      tkrk gS AA 17\&21॥           HkkokFkZ \& pqfYydk xzfUFk ds vUr%fLFkr jldkjd vo;o           'ySf\"edknZz'kksFk esa {kh.krk dks çkIr gks tkrs gSa vkSj Ropk   Myxedema ds y{k.kksa dk blls csgrj           ds uhps tks 'ys\"ek ¼esn½ jgrk gS og vR;Ur o`f) dks   fooj.k vkidks ugha feysxkA           çkIr gks tkrk gS ftlls Ropk vkSj 'ys\"ey dyk LFkwy   Hkkjrh; euhf\"k;ksa dks ;g rd Kkr Fkk fd myxedema           fn[kkbZ iM+us yxrh gS AA16AA                                                    XIII","ls fL=;ksa esa ck>¡iu gks ldrk gSA         {kh.krk rFkk dke'kfä dh eUnrk fo'ks\"k :i ls bl jksx           mxzn'kk;keL; xnL; cU/k;kRoa ;ksf\"kRlq fof'k\"; A  esa mRiUu gksrh gS AA 26\&30AA           loZ=Soa cgq'kks –\"Va rLek}S|Sfjg fufnZ\"Ve~ AA 22 AA  okeu jksx gksus ds dkj.k ij çdk'k Mkyrs gq, vkxs            fL=;ksa esa bl jksx dh mxzrk gksus ij vf/kdrj cU/;kiu   o.kZu gS           gks tkrk gS AA22AA                                       rL; dkj.kfunsZ'k%                                                                    rL; dkj.kfunsZ'k%                                                                    rL; dkj.kfunsZ'k%           xzUFk esa cretinism dh Hkh foLr`r           tkudkjh  nh  x;h  gSA  bls  okeu           vktUeuks Hkofr ;L; u pqfYydk[;ks xzafFkLrukoFk p           ¼ckSuk½ jksx dgk x;k gSA                   rn~HkonqcZyRoe~ A                                                      rfLeUujs  fu;erks  uuq  okeuRoa  rLekfUufeÙkr                         okeujksxfunkue~                         okeujksxfunkue~                         okeujksxfunkue~              bgksfnreso fo|kr~ AA 24 AA                          rL; ifjp;%                          rL; ifjp;%                          rL; ifjp;%                  xyx.Mxnsu jksfx.k% dqychtL; p nq\"Vrk lnk A                 'kjhjekughurk rFkk·frcqf)eUnrk A     vfi ns'kfo'ks\"krk·L; oS tuus L;kr~ lgdkfj dkj.ke~ AA             miLFklw{erk Hkosr~ lnk xns rq okeus AA 23AA  25 AA           'kjhj dh yEckbZ esa deh] cqf) dh vR;Ur eUnrk]   ftlds 'kjhj esa tUe ls gh pqfYydk uked xzfUFk ugha           fy³~xsfUæ;  dk  NksVk  gksuk  ;s  ç/kku  y{k.k  okeu   gksrh fdaok og nqcZy gksrh gS ml euq\"; esa okeu jksx           (cretinism) jksx esa gksrs gSa AA 23 AA    fu;er% mRiUu gksrk gSA bl jksx esa xyx.M jksx ls dqy            okeu jksx ds y{k.kksa dh foLr`r O;k[;k bl çdkj dh   ds cht dk nwf\"kr gksuk vkSj vkuwikfnfof'k\"V ns'k dks           x;h gS                                     fo'ks\"krk ;s nksuksa lgdkfjdkj.k gksrs- gS AA 24\&25AA               ç'kwus p uklkiqVs orqZya oS Hkosnkuua ukfldk   bu 'yksd esa dqN rF; /;ku nsus ;ksX; gSaA blesa fy[kk                           pk;rk·fi                   x;k gS fd ;fn ekrk x‚;Vj ¼bls myxedema le>sa½            yykVa fo'kkya rFkSokS\"B;qXea lnk ihoja ihojk·Fkks   jksx ls ihfM+r gks rc mlls dqy dk cht nwf\"kr gksus dh                        jlKk AA 21 AA                 lEHkkouk gksrh gS vkSj tUe ysus okys f'k'kq esa okeurk            eUnrk çk;'k'p ç.kk'k% Le`rsjsoeqxzRoekIrs xns rq  gks ldrh gSA                    çHksn% LojL;k= esn% leqRFk:       vkt ge foetal origin of adulthood disease dh                çtksRifÙkdkjhfUæ;{kh.krk p AA 30 AA   ckrsa dj jgs gSa vkSj lkroha 'krkCnh dk ;g lkfgR;             rFkk tk;rs dke'käs'p ekU|a o'ks\"kknxns okeus   bldks brus le; iwoZ bafxr dj pqdk FkkA                            uwuesoA                                                      blesa ,d 'kCn ^^vkuwikfnfof'k\"V ns'k** dk fd;k x;k           iwoZ esa 'ySf\"edknZz 'kksFk uked jksx ds ftrus y{k.k dgs   gSA vkuwi dk vFkZ gS og LFkku tgk¡ ty dh vf/kdrk gS           gq;s gSa] os gh lc okeu jksx esa Hkh O;ä gksrs gSaA fo'ks\"kr%   ¼vFkkZr rjkbZ dk {ks=½A xkS= ds nks çeq[k {ks= gSa]           blesa lHkh vax esn ls Hkjs gq;s rFkk NksVs\&NksVs gks tkrs gSa   fgeky; ,oa ,aMht ioZr {ks=A bl çdkj ge ns[krs gS fd           vkSj nksuksa tk¡?kksa rFkk ckgqvksa esa Vs<+kiu rFkk mnj esa   bl xzUFk esa HkkSxksfyd {ks=ksa dk Hkh lVhd fooj.k fn;k           vR;f/kd xq#rk] Ropk [kj Li'kZokyh] vR;Ur f'kfFky   x;k gSA ;|fi Hkkjrh; vk;qosZn vkSj mlls lEcaf/kr           rFkk LFkwy] nksuksa uFkqus Qwys gq;s] eq[k xksykdkj] ukd   'kkL=ksa esa ge ns[krs gSa dh Fkk;jkW;M xzafFk ds fodkj ,oa           pkSM+h] yykV fpiVk] nksuksa vksB vkSj ftºok eksVh gksrh   muds y{k.kksa dh foLr`r tkudkjh nh x;h gS ysfdu           gS rFkk cqf) dh eUnrk vkSj Le`fr dk uk'k gks tkrk gSA   mldh lVhd pathogenesis dh tkudkjh dk vHkko           bl jksx dh mxzrk gksus ij esnkst LojHksn gks tkrk gS   gSA vkSj og LokHkkfod Hkh gS D;ksafd rRdkyhu foKku           ¼iw-i`- †04½ A lUrku dks mRiUu djus okyh bfUæ; esa   vf/kdka'kr;%  yk{kf.kd  Fkk  tcfd  vktdk  çeq[kr%                                                    XIV","çk;ksfxdA ,d le; Fkk fd Fkk;jkW;M gkWeksZu dk ekiu   bl ys[k esa dqN vR;f/kd egRoiw.kZ Vkbe ykbu dks           dqN pqfuUnk mPph—r dsaæksa rd gh lhfer Fkk vkSj   ladfyr djus dk ç;kl fd;k x;k gSA ;fn vki vkSj           fjiksVZ vkus esa g¶rksa yx tkrs FksA vc dqN feuVksa esa ge   vf/kd v/;;u djus esa :fp j[krs gS rks opqZvy           ;g tkap dj ldrs gSaA tkap ds vk/kkj ij vkS\"kf/k dh   ykbczsjh vki dh çrh{kk dj jgh gSA           ek=k dk lVhd vkdyu dj ldrs gSaA thukse çkstsDV           vkSj tsfufVd bathfu;fjax ds ek/;e ls vc ,fDVo   esjs ys[ku ds eq[; lzksr fuEu gSa \&           Fkk;jkW;M QkWfydy dk l`tu LVse dksf'kdkvksa }kjk           djus esa oSKkfudksa us lQyrk çkIr dj yh gS vkSj blus   https://www.thyroid.org           Hkfo\"; esa Fkk;jkW;M jksx esa LVse lsy fFkjSih dh laHkkouk   https://www.hindawi.com/journals/jtr/2011/80                                                      9341/           dks cy fn;k gSA                                                      ek/kojksxfunkua] pkS[kEck çdk'ku] iksLV ckWDl 1150                                                                                                         XV","lefiZr                                               lefiZr                                               lefiZr                                               lefiZr                                               lefiZr                                               lefiZr                             izkphu dky ds lHkh _f’k eqfu;ksa ls ysdj vk/kqfud dky ds mu                             lHkh egkiq:’kksa dks] ftUgksaus fpfdRlk ds fofHkUu vk;keksa dk                             vfo’dkj fd;k ,oa mUgsa bl Kku ds vfHkykf’k;ksa dks lqyHk djkus                              ds fy, viuk\&viuk ;FkklaHko ;ksxnku fn;kA                                                                                            XVI","[kaM\&1                                                             Fkk;jkW;M xzafFk dh lajpuk                           (Basic Anatomy of The Thyroid Gland)","1       Fkk;jkW;M xzafFk dh lajpuk                      Basic Anatomy of The Thyroid Gland             Fkk;jkW;M xazfFk ,d egÙoiw.kZ baMksØkbu gkWeksZu dh xazfFk   ANATOMICAL POSITION           gS tks xys ds vxzHkkxds fupys Hkkx esa fLFkr gksrh gSA   Fkk;jkW;M xazfFk] xys ds vxzHkkx ds fupys Hkkx esa fLFkr           Fkk;jkW;M ds ukedj.k ds fo’k; esa ,d jkspd rF; ;g   gksrh gSA xys esa bldh okLrfod fLFkfr dks crkus ds fy,           gS fd izkjEHk esa ;g uke larynx ds thyroid cartilage   gesa fdlh fuf”pr fpUg dh enn ysuh iM+rh gS] ftlds           dk j[kk x;k Fkk tks xys ds vkxs ,d dop dh Hkkafr xys   rkSj ij lehi esa fLFkr fdlh soft tissue tSls larynx           ds van:uh vaxks dh j{kk djrk gS (xzhd thureos =   ,oa  trachea  vFkok  fixed  bony  tissue  tSls           dop] suffix-oid = dh Hkkafr)A D;ksafd Fkk;jkW;M xazfFk   vertebral column dh enn yh tk ldrh gSA           Hkh Fkk;jkW;M dkfVZyst dh Hkkafr xys ds vkxs gh ,d           dop dh Hkkafr gh j[kh jgrh gS (;|fi dkfVZyst dh   Soft tissues ds vk/kkj ij Fkk;jkW;M xazfFk dk Åijh           Hkkafr n`<+ rks ugha gksrh) blfy, bls Hkh Fkk;jkW;M uke ns   fljk larynx ds Fkk;jkW;M dkfVZyst ds e/; rd igq¡prk           fn;k x;kA                                  gS  tcfd  fupyk  fljk]  pkSFks  ;k  ik¡pos  tracheal                                                      cartilage ds Lrj rd A           EXTERNAL MORPHOLOGY                                                      Bony  tissues ds vk/kkj ij Fkk;jkW;M xazfFk] Åij           Fkk;jkW;M xazfFk dk otu yxHkx  25  xzke ,oa jax   ik¡poh ;k lkroha cervical vertebra (C5-C7) ,oa           Hkwjk\&yky gksrk gSA blds nks yksc gksrs gSaA izR;sd yksc   uhps igyh thoracic vertebra (T1) ds e/; fLFkr           fdlh “kadq (cone) ;k fijkfeM ds vkdkj dk gksrk gS   gksrh gSA           ftldh yEckbZ  (vertical  length) yxHkx  5  lseh,           pkSM+kbZ (transverse width) yxHkx 3 lseh ,oa eksVkbZ   COVERINGS OF THE THYROID GLAND           (anteroposterior thickness) yxHkx 2 lseh gksrh   Dissection ds nkSjku Fkk;jkW;M xazfFk] nks vyx vyx           gSA ;g nksuksa yksc vertically lh/ks u gksdj dqN ihNs dh   vkoj.kksa ls f?kjh feyrh gSA bUgsa Fkk;jkW;M xazfFk ds           vksj (laterally) >qds gksrs gSa ftlls muds Åijh fljksa   dSIlwy dgrs gSaA           (superior  poles)  ds  chp  dh  nwjh]  fupys  fljksa   Outer  false  capsule  - “kjhj esa fofHkUu  soft           (inferior poles) ds chp dh nwjh ls vf/kd gksrh gSA   tissues, fibrous fascial sheets ds }kjk gh vius                                                      vius LFkku ij O;ofLFkr jgrs gSaA xys esa ;gh dk;Z           vius fupys Hkkx esa ;g nksuksa yksc, e/; js[kk ij fLFkr           isthmus ds }kjk ijLij tqMs+ jgrs gSaA Isthmus dh   deep cervical fascia djrk gSA Fkk;jkW;M xazfFk blh           yEckbZ ,oa pkSM+kbZ nksuksa yxHkx 1.25 lseh gksrh gSA   dh pretracheal layer }kjk f?kjh jgrh gSA xzafFk ds                                                      pkjksa  vksj  ds  blh  fibrous  capsule  dks  false           vf/kdka”kr% ;g nwljh ,oa rhljh (dHkh\&dHkh pkSFkh)           tracheal rings ds lkeus fLFkr gksrk gSA    capsule dgrs gSaA ;gk¡ false “kCn bl ckr dk |ksrd                                                      gS fd bl dSIlwy dk Fkk;jkW;M xzafFk ls dksbZ lEcU/k ugha           iq:’kksa dh rqyuk esa ;g Fkk;jkW;M xazfFk efgykvksa esa   gSA blh false capsule dk xzafFk ,oa trachea ds e/;           vf/kd cM+h gksrh gSA ekfld /keZ (menstruation) ,oa   fLFkr  fiNyk  Hkkx]  vis{kkd`r  vf/kd  eksVk  gksdj           xHkkZoLFkk ds nkSjku ;g vkSj Hkh vf/kd c<+ tkrh gSA  suspensory ligament of Berry cukrk gSA blh ds           Isthmus vFkok fdlh ,d yksc ls dHkh dHkh ,d  }kjk Fkk;jkW;M xazfFk cricoid cartilage ls tqM+h jgrh gS           vfrfjDr “kadq ds vkdkj dk mHkkj ckgj fudyk gksrk  ,oa Hkkstu fuxyus ds le; cricoid cartilage ds Åij           gS ftls pyramidal lobe dgrs gSaA           mBus ds lkFk Lo;a Hkh Åij mBrh gSA Hkkstu fuxyus ds                                                      2","le; bldk Åij mBuk] vkdkj esa c<+h gqbZ Fkk;jkW;M   blds nks ckWMZj gksrs gSa \& anterior ,oa posterior           xazfFk (goiter) ;k blesa mRiUu gksus okyh fdlh xkaB   Apex - Fkk;jkW;M xazfFk ds nksuksa yksc ds dqN frjNs gksus           ¼ukWM~;wy½ dks xys dh vU; xkaBksa ls vyx igpkuus esa   ds  dkj.k  muds  Åijh  fljs  FkksM+s  ckgj  dh  vksj           enndkjd gksrk gSA                          (laterally)  fudys  gksrs  gSaA  izR;sd  yksc,  dsUnz  esa            Suspensory  ligament  of  Berry  ds  vfrfjDr   (medially) larynx ds Fkk;jkW;M dkfVZyst ,oa ik”oZ esa           Fkk;jkW;M xazfFk dHkh\&dHkh ,d Qkbczl vFkok Qkbczks   (laterally)  sternothyroid  muscle  ds e/; fLFkr           eLdqyj cSaM ls Hkh tqM+h gks ldrh gS tks bls Åij dh   jgrk gSA blh ds lehi ls superior thyroid artery            vksj  [khaprh  gSA  bls  levator  of  thyroid  gland   ,oa external laryngeal nerve xqtjrh gaSA           (levator  glandae  thyroideae)  dgrs  gSaA  ;g   Base - ;g pkSFkh ;k ikapoh tracheal ring ds Lrj ij           isthmus ds Åijh Hkkx dks hyoid bone ls tksM+rh gSA                                                      fLFkr gksrk gS blh ds lehi ls inferior thyroid artery           Inner true capsule - Outer false capsule ds   ,oa recurrent laryngeal nerve xqtjrh gSaA           Hkhrj Fkk;jkW;M dk inner  true  capsule gksrk gSA   Lateral and superficial surfaces - xys ds vxys           Fkk;jkW;M xazfFk dk ckgjh Hkkx gh ?kuk gksdj bldk   Hkkx dh lHkh ekalisf”k;ka] nksuksa Fkk;jkW;M xazfFk ds Åij           fuekZ.k djrk gS ftlds dkj.k gh bls Fkk;jkW;M dk   ls  xqtjrh  gSaA  dsUnz  ls  ckgj  dh  vksj  ;g  gSa]            true  capsule  dgrs  gSaA  Superior  ,oa  inferior                                                      sternohyoid,  superior  belly  of  omohyoid ,oa           thyroid  arteries ls cuus okyk dense  capillary   sternothyroid  rFkk  bu  lc  ds  Åij           plexus, blh true capsule ds Hkhrj fLFkr gksrk gSA   sternocleidomastoidA           blfy, Fkk;jkW;M xazfFk dks fudkyus (thyroidectomy)           ds le; bl capillary  plexus dks cpkus ds fy,   Medial surface - Fkk;jkW;M ds nksuksa yksc, trachea           lEiw.kZ Fkk;jkW;M xazfFk dks blds true capsule lesr gh   ,oa esophagus ij gh fLFkr gksrs gSaA pkj lajpuk,a           ckgj fudky fy;k tkrk gSA                   Fkk;jkW;M xazfFk rFkk trachea ,oa esophagus ds e/;                                                      fLFkr  gksrh  gSaA  ;g  gSa]  inferior  constrictor  of                                                      pharynx,  cricothyroid  muscle,  external           PARTS OF THE THYROID GLAND                 laryngeal nerve ,oa recurrent laryngeal nerve.           AND THEIR RELATIONS                        ;gh  pkjksa]  Fkk;jkW;M  ds  nksuksa  yksc  ds  medial           Fkk;jkW;M xazfFk ds eq[;r% rhu Hkkx gksrs gSaA nksuksa vksj   relations cukrh gSaA           fLFkr nks Fkk;jkW;M xzafFk ,oa budks tksM+us okyk e/; esa   Posterolateral surface - ;g carotid sheath ds           fLFkr  isthmusA  blesa  dHkh\&dHkh  ,d  rhljk   lEidZ esa jgrh gS tks uhps common carotid artery           fijkfeMy yksc Hkh feyrk gS tks vius uke ds vuq:i   ,oa Åij  internal  carotid  artery  rFkk  internal           fijkfeM ;k “kadq ds vkdkj dk gksrk gS ,oa isthmus ;k   juglar vein ,oa vagus nerve dks ?ksjs j[krh gSaA bu           fdlh ,d yksc ds Åijh Hkkx ls yxk jgrk gSA   lc esa carotid artery gh lcls dsUnz esa gksus ds dkj.k           Lobes - Trachea ds nksuksa vksj fLFkr nk;sa ,oa ck;sa   posterolateral surface ds lh/ks lEidZ esa jgrh gS           yksc gh Fkk;jkW;M xazfFk dk eq[; Hkkx cukrs gSaA blds   ,oa Fkk;jkW;M ds nksuksa yksc dk lateral relation cukrh           izeq[k Hkkx fuEufyf[kr gSa \&               gSA           Ends - blds nks fljs gksrs gSa \& Åijh apex ,oa fupyk           base                                       Anterior  border  - ;g vis{kkd`r iryk gksrk gS           Surfaces - bldh rhu lrgsa gksrh gSa \& lateral ;k   ftlij ls gksdj gh superior  thyroid  artery dh                                                      anterior branch Åij ls uhps mrjrh gSA           superficial, medial ,oa posterolateral Borders -                                                      3","Posterior border - ;g vis{kkd`r vf/kd pkSM+k  esVkckWfyTe dh n`f’V ls vR;ar lfØ; gksus ds dkj.k           gksrk gS ftl ij ls gksdj superior thyroid artery  Fkk;jkW;M xzafFk ,d vR;ar vascular structure gksrh           dh posterior branch Åij ls uhps mrjrh gSA blds  gSA okLro esa] otu ds vuqlkj] Fkk;jkW;M xzafFk dk           fupys Hkkx ls gksdj inferior thyroid artery Åij dh   blood flow (4-6 ml/min/g),  renal blood flow (3           vksj c<+rh gS rFkk superior  thyroid  artery dh   ml/min/g)  ls Hkh  vf/kd gksrk gSA ;g  vascular                                                      supply, Fkk;jkW;M xzafFk esa cuus okys Fkk;jkW;M gkWeksZUl           posterior branch ls anastomose djrh gSA Left           lobe ds posterior border ds lEidZ esa thoracic   dks “kjhj ds fofHkUu vaxksa rd igq¡pkus esa lgk;d gksrh           duct Hkh jgrh gSA                          gSA Fkk;jkW;M xzafFk dh arterial  supply eq[;r% nks                                                      arteries }kjk iw.kZ gksrh gS] superior thyroid artery           Isthmus - Hkwxksy esa isthmus, ikuh ls f?kjh Hkwfe dh   ,oa inferior thyroid arteryA buds vfrfjDr] 3%           ,d ladjh iV~Vh dks dgrs gSa tks fdUgh nks cM+s Hkw[k.Mksa                                                      O;fDr;ksa esa ,d rhljh thyroidea ima artery ,oa           dks ijLij tksM+rh gSA Fkk;jkW;M xzafFk esa nksuksa lateral   vU; accessory thyroid arteries Hkh fey ldrh gSA           lobes dks tksM+us dk ;gh dk;Z djus ds dkj.k bldk           e/; Hkkx isthmus dgykrk gSA                Superior thyroid artery - ;g  external carotid                                                      artery dh igyh anterior branch gS tks fudyus ds           Surfaces   - bldh nks lrgsa gksrh gSa] anterior ,oa   ckn external laryngeal nerve ds lkFk\&lkFk pyrh           posterior                                  gSA Fkk;jkW;M xzafFk ds Åijh fljksa ij igq¡p dj ;g           Borders  -  blds nks ckWMZj gksrs gSa  superior ,oa   vxyh ,oa fiNyh nks “kk[kkvksa esa caV tkrh gSA           inferior           Anterior surface - ;g fuEufyf[kr lajpukvksa ds     Anterior Branch, Fkk;jkW;M yksc ds vxys ckMZj ds           lEidZ esa vkrh gSA                         lkFk\&lkFk uhps mrjrh gqbZ isthmus ds Åijh ckMZj ij                                                      igq¡prh  gS  tgk¡  nksuksa  vksj  dh  czkap  ijLij           Right  ,oa  left  sternothyroid  ,oa   sternohyoid   anastomose dj ysrh gSaA            muscles,  tks  sternum  ls  fudydj  thyroid           cartilage ,oa hyoid bone rd tkrs gq, isthmus dks     Posterior Branch, Fkk;jkW;M yksc ds fiNys ckMZj ds           vkxs ls <d ysrh gSaA                       lkFk lkFk uhps mrjrh gS tgk¡ ;g inferior thyroid                                                      artery  dh  ascending  branch  ds  lkFk           Anterior jugular veins, tks median plane ds nksuksa   anastomose dj ysrh gSA           vksj pyrh gSaA bu lcds Åij skin ,oa superficial           cervical fascia A                          Inferior thyroid artery - ;g  subclavian artery                                                      ds thyrocervical trunk ls fudyrh gSA igys Åij           Posterior surface - ;g trachea dh nwljh] rhljh   ,oa fQj uhps dh vksj pyrh gqbZ ;g vkVZjh] xzafFk ds           ,oa pkSFkh tracheal rings  ds lEidZ esa jgrh gSA  fiNys ckMZj ds fupys Hkkx rd igq¡prh gS tgk¡ ;g           Upper border - Fkk;jkW;M xzafFk vxys ckWMZj ls uhps   recurrent laryngeal nerve ds vR;ar lehi jgrh gSA           mrjrh gqbZ right  ,oa left superior thyroid arteries,   ;gk¡ igq¡pdj ;g 4-5 glandular branches esa caV           isthmus ds Åijh ckWMZj ij igq¡p dj ;gha ,d nwljs ls  tkrh gS tks vyx vyx LFkkuksa ls xazfFk esa izos'k djrh           anastomose djrh gSaA                       gSA bldh ,d ascending branch, xazfFk ds fiNys            Lower border - ;gha ls   inferior thyroid vein,   ckWMZj  ds  lkFk\&lkFk  Åij  dh  vksj  c<+rh  gS  ,oa           Fkk;jkW;M xaazfFk ls ckgj fudyrh gSA       superior thyroid artery dh posterior branch ds                                                      lkFk anastomose djrh gSA ;gh czkap, iSjkFkk;jkW;M              VASCULAR SUPPLY                         xazfFk dks Hkh jDr igq¡pkrh gSA           ARTERIAL SUPPLY                                                     4","Thyroidea ima artery - yxHkx  3% O;fDr;ksa esa gh  fudyrh gS tks  internal juglar vein  esa Msªu  djrh gSA            ikbZ tkus okyh ;g vkVZjh] brachiocephalic trunk                                                      LYMPHATIC DRAINAGE           vFkok arch of aorta  ls lh/ks gh fudydj]  isthmus           ds fupys ckWMZj ls Fkk;jkW;M xzafFk esa izos'k djrh gSA   Fkk;jkW;M xazfFk ds Hkhrj ,oa blds pkjksa vksj fyEQSfVd                                                      oslsYl dk foLr`r tky QSyk gksrk gSA Subcapsular           Accessory  thyroid  arteries  -  ;g  lgk;d   lymphatic plexus loZizFke central compartment           vkVZjht, tracheal vFkok esophageal vkVZjht ls   ds  juxtathyroid  Delphian  ,oa  paratracheal           mRiUu gksdj Fkk;jkW;M xzafFk esa igq¡p ldrh gSaA                                                      nodes esa rFkk superior ,oa  inferior thyroid veins           VENOUS DRAINAGE                            ds lkFk fLFkr fyEQ uksM esa Mªsu djrk gSA ;g var esa           Fkk;jkW;M xzafFk ls venous  drainage eq[;r% rhu   deep cervical nodes ,oa mediastinal nodes esa           osUl ds }kjk fd;k tkrk gS] superior, middle ,oa  Msªu  djrs  gSaA  dqN  fyEQSfVDl]  Fkk;jkW;M  xzafFk  ls           inferior  thyroid  veinsA  dHkh\&dHkh  ,d  pkSFkh  fudydj lh/ks gh  thoracic duct esa Hkh [kqyrh gSaA           Kocher's vein Hkh blesa lgk;d gksrh gSA    budks bl izdkj Hkh ;kn j[kk tk ldrk gS \&            Superior thyroid vein - xazfFk ds Åijh fljs ls     Superiorly - Prelaryngeal nodes esa            fudyus ds i'pkr~ ;g osu] superior thyroid artery           ds lkFk\&lkFk pyrh gqbZ internal juglar vein  esa Msªu     Centrally - Pretracheal ,oa paratracheal nodes           djrh gSA                                   esaA                                                        Laterally - Superior mediastinum esa Fkkbel ds           Middle thyroid vein - xzafFk ds e/; Hkkx ls fudyus             ds i'pkr~ ;g NksVh osu Hkh internal juglar vein  esa Msªu   lkFk  yxs  brachiocephalic  nodesA  bu  lHkh           djrh gSA                                   superficial lymph nodes esa igq¡pus ds i'pkr~ fyEQ                                                      varr% deep cervical lymph nodes esa Msªu gksrk gSA           Inferior thyroid vein - Isthmus ds fupys ckMZj ls                                                      NERVE SUPPLY           fudyus ds i'pkr~ ;g osu] trachea ds lkeus plexus   ,d visceral  organ ds :i esa Fkk;jkW;M xazfFk dk           curk gqbZ left brachiocephalic vein  esa Msªu djrh gSA                                                      innervation autonomic gksrk gS tks bldh vascular           Kocher's vein - dqN O;fDr;ksa esa ;g pkSFkh osu Hkh   supply dks fu;af=r djus (vasomotor function) ds           middle ,oa inferior  thyroid  veins ds chp esa ls                                                      fy, gh vko';d gksrk gSA ;g sympathetic nerves                                                                            5","eq[;r% middle cervical ganglion  ls vkrh gSa ftlesa   vko';drk iM+ ldrh gSA           dqN fibers, superior ,oa inferior cervical ganglia   ltZjh ds le;] jDrlzko dks jksdus ds fy, loZizFke           ls Hkh izkIr gks ldrs gSaA ;g sympathetic fibers,                                                      Fkk;jkW;M oslsYl dks cka/kdj dkV fn;k tkrk gS (ligate           arteries  ds ek/;e ls  arterial  wall  ij  neural   and cut)A /;ku jgs] ;g Fkk;jkW;M oslsYl (vkVZjht           plexus cukrs gq,] xazfFk rd igq¡prs gSaA                                                      ,oa osUl), ,d neurovascular bundle ds :i esa] uoZ                                                      ds lkFk gh fLFkr jgrh gSA  External  laryngeal                                                      nerve, superior thyroid artery ds ,oa recurrent              APPLIED ANATOMY                                                      laryngeal nerve, inferior thyroid artery ds vR;ar           ;kn djsa] lkekU; voLFkk esa pharynx ,oa larynx   lehi gksrh gSA vr% bu oslsYl dks cka/krs ,oa dkVrs           ijLij ,d lh/k esa jgrs gSa ftlls lkal ysrs o NksM+rs   le; bu uoZ dks cpkuk vko';d gksrk gSA           le; ok;q lgtrk ls trachea esa vk\&tk ldsA blds           foijhr] Hkkstu fuxyrs le; pharynx,  larynx ls   Thyroidectomy ds le; dqN lko/kkfu;ksa dks /;ku           gVdj esophagus dh lh/k esa vk tkrk gS ftlls   j[kuk vR;ar vko';d gSA Fkk;jkW;M xazfFk ds vR;ar           Hkkstu dks trachea esa igq¡pus ls cpk;k tk ldsA blds   lfØ; gksus ds dkj.k ;g vR;ar oSLdqyj Hkh gksrh gSA           fy, Hkkstu fuxyrs le; larynx vkxs o Åij mBrs   blfy,] ltZjh ds nkSjku (per-operative) ,oa ltZjh           gq, pharynx dh lh/k ls gV tkrk gSA ge le> pqds gSa   ds  ckn  (post-operative)  gksus  okyk  jDrlzko           fd Fkk;jkW;M xazfFk] suspensory ligament of Berry   thyroidectomy dk izeq[k nq\"ifj.kke gksrk gSA blds           ds }kjk larynx ds cricoid cartilage ls tqM+h jgrh gSA   cpko ds fy, Fkk;jkW;M xzafFk dh lajpuk dh foLr`r           blfy,]  Hkkstu  fuxyrs  le;  og  Hkh  larynx  ds   tkudkjh vR;ar vko';d gksrh gSA           lkFk\&lkFk vkxs o Åij mBrh gSA Hkkstu fuxyrs le;   Fkk;jkW;M xzafFk dh nksuksa izeq[k vkVZjht (superior ,oa           Fkk;jkW;M xzafFk dk bl izdkj vius LFkku ls fgyuk]   inferior  thyroid  arteries), xzafFk esa izos'k djus ds           xkW;Vj dks xys dh vU; xkaBksa ls vyx igpkuus esa   ckn] ijLij feydj xzafFk ds pkjksa vksj ,d vascular           lgk;d gksrk gSA                            plexus dk fuekZ.k dj ysrh gSA jDrlzko dks jksdus ds                                                      fy, bldks {kfrxzLr gksus ls cpkuk vR;ar vko';d           Vascularity - FkkW;jksVkWfDldksfll esa xzafFk ds vf/kd           lfØ; gksus ds dkj.k bldh oSLdqySfjVh bruh vf/kd   gksrk gSA D;ksafd ;g vascular plexus, Fkk;jkW;M xzafFk            c<+ tkrh gS fd bls stethoscope ls bruit  ds :i esa   ds ckgjh Hkkx ds l?ku gksus ls cus true capsule ds                                                      Hkhrj gh gksrk gS vr% bl ckr dk fo'ks\"k :i ls /;ku           lquk tk ldrk gSA dHkh\&dHkh rks ;g thrill  ds :i esa   j[kk tkrk gS fd ltZjh ds nkSjku bl true capsule dks           gkFkksa ls eglwl Hkh dh tk ldrh gSA                                                      fcuk {kfr igq¡pk,] iwjh xzafFk dks cM+h lko/kkuh ls fudky           THYROIDECTOMY                              fy;k tk,A blds fy,] nksuksa thyroid  arteries dks            Fkk;jkW;M dSalj dh fLFkfr esa xzafFk dks iwjh (complete)   cka/kus ,oa dkVus  (ligate and cut) ds ckn Fkk;jkW;M           vFkok  vkaf'kd  :i  (partial)  ls  fudkyus   xzafFk dks deep cervical fascia ls cus false capsule           (thyroidectomy: suffix -ectomy = removal) dh   ,oa blds vius true capsule ds chp ds Lrj ij gh           vko';drk iM+ ldrh gSA blds vfrfjDr] Fkk;jkW;M   dissect  dj  fy;k  tkrk  gSA  bls  gh  plane  of           xzafFk ds vR;f/kd c<+ tkus (large goiter) ls mlds   cleavage dgrs gSaA /;ku jgs] izkWLVsV xzafFk dks fudkyrs           }kjk vxy cxy ds vax (tSls trachea, esophagus,   le; (prostatectomy) ;gh plane of cleavage,           neck veins vFkok recurrent laryngeal nerve) ij   izkWLVsV ds true capsule ds Hkhrj gh j[kk tkrk gS           ncko Hkh iM+ ldrk gS ftlds fy, Hkh ltZjh dh   D;ksafd izkWLVsV xzafFk dk vascular plexus, blds inner                                                       6","true capsule ,oa outer false dSIlwy ds chp esa gksrk  ls cpk;k tk ldsA           gSA  nksuksa  dSIlwy  dks  NksM+dj]  izksLVsV  ds  dsoy           glandular part dks gh fudkyus dh bl izfØ;k dks           enucleation dgrs gSaA                        HISTOLOGY OF THE THYROID GLAND                                                      Fkk;jkW;M xazfFk dh ckgjh lajpuk le>us ds i'pkr~           RECURRENT LARYNGEAL NERVE                                                      vkb;s] bldh lw{e lajpuk dks foLrkj ls le>rs gSaA           Brain stem ls mRiUu gksus ds i'pkr~ uhps mrjrs gq,           vagus nerve, xys ds fupys Hkkx esa ,d 'kk[kk mRiUu   Fibrous  capsule  - Fkk;jkW;M xazfFk pkjksa vksj ls           djrh gS tks larynx dks lIykbZ djus ds fy, nksckjk   fibrous  fascia  ls f?kjh jgrh gS tks bldk  false           Åij p<+rh gSA mRifÙk ds i'pkr~] igys uhps ,oa fQj   capsule  cukrk gSA blh  fascia  ls fudyus okys           Åij] nks foijhr fn'kk esa pyus ds dkj.k gh bls   fibrous septa, xzafFk ds vanj izos'k djds bldks vusd           recurrent laryngeal nerve (RLN) dgrs gSaA  Hkkxksa esa foHkDr dj nsrs gSa ftUgsa ykWC;wYl  dgrs gSaA            /;ku jgs] nk;ha ,oa ck;ha fn'kkvksa dh uoZ esa ,d eq[;   Thyroid lobule - izR;sd Fkk;jkW;M ykWC;wy ,d vyx           varj gksrk gSA xnZu ds fiNys Hkkx ls fudyus ds ckn]   vkVZjh ls jDr izkIr djrk gSA dk;Z dh n`f\"V ls Hkh           vkxs vkus ds fy, bl uoZ dks xys dh oslsYl ds uhps ls   izR;sd Fkk;jkW;M ykWC;wy ,d nwljs ls vyx\&vyx            pDdj dkVrs gq, fudyuk iM+rk gSA  ck;ha  vksj  ;g   {kerkvksa  ij  dk;Z  dj  ldrk  gSA  blh  dkj.k  ls           aorta  ds  uhps  ls  fudyrh  gS  tcfd  nk;ha  vksj   Fkk;jkW;M ykWC;wy dks Fkk;jkW;M dh functional unit  Hkh           subclavian artery dsA bl varj ds dkj.k ls ck;ha   dgrs gSaA           ,oa nk;ha RLN ds ekxZ (course of nerve) esa Hkh varj   Microscopic examination esa fdlh ykWC;wy dk eq[;           vk tkrk gSA Aorta ds uhps ls fudyus ds fy, left  y{k.k gksrk gS bldh   QkWfydYl (fluid filled sac)A           RLN dks vis{kkd`r vf/kd uhps ,oa dsUnz dh vksj  ;gh  Fkk;jkW;M  QkWfydYl,  Fkk;jkW;M  xazfFk  dh           mrjuk iM+rk gS ftlds dkj.k bldk ekxZ vf/kd yEck   structural units cukrh gSA izR;sd ykWC;wy esa 20-40           gks tkrk gS ,oa ;g trachea ds vf/kd lehi ls xqtjrh  Fkk;jkW;M QkWfydYl fey ldrs gSaA           gSA blds foijhr] right subclavian artery, tks aorta   Thyroid  follicle  -  Fkk;jkW;M  ,fiFkhfy;e  dh           ls Åij dh vksj ls mRiUu gksrh gS] mlds uhps ls   dksf'kdkvksa dh ,d ijr (layer), ijLij xksykbZ esa           fudyus ds fy, right RLN dks de gh uhps mrjuk   tqM+rs gq, Fkk;jkW;M QkWfydYl dk fuekZ.k djrh gSA           iM+rk gS ftlls ;g yEckbZ esa vis{kkd`r NksVh jgrh gS           ,oa dqN vf/kd nk;ha vksj fudyus ds dkj.k trachea           ds nwj ls xqtjrh gSA           viuh mRifÙk ds LFkku ls larynx dh vksj Åij p<+rs            le;] nksuksa vksj dh RLN,  tracheoesophageal           groove ls xqtjrh gSaA ;gha ls xqtjus okyh nks vU;           oslsYl, carotid artery ,oa inferior thyroid artery ds           lkFk feydj ;g ,d f=dks.k cukrh gS ftls Beahrs'           triangle dgrs gSaA Fkk;jkW;M xzafFk dk posterolateral           Hkkx (tubercle of Zuckerkandl)  bls <ds jgrk gSA           ltZjh ds nkSjku Fkk;jkW;M xzafFk ds nksuksa yksc dks gVkdj           budks igpkuk tk ldrk gS ftlls budks {kfrxzLr gksus                                                      7","bldk vkSlr vkdkj yxHkx 200 nm gksrk gSA izR;sd  vf/kd cM+h gksrh gSA cslesaV esEczsu ls yxh ;g cM+h]            QkWfydy  ds  e/;  [kkyh  LFkku  (cavity/sac)  dks  ckgjh lrg] basal ;k basolateral surface  dgykrh           follicular  lumen dgrs gSa ftlesa bu QkWfydy dh  gSA blds foijhr] follicular lumen dh vksj NksVh]           dksf'kdkvksa }kjk fudyus okyk izksVhu;qDr nzOk (fluid),  Hkhrjh  lrg]  apical  surface   dgykrh  gSA  fdlh           dksykW,M (colloid)  Hkjk jgrk gSA Hematoxylin ,oa   glandular epithelium dh Hkkafr bl apical surface           eosin  stained  section  esa  ;g  dksykW,M]  ls vusd microvilli, dksykW,M esa fudyrs jgrs gSaA ;gh           homogenous pink stain ysrk gSA             lrg] vk;ksfMus”ku ,oa dksykW,M ds fuekZ.k esa lfØ;                                                      Hkwfedk fuHkkrh gSA           QkWfydy  dh  dksf'kdk,a  ,d  cslesUV  esEczsu           (basement  membrane)  ij fLFkr jgrh gSa ;gh  QkWfydy dh dksf'kdkvksa esa lkekU;r% fdlh secretory           cslesUV esEczsu] QkWfydy dks blds pkjksa vksj fLFkr   cell ds lHkh y{k.k feyrs gSaA           connective tissue stroma ls vyx j[krh gSA  - ;g vkdkj esa pkSdksj (cuboidal) gksrh gSA                                                      - budk U;wfDy;l] basolateral  surface ds lehi           Thyroid  stroma  -  QkWfydYl ds e/; ds LFkku                                                       jgrk gSA           (interfollicular  space) esa mifLFkr   connective           tissue,  stroma  dgykrk gSA Fkk;jkW;M dks lIykbZ   - U;wfDy;l ds lehi izpqj ek=k esa xzSU;qyj vFkok jQ           djus okyh dSfiyjht] fyEQSfVDl ,oa flEiSFksfVd uOlZ   ,UMksIykfLed  jsfVdqye  (RER)  feyrs  gSa  ftuesa           lHkh  blh  stroma  esa  feyrs  gSaA  blds  vfrfjDr   Fkk;jksXykWC;qfyu izksVhu dk fuekZ.k gksrk gSA           parafollicular C-cells Hkh blh esa fLFkr jgrh gSaA  - bUgha RER ds Åij izpqj ek=k esa xkWYxh ckWMh Hkh                                                       feyrh gSa ftuesa bl Fkk;jksXykWC;qfyu dk izlaLdj.k           FOLLICULAR CELL                             (processing - carbohydrate moiety dk tqM+uk)           /;ku  jgs]  mRifÙk]  lajpuk  ,oa  dk;Z  ds  vuqlkj   gksrk gSA           Fkk;jkW;M xzafFk] fdlh gkWeksZu dh xazfFk ds vis{kk GIT dh   - QkWfydy dh dksf'kdkvksa ds Åijh Hkkx esa vusdksa           xzafFk;ksa ds leku vf/kd yxrh gSA blh izdkj bldh   secretory  vesicles  feyrh  gSa  ftuesa           QkWfydy dh dksf'kdk,a fdlh secretory epithelium   Fkk;jksXykWC;qfyu Hkjk jgrk gSA           ds leku gksrh gSaA fdlh QkWfydy esa dksf'kdk,a ,d ijr   - QkWfydy dh dksf'kdkvksa ds Åijh Hkkx ls fudys           esa ijLij xksykbZ esa tqM+h jgrh gSaA LokHkkfod :i ls bu   microvilli,  follicular  fluid  ds  vo'kks\"k.k           dksf'kdkvksa dh ckgjh lrg] Hkhrjh lrg dh vis{kk   (reabsorption) esa enn djrs gSaA                                                      - bu lHkh esVkckWfyd xfrfof/k;ksa ds fy, ATP miyC/k                                                       djokus ds fy, dksf'kdkvksa esa ekbVksdkWfUMª;k ,oa buds                                                       e/;  (interstitial  tissue)  esa izpqj ek=k esa CyM                                                       dSfiyjht Hkh miyC/k gksrh gSaA                                                           viuh lfØ;rk ds vk/kkj ij QkWfydy dh dksf'kdk,a                                                      vusd vkdkj dh gks ldrh gSa ,oa budh dksf'kdkvksa dh                                                      ljapuk Hkh fHkUu\&fHkUu gks ldrh gSA Fkk;jkW;M xzafFk dh                                                      lfØ;rk c<+us ij ;g dksf'kdk,a vkdkj esa c<+dj                                                      columnar gks tkrh gSaA ,sls esa ;g cM+h rhozrk ls                                                      follicular  fluid vo'kksf\"kr djrh gS ftlls mlls                                                      vf/kd ek=k esa Fkk;jkW;M gkWeksZu izkIr fd;k tk ldsA                                                      Follicular fluid ds ?kVus ls QkWfydYl Øe'k% vkdkj                                                     8","esa NksVh gksrh tkrh gSaA Fkk;jkW;M xzafFk dh lfØ;rk ?kVus   glands,  vk;ksMhu dk viVsd rks djrh gSa ijUrq            ij follicular fluid dk vo'kks\"k.k de gksrk tkrk gS  Fkk;jkW;M xzafFk dks fu;af=r djus okys gkWeksZu thyroid           ftlls mlds tek gksrs tkus ls QkWfydYl vkdkj esa   stimulating  hormone  (TSH) ds izHkko esa ugha           cM+h gksrh tkrh gSaA ,sls esa budh dksf'kdkvksa dh  jgrhaA           lfØ;rk Hkh de gks tkrh gS ftlls og vkdkj esa NksVh   Thyroid  analge  -  Fkk;jkW;M  xzafFk  dh  mRifÙk]           gksrh tkrh gSA c<+rs gq, follicular fluid ds ncko ls   xHkkZoLFkk ds 16osa fnu embryonic pharynx ds floor           cgq/kk ;g flat vFkok squamous vkdkj dh jg tkrh   ij first  pharyngeal  pouch ds e/; Hkkx esa ,d           gSA                                        endodermal  thickening ds :i esa gksrh gS ftls           PARAFOLLICULAR C-CELLS                     thyroid analge dgrs gSaA oL;dksa esa ;g LFkku thHk dh           Parafollicular C-cell dk vFkZ gS QkWfydYl ds lehi  e/; js[kk esa] vxys 2/3 o fiNys 1/3 dh laf/k ij gksrk           feyus okyh dksf'kdk,a (para = lkFk esa ;k vkl ikl)  gS tgk¡ bl mHkkj dks foramen caecum  dgrs gSa tks           tks stromal  connective  tissue esa QkWfydYl dh  okLro esa blh MDV dk vestigeal remnan t gSA           cslesUV esEczsu ls yxh gqbZ fLFkr jgrh gSaA  Thyroglossal duct and lobes of thyroid - dqN            - bUgsa medullary C cells, clear cells vFkok light  le; esa thyroid analge esa ,d xM~<k (pit)  mRiUu            cells Hkh dgrs gSaA                       gksrk gS tks 'kh?kz gh c<+rs gq, ,d diverticulum  ;k           - ;g fo'ks\"k :i ls Fkk;jkW;M xzafFk ds Åijh 1/3 ,oa   duct dk :i ys ysrk gSA bls   thyroglossal duct            fupys 2/3 dh laf/k ij ik;h tkrh gSaA      dgrs gSaA ;g diverticulum uhps c<+rs gq, Øe'k% xys           - QkWfydy  dh  dksf'kdkvksa  dh  Hkkafr  gh  buesa  Hkh  ds fupys Hkkx rd igq¡prk gSA ;gk¡ igq¡p dj bldk            secretory epithelium ds vf/kdk¡'k y{k.k ik;s tkrs  vxyk fljk nks Hkkxksa esa foHkDr gks tkrk gS ftuls            gSaA                                      Fkk;jkW;M xzafFk ds nksuksa yksCl mRiUu gksrs gSaA           buds fo\"k; esa ,d fo'ks\"k rF; ;g gS fd Fkk;jkW;M xzafFk   Lateral lobes of thyroid and parafollicular           esa feyus ij Hkh budh mRifÙk ,oa dk;Z] Fkk;jkW;M xzafFk   C-cells  -  QkWfydy  dh  dksf”kdkvksa  ds  vfrfjDr           ls loZFkk fHkUu gksrs gSaA buds fo\"k; esa foLrkj ls ge   Fkk;jkW;M xazfFk esa QkWfydy ds lkFk gh ik;s tkus okyh           vkxs le>saxsaA                             dqN vU; dksf'kdk,a Hkh gksrh gSa ftUgsa parafolliculac                                                      cells dgrs gSaA ;g parafollicular C-cells okLro esa                                                      embryonic  thyroid ls mRiUu u gksdj]  neural            DEVELOPMENT  OF  THE  THYROID            GLAND           lHkh bUMksØkbu xzafFk;ksa esa loZizFke fodflr gksus okyh           xzafFk Fkk;jkW;M gh gSA dk;Z dh n`f\"V ls Fkk;jkW;M xazfFk]           fdlh baMksØkbu xzafFk dh rqyuk esa GIT dh xzafFk ds           vf/kd  lehi  gksrh  gSA  okLro  esa  Fkk;jkW;M  xzafFk           embryonic  foregut  (endoderm) ls gh fodflr           gksrh gSA GIT dh xzafFk dh Hkkafr blesa Hkh secretory           follicles gksrs gSa ,oa bldh gh Hkkafr dqN GIT dh xzafFk           (salivary ,oa gastric glands)  vk;ksMhu dk viVsd           ,oa bldk concentrate  Hkh djrh gSaA ;gk¡ ;g /;ku            j[kuk gS fd ;g non-thyroidal  gastrointestinal                                                     9","crest ls mRiUu gksrh gSaA C-cells, neural crest ls   tkrk gSA bldk vFkZ ;g gqvk fd 10-12osa lIrkg ds           fourth  pharyngeal  pouch esa igq¡prh gaS tgk¡ ;g   iwoZ] xHkZLFk f'k'kq dh viuh Fkk;jkW;M xzafFk fodflr u           ultimobronchial bodies ls fey tkrh gSaA    gksus ds dkj.k og iw.kZ:i ls ek¡ ls izkIr gksus okys            xHkZoLFkk ds 8osa lIrkg rd thyroglossal  duct ds   Fkk;jkW;M gkWekZsu ij gh vkfJr jgrk gSA           nksuksa yksCl] Fkk;jkW;M xazfFk ds okLrfod LFkku ij igq¡p   xHkZ ds 5osa lIrkg rd Fkk;jksXykWC;qfyu dk fuekZ.k           tkrs gSaA ;gha ultimobronchial bodies  buls vkdj   vkjEHk gks tkrk gSA 11osa lIrkg rd QkWfydYl esa           feyrh gSaA tc thyroglossal duct  ds nksuksa yksCl]   vk;ksMkbM VSªfiax vkjEHk gks tkrh gS ,oa 12osa lIrkg            fourth pharyngeal pouch ls feyrs gSa rc C cells,   rd Fkk;jkW;M gkWekZsUl dk mRiknu vkjEHk gks tkrk gSA           ultimobronchial bodies ls gksrh gqbZ Fkk;jkW;M xazfFk   xHkZ ds 14osa lIrkg rd ;g QkWfydYl dksykW,M ls Hkj           esa  igq¡pdj  Fkk;jkW;M  QkWfydYl  ds  chp\&chp  dh   tkrh gSaA 19-20osa lIrkg ds e/; QkWfydYl ds vkdkj           parafollicular spaces esa QSy tkrh gSaA    esa dksbZ fo'ks\"k o`f) ugha gksrh gSA 30osa lIrkg  ds ckn           Parathyroid glands - pkjksa iSjkFkk;jkW;M xzafFk;ksa dh   dksykW,M ds mRiknu esa deh vk tkus ls QkWfydYl dk            mRifÙk 3rd  ,oa 4th pharyngeal pouches  ls gksrh   vkdkj Hkh igys ls ?kVus yx tkrk gSA           gSA 3rd pharyngeal pouch ls Fkkbel dk fuekZ.k Hkh   Postnatal  changes  in  thyroid  gland  - ge           gksrk gSA tc ;g Fkkbel] xys esa mRiUu gksus ds i'pkr~   tkurs gSa fd Fkk;jkW;M xazfFk 'kjhj dh esVkckWfyd           uhps mrjrk gqvk mediastinum rd tkrk gS rc   xfrfof/k;ksa dks fu;af=r djrh gSA xHkkZoLFkk ,oa tUe ds           vius lkFk ;g 3rd pharyngeal pouch ls mRiUu   igys 2 o\"kksaZ esa 'kkjhfjd fodkl dkQh rhoz gksus ds           gksus okyh nksuksa iSjkFkk;jkW;M xzafFk;ksa dks Hkh uhps [khap   dkj.k blds vkdkj esa rhozrk ls o`f) gksrh gS ftlls 2           ykrk gSA blds foijhr 4th pharyngeal pouch ls   o\"kZ dh mez esa gh ;g vius iw.kZ fodflr vkdkj ds           mRiUu gksus okyh nksuksa iSjkFkk;jkW;M xzafFk;ka Åij gh   yxHkx vk/ks vkdkj rd igq¡p tkrh gSA blds i'pkr~            NwV tkrh gSaA blh dkj.k ls Åijh 3rd pharyngeal   I;wcVhZ vkjEHk gksus rd bldk vkdkj yxHkx leku           pouch ls mRiUu gksus okyh nksuksa iSjkFkk;jkW;M xzafFk;ka   cuk jgrk gSA I;wcVhZ  ,oa xHkkZoLFkk esa esVkckWfyd            vkxs pydj inferior gks tkrh gSa tcfd fupys 4th   xfrfof/k;ksa ds c<+us ls ;g iqu% vkdkj esa c<+ tkrh gSA           pharyngeal  pouch  ls  mRiUu  gksus  okyh  nksuksa           iSjkFkk;jkW;M xzafFk;ka vkxs pydj superior A ;g lHkh   Embryonic  thyroid  ds  pkjksa  vksj  fLFkr           (2  superior  ,oa 2  inferior)  iSjkFkk;jkW;M xzafFk;ka]   mesenchymal tissue, blds dSIlwy ,oa septa dks           Fkk;jkW;M xzafFk dh fiNyh lrg ij fLFkr gks tkrh gSaA   mRiUu djrk gSA                                                      DEVELOPMENTAL ANOMALIES OF           THYROID FOLLICLES AND SYNTHESIS OF         THYROID GLAND           THYROID HORMONES                                                      Pyramidal  lobe  -  Thyroglossal  duct  ds           Fkk;jkW;M  xzafFk  dh  dksf'kdk,a  izkjEHk  esa  cellular   terminal bifurcations ls Fkk;jkW;M xzafFk ds fuekZ.k ds           aggregates ds :i esa feyrh gSa tks igys cords ds           :i esa O;ofLFkr gksdj fQj ckn esa Fkk;jkW;M QkWfydYl   i'pkr~ ;g MDV can (obliterate) gksdj yqIr gks tkrh           dk fuekZ.k djrh gSaA                       gSA ;fn bldk distal part, obliterate gksus ds LFkku                                                      ij dqN Fkk;jkW;M dh dksf”kdk;sa mRiUu djrk jgs rc           xHkkZoLFkk ds 10-12osa lIrkg ds e/; Fkk;jkW;M xazfFk esa   og eq[; xazfFk ls yxs gq, 'kadq dk vkdkj ds mHkkj           QkWfydYl dk fuekZ.k vkjEHk gks tkrk gSA Øe'k% ;g   (conical projection) ds :i esa fey ldrk gS ftls           QkWfydYl vk;ksMhu dk laxzg vkjEHk dj nsrs gSa ftlds   fijkfeMy yksc dgrs gSaA ,d short stump ls ysdj           i'pkr~ muesa Fkk;jkW;M gkeksZu dk mRiknu vkjEHk gks   prolonged  process  ds  :i  esa  ;g  vf/kdka'kr%                                                      10","isthmus ls yxk gksrk gS vFkok dHkh dHkh fdlh ,d   fLFkfr ls vkSj Hkh vf/kd uhps] mediastinum ;k           yksc ls Hkh tqM+k fey ldrk gSA              thorax esa igq¡p tk;sA            Fkk;jkW;M  xzafFk  dh  vU;  lajpukRed  fo—fr;ka   -  Other ectopic locations - ;fn Fkk;jkW;M xzafFk]           fuEukafdr gSaA                              neck, thorax vFkok abdominal viscera esa fey                                                       jgh gksA                   or           –  Small   absent isthmus                   or           –  Small   absent lobe                     Remnants  of  thyroglossal  duct  – Fkk;jkW;M           Abnormalities in thyroid descent - Ectopic   xzafFk ds iw.kZ:i ls viuh vafre fLFkfr rd mrj vkus           thyroid  –  Fkk;jkW;M xzafFk]  base  of  tongue  ds   (complete descent) ds ckn thyroglossal duct dk           foramen  caecum  ds  LFkku  ls  mRiUu  gksdj   dksbZ vkSfpR; ugha jg tkrk ftlls ;g Øe'k% can gksdj           thyroglossal duct ls gksrs gq, viuh o;Ldksa esa feyus   lekIr gks tkrh gSA Foramen caecum blh MDV ds           okyh fLFkfr ij vk tkrh gSA bl descent esa dksbZ   izkjfEHkd Hkkx dk vestigial remnant gSA dHkh\&dHkh           :dkoV vkus ij iwjh dh iwjh Fkk;jkW;M xzafFk vFkok   ;g iwjh MDV vFkok bldk dksbZ Hkkx o;Ldksa esa Hkh ,d           bldk dksbZ Hkkx viuh adult location ij u igq¡p dj   dkWMZ ds :i esa cpk jgrk gS ftls  remnant  of           chp esa NwV ldrk gSA                       thyroglossal duct dgrs gSaA            viuh fLFkfr ds vk/kkj ij ectopic  thyroid fuEu   Thyroglossal  duct  cyst  -  ;fn  bl  duct           izdkj dh gks ldrh gSA                      remnant  esa  dqN  nzo  (fluid)  ,df=r  gks  tk,A           - Lingual thyroid - ;fn ;g thHk dh Åijh lrg ij   LokHkkfod :i ls ;g cyst Hkh 'kjhj dh e/; js[kk esa gh            gksA                                      gksrh gS ,oa Hkkstu fuxyus (deglutition) dh izfØ;k esa           -  Intralingual  thyroid  -  ;fn  ;g  thHk  dh   Åij o uhps gksrh gSA            ekalisf'k;ksa ds chp esa gksA             Thyroglossal fistula - ;fn thyroglossal duct           -  Suprahyoid thyroid - ;fn ;g thHk ds uhps fdarq   dk dksbZ Hkkx ckgj [kqy jgk gksA vf/kdka'kr% ;g thHk            hyoid bone ds Åij gksA                    ds foramen caecum ij gh [kqyk jg tkrk gSA           -  Infrahyoid thyroid - ;fn ;g hyoid bone ds   Carcinoma  of  the  thyroglossal  duct  -            uhps fdarq viuh lkekU; fLFkfr ds Åij gksA   Thyroglossal duct remnant esa dSalj Hkh mRiUu gks           -  Intrathoracic thyroid - ;fn ;g viuh lkekU;   ldrk gSA                                                                             11","[kaM\&2                                                          Fkk;jkW;M xzafFk dh fØ;k iz.kkyh                             (Physiology of The Thyroid Gland)","2                             Synthesis of Thyroid Hormones             STEPS  OF  THYROID  HORMONE  (TH)         ldrkA blds fy, ,d vfrfjä VªkaliksVZj eSdsfuTe dh            SYNTHESIS                                                      vko';drk  iM+rh  gS  tks  vk;ksMkbM  dks  blds           Fkk;jkW;M gkWekZsu ¼T4½ dk yxHkx 65% Hkkx vk;ksMhu   concentration gradient ds foijhr fn'kk esa ys tk           ls curk gSA vr% vk;ksMhu esVkckWfyTe] Fkk;jkW;M   ldsA  ;g  dk;Z  nks  çdkj  ls  fd;k  tk  ldrk  gS]           gkWekZsUl ds mRiknu dk lcls egRoiw.kZ pj.k cu tkrk   vk;ksMkbM ds active transport ds }kjk vFkok bls           gSA Fkk;jkW;M QkWfydYl esa Fkk;jkW;M gkWekZsUl ¼T3 ,oa   fdlh vU; vk;u  ds lkFk tksM+dj tks Lo;a vius           T4½ dk mRiknu fuEukafdr pj.kksa esa laiUu gksrk gSA  concentration gradient ds vuqlkj vk\&tk jgk gks           1. Iodide  trapping  \&  vk;ksMkbM  dk  Fkk;jkW;M   (facilitated  transport)A  Fkk;jkW;M  QkWfydYl  esa             QkWfydy dh dksf'kdk esa ços'k            vk;ksMkbM viVsd ds fy, blh facilitated transport                                                      dh enn yh tkrh gSA           2. Oxidation of iodine – vk;ksMkbM dk vk;ksMhu esa                              +             cnyuk                                    - 'kjhj ds vfèkdka'k facilitated transport] Na  ds                                                       lkFk gh laiUu gksrs gSa vr% ;gk¡ Hkh vk;ksMkbM ds           3. Organification  of  iodine  or  iodination  of   facilitated transport dh ftEesnkjh Na  ij gh jgrh                                                                                     +             tyrosine  and  formation  of  iodotyrosines  -                                                                    –                                                                  I             vk;ksMhu dk Fkk;jksXykWC;qfyu ds Vk;jkslhu ls tqM+uk  gSA  Na +   ,oa  dks lkFk ys tkus okys bl VªkaliksVZj                                                       dks Na   ,oa I  symporter (NIS)  dgrs gSa tks ,d                                                             +                                                                  –           4. Coupling of iodotyrosines and formation of          –                  +             thyroid hormones - iodotyrosines ds ijLij   vk;ksMkbM 1 I   dks ys tkus ds fy, 2 Na   dk mi;ksx             feyus ls Fkk;jkW;M gkWekZsUl dk cuuk      djrk gSA                                                      - NIS ,d çdkj dk  secondary active transporter           5. Proteolysis of thyroglobulin and release of              gS tks vk;ksMkbM VªSfiax ds fy,             thyroid  hormones  \&  Fkk;jkW;M  gkWekZsUl  dk   ;k cotransporter             Fkk;jksXykWC;qfyu ls vyx gksdj jä ¼circulation½   QkWfydy  dh  dksf'kdkvksa  dh  basolateral             esa igqapuk                               membrane ij Na-K pump ds lkFk feydj dk;Z                                                       djrk gSA           vkb;s bUgsa foLrkj ls le>rs gSaA           - NIS ds }kjk QkWfydy dh dksf'kdkvksa esa vk;ksMkbM           IODIDE TRAPPING                             dks jä ls 20-40 xquh ek=k rd laxzfgr fd;k tk           ;g Fkk;jkW;M gkWekZsUl ds mRiknu dk çFke pj.k gS   ldrk gSA           ftlesa vk;ksMkbM] jä ls Fkk;jkW;M QkWfydy dh   - TSH ds }kjk mÙksftr fd;s tkus ls NIS dh lfØ;rk           dksf'kdk esa igq¡prk gSA Thyroid interstitium esa fLFkr   c<+ tkrh gS ftlls xzafFk esa vk;ksMkbM VªSfiax Hkh c<+           CyM  dSfiyjh,  bu  dksf'kdkvksa  dh  ckgjh  lrg   tkrh gSA           ¼basolateral surface½ ds laidZ esa jgrh gSaA vr%   - jä  ls  çkIr  gksus  okyh  extracellular  iodide           vk;ksMkbM  VªSfiax  dk  ;g  dk;Z  blh  basolateral   trapping ds vfrfjä] QkWfydy dh dksf'kdkvksa dks           surface ij laiUu gksrk gSA                  dqN ek=k esa vk;ksMkbM dksf'kdk ds vUnj ls Hkh                                                       feyrk  jgrk  gSA  ;g  bls  Fkk;jkW;M  gkWekZsUl  ds           è;ku jgs] jä esa vk;ksMkbM dh ek=k dkQh de gksrh gS           tcfd viVsd ls Fkk;jkW;M QkWfydy dh dksf'kdkvksa esa   intermediary  compounds,  MIT  ,oa  DIT  dh           bldh ek=k Øe'k% c<+rh tkrh gSA bl dkj.k ls ;g   esVkckWfyTe ls çkIr gksrk gSA vko';drk ls vfèkd           dk;Z simple diffusion ds }kjk laiUu ugha fd;k tk   cus MIT ,oa DIT esa miyCèk vk;ksMhu dks iqu% ç;ksx                                                    13","ds fy, deiodinase enzyme ds }kjk fudky fy;k  vk;ksMhu] Ýh Vk;jkslhu dk vkWxsZfufQds”ku ugha dj            tkrk gSA NIS ds fo’k; esa foLrkj ls ppkZ ge vkxs  ldrkA bl dk;Z ds fy, Vk;jkslhu dk FkkW;jksXykWC;qfyu            djsaxsA                                   ij yxs gksuk vko';d gSA vc D;ksafd FkkW;jksXykWC;qfyu]                                                      QkWfydy dh Y;wesu esa Hkjs dksykW,M esa laxzfgr jgrk gS            OXIDATION OF IODIDE                                                      blfy,  vkWxsZfufQds”ku dh çfØ;k Hkh QkWfydy dh           vk;ksMkbM  VªSfiax  ls  QkWfydy  dh  dksf'kdkvksa  esa           vk;ksMkbM ,df=r rks gks tkrk gS ijUrq bl fLFkfr esa   Y;wesu esa gh laiUu gksrh gSA           ;g Fkk;jksXykWC;qfyu dh Vk;jkslhu ls tqM+ ikus esa l{ke  Vk;jkslhu ij vk;ksMhu vusd LFkkuksa ij tqM+ ldrk gSA           ugha gksrkA blds fy, vk;ksMkbM dks vkWDlhMkbt  vk;ksMhu ds fHkUu\&fHkUu LFkkuksa ij tqM+us ls cuus okys           djkdj vkxsZfud vk;ksMhu esa cnyus dh vko';drk  inkFkZ Hkh fHkUu\&fHkUu gksrs gSaA           iM+rh gSA bl dk;Z esa vkWDlhMkbftax ,tsaV ds :i esa   tc ,d vk;ksMhu] Vk;jkslhu ds rhljs LFkku ij yxs           hydrogen  peroxidase  (H O )  ,oa  mRçsjd   dkcZu ls tqM+rk gS rc monoiodotyrosine (MIT)  ;k                                    2                                      2           (catalyst) ds :i esa thyroid peroxidase (TPO)    3-monoiodotyrosine cukrk gSA           ,atkbe dk ç;ksx gksrk gSA                                                      blh MIT ls tc nwljk vk;ksMhu] Vk;jkslhu ds ikaposa           H O ,,oa  TPO]  QkWfydy  dh  Y;wesu  esa  apical   LFkku  ij  yxs  dkcZu  ls  tqM+rk  gS  rc  og              2            2           membrane ds fudV gh miyCèk jgrs gSaA vk;ksMkbM   diiodotyrosine  (DIT)  ;k  3,5-diiodotyrosine           ds vkWDlhMs'ku ds fy, bldk QkWfydy dh dksf'kdkvksa   cukrk gSA           ls fudydj QkWfydy dh Y;wesu esa igq¡puk vko';d                                                      COUPLING OF IODOTYROSINES           gSA  vk;ksMkbM  ds  bl  vkokxeu  ds  fy,  apical           membrane  ij  mifLFkr  pendrin   uked  çksVhu   bl  çdkj]  Vk;jkslhu  ds  vk;ksfMus'ku  ls           lgk;d gksrh gSA                            vk;Mks\&Vk;jkslhu ¼MIT ,oa DIT½ dk fuekZ.k gksrk gS                                                      ftuesa  ,d\&,d  dkcZu  fjax  gksrh  gSA  ;fn  bu           QkWfydy dh dksf'kdkvksa esa vk;ksMkbM dks vk;ksMhu esa   vk;Mks\&Vk;jkslhu ds dksbZ nks v.kq ijLij fey tk,a rc           cnyus dk ,d mís'; vkSj Hkh gksrk gSA vk;ksMkbM   mu ls vk;Mks\&Fkk;jksuhu (iodothyronine) dk fuekZ.k           VªSfiax ds i'pkr~ QkWfydy dh dksf'kdkvksa esa vk;ksMkbM   gksrk gS ftuesa nks dkcZu fjax gksrs gSaA           dk Lrj] jä dh vis{kk 20-40 xquk rd c<+ tkrk gSA           LokHkkfod :i ls vk;ksMkbM dh bruh vfèkd ek=k]   ,d vk;ksMhu okys MIT ,oa nks vk;ksMhu okys DIT ds                                                      feyus ls rhu vk;ksMhu okys tri-iodothyronine (T3)           nksckjk jä esa yhd gksus dk ç;kl djsxhA vkWDlhMs'ku           dh  çfØ;k  ls  vk;ksMkbM  dh  vfrfjä  ek=k  dks   dk fuekZ.k gksrk gS tcfd nks\&nks vk;ksMhu okys nks DIT           vk;ksMhu esa ifjofrZr djk fn;k tkrk gS tks vk;ksMkbM   ds  ijLij  feyus  ls  pkj  vk;ksMhu  okys  tetra-           ds bl yhd dks jksdus esa Hkh lgk;d gksrk gSA  iodothyronine T4 ;k  thyroxine ¼Fkk;jkWfDlu½ dk                                                      fuekZ.k gksrk gSA           IODINATION OF TYROSINE           vkWDlhMs'ku  ds i'pkr~ vk;ksMkbM ¼vc vk;ksMhu½]   è;ku jgs] MIT ,oa DIT dh difyax dk ,d fo'ks\"k Øe                                                                                   T3           Fkk;jksXykWC;qfyu ds tqM+ ldus esa l{ke gks tkrk gSA bl   gSA tc MIT ls DIT feyrk gS rc ;g   dk fuekZ.k           çfØ;k dks Vk;jkslhu dk vk;ksfMus'ku dgrs gSaA blls   djrk gSA blds foijhr] tc DIT ls MIT feyrk gS rc           vk;Mks\&Vk;jkslhu (iodo-tyrosine) dk fuekZ.k gksrk gSA   reverse T3 curk gSA çFke –\"Vîk ;g çrhr gks ldrk           TPO ,atkbe bl çfØ;k esa Hkh mRçsjd dk dk;Z djrk   gS fd DIT] MIT ls feys ;k MIT] DIT ls] bu nksuksa esa           gSA                                        varj D;k gks ldrk gS\\ ijUrq D;ksafd difyax dh fØ;k                                                      Fkk;jksXykWC;qfyu ls tqM+s\&tqM+s gh laiUu gksrh gS vr%           bl fo\"k; esa è;ku j[kus ;ksX; rF; ;g gS fd vkxsZfud                                                    14","buds tqM+us okys Nksjksa ds cny tkus ls muls cuus okys  vk;ksMkbM  ds  vkWDlhMs”ku  ,oa  Vk;jkslhu  ds           gkeksZu Hkh cny tkr gSaA Fkk;jksXykWC;qfyu dh dYiuk ,d  vkWxZsfufQds”ku dh Hkkafr gh TPO ,atkbe] difyax dh           iqLrdksa  dh  vyekjh  ls  dh  tk  ldrh  gS  ftlesa  çfØ;k esa Hkh mRçsjd dk dk;Z djrk gSA           vyx\&vyx [kkuksa esa MIT, DIT, T3 ,oa T4 iqLrdksa ds   vk;ksMkbM  VªSfiax  dh  Hkkafr  vkWDlhMs'ku  ,oa           :i esa yxs gSaA ;fn MIT okys [kkus esa DIT dks Åij ls   vkWxsZfufQds”ku dh nksuksa çfØ;k,a Hkh TSH }kjk mÙksftr           tksM+saxs rc MIT iqLrd dh ftYn] DIT iqLrd ds [kqys   gks ldrh gSaA Fkk;jksXykWC;qfyu ds fo’k; esa foLrkj ls           i`\"B dh vksj ls tqM+sxh] tcfd ;fn DIT okys [kkus esa   ppkZ ge vkxs djsaxasA           MIT dks Åij ls tksM+saxs rc DIT iqLrd dh ftYn] MIT           iqLrd ds [kqys i`\"B dh vksj ls tqM+saxhA bl çdkj] tqM+us    THYROID PEROXIDASE (TPO) ENZYME           dk Øe cny tkus ls bu nksuksa fØ;kvksa esa vyx\&vyx   ;g Fkk;jkW;M gkWeksZUl ds mRiknu esa ç;qä gksus okyk           gkWekZsUl dk fuekZ.k gksxkA                ,d çeq[k ,atkbe gS tks blds rhu pj.kksa ij dk;Z                                                      djds mUgsa mÙksftr djrk gS] 1) oxidation of iodide,           - T3  dh lajpuk esa Hkhrjh dkcZu fjax ds rhljs ¼3½ ,oa   2) organification of tyrosine ,oa  3) coupling of            ikaposa ¼5½ LFkkuksa ij vk;ksMhu yxs gksrs gSa tcfd   iodotyrosine.            ckgjh dkcZu fjax ds dsoy rhljs ¼3'½ LFkku ijA           - T3 ds foijhr reverse T3 dh lajpuk esa Hkhrjh   ;gh ,atkbe] Fkk;jkW;M dk ,d çeq[k microsomal                                                      antigen  Hkh gS ftlds fo#) vusd  vkWVks\&bEE;wu            dkcZu fjax ds dsoy rhljs ¼3½ LFkku ij vk;ksMhu            yxk gksrk gS tcfd ckgjh dkcZu fjax ds rhljs ¼3'½   fodkjksa  esa  ,aVhckWMh  cu  tkrh  gSaA  bUgsa  thyroid                                                      microsomal antibodies ;k            ,oa ikaposa ¼5'½ nksuksa LFkkuksa ijA     dgrs gSaA              anti-TPO antibodies           - vk;ksMhu ds vyx\&vyx LFkkuksa ij tqM+us dk çHkko            buls cuus okys gkWekZsUl dh dk;Z{kerk ij Hkh iM+rk   vkWVks\&bEE;wu fodkjksa esa cuus okyh ;g ,aVhckWMh] TPO            gSA tgk¡ lokZfèkd Fkk;jkW;M gkWeksZu gS ogha okLro esa   dh dk;Z{kerk dks ?kVkdj Fkk;jkW;M gkWekZsUl ds mRiknu            gkWekZsu gksrk gSA                        esa ckèkk mRiUu djrh gSa ftlls gkbiksFkk;jkW;fMTe           - T4 dh lajpuk esa Hkhrjh dkcZu fjax ds rhljs ¼3½ ,oa   mRiUu gks ldrh gSA bl çdkj] ;fn fdlh O;fä esa            ikaposa ¼5½ LFkkuksa ds lkFk\&lkFk ckgjh dkcZu fjax ds   anti-TPO  antibodies  lkekU; ls vfèkd ek=k esa            Hkh  rhljs  ¼3'½  ,oa  ikaposa  ¼5'½  nksuksa  LFkkuksa  ij   feyrh gSa rc ;g lEHkkouk c<+ tkrh gS fd ml O;fä            vk;ksMhu yxs gksrs gSaA                   dks Hkfo\"; esa gkbiksFkk;jkW;fMTe mRiUu gks tk,A            FkkW;jksXykWC;qfyu ds çR;sd v.kq esa T4 ds 3-4 v.kq ,oa   PROTEOLYSIS OF THYROGLOBULIN AND                                                      RELEASE OF THYROID HORMONES           FkkW;jksXykWC;qfyu ds yxHkx 5 v.kqvksa ds chp T3 dk           dsoy  ,d  v.kq  feyrk  gSA  bl  çdkj]  lkekU;   difyax dh çfØ;k ls Fkk;jksXykWC;qfyu ij cus Fkk;jkW;M                                                      gkWekZsUl ¼T4 ,oa T3½] vHkh Hkh QkWfydy dh Y;wesu esa           ifjfLFkfr;ksa esa T3 ds çR;sd v.kq ds lkFk T4 ds 15-20   gh laxzfgr jgrs gSaA Fkk;jkW;M xzafFk ls fudyus ds iwoZ           v.kq  curs  gSaA  ijUrq  gkbijFkk;jkW;fMTe  esa  tc   bUgsa QkWfydy dh Y;wesu ls dksf'kdk esa ,oa blds ckn           Fkk;jkW;M gkWekZsUl dk mRiknu lkekU; ls vfèkd rhozrk   dksf'kdk ls jä esa igqapuk gksrk gSA vkb;s bu nksuksa           ls gksus yxrk gS rc T3 ds mRiknu dh ek=k c<+rh tkrh   çfØ;kvksa dks Hkh foLrkj ls le>rs gSaA           gSA                                                      loZçFke] QkWfydy dh Y;wesu ls dksykW,M ¼,oa blesa           vkWxsZfufQds”ku dh Hkkafr gh difyax dh çfØ;k Hkh           Fkk;jksXykWC;qfyu ds Åij vFkkZr QkWfydy dh Y;wesu esa   feys gq, Fkk;jksXykWC;qfyu½ dh dqN ek=k] endocytic                                                      ¼æo ds fy, pinocytic½ vesicle ds :i esa dksf'kdk esa           gh laiUu gksrh gSA                                                      ços'k djrh gSA ;gk¡ lysosomes bu vesicles ds                                                     15","laidZ esa vkdj buls feydj phagolysosome cuk  esa vkus ds i'pkr~ og Fkk;jksXykWC;qfyu ls vyx dj           ysrs gSaA bl çdkj lysosomal protease enzymes,  fn, tkrs gSa ftlls og Fkk;jkW;M xzafFk ls jä esa lzkfor            Fkk;jksXykWC;qfyu  ds  laidZ  esa  vk  tkrs  gSa  ftlls  fd;s tk ldsaA dksf'kdk dh basolateral membrane           Fkk;jksXykWC;qfyu esa yxs MIT, DIT, T3 ,oa T4 vyx  ij yxs monocarboxylate transporters (MCT),           gksdj dksf'kdk esa eqä djk fn, tkrs gSaA   Fkk;jkW;M gkWekZsUl dks dksf'kdk ls fudky dj jä esa            bl çdkj eqä gq, T4 ,oa T3 rks vko';drkuqlkj jä   igq¡pkus esa enn djrs gSaA ;gh MCT   ,o organic           esa lzkfor ¼secrete½ dj fn, tkrs gSa ijUrq MIT ,oa   anion  transporter  protein  (OATP),  Fkk;jkW;M                                                      gkWekZsUl dks 'kjhj dh fofHkUu dksf'kdkvksa esa ços'k djkus           DIT dksf'kdk esa gh NwV tkrs gSaA okLro esa] iodinated           tyrosines esa 75% ek=k bUgha MIT ,oa DIT dh gh   esa Hkh lgk;d gksrs gSaA           gksrh gSA ;fn vk;ksMhu ,oa Vk;jkslhu dh bruh cM+h   APPLIED PHYSIOLOGY           ek=k ;wa gh ç;ksx esa vkus ls jg tkrh gS rc ;g cM+s   Antithyroid  drug,  propylthiouracil  (PTU),           uqdlku dk dkj.k cu ldrh gSA blhfy,] dksf'kdk esa   Fkk;jkW;M gkWekZsUl ds mRiknu ds vU; pj.kksa dks ?kVkus                                                      ds lkFk\&lkFk T4 ls T3 ds cuus dh izfØ;k esa Hkh           iodotyrosine  deiodinase  vFkok   dehaloginase           enzymes ds }kjk MIT ,oa DIT dks nksckjk vk;ksMhu   #dkoV  mRiUu  djrh  gSA  blhfy,]  vfr  xaHkhj           ,oa Vk;jkslhu  esa rksM+ fn;k tkrk gS ftlls budh   gkbijFkk;jkW;fMTe esa lfØ; gkeksZu T3 dh ek=k rsth           vk;ksMhu dks iqu% ç;ksx esa yk;k tk ldsA   ls ?kVkdj ;g nok 'kh?kz ykHk igq¡pkus esa lgk;d gksrh                                                      gSA           è;ku jgs] FkkW;jksXykWC;qfyu esa rks T4:T3 dk vuqikr           15-20:1 gksrk gS tcfd Fkk;jkW;M xzafFk ls fudyrs ;g   ge ;g rks tkurs gh gSa fd Fkk;jkW;M xzafFk ds lqpk# :i           10-13:1 gh jg tkrk gSA okLro esa] QkWfydy dh   ls dk;Z djus ds fy, vk;ksMkbM vR;ar vko';d gSA           dksf'kdkvksa esa deiodinase enzymes }kjk T4 dh   ijUrq vk;ksMkbM dh ek=k vR;fèkd gks tkus ij ;g           dqN ek=k] T3 esa Hkh cny tkrh gSA è;ku jgs] T4 dks   xzafFk ls Fkk;jkW;M gkWekZsUl ds lzko.k dks Hkh ?kVk nsrh gSA                                                      bl çdkj cM+h ek=k esa nh x;h vk;ksMkbM] vfr xaHkhj           T3 esa cnyus okyk ;g deiodinase enzyme,  MIT                                                      gkbijFkk;jkW;fMTe ds mipkj esa vR;ar lgk;d gks           ,oa  DIT  ij  dk;Z  djus  okys  iodotyrosine           deiodinase ls fHkUu gksrk gSA              ldrh gSA            vius uke ds vuq:i deiodinase enzyme, T4 ls           ,d vk;ksMhu dks vyx djrs gSaA è;ku jgs] T4 esa nks     SODIUM IODIDE SYMPORTER (NIS)           dkcZu fjax gksrs gSa ftuesa nks\&nks vk;ksMhu yxs jgrs gSaA  'kjhj ds vfèkdka'k facilitated transport, Na  ds lkFk                                                                                        +           ;fn fM\&vk;ksfMus”ku dh bl çfØ;k esa T4 dh ckgjh  gh laiUu gksrs gSaA Fkk;jkW;M xzafFk esa Hkh vk;ksMkbM ds                                                                                    +           dkcZu  fjax  dk  vk;ksMhu  gVrk  gS  (outer  ring   facilitated transport dh ftEesnkjh Na  ij gh jgrh           deiodination) rc mlls  T3 mRiUu gksrk gS tks lfØ;  gSA blds fy, loZçFke Na-K pump ds }kjk 3 Na ,                                                                                             +           gkWekZsu gSA blds foijhr ;fn T4 dh Hkhrjh dkcZu fjax  QkWfydy dh dksf'kdkvksa ds ckgj actively ¼ÅtkZ dk                                                                                     +           dk vk;ksMhu gVrk gS (inner ring deiodination)  rc  ç;ksx djrs gq,½ iai fd;s tkrs gSa ,oa 2 K  dksf'kdk ds           mlls reverse T3 ¼rT3½ mRiUu gksrk gS tks fuf\"Ø;  Hkhrj ys fy, tkrs gSaA blls ECF esa Na  dh ek=k                                                                                      +           gkWekZsu gSA                               Øe'k% c<+rh tkrh gSA blds i'pkr~ tc ;g Na  vius                                                                                         +           bl çdkj Fkk;jkW;M gkWeksZUl tc rd QkWfydy dh   concentration gradient ds vuqlkj ECF ls ICF esa                                                                                             –           Y;wesu  esa  dksykW,M  ds  lkFk  laxzfgr  jgrs  gSa]  og   vkus dk ç;kl djrk gS rc blds lkFk vk;ksMkbM ¼I ½                                                                             +                                                                                 –           Fkk;jksXykWC;qfyu ls tqM+s jgrs gSaA QkWfydy dh dksf'kdk   dks Hkh tksM+ fn;k tkrk gSA Na ,oa I  dks lkFk ys tkus                                                   16","okys bl VªkaliksVZj dks Na–I  symporter ¼NIS½ dgrs   Stimulators of NIS - TSH, NIS dks Hkh mÙksftr           gSa tks ,d vk;ksMkbM 1 I dks ys tkus ds fy, 2Na  dk  djrk gS ,oa bl çdkj ls Fkk;jkW;M gkWeksZUl dk mRiknu                                                +                            –           mi;ksx djrk gSA                            c<+kus ds fy, vk;ksMkbM dh vfèkd ek=k miyCèk           è;ku jgs] bl dk;Z esa ÅtkZ dk mi;ksx Na  iai djus   djkrk gSA blds vfrfjä] vk;ksMhu dh deh  Hkh NIS                                           +           ds igys pj.k esa gh gqvk gS] vk;ksMkbM VSªfiax ds nwljs   thu ds expression dks ,oa NIS dh gkQ ykbQ c<+krh           pj.k  esa  ughaA  bl  çdkj]  NIS  ,d  çdkj  dk   gS ftlls jä esa vk;ksMkbM dh ek=k de gksrs gq, Hkh           secondary active transport ;k cotransport gS tks   bldks Fkk;jkW;M xzafFk esa vfèkd lfØ;rk ds lkFk           vk;ksMkbM VSªfiax ds fy, QkWfydy dh dksf'kdkvksa dh   laxzfgr fd;k tk ldsA           basolateral membrane ij Na-K pump ds lkFk   Inhibitors  of  NIS  -  Thiocynates bl NIS dh           feydj dk;Z djrk gSA                        lfØ;rk dks ?kVkrs gSaA blhfy,] ftu HkksT; inkFkksZa esa            NIS in salivary gland \& Fkk;jkW;M xzafFk ds vfrfjä   thiocynates dh ek=k vfèkd gksrh gS ¼tSls QwyxksHkh]           NIS, salivary gland ¼,oa gastric mucosa½ esa Hkh   iÙkkxksHkh] 'kyte] jkxh bR;kfn½ os vk;ksMkbM viVsd           feyrk gSA blhfy,] vk;ksMhu LdSu esa Fkk;jkW;M ds   dks ?kVkdj xkW;Vj mRiUu djk ldrs gSaA           vfrfjä salivary glands Hkh fn[kykbZ nsrh gSaA ijUrq  ftl çdkj vk;ksMhu dh deh gksus ij NIS vR;f/kd           bu LFkkuksa ij feyus okyk NIS, TSH ds }kjk çHkkfor  lfØ; gks tkrk gS Bhd mlh çdkj vk;ksMhu dh           ugha gksrkA                                vfèkdrk (acute iodide excess)  esa NIS fuf\"Ø; Hkh            Role of NIS in placenta \& ge tkurs gSa fd] xHkZLFk   gks tkrk gSA okLro esa ;g ,d vkWVks\&jsxqys”ku dh           f'k'kq  ds  fodkl  ds  fy,  Fkk;jkW;M  gkWekZsUl  ¼,oa   izfØ;k gS ftlds }kjk xzafFk Lo;a dks vR;f/kd ek=k esa           vk;ksMhu½ vR;ar egRoiw.kZ gksrs gSaA f'k'kq dks vk;ksMhu   vk;ksMkbM ls cpkrh gSA bls Wolff Chaikoff effect            dh i;kZIr ek=k miyCèk djkus ds fy, NIS, IyklsaVk dh   dgrs gSaA blhfy,] vR;f/kd xaHkhj gkbijFkk;jkW;fMTe           cytotrophoblasts  ,oa  syncytiotrophoblasts  ij   (thyrotoxic  crisis) esa vk;ksMhu dh cM+h ek=k dk           Hkh mifLFkr jgrk gS tks vk;ksMkbM dks ek¡ ds jä ls   ç;ksx fd;k tkrk gS ftlls vk;ksMkbM VSªfiax dks jksddj           çkIr djds f'k'kq rd igq¡pkus esa lgk;d gksrk gSA  Fkk;jkW;M gkekZsUl ds mRiknu esa deh yk;h tk ldsA                                                      vk;ksMhu dh vf/kdrk ds yEcs le; rd cus jgus ij           Role of NIS in mammary gland \& blh çdkj                                                      xzafFk blls mcj dj ¼escape  djds½ iqu% vk;ksMkbM           NIS,  Lruiku djk jgh ek¡ ds Lru  (mammary   VSªfiax vkjEHk dj nsrh gS ftlls Fkk;jkW;M gkekZsUl ds           gland) esa Hkh feyrk gS tks vk;ksMkbM dks ek¡ ds jä ls   mRiknu esa ckèkk u iM+sA           mammary gland ,oa nwèk esa igq¡pkus esa enn djrk gSA           Endemic zone esa vk;ksMhu dh deh ls f'k'kq dh j{kk   Significance of NIS in diagnosis of thyroid                                                      disorders  \&  vk;ksMkbM  ds  vfrfjä  NIS,           djus ds fy,] mammary gland ij fLFkr blh NIS   pertechnetate ions dks Hkh QkWfydy dh dksf'kdkvksa           ds }kjk vk;ksMhu dh i;kZIr ek=k f'k'kq dks miyCèk   esa laxzfgr djrs gSaA blh dkj.k ls  Fkk;jkW;M LdSu ds           djkbZ tkrh gSA                             fy,  jsfM;ks,fDVo  vk;ksMhu  ,oa  jsfM;ks,fDVo           Role of NIS in thyroid disorders \& NIS thu ds   pertechnetate] nksuksa] dks ç;ksx esa yk;k tk ldrk gSA           E;wVs”ku ls NIS dh deh gks tkrh gS ftlls vk;ksMkbM   NIS ds }kjk gh ;g nksuksa jsfM;ks,fDVo inkFkZ] Fkk;jkW;M           VSªfiax u gks ikus ds dkj.k Fkk;jkW;M gkWekZsUl dk mRiknu  xzafFk esa laxzfgr dj fy, tkrs gSa tks Fkk;jkW;M xzafFk dh           ugha  gks  ikrkA  ;g  congenital  hypothyroidism   cukoV ¼structure½ ,oa dk;Z{kerk ¼function½ dh           mRiUu djk ldrk gSA                         tkudkjh miyCèk djkrs gSaA                                                      17","Significance  of  NIS  in  therapeutics  \&  Fkk;jkW;M gkWekZsUl ds laxzg dh bl {kerk dk fodkl           vk;ksMkbM dh Hkkafr gh NIS] perchlorate ions dks Hkh  laHkor% blfy, gqvk gksxk ftlls vkfne ekuo dks ,d           QkWfydy dh dksf'kdkvksa esa laxzfgr djrs gSaA NIS }kjk  LFkku ls nwljs LFkku ij vkrs\&tkrs le; ;fn dqN le;           dksf'kdk esa ços'k djus ds fy, ;g perchlorate ions]  vk;ksMhu dh deh okys {ks=ksa esa jguk iM+s rc ml deh           vk;ksMkbM ls çfrLièkkZ ¼compete½ djrs gSaA blhfy,]  ls mRiUu gqbZ Fkk;jkW;M gkWekZsUl dh deh ls 'kjhj dh           gkbijFkk;jkW;fMTe dh fLFkfr esa perchlorate ion dh  esVkckWfyTe çHkkfor u gksA gkWekZsUl ds laxzg dh ,slh           cM+h ek=k dk ç;ksx fd;k tkrk gS tks competitive  {kerk] Fkk;jkW;M xzafFk ds vfrfjä fdlh vU; gkWekZsu           inhibition  ds  }kjk]  QkWfydy  dh  dksf”kdkvksa  esa  mRiknd xzafFk esa ugha feyrhA           vk;ksMkbM  ds  viVsd  dks  CykWd  djrk  gS  ftlls   jä esa Fkk;jksXykWC;qfyu dk lkekU; Lrj yxHkx 20-50           Fkk;jkW;M gkekZsUl ds mRiknu dks ?kVk;k tk ldsA  ng/ml jgrk gSA Fkk;jkW;M gkWeksZUl dh vko';drk                                                      c<+us ¼tSls xHkkZoLFkk ,oa uotkr f'k'kqvksa esa½] Fkk;jkW;M             THYROGLOBULIN                            xzafFk dk vkdkj c<+us ¼tSls flaiy xkW;Vj esa½] Fkk;jkW;M           Fkk;jkW;M QkWfydy dh dksf'kdk;sa okLro esa çksVhu dk  gkWeksZUl dk mRiknu c<+us ¼tSls Fkk;jksVkWfDldksfll esa½           fuekZ.k djus okyh fof'k\"V dksf'kdk,a gksrh gSaA ijUrq  vFkok Fkk;jkW;M QkWfydy dh dksf'kdkvksa esa fdlh           blls cuus okyh izksVhu] Fkk;jkW;M gkWeksZu u gksdj  çdkj dh {kfr igq¡pus esa ¼tSls Fkk;jkW;MkbfVl esa xzafFk esa           Fkk;jksXykWC;qfyu gksrh gSA                laxzfgr gkWekZsu ds jä esa yhd gks tkus ls½] jä esa blds                                                      Lrj c<+ tkrs gSaA TSH }kjk Fkk;jkW;M xzafFk dks mÙksftr           blds fy, QkWfydy dh dksf'kdkvksa esa çpqj ek=k esa           ,aMksIykfTed  jsfVdqye  miyCèk  jgrk  gS  ftlesa   fd;s tkus ls Hkh Fkk;jksXykWC;qfyu dk Lrj c<+ tkrk gSA           Fkk;jksXykWC;qfyu dh izksVhu dh lajpuk curh gSA xkWYxh  ijUrq mijksä fdlh Hkh fLFkfr esa bldh tkap djkus dh           ckWMh  esa  bl  v/kZfodflr  Fkk;jksXykWC;qfyu  esa  dksbZ vko';drk ugha gksrhA lhje Fkk;jksXykWC;qfyu dks           dkcksZgkbMsªV  ;wfuV  ds  tqM+us  ls  iw.kZ  fodflr  ukius  dh  vko';drk  eq[;r%  Fkk;jkW;M  dSalj  ls           Fkk;jksXykWC;qfyu dk fuekZ.k gksrk gSA     çHkkfor O;fä;ksa esa] total thyroidectomy ds i'pkr]            çR;sd Fkk;jksXykWC;qfyu esa Vk;jkslhu ds yxHkx 123   recurrence dks igpkuus ds fy, dh tkrh gSA okLro           ,ehuks ,flM feyrs gSaA buesa ls dsoy 4-8 gh vk;ksMhu   esa] total thyroidectomy esa lEiw.kZ Fkk;jkW;M xzafFk ds           ls tqM+dj  T3 ,oa  T4 dk fuekZ.k djrs gSaA ;gk¡   fudy tkus ds i'pkr~ rks Fkk;jksXykWC;qfyu dh mRifÙk gh           Fkk;jksXykWC;qfyu ds fo\"k; esa egRoiw.kZ rF; ;g gS fd   can gks tkuh pkfg,A ;fn blds i'pkr~ Hkh jä esa           Fkk;jkW;M  gkWekZsUl  ds  fuekZ.k  dh  çfØ;k,a]   Fkk;jksXykWC;qfyu  fey  jgk  gks]  rc  og  residual           Fkk;jksXykWC;qfyu ds fo'kky v.kq ds Åij gh laiUu gksrh   thyroid tissue, ectopic tissue ;k recurrence dk           gSaA cuus ds ckn Hkh ;g gkekZsUl] Fkk;jksXykWC;qfyu ls gh   |ksrd gksrk gSA           tqM+s jgrs gSa tks buds laxzg esa enn djrk gSA çR;sd           Fkk;jksXykWC;qfyu ls yxHkx 3-4 T4 tqM+s jgrs gSa tcfd      DEIODINASES           5 esa ls dsoy 1 Fkk;jksXykWC;qfyu ls gh ,d T3 tqM+k  vius uke ds vuq:i ;g ,atkbe] vk;Mks\&Fkk;jksuhu           gksrk gSA bl çdkj] Fkk;jksXykWC;qfyu esa laxzfgr gkWekZsUl  ekWyhD;wy ls ,d vk;ksMhu dks vyx djrs gSaA buesa           esa T4:T3 dk vuqikr yxHkx 15-20:1 jgrk gSA  mifLFkr selenium]  bl çfØ;k esa iodine acceptor           Fkk;jkW;M xzafFk esa yxHkx 5000 ekbØksxzke T4 laxzfgr   dh Hkkafr dk;Z djrk gSA           jgrk gSA 80 ekbØksxzke çfrfnu lzko.k dh nj ls ;g   T4 ,oa T3 esa nks\&nks dkcZu fjax gksrh gSaA gkbMªkWDlh           yxHkx 60 fnuksa ¼2 ekg½ ds fy, i;kZIr jgrk gSA  VfeZuy dh vksj Hkhrjh fjax ,oa ,ehuks VfeZuy dh vksj                                                     18","ckgjh fjaxA T4 dh ckgjh fjax ds ikapos dkcZu ¼5'½ ls  vfu;af=r gksus ls jksdus esa egRoiw.kZ Hkwfedk fuHkkrk gSA           vk;ksMhu gVkus ls lfØ; T3 dk fuekZ.k gksrk gSA blds           foijhr] T4 dh Hkhrjh fjax ds ikapos dkcZu ¼5½ ls     EFFECTS OF lODINE ON THYROID GLAND           vk;ksMhu gVkus ls fuf\"Ø;  reverse  T3 ¼rT3½ dk   ge tkurs gSa fd Fkk;jkW;M gkWekZsUl gekjs 'kkjhfjd           fuekZ.k gksrk gSA fM\&vk;ksfMus”ku ckgjh fjax dk gks jgk   fodkl ,oa esVkWckfyTe ds fy, vR;ar egRoiw.kZ gSaA           gS vFkok Hkhrjh fjax dk] ,oa ;g ,atkbe ds 'kjhj ds   lkFk gh Fkk;jkW;M gkWekZsUl ds fuekZ.k ds fy, vk;ksMhu           fdl  vax  esa  fey  jgk  gS]  blds  vkèkkj  ij   vR;ar vko';d gSA dSfY'k;e ,oa vk;ju tSls rRoksa ds           deiodinases dks rhu çdkjksa esa ckaVk tk ldrk gSA  foijhr] ç—fr esa vk;ksMhu vR;ar de ek=k esa miyCèk           Type 1 deiodinases (D1) - ;g T4 dh ckgjh fjax  gksrh gSA blhfy,] 'kjhj esa vk;ksMhu dh deh ls cpko           ds ikaposa dkcZu ¼5’½ ls vk;ksMhu gVkdj T3 dk fuekZ.k   ds fy, dqN vU; O;oLFkk,a Hkh fodflr gqbZaA vkb;s           djrs gSaA Fkk;jkW;M xzafFk esa ;gh D1, T4 dks T3 esa  budks le>rs gSaA           cnydj] xzafFk ls lzkfor gksus okys T3 dk çeq[k dkj.k   COMPENSATARY RESPONSES TO IODINE           curk gSA fyoj] fdMuh  ,oa Fkk;jkW;M  bR;kfn vusd   DEFICIENCY           vaxksa esa D1] lsy esEczsu ds fudV gh mifLFkr jgrk gSA  nksuksa Fkk;jkW;M gkWekZsUl esa T4 esa 4 vk;ksMhu ,oa T3 esa           blds çHkko ls dksf'kdk ds Hkhrj mRiUu T3 cM+h   3 vk;ksMhu yxs gksrs gSaA bu nksuksa esa T3 gh lfØ;           ljyrk ls lsy esEczsu ls yhd gksdj okil jä esa igq¡p  gkWekZsu gSA blhfy,] vk;ksMhu dh deh esa T4 dh vis{kk            tkrk gSA bl çdkj] fofHkUu vaxksa esa mifLFkr ;gh D1,   T3 dk mRiknu vfèkd c<+ tkrk gS ftlls vk;ksMhu dk           T4 dks T3 esa cnydj] jDr esa izokfgr gksus okys T3  ç;ksx de djds Hkh dke pyk;k tk ldsA vk;ksMhu dh           dk çeq[k dkj.k curk gSA                    deh esa peripheral deiodinase enzyme (D1)  dh           Type 2 deiodinases (D2) \& ;g Hkh T4 dh ckgjh   lfØ;rk c<+ tkus ls Hkh T4 dk T3 esa ifjorZu c<+           fjax ds ikaposa dkcZu ¼5'½ ls vk;ksMhu gVkdj T3 dk   tkrk gSA           fuekZ.k djrs gSaA ;g eq[;r%  efLr\"d] fiVîwVjh ,oa  ge tku pqds gSa fd jä esa mifLFkr T4 gh fiVîwVjh esa           brown adipose tissues esa dksf'kdk ds U;wfDy;l ds  igqapdj T3 esa cnyrk gS ,oa TSH ds lzko.k dks           fudV gh mifLFkr jgrs gSaA blds çHkko ls mRiUu T3]  fu;af=r djrk gSA T4 ds ?kV tkus ls ;g fuxsfVo           cM+h ljyrk ls U;wfDy;j esEczsu ls gksrs gq, U;wfDy;l  QhMcSd ?kV tkrk gS ,oa TSH dk lzko.k c<+us yxrk           ds Hkhrj igq¡p tkrk gS tgk¡ og Fkk;jkW;M gkWekZsUl }kjk  gSA           fu;af=r dk;ksZa ds laiknu esa egRoiw.kZ Hkwfedk fuHkkrk   TSH ds c<+us ls QkWfydy dh dksf'kdkvksa esa NIS,           gSA efLr\"d esa ;g U;wjkWUl dh xfrfof/k;ksa dks fu;af=r   TPO ,oa Fkk;jksXykWC;qfyu dk mRiknu c<+ tkrk gS           djrk gS] fiVîwVjh esa ;g Fkk;jkW;M gkWekZsUl dk QhMcSd   ftlds }kjk Fkk;jkW;M gkWekZsUl ds mRiknu dks c<+kus dh           dk fu;a=.k djkus ds fy, vko';d gksrk gS rFkk   ps\"Vk dh tkrh gSA           brown adipose tissues esa ;g thermogenesis esa           lgk;d gksrk gSA                            TSH] QkWfydy dh dksf'kdkvksa esa budk foHkktu Hkh                                                      c<+krk gS ftlls Fkk;jkW;M xzafFk vkdkj esa c<+dj           Type 3 deiodinases (D3) \& ;g T4 dh Hkhrjh   xkW;Vj dk :i ys ysrh gSA ;g Hkh Fkk;jkW;M gkWekZsUl ds           fjax ds ikaposa dkcZu ls vk;ksMhu dks gVkrs gq, rT3 dk   mRiknu dks c<+kus dk gh ,d ç;kl gSA           fuekZ.k djrs gSaA o;Ldksa esa ;g eq[;r%  efLr\"d ,oa   COMPENSATORY  RESPONSES  TO           IyklsaVk esa gh feyrk gS tgk¡ ;g T4 dks rT3 ds :i esa   CHRONIC IODINE EXCESS           fuf\"Ø; djrs gq, Fkk;jkW;M gkWekZsUl ds çHkkoksa dks   ftl çdkj] vk;ksMhu dh deh ls Fkk;jkW;M gkWekZsUl dk                                                      19","mRiknu  ?kV  ldrk  gS  mlh  çdkj  vk;ksMhu  dh  ls 'escape' dgrs gSaA           vfèkdrk] Fkk;jkW;M gkWekZsUl ds mRiknu dks c<+k Hkh   EFFECTS  OF  VERY  LARGE  DOSE  OF           ldrh gSA ijUrq ,slk çk—frd dkj.kksa ls u gksdj   IODINE           vfèkdrj vk;ksMhu dks nok ds :i esa ç;ksx fd;s tkus   Decrease in vascularity - vk;ksMhu dh ,d lkFk           ls gksrk gSA Ropk ij yxk;h tkus okyh povidone  nh x;h vR;fèkd ek=k dk çHkko yEcs le; rd feyh           iodine, radiographic contrast ds fy, ç;qä gksus  lkekU; ls vfèkd ek=k ls loZFkk fHkUu gksrk gSA blesa           okyh intravenous dye ,oa cardiac arrhythmias ds  QkWfydy  dh  dksf'kdkvksa  dks  Fkk;jksXykWC;qfyu  dk           fy, ç;qä gksus okyh  amiodarone] dqN ,slh gh  vkWxsZfufQds”ku ?kVkus vFkok NIS  expression de           vk;ksMhu ;qä nokvksa ds mnkgj.k gSaA       djds vk;ksMkbM VSªfiax ?kVkus dk Hkh le; ugha feyrkA           'kjhj  dks  vk;ksMkbM  dh  vfèkd  ek=k  feyus  ij   ,sls esa xzafFk esa rhu çdkj ds ifjorZu gksrs gSaA           Fkk;jkW;M xzafFk blls lkeatL; LFkkfir djus dk ç;kl   Decrease in follicular proliferation - QkWfydy           fuEu çdkj ls djrh gSA                      dh dksf'kdkvksa esa vkWVks\&jsxqys”ku  ds }kjk Fkk;jkW;M           loZçFke] vk;ksMkbM dh vfèkd ek=k Fkk;jkW;M esa   gkWekZsUl ds lzko.k dks gh ,dk,d jksd fn;k tkrk gSA tks           igqapdj Fkk;jkW;M gkWekZsUl dk mRiknu c<+kus yxrh gSA  FkksM+k\&cgqr gkWekZsUl lzkfor gks Hkh ik jgk gksa] muds                                                      'kjhj esa igq¡pus dh xfr dks èkhek djus ds fy,           Wolff-Chaikoff  effect-  'kh?kz  gh  tc  Fkk;jkW;M           QkWfydy  dh  dksf'kdkvksa  esa  vk;ksMkbM  dh  ek=k   vasoconstriction ds }kjk xzafFk esa jä çokg dks èkhek           vko';drk  ls  vfèkd  gks  tkrh  gS  rc  'kjhj  dks   djk fn;k tkrk gSA           Fkk;jkW;M gkWekZsUl dh vfèkdrk ds nq\"çHkko ls cpkus ds   Clinical  application  -  bl çdkj ls 'kjhj dks           fy,  bu  dksf'kdkvksa  esa  vkWVks\&jsxqys”ku  dh  çfØ;k  Fkk;jkW;M gkWekZsUl dh vfèkdrk ds rkRdkfyd nq\"çHkkoksa           vkjEHk gks tkrh gSA ,sls esa QkWfydy dh dksf'kdkvksa esa  ls cpk fy;k tkrk gSA bl cpko dks vkxs cuk;s j[kus           vk;ksMkbM  dh  ek=k  vfèkd  gksrs  gq,  Hkh]  budk  ds fy, QkWfydy dh dksf'kdkvksa ds foHkktu ,oa çlkj           Fkk;jksXykWC;qfyu ls tqM+dj mldk vkWxsZfufQds”ku djk  ¼proliferation½ dks Hkh ?kVk fn;k tkrk gSA           ikuk #dus yxrk gS ftlls Fkk;jkW;M gkWekZsUl dks   vk;ksMhu dh acute, large dose ds çfr Fkk;jkW;M           vfu;af=r ek=k esa cuus ls jksdk tk ldsA bls Wolff-  xzafUFk  dh  mijksä  çfrfØ;kvksa  dk  mi;ksx  xaHkhj]           Chaikoff effect  dgrs gSaA                                                       vfu;af=r  gkbijFkk;jkW;fMTe  ¼tSls  thyrotoxic           Escape from wolff-chaikoff effect vfèkd yEcs   crisis½ esa fd;k tkrk gSA blls Fkk;jkW;M gkWekZsUl ds           le; rd vk;ksMkbM dh vfèkd ek=k feyrs jgus ij]  lzko.k dks jksd djds Fkk;jkW;M gkWekZsUl ds Lrj dks           QkWfydy dh dksf'kdkvksa esa blls cpus dk ,d vkSj  rkRdkfyd rkSj ij ?kVk ikus esa lQyrk fey tkrh gSA           ekè;e Hkh vkjEHk gks tkrk gSA QkWfydy dh dksf'kdkvksa  blds vfrfjä] gkbijFkk;jkW;fMTe esa Fkk;jkW;M dh           dh  basolateral  membrane  ij  NIS  dk  ltZjh  dh  vko';drk  iM+us  ij  bldks  xzafFk  dh           expression ?kVus yxrk gS ftlls vk;ksMkbM VSªfiax  oSLdqySfjVh de djus ds fy, Hkh ç;ksx esa yk;k tk           ?kVus yxrh gSA blls vk;ksMkbM dh vfèkd ek=k dks  ldrk gSA           QkWfydy dh dksf'kdkvksa esa ços'k djus ls gh cpk fy;k   vk;ksMhu dh acute, large dose ds izfr Fkk;jkW;M           tkrk gSA bl çdkj vk;ksMkbM VSªfiax ds ?kVus ls dqN   xazfUFk  dh  mijksDr  izfrfØ;kvksa  dk  mi;ksx  xaHkhj]           le; esa dksf'kdkvksa ds Hkhrj vk;ksMhu dh ek=k Hkh de           gks tkrh gS ftlls acute Wolff-Chaikoff effect Hkh   vfu;af=r  gkbijFkk;jkW;fMTe  ¼tSls  thyrotoxic                                                      crisis½ esa fd;k tkrk gSA blls Fkk;jkW;M gkWekZsUl ds           Øe'k% lekIr gks tkrk gSA bls Wolff-Chaikoff effect                                                      lzko.k dks jksd djds Fkk;jkW;M gkWekZsUl ds Lrj dks                                                    20","rkRdkfyd rkSj ij ?kVk ikus esa lQyrk fey tkrh gSA  oSLdqySfjVh de djus ds fy, Hkh ç;ksx esa yk;k tk           blds vfrfjä] gkbijFkk;jkW;fMTe esa Fkk;jkW;M dh  ldrk gSA           ltZjh  dh  vko';drk  iM+us  ij  bldks  xzafFk  dh                                                                                                                       21","3                             Transport and Regulation of Secretion of Thyroid Hormones (TH)             TRANSPORT OF TH IN CIRCULATION              i'pkr~ çHkko yxHkx 40 fnu ¼T1/2 x 5 = 40½ rd           Fkk;jkW;M xzafFk ls lzkfor gksus okys Fkk;jkW;M gkWekZsUl dk   cuk jgrk gSA blds foijhr] T3 dk caèku vis{kk—r           yxHkx 93% Hkkx T4 ,oa dsoy 7% Hkkx gh T3 gksrk   detksj gksus ds dkj.k ;g 'kh?kzrk ls eqä gksrk tkrk           gSA okLro esa ;g T3 gh lfØ; Fkk;jkW;M gkWekZsu gSA T4   gS ¼gkQ ykbQ ~1 fnu½ ftlds dkj.k bldk çHkko           dks rks bldk izks\&gkWeksZu gh ekuuk pkfg, D;ksafd lzko.k   Hkh FkksM+s le; ¼4–5 fnu½rd gh jgrk gSA            ds ckn ;g T4] type 1 deiodinase enzyme (D1)    2. Prevents excretion of TH - IykTek çksVhUl ls           dh enn ls Øe'k%  T3  esa cnyrk tkrk gSA ;g   tqM+s gksus ds dkj.k Fkk;jkW;M gkWekZsUl dh fyoj ds           deiodinase enzyme, T4 dh ckgjh dkcZu fjax ds    }kjk  esVkckWfyTe  ,oa  fdMuh  ds  }kjk  mRltZu           ikaposa LFkku ¼5'½ dh vk;ksMhu dks gVkdj T3 dk   ¼excretion½ Hkh ?kV tkrk gSA bl çdkj ls IykTek           fuekZ.k djrh gSA bl çdkj ls jä esa feyus okyk   çksVhUl] Fkk;jkW;M gkWekZsUl dh dk;kZofèk ¼duration           yxHkx 80% T3, T4 ds fM\&vk;ksfMus”ku ls gh çkIr   of action½ c<+kus esa Hkh lgk;d gksrh gSaA           gksrk gSA                                                      3. Helps in transport of TH - buds vfrfjä] ;g           Fkk;jkW;M  gkWekZsUl  ,oa  LVsjkW;M  gkWekZsUl  esa  vusd   Fkk;jkW;M gkWekZsUl ds jä esa vkokxeu esa rks enn           lekurk,a gSaA ty esa ?kqyu'khy u gksus ds dkj.k bu   djrh gh gSaA           nksuksa dk jä esa vkokxeu Lora= :i ls ugha gks ldrkA   THYROXINE BINDING GLOBULIN (TBG)           blhfy,] Fkk;jkW;M xzafFk ls lzkfor gksus ds i'pkr]           'kjhj dh fofHkUu dksf'kdkvksa rd igq¡pus ds fy, bUgsa   ;g Fkk;jkW;M gkWekZsUl dh loZçeq[k VªkaliksVZj izksVhu gSA           IykTek çksVhUl dh lgk;rk ysuh iM+rh gSA yxHkx 99%   Fkk;jkW;M gkWekZsUl ds çfr bldh tqM+us dh {kerk vfèkd           Fkk;jkW;M gkWekZsUl] IykTek çksVhUl ls tqM+s jgrs gSaA buesa   gksus ¼high affinity½  ds dkj.k jä esa mifLFkr yxHkx                                                      80% T4 ,oa T3 blh ls tqM+s jgrs gSaA ijUrq] jä esa           çeq[k  gSa]  thyroxine  binding  globulin  (TBG),                                                      budh ek=k lhfer (low capacity)  gksus ds dkj.k] ,d           transthyretin ;k thyroxine binding prealbumin                                                      lhek rd gh Fkk;jkW;M gkWekZsUl blls tqM+ ldrs gSA           (TBPA) ,oa albumin.                                                      TBG dk çR;sd v.kq] ,d T4 vFkok ,d T3 ls tqM+           FUNCTIONS OF PLASMA PROTEINS               ikrk gSA jä esa TBG dk Lrj c<+us ls ;g vfèkdkfèkd           okLro esa ;g IykTek çksVhUl] Fkk;jkW;M gkWekZsUl dh   T4 ,oa T3 dks vkdf\"kZr djds vius ls tksM+rh tkrh gS           esVkckWfyTe dks eq[;r% rhu çdkj ls çHkkfor djrh gSaA   ftlls T4 ,oa T3 ds jä esa Lrj Hkh c<+rs tkrs gSaA           1. Storage of TH - ;g Fkk;jkW;M gkWekZsUl ds Hk.Mkj   Dyhfudy egÙo \& xHkkZoLFkk ,oa  bZLVªkstsu ds mi;ksx ls              ds  :i  esa  dk;Z  djrh  gSa  ftuesa  ls  gkWekZsUl   TBG ds Lrj c<+ tkrs gSa tks total T4 ,oa T3 ds Lrjksa             vko';drkuqlkj èkhjs\&èkhjs eqä gksrs jgrs gSaA IykTek   dks Hkh c<+k nsrs gSaA buds foijhr] VsLVksLVsjkWu  dk             çksVhUl ,oa Fkk;jkW;M gkWekZsUl ds eè; dk ;g caèku]   mi;ksx] TBG ds Lrj dks ?kVkdj] total T4 ,oa T3 ds             T3 dh vis{kk T4 ds fy, vfèkd 'kfä'kkyh gksrk gS   Lrjksa dks Hkh ?kVk nsrk gSA             ftlds dkj.k] T3 dh vis{kk T4 dh eqfä] vfèkd             èkhjs gksrh gSA okLro esa dqy T4 dh vkèkh ek=k dks   TBG] Fkk;jkW;M gkWekZsUl ds mrkj\&p<+koksa ds le;             eqä gksus esa yxHkx 6-8 fnu yx tkrs gSa ¼gkQ ykbQ   'kjhj esa larqyu cuk;s j[kus esa Hkh lgk;d gksrh gSA             ;k T1/2 ~8 fnu½ ftlls bldk jä esa igq¡pus ds   gkbijFkk;jkW;fMTe esa jä esa Fkk;jkW;M gkWekZsUl dh                                                     22","ek=k c<+ tkus ij TBG ds Lrj Hkh c<+ tkrs gSa ftlls  çksVhUl ls tqM+s gksus ds dkj.k ;g dSfiyjh ls fudydj           og ,d lhek rd Fkk;jkW;M gkWekZsUl dh vfèkd ls  'kjhj  dh  fofHkUu  dksf'kdkvksa  esa  ugha  igq¡p  ikrsA           vfèkd ek=k dks vius ls tksM+dj] 'kjhj dks mlds  blhfy, çksVhu ls tqM+s gq, Fkk;jkW;M gkWekZsUl 'kjhj dh           nq\"ifj.kkeksa  ls  cpk  ysrh  gSA  blds  foijhr]  fofHkUu dksf'kdkvksa dks miyCèk ugha gksrsA ;g Fkk;jkW;M           gkbiksFkk;jkW;fMTe esa jä esa Fkk;jkW;M gkWekZsUl dh ek=k  gkWekZsUl ds fuf\"Ø; va'k ¼inactive fraction½ dgykrs           ?kV tkus ij TBG ds Lrj Hkh ?kV tkrs gSa ftlls vfèkd  gSa o buds HkaMkj ds :i esa miyCèk jgrs gSaA           ls vfèkd ek=k esa Fkk;jkW;M gkWekZsUl] eqä ¼free T4 ,oa   Free fraction \& T4 ,oa T3 dk 1% ls Hkh de Hkkx]           T3½ gksdj dk;Z djus ds fy, Lora= gks tkrs gSaA  IykTek çksVhUl ls tqM+k u gksus ds dkj.k] dSfiyjh ls           ALBUMIN                                    fudydj 'kjhj dh fofHkUu dksf'kdkvksa rd igq¡pus ds           TBG ds foijhr ,YC;wfeu dh Fkk;jkW;M gkWekZsUl dks  fy, Lora= gksrk gSA okLro esa ;gh Fkk;jkW;M gkWekZsUl dk           vkdf\"kZr djus dh {kerk de gksrh gS (low affinity) A  lfØ; va'k ¼active fraction½ gS tks 'kjhj dh fofHkUu           blhfy, T4 ,oa T3 dk dsoy 10% Hkkx gh ,YC;wfeu  dksf'kdkvksa ij dk;Z djus ds fy, ,oa fiVîwVjh ij           ds caèku esa jgrk gSA ijUrq ,YC;wfeu dk jä esa Lrj  fuxsfVo QhM cSd çHkko mRiUu djus ds fy, miyCèk           vR;fèkd (4 mg/dl) gksus ds dkj.k ;g T4 ,oa T3 dh  jgrk gSA           cM+h ek=k dk ogu dj ldrs gSa (high capacity) A  Dyhfudy egÙo \& gkbiksFkk;jkW;fMTe esa Fkk;jkW;M            Dyhfudy egÙo \& Liver cirrhosis ,oa  nephrotic  gkWekZsUl dk mRiknu ?kVus ij free T4 ,oa T3 ds Lrj           syndrome esa jä esa ,YC;wfeu dk Lrj ?kV tkus ds  Hkh ?kVus yxrs gSa ftlls 'kjhj esa Fkk;jkW;M gkWekZsUl ds           dkj.k bu ifjfLFkfr;ksa esa total T4 ,oa T3 ds Lrj Hkh  çHkko de gksus yxrs gSaA bldks larqfyr djus ds ç;kl           ?kV  tkrs  gSaA  buds  vfrfjä]  dqN  familial  esa  TBG ds Lrj Hkh ?kV tkrs gSa ftlls miyCèk           dysalbuminic syndromes esa tgk¡ ,YC;wfeu ds Lrj  Fkk;jkW;M gkWekZsUl dh vfèkd ek=k] IykTek çksVhUl ls           de gksrs gSa] muesa Hkh total T4 ,oa T3 ds Lrj de  tqM+s jgus ds LFkku ij eqä ,oa lfØ; :i esa miyCèk gks           feyrs gSaA blhfy,] bu lHkh ifjfLFkfr;ksa esa Fkk;jkW;M  tkrh gSA bl çdkj] Fkk;jkW;M gkWekZsUl ds mRiknu ,oa           gkWekZsUl dh okLrfod fLFkfr dk vkdyu djus ds fy,  lzko.k dks çHkkfor fd;s fcuk gh] dqN lhek rd budk           free T4 ,oa T3 dh tkap dk mi;ksx fd;k tkuk  çHkko ?kVk ,oa c<+k fy;k tkrk gSA           pkfg,A                                     THYROID HORMONES IN CIRCULATION            TRANSTHYRETIN                              FkkW;jksXykWC;qfyu esa laxzfgr Fkk;jkW;M gkWekZsUl esa T4:T3           blds uke (Trans - thy - retin) ls gh Li\"V gS fd ;g  yxHkx 15-20:1 gksrk gSA           çksVhu] Fkk;jkW;M gkWekZsUl ,oa foVkfeu E (retinol) ds   Fkk;jkW;M xzafFk ls lzkfor gksus okys gkWekZsUl dk 93%            vkokxeu ds fy, ç;qä gksrh gSA iwoZ esa bls thyroid   Hkkx T4 ,oa 7% Hkkx T3 ¼T4:T3 yxHkx 10-13:1½           binding prealbumin (TBPA) Hkh dgk tkrk FkkA T3   gksrk gSA ,slk blfy, D;ksafd QkWfydy dh dksf'kdkvksa esa           ux.; :i ls ,oa T4 dk dsoy 10% Hkkx gh blds   mifLFkr ,atkbe D1 ds dkj.k T4 dh dqN ek=k] T3 esa           }kjk ys tk;k tkrk gSA                      cny tkrh gSA            PROTEIN BOUND AND FREE HORMONES            T4 \& jä esa feyus okyk 100% T4] Fkk;jkW;M xzafFk ds           jä esa Fkk;jkW;M gkWekZsUl nks :iksa esa feyrs gSaA  }kjk lzkfor gksrk gSA           Protein bound fraction \& ty esa ?kqyu'khy u gksus           ds dkj.k 99% ls vfèkd T4 ,oa T3] IykTek çksVhUl   T3 \& blds foijhr] jä esa feyus okyk dsoy 20% T3           ls tqM+s jgdj gh jä esa lapj.k dj ikrs gSaA IykTek   gh Fkk;jkW;M xzafFk ds }kjk lzkfor gksrk gSA 'ks\"k 80%                                                     23","T3] 'kjhj ds vU; vaxksa ¼eq[;r% fyoj½ esa] D1 ds }kjk  fofHkUu dksf'kdkvksa ds Hkhrj ços'k dj tkrs gSaA ijUrq           T4 ds fM\&vk;ksfMus”ku  ls çkIr gksrk gSA   vc ;g tkuk tk pqdk gS fd bl dk;Z esa dqN VªkaliksVZlZ            rT3 \& jä esa feyus okyk 100% rT3] 'kjhj ds vU;   dh vko';drk Hkh iM+rh gSA ;s gSa \&           vaxksa ¼eq[;r% efLr\"d] IyklsaVk ,oa fyoj½ esa] D3 ds   1. Organic anion transporting polypeptide                                                        (OATP) \& ;g 'kjhj dh vfèkdk¡'k dksf'kdkvksa esa           }kjk T4 ds fM\&vk;ksfMus”ku ls çkIr gksrk gSA  feyrs gSaA T4 ,oa T3 nksuksa buds }kjk dksf'kdkvksa esa                                                        ços'k dj ldrs gSaA             METABOLISM OF TH                         2. Monocarboxylase transporter 8 (MCT8) \&           Metabolites of TH                            ;g eq[;r% U;wjkWu esa feyrs gSaA buds }kjk dsoy T4           'kjhj esa T4 dks vusd fofèk;ksa }kjk vU; inkFkksZa esa   gh U;wjkWu esa ços'k dj ikrs gSaA           cnyk tk ldrk gSA                           3. L-type amino acid transporter (LAT)           Recycling \& Fkk;jkW;M QkWfydy dh dksf'kdkvksa esa                                                        ACTIONS OF TH           lzko.k  ls  iwoZ  gh  T4  dh  vfrfjä  ek=k  dks   dksf'kdkvksa  ds  Hkhrj  igqapdj  Fkk;jkW;M  gkWekZsUl]           iodotyrosine  deiodinase  ds  }kjk  nks  DIT  esa   dksf'kdk dh çksVhu ls tqM+dj laxzfgr gks tkrs gSaA ;gk¡ ls           cnydjA                                     og èkhjs\&èkhjs eqä gksdj U;wfDy;l esa fLFkr vius           Activation \& Fkk;jkW;M QkWfydy dh dksf'kdkvksa]           yhoj ,oa fdMuh esa T4 dks D1 ds }kjk ,oa efLr\"d]   fjlsIVlZ rd igq¡prs gSaA Fkk;jkW;M gkWekZsUl viuk çHkko                                                      gene transcription dks çHkfor djds] u;h çksVhu ds           fiVîwVjh ,oa brown adipose tissue esa D2 ds }kjk           T3 esa cnydjA                              fuekZ.k ds ekè;e ls mRiUu djrs gSaA bl leLr çfØ;k           Inactivation \& efLr\"d ,oa IyklsaVk esa T4 dks D3 ds   esa yxHkx 2-3 fnuksa dk le; yx tkrk gSA           }kjk rT3 esa cnydjA                        bl çdkj ge le> ldrs gSa fd u;h çksVhu ds fuekZ.k           Glucuronidation and sulfation \& yhoj esa T4  ds ekè;e ls dk;Z djus ds dkj.k Fkk;jkW;M gkWekZsUl dk           dks  glucuronic  acid  vFkok  sulphate  ds  lkFk  çHkko èkhjs\&èkhjs vkjEHk gksrk gS ,oa dksf'kdk dh çksVhu           tksM+dj] ty esa ?kqyu'khy cukdj] ckby ds }kjk 'kjhj   ls caèks gksus ds dkj.k ;g yEcs le; rd cuk jgrk gSA           ls ckgj fudkyus ds fy,A                    ge tkurs gSa fd fdlh inkFkZ dh dk;kZofèk mldh gkQ            Dyhfudy egÙo \& Phenytoin, phenobarbi - tone,   ykbQ ds yxHkx 5 xqus ds cjkcj gksrk gSA bl çdkj]           rifampicin ,oa  sertraline dqN çeq[k nok,a gSa tks           Fkk;jkWfDlu dk  glucuronidation c<+kdj jä esa   T4 dh dk;kZofèk yxHkx 40 fnu gksrh gSA T3 dh           blds Lrj dks ?kVkrh gSaA blhfy,] bu nokvksa ds mi;ksx   lfØ;rk vfèkd gksus ,oa bldh çksVhu ls tqM+s gksus dh           ds lkFk Fkk;jkWfDlu dh Mkst dks Hkh c<+kuk iM+rk gSA   'kfä de gksus ds dkj.k ;g 8-12 ?kaVksa esa gh dk;Z                                                      djuk vkjEHk dj nsrh gS vkSj yxHkx 4-5 fnuksa rd           T3 dk ,d vU; esVkcksykbV] 3-iodo thyronamine                                                      viuk çHkko cuk;s j[k ldrh gSA Fkk;jkW;M gkWekZsUl dk           (T1AM)  Hkh çLrkfor gS tks dqN vKkr  orphan           receptors ds }kjk Fkk;jkW;M gkWekZsUl ds foijhr dk;Z   xzafFk esa laxzfgr jguk] jä esa IykTek çksVhu ls tqM+s           djrk gSA                                   jguk ,oa var esa 'kjhj dh fofHkUu dksf'kdkvksa esa iqu%                                                      çksVhu ls tqM+dj laxzfgr gks tkuk okLro esa fodkl\&Øe           ENTRY OF TH  IN PERIPHERAL CELLS           çkjEHk esa ;g le>k tkrk Fkk fd fyfiM esa ?kqyu'khy   esa mRiUu gqvk ,d y{k.k gS ftlls fofHkUu _rqvksa esa           gksus ds dkj.k] Fkk;jkW;M gkWekZsUl cM+h ljyrk ls   cnyrh  gqbZ  vk;ksMhu  dh  miyCèkrk  ls  Fkk;jkW;M                                                      24","gkWekZsUl ds Lrj çHkkfor u gks ldsaA       LokHkkfod :i ls tks gkbiksFkSysfed U;wjkWUl] median                                                      eminence rd gh tkrs gSa] os yEckbZ esa NksVs gksrs gSaA            HYPOTHALMIC - PITUITARY - THYROID            AXIS (HPT AXIS)                           blhfy, mUgsa parvicellular  neurons   ¼ySfVu 'kCn           vU; gkWekZsUl dh Hkkafr Fkk;jkW;M gkWekZsUl ds Lrjksa esa   parvi ¾ NksVk½ dgrs gSa ,oa buds feyus ls cuus okys           nSfud :i esa vfèkd mrkj\&p<+ko ugha feyrkA tjk   lewg dks  hypophyseotropic  tract  dgrs gSaA buds           lkspsa] bldk D;k dkj.k gks ldrk gS\\ okLro esa] vU;   foijhr]  gkbiksFkSysel  ls  fudydj]  median           baMksØkbu xzafFk;ksa ls Fkk;jkW;M ,d :i esa fHkUu gS fd   eminence dks ikj djds] iksLVhfj;j fiV~;wVjh rd           blesa yxHkx nks ekg dh vko';drk Hkj dh vk;ksMhu   tkus okys U;wjkWUl dks magnicellular neurons ¼ySfVu           ,oa Fkk;jkW;M gkWekZsUl laxzfgr jgrs gSaA ;gh laxzfgr   'kCn magni ¾ cM+k½ dgrs gSa ,oa buls cuus okys lewg           vk;ksMhu ,oa Fkk;jkW;M gkWekZsUl ,d buffer ds :i esa   dks neurohypophyseal tract dgrs gSaA           dk;Z djrs gq,] 'kjhj esa blds Lrjksa dks ,d leku   TRH           cuk;s j[kus esa enn djrs gSaA blhfy,] vU; gkWekZsUl ds   'kjhj esa Fkk;jkW;M gkWekZsUl ds çHkkoksa dks fu;af=r djus           foijhr] Fkk;jkW;M gkWekZsUl ds QhMcSd jsxqys”ku dk   ds fy, hypophyseotropic tract ds parvicellular           çHkko mRiUu gksus esa vis{kk—r vfèkd le; yxrk gSA  neurons]  gkbiksFkSysel  ds  periventricular   ,oa                                                      paraventricular nuclei ls vkjEHk gksrs gSaA Median           vius uke ds vuq:i HPT Axis ds rhu Lrj gksrs gSa]                                                      eminence  rd  igqapdj  ;g  hypothalamo  -           gkbiksFkSysel]  fiVîwVjh  ,oa  Fkk;jkW;M  xzafFkA  buds                                                      hypophyseal  portal  vessels  esa  thyrotropin           vfrfjä ,d Lrj 'kjhj dh mu lHkh dksf'kdkvksa dk Hkh   releasing hormone (TRH) dk lzko.k djrs gSaA vU;            gksrk gS ftu ij Fkk;jkW;M gkWekZsUl dk;Z djrs gSaA ijUrq   isIVkbM gkWekZsUl dh Hkkafr gh TRH Hkh igys ,d cM+s           'kjhj dh ;g dksf'kdk,a] Fkk;jkW;M gkWekZsUl ds lzko.k   prepro-TRH ds :i esa curk gS ftlds la'ys\"k.k ls 3           (secretion) dks fu;af=r djus esa dksbZ Hkwfedk ugha   ,ehuks ,flM okyk (tripeptide)  TRH mRiUu gksrk gSA           fuHkkrhaA                                  Hypothalamic-pituitary portal system }kjk ;g            HYPOTHALAMUS                               TRH,  ,UVhfj;j fiV~;wVjh esa igq¡prk gS tgk¡ ;g                                                      thyrotropes dks mÙksftr djrk gSA           ;kn jgs] fiVîwVjh xzafFk dks 'master of endocrine           orchestra' dgk tkrk gS ijUrq] gkbiksFkSysel rks bl   PITUITARY           ekLVj xzafFk dk Hkh ekLVj gSA okLro esa] ,UVhfj;j   'kjhj esa Fkk;jkW;M gkWekZsUl ds çHkkoksa dks fu;af=r djus           fiV~;wVjh ls fudyus okys lHkh gkWekZsUl] gkbiksFkSysel ls   ds fy,  ,UVhfj;j fiV~;wVjh esa thyrotrope   (suffix           fudyus okys gkWekZsUl ds fu;a=.k esa gh jgrs gSa] tks   trope=direction vFkkZr Fkk;jkW;M dh vksj directed½           gkbiksFkSysfed U;wjkWUl ds fljksa ls] pituitary stalk ds   ;k thyrotroph  ¼suffix troph - nutrient vFkok food(           Åij] median eminence esa lzkfor gksrs gSa ,oa ogka   vFkkZr Fkk;jkW;M ds fy, iks\"k.k dh Hkkafr dk;Z djds           ls hypothalamo-hypophyseal portal system  ds   mlds fodkl esa enn djus okyh½ dksf'kdkvksa ds }kjk           ekè;e ls ,UVhfj;j fiV~;wVjh rd igq¡prs gSaA iksLVhfj;j   thyroid stimulating hormone (TSH) dk fuekZ.k           fiV~;wVjh ls rks okLro esa bldk dksbZ viuk gkWekZsu   fd;k tkrk gSA Thyrotropes esa cuus ds dkj.k bls           fudyrk gh ugha gSA blds nksuksa gkWekZsUl] gkbiksFkSysel   thyrotropin  Hkh  dgrs  gSaA  Thyrotrope  cells]           esa gh curs gSa ,oa mlh ls fudyus okys gkbiksFkSysfed   fiVîwVjh ds anteromedial Hkkx esa fLFkr gksrh gSa ,oa           U;wjkWUl] tks posterior pituitary rd tkrs gSa] mUgha ds   xzafFk dk yxHkx 5% Hkkx cukrh gSaA Thyrotropes ij                                                      gh TRH ds fjlsIVlZ gksrs gSa ftuij dk;Z djds TRH]           fljksa ls lzkfor (secrete) gksrs gSaA                                                      thyrotropes }kjk TSH ds fuekZ.k dks c<+krk gSA                                                    25","TSH                                        lajpukRed ,oa dk;kZRed ifjorZu nksuksa çdkj ds           TRH }kjk mÙksftr fd;s tkus ij thyrotropes] TSH  ifjorZu mRiUu djkrk gSA           dk fuekZ.k djrh gSaA lajpukRed :i ls TSH ,d   STRUCTURAL CHANGES            XykbdksçksVhu  gkekZsu  gS  tks   vYQk  ,oa  chVk  nks   - Fkk;jkW;M gkWekZsUl dk mRiknu c<+kus ds fy, QkWfydy           lc;wfuV~l ds feyus ls curk gSA              dh dksf'kdkvksa ds vkdkj ,oa la[;k esa o`f)            fdlh Hkh vU; çksVhu dh Hkkafr gh TSH dk fuekZ.k Hkh   - Fkk;jksXykWC;qfyu  dk  mRiknu  c<+kus  ds  fy,  jQ           thyrotropes ds jQ ,.MksIykfTed jsVhdqye esa gksrk   ,.MksIykfTed jsVhdqye ,oa xkWYxh vijsVl dh ek=k           gSA blds i'pkr~ xkWYxh vijsVl esa blesa dkckZsgkbMªsV   esa o`f)           ;wfuV tksM+h tkrh gS (glycosylation / sialylation)A   - vis{kk—r de lfØ; pkSdksj ¼cuboidal½ dksf'kdkvksa           fdlh XykbdksçksVhu dh dkckZsgkbMªsV ;wfuV gh mldh                                                       ds Åijh Hkkx esa Fkk;jkW;M gkWekZsUl ls Hkjh secretory           lfØ;rk ds fy, vko';d gksrh gSA TRH] eq[; :i ls   vesicles  ds ,df=r gksrs tkus ds dkj.k mudk           blh glycosylation / sialylation dks c<+kdj TSH dks           vkSj vfèkd lfØ; ¼bioactive½ cukrk gSA       vfèkd lfØ; LraHkkdkj ¼columnar½ dksf'kdkvksa esa                                                       ifjorZu           fdlh Hkh vU; fiVîwVjh gkWekZsu dh Hkkafr TSH dk           lzko.k Hkh yxkrkj ,dlkj u gksdj] dqN\&dqN nsj esa   - QkWfydy dh dksf'kdkvksa esa laxzfgr FkkW;jksXykWC;qfyu           NksVh\&NksVh  pulses  ds :i esa gksrk gSA ijUrq bu   ,oa Fkk;jkW;M gkWekZsUl dks 'kh?kzrk ls fudkyus ds fy,                                                       buds Åijh Hkkx esa villous projections dh mRifÙk           pulses ds amplitude de ,oa TSH dh gkQ ykbQ           yEch gksus ds dkj.k ;g jä esa TSH ds Lrj ij dksbZ   - bu lHkh ifjorZuksa ds dkj.k Fkk;jkW;M xzafFk ds vkdkj           fo'ks\"k çHkko ugha Mky ikrh gSaA            esa o`f) ¼goiter formation½            THYROID                                    - c<+h gqbZ esVkckWfyd xfrfofèk;ksa ds dkj.k QkWfydy dh           TSH] jä ds }kjk Fkk;jkW;M xzafFk rd igq¡prk gSA ,d   dksf'kdkvksa dh vko';drkvksa dks iwjk djus ds fy,                                                       Fkk;jkW;M xzafFk esa jä çokg dk c<+uk           isIVkbM gkWekZsUk gksus ds dkj.k TSH ds fjlsIVlZ ¼TSH-           R½] Fkk;jkW;M QkWfydy dh dksf'kdk dh ckgjh lrg   FUNCTIONAL CHANGES           ¼basolateral membrane½ ij gh jgrs gSaA ;g  G   - Fkk;jkW;M gkWekZsUl ds mRiknu esa o`f) ds fy, TSH]           protein  coupled  receptors  (GPCR)  gksrs  gSa   blds  lHkh  pj.kksa  (iodide  trapping,  iodide           ftlesa ,d extracellular  ligand  (TSH)  binding   oxidation  and  organification,  coupling,           domain,  7  transmembrane  domains ,oa ,d   storage ,oa release) dks c<+krk gSA           intracellular  domain gksrs gSaA blh intracellular   - vk;ksMkbM VSªfiax dks c<+kus ds fy, Na-I symporter           domain ls yxh Gs  alpha  protein dks mÙksftr   (NIS) dk fuekZ.k           djkdj TSH] adenylyl cyclase ,oa cyclic AMP                                                      - vk;ksMkbM vkWDlhMs”ku dks c<+kus ds fy, TPO ,oa           dks c<+krk gSA Cyclic  AMP gh  TSH dk  second   hydrogen peroxide dk fuekZ.k           messenger  gS  tks  QkWfydy  dh  dksf'kdkvksa  esa           Fkk;jkW;M gkWekZsUl ds mRiknu dks c<+krk gSA   - Fkk;jkW;M  gkWekZsUl  dk  mRiknu  c<+kus  ds  fy,                                                       FkkW;jksXykWC;qfyu dk fuekZ.k             EFFECTS OF TSH ON THYROID GLAND          - FkkW;jksXykWC;qfyu esa laxzfgr Fkk;jkW;M gkWekZsUl dk           Fkk;jkW;M  QkWfydy  dh  dksf'kdkvksa  ij  TSH]   lzko.k djkus ds fy, bldh proteolysis esa o`f)                                                     26","REGULATION OF THYROID HORMONE             ij ;g fuxsfVo QhMcSd ?kV tkrk gS ftlls TRH ,oa            SECRETION                                                      TSH ds lzko.k nksckjk c<+us yxrs gSa ftlls Fkk;jkW;M           mijksä fooj.k ls ge le> ldrs gSa fd TRH, TSH   gkWekZsUl dk mRiknu ds c<+us ls T3 ,oa T4 ds Lrj           ,oa  Fkk;jkW;M  gkWekZsUl  ¼T3  ,oa  T4½  ds  :i  esa]   c<+rs gq, nksckjk lkekU; gks tkrs gSaA           gkbiksFkSysel] fiVîwVjh ,oa Fkk;jkW;M xzafFk] ,d Øe esa           dk;Z djrs gq,] ,d nwljs dh xfrfofèk;ksa dks çHkkfor   vkb;s]  Fkk;jkW;M  gkWekZsUl  ds  fuxsfVo  QhMcSd  ls           djrs gSaA blh dks HPT axis  dgrs gSaA var esa T3 ,oa   lEcafèkr ,d jkspd rF; dks le>rs gSaA ge tku pqds gSa                                                      fd nksuksa Fkk;jkW;M gkWekZsUl esa T3 gh lfØ; gkWekZsu gS           T4 gkWekZsUl] 'kjhj dh leLr dksf'kdkvksa ¼target           cells½ ij viuk çHkko mRiUu djrs gSaA è;ku jgs]   vr% LokHkkfod :i ls gesa ;gh yxuk pkfg, fd ;g           HPT axis ds rhuksa Lrj rks ,d\&nwljs dks çHkkfor djrs   fuxsfVo QhMcSd Hkh eq[;r% T3 }kjk gh lapkfyr gksrk           gSa ijUrq target cells lhèks rkSj ij HPT axis dh   gksxkA ijUrq ,slk ugha gksrk ,oa ;g dk;Z T4 }kjk           xfrfofèk;ksa dks çHkkfor ugha djrhaA       lEikfnr gksrk gSA okLro esa] T3] bood brain barrier                                                      dks ikj ugha dj ikrk tcfd T4 bls ljyrk ls ikj dj           gkbiksFkSysel ls cuk TRH] fiVîwVjh dh thyrotropes   ysrk gSA blhfy,] Fkk;jkW;M gkWekZsUl dk gkbiksFkSysel           ls TSH dk mRiknu ,oa lzko.k c<+krk gS tks iqu%   ,oa  fiVîwVjh  ij  fuxsfVo  QhMcSd]  T4  }kjk  gh           Fkk;jkW;M xzafFk ls Fkk;jkW;M gkWekZsUl dk mRiknu ,oa   lapkfyr gksrk gSA           lzko.k c<+krk gSA Fkk;jkW;M xzafFk ls i;kZIr ek=k esa           Fkk;jkW;M gkWekZsUl dk fuekZ.k gks ldk ;k ugha] bldh   ;gk¡ ,d vkSj ç'u dk mBuk LokHkkfod gh gS fd           lwpuk gkbiksFkSysel ,oa fiVîwVjh dks circulating T3   Fkk;jkW;M gkWekZsUl ds fjlsIVlZ dh T4 ds izfr affinity rks           ,oa T4 ds Lrj ds ekè;e ls feyrh jgrh gSA bls gh   T3 dh vis{kk vR;Ur de gksrh gSA ,sls esa og           QhMcSd flLVe dgrs gSaA bl çdkj HPT axis] ,d   thyrotropes ij dSls dk;Z dj ldsxk\\ okLro esa]           pØ ¼loop½ ds :i esa dk;Z djrh gS ftlesa lHkh   fiVîwVjh esa igqapdj ;g T4] deiodinase 2 }kjk T3           gkekZsUl] ,d nwljs dh xfrfofèk;ksa dks çHkkfor djrs   esa ifjofrZr gks tkrk gS tks TSH thu dks nckdj           jgrs gSaA                                  (suppress djds)  TSH ds mRiknu ,oa lzko.k dks                                                      ?kVkrk gSA Lej.k jgs] Fkk;jkW;M gkWekZsUl] leLr thu dh           Fkk;jkW;M xzafFk ds }kjk i;kZIr ek=k esa T3 ,oa T4 dk   xfrfofèk;ksa dks c<+krs gSa ,oa dsoy TSH thu gh ,dek=           fuekZ.k gksus ij mls vkSj vfèkd mÙksftr fd;s tkus dh   thu gS ftldh xfrfofèk;ksa dks ;g ?kVkrs gSaA           vko';drk ugha jgrhA blhfy,] jä esa T3 ,oa T4                                                      ;gk¡ ,d rF; dks vkSj Hkh Lej.k j[kuk pkfg, fd 'kjhj           c<+us ij ;g gkbiksFkSysel ls TRH ,oa fiVîwVjh ls           TSH dk mRiknu ,oa lzko.k ?kVk nsrs gSaA D;ksafd T3 ,oa   ds lHkh Hkkxksa esa Fkk;jkW;M gkWekZsUl] Fkk;jkW;M fjlsIVj                                                      vYQk  ij  dk;Z  djrs  gSa  tcfd  fiVîwVjh  esa  ;g           T4 ds c<+us dh çfrfØ;k] TRH ,oa TSH ds ?kVus ds   Fkk;jkW;M fjlsIVj chVk ds ekè;e ls viuk fuxsfVo           :i esa gksrh gS ¼vFkkZr igys ifjorZu dh çfrfØ;k   QhMcSd çHkko mRiUu djrs gSaA bl çdkj fiVîwVjh ij           mlds foijhr fn'kk esa gksrh gS½ blhfy, bls fuxsfVo   iM+us okys fuxsfVo QhMcSd ds fy, circulating T4           QhMcSd d.Vªksy flLVe dgrs gSaA             ijUrq intrapituitary T3 mÙkjnk;h gksrs gSaA            blh fuxsfVo QhMcSd ds }kjk T3 ,oa T4 ds c<+us ij           TRH ,oa TSH dk mRiknu ,oa lzko.k ?kVus yxrk gS           ftlls Fkk;jkW;M gkWekZsUl dk mRiknu ?kVus ls T3 ,oa     APPLIED PHYSIOLOGY           T4 ds Lrj nksckjk lkekU; gks tkrs gSaA blh çdkj T3   Embryonic  life  - Hkzw.kkoLFkk esa  TSH dk fuekZ.k                                                      yxHkx 12 lIrkg ds i'pkr~ gh vkjEHk gksrk gSA bldk           ,oa T4 gkWekZsUl ds ?kVus ij] gkbiksFkSysel ,oa fiVîwVjh                                                     27","vFkZ ;g gqvk fd 12 lIrkg ds iwoZ Fkk;jkW;M xzafFk dk   ligand rks TSH gh gksrk gS ijUrq blds vfrfjä dqN           fodkl] Hkwz.k dh fiVîwVjh ij fuHkZj u jgdj ek¡ ds  vU; inkFkZ ¼tSls ,aVhckWMh½ Hkh TSH fjlsIVj ls tqM+dj           TSH ds vkèkhu jgrk gSA                     Fkk;jkW;M gkWekZsUl ds mRiknu dks çHkkfor dj ldrs gSaA           TSH - A glycoprotein hormone - lajpukRed   buesa dqN ,aVhckWMh rks TSH fjlsIVj dks mÙksftr djrs           :i ls TSH ,d XykbdksçksVhu gkWekZsu gS tks vYQk ,oa   gSa ¼thyroid stimulating immunoglobulins - TSI½           chVk lc;wfuV~l ls feydj curk gSA okLro esa] TSH   ,oa dqN bls ckfèkr djrs gSa ¼thyroid  blocking                                                      antibodies - TBAb½A           dh vYQk lc;wfuV] vU; XykbdksçksVhu gkWekZsUl ¼LH,           FSH ,oa hCG½ ds leku gh gksrh gSA bu pkjksa gkWekZsUl   Thyroid  stimulating  antibody  or  immuno-           ds fof'k\"V y{k.k budh chVk  lc;wfuV ds dkj.k gksrs   globulin  (TSAb  or  TSI) \& ;g ,aVhckWMh] TSH           gSaA vYQk   lc;wfuV ds leku jgus ds dkj.k ;g   fjlsIVj ls tqM+ dj mls yxkrkj mÙksftr djrh jgrh           gkWekZsUl] ,d nwljs ds fjlsIVlZ ls ØkWl fj,DV Hkh dj   gSaA blls Fkk;jkW;M gkWekZsUl dk mRiknu vR;fèkd ek=k           ldrs gSaA bu vU; XykbdksçksVhu gkWekZsUl] dh lkekU;   esa gksrk tkrk gS ftlls gkbijFkk;jkW;fMTe mRiUu gks           ek=k rks Fkk;jkW;M dks çHkkfor ugha dj ikrh ijUrq c<+h   tkrh gSA ,sls esa] Fkk;jkW;M gkWekZsUl ds vR;fèkd ek=k esa           gqbZ ek=k TSH fjlsIVlZ dks mÙksftr djrs gq, TSH dh   cuus ls og fuxsfVo QhMcSd ds }kjk fiVîwVjh ls TSH           c<+h gqbZ ek=k dh gh Hkkafr] gkbijFkk;jkW;fMTe mRiUu   dk lzko.k rks ?kVk nsrs gSa ijUrq fQj Hkh og Fkk;jkW;M                                                      gkWekZsUl ds mRiknu dks lkekU; ugha cuk ikrsA ,slk           dj ldrh gSA lkekU; xHkkZoLFkk dh çFke frekgh esa Hkh]           hCG dh ek=k vR;fèkd c<+ tkus ij ,slk gh gksrk gSA  blfy, D;ksafd TSAb/TSI, TSH fjlsIVlZ ls tqM+dj                                                      Fkk;jkW;M xzafFk dks TSH dh Hkkafr gh mÙksftr djrh gS           Effect of TRH on prolactin -  gkbiksFkSysel ls   ,oa Fkk;jkW;M gkWekZsUl dk vfu;af=r mRiknu djkrh           fudyus okyk TRH] thyrotropes ij fLFkr TRH   tkrh gSA fjlsIVj ls tqM+us ds ckn TSH dk mÙkstd           fjlsIVlZ ij dk;Z djds TSH dk lzko.k djkrk gSA   çHkko tgk¡ dsoy 1.5-3 ?kaVksa rd gh jgrk gS ogh ;g           Thyrotropes ds vfrfjä ;g TRH fjlsIVlZ] FkksM+h   TSI, TSH fjlsIVj dks 16-24 ?kaVksa rd mÙksftr djrh           la[;k esa lactotropes ij Hkh gksrs gSaA lkekU;r;% ;g   jgrh gSaA è;ku jgs] ;g ,d bEE;wu fodkj gS ftlesa           lactotropes,  gkbiksFkSysfed  Mksikehu  ds  ncko   Fkk;jkW;M xzafFk dk fu;a=.k] fiVîwVjh ds TSH }kjk u           ¼inhibitory control½ esa jgrh gSa ftlls çksySfDVu dk   gksdj] ,d ckgjh inkFkZ TSAb/TSI ds }kjk gksus yxrk           lzko.k #dk jgrk gSA ijUrq TRH fjlsIVlZ dh mifLFkfr   gSA ;g Bhd oSls gh gqvk tSls dksbZ ckgjh O;fä] fdlh           ds dkj.k ;g TRH }kjk mÙksftr Hkh gks ldrh gSa ftlls   Mªkboj dks mldh lhV ls tcjnLrh gVkdj xkM+h Lo;a           buls çksySfDVu dk lzko.k c<+ ldrk gSA fdlh gkWekZsu   pykus yxsA vc Mªkboj ds u pkgrs gq, Hkh xkM+h mlh           ds vius LokHkkfod fjlsIVj ds vfrfjä fdlh vU;   O;fä dh euekuh ij pysxhA bl çdkj mRiUu gq, jksx           fjlsIVj ij dk;Z djus dh ;g çfØ;k cross reactivity   dks Graves' disease  dgrs gSaA           dgykrh gSA blhfy,] gkbiksFkk;jkW;fMTe ds c<+s gksus           ij tc fuxsfVo QhMcSd ds }kjk TRH c<+ tkrk gS rc   Thyroid  blocking  antibodies  (TBAb)  -                                                      TSAb/TSI ds foijhr ;g ,aVhckWMh] TSH fjlsIVj ls           ;g TSH ds lkFk\&lkFk çksySfDVu dk lzko.k Hkh c<+k   tqM+ dj mls ckfèkr dj nsrh gSa ftlls TSH mlls tqM+           ldrk  gSA  blhfy,]  vR;f/kd  c<+h  gq;h                                                      dj dk;Z ugha dj ikrkA TSH }kjk mRiUu gksus okyh           gkbiksFkk;jkW;fMTe  esa  dHkh\&dHkh  hyper-  mÙkstuk ds vHkko esa Fkk;jkW;M xzafFk Øe'k% vkdkj esa           prolactinemia ,oa galactorrhea Hkh fey ldrs gSaA                                                      ?kVrh tkrh gS ,oa mlls cuus okys Fkk;jkW;M gkWekZsUl           Other ligands of TSH receptor -  fdlh fjlsIVj  Hkh  ?kVrs  tkrs  gSa  ftlls  autoimmune  atrophic           ls tqM+dj mlij dk;Z djus okys inkFkZ dks ml fjlsIVj   thyroiditis ,oa gkbiksFkk;jkW;fMTe mRiUu gks ldrs gSaA                                                               ,oa                                                                 gkbiksFkk;jkW;fMTe                                                                               mRiUu                                                               ,oa gkbiksFkk;jkW;fMTe mRiUu gks ldrs gSaA                                                                                       ldrs                                                                                           gSaA                                                                                     gks                                                      thyroiditis           dk  ligand dgrs gSaA  TSH  fjlsIVj dk LokHkkfod                                                   28","4                             Physiology of Thyroid Hormone Actions            GENERAL PRINCIPALS OF HORMONE              ,oa lkFk gh lkFk MCT8 ,oa OATP ds :i esa ,d           ACTIONS                                                      vyx carrier mediated transport dh O;oLFkk }kjk           ge tkurs gSa fd gkWekZsu] 'kjhj ds fdlh ,d fo'ks\"k Hkkx   Hkh dksf'kdk esa lqpk# :i ls ços'k dj ldrs gSaA           esa gh lzkfor u gksdj] jä esa lzkfor fd;s tkrs gSaA ;gk¡   blhfy,] LVsjkW;M gkWekZsUl] foVkfeu A ,oa foVkfeu D           ls ;g lEiw.kZ 'kjhj dh lHkh dksf'kdkvksa rd igq¡p   ds fjlsIVlZ dh Hkkafr gh Fkk;jkW;M gkWekZsUl ds fjlsIVlZ           ldrs gSaA tjk lksfp;s] fQj ,slk dSls gqvk fd budk   Hkh dksf'kdk ds Hkhrj gh mifLFkr jgrs gSaA è;ku jgs]           çHkko 'kjhj ds dqN Hkkxksa ij gh iM+rk gS ,oa vU; Hkkxksa   buesa ls vU; rhuksa fjlsIVlZ rks lkbVksIykTe esa mifLFkr           ij ugha\\ okLro esa fdlh gkWekZsu dk fdlh vax fo'ks\"k   jgrs gSa ijUrq Fkk;jkW;M gkWekZsUl ds fjlsIVlZ] U;wfDy;l           ij dk;Z djuk bl rF; ij fuHkZj djrk gS fd ml   esaA           gkWekZsu  ds  fjlsIVlZ  'kjhj  dh  fdu\&fdu  vaxksa  ij     THYROID HORMONE RECEPTORS (TR)           mifLFkr gSaA ftl çdkj ls dksbZ pkHkh dsoy mlds   TR  are  present  on  almost  all  organs  -           fof'k\"V rkys esa gh yx ldrh gS ,oa mls [kksy ldrh gS   Fkk;jkW;M gkWekZsUl ds fjlsIVlZ] iw.kZ fodflr efLr\"d           Bhd mlh çdkj çR;sd gkWekZsu dsoy vius fof'k\"V   ,oa tuukaxksa ¼gonads½ ds vfrfjä 'kjhj ds vU;           fjlsIVj ls gh tqM+ ldrk gS ,oa mlds }kjk gh viuk   lHkh vaxksa esa feyrs gSa ftlds dkj.k Fkk;jkW;M gkWekZsUl           çHkko mRiUu dj ldrk gSA bl çdkj] 'kjhj dh   dk çHkko Hkh 'kjhj dh bu lHkh dksf'kdkvksa ij iM+rk           ftu\&ftu vaxksa ij fdlh gkWekZsu ds fjlsIVj mifLFkr   gSA è;ku jgs] ;|fi iw.kZ fodflr efLr\"d ij Fkk;jkW;M           gksaxsa] dsoy ogh\&ogh vax ml gkWekZsu }kjk çHkkfor gksaxsa   gkWekZsUl dk dksbZ fo'ks\"k çHkko ugha iM+rk] ijUrq Hkwz.k ,oa           ,oa mUgha dh dksf'kdkvksa ij ml gkWekZsu dk çHkko   uotkr f'k'kqvksa esa efLr\"d ,oa U;wjkWUl ds fodkl ds           mRiUu gksxkA                               fy, ;g vR;ar egRoiw.kZ gksrk gSA nks o\"kZ dh mez ds iwoZ            TYPES OF HORMONE RECEPTORS                 mRiUu gqbZ Fkk;jkW;M gkWekZsUl dh deh] f'k'kq ds efLr\"d           lajpukRed vkèkkj ij gkekZsUl eq[;r% rhu çdkj ds  ,oa U;wjkWUl ds fodkl ij viw.kZuh; {kfr mRiUu dj                              W           gksrs gSa] isIVkbM gkekZsUl] LVsjkW;M gkekZsUl ,oa ,ehuks  ldrh gSA                         W                                      W           ,flM ls mRiUu gkekZsUlA buesa ls isIVkbM gkekZsUl rks   TR are intranuclear - ge tkurs gSa fd 'kjhj dh                         W                                             W           ty  esa  ?kqyu'khy  ,oa  fyfiM  esa  v?kqyu'khy   vfèkdk¡'k çfØ;kvksa dks laiUu djkus ds fy, çksVhUl           ¼hydrophilic ,oa  lipophobic½ gksus ds dkj.k lsy   ¼tSls ,atkbe] fjlsIVj vFkok VªkaliksVZj½ dh vko';drk           esEczsu dks ikj ugha dj ikrsA blhfy,] buds fjlsIVlZ   iM+rh gSA çksVhu ,oa isIVkbM gkekZsUl rks vius çHkko                                                                              W           dks lsy esEczsu ij gh miyCèk gksuk iM+rk gSA blds   lhèks\&lhèks  gh  mRiUu  djk  ysrs  gSa  tcfd  LVsjk;M                                                                                            W           foijhr]  LVsjkW;M  gkWekZsUl]  fyfiM  esa  ?kqyu'khy   gkekZsUl] foVkfeu A] foVkfeu D ,oa Fkk;jkW;M gkWekZsUl                                                       W           (Iipophilic  ,oa  hydrophilic) gksus ds dkj.k cM+h   dks fdlh vU; çksVhu ds fuekZ.k dh vko';drk iM+rh           ljyrk ls lsy esEczsu dks ikj djds dksf'kdk ds Hkhrj   gSA blhfy,] ;g gkWekZsUl loZçFke DNA ls tqM+dj u;h           ços'k dj ysrs gSaA bl dkj.k ls buds fjlsIVlZ dks lsy   çksVhu ds fuekZ.k dks çksRlkfgr djrs gSa tks iqu% bu           esEczsu ij yxs jgus dh ckè;rk ugha jgrh ,oa og   gkWekZsUl ds dk;ksZa dks laiUu djkrh gSA           dksf'kdk ds Hkhrj mifLFkr jg ldrs gSaA ,ehuks ,flM           ls  mRiUu  gksus  okys  Fkk;jkW;M  gkWekZsUl]  fyfiM  esa   DNA dk ;g Hkkx hormone response element           ?kqyu'khy gksus ds dkj.k lsy esEczsu dks ikj dj ldrs gSa   (HRE)  ;k  Fkk;jkW;M  gkWekZsUl  ds  fy,   thyroid                                                     29","response element (TRE) dgykrk gSATRE ij ;g     TYPES OF TH ACTIONS           TR vdsys u jgdj] retinoid X receptors (RXR) ds   GENOMIC ACTIONS OF TH           lkFk  heterodimer   ¼ftlesa  yxh  nksuksa  lc;wfuV  Fkk;jkW;M gkWekZsUl }kjk lEikfnr gksus okys vfèkdk¡'k           fHkUu\&fHkUu gksa½ ds :i esa yxs jgrs gSaA lkekU; voLFkk  dk;Z] thUl }kjk VªkalfØI'ku dks çHkkfor djds gh           esa ;g heterodimer, corepressor çksVhUl ds }kjk  laiUu gksrs gSaA Fkk;jkW;M gkWekZsUl ds bl çdkj gksus okys            fuf\"Ø; :i esa j[kk tkrk gSA Fkk;jkW;M gkWekZsUl ds TR  dk;ksZa dks genomic actions of thyroid hormones           ls tqM+us ij ;g corepressor çksVhUl, heterodimer  dgrs gSaA           ls vyx gks tkrh gSa ,oa TRE,  target  gene dks   Fkk;jkW;M gkWekZsUl] dksf'kdk dh esVkckWfyTe ls lEcafèkr           mÙksftr djus yxrk gSA                                                      vusdksa thUl dk fuekZ.k djkrh gSaA buesa ,atkbe çksVhu]           Target gene ds mÙksftr gksus ls mRNA VªkalfØI'ku  VªkaliksVZj çksVhu ,oa dksf'kdk dh lajpukRed çksVhu           ,oa rRi'pkr Vªkalys'ku dh çfØ;kvksa }kjk u;h çksVhu  lfEefyr gSaA buesa loZçeq[k gS Na-K ATPase  çksVhu           dk fuekZ.k vkjEHk gksrk gSa tks Fkk;jkW;M gkWekZsUl ds  tks ekbVksdkWfUMª;k dh xfrfofèk c<+kdj] dksf'kdk dk           fofHkUu dk;ksZa dks laiUu djkrh gSaA       vkWDlhtu  dk  mi;ksx  ¼oxygen  consumption½                                                      c<+krh  gSA  blds  vfrfjä]  ekbVksdkWfUMª;k  ,oa           TYPES OF TH RECEPTORS                                                      respiratory chain ds dbZ vU; ,atkbe ds fuekZ.k Hkh           TR Hkh nks çdkj ds gksrs gSaA TR-α ,oa TR-β                                                      Fkk;jkW;M gkWekZsUl ds çHkko esa c<+ tkrs gSa tks lfEefyr           TR-α \& 'kjhj dh vfèkdk¡'k dksf'kdkvksa esa ;gh TR-α           feyrs gSaA bl çdkj] 'kjhj ij Fkk;jkW;M gkWekZsUl ds   :i ls basal metabolic rate (BMR)  ,oa Å\"ek ds           vfèkdk¡'k dk;Z TR-α ds }kjk gh laiUu gksrs gSaA ;g Hkh   mRiknu (heat production)  dks c<+krs gSaA           nks çdkj ds gks ldrs gSa] TRα1 ,oa TRα2 A  Fkk;jkW;M gkWekZsUl ftu thUl ds fuekZ.k dks ckfèkr djrs           TR-β \& gkbiksFkSysel] fiVîwVjh ,oa fyoj esa TR-β  gSa muesa loZçeq[k gS fiVîwVjh dh TSH - β lc;wfuV           feyrs  gSaA  bl  çdkj]  Fkk;jkW;M  gkWekZsUl  dk   thu ftlds }kjk TSH dk fuekZ.k gksrk gSA           gkbiksFkSysel ,oa fiVîwVjh ij fuxsfVo QhMcSd] TR-β   Fkk;jkW;M gkWekZsUl ds genomic actions  ds }kjk laiUu           }kjk laiUu fd;k tkrk gSA TR-β Hkh nks çdkj ds gks  gksus okys çeq[k dk;Z fuEukafdr gSa \&           ldrs gSa] TRβ1 ,oa TRβ2 A                  - 'kjhj dk fodkl            è;ku jgs] T3 ,oa T4 nksuksa] TR-α ,oa TR-β nksuksa   - CNS dk fodkl           çdkj ds fjlsIVlZ ls tqM+dj viuk\&viuk çHkko mRiUu   - CVS ij iM+us okys çHkko           dj ldrs gSaA ;gk¡ ç'u ;g mBrk gS fd tc T3 ,oa T4   - esVkckWfyTe ij iM+us okys çHkko           nksuksa gh] nksuksa çdkj ds fjlsIVlZ ls tqM+ ldrs gSa rFkk   NONGENOMIC ACTIONS OF TH           jä esa T4 dh ek=k] T3 dh rqyuk esa dgha vfèkd gksrh   LokHkkfod :i ls Fkk;jkW;M gkWekZsUl ds ¼,oa LVsjkW;M           gS] rc T3 dks lfØ; ,oa T4 dks çks\&gkWekZsu D;ksa dgk   gkWekZsUl] foVkfeu A ,oa D ds Hkh½ fjlsIVj ij igq¡pus                                                      ,oa u;h çksVhu ds fuekZ.k vkjEHk gksus ds eè; dkQh           tkrk gS\\ okLro esa] nksuksa çdkj ds TR (TR-α, o TR-           β) dh Fkk;jkW;M gkWekZsUl ls tqM+us dh {kerk ¼affinity½]   le; yxrk gS tks dqN feuV] dqN ?kaVs vFkok dqN fnu           T4 dh rqyuk esa T3 ds fy, 10-15 xquk vfèkd gksrh   Hkh gks ldrk gSA ijUrq] Fkk;jkW;M gkWekZsUl }kjk mRiUu           gSA blhfy,] U;wfDy;l esa ços'k djus ds iwoZ T4 dks T3   gksus okys dqN dk;Z ,sls Hkh gksrs gSa tks fcuk le; yxk,]                                                       yxHkx rqjar gh çkjEHk gks tkrs gSaA vr% ;g ekuk tk           esa  ifjofrZr  djk  fn;k  tkrk  gS  ftlls  mldk   ldrk gS fd Fkk;jkW;M gkWekZsUl ds dqN çHkko] fcuk u;h           vfèkdkfèkd çHkko çkIr fd;k tk ldsA         çksVhu ds fuekZ.k ds ;k fcuk thUl dks çHkkfor fd;s gq,                                                     30","Hkh gks ldrs gSaA ;fn fdlh çdkj ls VªkalfØI'ku dh  }kjk TSH dk lzko.k ugha ?kV ikrkA ,sls esa TSH ds           çfØ;k dks ckfèkr dj fn;k tk;s rc blds i'pkr~ Hkh  lzko.k ds c<+rs jgus ls T3 ,oa T4 ds Lrj Hkh c<+ tkrs           ;g çHkko cus jgrs gSaA Li\"V gS fd ;g dk;Z genomic  gSaA vc D;ksafd 'kjhj ds fofHkUu Hkkxksa ij iM+us okys           stimulation  }kjk u gksdj fdlh vU; fofèk }kjk  Fkk;jkW;M gkWekZsUl ds çHkko] TR-vYQk ds }kjk gh           laiUu gksrs gSaA bu çHkkoksa dks nongenomic actions  laiUu gksrs gSa tks lkekU; :i ls dk;Z dj jgs gSa]           of thyroid hormones dgrs gSaA              blfy, TR-chVk ds E;wVs'ku ls T3 ,oa T4 ¼,oa TSH           buesa ls dqN çeq[k çHkko fuEukafdr gSaA    Hkh½ dh ek=k c<+us ls 'kjhj esa gkbijFkk;jkW;fMTe ds                                                      y{k.k mRiUu gksus yxrs gSaA           - ekbVksdkWfUMª;k esa oxidative phosphorylation  dks            çHkkfor  djds  c e l l u l a r   e n e r g y   ,oa            thermogenesis dk fu;a=.k                   EFFECTS OF  TH ON CELLULAR META-           - dksf'kdk ds Hkhrj secondary messenger system   BOLISM            tSls cAMP  ,oa protein kinase dks mÙksftr djuk   ON OXIDATIVE PHOSPHORYLATION AND           - ân; ,oa CyM oslsYl esa vk;u pSuy dks çHkkfor   ATP            djds  heart  rate,  cardiac  contractility  ,oa   ;kn  djsa]  anaerobic  organisms  dh  rqyuk  esa            vascular resistance dk fu;a=.k            aerobic  organisms] fdlh [kk| inkFkZ ls vfèkd            è;ku  jgs]  Fkk;jkW;M  gkWekZsUl  }kjk  genomic  ,oa   ek=k  esa  ÅtkZ  mRiUu  djk  ysrs  gSaA  ;g  cellular                                                      respiration  esa  oxidative  phosphorylation  ds           nongenomic nksuksa gh çHkko] TR-α ,oa TR-  }kjk                                              β           gh laiUu gksrs gSaA Nongenomic actions ds fy, ,d   dkj.k gh laHko gks ikrk gSA okLro esa oxidative                                                      phosphorylation og çfØ;k gS ftlesa fdlh iks\"kd           fHkUu çdkj ds integrin alpha v beta 3 receptor  Hkh   rRo  ds  vkWDlhMs'ku  ls  çkIr  ÅtkZ  ls  ADP  dk           çLrkfor gSaA                                                      phosphorylation ¼,d high energy phosphate           THYROID HORMONE RESISTANCE                 bond ds ekè;e ls ADP esa ,d phosphate ds           TR esa E;wVs'ku gksus ij muds }kjk laiUu gksus okys   tqM+us½  ls  ATP  dk  fuekZ.k  gksrk  gSA  ;g  çfØ;k           dk;ksZa esa ckèkk mRiUu gksrh gSA TR dh Hkkafr gh muls   ekbVksdkWfUMª;k dh Hkhrjh esEczsu ij laiUu gksrh gSA           mRiUu gksus okys jftLVsal Hkh nks çdkj ds gks ldrs gSaA  Fkk;jkW;M gkWekZsUl bl oxidative phosphorylation            Mutations of TR-α - ge tkurs gSa fd 'kjhj ds   dh çfØ;k dks c<+krs gSaA D;ksafd bl çfØ;k ds fy, çpqj           fofHkUu Hkkxksa ij iM+us okys Fkk;jkW;M gkWekZsUl ds çHkko]   ek=k esa vkWDlhtu dh vko';drk iM+rh gS blfy,           TR-vYQk ds }kjk gh laiUu gksrs gSaA ,sls esa buds   blds  dkj.k  ls  'kjhj  esa  vkWDlhtu  dk  mi;ksx           E;wVs'ku ls 'kjhj esa gkbiksFkk;jkW;fMTe ds y{k.k mRiUu   (oxygen consumption) Hkh c<+ tkrk gSA           gksus yxrs gSaA vc D;ksafd fiVîwVjh ij Fkk;jkW;M   'kjhj dh dksf'kdkvksa esa oxidative phosphorylation           gkWekZsUl dk fuxsfVo QhMcSd çHkko  TR-chVk }kjk   c<+kus ds fy, Fkk;jkW;M gkWekZsUl fuEukafdr ifjorZu           laiUu gksrk gS] vr% blds dk;Z djrs jgus ls TSH ds   mRiUu djrs gSaA           Lrj lkekU; jgrs gSa ftlls T3 ,oa T4 ds Lrj Hkh   - ekbVksdkWfUMª;k  dh la[;k c<+ tkrh gS           vfèkdrj lkekU; gh cus jgrs gSaA            - ekbVksdkWfUMª;k  ds  ,atkbe  tSls  cytochrome            Mutations of TR-β - D;ksafd fiVîwVjh ij Fkk;jkW;M   oxidase dh ek=k c<+ tkrh gS           gkWekZsUl dk fuxsfVo QhMcSd çHkko] TR-chVk }kjk   - ATP  dk mRiknu c<+ tkrk gS           laiUu gksrk gS] vr% blds E;wVs'ku ls T3 ,oa T4 ds   ON BASAL METABOLIC RATE (BMR)                                                      31","W               W           Fkk;jk;M gkekZsUl ds }kjk 'kjhj dh dksf'kdkvksa dh  vfrfjä]  Fkk;jkW;M  gkWekZsUl]  brown  adipose               W           esVkckfyTe c<+us ls 'kjhj esa Hkh fuEukafdr y{k.k   tissues esa thermogenin ;k UCP-1 dk fuekZ.k Hkh           mRiUu gksrs gSaA                           c<+k  nsrs  gSa,  ftlls  catecholamines  dk           - BMR vius lkekU; Lrj (~1400-1800 kcal/d) ls   thermogenic action vkSj Hkh c<+ tkrk gSA mijksä            60-100% rd c<+ tkrk gS                    nksuksa çHkkoksa ls Fkk;jkW;M gkWekZsUl] rki dk mRiknu           - vkWDlhtu dk mi;ksx Hkh mlh vuqikr esa lkekU;   ¼thermogenesis½ c<+k nsrs gSaA            Lrj ¼~250 ml/min½ ls 60-100% rd c<+ tkrk gS   Thermogenesis ds nks Hkkx gksrs gSa \&             'kjhj ds BMR dk vfèkdk¡'k Hkkx] Na-K ATPase    - Basal  thermogenesis  \&  'kjhj  dh  çR;sd           pump dh lfØ;rk ds dkj.k gh gksrk gSA blhfy,   dksf'kdk esa ;g gj le; pyrh jgrh gSA           Fkk;jkW;M gkWekZsUl ds çHkko esa 'kjhj esa \&   - Adaptive  thermogenesis  \& B.M c<+us ij            - Na channels  dh la[;k c<+ tkrh gS         mlls cpko ds fy, gksus okyk rki dk mRiknu]           - Na K ATPase pump  dh lfØ;rk c<+ tkrh gS   adaptive  thermogenesis  dgykrk gSA uotkr                                                       f'k'kqvksa esa ;g brown adipose tissues (BAT)   esa           ON THERMOGENESIS                            ,oa o;Ldksa esa ;g ekalisf'k;ksa esa gksrk gSA           lkekU;r%  'kjhj  esa  iks\"kd  rRoksa  ds  vkWDlhMs'ku                                                      bl çdkj rki ds mRiknu ds fy, Fkk;jkW;M gkWekZsUl ds           ¼dSVkckWfyTe½ ls mRiUu gksus okyh ÅtkZ ,oa ADP ds                                                      }kjk fuEukafdr çHkko mRiUu gksrs gSa \&           phosphorylation ¼,ukckWfyTe½ ls cuus okyk ATP,            ijLij  lEc)  ¼coupled½  jgrs  gSaA  dqN  fo'ks\"k   - Catecholamines  ds  fy,  chVk  fjlsIVlZ  dh           ifjfLFkfr;ksa esa] tSls  sympathetic  stimulation  ds   laosnu”khyrk c<+ tkrh gS           nkSjku] dSVkckWfyTe dh çfØ;k ,ukckWfyTe ls rhoz gks   - UCP-1 dh la[;k c<+ tkrh gS ,oa og mÙksftr gks           tkrh gSA ,sls esa ;g nksuksa çfØ;k,a ,d nwljs ls i`Fkd   tkrs gSa           ¼uncoupled½ gks tkrh gSaA ,slh voLFkk esa iks\"kd rRoksa   - rki ds vfèkd mRiknu ls 'kjhj dk rkieku c<+ tkrk           ds vkWDlhMs'ku ls mRiUu gksus okyh ÅtkZ] ATP fuekZ.k   gS           esa  ç;qä  gksus  ds  LFkku  ij  thermogenin   ;k   - Basal thermogenesis yxHkx 30% rd c<+ tkrh           uncoupling protein 1 (UCP1) ds }kjk rki ¼heat½   gS           mRiUu djus ds fy, ç;qä gksus yxrh gSA      - Adaptive  thermogenesis ds fy, rks Fkk;jkW;M                                                       gkWekZsUl vR;ar vko';d gSA Fkk;jkW;M gkWekZsUl ds           'kjhj dh dksf'kdkvksa esa esVkckWfyTe c<+us ls Hkh muesa   fcuk ;g laHko gh ugha gks ikrhA           vfèkd ek=k esa Å\"ek mRiUu gksrh gSA blh dks Fkk;jkW;M                                                      è;ku jgs] Fkk;jkW;M gkWekZsUl ds çHkko esa 'kjhj ds           gkWekZsUl dk thermogenic action  vFkok calorigenic           action  dgrs gSaA                          yxHkx lHkh Hkkxksa dh esVkWcksfyd xfrfofèk;ka c<+ tkrh                                                      gS] flok; mu Hkkxksa ds ftu ij Fkk;jkW;M gkWekZsUl dk           Lej.k  jgs]  Fkk;jkW;M  gkWekZsUl]  'kjhj  ij   dksbZ lhèkk çHkko ugha gSA ;g Hkkx gSa] efLr’d] VsfLVl]           catecholamines  dh Hkkafr gh dk;Z djrs gSaA ;g   ;wV~jl] fyEQ uksM~l] LIyhu ,oa ,aVhfj;j fiV~;wVjhA           catecholamine dk lzko.k rks ugha c<+krs ijUrq ân;]   D;ksafd Fkk;jkW;M gkWekZsUl] fiVîwVjh esa cuus okys TSH           ekalisf'k;ksa ,oa adipose tissues ij chVk fjlsIVlZ dh   dks ?kVkrs gSa blfy, okLro esa Fkk;jkW;M gkWekZsUl ds           la[;k ,oa mudh laosnu”khyrk  (sensitivity) c<+kdj   çHkko esa fiVîwVjh dh esVkckWfyd xfrfofèk ?kV tkrh gSA           catecholamines  ds çHkko dks c<+k nsrs gSaA                                                      Dyhfudy mi;ksfxrk \& gkbiksFkk;jkW;fMTe esa basal           Catecholamines  dh  laosnu”khyrk  c<+kus  ds   thermoge nesis 30% rd ?kV tkrh gSA blls 'kjhj                                                     32","dk rkieku Hkh ?kV tkrk gSA Myxedema coma  tSlh   ,oa dSVkckWfyTe nksuksa dks gh dqN u dqN ek=k esa           fLFkfr;ksa esa tgk¡ Fkk;jkW;M gkWekZsUl dk Lrj vR;fèkd   çHkkfor djrs gSaA vkb;s fofHkUu iks\"kd rRoksa ij iM+us            de gks tkrk gS] hypothermia  rd mRiUu gks ldrk   okys buds çHkkoksa dk vkdyu vyx\&vyx djrs gSa           gSA                                        rFkk gkbijFkk;jkW;fMTe ,oa gkbiksFkk;jkW;fMTe esa bu                                                      ij D;k\&D;k çHkko iM+rs gSa] og Hkh lkFk gh le>rs gSaA           blds  foijhr]  gkbijFkk;jkW;fMTe  esa  basal  ,oa           adaptive thermogenesis, 70-100% rd c<+ tkrh   PROTEIN METABOLISM           gSA Fkk;jkW;M gkWekZsUl 'kjhj ds ,DlsyjsVj dh Hkkafr   Fkk;jkW;M gkWekZsUl 'kjhj ds fodkl esa fy, vR;ar           dk;Z djrs gSaA ftl çdkj] xkM+h dks rst nkSM+kus ij   egRoiw.kZ gSa ftlds fy, çksVhu dh vko';drk iM+rh           mldk batu xeZ gksus yxrk gS mlh çdkj] Fkk;jkW;M   gSA blhfy, ekalisf'k;ksa ,oa gfì;ksa esa o`f) ds fy,           gkWekZsUl ds }kjk mÙksftr gksus ls 'kjhj dk rkieku Hkh   Fkk;jkW;M gkWekZsUl] ,ehuks ,flM~l ls u;h çksVhu ds           c<+us yxrk (hyperthermia)  gSA ftl çdkj] vdkj.k   fuekZ.k dks c<+krs gSaA           gh ,DlsyjsVj nck;s j[kus ls isVªksy dh [kir c<+ tkrh   è;ku jgs] Fkk;jkW;M gkWekZsUl dh vfèkdrk dk çHkko           gS] mlh çdkj] Fkk;jkW;M gkWekZsUl dh vfèkdrk ls Hkh   blds lkekU; Lrj ij gksus okys çHkkoksa ls fHkUu gSA tgk¡           'kjhj ds bZaèku ¼eq[;r% fat½ ?kVrs tkrs gSa ftlls otu   Fkk;jkW;M  gkWekZsUl  ds  lkekU;  Lrj]  ,ukckWfyd           Hkh  ?kVrk  tkrk  gSA  yEcs  le;  rd  jgh   xfrfofèk;ksa dks c<+krs gSa tks dkckZsgkbMªsV ,oa QSV ds           gkbijFkk;jkW;fMTe ls rks çksVhu dSVkckWfyTe rd c<+   mi;ksx dks c<+kdj u;h çksVhu ds fuekZ.k dks c<+krs gSa]           tkrh gS ftlls ekalisf'k;ka Hkh ?kV tkrh gSaA blds   ogha gkbijFkk;jkW;fMTe] dSVkckWfyd xfrfofèk;ksa dks Hkh           foijhr] gkbiksFkk;jkW;fMTe esa BMR ds ?kV tkus ls ,oa   c<+k  nsrs  gSaA  blesa  eq[;r%  QSV  ,oa  çksVhu  dh           blds dkj.k ls ÅtkZ ds mi;ksx ds ?kV tkus ls 'kjhj dk   dSVkckWfyTe c<+rh gS ftlls c<+rh gqbZ esVkckWfyd           otu c<+ tkrk gSA                           vko';äkvksa dks iwjk djus ds fy, dkckZsgkbMªsV mRiUu                                                       gks ldsA gkbiksFkk;jkW;fMTe esa çksVhu dh esVkckWfyTe                                                      ,oa ,ehuks ,flM~l dk vkWDlhMs'ku ?kV tkrs gSaA            EFFECTS  OF  TH  ON  INTERMEDIARY            METABOLISM                                CARBOHYDRATE METABOLISM           ge tkurs gSa fd Fkk;jkW;M gkWekZsUl] BMR ,oa 'kjhj dh   Fkk;jkW;M gkWekZsUl] dkckZsgkbMªsV esVkckWfyTe ds lHkh           vkWDlhtu dh vko';drk dks c<+krs gSaA blds fy,   i{kksa dks mÙksftr djrs gaS ftlls] 'kkjhfjd vko';drk,a           'kjhj dks vfèkd ek=k esa ÅtkZ dh vko';drk iM+rh gSA   Xywdkst ds }kjk iwjh dh tk ldsaA           ÅtkZ dks vfèkd ek=k esa çkIr djus ds fy, Fkk;jkW;M   - 'kjhj dh fofHkUu dksf'kdkvksa }kjk Xywdkst dks xzg.k           gkWekZsUl fuEukafdr ifjorZu mRiUu djrs gSa\&  djus ¼uptake½ ,oa blds mi;ksx dks c<+krk gSA           - GIT  ls  iks\"kd  rRoksa  ¼nutrients½  dk  vo'kks\"k.k   - blds fy, bu dksf'kdkvksa esa glycolysis dks c<+krk            ¼absorption½ c<+k nsrs gSaA                gSA           - bu iks\"kd rRoksa dh esVkckWfyTe ds fy, vko';d   - blds fy, bUlqfyu dk lzko.k c<+krk gSA            ,UtkbEl dk mRiknu c<+k nsrs gSaA          Xywdkst dk mi;ksx c<+us ls Xywdkst dh vko';drk Hkh           - bl çdkj bu iks\"kd rRoksa dk vkWDlhMs'ku c<+kdj   c<+ tkrh gSA bls miyCèk djkus ds fy, Fkk;jkW;M            mlls vfèkd ek=k esa ÅtkZ mRiUu djk nsrs gSaA  gkWekZsUl fuEukafdr çfØ;k,a c<+krs gSaA           'kjhj ds vfèkdk¡'k gkWekZsUl] esVkckWfyTe ds fdlh ,d   - GLUT4 dks mÙksftr djds  GIT ls Xywdkst ds           i{k] ,ukckWfyTe vFkok dSVkckWfyTe dks gh çHkkfor   vo'kks\"k.k dks c<+krs gSaA           djrs gSaA buds foijhr Fkk;jkW;M gkWekZsUl] ,ukckWfyTe   - ekalisf'k;ksa ,oa yhoj esa glycogenolysis dks c<+krs                                                     33","gSaA                                      tkrs gSaA           - Xywdkst  ds  ;g  lzksr  lekIr  gksus  ij   SECONDARY EFFECTS OF INCREASED            gluconeogenesis dks c<+krs gSaA           METABOLISM            bl çdkj ls Fkk;jkW;M gkWekZsUl] Xywdkst ds mRiknu ,oa   Fkk;jkW;M  gkWekZsUl  dh  vfèkdrk  esa  esVkckWfyd           Xywdkst ds mi;ksx dks leku :i ls mÙksftr djrs gSa   xfrfofèk;ksa ds vR;fèkd c<+ tkus ls vusd vU; çHkko           ftlls jä esa Xywdkst ds Lrj leku cus jgrs gSaA   mRiUu gksus yxrs gSaA           Fkk;jkW;M gkWekZsUl dh vfu;ferrkvksa esa ;g larqyu   - çksVhu esVkckWfyTe ds c<+us ls blood urea nitrogen           fcxM+  tkrk  gS  ftlls  gkbiksFkk;jkW;fMTe  esa   esa o`f) gksrh gS ,oa K ] uric acid rFkk hexosamine                                                                       +           gkbiksXykblhfe;k  ,oa  gkbijFkk;jkW;fMTe  esa   dk mRltZu c<+ tkrk gSA           gkbijXykblhfe;k dh lEHkkouk c<+ tkrh gSA                                                      - QSV esVkckWfyTe ds c<+us ls otu ?kVus yxrk gS ftls           FAT METABOLISM                              cuk;s j[kus ds fy, Hkkstu dh vko';drk ;k Hkw[k           Fkk;jkW;M gkWekZsUl ds }kjk esVkckWfyd xfrfofèk;ksa ds   c<+ tkrh gSA esVkckWfyd xfrfofèk;ksa ds c<+us ls           c<+us ij Xywdkst dh vko';drk c<+ tkrh gSA blds   foVkfeUl ,oa feujYl dh vko';drk Hkh c<+ tkrh           fy, Fkk;jkW;M gkWekZsUl] QSV esVkckWfyTe dks c<+kok nsrs   gSA           gSaA            - Catecholamines  ds  fy,  chVk  fjlsIVlZ  dh      EFFECTS OF TH ON SKELETAL SYSTEM            laosnu”khyrk c<+kdj hormone sensitive lipase   lrgh rkSj ij ;g lkspk tk ldrk gS fd 'kkjhfjd o`f)            dks mÙksftr djrs gSaA                     (linear growth) ds fy, lokZf/kd egRoiw.kZ gkWeksZu]           - blls adipose tissues esa lipolysis c<+ tkrh gSA           - blls lhje FFA ds Lrj c<+ tkrs gSaA       xzksFk gkWeksZu (GH) gksuk pkfg,A ijUrq ,slk ugha gksrkA           - bl FFA  dk vkWDlhMs'ku c<+kdj dksf'kdkvksa dh   vo'; gh GH 'kkjhfjd o`f) ds fy, vR;Ur vko';d            ÅtkZ dh vko';drk dks iwjk djrs gSaA       gksrs gSa ijUrq GH ds iw.kZ:i ls u cuus ij Hkh 'kjhj 2-                                                      3 lseh izfro\"kZ c<+rk jgrk gSA ogha] Fkk;jkW;M gkWeksZUl           - Lipolysis  ls  mRiUu  glycerol  ls  gluconeog-            enesis c<+kdj 'kjhj esa Xywdkst dh vko';drk dks   ds iw.kZ:i ls u cuus ij yEckbZ dk c<+uk iw.kZ :i ls            iwjk djrs gSaA                            #d tkrk gS  (absolute  cessation  of  growth)A           - jä esa lipoprotein lipase dks mÙksftr djrs gSaA  bldk vFkZ ;g gqvk fd] 'kkjhfjd o`f) ds fy,           - blls jä esa dksysLVªkWy ,oa VªkbfXyljkbM ds Lrj ?kV  Fkk;jkW;M gkWeksZUl] GH ls Hkh vf/kd egÙoiw.kZ gaSA            tkrs gSaA                                 GH  dependent  effects  (indirect  actions)  -           - fyoj esa lipogenesis dks c<+krs gSaA     Fkk;jkW;M gkWeksZUl] GH ds mRiknu ,oa lzko.k dks Hkh           - blls fatty liver dh lEHkkouk c<+ tkrh gSA  fu;af=r  djrs  gSa  (permissive  effect)  ftlls            gkbijFkk;jkW;fMTe esa lipolysis ds vR;fèkd c<+ tkus   Fkk;jkW;M gkWeksZUl dh vuqifLFkfr esa GH dk mRiknu           ds dkj.k 'kjhj ds adipose tissues ?kVrs tkrs gSa   ,oa lzko.k iw.kZ:i ls #d tkrk gSA GH dk mRiknu ,oa           tcfd gkbiksFkk;jkW;fMTe esa ;g c<+ tkrs gSaA   lzko.k c<+kdj Fkk;jkW;M gkWeksZUl] IGF-1 dk mRiknu                                                      Hkh c<+k nsrs gSaA GH tgk¡ tUe ds le; ls I;wcVhZ rd           gkbijFkk;jkW;fMTe esa QSV esVkckWfyTe ds c<+ tkus ls           jä esa dksysLVªkWy ,oa VªkbfXyljkbM ds Lrj ?kV tkrs gSa   f'k'kq dh 'kkjhfjd o`f) ds fy, vko';d gksrk gS ogha           tcfd gkbiksFkk;jkW;fMTe esa QSV esVkckWfyTe ds ?kV   insulin like growth factor-1 (IGF-1), xHkZLFk f'k'kq           tkus ls jä esa dksysLVªky ,oa VªkbfXyljkbM ds Lrj c<+   ds fodkl esa vR;Ur egRoiw.kZ Hkwfedk fuHkkrk gSA                                                    34","GH  independent  effects  (direct  actions)  -    dsoy yEckbZ (;k skeletal growth) dks gh izHkkfor           ,slk ugha fd Fkk;jkW;M gkWeksZUl dsoy GH ds ek/;e ls   djrs gSa] soft tissue growth buls vf/kd izHkkfor ugha           gh 'kkjhfjd o`f) dks izHkkfor djrs gSa “kkjhfjd o`f) dks   gksrhA blfy, gkbiksFkk;jkW;fMTe esa vf/kdka'k cPps           ;g lh/ks Hkh izHkkfor djrs gSaA okLro esa Fkk;jkW;M   yEckbZ  esa  rkss  NksVs  ijUrq  gkFk\&iSjksa  dh  eksVkbZ  esa           gkWeksZUl] dkfVZyst ,oa gfM~M;ksa dh o`f) ds fy, vR;Ur   vis{kkd`r eksVs ,oa viuh vk;q ls cM+s fn[kkbZ nsrs gSaA           egRoiw.kZ gksrs gSa ,oa bUgha ds ek/;e ls ;g 'kkjhfjd           o`f) dks izHkkfor djrs gSaA                Fkk;jkW;M  gkWeksZUl  dh  vR;f/kd  deh  (severe                                                      hypothyroidism) esa rks skeletal maturation bl           Effects of TH on cartilages -  Fkk;jkW;M gkWeksZUl]   lhek rd ?kV tkrk gS fd gkbiksFkk;jkW;fMTe gksus ds           chondrocytes  ds prolifera-tion,  differentiation   ckn bone age fcYdqy Hkh ugha c<+rhA bl izdkj]           ,oa mineralisation dks c<+krs gSaA lkFk gh ;g o`f) ds   bone  age ds vkdyu ls ;g vuqeku yxk;k tk           fy, vko';d iks\"kd rRoksa dks igq¡pkus ds fy, buesa   ldrk gS fd gkbiksFkk;jkW;fMTe yxHkx fdl mez esa           angiogenesis dks Hkh c<+krs gSaA bUgha izfØ;kvksa ds   vkjEHk gqbZ gksxhA           }kjk fdlh f'k'kq esa dkfVZyst ds }kjk long bones dh           mRifÙk gksrh gSA                           gkbiksFkk;jkW;fMTe ls izHkkfor bu cPpksa esa Fkk;jkWfDlu                                                      vkjEHk djus ds ckn chondrocytes esa proliferation           Effects of TH on bones - gfM~M;ksa  ds mRiUu gksus   ,oa differentiation iqu% vkjEHk gks tkrk gS ftlls           ds i'pkr~ Fkk;jkW;M gkWeksZUl] budh epiphysis dh   #dh gqbZ 'kkjhfjd o`f) nqckjk vkjEHk gks tkrh gSA           o`f) djkrs gSa ,oa metaphyseal growth plates dks   Fkk;jkWfDlu vkjEHk djus ds ckn dqN le; esa ;g           mÙksftr djds ogk¡ ubZ gM~Mh dk fuekZ.k djkrs gSa ftlls   'kkjhfjd o`f) dh nj (growth rate) lkekU; ls Hkh           gM~Mh (diaphysis) yEckbZ esa c<+rh gSA     vf/kd gksrh gSA bls catch up growth dgrs gSaA            EFFECTS  OF  HYPOTHYROIDISM  ON            EFFECTS  OF  HYPOTHYROIDISM  ON           LINEAR GROWTH                              SKELETAL MATURATION           gkbiksFkk;jkW;fMTe 'kkjhfjd o`f) dks fuEu izdkj ls   gkbiksFkk;jkW;fMTe  esa  skeletal  maturation  esa  nks           izHkkfor dj ldrh gS \&                      izdkj ds ifjorZu gksrs gSa \&            -  izksVhu ds fuekZ.k esa ck/kk igq¡pkdj   - Abnormal  endochondral  ossification  ,oa           - GH dk mRiknu ,oa lzko.k ?kVkdj            epiphyseal dysgenesis           - IGF-1 dk mRiknu ?kVkdj                   - Long bones dh growth plate ds ,Dljs esa ;g            - Chondrocytes  ds  proliferation,  differentia-  ifjorZu 'stippled epiphyses'  ds :i esa fn[kykbZ            tion, mineralisation ,oa buesa angiogenesis dks   iM+rs gSaA            ?kVkdj           - Epiphysis  ,oa  metaphysis  ds fuekZ.k  esa ck/kk   gkbiksFkk;jkW;fMTe dk vkjEHk ;fn fdlh o;Ld esa            Mkydj                                     'kkjhfjd o`f) #d tkus ds i'pkr~ gksrk gS rc mldk                                                      izHkko  growth  plate  ij  u  iM+  dj  bone           Long  bones ds fodflr u gks ikus ds dkj.k gh   mineralisation ij iM+rk gSA Fkk;jkW;M gkWeksZUl dh           cretinism esa gkFk\&iSjksa dh yEckbZ leqfpr :i ls ugha   deh ls osteoblastic  activity ?kV tkrh gS ftlls           c<+  ikrhA  blfy,  cretinism  ls  izHkkfor  cPpksa           (cretins) esa flj ,oa /kM+ vf/kd fodflr fn[krs gSa   osteoid dk cuuk Hkh ?kV tkrk gSA blls ,d low           tcfd budh rqyuk esa gkFk ,oa iSj vis{kkd`r dkQh   bone turnover dh fLFkfr mRiUu gks tkrh gSA tc bl           NksVsA /;ku jgs] 'kkjhfjd o`f) esa Fkk;jkW;M gkWeksZUl   FkksM+h ek=k esa cus gq, osteoid dk mineralisation                                                     35","/kheh xfr ls gh lgh ijUrq yEcs le; rd gksrk jgrk gS  Fkk;jkW;M gkeksZUl Lo;a gh vf/kd izHkkoh ugha gksrsA           rc og gM~Mh hypermineralised lh izrhr gks ldrh   EFFECTS  OF  TH  ON  NEUROLOGICAL            gSA /;ku jgs] bone turnover ls gM~Mh yxkrkj vius   DEVELOPMENT           vki dks cnyrs gq, ncko ds vuqlkj <kyrh jgrh gSA  ftl izdkj Fkk;jkW;M gkWeksZUl “kkjhfjd o`f) ds fy,           Bone  turnover ds ?kV tkus ls izHkkfor gM~Mh esa  vR;f/kd egRoiw.kZ gSa] mlh izdkj efLr’d ,oa U;wjkWUl           remodelling Hkh ?kV tkrh gS ftlls ÝSDpj dh   ds fodkl ds fy, Hkh budh vR;f/kd vko”;drk gksrh           lEHkkouk c<+ tkrh gSA                      gSA /;ku jgs] U;wjkWUl dk ;g fodkl dsoy Hkzw.kkoLFkk                                                      ,oa tUe ds izFke o’kZ esa gh laHko gSA Fkk;jkW;M gkWeksZUl           EFFECTS  OF  HYPERTHYROIDISM  ON           LINEAR GROWTH                              dh vuqifLFkfr esa ;g lEHko gh ugha gks ikrkA bl le;           Cretinism esa severe short stature dks ns[krs gq, ;g   esa mRiUu gqbZ gkbiksFkk;jkW;fMTe] f”k”kq ds ekufld                                                      fodkl ij viw.kZuh; {kfr ig¡qpk ldrh gSA tUe ds 1-2           Hkh lkspk tk ldrk gS fd gkbijFkk;jkW;fMTe esa tall   o’kksZa ds i”pkr~ fn;k x;k Fkk;jkWfDlu Hkh bldks okfil           stature feyuk pkfg,A ijUrq ,slk Hkh ugha gksrkA ;g           rks lR; gS fd Fkk;jkW;M gkWeksZUl]  long  bones dh   lkekU; ugha cuk ldrkA           metaphyseal  growth  plates  dks mÙksftr djds   ge tkurs gSa fd T3, blood brain barrier (BBB) dks                                                      ikj ugha dj ldrk blfy,] T4 gh BBB dks ikj dj           new bone formation djokrs gSa ftlls diaphysis           dh  yEckbZ  c<+rh  gSA  ijUrq  Fkk;jkW;M  gkWeksZUl]   fodflr gks jgs efLr’d esa igq¡prk gSA efLr’d dh glial           epiphyseal  maturation  rFkk  epiphysis  ,oa   cells (astrocytes), bl T4 dks T3  esa cnydj vius           metaphysis ds ¶;wtu dks Hkh c<+krs gSaA bl izdkj tks   lehiorhZ U;wjkWUl dks miyC/k djkrh gSA bl izdkj           long bones izkjEHk esa yEckbZ esa rhozrk ls c<+rh gSa og   QhMcSd }kjk fu;U=.k dh Hkkafr gh U;wjkWUl dk fodkl           dqN le; i'pkr~ epiphysial fusion ds dkj.k c<+uk   Hkh circulating T4 ls U;wjkWUl esa gh cus T3 ds }kjk                                                      lEiUu gksrk gSA           #d tkrh gSaA bl izdkj gkbijFkk;jkW;fMTe ls izHkkfor           cPps vkjEHk esa rks lkFk ds nwljs cPpksa ls vf/kd yEcs   EFFECT OF TH ON NEURONS           fn[krs gSa ijUrq var esa og muls NksVs jg tkrs gSaA   Fkk;jkW;M gkWeksZUl ds U;wjkWUl ij iM+us okys dqN izeq[k           gkbijFkk;jkW;fMTe esa skeletal maturation ds c<+   izHkko fuEufyf[kr gSa %           tkus  ls  izHkkfor  cPps  dh  bone  age,  mldh   a)  DURING  EMBRYOGENESIS  \&  FIRST                                                      TWO YEARS OF LIFE           chronological age (mez) ls c<+h gqbZ feyrh gSA                                                      - ;g  U;wjkWUl  ds  migration,  differentiation  ,oa           DIFFERENTIAL  EFFECTS  OF  TH  ON           maturation esa lgk;d gksrs gSaA           PRENATAL GROWTH           /;ku jgs] Fkk;jkW;M gkWeksZUl] 'kkjhfjd o`f) dks eq[;r%   - ;g  U;wjkWUl  esa  dendritic  branching,  axonal           tUe ds ckn gh izHkkfor djrs gSa] blds iwoZ ughaA   proliferation ,oa myelination esa lgk;d gksrs gSaA           Hkzw.kkoLFkk esa 'kkjhfjd o`f) eq[;r% IGF-1 ds vk/khu   - ;g  synapse  ds  fodkl]  mlesa  neurotrans-           jgrh gSA                                    mitters ,oa fjlsIVlZ ds fuekZ.k esa lgk;d gksrs gSaA                                                      - blhfy,  cretinism  esa  U;wjkWUl  v/kZfodflr  ,oa           ge  le>  pqds  gSa  fd  Fkk;jkW;M  gkWeksZUl]   unmyelinated jg tkrs gSaA           chondrocytes ds maturation dks c<+krs gSaA ijUrq   - efLr’d ds dqN fof”k’V Hkkx Fkk;jkW;M gkWeksZUl ds           Hkzw.kkoLFkk  esa  placental  deiodinase  (D3)  dh   izHkkoksa ds fy, vR;f/kd laosnu”khy gksrs gSa] tSls           lfØ;rk  ds  dkj.k  Fkk;jkW;M  gkWeksZUl  dk    cerebral  cortex,  cerebellar  cortex,  basal           inactivation Hkh gksrk jgrk gSA blfy;s] Hkzw.kkoLFkk esa   ganglia ,oa cochlea A blhfy, cretinism esa buds                                                     36","vfodflr jgus ij Øe”k% mental  retardation,  mÙksftr gks tkus (muscular hyperexcitability), gkFk            ataxia, motor rigidity ,oa deaf mutism mRiUu gks  iSjksa dk vdkj.k gh fgyrs jgus (hyperkinesis), fdlh            ldrs gSaA                                 dk;Z  dks  djrs  le;  “kh?kz  gh  Fkd  tkus  (early                                                      exhaustion), fcuk dksbZ dk;Z fd;s gh Fkdku dk           b) AFTER NEURONAL DEVELOPMENT                                                      vuqHko gksus (fatigue) ,oa gkFk\&iSjksa esa dEiu gksus           efLr’d ds iw.kZ:i ls fodflr gksus ds ckn Hkh blds           vusd dk;Z Fkk;jkW;M gkWeksZUl ij fuHkZj jgrs gSa %  (fine tremors) ds :i esa izdV gks ldrk gSSA uhan esa                                                      O;o/kku iM+us (sleep interference) dk Hkh ;gh izeq[k           General alertness or cerebration - Fkk;jkW;M   dkj.k gksrk gSA           gkWeksZUl]  U;wjkWUl  dh  catecholamines  ds  izfr                                                      Cerebral vascularity - Fkk;jkW;M gkWeksZUl efLr’d           laosnu”khyrk  c<+k  nsrs  gSaA  Catecholamine           sensitivity c<+us ls reticular activating system   esa jDr izokg Hkh c<+krs gSaA blhfy, vR;f/kd c<+h gqbZ           vkSj vf/kd lfØ; gks tkrk gS ,oa ckgjh ifjorZuksa ds   gkbiksFkk;jkW;fMTe  esa  cerebral  vessels  dh           izfr vkSj Hkh vf/kd ltx gks tkrk gSA       atherosclerosis  c<+us ls efLr’d esa  ischemic,                                                      degenerative  foci  ,oa  ;gk¡  rd  fd  cerebral           Behaviour  and  sleep  -  Fkk;jkW;M  gkWeksZUl   hypoxia rd mRiUu gks ldrk gSA ,sls esa efLr’d esa           cerebral  functions dks Hkh mÙksftr djrs gSa tks   glial  tissues dh ek=k c<+us yxrh gS ,oa mlesa           gkbijFkk;jkW;fMTe esa mÙkstuk (hyperexcit ability),   myxomatous  deposition  Hkh  c<+us  yxrk  gSA           gM+cM+h (restlessness), ?kcjkgV (anxiety) ds :i   vR;f/kd c<+h gqbZ gkbiksFkk;jkW;fMTe esa serous otitis           esa izdV gks ldrs gSaA blhfy, gkbiksFkk;jkW;fMTe esa   media  gksus  ls  perceptive  deafness,  night           lqLrh  (dullness),  vkyL;  (lethargy),  Fkdku   blindness ,oa cerebellar ataxia dh lEHkkouk Hkh           (fatigue,  tiredness)  ,oa  mnklh  (apathy  ,oa  c<+ tkrh gSA           depression) bR;kfn y{k.k mRiUu gks ldrs gSaA  Peripheral nervous system - Fkk;jkW;M gkWeksZUl            Fkk;jkW;M gkWeksZUl }kjk mRiUu mÙkstuk] uhan dks ?kVkrh   neuronal ,oa synaptic transmission esa Hkh lgk;d           gSA uhan vkus esa le; Hkh vf/kd yx ldrk gS ,oa  gksrs gSaA blhfy, vR;f/kd c<+h gqbZ gkbiksFkk;jkW;fMTe           chp\&chp esa uhan VwVrh Hkh jg ldrh gSA blds foijhr   esa buds /khes iM+ tkus ls muscle contraction ,oa           gkbiksFkk;jkW;fMTe esa vkyL; c<+us ls uhan vkSj vf/kd   relaxation /khes iM+ tkrs gSa tks fo”ks’k:i ls ankle           vkrh gSA                                   reflex elicit djus esa classical delayed relaxation                                                      ;k hung up reflex  ds :i esa fn[kkbZ iM+rs gSaA /;ku           Memory  and  intellectual  capacity  - Lej.k   jgs] ;gk¡ muscle contraction ,oa relaxation nksuksa           “kfDr (memory), lh[kus dh {kerk (learning) ,oa   esa leku :dkoV vkrh gS ijUrq fn[kus esa ;g dsoy           ckSf)d {kerk (intellectual capacity) dk fodkl Hkh   relaxation abnormality ds :i esa yxrk gSA blds           Fkk;jkW;M gkWeksZUl ij vk/kkfjr jgrk gSA vR;f/kd c<+h   foijhr  gkbijFkk;jkW;fMTe  esa  tendon  reflexes,           gqbZ gkbiksFkk;jkW;fMTe esa cksyh (speech), dk;Z vkjEHk   brisk gks tkrs gSaA           djus dh {kerk (initiative) ,oa ckSf)d {kerk ean iM+   gkbiksFkk;jkW;fMTe esa gh pernicious  anemia ,oa           tkrh gS rFkk Lej.k “kfDr rd ean iM+ ldrh gSA                                                      foVkfeu B12 dh deh gksus dh lEHkkouk Hkh c<+ tkrh           gkbijFkk;jkW;fMTe  ds  yEcs  le;  rd  jgus  ls   gS ftlls iSjksa esa vibration sensation ?kV tkrk gS ,oa           Alzheimer's disease dh lEHkkouk c<+ ldrh gSA  plantar reflex extensor fey ldrk gSA           Neuromuscular  \&  synaptic  stimulation  -           gkbijFkk;jkW;fMTe esa ;g ekalisf”k;ksa dk ljyrk ls   gkbiksFkk;jkW;fMTe  esa  gh  soft  tissues  esa                                                    37","myxomatous  deposition ds dkj.k  carpal ,oa   gksus yxrs gSaA ,sls esa 'kjhj ds fofHkUu Hkkxksa dks           tarsal tunnels tSls pkjksa vksj ls f?kjs LFkkuksa esa buls   vkWDlhtu miyC/k djkus ,oa muls rki ,oa waste           gksdj xqtjus okyh uoZ ij ncko iM+ ldrk gS ftlls   products dks ys tkus ds fy, jDr izokg c<+kus dh           gkFkksa ,oa iSjksa esa lqUuiu (numbness) ,oa >qu>quh   vko';drk  iM+rh  gSA  Fkk;jkW;M  gkWeksZUl  ds  }kjk           (paresthesias) mRiUu gks ldrh gSaA         esVkckWfyd xfrfof/k;ksa ds c<+us ls hemodynamics esa            Muscular  system  - gkbiksFkk;jkW;fMTe ds izeq[k   fuEukafdr izHkko mRiUu gks ldrs gSaA           y{k.kksa esa ls fo”ks’k gSa] muscular stiffness, aches   EFFECTS OF TH ON HEMODYNAMICS           ,oa pains A B.M esa ;g vkSj Hkh vf/kd c<+ tkrs gSaA  - ‚n; xfr (heart rate - HR) c<+ tkrh gS (positive                                                       chronotropic effect)A           gkbiksFkk;jkW;fMTe esa ekalisf”k;ksa esa Hkh myxomatous           deposition ds dkj.k muscle  hypertrophy fey   - ‚n;  dh  ekalisf'k;ksa  ds  ladqpu  dh  {kerk           ldrh gS tks cPpksa dh calf muscles esa fo”ks’k:i ls   (myocardial contractility) c<+ tkrh gS (positive                                                       inotropic effect)A           fn[kkrh  nsrh  gSA  bls  Hoffman  syndrome   ;k           Kocher-Debre-Semelaigne syndrome dgrs gSaA  - blls stroke volume (SV) c<+ tkrk gSA                                                      - SV ds c<+us ls systolic blood pressure (SBP)           gkbijFkk;jkW;fMTe  esa  yEcs  le;  ls  py  jgh   c<+ tkrk gSA           dSVkckWfyTe ds dkj.k ekalisf”k;ka detksj gksrh tkrh gSaA   - Metabolic  waste  products  ds  c<+us  ls           D;ksafd proximal muscles dks distal muscles dh   vasodilatation gksrk gSA blds vfrfjDr] Fkk;jkW;M           vis{kk vf/kd Hkkj mBkuk iM+rk gS] vr% ;g muesa igys   gkWeksZUl ls gksus okys thermogenesis ds dkj.k Hkh           izdV gksrk gSA gkFkksa dks Åij mBkdj dke djus]   vasodilatation gksrk gSA           cSBdj uhps ls mBus ;k lh<+h p<+us esa FkdkoV] ;g   - Vasodilatation  ls  peripheral  vascular           blds izkjfEHkd y{k.k gksrs gSaA ekalisf”k;ksa esa bl izdkj   resistance (PVR)   ,oa after load ?kV tkrs gSa            dh detksjh dks thyrotoxic myopathy   dgrs gSaA  ftuls diastolic BP (DBP) ?kV tkrk gSA           Graves' disease ds 1% jksfx;ksa esa myasthenia   - SBP ds c<+us ,oa DBP ds ?kVus ls mean arterial           gravis  Hkh  fey  ldrk  gS  ftlesa  jksxh  occular   pressure (MAP) yxHkx leku gh cuk jgrk gS           muscular weakness ds lkFk fn[kkus vkrs gSaA   tcfd pulse pressure c<+ tkrk gSA                                                      - HR ,oa SV ds c<+us ls cardiac output (CO) c<+           gkbijFkk;jkW;fMTe esa dHkh\&dHkh periodic paralysis           Hkh  mRiUu  gks  ldrh  gS  tks  vf/kdka”kr;%   tkrk gSA                                                      - mijksDr  lHkh  dkj.kksa  ls  circulation           hypokalemia ds dkj.k mRiUu gksrh gSA Thyroid           functions ds lkekU; gksus ds lkFk gh blesa lq/kkj vkus   hyperdynamic  gks tkrk gS ftlls  circulation           yxrk gSA                                    time ?kV tkrk gSA                                                      EFFECTS OF TH ON MYOCARDIUM                                                       - Myosine  heavy  chain  alpha dk expression            EFFECTS  OF  TH  ON  HEART  AND            CIRCULATION                                c<+kdj Fkk;jkW;M gkWeksZUl] ‚n; dh ekalisf'k;ksa ds           Fkk;jkW;M  gkWeksZUl  ds  dkj.k  BMR  ,oa  fofHkUu   ladqpu dh {kerk c<+krs gSaA           esVkckWfyd xfrfof/k;ksa ds c<+ tkus ls vkWDlhtu dh   - blds vfrfjDr myocardial sarcoplasm esa Ca-           vko';drk  c<+  tkrh  gS  ftlls  rki  (heat)  ,oa   ATPase dh lfØ;rk c<+kdj ;g sarcoplasmic           metabolic waste products vf/kd ek=k esa mRiUu   reticulum esa i;kZIr dSfY'k;e ,df=r djus esa Hkh                                                       enn djrs gSa tks ekalisf'k;ksa ds ladqpu esa lgk;d gks                                                     38","ldsA                                       ckgj fudkyus ds fy, 'olu xfr  (respiratory                                                       rate) c<+ tkrh gSA           - bl  izdkj  gkbiksFkk;jkW;fMTe  esa  myocardial            contractility ?kVrh gS tcfd gkbijFkk;jkW;fMTe esa   - 'olu xfr ds c<+us ds lkFk\&lkFk lkal dh xgjkbZ            ;g c<+rh gSA                               (depth of respiration) Hkh c<+rh tkrh gSA                                                      - Minute ventilation esa o`f) gksrh gSA           EFFECTS  OF  SEVERE  HYPERTHYROI-          - 'olu dsUnzksa (respiratory centers) dh hypoxic           DISM ON CIRCULATION                                                       ,oa hypercapnic drive c<+ tkrh gS] vFkkZr] O                                                                                              2           Lej.k jgs] xaHkhj :i ls vR;f/kd c<+h gqbZ (severe)   ?kVus ;k CO  c<+us ij respiratory centers ftruk           gkbijFkk;jkW;fMTe ds ‚n; ij iM+us okys izHkko] gYdh   2           (milder) gkbijFkk;jkW;fMTe ls iw.kZr;% fHkUu gks ldrs   mRrsftr gksus pkfg, Fks] os mlls vf/kd mRrsftr           gSaA xaHkhj gkbijFkk;jkW;fMTe] circulation ij loZFkk   gksdj 'olu xfr dks vkSj Hkh vf/kd c<+k nsrs gSaA           foijhr izHkko Mky ldrh gSA                 RESPIRATORY SYSTEM IN HYPOTHYROI-                                                      DISM           Fkk;jkW;M gkWeksZUl] HR dks c<+krs gSa ijUrq Fkk;jkW;M   gkbijFkk;jkW;fMTe esa tgk¡ hyperventilation ns[kus           gkWeksZUl ds vR;f/kd c<+s gksus ij HR ds vR;f/kd c<+us   dks  feyrk  gS]  ogha  gkbiksFkk;jkW;fMTe  esa           ls nks heart beats ds e/; dk le; ?kVrk tkrk gSA   hypoventilation  feyrk  gSA  gkbiksFkk;jkW;fMTe  esa            /;ku jgs blls] cardiac  cycle ds systolic  time   blds izHkko vusd Lrjksa ij mRiUu gksrs gSaA           interval dh rqyuk esa] diastolic time interval vf/kd                                                      - 'olu dsUnzksa dh hypoxic ,oa hypercapnic drive           izHkkfor gksrk gSA blds dkj.k severe tachycardia                                                       ?kV tkrh gSA vFkkZr] O  ?kVus ;k CO  c<+us ij 'olu           gksus ij]  diastolic  time ds ?kVus ds dkj.k  left           2         2                                                       dsUnz ftruk mRrsftr gksus pkfg, Fks] og ugha gks ikrs           ventricular filling time de gksrk tkrk gS tks iqu% SV           ,oa CO dks Hkh ?kVk nsrk gSA CO esa bl izdkj vk;h   ftlls 'olu xfr vis{kkd`r de jg tkrh gSA           deh dks high output heart failure  dgrs gSaA  - 'okl uky esa myxomatous tissue ds tek gksus ls           Fkk;jkW;M gkWeksZUl tgk¡ myocardial contractility dks   obstructive airway disorders ,oa sleep apnea           c<+krs gSa ogha buds vR;f/kd c<+s gksus ij izksVhu   mRiUu gks ldrs gSaA blh izdkj thHk ,oa larynx esa           dSVkckWfyTe ds c<+us ls ekalisf'k;ksa dh dqy ek=k esa Hkh   myxomatous deposits gksus ds dkj.k] Loj eksVk]                                                       yViVk ,oa Hkkjh (voice thick, slurred ,oa hoarse)           deh vkrh tkrh gSA blls myocardial contractility           ?kVus  yxrh  gSA  yEcs  le;  rd  detksj  gks  jgh   gks ldrk gSA           myocadial weakness dks thyrotoxic myopathy   - Respiratory muscles detksj gksus yxrh gS ftlls           dgrs gSaA                                   vital capacity ?kVus yxrh gSA           EFFECTS  OF  TH  ON    RESPIRATORY         - Pleural  effusion  gksus  dh  fLFkfr  esa  alveolar           SYSTEM                                                       ventilation  vkSj Hkh vf/kd ?kVrk gS ,oa  CO                                                                                              2           Fkk;jkW;M gkWeksZUl ds dkj.k esVkckWfyd xfrfof/k;ksa ds   retention c<+us yxrk gSA           c<+us ls ftl izdkj jDr ifjlapj.k dks lfØ; gksuk           iM+rk gS Bhd ogh izHkko 'olu ra= ij Hkh iM+rk gSA                                                       EFFECTS OF TH ON ENDOCRINE SYSTEM           - 'kjhj  esa  vkWDlhtu  dk  mi;ksx  (oxygen            utilization) c<+rk gSA                    'kjhj dh esVkckWfyd xfrfofèk;ksa ds c<+us ls vfèkdk¡'k           - blls 'kjhj esa vf/kd ek=k esa CO  mRiUu gksrh gSA  gkWekZsUl dh vko';drk,a Hkh c<+ tkrh gSaA ijUrq]                                     2                Fkk;jkW;M gkWekZsUl esa lhfer ek=k esa gksus okys FkksM+s           - O  dh vko';drk dks iw.kZ djus ds fy, ,oa CO  dks             2                                  2                                                   39","mrkj\&p<+ko] lkekU;r% vU; gkWekZsUl esa dksbZ fo'ks\"k   sperm maturation esa Hkh O;oèkku mRiUu dj ldrk           ifjorZu mRiUu ugha djrsA                   gSA blds foijhr] gkbijFkk;jkW;fMTe esa erection dh                                                      çfØ;k esa ckèkk iM+us ls erectile  dysfunction            PANCREAS                                                                        ;k           lkekU; ek=k esa jgus rd Fkk;jkW;M gkWekZsUl] bUlqfyu   impotence rd mRiUu gks ldrk gSA           dk lzko.k ,oa çHkko rks c<+k nsrs gSa ijUrq jä esa Xywdkst   In females - efgykvksa esa Fkk;jkW;M gkWekZsUl] fu;fer           ds Lrj dks çHkkfor ugha dj ikrsA           ekfld pØ] ovulation, implantation ,oa xHkkZoLFkk           gkbijFkk;jkW;fMTe  esa  Fkk;jkW;M  gkWekZsUl  dh  ek=k   ds nkSjku Hkzw.k ds fodkl ¼fetal development½] çR;sd           vR;fèkd c<+ tkus ij budk ;g çHkko cny tkrk gSA   fØ;k  ds  fy,  vR;ar  egRoiw.kZ  gksrs  gSaA  Fkk;jkW;M                                                      gkWekZsUl dh xM+cfM+;ksa ls fdlh Hkh çdkj dh ekfld èkeZ           gkbijFkk;jkW;fMTe  esa  dSVkckWfyd  xfrfof/k;k¡           (lipolysis, muscle breakdown, glycogenolysis   dh vfu;ferrk,a mRiUu gks ldrh gSaA           ,oa gluconeogenesis) bruh vfèkd c<+ tkrh gSa fd   gkbijFkk;jkW;fMTe \& gkbijFkk;jkW;fMTe esa ekfld           og jä esa Xywdkst ds Lrj dks Hkh c<+k nsrh gSaA GIT dh   jälzko vfèkdrj ?kV tkrk gS ¼hypomenorrhea    ½           xfr'khyrk c<+ tkus ls Hkh Hkkstu ls çkIr gksus okys   ,oa nks ekfld èkeksZa ds eè; dk varjky ¼ekfld pØ ;k           Xywdkst ds rhozrk ls vo'kksf\"kr ¼absorb½ gksus ds   menstrual  cycle½  yEch  gksrh  tkrh  gSa           dkj.k Hkkstu ds mijkUr jä esa Xywdkst ds Lrj esa gksus   ¼oligomenorrhea ½A dqN efgykvksa esa rks ;g dqN           okyh c<+ksÙkjh ¼postprandial glucose excursion½   le; ds fy, can ¼amenorrhea ½  rd gks ldrh gSaA           lkekU; ls vfèkd gks tkrh gSA               vksO;wys”ku ?kV tkus ¼oligoovulation ½  ;k fcydqy           blds  foijhr]  gkbiksFkk;jkW;fMTe   esa  GIT  dh   #d  tkus  ¼anovulation ½   ls  xHkZèkkj.k  djus  dh           xfr'khyrk ?kV tkus ls Hkkstu ls çkIr gksus okys Xywdkst   lEHkkouk ?kV tkrh gS ,oa xHkZèkkj.k dj ysus ij Hkh ek¡           ds vis{kk—r èkhes :i ls vo'kksf\"kr gksus ds dkj.k   dh catabolic state ds dkj.k Hkwz.k dk fodkl ckfèkr           postprandial  glucose  excursion Hkh lkekU; ls   gksrk  gS  ftlls  miscarriage   vFkok  premature           de gks tkrk gSA vR;fèkd c<+h gqbZ gkbiksFkk;jkW;fMTe   delivery dh lEHkkouk Hkh c<+ tkrh gSA           esa  glycogenolysis  ,oa  gluconeogenesis  dh   gkbiksFkk;jkW;fMTe \& gkbijFkk;jkW;fMTe ds foijhr]           çfØ;kvksa esa Hkh deh vkus yxrh gSA blds dkj.k yEcs   gkbiksFkk;jkW;fMTe esa ekfld jälzko vfèkdrj c<+            le; rd Hkkstu u djus ij fyoj ls endogenous   tkrk gS ¼menorrhagia½ A ijUrq] gkbijFkk;jkW;fMTe           glucose dk fuekZ.k Hkh lqpk# :i ls ugha gks ikrkA   dh Hkkafr gh gkbiksFkk;jkW;fMTe esa Hkh ekfld pØ yEcs           blls gkbiksXykblhfe;k rd dh lEHkkouk mRiUu gks   gks ldrs gSa ¼oligomenorrhea½ ] dqN le; ds fy,           ldrh gSA                                   can Hkh gks ldrs gSa (amenorrhea)  ovulation, ?kV            REPRODUCTIVE SYSTEM                        ldrk gS ¼oligoovulation½  vFkok fcydqy #d ldrk           Normal  sexual  functions  ds fy, Hkh Fkk;jkW;M   gS  ¼anovulation½ A  bu  lcls  xHkZèkkj.k  djus  dh            gkWekZsUl dk lkekU; gksuk vfrvko';d gSA ;g libido,   lEHkkouk ?kV ldrh gSA xHkZèkkj.k dj ysus ij Hkh ek¡ esa           act  ,oa gametogenesis, lHkh ij çHkko Mkyrs gSaA  Fkk;jkW;M gkWekZsUl dh deh ds dkj.k Hkwz.k dk fodkl            In males -  iq:’kksa esa gkbiksFkk;jkW;fMTe ls  libido ?kV   ckfèkr gksrk gS ftlls miscarriage  dh lEHkkouk Hkh                                                      c<+ tkrh gSA           ldrh gSA gkbiksFkk;jkW;fMTe spermatogenesis ,oa                                                          40","[kaM\&3                                                       Fkk;jkW;M xzafFk ds fodkj \& esfMdy                        (Medical Disorders of The Thyroid Gland)","5                             Laboratory Evaluation of The Thyroid Gland            Fkk;jkW;M xzafFk ds vkdyu ds fy, vusd çdkj dh   Fkk;jkW;M xzafFk dh fØ;k'khyrk ds vkdyu ds fy,           tkapsa djkbZ tkrh gSaA loZçFke rks ;g tkuuk vko';d   Fkk;jkW;M gkWeksZUl (T3 ,oa T4) dh tk¡p djkbZ tkrh gSaA           gS fd bu tkapksa dh vko';drk fdu yksxksa dks ,oa   Low S. T3/T4 \& buds Lrj lkekU; ls de gksuk           fdu\&fdu ifjfLFkfr;ksa esa iM+rh gSA        gkbiksFkk;jkW;fMTe dk |ksrd gks ldrk gSA            ;gk¡ ;g /;ku j[kuk vko';d gS fd Fkk;jkW;M xzafFk dh   High S. T3/T4 \& buds Lrj lkekU; ls vf/kd gksuk           vfu;ferrk,a vR;ar O;kid gSaA buesa Hkh lokZf/kd   gkbijFkk;jkW;fMTe dk |ksrd gks ldrk gSA           feyus okyk jksx gS gkbiksFkk;jkW;fMTeA gekjs ns'k esa   Concept  of  total  and  free  hormones  - ge           yxHkx 10-12% o;Ld efgykvksa ,oa iq#\"kksa esa ;g   tkurs gSa fd ;g T3 ,oa T4, jä esa fofHkUu IykTek           fdlh u fdlh :i esa fey ldrk gSA            çksVhUl ls tqM+s gq, çokfgr gksrs gSaA çksVhu ls tqM+s gq,                                                      ;g gkWeksZu (protein bound fraction) okLro esa 'kjhj           fQthf'k;u ;g tkapsa vf/kdrj lqLrh] dfCt;r] 'kjhj           esa nnZ ;k lwtu bR;kfn y{k.kksa esa gkbiksFkk;jkW;fMTe dh   dh fofHkUu dksf'kdkvksa ij dk;Z djus ds fy, miyC/k           lEHkkouk ds fy, vFkok otu ?kVrs tkus] gkFk\&iSjksa esa   ugha gksrs ,oa jä esa gkWeksZu ds Hk.Mkj dks çnf'kZr djrs           dEiu  ;k  nLr  gksus  ij  gkbijFkk;jkW;fMTe  dh   gSaA buds foijhr] jä esa eqä :i ls çokfgr gks jgs           lEHkkouk ds fy, djkrs gSaA                 gkWeksZu (free fraction), 'kjhj dh fofHkUu dksf'kdkvksa                                                      ij  dk;Z  djus  ds  fy,  miyC/k  jgrs  gSa  (active           - ckyjksx fo'ks\"kK bls cPpksa dh yEckbZ u c<+us ij   fraction;  free  T3 ,oa  free  T4)A bu nksuksa dh            djkrs gSaA                                lfEefyr :i ls bUgsa total hormone concentration           - L=h  jksx  fo'ks\"kKk,a  bls  ekfld  pØ  dh   (protein bound + free fractions; total T3 ,oa  total            vfu;ferrkvksa ds fy,] larkughurk ds fy,] vFkok   T4) dgrs gSaA            ckj\&ckj xHkZikr gksus dh fLFkfr esa djkrh gSaA           - ltZu bls xkW;Vj vFkok xys dh xk¡B dh igpku ds   lS)kafrd :i ls Ýh gkWeksZUl dks VksVy gkWeksZUl ls            fy, djkrs gSaA                            vf/kd mi;ksxh ekuk tk ldrk gS ijUrq buds vkdyu                                                      ds fy, vR;k/kqfud e'khuksa ,oa fj,tsUV~l (assay) dh           mijksä tkapksa dks djkus ds eq[;r% nks mís'; gks ldrs   vko';drk iM+rh gSA blhfy,] vHkh Hkh VksVy gkWeksZUl           gSa                                        gh vf/kd çpfyr gSaA Ýh gkWeksZUl dk mi;ksx fo'ks\"k:i           - Fkk;jkW;M xzafFk dh dk;Z{kerk ds vkdyu ds fy,   ls IykTek çksVhu dh deh tSlh fLFkfr;ksa esa gh fd;k            (functional assessment),                  tkrk gSA           - Fkk;jkW;M  xzafFk  dh  lajpuk  ds  vkdyu  ds  fy,            (structural assessment),                  b)  SERUM TSH           buds vfrfjä Hkh dqN tkapsa] bu vfu;ferkvksa ds   fdlh Hkh vU; gkWeksZu xzafFk dh Hkkafr Fkk;jkW;M xzafFk ds           dkj.kksa dh [kkst ds fy, Hkh djkbZ tkrh gSaA  fy, Hkh dsoy xzafFk ls cuus okys gkWeksZUl ls gh fLFkfr                                                      dk iw.kZ vkdyu ugha gks ikrk gSA blds fy,] xzafFk ls           vkb;s bUgsa foLrkj ls le>rs gSaA                                                      cuus okys gkWeksZu ds vfrfjä mldks fu;af=r djus             FUNCTIONAL  ASSESSMENT                   okys gkWeksZu dh tkap Hkh vko';d gksrh gSA xzafFk ls cuus           THYROID FUNCTION TESTS (TFT)               okys gkWeksZu ,oa bldks fu;af=r djus okys gkWeksZu nksuksa           a)  SERUM T3 AND T4                        ds lfEefyr v/;;u }kjk gh jksx dh xaHkhjrk ,oa blds                                                     42","dkj.k dks Hkyh\&Hkkafr igpkuk tk ldrk gSA Serum  lkekU; ls c<+k jguk ¼;k de u gksuk½] lsdsaMjh           TSH dh tkap blesa fo'ks\"k :i ls çHkkoh gksrh gSA  gkbijFkk;jkW;fMTe ¼fiVîwVjh xzafFk dh vfrlfØ;rk ds           gkbiksFkSysfed\&fiVîwVjh\&Fkk;jkW;M  ,fDll  dh  dkj.k Fkk;jkW;M xzafFk ds vf/kd fØ;k'khy gksus½ ds           laosnu'khyrk dh dkj.k] Fkk;jkW;M gkWeksZUl esa vk;s FkksM+s  |ksrd gksrs gSaA           Hkh ifjorZu ¼pkgs og lkekU; jsat esa gh D;ksa u gksa½]   Normal T3/T4, minimally high TSH - dHkh dHkh           lhje TSH ds Lrjksa dks çHkkfor dj nsrs gSaA blhfy,]   Fkk;jkW;M xzafFk dh vkaf'kd detksjh dh fLFkfr esa tc           bls lokZf/kd egRoiw.kZ tkap ekuk tkrk gSA   T3 ,oa T4 ds Lrj ?kVuk vkjEHk gksrs gSa rc fiVîwVjh           ge tkurs gSa fd lhje TSH ds Lrj] Fkk;jkW;M gkWeksZUl  xzafFk }kjk TSH dk lzko.k c<+kdj bUgsa lkekU; cuk           ds  Lrjksa  }kjk  fu;af=r  gksrs  gSaA  vr%  tc  fy;k tkrk gSA ,sls esa lhje T3 ,oa T4 ds Lrj lkekU;           gkbiksFkk;jkW;fMTe esa lhje T3 ,oa T4 ds Lrj ?kVrs gSa  ijUrq lhje TSH ds Lrj lkekU; ls FkksM+k vf/kd           rc fuxsfVo QhMcSd ds dkj.k lhje TSH ds Lrj c<+rs  feyrs  gSaA  bl  fLFkfr  dks  subclinical  hypo-           gSaA blh çdkj tc gkbijFkk;jkW;fMTe esa lhje T3 ,oa   thyroidism dgrs gSaA           T4 ds Lrj c<+rs gSa rc fuxsfVo QhMcSd ds dkj.k   Normal T3/T4, low TSH - blh çdkj] Fkk;jkW;M           lhje  TSH  ds  Lrj  ?kVrs  gSaA  bls  inverse   xzafFk ds vkaf'kd :i ls vfrlfØ; gksus dh fLFkfr esa tc           lagarithmic  relationship  dgrs  gSaA  /;ku  jgs]   T3 ,oa T4 ds Lrj c<+uk vkjEHk dj nsrs gSa rc           gkbiksFkk;jkW;fMTe ds c<+s gq, lhje TSH dh tkap rks   fiVîwVjh xzafFk }kjk  TSH dk lzko.k ?kVkdj bUgsa           lkekU;  fof/k;ksa  ls  Hkh  gks  tkrh  gS  ijUrq]   lkekU; cuk fy;k tkrk gSA ,sls esa lhje T3 ,oa T4 ds           gkbijFkk;jkW;fMTe esa ?kVs gq, lhje TSH dks ukius ds   Lrj iqu% lkekU; gks tkrs gSa ijUrq lhje TSH ds Lrj            fy, ultrasensitive  third  generation  assay   dh   lkekU;  ls  FkksM+k  de  feyrs  gSaA  bl  fLFkfr  dks           vko';drk iM+rh gSA                         subclinical hyperthyroidism dgrs gSaA            INTERPRETATION OF TFT                                                      CHOICE OF TEST           Low T3/T4, high TSH - vr%] lhje T3/T4 ds de   ;gk¡ ç'u ;g mBrk gS fd mijksä rhu iSjkehVj esa fdl           gksus  ds  lkFk  lhje  TSH  dk  c<+k  gksuk  çkbejh   tkap dks djk;k tk;s\\ okLro esa ;g gekjh tkap djkus           gkbiksFkk;jkW;fMTe ¼Fkk;jkW;M xzafFk dh viuh detksjh½                                                      ds mís'; ij fuHkZj djrk gSA           dk |ksrd gksrk gSA                                                      Population based screening - ;fn gesa cM+s Lrj           Low  T3/T4,  low  TSH  -  blds foijhr] lhje   ij vusd yksxksa dks LØhu djuk gS ¼vFkkZr ftuesa jksx           T3/T4 ds de gksus ds ckn Hkh lhje TSH dk Lrj   dh lEHkkouk vf/kd u gks½ rc blds fy, S. TSH  dh           lkekU; ls de jguk ¼;k lkekU; jguk Hkh½] lsdsaMjh   tkap lokZf/kd mi;qä jgrh gSA ,slk blfy, D;ksafd           gkbiksFkk;jkW;fMTe  ¼fiVîwVjh  xzafFk  dh  detksjh  ds   bldh laosnu'khyrk vf/kd gksrh gS ¼vFkkZr Fkk;jkW;M           dkj.k Fkk;jkW;M xzafFk dh fØ;k'khyrk esa deh½ ds |ksrd   xzafFk dh vkjafHkd vfu;ferrkvksa esa gh blds Lrj           gksrs gSaA bls lsaVªy gkbiksFkk;jkW;fMTe  Hkh dgrs gSaA                                                      çHkkfor gksus yx tkrs gSa½ ,oa blesa false negative           High T3/T4, low TSH - blh çdkj] lhje T3/T4   test dh lEHkkouk de gksrh gSA bldk ,d dkj.k ;g           ds vf/kd gksus ds lkFk lhje TSH dk ?kVk gksuk]  Hkh gS fd Fkk;jkW;M lEcaf/kr vf/kdk¡'k jksx] Fkk;jkW;M           çkbejh  gkbijFkk;jkW;fMTe  ¼Fkk;jkW;M  xzafFk  dh  xzafFk dh viuh vfu;ferrk ds dkj.k ¼çkbejh fodkj½           vfrlfØ;rk½ ds |ksrd gksrs gSaA             mRiUu gksrs gSa ftudh igpku ds fy, lhje TSH            High  T3/T4,  high  TSH  - blds foijhr] lhje   vdsys gh i;kZIr gSA           T3/T4 ds vf/kd gksus ds ckn Hkh lhje TSH dk Lrj   Case based screening - blds foijhr] ;fn gesa                                                    43","fdlh O;fä fo'ks\"k esa y{k.kksa ds vk/kkj ij LØhu djuk   Fkk;jkW;M xzafFk dh dk;Z{kerk Øe'k% ?kVrh tkrh gSA           gks ¼vFkkZr ftuesa jksx dh lEHkkouk vf/kd gks½ rc   ;g ,aVh\&Fkk;jkW;M ,aVhckWMht] Fkk;jkW;M xzafFk ds fdl           blds fy, vkSj Hkh vf/kd laosnu'khy tkapsa djkuk   Hkkx ds fo#) cuh gSa] bl vk/kkj ij ;g eq[;r% rhu           mi;qä jgrk gS ftlls  false  negative  test dh   çdkj dh gks ldrh gSaA           lEHkkouk vkSj Hkh de gks ldsA ,sls esa S. T4, S. TSH           nksuksa dks djkuk vf/kd csgrj jgrk gSA ;gk¡ S- TSH   a) ANTI  THYROID  PEROXIDASE  ANTI-                                                        BODIES (ANTI- TPO Ab)           ds lkFk\&lkFk  S.  T4 dh vko';drk blfy, Hkh gS           D;ksafd fdlh O;fä\&fo'ks\"k esa ¼ftuesa fdlh jksx dks   Fkk;jkW;M  gkWeksZUl  ds  mRiknu  esa  peroxidase                                                      enzyme vR;ar egRoiw.kZ Hkwfedk fuHkkrk gSA blds           feyus dh lEHkkouk vf/kd gks½ gesa Fkk;jkW;M xzafFk ds   fo#) cuus okyh ,aVhckWMh ls Fkk;jkW;M gkWeksZUl dk           vf/kd O;kid çkbejh fodkjksa ds vfrfjä] fiVîwVjh   mRiknu çHkkfor gksrk tkrk gS ftlls dqN le; esa           xzafFk dh vfu;ferrkvksa ls mRiUu gksus okys lsdsaMjh   gkbiksFkk;jkW;fMTe mRiUu gks ldrh gSAbl ,aVhckWMh ds           fodkjksa dks Hkh igpkuuk vko';d gks tkrk gSA çkbejh                                                      Lrj  c<+s  gksus  dks  vkWVks\&bE;wu  Fkk;jkW;M  fMlht           ,oa lsdsaMjh fodkjksa esa foHksn djus ds fy, S. TSH ,oa   ¼AITD½ dgrs gSaA blls çHkkfor O;fä;ksa esa] ,aVhckWMh           S. T4 ds e/; lacU/k LFkkfir djuk vko';d gksrk gSA                                                      ds Lrj c<+s gksus ds ckn Hkh] dqN le; rd rks Fkk;jkW;M           Role of T3 - ;gk¡ ;g le>uk vko';d gS fd S. T3   xzafFk i;kZIr ek=k esa Fkk;jkW;M gkWeksZUl dk fuekZ.k djk           dh tkap dh vko';drk vR;ar de iM+rh gSA ,slk   ysrh gS ftlls çHkkfor O;fä lkekU; ¼euthyroid½           blfy, D;ksafd xzafFk }kjk T3 dk mRiknu vR;ar FkksM+h   cuk jgrk gS ijUrq lkFk\&lkFk bl dk;Z esa ck/kk vkrh           ek=k esa gh fd;k tkrk gSA ;g eq[; :i ls T4 dh   tkrh gS ftlls igys subclinical hypothyroidism           peripheral  metabolism  ls  mRiUu  gksrk  gS  tks   ,oa var esa overt hypothyroidism  mRiUu gks tkrh           ifjfLFkfr;ksa ds vuqlkj ifjofrZr fd;k tk ldrk gSA   gSA /;ku jgs] bl ,aVhckWMh dk feyuk fdlh Hkh jksx           tSls] gkbiksFkk;jkW;fMTe esa 'kjhj esa T4 ls T3 dk   iqf\"V ugha djrk D;ksafd yxHkx 10% lkekU; yksxksa esa           cuuk c<+ tkrk gS ftlls T4 ds ?kVus ds ckn Hkh T3 ds   Hkh  budh  ek=k  c<+h  gqbZ  fey  ldrh  gSA  mez  ds           Lrj lkekU; cus jg ldrs gSaA S. T3 dh vko';drk   lkFk\&lkFk jä esa budh ek=k Hkh c<+rh tkrh gSA           çeq[k :i ls T3 toxicosis dh igpku ds fy, iM+rh gS   Fkk;jkW;M xzafFk ds vkdkj esa c<+us ¼xkW;Vj½ ds lkFk ;g           tgk¡ xzafFk }kjk dsoy T3 dk gh fuekZ.k fd;k tk jgk gksA   yxHkx 20-30% yksxksa esa fey ldrh gSaA Graves’            ANTI THYROID ANTIBODIES                    disease (GD) ls çHkkfor yxHkx 50% O;fä;ksa esa           ,aVhckWMh] 'kjhj }kjk fufeZr og inkFkZ gksrs gSa tks jksx   ,oa  eq[;r%  Hashimoto’s  thyroditis   ls  çHkkfor           mRiUu djus okys fdlh ckgjh rRo ds fo#) dk;Z djrs   yxHkx 90% O;fä;ksa esa budh ek=k c<+h gqbZ fey           gSaA dHkh\&dHkh vius bE;wu ra= ds vfrlfØ; gks tkus ls   ldrh gSA           og ckgjh rRoksa ds LFkku ij 'kjhj ds vius vaxksa dks gh   b) ANTI  THYROGLOBULIN  ANTIBODIES           ckgjh ekurs gq, muds ¼auto-antigens½ fo#) gh   (ANTI-TG Ab)           ,aVhckWMh ¼auto-antibodies½ dk fuekZ.k djus yxrs gSaA   FkkbjksXykWC;qfyu ¼Tg½ ,d egRoiw.kZ çksVhu gS ftlls           ;g ,aVhckWMh fdlh y{;Hksnh felkby dh Hkkafr vius   tqM+dj gh Fkk;jkW;M xzafFk dh  follicular  lumen  esa           'kjhj ds vaxksa dks gh {kfr igqapkrh tkrh gSaA bl fLFkfr   Fkk;jkW;M gkWeksZUl ¼T3 ,oa T4½ laxzfgr gksrs gSaA Anti-           dks  vkWVks\&bE;wu  fodkj  ¼autoimmune  disorder½   TPO Ab dh gh Hkkafr anti-Tg Ab Hkh yxHkx 10%           dgrs gSaA 'kjhj esa Fkk;jkW;M xzafFk ds fo#) cuus okyh   lkekU; yksxksa esa c<+h gqbZ fey ldrh gSa ijUrq anti-Tg           ,slh ,aVhckWMh] ,aVh\&Fkk;jkW;M ,aVhckWMht dgykrh gSa   Ab ds Lrj] anti-TPO Ab dh Hkkafr] gkbiksFkk;jkW;-           ftudh ek=k ds ,d lhek ls vf/kd c<+ tkus ls   fMTe dh lEHkkouk c<+us ds |ksrd ugha gksrsA Fkk;jkW;M                                                    44","xzafFk ds vkdkj esa c<+us ds lkFk\&lkFk budh ek=k Hkh  vuqeku yxkus ds fy, bldk mi;ksx ugha fd;k tkrkA           c<+rh tkrh gSA okLro esa] ,d lhek rd anti-TG AB  ;g dk;Z vYVªklksuksxzkQh }kjk csgrj :i ls fd;k tk           ds Lrj] Fkk;jkW;M xzafFk ds vkdkj ds |ksrd gks ldrs  ldrk gSA           gSaA blhfy, budk çeq[k mi;ksx Fkk;jkW;M dSalj ls   Serum TG dh tkap dsoy nks gh ifjfLFkfr;ksa esa djkbZ           çHkkfor O;fä;ksa esa total thyroidectomy ds i'pkr~   tkrh gSA           recurrence dh lEHkkouk dks igpkuus ds fy, fd;k           tkrk gSA Fkk;jkW;M xzafFk dks iw.kZ:i ls fudky fn;s tkus   - Total  thyroidectomy  ds  i'pkr~  cps  gq,           ds i'pkr~ FkkbjksXykWC;qfyu ds 'ks\"k u cpus ds dkj.k   (remnant)  fV'kw  vFkok  iqu%  mRiUu  gks  x,           budh ek=k ux.; jg tkrh gSA dSalj dh recurrence   (recurrence) fV'kw dks igpkuus ds fy, \& okLro esa]           gksus ij tSls\&tSls Fkk;jkW;M xzafFk dh dksf'kdkvksa dh   Fkk;jkW;M dSalj esa iwjh xzafFk dks fudky fn, tkus ds                                                       i'pkr~ rks blds Lrj ux.; gks tkus pkfg;saA ijUrq           la[;k c<+rh tkrh gS] FkkbjksXykWC;qfyu dh ek=k c<+us ls           anti-Tg Ab ds Lrj Hkh c<+rs tkrs gSaA       ;fn dgha xzafFk dk dqN Hkkx NwV x;k gks vFkok og dqN                                                       le; i'pkr~ nqckjk mRiUu gks x;k gks rc ;g Lrj           c)  ANTI TSH RECEPTOR ANTIBODIES                                                       c<+s gh jgrs gSaA           Fkk;jkW;M  QkWfydy  dh  dksf'kdkvksa  dh  ckgjh   - Iatrogenic  (exogenous) gkbijFkk;jkW;fMTe dks           basolateral membrane ij TSH fjlsIVj gksrs gSa   endogenous gkbijFkk;jkW;fMTe ls vyx igpkuus           ftuls tqM+dj  TSH] bUgha dksf'kdkvksa dks mÙksftr   ds fy, \& ;gk¡ xzafFk }kjk gkWeksZu ds vf/kd ek=k esa           djrk gSA bUgha TSH fjlsIVj ds fo#) cuus okyh   mRiknu djus ij rks blds Lrj c<+ tkrs gSa ijUrq ;fn           ,aVhckWMh] vius dk;ksaZ ds vuqlkj nks çdkj dh gks ldrh   dksbZ ckgj ls gkWeksZu dh vf/kd ek=k dk lsou dj           gSaA                                        jgk gS rks blds Lrj ?kV tkrs gSaA            TSH  receptor  stimulatory  antibodies  - tks      STRUCTURAL  ASSESSMENT           TSH  fjlsIVj  ls  tqM+dj]  Fkk;jkW;M  QkWfydy  dh   THYROID IMAGING           dksf'kdkvksa dks TSH dh gh Hkkafr mÙksftr djrh gSaA ;gh   Fkk;jkW;M xzafFk dh imaging Hkh nks çdkj dh gksrh gSA           ,aVhckWMht   mRiUu djrh gSaA                   GD                                                      - Structural imaging - ftuls Fkk;jkW;M xzafFk dh           TSH receptor blocking antibodies - tks TSH   lajpuk  dh  foLr`r  tkudkjh  feyrh  gSA  ;Fkk]           fjlsIVj ls tqM+dj] Fkk;jkW;M QkWfydy dh dksf'kdkvksa   vYVªklksuksxzkQh] lhVh LdSu MRI ,oa PET LdSuA           ij TSH dks dk;Z djus ls jksdrh gSaA ;gh ,aVhckWMht   - Functional imaging - ftlls Fkk;jkW;M xzafFk dh           atrophic hypothyroidism mRiUu djrh gSa      lajpuk dk dsoy vuqeku feyrk gS ijUrq blds            THYROGLOBULIN (TG)                          lkFk\&lkFk xzafFk dh dk;Z{kerk dh tkudkjh Hkh fey           ge tkurs gSa fd bl çksVhu dk fuekZ.k Fkk;jkW;M xzafFk esa   tkrh gSA ;Fkk] jsfM;ksU;wDykbM LdSuA           gksrk gSA okLro esa] jä esa blds Lrj] Fkk;jkW;M xzafFk ds   Ultrasonography  (USG)  -  High  resolution           vkdkj  dk  vuqeku  yxkus  esa  lgk;d  gksrs  gSaA   USG ds ek/;e ls xzafFk ,oa blesa cu jgs ukWMîwy dk           Atrophic thyroiditis esa blds Lrj ?kV tkrs gSa ,oa   foLr`r v/;;u fd;k tk ldrk gSA           Fkk;jkW;M ukWMîwy ,oa xkW;Vj esa Øe'k% c<+rs gq, ;g   - xzafFk dk vkdkj (size) ,oa vk—fr (shape)A           eYVhukWMîqyj  xkW;Vj  ,oa  Fkk;jkW;M  dSalj  esa  rks   - ukWMîwy dk vkdkj ,oa mldh cukoV tSls] Bksl           vR;f/kd c<+ tkrs gSaA Fkk;jkW;MkbfVl esa QkWfydYl esa   (solid), æo ls Hkjh (cystic) vFkok fefJrA           Hkjs TG ds jä esa yhd dj tkus ls Hkh budk Lrj c<+   - lehiorhZ vaxksa ls xzafFk dk lEcU/kA           tkrk gSA bl ij Hkh] Fkk;jkW;M xzafFk ds vkdkj dk   - lEcaf/kr fyEQ uksM dh la[;k ,oa mudk vkdkjA                                                     45","- le; ds lkFk ukWMîwy ds vkdkj dh ekWuhVfjaxA   ls nsdj 8–24 ?kaVs i'pkr~ xkek dSejk ls LdSu djrs gSaA           - blds vfrfjä USG] ukWMîwy ls FNAC djus esa Hkh   Tc ds fy, bldh 1–10  mCi ek=k dks IV nsdj                                                        99m            lgk;d gksrs gSaA                          30–60 feuV~l ds i'pkr~ LdSu djrs gSaA           y{k.k tks fdlh ukWMîwy esa dSalj dh lEHkkouk ds |ksrd   INDICATIONS OF RADIONUCLIDE SCAN           gksrs gSa \&                                In differential diagnosis of thyrotoxicosis -           - ;fn ukWMîwy dh echogenecity de gksA      xzsOl fMlht ¼lEiw.kZ xzafFk esa viVsd c<+k gksrk gS½]           - ;fn blds fdukjs vfu;fer (irregular) gksaA  VkWfDld ukWMîwy ¼xzafFk ds dsoy ,d Hkkx esa viVsd           - ;fn blesa ekbØks\&dSfYlfQds'ku fey jgk gksA   c<+k gksrk gS½ ,oa Fkk;jkW;MkbfVl ¼lEiw.kZ xzafFk esa                                                      viVsd ?kVk gqvk ,oa vfu;fer gksrk gS½ esa foHksn djus           CT scan / MRI - xnZu ds ihNs (posterior) vFkok   esaA           Nkrh ds vanj  (substernal)  c<+us okys fdlh cM+s           xkW;Vj ds v/;;u esa USG dh vis{kk ;g fo'ks\"k :i ls   In differential diagnosis of thyroid nodules                                                      - ;fn ukWMîwy esa viVsd c<+k gks ¼gkWV ukWMîwy½ rc           lgk;d gksrs gSaA blds vfrfjDr] ;g esVkLVsfll dks           igpkuus esa Hkh enn djrs gSaA              mlesa dSalj dh lEHkkouk de gksrh gSA blds foijhr]                                                      ;fn 'ks\"k xzafFk dh rqyuk esa ukWMîwy esa viVsd ?kVk gqvk           PET scan - ;g Hkh NksVh esVkLVsfll dh igpku esa   gks ¼dksYM ukWMîwy½ rc mlesa dSalj dh lEHkkouk vf/kd           lgk;d gksrs gSaA                                                      gksrh gSA /;ku jgs] ;g Hksn ges'kk lgh ugha gksrk           Radionuclide  scan  -  jsfM;ksU;wDykbM LdSu dh   In  searching  for  metastatic  functional           fo'ks\"krk ;g gS fd ;g xzafFk dh lajpuk ds fo\"k; esa rks   thyroid tissue - jsfM;ksU;wDykbM inkFkZ] jä }kjk           dsoy ,d vuqeku gh crkrs gSa ijUrq mldh lfØ;rk   lEiw.kZ 'kjhj esa çokfgr gksrs gq, tgk¡ dgha Hkh Fkk;jkW;M           ¼gkWeksZu mRiknu dh {kerk½ ds fo\"k; esa lVhd tkudkjh   QkWfydYl miyC/k gksa] ogha ,df=r gksrs tkrs gSaA           miyC/k djrs gSaA ;gk¡ ;g Hkh lkspk tk ldrk gS fd ;gh   Fkk;jkW;M dSalj esa total thyroidiectomy ds i'pkr~           tkudkjh rks gesa TFTs ls Hkh fey ldrh gS] fQj LdSu   remnant vFkok metastatic Fkk;jkW;M fV';w Hkh buds           dh D;k vko';drk gS\\ okLro esa] TFTs gesa iwjh xzafFk   }kjk igpkuk tk ldrk gSA           dh  dqy  dk;Z{kerk  ds  fo\"k;  esa  crkrs  gSa  tcfd           jsfM;ksU;wDykbM LdSu ls gesa xzafFk dk dkSu lk Hkkx   In searching for ectopic thyroid - blh çdkj]           fdruk dk;Z dj jgk gS] ;g Hkh Kkr gks ldrk gSA   buds  }kjk  thHk  esa  lingual  thyroid]  xys  esa                                                      thyroglossal  duct/cyst,  mediastinum  esa           bl  dk;Z  ds  fy,  eq[;r%  iodine-123  (I )  ,oa   substernal goiter ,oa isfYol esa struma ovarii dks                                             123                          99m                                                 123           technicium-99 (Tc ) dk mi;ksx fd;k tkrk gSA     Hkh igpkuk tk ldrk gSA                                                 I           LdSu ds fy, bldh 200–300 microCi ek=k dks eq[k                                                                   46","6                            (The Art of Interpretation of Thyroid Function Tests – TFTs) (Clinical Skill)           Case 1                                     vf/kd ?kV tkus ij buls T3 dk fuekZ.k Hkh i;kZIr :i                                                      ls ugha gks ikrk ,oa ,sls esa T3 ds Lrj Hkh ?kVrs tkrs gSaA                        Observed       Normal            Parameter                          value    reference range    blhfy,] gkbiksFkk;jkW;fMTe dh lEHkkouk gksus ij T3              S.T3      120 ng/dl    60-180 ng/dl     dh mis{kk djuk gh mfpr gSA gkbiksFkk;jkW;fMTe dh              S.T4      4.5 ug/dl     5-12 ug/dl      lEHkkouk gksus ij dsoy T4 ,oa TSH dh tkap gh djkbZ                                                      tkuh pkfg,A              S.TSH     28 mlU/L     0.5-5.0 mlU/L           S.T4 - 'kjhj esa Fkk;jkW;M gkWeksZUl dh i;kZIrrk dk   S.TSH  -  T4  ds  Lrj  de  feyus  ls  dsoy           vkdyu eq[;r% jä esa T4 ds Lrj (ST4) ds vk/kkj   gkbiksFkk;jkW;fMTe dh tkudkjh gh feyrh gS] ;g fdl           ij fd;k tkrk gSA ;gk¡ ;g 'kadk mruh LokHkkfod gS fd   çdkj dk gS ,oa bldk dkj.k D;k gS] bldh ughaA           tc T3 ,oa T4 esa] T3 gh ,fDVo gkWeksZu gS ,oa T4 ,d   gkbiksFkk;jkW;fMTe ds dkj.k dh foospuk ds fy, ge           çksgkWeksZu tks T3 esa cny dj gh dk;Z djrk gS] rc   HPT  axis dk v/;;u djrs gSaA ge tkurs gSa fd           budh foospuk ds fy, T3 dk ç;ksx D;ksa ugha fd;k   Fkk;jkW;M gkWeksZUl] fuxsfVo QhMcSd d.Vªksy flLVe ds           tkrk\\ okLro esa bldk dkj.k ;g gS fd  T4 gh   }kjk fiVîwVjh ls fu;af=r gksrs gSaA vr% T4 ds ?kVus           Fkk;jkW;M xzafFk ls cuus okyk çeq[k gkWeksZu gS] T3 ughaA   ij] bldks c<+kus ds ç;kl esa fiVîwVjh ls TSH dk           T3 dk fuekZ.k eq[;r;k% ldqZys'ku esa T4 ds T3 esa   secretion c<+ tkrk gSA TSH ds Lrj c<+us ds ckn Hkh           cnyus ls gksrk gSA blds vfrfjä] ldqZys'ku esa T3 dh   ;fn Fkk;jkW;M xk¡fB ls i;kZIr ek=k esa T4 dk mRiknu           gkQ ykbQ T4 dh rqyuk esa yxHkx 1/8 gh gksrh gS   ugha gks ikrk ,oa blds Lrj lkekU; ugha gks ikrs] rc           ftlds dkj.k blds Lrj ?kVrs c<+rs jgrs gSaA blds   ;g Fkk;jkW;M xzafFk dh foQyrk dk |ksrd gksrk gSA ,slh           foijhr] yEch gkQ ykbQ ¼yxHkx 8 fnu½ gksus ds   fLFkfr dks çkbejh gkbiksFkk;jkW;fMTe ;k thyroprivic           dkj.k T4 ds Lrj vf/kd LFkkbZ gksrs gSa ,oa Fkk;jkW;M   hypothyroidism dgrs gSaA           gkWeksZUl dh i;kZIrrk ds vkdyu esa vf/kd lgk;d gksrs   Interpretation  -  bl  çdkj]  bl  O;fä  dks           gSaA bl O;fä esa  ST4 dk lkekU; ls de gksuk]   gkbiksFkk;jkW;fMTe (low T4) gS ftldk dkj.k Fkk;jkW;M           gkbiksFkk;jkW;fMTe dk |ksrd gSA            xzafFk dh foQyrk ¼çkbejh gkbiksFkk;jkW;fMTe] high                                                      TSH½ gSA ;gk¡ T3 dk lkekU; gksuk] gkbiksFkk;jkW;fMTe           S.T3 - lkekU; Kku ds vuqlkj gkbiksFkk;jkW;fMTe esa           ST4 ds lkFk\&lkFk ST3 ds Lrj Hkh de gksus pkfg;sa   esa 'kjhj dk compensatory response gSA           ijUrq yxHkx 25% O;fä;ksa esa ,slk ugha gksrkA bldk   Case 2           dkj.k ;g gS fd Fkk;jkW;M gkWeksZUl ds Lrj ?kVus ds   Parameter  Observed   Normal           lkFk\&lkFk gh 'kjhj esa bldh {kfriwfrZ ds mik; Hkh         value    reference range           vkjEHk gks tkrs gSaA Fkk;jkW;M gkWeksZUl ds çHkko dks   S.T3  50 ng/dl  60-180 ng/dl           lkekU; cuk;s j[kus ds fy,] deiodinase  1  (D1)   S.T4    2.5 ug/dl   5-12 ug/dl           ,atkbe dh lfØ;rk c<+ tkrh gS ftlls çksgkWeksZu T4,   S.TSH  88 mlU/L  0.5 - 5.0 mlU/L           lfØ; gkWeksZu T3 esa cnyus yxrk gSA blls T4 ds Lrj   mijksä foospuk ds vuqlkj ge ljyrk ls ;g dg           vkSj Hkh vf/kd ?kV tkrs gSa ijUrq vkjfEHkd deh esa T3           ds Lrj lkekU; cus jgrs gSaA tc T4 ds Lrj vkSj Hkh   ldrs gSa fd bl O;fä dks gkbiksFkk;jkW;fMTe gS (low                                                         ,oa                                                      T4                                                             low  T3) ftldk dkj.k Fkk;jkW;M xzafFk dh                                                   47","foQyrk ¼çkbejh gkbiksFkk;jkW;fMTe] high TSH½  gSA  xzafFk ,oa fiVîwVjh ijLij ca/ks gq, gSaA ftl çdkj TSH           ;gka T4 ds vR;f/kd de gksus ds dkj.k T3 dk fuekZ.k  c<+us ij Hkh T4 ds Lrj dk u c<+uk Fkk;jkW;M xzafFk dh           Hkh i;kZIr ek=k esa ugha gks ik jgk ftlls T3 ds Lrj Hkh  foQyrk ¼çkbejh gkbiksFkk;jkW;fMTe½ ekuk tkrk gS]           de fey jgs gSaA                            Bhd mlh çdkj] T4 ds ?kVus ij TSH dk u c<+uk Hkh                                                      fiVîwVjh  xzafFk  dh  foQyrk  ¼lsdsaMjh           Case 3                                                      gkbiksFkk;jkW;fMTe½ dk |ksrd gksrk gSA                        Observed       Normal            Parameter                          value    reference range                                                      bl çdkj ls bl O;fä dks gkbiksFkk;jkW;fMTe (low T4              S.T3       50 ng/dl   60-180 ng/dl      ,oa  low  T3) gS ftldk dkj.k fiVîwVjh xzafFk dh              S.T4      2.5 ug/dl   5-12 ug/dl        foQyrk  ¼lsdsaMjh  gkbiksFkk;jkW;fMTe]   failure  to              S.TSH     0.1 mlU/L   0.5 - 5.0 mlU/L   increase TSH½ gSA           bl O;fä dks Hkh gkbiksFkk;jkW;fMTe gS (low T4 ,oa   dHkh\&dHkh T4 ds vR;f/kd de gksus ij Hkh TSH ds           low T3) ijUrq blesa TSH ds Lrj c<+s feyus ds LFkku   Lrj cgqr FkksM+s ls gh c<s gksrs gSa ¼tSls 5-10 mIU/L½A           ij ?kVs gq, gSaA lkekU; ifjfLFkfr;ksa esa T4 ds ?kVus ls   Very low T4 dh lkis{krk esa bls Hkh TSH dh relative           fuxsfVo QhMcSd ds dkj.k fiVîwVjh ls  TSH dk   deficiency gh ekuk tkuk pkfg;sA bl çdkj] low T4           secretion c<+uk pkfg, Fkk ijUrq ;gk¡ TSH ds Lrj   ,oa low  T3 ds lkFk low,  normal vFkok mildly           ?kVs gq, gSaA bldk vFkZ ;g gqvk fd fiVîwVjh xzafFk]   (inappropriately)  raised  TSH  Hkh  lsdsaMjh           TSH dk mRiknu djus esa vleFkZ gSA bls fiVîwVjh   gkbiksFkk;jkW;fMTe ds gh |ksrd gksrs gSaA           xzafFk dh foQyrk ¼lsdsaMjh gkbiksFkk;jkW;fMTe½  dgrs gSaA           ;gk¡ lsdsaMjh dk vFkZ gqvk] Fkk;jkW;M ds vius ls   Case 5           vfrfjä vU; dkj.kA gSA D;ksafd Fkk;jkW;M xzafFk ds fy,   Parameter  Observed   Normal           TSH ,d iks\"kd (trophic hormone) dh Hkkafr dk;Z            value    reference range                                                         S.T3       80 ng/dl    60-180 ng/dl           djrk  gS  blfy,  bldks  trophoprivic           hypothyroidism Hkh dgrs gSaA gkbiksFkk;jkW;fMTe dk   S.T4  6.5 ug/dl  5-12 ug/dl                                                         S.TSH     8.8 mlU/L    0.5 - 5.0 mlU/L           dkj.k lsaVªy uoZl flLVe esa gksus ds dkj.k bls central           hypothyroidism Hkh dgrs gSaA               ;gk¡ T3 ,oa T4 ds Lrj lkekU; fey jgs gSaA bldk vFkZ           bl çdkj ls bl O;fä dks gkbiksFkk;jkW;fMTe (low T4  gqvk fd ;g O;fä euthyroid gksuk pkfg,A ijUrq            ,oa  low  T3)   gS ftldk dkj.k fiVîwVjh xzafFk dh   TSH ds Lrj lkekU; ls vf/kd gSaA bldk vFkZ gqvk fd           foQyrk ¼lsdsaMjh gkbiksFkk;jkW;fMTe] low TSH½  gSA  T4 dk Lrj lkekU; cuk;s j[kus ds fy, fiVîwVjh dks                                                      vf/kd ek=k esa TSH cukuk iM+ jgk gSA ,d çdkj ls           Case 4                                                      ;g Hkh Fkk;jkW;M xzafFk dh detksjh dk gh y{k.k gSA ;gk¡                        Observed       Normal            Parameter                          value    reference range    T3 ,oa T4 ds Lrj lkekU; feyus dk rkRi;Z ;g gqvk                                                      fd Fkk;jkW;M xzafFk cgqr detksj ugha gSA mls dsoy              S.T3       50 ng/dl   60-180 ng/dl                                                      vfrfjä :i ls mÙksftr fd;s tkus dh vko';drk gSA              S.T4      2.5 ug/dl   5-12 ug/dl                                                      vr% bl fLFkfr dks fcydqy lkekU; (euthyroidism)              S.TSH     4.8 mlU/L   0.5 - 5.0 mlU/L                                                      ,oa fcydqy vlkekU; ¼gkbiksFkk;jkW;fMTe½ ds chp esa           bl O;fä dks Hkh gkbiksFkk;jkW;fMTe gS (low T4 ,oa           low T3) ijUrq blesa TSH ds Lrj c<+s ;k ?kVs feyus ds   ekuk tk ldrk gSA bls subclinical hypothyroidism                                                      (SCH) dgrs gSaA ;g lgh gS fd SCH esa O;fä esa           LFkku ij lkekU; gSaA /;ku jgs] HPT axis esa Fkk;jkW;M                                                     48","gkbiksFkk;jkW;fMTe ds dksbZ eq[; y{k.k ugha gksrs ijUrq  lfØ;rk c<+kdj] T4 dks T3 esa cnydj] T3 ds Lrjksa           ;gk¡  lcDyhfudy  'kCn  dk  vFkZ  O;fä  esa  dks lkekU; j[kk tk ldsA           gkbiksFkk;jkW;fMTe ds Dyhfudy y{k.kksa ds vk/kkj ij   Moderate hypothyroidism [Low T3; low T4;           le>uk mfpr ugha gSA bls misnomer Hkh ekuk tk   moderately raised TSH] \& tc T3 ds Lrj ?kVs           ldrk gSA  SCH dh Mk;Xuksfll dk eq[; vk/kkj  gq, gksa ,oa TSH ds Lrj dkQh c<s gq, gksaA           ck;ksdSfedy] normal T3 ,oa T4 ,oa mildly raised   Severe hypothyroidism [Low T3; very low           (5-10 mIU/L) TSH, gh gksrk gSA             T4; markedly raised TSH] \& /;ku jgs] vkjEHk esa           A S S E S S M E N T   O F   S E V E R I T Y   O F  gkbiksFkk;jkW;fMTe dh xaHkhjrk dk vuqeku TSH ds           HYPOTHYROIDISM                             Lrjksa ls yxk;k tk ldrk gSA ijUrq] TSH ,oa T4 dk           bl çdkj] gkbiksFkk;jkW;fMTe ds fodklØe dks ge  lEcU/k inverse log-linear relationship dk u gksdj           fuEukafdr voLFkkvksa esa foHkkftr dj ldrs gSa \&  inverse curvilinear gksrk gSA bldk vFkZ ;g gqvk fd                                                      vkjEHk esa T4 ds ?kVus ij TSH cM+h rhozrk ls c<+rk gS           Euthyroid state [Normal T3 and T4; normal           TSH] \& tgk¡ Fkk;jkW;M xzafFk ds lqpk# :i ls dk;Z  ijUrq yxHkx 60 mIU/L rd c<+us ds ckn blesa vf/kd           djus ds dkj.k T3 ,oa T4 ds Lrj lkekU; gSa ,oa  c<+ksÙkjh ugha gksrhA blls ;g fu\"d\"kZ Hkh fudkyk tk           blhfy, fiVîwVjh ls cuus okys TSH ds Lrj Hkh  ldrk gS fd TSH ds 60 mIU/L ls vf/kd feyus dh           lkekU; gSaA                                fLFkfr esa gkbiksFkk;jkW;fMTe dh xaHkhjrk dk vuqeku]                                                      T4 ds Lrj ds vuqlkj yxkuk pkfg,A           Subclinical hypothyroidism (SCH) [Normal           T3 and T4; mildly raised (5-10 mIUL) TSH -   Case 6           tc Fkk;jkW;M xzafFk dh vkjafHkd detksjh ds dkj.k T3                     Normal           ,oa T4 ds Lrj ?kVuk vkjEHk gksrs gSa ijUrq 'kh?kz gh ;g   Parameter  Observed   reference range                                                                     value           fiVîwVjh }kjk TSH dh vf/kd ek=k esa cuus ls   S.T3       200 ng/dl   60-180 ng/dl           lkekU;  dj  fy,  tkrs  gSaA  bl  çdkj]  SCH  dks   S.T4  16.5 ug/dl  5-12 ug/dl           compensated hypothyroidism Hkh dgk tk ldrk    S.TSH    0.008 mlU/L   0.5 - 5.0 mlU/L           gSA bldh igpku y{k.kksa ds vk/kkj ij u gksdj dsoy           tkapksa ds vk/kkj ij gh dh tk ldrh gSA     S.T3 and S.T4 \& ;gk¡ T3 ,oa T4 ds c<+s gq, Lrj]                                                      Fkk;jksVkWfDldksfll ¼jä esa Fkk;jkW;M gkWeksZUl ds Lrjksa           Overt  hypothyroidism  [Low  T3  and  T4;   dk lkekU; ls vf/kd gksuk½ ds ifjpk;d gSaA /;ku jgs]           raised (>10 mIUL) TSH] \& tc TSH ds vf/kd   bls gkbijFkk;jkW;fMTe ¼Fkk;jkW;M gkWeksZUl dk lkekU;           ek=k (>10 mIUL) esa cuus ds ckotwn T3 ,oa T4 ds   ls vf/kd ek=k esa mRiknu gksuk½ ugha dgk tk ldrkA           Lrj lkekU; ugha jg ikrsA bl fLFkfr dks clinical   ;g Fkk;jkW;M gkWeksZUl dks vf/kd ek=k esa ckgj ls fn,           ;k overt hypothyroidism dgrs gSa (overt¾çR;{k]   tkus ij vFkok Fkk;jkW;M xzafFk esa laxzfgr Fkk;jkW;M           tks fn[kkbZ ns jgk gks) A bl fLFkfr dk vuqeku y{k.kksa ds           vk/kkj ij yxk;k tk ldrk gS ¼;|fi ;g Hkh ges'kk   gkWeksZUl ds jä esa yhd gks tkus ls Hkh c<+ ldrs gSaA           ugha feyrs½ ,oa tkapksa ds }kjk bldh iqf\"V dh tk ldrh   S.TSH \& T3 ,oa T4 ds c<+us ij ;g fuxsfVo           gSA dsoy le>kus dh –f\"V ls bldks Hkh rhu voLFkkvksa   QhMcSd ds }kjk TSH dk lzko.k ?kVk nsrk gSA ;g           esa foHkkftr fd;k tk ldrk gSA /;ku jgs] bl çdkj dk   fiVîwVjh dk lkekU; O;ogkj gSA           dksbZ oxhZdj.k Li\"V ,oa ekU; ugha gksrkA   bl çdkj] bl O;fä dks Fkk;jksVkWfDldksfll  (high            Mild  hypothyroidism  [Normal  T3;  low  T4;    T3/T4) gS ftldk dkj.k fiVîwVjh ls vyx (TSH           raised  (>10  mIUL)  TSH]  \& tc rd D1 dh   c<+k gqvk u gksuk) gSA bldh foLr`r tkudkjh çkIr                                                      49","djus ds fy, gesa vU; tkapksa dh lgk;rk ysuh gksxhA   S.TSH \& blds Lrj ?kVs gq, gSa tks çk;% T3 ,oa T4 ds           ;fn ;gh o.kZu gkbijFkk;jkW;fMTe ds lUnHkZ esa fd;k  c<+us ij feyrs gSaA blls ;g vuqeku yxk;k tk ldrk           tk;s] rc ;g Fkk;jkW;M xzafFk ds }kjk vf/kd ek=k esa  gS fd ;g gkbijFkk;jkW;fMTe dh vkjfEHkd voLFkk gks           gkWeksZUl ds mRiknu dk ifjpk;d gksxkA bl fLFkfr dks  ldrh gS ftlesa T3 ,oa T4 ds mRiknu c<+us ij mUgksusa           çkbejh gkbijFkk;jkW;fMTe dgrs gSaA         TSH dks nck fn;k gksxk ftlls Fkk;jkW;M xzafFk dks                                                      TSH ds }kjk gksus okyk mÙkstu de gksus ls T3 ,oa           Case 7                                                      T4 dk mRiknu Hkh ?kV x;k gksxkA bl çdkj ls T3 ,oa                        Observed       Normal         T4 ds Lrj rks lkekU; gks x, ijUrq TSH ds Lrj ?kVs            Parameter                          value    reference range                                                      gh jg tkrs gSaA              S.T3      200 ng/dl   60-180 ng/dl                                                      ftl çdkj ls T3 ,oa T4 ds Lrj lkekU; gksus ,oa              S.T4      16.5 ug/dl  5-12 ug/dl                                                      dsoy TSH ds Lrj FkksM+k c<s gksus dks lcDyhfudy              S.TSH     38 mlU/L    0.5 - 5.0 mlU/L                                                      gkbiksFkk;jkW;fMTe dgrs gSa mlh çdkj T3 ,oa T4 ds           S.T3 and S.T4 \& ;gk¡ T3 ,oa T4 ds c<+s gq, Lrj]  Lrj lkekU; gksus ,oa dsoy TSH ds Lrj FkksM+k ?kVs gksus           Fkk;jksVkWfDldksfll ¼jä esa Fkk;jkW;M gkWeksZUl ds Lrjksa  dks lcDyhfudy gkbijFkk;jkW;fMTe  dgrs gSaA           dk lkekU; ls vf/kd gksuk½ ds ifjpk;d gSaA  SIGNIFICANCE  OF  T3  IN  HYPER-           S.TSH \& T3 ,oa T4 ds c<+us ij] fuxsfVo QhMcSd ds   THYROIDISM           dkj.k TSH dk lzko.k ?kVk gksuk pkfg,A ;gk¡ TSH dk   geus le>k Fkk fd gkbiksFkk;jkW;fMTe dh Mk;Xuksfll           c<+k gksuk vlkekU; gS ,oa ;g bafxr djrk gS fd   esa  T3  dh  dksbZ  mi;ksfxrk  ugha  gksrh  D;ksafd  ,d           fiVîwVjh }kjk gh vf/kd ek=k esa TSH dk mRiknu   compensatory  mechanism ds :i esa  D1 ds           fd;k tk jgk gS tks iqu% Fkk;jkW;M xzafFk dks mÙksftr   mÙksftr gksus ls T4 gh T3 esa ifjofrZr gksdj bldks                                                      lkekU; cuk;s j[kus dk ç;kl djrk gSA vkb;s le>rs           djds Fkk;jkW;M gkWeksZUl dk vf/kd ek=k esa mRiknu   gSa fd D;k gkbijFkk;jkW;fMTe esa T3 dh dksbZ mi;ksfxrk           djk jgk gSA Fkk;jkW;M gkWeksZUl ds lkekU; ls vf/kd   gS vFkok ughaA           ek=k esa cuus ds dkj.k ;g fLFkfr gkbijFkk;jkW;fMTe           (high T3/T4) dh gS ,oa bldk dkj.k Fkk;jkW;M xzafFk ls   okLro esa  T3 dh mi;ksfxrk gkbijFkk;jkW;fMTe esa           vyx ¼fiVîwVjh esa  high TSH½  gksus ds dkj.k bls   dsoy nks ifjfLFkfr;ksa esa gh gksrh gSA vR;ar nqyZHk :i esa           lsdsaMjh gkbijFkk;jkW;fMTe dgrs gSaA /;ku jgs] ;g   gkbijFkk;jkW;fMTe esa Fkk;jkW;M xzafFk ds }kjk dsoy T3                                                      dk gh mRiknu gksrk gS] T4 dk ughaA bl fLFkfr dks T3           vR;ar  nqyZHk  voLFkk  gS  tks  fiVîwVjh  esa  TSH           secreting adenoma ds dkj.k ls mRiUu gksrh gSA  toxicosis dgrs gSaA bldh fof'k\"Vrk gS]  high T3,                                                      normal T4 ,oa  low TSH A ,slk gkbijFkk;jkW;fMTe           Case 8                                     dh çkjafHkd voLFkk esa gks ldrk gSA blds vfrfjä]                                                      vk;ksMhu dh deh gksus ij Hkh 'kjhj T4 ds LFkku ij                        Observed       Normal            Parameter                          value    reference range    T3 ds mRiknu dks ojh;rk nsus yxrk gSA ,slh fLFkfr esa              S.T3       80 ng/dl   60-180 ng/dl      Hkh T3 ds Lrj c<s fey ldrs gSaA              S.T4      6.5 ug/dl   5-12 ug/dl        APPROACH TO A CASE WITH HIGH T3, T4              S.TSH    0.008 mlU/L  0.5 - 5.0 mlU/L   AND LOW TSH                                                      ge le> pqds gSa fd ,slk nks dkj.kksa ls gks ldrk gS] 1)           S.T3 and S.T4 \& ;gk¡ T3 ,oa T4 ds Lrj lkekU; gSa   Fkk;jkW;M xzafFk ds }kjk Fkk;jkW;M gkWeksZUl dh vR;f/kd           tks euthyroid voLFkk dk vuqeku nsrs gSaA                                                     50","ek=k esa mRiknu gksus ls ¼ftls gkbijFkk;jkW;fMTe dgrs  Fkk;jksVkWfDldksfll dgrs gSa½A LokHkkfod :i ls bu           gSa½ ,oa 2) fcuk mRiknu c<+s gh Fkk;jkW;M xzafFk esa  nksuksa  dk  mipkj  fcydqy  vyx  gksrk  gSA           laxzfgr Fkk;jkW;M gkWeksZUl ds jä esa yhd dj tkus ls  Fkk;jksVkWfDldksfll esa Fkk;jkW;M gkWeksZUl dk mRiknu           ¼tSls Fkk;jkW;MkbfVl esa½ vFkok Fkk;jkW;M gkWeksZUl dh  ?kVkus  okyh  anti-thyroid  drugs  (ATD)  nsus  dh           vR;f/kd ek=k dks ckgj ls fy, tkus ij (iatrogenic)  vko';drk ugha gS tcfd gkbijFkk;jkW;fMTe esa ;gh           ¼ftUgsa gkbijFkk;jkW;fMTe ls vyx fn[kkus ds fy,  mipkj dk çeq[k vax gksrh gSaA                                                                                                                  51","7                             Hypothyroidism            okLro esa gkbiksFkk;jkW;fMTe dksbZ ,d fof'k\"V jksx u   Tertiary  hypothyroidism  -  gkbiksFkSysel  ds           gksdj ,d Dyhfudy flaMªkse gSA vFkkZr ;g Fkk;jkW;M   çHkkfor  gksus  ijA  Tertiary  ,oa  lsdsaMjh           gkWeksZUl dh deh ls gksus okys vusd y{k.kksa dk lewg gS   gkbiksFkk;jkW;fMTe  dks  lfEefyr  :i  ls  lsaVªy           tks vusd dkj.kksa ls mRiUu gks ldrs gSaA ;g y{k.k]   gkbiksFkk;jkW;fMTe dgrs gSaA           thou dh fofHkUu voLFkkvksa esa fHkUu\&fHkUu gks ldrs   Peripheral  thyroid  hormone  resistance  -           gSaA  uotkr  f'k'kqvksa  esa  ;g  eq[;r%  'kkjhfjd  ,oa   'kjhj dh fofHkUu dksf'kdkvksa ij Fkk;jkW;M gkWeksZUl dk           ekufld o`f) dh deh ds :i esa çdV gksrs gSa tcfd   çHkko mRiUu u gksus ijA gkbiksFkk;jkW;fMTe dk ;g           cM+s cPpksa esa 'kkjhfjd fodkl ,oa I;wcVhZ esa ck/kk iM+us   :i vR;ar nqyZHk gSA           ds :i esaA o;Ld ;qofr;ksa esa ;g ekfld /keZ dh   ETIOLOGIES           vfu;ferrkvksa ds :i esa çdV gks ldrk gS rks fookg   ge le> pqds gSa fd çkbejh gkbiksFkk;jkW;fMTe gh           ds mijkar ;g xHkZ/kkj.k esa ck/kk iM+us ;k ckj\&ckj   lokZf/kd çpfyr :i gSA çkphu dky ls gh bldk           xHkZikr gks tkus ds :i esaA                                                      loZçeq[k dkj.k vk;ksMhu dh deh jgk gS ftlds dkj.k           o;Ldksa esa ;g eq[;r% calorigenesis ,oa oxygen           consumption  esa  ck/kk  iM+us]  Ropk  esa   CAUSES OF HYPOTHYROIDISM           glycosaminoglycans  ds  ,df=r  gksus  rFkk   PRIMARY HYPOTHYROIDISM           cardiac,  pulmonary,  gastrointestinal  ,oa   Autoimmune hypothyroidism                                                       Hashimoto’s thyroiditis           neurological systems dh xfrfof/k;ksa ds ckf/kr gksus   Reduced synthesis of thyroid hormones           ds y{k.kksa ds lkFk çdV gks ldrk gSA Fkk;jkW;M gkWeksZUl   Iodine deficiency           dh tkapksa dh miyC/krk ds c<+rs tkus ds dkj.k vc   Overuse of antithyroid drugs           bldh Mk;Xuksfll cM+h ljyrk ls gks tkrh gSA blh   Thiocyanate containing food                                                       Inborn errors - Dyshormonogenesis           dkj.k ls gekjs ns'k esa bldh O;kidrk (prevalence)   Reduced amount of functioning thyroid           yxHkx 11% rd ik;h x;h gSA vkb;s] bl egRoiw.kZ   tissue           fodkj dks foLrkj ls le>rs gSaA              After subtotal thyroidectomy                                                       After radio iodine ablation therapy           CLASSIFICATION OF HYPOTHYROIDISM            After subacute (destructive) thyroiditis           HPT ,fDll ds fofHkUu Lrjksa ds çHkkfor gksus ds   Drug induced           vuqlkj gkbiksFkk;jkW;fMTe Hkh 4 çdkj dh gks ldrh   Excessive  dose  of  iodide  containing           gSA                                         contrast media, Lithium,  Amiodarone,                                                       Interferon-alpha           Primary  hypothyroidism  -  Fkk;jkW;M xzafFk ds   SECONDARY HYPOTHYROIDISM           çHkkfor gksus ijA gkbiksFkk;jkW;fMTe dk ;gh :i lcls   Pituitary adenoma                                                       Pituitary destruction due to injury, ischemia,           vf/kd çpfyr (95%) gSA                       infection,  irradiation  or  immunological                                                       disorders           Secondary hypothyroidism - fiVîwVjh xzafFk ds   TERTIARY HYPOTHYROIDISM            çHkkfor gksus ijA gkbiksFkk;jkW;fMTe ls çHkkfor dsoy   Hypothalamic disorders           5% O;fä;ksa esa ;g feyrk gSA                PERIPHERAL  RESISTANCE  TO  THE                                                       ACTION OF THYROID HORMONES                                                    52","Fkk;jkW;M xzafFk ls i;kZIr ek=k esa Fkk;jkW;M gkWeksZUl dk   dks  lkekU;  cuk;k  tk  lds]  subclinical           mRiknu ugha gks ikrk gSA ijUrq] vk/kqfud dky esa   hypothyroidism  ¼high  TSH  +  normal  T4½           vk;ksMkbTM ued ds ç;ksx ls tSls\&tSls vk;ksMhu dh   dgykrh gSA           miyC/krk c<+rh tk jgh gS] oSls\&oSls gkbiksFkk;jkW;fMTe   - bE;wuksykWftdy fj,D'ku c<+us ds lkFk\&lkFk vkSj           ds çeq[k dkj.kksa esa vkWVks\&bEE;wfuVh dh O;kidrk c<+rh   vf/kd Fkk;jkW;M QkWfydYl dks {kfr igq¡prh tkrh gS           tk jgh gSA gkbiksFkk;jkW;fMTe ds vU; dkj.k fuEukafdr   ftlls Fkk;jk;M gkWeksZUl dk mRiknu vkSj Hkh ?kVrk           gSaA                                        tkrk gSA ,sls esa c<+k gqvk TSH Hkh T4 dk mRiknu                                                       vkSj vf/kd ugha c<+k ikrk ftlls T4 ds Lrj iqu%              AUTOIMMUNE HYPOTHYROIDISM                                                       ?kVus yxrs gSaA           i;kZIr  vk;ksMhu  okys  {ks=ksa  esa  vkWVksbE;wfuVh  gh   - ;g fLFkfr clinical hypothyroidism                                                                                    vFkok overt           gkbiksFkk;jkW;fMTe dk loZçeq[k dkj.k gksrh gSA fdlh   hypothyroidism ¼high TSH + low T4½ dgykrh           Hkh vU; bE;wuksykWftdy fodkj dh Hkkafr gh Fkk;jkW;M   gSA           xzafFk esa Hkh ;g bE;wuksykWftdy {kfr nks çdkj ls mRiUu           gks ldrh gSA                               STUCTURAL CHANGES                                                      Diffuse enlargement \& lkekU;r;% bl çfØ;k ds           - Cell  mediated  - lh/ks\&lh/ks CD8  +  cytotoxic                                                      nkSjku çkjEHk esa iwjh Fkk;jkW;M xzafFk vkdkj esa c<+uk            cells }kjk ;k buls mRiUu cytokines ¼tSls TNF]            IL-1 ;k IFN-y½ ds }kjkA                   vkjEHk djrh gSA ,slk izk;% nks dkj.kksa ls gksrk gS \&            - Antibody  mediated  -  Anti-TPO]  anti-   - Hashimoto’s  thyroiditis  esasa  lymphocytic            thyroglobulin ¼Anti-Tg½ vFkok TSH recep-tor   infiltration ,oa germinal center cuus ds dkj.k]            blocking  antibodies ds }kjkA ijUrq ;g lHkh   ,oa            ,aVhckWMht]  Lo;a  gh  vf/kd  {kfr  u  igqapk  dj]   - TSH ds }kjk mÙksftr gksus ls xzafFk dh hyperplasia            eq[;:Ik ls autoimmune response dks gh c<+kus   ,oa hypertrophy ds dkj.kA            dk dk;Z djrh gSaA                         Rubbery consistency - vkjEHk esa xzafFk eqyk;e gks                                                      ldrh gS ijUrq le; chrus ds lkFk Qkbczksfll ds           Cell mediated vFkok antibody mediated nksuksa   dkj.k ;g Øe'k% jcj ds leku l[r gksrh tkrh gSA           çdkj dh {kfr] Fkk;jkW;M xzafFk dh dk;Z{kerk ,o           lajpuk] nksuksa] dks çHkkfor djrh gSaA     Atrophy - vkjaHk esa vkdkj esa c<+us ds ckn xzafFk dk                                                      vkdkj Øe'k% ?kVuk çkjEHk gks tkrk gSA ;g Hkh nks           FUNCTIONAL CHANGES                                                      dkj.kksa ls gks ldrk gS -           mijksä nksuksa çdkj ds bE;wuksykWftdy fj,D'ku ls   - Fkk;jkW;M QkWfydYl dks gqbZ {kfr ds dkj.k] ,oa           Fkk;jkW;M QkWfydYl dks {kfr igq¡prh tkrh gS ftlls   - xzafFk esa c<+rh tk jgh Qkbczksfll ds dkj.k           Fkk;jkW;M gkWeksZUl dk mRiknu ckf/kr gksrk gSA blds   bl çdkj dh xzafFk Nwus ij vyx ls çrhr ugha gks ikrh           ifj.kkeksa dks Øekuqlkj of.kZr djrs gSaA                                                      gS  (nonpalpable)  ftlds  dkj.k  bl  fLFkfr  dks           - T4 ds Lrj ?kVuk vkjEHk gksrs gSaA        atrophic thyroiditis dgrs gSaA           - fiVîwVjh ij fuxsfVo QhMcSd ds }kjk blls TSH dk   dHkh\&dHkh xzafFk çkjEHk ls gh vkdkj esa NksVh jg tkrh            lzko.k c<+uk vkjEHk gksrk gSA             gSA cgq/kk ,slk TSH receptor blocking antibodies           - TSH] Fkk;jkW;M xzafFk dks mÙksftr djds  T4 dk   ds cuus ij gksrk gSA ge tkurs gSa fd TSH] Fkk;jk;M            mRiknu c<+ us dk ç;kl djrk gS ftlls   ds Lrj   xzafFk ds fy, iks\"kd ¼trophic½ gkWeksZu gS tks blds                    k                                           T4            iqu% lkekU; gks tkrs gSaA                 vkdkj esa o`f) djkrk gSA ;g ,aVhckWMht] TSH fjlsIVj           - ;g fLFkfr ftlesa TSH dk lzko.k c<+kdj T4 ds Lrj   ij yxdj mlij TSH dks gh yxus ls jksd nsrh gSa                                                     53","ftlls TSH xzafFk ij viuk çHkko gh mRiUu ugha dj   Voice - Vocal cords esa Hkh GAG ds tek gksus ls           ikrkA yxHkx 20% O;fä;ksa esa ,slk gh gksrk gSA  vkokt Hkkjh (husky voice)  gks tkrh gS ftls lqudj                                                      Qksu ij ckr djrs gq, gh gkbiksFkk;jkW;fMTe dk              CLINICAL MANIFESTATIONS                                                      vuqeku yxk;k tk ldrk gSA blh çdkj] thHk esa Hkh           mijksä pathogenesis ds }kjk ge ;g le> ldrs           gSa fd gkbiksFkk;jkW;fMTe dksbZ ,dk,d vkjEHk gks tkus   GAG ds tek gksus ls cksyrs le; 'kCn ijLij feys gq,           okyk jksx ugha gSA yEcs le; rd 'kjhj blls mcjus dk   çrhr gksrs gSa (slurred speed) f tlls 'kCn Li\"V le>           ç;Ru djrk jgrk gS ,oa tc og blesa lQy ugha gks   esa ugha vkrsA           ikrk rHkh blds y{k.k Øe'k% mRiUu gksus vkjEHk gksrs   Skin - Basal metabolism ds ?kVus ls 'kjhj dk           gSaA ;g Øe bruk /khek gksrk gS fd vf/kdk¡'k O;fä  rkieku Hkh ?kV tkrk gS ftls lajf{kr djus ds fy,           bldks çrhr gh ugha dj ikrsA tc bu O;fä;ksa esa   cutaneous vasoconstriction gks tkrk gS ,oa ilhuk           Fkk;jkWfDlu vkjEHk gksrk gS rc gh og vuqHko djrs gSa  vkuk ?kV tkrk gSA blhfy,] Ropk lkekU; ls lw[kh ,oa           fd iwoZ esa og fdrus vlkekU; FksA gkbiksFkk;jkW;fMTe esa  BaMh  (dry  and  cold  skin)   gksrh  gSA  Stratum           feyus okys dqN y{k.k fuEukafdr gSaA        corneum  dh  hyperkeratosis  ds  dkj.k  blesa                                                      :[kkiu Hkh vk tkrk gS ,oa vR;f/kd c<+ tkus ij ;g           Gross  appearance  -  Overt ¼çR;{k] Li\"V] tks           lkQ fn[k jgk gks½ gkbiksFkk;jkW;fMTe esa rks O;fä dks   icthyosis ¼eNyh dh Hkkafr [kqjnjh½ tSlh yxus yxrh                                                      gSA Ropk esa bldh LokHkkfod ykfyek u feydj Qhdk           ns[krs gh igpkuk tk ldrk gSA iwjk psgjk lwtk yxrk gS                                                      ;k ihykiu  (pale  skin)  fey ldrk gS tks blesa           (puffy face)] vk¡[kksa ds pkjksa vksj lwtu vf/kd Li\"V   carotene ds tek gksus ls gksrk gSA           yxrh gS (periorbital puffiness)]  xys esa lwtu ds            dkj.k  double  chin   fn[kkbZ  nsrh  gS  ,oa   Hair - cky Hkh :[ks gks tkrs gSa ,oa vklkuh ls VwVus           supraclavicular fossae Hkh Hkjs gq, ,oa mHkjs fn[krs   yxrs gSa (dry and brittle hair) A dHkh\&dHkh flj esa dqN           gSaA blh lwtu ds dkj.k O;fä fn[kus esa eksVs yxrs gSa   LFkku ds cky xk;c gks tkrs gSa (alopecia)  ftlls           ftlds  dkj.k  ;g  /kkj.kk  cu  x;h  gS  fd   chp\&chp esa [kkyh LFkku cu tkrk gSA vk¡[kksa ds Åij           gkbiksFkk;jkW;fMTe esa O;fä eksVs gks tkrs gSaA okLro esa   HkkSagksa ¼lateral eyebrows½ ds cky fo'ks\"k:i ls de gks                                                                       A           vf/kdk¡'k O;fä;ksa dk otu dsoy dqN fdyks gh c<+rk gS   ldrs gSa (madarosis)           tks fd eq[;r% 'kjhj esa ty dh vf/kd ek=k esa #dus   Nail - uk[kwuksa dk c<+uk ?kV tkrk gS ,oa ;g cM+h           ¼water  retention½ ds dkj.k gksrk gSA /;ku jgs]   ljyrk ls VwVus yxrs gSa (brittle nails) A           vR;f/kd eksVkik dHkh Hkh gkbiksFkk;jkW;fMTe ds dkj.k   Goiter - Iodine deficiency disorder (IDD) ,oa           ugha gksrkA                                Hashimoto’s  thyroiditis  dk ;g çeq[k y{k.k gSA            Edema - psgjs dh lwtu ds vfrfjä] gkFk ,oa iSj Hkh   vkjaHk esa ;g eqyk;e (soft in consistency)  gksrk gS           lwts yxrs gSaA /;ku jgs] gkbiksFkk;jkW;fMTe esa ;g lwtu   ijUrq Qkbczksfll ds dkj.k ;g Øe'k% l[r gksrk gqvk                                                      jcj ds leku (rubbery consistency)  dk gks tkrk           vf/kd ikuh #dus ds dkj.k u gksdj] Ropk dh dermis   gSA Atrophic  thyroiditis esa Fkk;jkW;M xzafFk esa gksus           esa glycosaaminoglycans (GAG)  ds tek gksus ds   okyh atrophy ls mlds vkdkj esa Øe'k% deh vkrs gq,           dkj.k gksrh gSA blhfy, tibia ds Åij maxyh ls nckus   og var esa nonpalpable gks tkrh gSA           ij blesa xïk ugha iM+rk (nonpitting edema) tSlk           fd lkekU; lwtu esa dermis esa vf/kd ikuh ds #dus ls   GIT -  Intestinal motility ds ?kV tkus ds dkj.k dCt           iM+rk gSA                                  (constipation) fey ldrk gSA blls isV Hkjk\&Hkjk                                                      jgrk gS ,oa Hkw[k de gks tkrh gSA                                                    54","Reproductive functions - efgykvksa esa ekfld  mRiUu gks ldrh gSA gkFkksa esa carpal tunnel  ls gksdj           /keZ dh vfu;ferrk,a] gkbiksFkk;jkW;fMTe dk çeq[k  xqtjus okyh median nerve ,oa iSjksa esa tarsal tunnel           y{k.k gSaA okLro esa bUgha ds dkj.k vusd efgykvksa esa  ls xqtjus okyh posterior tebial nerve blls çHkkfor           gkbiksFkk;jkW;fMTe dh 'kh?kz igpku gks ikrh gSA ;wa rks   gks ldrh gSaA bu ij iM+us okys ncko ls gkFk vFkok iSj           fdlh Hkh çdkj dh ekfld /keZ dh vfu;ferrk]   esa  nnZ  (pain)]  >qu>qukgV  (tingling)  ;k  lqUuiu           gkbiksFkk;jkW;fMTe  esa  fey  ldrh  gS  ijUrq   (numbnes) mRiUu gks ldrh gSA gkFkksa esa lateral 3½           oligomenorrhea ¼nks ekfld /keksaZ ds e/; 35 fnuksa   maxfy;k¡ rFkk iSjksa esa yxHkx iwjk ryoksa ¼sole½] blls           ls vf/kd varjky gksuk ;k o\"kZ esa 9 ls de ekfld /keZ   çHkkfor gks ldrk gSA            dk gksuk½] amenorrhea  ¼le; ls ,d ekg ckn rd   Mentation - gkbiksFkk;jkW;fMTe esa O;fä dh /;ku           ekfld /keZ dk u vkuk½ vFkok menorrhagia  ¼fdlh  dsafær djus dh {kerk (concentration power)  ,oa           ekfld /keZ esa lkekU; ls vf/kd jälzko dk gksuk½   Lej.k 'kfä (memory)  Hkh çHkkoh gks ldrh gSA dbZ                                                      O;fä mnkl ¼depressed½  Hkh jg ldrs gSaA dHkh\&dHkh           blds çeq[k y{k.k gSaA ovulation esa ck/kk iM+us (non-           ovulatory  cycles)  ds  dkj.k  xHkZ/kkj.k  djus  esa   vR;ar  c<+h  gqbZ  voLFkk  esa  cerebellar  ataxia,           #dkoV vk ldrh gSA ekfld /keZ dh vfu;ferrkvksa   dementia ,oa  coma  (myxedema  coma) rd           dh Hkkafr larkughurk (infertility)  Hkh] efgykvksa esa   mRiUu gks ldrk gSA           gkbiksFkk;jkW;fMTe dh igpku dk ,d çeq[k dkj.k gSA   PET  scan  esa  dqN  {ks=  ¼tSls  amygdala]           ;fn fdlh çdkj ls xHkZ Bgj Hkh tk, rc blesa   hippocampus rFkk cingulate gyrus½ esa cerebral           miscarriage  ¼20th  week  ds  iwoZ  xHkZikr½  dh   activity  ?kVh  gqbZ  fey  ldrh  gSA  Hashimoto’s           lEHkkouk c<+ tkrh gSA vR;f/kd c<+h gqbZ ¼severe½   thyroiditis  esa  ;g  y{k.k  Hashimoto’s                                                      encephalopathy dgykrs gSa tks steroid therapy ls           gkbiksFkk;jkW;fMTe]  f'k'kq  esa  congenital           malformations dk dkj.k Hkh cu ldrh gSA efgykvksa   Bhd gks ldrs gSaA           dh vis{kk] iq#\"kksa esa larkuksRifÙk ¼fertility½ ij dksbZ   Cardiovascular functions - CVS ij Fkk;jkW;M           fo'ks\"k çHkko ugha iM+rk ,oa dsoy libido ¼'kkjhfjd  gkWeksZUl ds çHkko eq[;r% nks çdkj ls mRiUu gksrs gSaA           lalxZ ds çfr :fp½ ?kV ldrh gSA             - Direct effects - Myocardial myosine heavy                                                       chain  alpha  dk  expression  c<+kdj]  ,oa           Musular system - ekalisf'k;ksa esa nnZ] vdM+u ,oa                                                       myocardial  sarcoplasm  esa  Ca-ATPase  dh           ,saBu  (muscular  pain]  stiff-ness  and  cramps)   lfØ;rk  c<+kdj  Fkk;jkW;M  gkWeksZUl  ân;  dh           gkbiksFkk;jkWfMTe ds vR;ar O;kid y{k.k gSaA dHkh\&dHkh   ekalisf'k;ksa  dh  ladqpu  dh  {kerk  (myocardial           ekalisf'k;ka ¼fo'ks\"k :i ls calf muscle½ Nwus esa l[r   contraction) c<+krs gSaA blhfy,] gkbiksFkk;jkW;fMTe           (pseudomyotonia)  çrhr  gksrh  gSaA  Ankle  jerk   esa  myocardial  contractility  ?kV  tkrh  gS            ns[kus esa hung up reflex  bldk fof'k\"V y{k.k gS ftlesa   (negative  inotropic  effect)  ijUrq  blds           ekalisf'k;ksa  dh  contraction  phase  dh  vis{kk   vR;f/kd ?kV tkus ls cardiomyopathy  mRiUu gksus           relaxation phase vf/kd /khek çrhr gksrk gSA  dh lEHkkouk yxHkx ux.; gh gksrh gSA            Neurological function - Soft tissues esa GAG ds   - Indirect  effects  -  Fkk;jkW;M  gkWeksZUl]  beta           tek gksus ds dkj.k budk vk;ru c<+ tkrk gSA blds   adrenergic  receptors  dh  catecholamines  ds           dkj.k fdlh ladjs LFkku ls fudyus okyh nerves ij   izfr  laosnu'khyrk  (sensitivity)  c<+k  nsrs  gSaA           ncko iM+rk gS ftlls nerve conduction esa ck/kk   gkbiksFkk;jkW;fMTe esa hemodynamics ij iM+us okys                                                      55","vf/kdk¡'k  çHkko  sympathetic  stimulation  ds  tks eq[;r% Graves’ disease esa feyrk gSA ijUrq ;g            çHkko ds ?kVus ls gh mRiUu gksrs gSaA     vko';d ugha fd TAO ls çHkkfor çR;sd O;fä]                                                      rkRdkfyd :i ls gkbijFkk;jkW;M gh feysA TAO ds          HEMODYNAMICS                                                      lkFk\&lkFk  og  euthyroid  Hkh  gks  ldrk  gS  ,oa          - Heart  rate    (HR),  stroke  volume  (SV)]            systolic BP (SBP) ,oa cardiac output (CO) ?kV   autoimmune thyroiditis gksus ij gkbiksFkk;jkW;M HkhA            tkrs gSaA Thermogenesis ,oa esVkckWfyd xfrfof/k;ksa   Childhood  hypothyroidism  -  vk;ksMhu  ;qä            ds ?kVus ls buds }kjk gks jgk reflex vasodilatation  ued ds ç;ksx ds dkj.k o;Ldksa esa vk;ksMhu dh deh            ?kV  tkrk  gSA  blls  peripheral  vascular  ?kVrh tk jgh gS ,oa  autoimmune  thyroiditis dh            resistance ¼PVR½]  after  load]  diastolic  BP  lEHkkouk  c<+rh  tk  jgh  gSA  ijUrq]  cPpksa  esa            ¼DBP½ ,oa  mean  arterial  pressure ¼MAP½  gkbiksFkk;jkW;fMTe dk çeq[k dkj.k vHkh Hkh vk;ksMhu            c<+us yxrs gSa tcfd pulse pressure ?kV tkrk gSA  dh deh gh gksrk gSA tUe ds çFke o\"kZ ¼neonatal          - Circulation time - mijksä lHkh dkj.kksa ls jä   age½ esa ;g ekufld fodkl vo#) djds cretinism            çokg /khek gks tkrk gS ftlls circulation time c<+  mRiUu dj ldrk gSA ;fn vk;ksMhu dh deh çFke o\"kZ            tkrk gSA                                  ds i'pkr~ mRiUu gqbZ gks rc Li\"V :i ls cretinism ds          - Pericardial  effusion-  gkbiksFkk;jkW;fMTe  ds  y{k.k rks mRiUu ugha gksrs] ijUrq 3 o\"kZ dh voLFkk rd            vR;f/kd c<+ tkus ij fofHkUu body cavities esa  Hkh ;g intellectual development dks çHkkfor dj            fluid collection gks ldrk gSA yxHkx 30% O;fä;ksa  ldrh gSA bl mez ds i'pkr~ vk;ksMhu dh deh gksus ij            esa  pericardial  effusion  fey  ldrk  gSA  ekufld fodkl esa dksbZ deh ugha vkrh ,oa eq[;r%            vf/kdka'kr;% ;g FkksM+k (mild) gh gksrk gS ftlls  'kkjhfjd fodkl çHkkfor gksrk gSA blls cPps yEckbZ esa            cardiac functions vf/kd çHkkfor ugha gks ikrsA  ugha c<+rs  (short  stature) A /;ku jgs] Fkk;jkW;M           Other autoimmune disorders \& ge tkurs gSa   gkWeksZUl ds u cuus ls 'kkjhfjd o`f) ,dne #d ldrh                                                      gS (absolute cessation of growth)  tcfd growth          fd vk;ksMhu dh i;kZIr miyC/krk okys {ks= (iodine          sufficient zones) esa autoimmune thyroiditis gh   hormone ds u cuus ij Hkh cPpk 2-3 lseh çfro\"kZ          gkbiksFkk;jkWfMTe dk loZçeq[k dkj.k gksrk gSA lkFk gh   rd c<+ ldrk gSA cM+s cPpksa esa gkbiksFkk;jkW;fMTe gksus          fdlh ,d autoimmune disorder ds gksus ij mlh   ls  I;wcVhZ  le;  ls  ugha  vkjEHk  gksrh  ¼delayed          O;fä esa vU; autoimmune disorders Hkh fey ldrs   puperty½ vFkok vkjEHk gksus ds ckn Hkh I;wcVhZ dk          gSa ftuesa 'kjhj ds vU; Hkkxksa ds fo#) Hkh ,aVhckWMh   fodkl dkQh /khek gksrk gSA          cuus  yxrh  gSaA  buesa  çeq[k  gSa]  vitiligo  cPpksa esa gkbiksFkk;jkW;fMTe ds dqN fof'k\"V y{k.k feyrs          ¼melanocytes½] alopecia areata ¼hair follicles½]  gSaA  buesa  çeq[k  gSa]  muscular  swelling  ,oa          pernicious  anemia  ¼gastric  parietal  cells½]    myopathy A ;g Hkh eq[;r% calf muscles esa feyrh          Addison’s  disease ¼adrenocortical  cells½  ,oa  gS  ¼calf  hypertrophy½  ftls  Hoffmann’s          type  1  diabetes  ¼beta  cells  of  pancres½ A   syndrome dgrs gSaA           dHkh\&dHkh  celiac  disease]  chronic  active          hepatitis]  rheumatoid  arthritis]  SLE]          myasthenia  gravis]  Sjogren  syndrome  ,oa     DIAGNOSIS OF HYPOTHYROIDISM          dermatitis herpetiformis bR;kfn Hkh fey ldrh gSaA  ge tkurs gSa fd Fkk;jkW;M gkWeksZUl dh vfu;ferrk,a nks                                                      çdkj ls mRiUu gks ldrk gS          Thyroid  associated  ophthalmopathy  -          (TAO) - /;ku jgs] ;g Hkh ,d vkWVks bEE;wu fodkj gS   Primary, 1° or thyroprivic hypothyroidism -                                                    56","vFkkZr Fkk;jkW;M xzafFk dh Lo;a dh vfu;ferrk ls   1. Increasing conversion of prohormone T4           mRiUu gkbiksFkk;jkW;fMTeA blds Hkh nks :i gks ldrs gSa   into active T3 \& /;ku jgs] Fkk;jkW;M xzafFk esa cuus            (i)  Subclinical  hypothyroidism  -   raised  TSH,  okyk eq[; gkWeksZu T4 gh gS ,oa ;gh jä esa Fkk;jkW;M           normal  T4  vFkok  (ii)  overt   ;k  clinical   gkWeksZUl dk Hk.Mkj (reserveoir) cukrk gSA ijUrq           hypothyroidism - raised TSH, low T4 çdkj ls   T4 ,d çks\&gkWeksZu gS ftldks vko';drkuqlkj type           dk;Z u djus ij fiVîwVjh bls mÙksftr djus ds fy,   1  deiodinase  enzyme ¼D1½ ds }kjk  lfØ;           thyroid  stimulating  hormone ¼TSH½ dk lzko.k   gkWeksZu T3 esa cny fn;k tkrk gSA 'kjhj esa T4 dh           c<+krh gSA TSH ds }kjk mÙksftr gksus ls Fkk;jkW;M xzafFk   deh gksus ij ;g D1 lfØ; gksdj vf/kd ek=k esa           dk vkdkj c<+us yxrk gS tks T3 ,oa T4 gkWeksZUl ds   T4 dks  T3 esa ifjofrZr djus yxrk gS ftlls           lzko.k dks c<+kus esa enn dj ldrk gSA ;fn TSH ds   Fkk;jkW;M gkWeksZUl dk çHkko cuk;s j[kk tk ldsA bl                                                        çdkj]  vkjEHk  esa  yxHkx  25%  gkbiksFkk;jkW;M           c<+us ls T3 ,oa T4 ds Lrj lkekU; gks tkrs gSa rc mls   O;fä;ksa esa T4 dh deh gksus ds ckn Hkh T3 ds Lrj           subclinical  hypothyroidism dgrs gSa tcfd ;fn   lkekU; cus jg ldrs gSaA           TSH ds c<+us ds ckn Hkh T3 ,oa T4 ds Lrj de gh                                                      2. Stimulating  thyroidogenesis  by           jgs rc mls overt hypothyroidism dgrs gSaA    increasing  secretion  of  TSH  from                                                        pituitary \&  jä esa  T3 ,oa  T4 ds ?kVus ij           Secondary,  2°  or  central  or  trophoprivic           hypothyroidism – vFkkZr Fkk;jkW;M xzafFk dh Lo;a   fiVîwVjh budks nqckjk c<+kus dk ç;kl djrh gS           dh vfu;ferrk ds vfrfjä fdlh vU; dkj.k ¼tSls   ftlls  TSH  dk  lzko.k  c<+  tkrk  gS  ¼fuxsfVo           fiVîwVjh vFkok gkbiksFkSysel ds fodkjksa½ ls mRiUu   QhMcSd½A  TSH ds }kjk mÙksftr fd;s tkus ij                                                        Fkk;jkW;M xzafFk vf/kd dk;Z djrh gS ftlls T3 ,oa           gkbiksFkk;jkW;fMTeA bls dgrs gSa central  hypothy-           roidism esa T3] T4 ,oa TSH rhuksa gkWeksZUl ds Lrj   T4 dk mRiknu c<+us yxrk gSA blds Hkh nks ifj.kke           ?kVs gq, feyrs gSaA                          gks ldrs gSa \&                                                      Subclinical hypothyroidism -  ;fn  TSH  ds            STAGES  IN  DEVELOPMENT  OF  HYPO-            THYROIDISM                                }kjk mÙksftr fd;s tkus ij Fkk;jkW;M xzafFk] T3 ,oa T4           gkbiksFkk;jkW;fMTe  dk  vFkZ  gS]  'kjhj  esa  Fkk;jkW;M   dk mRiknu i;kZIr ek=k esa dj ysrh gS rc TSH ds           gkWeksZUl dh dehA vr% LokHkkfod rkSj ij bldks   c<+us ls T3 ,oa T4 ds Lrj lkekU; vk tkrs gSaA bls           igpkuus ds fy, gesa Fkk;jkW;M gkWeksZUl ¼T3 ,oa T4½   subclinical hypothyroidism dgrs gSaA           dh tkap djkdj budh deh dh iqf\"V djuh pkfg,A iw.kZ   Clinical/ overt hypothyroidism - ;fn jksx ds           fodflr gkbiksFkk;jkW;fMTe esa T3 ,oa T4 dh deh dh   dkj.k] mÙksftr fd;s tkus ij Hkh Fkk;jkW;M xzafFk T3 ,oa           iqf\"V ljyrk ls gks tkrh gS ijUrq jksx dh vkjafHkd   T4 dks i;kZIr ek=k esa ugha cuk ikrh] rc TSH ds           voLFkk esa 'kjhj blls mcjus dk ç;kl djrk gS ftlls   c<+us ds ckotwn T3 ,oa T4 ds Lrj de gh cus jgrs           bu tkapksa esa dqN ifjorZu vkus yxrs gSaA vkb;s] budks   gSaA bls clinical  ;k overt hypothyroidism  dgrs gSaA           foLrkj ls le>rs gSaA                       Stages in development of hypothyroidism -                                                      vkn'kZ:i esa gkbiksFkk;jkW;fMTe ds fodklØe dks dqN           Fkk;jkW;M xzafFk ds jksxksa esa blesa cuus okys Fkk;jkW;M           gkWeksZUl dk fuekZ.k i;kZIr ek=k esa ugha gks ikrk ftlls   bl çdkj fy[kk tk ldrk gSA                                                      - Euthyroidism  \&  gkbiksFkk;jkW;fMTe  ds  iwoZ  \&           buds Lrj ?kVus yxrs gSaA 'kjhj bldh iwfrZ nks çdkj ls                                                       Normal S. T4, normal S. T3 ,oa normal S.           djus dk ç;kl djrk gS\& (i) T4 dks T3 esa cnydj ,oa   TSH ¼<5 mIU/L½           (ii) TSH dk secretion c<+kdjA                                                     57","- Subclinical  hypothyroidism  \&  gkbiksFkk;-  dk;Z djrk gS blhfy,] bl dk;Z ds fy, T4 dk gh            jkW;fMTe ds vkjEHk esa \& Normal S. T4, normal S.   p;u fd;k tkrk gSA            T3 ,oa mildly high S. TSH ¼<10 mIU/L½     a)  LIOTHYRONINE           - Early clinical or overt hypothyroidism \&   ge tkurs gSa fd Fkk;jkW;M gkWeksZUl nks çdkj ds gksrs gSa]             blds i'pkr~ \& Low S. T4, normal S. T3 ,oa high   T3 ,oa T4 A loZçFke rks ;g lkspuk gksxk fd buesa ls            S. TSH ¼>10 mIU/L½ \& yxHkx 25% O;fä;ksa esa   nksuksa dks ç;ksx esa yk;k tk ldk gS vFkok fdlh ,d dks\\           - Advanced  clinical  or  overt  hypothyroi-  ;kn jgs] T4 ,d çks\&gkWeksZu gS tks 'kjhj esa D1 ds }kjk            dism \& var esa \& Low S. T4, low S. T3 ,oa high   lfØ; gkWeksZu T3 esa cny fn;k tkrk gSA bl çdkj ls            S. TSH ¼>10 mIU/L½                                                      gkbiksFkk;jkW;fMTe esa rks ;g nksuksa gh çHkkoh gksus pkfg;sa                                                      ,oa bu nksuksa esa Hkh T3 vf/kd çHkkoh gksuk pkfg,             MANAGEMENT OF HYPOTHYROIDISM             D;ksafd lfØ; gkWeksZu gksus ds dkj.k xzg.k djus ds ckn           vkb;s le>rs gSa fd gkbiksFkk;jkW;fMTe esa bu gkWeksZUl   og rqjar dk;Z djus yxsxkA okLro esa ;g lR; rks gS           dks fdl\&fdl çdkj ls ckgj ls fn;k (Supplement   ijUrq T3 ds ç;ksx ds lkFk dqN vlqfo/kk;sa tqM+h gksrh           fd;k½ tk ldrk gSA                          gSaA           DESICCATED THYROID EXTRACT                 - IykTek gkQ ykbQ vR;ar de gksus ds dkj.k bls fnu           1891 esa igyh ckj ;g ns[kk x;k Fkk fd  sheep   esa rhu ckj ¼TDS½ nsuk iM+rk gSA           thyroid extract ls gkbiksFkk;jkW;fMTe ds y{k.kksa dks   - fnu esa rhu ckj fn, tkus ds ckn Hkh jä esa blds Lrj           Bhd fd;k tk ldrk gSA blds ckn ls tarqvksa dh   cM+h rsth ls ifjofrZr gksrs gSa ftlls xksyh ysus ds           Fkk;jkW;M xzafFk dks lq[kkdj ¼desiccated  animal   i'pkr~ rks thyrotoxic  features mRiUu gksus yx           thyroid gland½ dks gh Fkk;jkW;M gkWeksZUl ds :i esa   tkrs gSa tcfd vxyh xksyh ysus ds igys ds le; rd           ç;ksx esa yk;k tkrk FkkA blesa T4 ,oa T3 yxHkx 4:1   gkbiksFkk;jkW;fMTe  dsA  jä  esa  buds  Lrj  ds           ds vuqikr esa feyrs Fks ftldh 1 grain ¼~60 fexzk½   mrkj\&p<+ko ls jksxh cgq/kk /kM+du] dEiu] Fkdku           ek=k ls yxHkx 80 mcg LT4 ds cjkcj Fkk;jkW;M   vFkok mnklh dh f'kdk;r djrs gSaA           gkWeksZu çkIr gksrk FkkA ;|fi budks dkQh le; rd bl   - 'kjhj ds vusd vax] jä ds T3 dks lh/ks\&lh/ks mi;ksx           :i esa ç;ksx esa yk;k tkrk jgk ijUrq tarqvksa dh   esa u ykdj jä ds  T4 dks ç;ksx esa ykrs gSaA           Fkk;jkW;M xzafFk esa Fkk;jkW;M gkWeksZUl dh ek=k fuf'pr u   dksf'kdkvksa esa igq¡pus ds ckn ;g çks\&gkeksZu T4] D1           gksus ds dkj.k buds }kjk fine dosage adjustment   dh enn ls lfØ; gkWeksZu T3 esa cny fy;k tkrk gSA           laHko  ugha  gks  ikrk  FkkA  Synthetic  thyroxine   lh/ks T3 ds fn, tkus ls bu vaxksa ds lqpk# :i ls           preparations  dh  miyC/krk  ds  i'pkr~  ;g  vc   dk;Z djus esa ck/kk iM+rh gSA /;ku jgs] efLr\"d og           mi;ksx esa ugha yk;s tkrs A                 çeq[k vax gS tks T4 dks gh ç;ksx esa ykrk gSA            THYROID HORMONES                           mijksä  vlqfo/kkvksa  ds  dkj.k  gh  T3  dks           gkbiksFkk;jkW;fMTe dk vFkZ gS Fkk;jkW;M gkWeksZUl dh   gkbiksFkk;jkW;fMTe esa fu;fer :i ls ç;ksx fd;s tkus           dehA vr% bldk mipkj gqvk bUgha gkWeksZUl dh deh   ds LFkku ij dsoy mUgha fLFkfr;ksa esa ç;ksx esa yk;k tkrk            dks ckgj ls nsdj bldh iwfrZ djuk ¼exogenous   gS tgk¡ replacement therapy vkjEHk djrs le;           supplementation  vFkok  replacement½A  ge   blds  çHkkoksa  dks  vfr'kh?kz  çkIr  fd;s  tkus  dh           tkurs gSa fd T4 gh Fkk;jkW;M xzafFk ls cuus okyk çeq[k   vko';drk gks] tSls myxedema coma  esaA           gkWeksZu gS tks vko';drkuqlkj T3 esa ifjofrZr gksdj   /;ku jgs] synthetic thyronine ¼T3½ molecule ds                                                      58","nks optical isomers gks ldrs gSa] levo ,oa dextro  i'pkr] T4 dk jä Lrj 2-4 ?kaVksa rd c<+k jgrk gSA           forms A buesa levo form ds vf/kd lfØ; gksus ds  ;g rF; blfy, egRoiw.kZ gks ldrk gS D;ksafd bl le;           dkj.k  pharmacological  replacement  ds  fy,  esa fy;s x;s jä esa T4 ds Lrj c<+s gq, feysaxsa tks           bldh  synthetic  preparation  (lio-thyronine  Fkk;jkWfDlu dh Mkst fu/kkZfjr djus esa Hkze mRiUu dj           sodium - LT3) dks gh ç;ksx esa yk;k tkrk gSA  ldrs gSaA blhfy, jä esa T4 dh tkap ds fy, fy;k                                                      tkus okyk lSaiy] Fkk;jkWfDlu dh xksyh [kkus ds iwoZ gh           b)   LEVOTHYROXINE           T3 ds foijhr] T4 dh IykTek gkQ ykbQ 7-8 fnu   fy;k tkuk pkfg,A           gksrh gS ftlls blds jä ds Lrj esa fdlh ,d xksyh ysus   Steady  state  concentration  - Fkk;jkWfDlu dh           ;k u ysus ls Hkh FkksM+s le; esa vf/kd varj ugha iM+rkA  IykTek gkWQ ykbQ ds 7-8 fnu rd gksus ds dkj.k fdlh           blh dkj.k ls T3 ,oa T4 ds e/;] T4 dks ojh;rk nh  ,d xksyh dk çHkko] 8 fnuksa ds ckn Hkh yxHkx 50%           tkrh gSA bl Fkk;jkWfDlu dh Hkh nks isomeric forms  rd] 16 fnuksa ds ckn 25%, 24 fnuksa ds ckn ~12%           gks  ldrh  gSa]  levo  ,oa  dextroA  bu  nksuksa  esa  ,oa 32 fnuksa ds ckn Hkh  ~6% rd cuk jgrk gSA           levothyroxine (LT4) dks natural isomer gksus ds  blhfy,] 4-5 fnuksa rd nok ysrs jgus ds ckn jä esa           dkj.k ç;ksx esa yk;k tkrk gSA              T4 ds Lrj esa mrkj\&p<+ko Øe'k% de gksrs tkrs gSa ,oa                                                       1 ekg esa og yxHkx larqfyr voLFkk esa (equilibrium           Formulations - nok ds :i esa bls levothyroxine           sodium ds :i esa mi;ksx esa yk;k tkrk gSA ;wa rks ;g   state) igq¡p tkrs gSaA blhfy,] nh?kZdky ls nok ysrs gq,                                                      ;fn dksbZ O;fä fdlh ,d fnu nok ysuk Hkwy Hkh tkrk gS           tablets,  liquid  filled  capsules ,oa lyophilized           powder for injection] bu rhuksa :iksa esa miyC/k gS   rc mlls jä esa T4 ds Lrj esa dksbZ fo'ks\"k varj ugha                                                      vkrkA gk¡] gkWeksZu ds çHkko dks mfpr çdkj ls cuk;s           ijUrq  bldk  vkgkj  uky  ls  vo'kks\"k.k  (GI           absorption) iz;kZIr gksus ds dkj.k bls lkekU;r;k%   j[kus ds fy, ml Hkwyh gqbZ Mkst dks] vxys fnu dh Mkst                                                      ds lkFk gh ¼vFkkZr nks xksfy;ka ,d lkFk½ ys ysuk pkfg,A           xksyh ds :i esa gh ç;ksx fd;k tkrk gSA GIT ds fdlh           absorption  defect  ds  gksus  ij  liquid  filled   T4:T3 ratio - fdlh Mk;fcfVd O;fä esa ckgj ls nh tk           capsules  vf/kd  çHkkoh  gks  ldrs  gSa  tcfd   jgh ¼subcutaneous,  exogenous½ bUlqfyu ,oa           injectable thyroxine dks gkbiksFkk;jkW;fMTe ls tqMh   iSafØ;kl ls fudyus okyh ¼endogenous½ bUlqfyu esa           fdlh esfMdy bejtsalh ¼tSls myxedema coma½ esa   ,d varj jgrk gSA og ;g gS fd iSafØ;kl ls fudyus           gh ç;ksx esa yk;k tkrk gSA                 okyh bUlqfyu dh lokZf/kd ek=k portal circulation ls                                                      gksrs gq, fyoj esa igqaprh gS tgk¡ ls esVkckWfyTe ds ckn           Absorption  - ekSf[kd nok ysus ¼eq¡g ls ;k oral                                                      mldh dqN de ek=k systemic circulation esa igqaprh           ingestion½ ds i'pkr] Fkk;jkWfDlu dk yxHkx 70-           80%  Hkkx  jejunum  ,oa  ileum  ls  vo'kksf\"kr   gSA D;k vki lksp ldrs gSa fd blh çdkj dk dksbZ varj                                                      Fkk;jkWfDlu ds i'pkr Hkh gksrk gksxk\\ okLro esa]           ¼absorb½ gks tkrk gSA i;kZIr vo'kks\"k.k ds fy,           stomach esa  acidic  pH  dh vko';drk gksrh gSA   bUlqfyu dh Hkkafr Fkk;jkWfDlu fFkjSih ds nkSjku dksbZ           blhfy, Fkk;jkWfDlu dh xksyh dks [kkyh isV gh ysuk   portal-systemic  concentration  difference  rks           pkfg, ftlls Hkkstu] xSfLVªd ,flM dks gYdk djds   ugha gksrk ijUrq Fkk;jkWfDlu ¼T4½ ds ysus ds ckn jä esa           blds vo'kks\"k.k esa O;o/kku mRiUu u djus ik,A js'ks   T4:T3  ds vuqikr esa varj vo'; vk tkrk gSA           ,oa lks;k ;qä HkksT; inkFkZ blds vo'kks\"k.k esa lokZf/kd   lkekU;r;% jä dk yxHkx 20% T3] Fkk;jkW;M xzafFk           O;o/kku mRiUu djrs gSa ftlds dkj.k nok ds lkFk bl   ls vkrk gS tks gkbiksFkk;jkW;fMTe esa ?kV tkrk gSA blds           çdkj ds HkksT; inkFkZ ugha ysus pkfg,A     foijhr] Fkk;jkWfDlu ¼T4½ ysus ds ckn jä esa T4 dh                                                      ek=k vis{kk—r vf/kd c<+ tkrh gSA bl çdkj ls]           Plasma  concentrations  -  eqag ls nok ysus ds                                                     59","Fkk;jkWfDlu fFkjSih ds mijkar T4:T3 lkekU; ls vf/kd   gks ldrs gSaA           c<+k gqvk feyrk gSA                        Long term ADR - Fkk;jkWfDlu fFkjSih dh yEcs le;            ADVERSE  DRUG  REACTIONS  AND              rd nh x;h vksojMkst ds nq\"çHkko eq[;r% ân; ,oa           TOXICITY                                   gfì;ksa  ij  iM+rs  gSaA  esVkckWfyTe  ds  c<+  tkus  ls           /;ku jgs] ckgj ls nh tk jgh Fkk;jkWfDlu fFkjSih]   ek;ksdkfMZ;e dh vkWDlhtu dh vko';drk c<+ tkrh gS           lajpuk ,oa dk;Z ds :i esa iw.kZ:i ls 'kjhj esa cuus   ftlls ân; jksfx;ksa esa angina  mRiUu gks ldrk gSA           okys çk—frd T4 ds gh leku gksrh gSA vr% blds lHkh   yEcs le; rd nh x;h vksojMkst] ân; dh ekalisf'k;ksa           xq.k ,oa voxq.k Hkh çk—frd T4 ds gh leku gksus   dks Hkh gkfu igqap ldrh gS tks fo'ks\"k :i esa o`)           pkfg;saA okLro esa] Fkk;jkWfDlu fFkjSih }kjk mRiUu gks   O;fä;ksa esa heart failure  rd mRiUu dj ldrh gSA           ldus okys laHkkfor nq\"ifj.kke] bldh vksojMkst ls gh   'kkjhfjd ekalisf'k;ksa esa ;gh çHkko fo'ks\"kr;% proximal           mRiUu gksrs gSa] i;kZIr ek=k esa fy;s tkus ij ughaA  muscular weakness ds :i çdV gksrk gSA blds           Immediate ADR - Fkk;jkWfDlu fFkjSih dh FkksM+s le;  vfrfjä] Fkk;jkWfDlu }kjk bone resorption c<+us           rd nh x;h vksojMkst ls /kM+du ¼palpitation½]  ls] bldh vksojMkst ls osteoporosis  mRiUu gks           dEiu ¼tremors½]  ?kcjkgV ¼anxiety½]  gM+cM+kgV  ldrh gSA           ¼restlessnes½] nLr  ¼diarrhea½ bR;kfn y{k.k mRiUu                                                                                                60","8       The Art of Managing Hypothyroidism (Clinical Skill)                                    TH  REPLACEMENT THERAPY                    lkekU;r% Fkk;jkWfDlu dh vko';drk 150 ekbØksxzke           gkbiksFkk;jkW;fMTe esa Fkk;jkW;M gkWeksZUl dh deh dks   çfrfnu ls vf/kd ugha gksuh pkfg,A           iwjk djus ds fy, nh tkus okyh Fkk;jkWfDlu fFkjSih   vU; O;fä;ksa esa bldk fu/kkZj.k gkbiksFkk;jkW;fMTe dh           ¼thyroid hormone replacement therapy½ ds fy,   xaHkhjrk  ds  vuqlkj  fd;k  tkrk  gS  tks  çkbejh                                                                                      ,oa           LT4 dks gh pquk tkrk gS D;ksafd desiccated thyroid   gkbiksFkk;jkW;fMTe esa lhje TSH ds }kjk  lsdsaMjh           extract dh rqyuk esa bldh {kerk ¼potency½ vf/kd   gkbiksFkk;jkW;fMTe esa lhje T4 ds }kjk yxk;k tk           fLFkj ¼consistent½ gksrh gS ,oa LT3 dh rqyuk esa   ldrk gSA çkbejh gkbiksFkk;jkW;fMTe esa TSH ds Lrj           bldh gkQ ykbQ vf/kd gksrh gSA mijksä çkbejh   dh nksxquh la[;k dks Fkk;jkWfDlu dh vkjafHkd Mkst ds           gkbiksFkk;jkW;fMTe ds jksxh ds O;ogkfjd mipkj dh   :i esa vktek;k tk ldrk gSA bl çdkj] 10-15           ppkZ djrs gSaA                             mIU/L ij 25 ekbØksxzke] 20-25  mIU/L ij 50           Which  drug? \& ge le> pqds gSa fd Fkk;jkW;M   ekbØksxzke] 30-40 mIU/L ij 75 ekbØksxzke] 50-60           gkWeksZUl dks ckgj ls nsus ds fy, flaFksfVd Fkk;jkW;M   mIU/L ij 100 ekbØksxzke ,oa 60 mIU/L ls vf/kd                                                      TSH ds fy, 125 ekbØksxzke dh Mkst ls vkjEHk fd;k           gkWeksZu  ¼Fkk;jkWfDlu½ dk p;u djrs gSa D;ksafd ,uhey   tk ldrk gSA vkjafHkd Mkst ds :i esa ;g çLrko]           Fkk;jkW;M ,DlVªSDV dh rqyuk esa blesa nok dh ek=k   O;fäxr vuqHkoksa ds vk/kkj ij fn;k x;k gS ,oa fdlh           LFkk;h gksrh gS ,oa bldh gkQ ykbQ  vf/kd ¼yxHkx 8   Hkh laLFkk }kjk vuqeksfnr ugha gSA           fnu½ gksrh gS ftlls levothyronine dh rqyuk esa jä           esa blds Lrjksa esa nSfud :i esa vf/kd mrkj\&p<+ko u   When to give? \& ekSf[kd :i ls fy, tkus (oral                                                      administration) ds i'pkr~ Fkk;jkWfDlu dh yxHkx           gksdj og vf/kd LFkk;h jgrs gSa ftlls  cardiac           tachyarrhythmias dh lEHkkouk Hkh de gksrh gSA   75% ek=k ,CtkWcZ gks tkrh gS (oral bioavailability ~                                                      75%)A blds ,CtkWiZ~'ku ds fy, ,flfMd pH dh           At what dose? \& ge le> pqds gSa fd Fkk;jkWfDlu   vko';drk gksrh gSA blhfy,] bldks [kkyh isV  gh ysuk           dh Mkst dk p;u O;fä ds otu ds vuqlkj ugha fd;k   pkfg, D;ksafd Hkkstu ls feydj xSfLVªd ,flM dh           tkrkA ,slk blfy, D;ksafd ;g vko';d ugha fd   ,flfMVh ?kV tkrh gS ftlls Fkk;jkWfDlu dk ,CtkWiZ~'ku           gkbiksFkk;jkW;fMTe ls çHkkfor çR;sd O;fä esa Fkk;jkWM   ,oa bldk çHkko Hkh ?kV tkrk gSA vr% Fkk;jkWfDlu dks           gkWeksZUl dk cuuk iw.kZ:i ls can gks pqdk gksA dsoy ftu   i;kZIr :i ls ,CtkWcZ gksus nsus ds fy, bls ysus ds de ls           O;fä;ksa esa Fkk;jkW;M xzafFk dk fcydqy Hkh lfØ; Hkkx   de ,d ?kaVs ckn Hkkstu ysuk pkfg,A ;fn fdlh dkj.k           'ks\"k ugha cprk ¼tSls athyreotic  O;fä;ksa esa vFkok   ls bls çkr% [kkyh isV ys ikuk laHko u gks rc bls           total thyroidectomy ;k  radioablation dk i'pkr~½]   Hkkstu ds de ls de pkj ?kaVs ckn Hkh fy;k tk ldrk                                                      gSA  xSfLVªd  ,flfMVh  dks  ?kVkus  okyh  nok,a  ¼tSls           muesa gh bldh x.kuk otu ds vuqlkj ¼çfrfnu 1.6-           1.7 x otu fdxzk esa½ ds vuqlkj dh tkrh gSA blds   antacids ,oa proton pump inhibitors½ Fkk;jkWfDlu           vuqlkj] fdlh 60 fdyks ds O;fä esa Fkk;jkWfDlu dh   dk ,CtkZI'ku ,oa çHkko ?kVk nsrh gSaA dSfY'k;e] vk;ju           vkjafHkd Mkst] 1.6 x otu ds vuqlkj] 60 fdyksxzke   ,oa lks;k mRikn Hkh blds ,CtkZI'ku esa ck/kk igqapkrs gSaA           ds O;fä esa 100 ekbØksxzke ,oa 90 fdyksxzke ds O;fä   vr% bu nokvksa dks Fkk;jkWfDlu ds de ls de pkj ?kaVs           esa  150  ekbØksxzke  ls  vf/kd  ugha  curhA  vr%]   i'pkr~ gh ysuk pkfg,A                                                     61","How  to  initiate?  \& ge tkurs gSa fd Fkk;jkW;M  pkj gkQ ykbQ ds ckn 93% ,oa ikap gkQ ykbQ ds           gkWeksZUl 'kjhj dh esVkckWfyTe dks c<+krs gSaA yEcs le;  ckn  yxHkx  97%  igq¡prk  gSA  blh  dkj.k  ls           ls jgh çkbejh gkbiksFkk;jkW;fMTe esa] tgk¡ 'kjhj bl  Fkk;jkWfDlu dk iw.kZ çHkko Hkh yxHkx 8 x 5 ¾ 40 fnuksa           ?kVs gq, BMR dk vH;Lr gks pqdk gks] Fkk;jkWfDlu  ckn gh mRiUu gksrk gSA blh dkj.k ls bldk vkdyu           fFkjSih ds }kjk bls ,dne c<+k nsuk Bhd ugha gksrkA  Hkh yxHkx 40 fnu ckn  ¼de ls de 30 fnu ckn½ gh           Fkk;jkWfDlu fFkjSih }kjk esVkckWfyd xfrfof/k;ka c<+us ls  djkuk pkfg,A           ân; xfr ,oa ek;ksdkfMZ;e dh vkWDlhtu fMekaM c<+us   How to monitor? \& Fkk;jkWfDlu fFkjSih dk mís'; gS           yxrh gS tks ân; dks mÙksftr djds angina vFkok   'kjhj esa Fkk;jkWfDlu dh deh dks ckgj ls nsdj iw.kZ           myocardial infarction rd dk dkj.k cu ldrh gSA   djukA Fkk;jkWfDlu fFkjSih ls T4 ds Lrj c<+us ,oa           o`) O;fä;ksa ,oa ân; jksfx;ksa esa bl rF; dk fo'ks\"k:i   TSH ds Lrj ?kVus vkjEHk gks tkrs gSaA vr% i;kZIr           ls /;ku j[kuk pkfg,A bu ifjfLFkfr;ksa esa Fkk;jkWfDlu   Mkst dk vFkZ gqvk] og Mkst ftl ij Fkk;jkW;M gkWeksZUl           dks de Mkst ¼tSls 12.5 ;k 25 ekbØksxzke½ ls vkjEHk   ¼T4 ,oa TSH½ ds Lrj lkekU; vk ldsaA LokHkkfod           djds Øe'k% ¼tSls 12.5 ;k 25 ekbØksxzke çfr lIrkg½   :i ls ftl O;fä esa tks gkWeksZu ewy:i ls çHkkfor gks]           c<+krs gq, çLrkfor Mkst rd ys tkuk pkfg,A de   mldh ekWuhVfjax mlh gkWeksZu }kjk gksuh pkfg,A çkbejh           vk;qoxZ ds O;fä;ksa esa ;g ck/;rk ugha jgrh D;ksafd og   gkbiksFkk;jkW;fMTe ¼overt ,oa subclinical] nksuksa½ esa           esVkckWfyTe esa vk, bu ifjorZuksa dks ljyrk ls lgu   bldh  fooospuk  ds  fy,  lhje  TSH  ,oa  lsaVªy           dj ysrs gSaA                               gkbiksFkk;jkW;fMTe esa lhje T4 dk ç;ksx djrs gSaA ,d           At what interval? \& fdlh nok dk çHkko (duration  ckj iqu% ;kn dj ysa] Fkk;jkWfDlu dh fdlh Mkst dks           of action) mldh ikap gkQ ykbQ rd cuk jgrk gSA  vkjEHk djus ds ckn mldh Mkst dh i;kZIrrk dh tkap           ;g ,d gkQ ykbQ ds ckn 50%] nks gkQ ykbQ ds  ds fy, lhje TSH] de ls de 40 fnuksa ckn ,oa           ckn 25%] rhu gkQ ykbQ ds ckn 12.5%] pkj gkQ   lhje T4] de ls de 30 fnuksa ckn gh djkuk pkfg,A           ykbQ ds ckn 6.25% ,oa ikap gkQ ykbQ ds ckn dsoy   How to titrate the dose? \& vkjafHkd Mkst ds           3% cprk gSA Fkk;jkWfDlu dh yEch gkQ ykbQ ¼yxHkx  p;u ,oa i;kZIr le; ds ckn djk;s x, QkWyksvi ds           8 fnu½ ds dkj.k ,d Mkst dk çHkko yxHkx 8 x 5 ¾  ckn vxyk egRoiw.kZ ç'u Fkk;jkWfDlu dh Mkst dks           40 fnuksa rd jgrk gSA blhfy, bls fnu esa ,d ckj gh  iqufuZ/kkZfjr djus dk gSA ;g ,d dyk gS ftlesa ikjaxr           fn;k tk ldrk gSA ;fn fdlh dkj.k ls ,d fnu nok  gksdj dksbZ Hkh fpfdRld] çkbejh gkbiksFkk;jkW;fMTe           ysuh jg tk;s rc mldk dksbZ çHkko O;fä dks mlh  dk lQyrk iwoZd mipkj dj ldrk gSA /;ku jgs] bl           le; çrhr ugha gksrkA ijUrq] yEcs le; rd bl   çfØ;k esa dHkh Hkh Mkst dks ,dk,d vf/kd ek=k ¼50-           gkWeksZu dh deh gksus ls cpus ds fy, bl NwVh gqbZ Mkst   100  ekbØksxzke½ esa c<+kuk ;k ?kVkuk ugha pkfg,A           dks vxys fnu vo'; ys ysuk pkfg,A ;fn nks ;k rhu   okLro esa ;g varj] lCth esa ued dh Hkkafr gh vR;ar           fnu dh nok NwV tk;s] rc bl NwVh gqbZ Mkst dks Hkh   FkksM+h\&FkksM+h ek=k ¼25 ekbØksxzke o`) O;fä;ksa ,oa ân;           Øe'k% vxys nks\&rhu fnuksa esa iwjk fd;k tk ldrk gSA   jksfx;ksa esa blls Hkh de 12.5 ekbØksxzke½ esa gh djuk                                                      pkfg,A blds fy, ftl çdkj TSH ds Lrj ds vk/kkj           Follow up \& yxkrkj fy, tkrs jgus ij dksbZ nok   ij Fkk;jkWfDlu dh vkjafHkd Mkst dk p;u fd;k tkrk           viuh ikap gkQ ykbQ ds i'pkr~ ,d fLFkj Lrj   gS] mlh ds vuqlkj Mkst esa deh vFkok c<+ksÙkjh Hkh dh           (steady state concentration, SCC) ij igq¡prh   tk ldrh gSA vkb;s bldks mnkgj.kksa ls le>rs gSaA           gSA ;g Lrj] ,d gkQ ykbQ ds ckn ;g 30%] nks gkQ           ykbQ ds ckn 75%] rhu gkQ ykbQ ds ckn 87%]   If TSH is still high \& fuxsfVo QhMcSd ds fu;e ds                                                     62","vuqlkj] TSH dk lkekU; Lrj ls vf/kd gksus dk vFkZ  nh tk jgh Mkst i;kZIr gSA ,sls esa blesa dksbZ ifjorZu           gS fd vHkh Fkk;jkWfDlu dh Mkst i;kZIr ek=k esa ugha  ugha djuk pkfg,A           igqaph gS ,oa bls vkSj vf/kd c<+kuk gksxkA blds fy,   Long term follow-up \& bl çdkj ls larqyu çkIr           ns[kuk gksxk fd lhje TSH dk Lrj] TSH ds mPpre   djus ds i'pkr] bldh iqufoZospuk çkjEHk esa 3-6 ekg           Lrj 5.0 mIU/L ls fdruk vf/kd gSA lhje TSH esa   i'pkr~ ,oa ckn esa 6-12 ekg ij djkrh jguh pkfg,A           ;g varj 1-5 mIU/L vf/kd gksus ij Fkk;jkWfDlu dh           Mkst  dks  12.5  ekbØksxzke  5-10  mIU/L  ij  25   Re-evaluation  \&  mijksä  fof/k;ksa  }kjk  larqfyr           ekbØksxzke  ,oa  10-20  mIU/L  ij  50  ekbØksxzke   gkbiksFkk;jkW;fMTe esa Hkh dHkh\&dHkh le; iwoZ gh tkapsa           c<+k;k tk ldrk gSA /;ku jgs] tks'k esa ,d lkFk vf/kd   djkus dh vko';drk iM+ ldrh gSA blds ewy dkj.k           ek=k esa c<+ksÙkjh djus ij bl Mkst ds VkWfDld Lrj ij   gks ldrs gSa] fdlh dkj.k ls nok dk NwV tkuk ;k bldks           igq¡p tkus dh lEHkkouk c<+ tkrh gS ftlls Mkst dks   cnyh gqbZ ek=k esa ysus yxuk] otu esa cM+k cnyko           iqu% ?kVkuk iM+rk gSA blh iatrogenic thyrotoxicosis   vkuk ¼tSls vR;f/kd c<+ tkuk ;k cSfj;kfVªd ltZjh ds           ls cpus ds fy, gh Mkst dks FkksM+h ek=k esa c<+kuk gh   mijkar bldk ,dk,d ?kV tkuk½] xHkZ /kkj.k dj ysuk           mfpr jgrk gSA iqu%] Mkst esa dh x;h bl c<+ksÙkjh dh   ;k  çlo  ;k  ,ckW'kZu  gks  tkuk]  Fkk;jkWfDlu  dh           i;kZIrrk dh tkap Hkh 40 fnuksa ds i'pkr~ djk ysuh   esVkckWfyTe dks çHkkfor djus okyh nokvksa ¼tSls]           pkfg,A                                     rifampicin, phenytoin, PPI½ dk vkjEHk gks tkuk                                                      vFkok xHkZ fujks/kd xksfy;ksa ;k bLVªkstsu dk lsou djus           If TSH becomes low \&  TSH dk lkekU; Lrj ls   yxuk] bR;kfnA           de gksuk] Fkk;jkWfDlu dh Mkst dk vko';drk ls           vf/kd  gksus  dk  y{k.k  gksrk  gSA  çkbejh  gkbiks\&   INTERPRETATION OF TFT ON THYROXINE                                                      THERAPY           Fkk;jkW;fMTe esa TSH dks 0.5 mIU/L ls uhps Hkh ugha   gkbiksFkk;jkWbfMTe  ls  çHkkfor  fdlh  O;fä  esa]  tks           tkus nsuk pkfg,A bl suppressed TSH dks ukius ds   çfrfnu Fkk;jkWfDlu dh Mkst ys jgk gS] mlesa TFT dh           fy, sensitive ,oa 0.1 mIU/L ls Hkh de TSH dks   foospuk djrs le; gkbiksFkk;jkW;fMTe ds vfrfjä           ukius  ds  fy,  ultrasensitive  TSH  assay  dh   dqN vU; Dyhfudy rF;ksa dks /;ku esa j[kus dh           vko';drk iM+rh gSA /;ku jgs] TSH  assay dh   vko';drk Hkh iM+rh gSA vkb;s mipkj ds nkSjku           lsaflfVfoVh dh vko';drk Fkk;jksVkWfDldksfll esa ?kVs   vko';d bu ckjhfd;ksa dks Hkh le> ysrs gSaA           gq, TSH dks ukius ds fy, iM+rh gS] gkbiksFkk;jkWfMTe           esa c<s gq, TSH dks ukius ds fy, ughaA lhje TSH dk   Low T4 and high TSH - LokHkkfod :i ls ;g vHkh           Lrj 0.5 mIU/L ls de gksus ij Fkk;jkWfDlu dh Mkst   Hkh Fkk;jkW;M gkWeksZUl dh deh dks  bafxr dj jgk gSA           dks 12.5 ekbØksxzke ,oa 0.1 mIU/L ls Hkh de gksus ij   ijUrq ,slk feyus ij çR;sd O;fä esa Fkk;jkWfDlu dh           25 ekbØksxzke ?kVk ysuk pkfg,A iqu%] ?kcjkdj Mkst dks   Mkst c<+kus dk fu.kZ; gh ugha ys ysuk pkfg,A ,slk vU;           vR;f/kd ek=k esa ?kVk ysus ij Hkh vxyk TSH dkQh   ifjfLFkfr;ksa esa Hkh gks ldrk gSA           c<+k gqvk fey ldrk gS ftlds dkj.k Mkst dks iqu%   - ;fn dqN le; ls nok yh gh u tk jgh gks           c<+kuk iM+ ldrk gSA vr%] Mkst esa ?kVkuk vFkok   - ;fn dqN le; ls nok mfpr çdkj ls u yh tk jgh           c<+kuk] ,d ckj esa FkksM+h Mkst esa gh djuk mfpr jgrk   gks\&tSls nok ds lkFk pk;] nw/k ;k uk'rs dk lsou dj           gSA iqu%] bl çdkj ?kVk;h x;h Mkst dk iqufuZ/kkZj.k Hkh   ysuk vFkok buds e/; ,d ?kaVs ls de varjky j[kukA           yxHkx 40 fnuksa ds i'pkr~ dj ysuk pkfg,A   - ;fn nok rks fu;fer :i ls yh tk jgh gks ijUrq mlds            If  TSH  is  within  normal  limits  \& TSH dk   lkFk dqN vU; inkFkZ Hkh fy, tk jgs gksa           lkekU; lhek esa gh gksus dk vFkZ gS fd Fkk;jkWfDlu dh   - inkFkZ tks Fkk;jkWfDlu dks Bhd çdkj ls ,CtkWcZ u gksus                                                    63","ns jgs gksa \& tSls dSfY'k;e] vk;ju] çksVhu ,oa lks;k  ys yh x;h\\ vU;Fkk Fkk;jkWfDlu dh Mkst ?kVkus ij            fufeZr inkFkZA blhfy,] bu inkFkksaZ dks Fkk;jkWfDlu  fopkj gksuk pkfg,A            ysus ds de ls de pkj ?kaVs ds ckn gh ysuk pkfg,A  MANAGEMENT  OF  SECONDARY  HYPO-           - nok,a tks xSfLVªd ,flM ?kVkrh gksa tSls] çksVkWu iai   THYROIDISM            bufgfcVj ,oa ,aVkflM bR;kfnA blhfy,] bu nokvksa  ;wa rks gkbiksFkk;jkW;fMTe pkgs çkbejh gks vFkok lsdsaMjh            dks Fkk;jkWfDlu ysus ds de ls de pkj ?kaVs ds ckn gh   ¼;k lsaVªy½] nksuksa gh ifjfLFkfr;ksa esa mipkj dk eq[;            ysuk pkfg,A                               mís';  Fkk;jkWfDlu  dks  ckgj  ls  nsuk           - nok,a tks Fkk;jkW;M xzafFk ls Fkk;jkW;M gkWeksZUl dk   (supplementation  vFkok  replacement)  gh  gS            mRiknu ?kVk nsa tSls] fyfFk;e             ijUrq bldh çfØ;k fHkUu fHkUu gksrh gS ,oa blesa dqN           - nok,a tks Fkk;jkWfDlu dh esVkckWfyTe c<+k nsa tSls]   vfrfjä igyqvksa ij /;ku nsus dh vko';drk gksrh gSA            rifampicin,  barbiturates,  phenytoin,            carbamazepine bR;kfnA                     1) lsaVªy gkbiksFkk;jkW;fMTe (CH) esa fiVîwVjh xzafFk ds           - nok,a tks Fkk;jkWfDlu dk ,DlØh'ku c<+k nsa tSls]   }kjk TSH secretion gh çHkkfor gksus ds dkj.k TSH            phenytoin                                 ds Lrj rks ?kVs gq, gh feyrs gSa ftlls ;g Hkze gks ldrk           vr%] tkap ls dksbZ fu\"d\"kZ fudkyus ds iwoZ mijksä   gS fd Fkk;jkWfDlu dh Mkst i;kZIr vFkok vf/kd gks jgh           rF;ksa ds fo\"k; esa tkudkjh vo'; ys ysuh pkfg,A    gSA okLro esa CH dh Mk;Xuksfll ,oa ekWuhVfjax lhje                                                      T4/FT4 }kjk gh dh tkuh pkfg, ,oa bldks lkekU;           High T4 and normal TSH - TSH dk lkekU; gksuk           'kjhj esa Fkk;jkW;M gkWeksZUl dh i;kZIrrk dks n'kkZrk gSA   lhek ds Åijh Lrj (upper half of normal) ij j[kus           ijUrq T4 dk c<+k gksuk n'kkZrk gS fd jä esa T4 dk   dk ç;kl djuk pkfg,A 2) fiVîwVjh xzafFk ds fodkjksa esa           Lrj vf/kd gSA ,slk rc gks ldrk gS tc fdlh dkj.k   lEHkkouk  ;g  Hkh  gksrh  gS  fd  thyrotropes    ds           ls  'kjhj  esa  Fkk;jkWfDlu  ckbafMax  çksVhu  ¼eq[;r%   lkFk\&lkFk fiVîwVjh dh vU; dksf'kdk,a Hkh çHkkfor gks           XykWC;qfyu½ c<+ tk;s ftlls vf/kd ek=k esa T4 çksVhu   jgh gksaA blls vU; gkWeksZUl tSls dkWfVZlksy] xzksFk gkWeksZu]           ls tqM+dj T4 dk Lrj c<+k nsA ,slk bZLVªkstsu ysus ij   çksySfDVu  vFkok  gonadotropins  dh  deh  Hkh           gksrk gSA                                  lkFk\&lkFk fey ldrh gSA buesa ls Fkk;jkWfDlu fFkjSih                                                      ds lkFk dkWfVZlksy dh deh vR;ar egRoiw.kZ gksrh gSA           Low T4 and normal TSH - TSH dk lkekU; gksuk           'kjhj esa Fkk;jkW;M gkWeksZUl dh i;kZIrrk dks n'kkZrk gSA   /;ku jgs] Fkk;jkW;M gkWeksZUl] dkWfVZlksy dh esVkckWfyTe           ijUrq T4 dk ?kVk gksuk n'kkZrk gS fd jä esa T4 dk Lrj   c<+krs gSaA gkbiksFkk;jkW;fMTe esa ;g ?kV tkrh gS ftlls           de gSA ,slk rc gks ldrk gS tc fdlh dkj.k ls 'kjhj   dkWfVZlksy dh vkaf'kd deh nch (masked) jg ldrh           esa Fkk;jkWfDlu ckbafMax çksVhu ¼eq[;r% XykWC;qfyu½ ?kV   gSA Fkk;jkWfDlu fFkjSih ds vkjEHk ds lkFk gh dkWfVZlksy           tk;s ftlls T4 dh de ek=k gh çksVhu ls tqM+ lds   dh esVkckWfyTe c<+ tkus ls ;g deh unmasked           ftlls T4 dk Lrj ?kV tk;sA ,slk ,.Mªkstsu ysus ij    gksdj hypocortisolism ds y{k.k ¼tSls weakness,           gksrk gSA dqN vuqokaf'kd dkj.kksa ls ,YC;wfeu ds ?kV   lethargy,  giddiness,  postural  hypotenson           tkus ij Hkh ,slk gh gksrk gSA              bR;kfn) ,oa ;gk¡ rd fd  Addisonian  crisis Hkh                                                      mRiUu dj ldrh gSA blls cpko ds fy, CH esa ges'kk           High  T4  and  low  TSH  - LokHkkfod :i ls ;g   lhje dkWfVZlksy dh tkap Hkh vo'; djkuh pkfg, ,oa           Fkk;jkW;M gkWeksZUl dh vf/kdrk dks bafxr djrk gSA ,slk   Fkk;jkWfDlu dks de Mkst ls vkjEHk djds Øe'k%           feyus ij ;g lqfuf'pr dj ysuk pkfg, fd fdlh Hkh           dkj.k ls nok dh çrkfor Mkst ls vfrfjä Mkst rks ugha   c<+kuk pkfg,A fdlh Hkh bejtsalh ls fucVus ds fy, inj                                                      hydrocortisone dks Hkh rS;kj j[kuk pkfg,A                                                     64","Management  of  primary  hypothyroidism    bl le; bldh vko';drk eq[;r% 'kkjhfjd o`f) ds           and  hypocortisolism  \&  lsdsaMjh  gkbiks\&   fy, iM+rh gSA bl voLFkk esa Fkk;jkWfDlu dks i;kZIr           Fkk;jkW;fMTe dh Hkkafr çkbejh gkbiksFkk;jkW;fMTe esa   Mkst esa u nsus ij 'kkjhfjd esa ck/kk mRiUu gks ldrh gSA           thyrotropes  ,oa  corticotropes  lkFk\&lkFk  rks           çHkkfor  ugha  gksrs  ijUrq  autoimmune    During puberty \& I;wcVhZ ds nkSjku growth spurt           polyglandular syndrome (APS) esa ,slk gks ldrk   ds dkj.k BMR ds c<+us ls ,d ckj iqu% Fkk;jkWfDlu           gSA bl lEHkkouk ds gksus ij Hkh mijksä lko/kkfu;ka   dh Mkst c<+rh gSA bl rF; dks /;ku esa u j[kus ij           j[kuh pkfg;saA                             I;wcVZy fodkl esa ck/kk iM+ ldrh gSA                                                      During  gestation  and  lactation  \& bu nksuksa           DOES  AGE  OF  THE  PATIENT  AFFECT           GOALS OF MANAGEMENT?                       voLFkkvksa esa Hkh BMR  dkQh vf/kd c<+ tkrk gS           ge  tkurs  gSa  fd  Fkk;jkW;M  gkWeksZUl  'kjhj  dh   ftlds dkj.k Fkk;jkWfDlu dh Mkst 25-50% rd c<+           esVkckWfyTe dks mÙksftr djrs gSaA tjk lkspsa] bl   ldrh gSA xHkZ/kkj.k ds lkFk gh Mkst u c<+kus ij           esVkckWfyTe dh vko';drk fdl vk;q esa vf/kd gksxh\\   miscarriage ;k IUGR dh lEHkkouk c<+ ldrh gSA           LokHkkfod :i ls thou ds vkjafHkd o\"kksaZ esa tc BMR   blds fo\"k; esa ge foLrkj ls vkxs le>saxsaA           vf/kdre  gksrk  gS]  rc  Fkk;jkW;M  gkWeksZUl  dh   With aging \& vk;q c<+us ds lkFk BMR esa deh vkrh           vko';drk  Hkh  vf/kdre  gksrh  gS  ,oa  vk;q  ds   tkrh gS ftlls Fkk;jkWfDlu dh vko';drk Hkh ?kVrh           lkFk\&lkFk  tSls\&tSls  BMR  ?kVrk  tkrk  gS]  rc   tkrh gSA vusd losZ{k.kksa esa ik;k x;k gS fd vk;q ds lkFk           Fkk;jkW;M gkWeksZUl dh vko';drk Hkh ?kVrh tkrh gSA   TSH ds Lrj lkekU; :i esa Hkh c<+rs tkrs gSaA blfy,           In newborns \& Congenital hypothyroidism esa   c<+rh vk;q ds lkFk Fkk;jkWfDlu dh Mkst dk fu/kkZj.k           uotkr f'k'kq dks o;Ldksa dh rqyuk esa yxHkx 10 xquh   djrs le; gesa TSH dks bldh lkekU; lhek ds Åijh           Mkst  ¼10-15  ekbØksxzke  çfr  fdxzk  otu½  dh   Hkkx ¼2.5-5.0 mIU/L½ esa j[kuk pkfg,A           vko';drk iM+rh gSA bl voLFkk esa Fkk;jkW;M gkWeksZUl]   In old ages \& fdlh vk;q ds fy, mi;qä TSH]           'kkjhfjd o`f) ds lkFk\&lkFk ekufld fodkl ds fy, Hkh   laHkor% vk;q dks 10 ls Hkkx nsus ds i'pkr~ feyh la[;k           vko';d gksrk gSA bl le; gesa T4 dk y{; bldh   ftruk gksuk pkfg,A vr%] 85 o\"khZ; O;fä ds fy,           lkekU; lhek ds Åijh Hkkx esa ¼10-15 mcg/dl½ rFkk   TSH dk y{; laHkor% 85/10¾8.5 mIU/L j[kuk gh           TSH dk y{; bldh lkekU; lhek ds fupys Hkkx   mfpr gksxkA bl voLFkk esa Fkk;jkWfDlu dks vko';drk           ¼0.5-2.5 mIU/L½ esa j[kuk pkfg,A blesa f'kfFkyrk   ls vf/kd ek=k esa ç;ksx djus ij blds dkj.k ân; dks           j[kus ij 'kkjhfjd ,oa ekufld fodkl esa ck/kk mRiUu   vuko';d :i ls mÙksftr djus ls angina ,oa gfì;ksa           gks ldrh gSA                               esa dSfY'k;e VuZvksoj esa o`f) gksus ls osteoporosis            In childhood \& çFke o\"kZ ds i'pkr~ Fkk;jkWfDlu dh   mRiUu gks ldrh gSA           Mkst Øe'k% ?kVrs gq, o;Ld Mkst ij vkrh tkrh gSA                                                                 65","9                             Thyrotoxicosis            Fkk;jksVkWfDldksfll 'kCn ls gh Li\"V gS fd 'kjhj esa   vf/kd Fkk;jkW;M gkWeksZUl dk fuekZ.k dj jgh gksA ;g           Fkk;jkW;M gkWeksZUl dh ek=k dk vR;f/kd ¼toxic½ Lrj   fuEukafdr ifjfLFkfr;ksa esa gks ldrk gSA           rd igq¡p tkukA ysfdu blh çdkj dk ,d 'kCn vkSj Hkh   - Graves disease \& ;fn lEiw.kZ Fkk;jkW;M xzafFk gh           gS] gkbijFkk;jkW;fMTeA ;g nksuksa ijLij feyrs\&tqyrs   vkdkj  esa  c<+dj  vfu;af=r  ek=k  esa  Fkk;jkW;M           ls 'kCn gSa ,oa vDlj ,d nwljs ds i;kZ;okph le>   gkWeksZUl dk fuekZ.k dj jgh gksA           fy;s tkrs gSaA ijUrq okLro esa ;g lgh ugha gSA vkb;s   - Toxic multinodular goiter Toxic (MNG) \&           bu nksuksa 'kCnksa esa varj dks le>rs gSaA  ;fn yEcs le; ls jgs eYVh ukWMîqyj xkW;Vj ds ,d            Hyperthyroidism  - bldk vFkZ gS fd 'kjhj esa   ;k  ,d  ls  vf/kd  ukWMîwy  vfu;af=r  ek=k  esa           Fkk;jkW;M gkWeksZUl dk fuekZ.k lkekU; ls vf/kd ek=k esa   Fkk;jkW;M gkWeksZUl dk fuekZ.k dj jgs gksaA           gks jgk gS ftlls 'kjhj esa Fkk;jkW;M gkWeksZUl dh ek=k   - Solitary  toxic  nodule  (STN)  or  toxic                                                       adenoma \& ;fn Fkk;jkW;M xzafFk ds fdlh Hkkx esa           vf/kd gks x;h gSA                           mRiUu dksbZ ,d ukWMîwy vfu;af=r ek=k esa Fkk;jkW;M            Thyrotoxicosis  -  bldk vFkZ gS fd 'kjhj esa   gkWeksZUl dk fuekZ.k dj jgk gksA           Fkk;jkW;M gkWeksZUl dh ek=k vf/kd gS pkgs og fdlh Hkh   b) SECONDARY (2°) HYPERTHYROIDISM           dkj.k ls D;ksa u gksA blds dkj.kksa esa Fkk;jkW;M gkWeksZUl   lsdsaMjh] vFkkZr ftldk eq[; dkj.k Fkk;jkW;M xzafFk ds           dk lkekU; ls vf/kd ek=k esa fufeZr gksuk Hkh gks ldrk   vfrfjä dgha vkSj gks fdarq mlds vlj ls Fkk;jkW;M           gS ¼gkbijFkk;jkW;fMTe½ ,oa fcuk vf/kd ek=k esa cus gh   xzafFk dh xfrfof/k;ka c<+ xbZ gksA ,slk TSH-secreting                                                                            a           fdlh vkSj fof/k ls c<+ tkuk Hkh gks ldrk gSA  pituitary  adenoma  ,oa  gestational            bl çdkj] gkbijFkk;jkW;fMTe ls çHkkfor lHkh O;fä;ksa   thyrotoxicosis ¼GTT½ bR;kfn esa gksrk gSA buesa           dks Fkk;jksVkWfDldksfll ls xzflr dgk tk ldrk gS   Fkk;jkW;M xzafFk ds vfrfjä dgha vkSj cuus okyk dksbZ           ijUrq  Fkk;jksVkWfDldksfll  ls  çHkkfor  O;fä;ksa  dks   vU; mÙkstd inkFkZ] tSls TSH ¼pituitary adenoma½           gkbijFkk;jkW;fMTe ugha dgk tk ldrkA vkb;s bu   ;k  hCG ¼GTT½] Fkk;jkW;M xzafFk dks mÙksftr dj           nksuksa fLFkfr;ksa dks foLrkj ls le>rs gSaA  vfu;af=r  ek=k  esa  Fkk;jkW;M  gkWeksZUl  dk  fuekZ.k                                                      djokrk gSA             ETIOLOGIES           Fkk;jksVkWfDldksfll eq[;r% nks çeq[k dkj.kksa ls gks   THYROTOXICOSIS  WITHOUT  HYPER-                                                      THYROIDISM           ldrh gSA                                                      'kjhj esa vf/kd ek=k esa fufeZr gq, fcuk gh Fkk;jkW;M           THYROTOXICOSIS  DUE  TO  HYPER-            gkWeksZUl] eq[;r% nks dkj.kksa ls jä esa c<+ ldrs gSaA           THYROIDISM           tc Fkk;jkW;M xzafFk }kjk Fkk;jkW;M gkWeksZUl dk fuekZ.k   - Exogenous intake \& ;fn Fkk;jkW;M gkWeksZUl dh           vko';drk ls vf/kd ek=k esa gksus yxsA ;g iqu% nks   xksfy;ka vR;f/kd ek=k esa ckgj ls ys yh tk,] xyrh           çdkj dh gks ldrh gSA                        ls  ¼accidentally½  ;k  tkucw>dj  fNikdj                                                       ¼factitious½; vFkok gkbiksFkk;jkW;fMTe ds mipkj ds           a) PRIMARY (1°) HYPERTHYROIDISM             fy,  vko';drk  ls  vf/kd  ek=k  nsus  ij           çkbejh] vFkkZr ftldk eq[; dkj.k Lo;a Fkk;jkW;M xzafFk           esa gksA vFkkZr] Fkk;jkW;M xzafFk Lo;a gh vko';drk ls   ¼iatrogenic½ A 'kjhj esa gksus okyh fdlh xM+cM+h ls                                                       u gksdj tku\&cw>dj ¼artificially½ mRiUu dh tkus                                                     66","okyh  ifjfLFkfr  dks  thyrotoxicosis  factitia    - Fkk;jkWfDlu  fFkjSih  dk  fooj.k  iatrogenic            ¼factitious  =  fake  ;k  artificially  created½ Hkh   Fkk;jksVkWfDldksfll dh lEHkkouk dks O;ä djrk gSA            dgrs gSaA                                 - iwoZ esa URTI ,oa xys ds vxys Hkkx esa nnZ gksus dk            - Endogenous release \& ;fn Fkk;jkW;M xzafFk esa   fooj.k Fkk;jkW;MkbfVl dh lEHkkouk dks O;ä djrk            fdlh  çdkj  dh  {kfr  igq¡pus  ij  mlesa  laxzfgr   gSA            Fkk;jkW;M gkWeksZUl dh cM+h ek=k yhd djds jä esa   - yEcs le; ls fey jgs y{k.k gkbijFkk;jkW;fMTe dh            igq¡p tk,A bls destructive thyrotoxicosis  dgrs   lEHkkouk c<+krs gSaA                                                      - buds vfrfjä] Fkk;jkW;M xzafFk dh lajpuk ds vk/kkj            gSaA  ,slk  Fkk;jkW;M  xzafFk  esa  immunological,                                                       ij gkbijFkk;jkW;fMTe ds dkj.k dk vuqeku Hkh            medicinal,  radiational  vFkok  operational            damage ds dkj.k ls gks ldrk gSA            yxk;k tk ldrk gSA  Diffuse  goiter   feyus ij                                                       Graves' disease, ,d ukWMîwy feyus ij  toxic            DIFFERENTIATION  BETWEEN  THYRO-           TOXICOSIS WITH AND WITHOUT HYPER-           nodule ,oa vusd NksVs\&cM+s ukWMîwYl feyus ij           THYROIDISM                                  toxic MNG dh lEHkkouk gks ldrh gSA           gkbijFkk;jkW;fMTe ,oa Fkk;jksVkWfDldksfll esa foHksn   ;gk¡ ç'u ;g mBrk gS fd vkf[kj bu nksuksa fLFkfr;ksa esa           fuEu fof/k;ksa }kjk fd;k tk ldrk gSA       varj djus dh vko';drk gh D;k gS\\ okLro esa           Radionuclide scan \& ;g bl dk;Z ds fy, loksZÙke  gkbijFkk;jkW;fMTe esa rks Fkk;jkW;M xzafFk esa cuus okys           fof/k gSA gkbijFkk;jkW;fMTe esa Fkk;jkW;M xzafFk dh  Fkk;jkW;M gkWeksZUl ds fuekZ.k dks de djus ds fy,           lfØ;rk c<+h gksus ds dkj.k xzafFk dk jsfM;ksU;wDykbM   antithyroid drugs ¼ATD½ nsus dh vko';drk iM+rh           viVsd c<+k feyrk gS tcfd Fkk;jksVkWfDldksfll esa ;g  gS  tcfd  destructive  thyrotoxicosis  ;k           ?kVk gksrk gSA                             exogenous intake dh fLFkfr esa rks ;g igys ls gh                                                      ?kVk gqvk gksrk gSA bu nksuksa fLFkfr;ksa esa rks ATD dk           Ultrasonography \& ;wa rks USG ds }kjk gesa xzafFk           dh lajpuk dk gh vuqeku feyrk gS ijUrq blesa jä   ç;ksx oftZr gSA           çokg ds Doppler signals ,oa velocity ds }kjk xzafFk           dh lfØ;rk dk vuqeku Hkh yxk;k tk ldrk gSA     CLINICAL MANIFESTATIONS           Fkk;jksVkWfDldksfll esa xzafFk dh lfØ;rk ?kV tkus ds   Symptoms  -  vc  ç'u  ;g  mBrk  gS  fd  bl           dkj.k xzafFk esa jä çokg ,oa Doppler signals ?kV   Fkk;jksVkWfDldksfll dks igpkusaxs dSls\\ blds y{k.k           tkrs gSa tcfd gkbijFkk;jkW;fMTe esa ;g c<+ tkrs gSaA  D;k\&D;k gksaxsa\\ ;kn j[ksa] ;gk¡ ewy xM+cM+h gS Fkk;jkW;M            T3:T4 ratio \& gkbijFkk;jkW;fMTe esa T3 ds dqN Hkkx   gkWeksZUl dh vR;f/kd ek=k] ftlds dkj.k Fkk;jkW;M           dk mRiknu xzafFk esa mRiknu c<+us ds dkj.k gksrk gS   gkWeksZUl ds }kjk gksus okys lHkh çHkko c<+ tk;saxsaA buls           tcfd eq[; Hkkx  T4 ls cuus lsA blds foijhr   mRiUu gksus okys dqN y{k.k rks vR;ar çpfyr gks ldrs           Fkk;jksVkWfDldksfll esa yxHkx lEiw.kZ Hkkx T4 ls gh   gSa \& tSls mÙkstuk dk c<+ tkuk ¼anxiety½] gM+cM+kgV           curk gSA blh dkj.k ls T3:T4 (ng/μg) vf/kd gksuk   ,oa  fpM+fpM+kiu  ¼hyperexcitability,  irritability½]           (>20) gkbijFkk;jkW;fMTe dk y{k.k gks ldrk gS tcfd   vf/kd xehZ yxuk ;k xehZ lgu u gksuk ,oa vf/kd           blls de gksuk Fkk;jksVkWfDldksfll dkA      ilhuk vkuk ¼excessive warmth, intolerance to                                                      heat½] Fkdku ,oa detksjh eglwl djuk ¼fatigue,           Clinical features \& buds vfrfjä] dqN y{k.k Hkh   generalised weakness½] vf/kd Hkw[k yxus ds ckn           bl dk;Z esa lgk;d gks ldrs gSaA            Hkh otu ?kVrs tkuk ¼increased appetite, weight                                                     67","loss½] ckj\&ckj nLr tkuk ¼increased frequency   dk vis{kk—r xeZ] ue ,oa vf/kd yky gksuk  ¼warm,           of  defecation½] /kM+du c<+ tkuk ¼palpitation½]   moist and blushed skin½] vk¡[kksa dk ckgj fudy           gkFkksa esa daidaikgV gksuk ¼tremulousnes½ bR;kfnA   vkuk ;k mHkjk gqvk çrhr gksuk ¼proptosis and or           dHkh\&dHkh jksxh vk¡[kksa dk lkekU; ls vf/kd [kqyk gksuk   exophthal-mos½] Fkk;jkW;M xzafFk dk vkdkj esa c<+k           ¼wide opening of eyes½ ,oa xnZu ds vxys Hkkx esa   gksuk  ¼goiter½]  ân;  xfr  dk  c<+  tkuk           lwtu ¼sweling in front of neck½ dh f'kdk;r Hkh   ¼tachycardia½] gkFkksa dks QSykus esa muesa daidaikgV           djrs gSaA                                  dk gksuk ¼fine tremors in outstretched hands½]           ;g y{k.k bl rF; ij fuHkZj djrs gSa fd Fkk;jkW;M   da/ks ,oa dwYgs dh ekalisf'k;ksa dh detksjh ¼proximal           gkWeksZUl fdruh vf/kd ek=k esa ,oa fdrus le; ls   muscular weakness½ ,oa deep tendon jerks dk           fufeZr gks jgsa gSa ,oa jksxh dh mez ,oa mldh 'kkjhfjd   fczLd gks tkuk ¼exaggerated  tendon  reflexes½           lajpuk dSlh gSA LokHkkfod :i ls Fkk;jkW;M gkWeksZUl   bR;kfnA           ftruh vf/kd ek=k esa o ftrus vf/kd le; rd cusaxsa]   vkb;s bu y{k.kksa dks fofHkUu vaxksa ds vuqlkj foLrkj           ml ds y{k.k mrus gh vf/kd xaHkhj gksaxsaA vk'p;Ztud   ls le>rs gSA           :i ls] cM+h mez ds O;fä;ksa esa GD ds vusd y{k.k   Neuromuscular manifestations \& U;wjkWUl dh           çdV ugha gksrs ¼masked jgrs gSa½ ,oa ,sls O;fä dsoy   mÙkstuk çeq[k :i ls gydh daidaih ¼fine temors½ ds           detksjh ,oa Fkdku ¼lethargy ,oa fatigue½ rFkk otu   :i esa çdV gksrh gSA gkFkksa dks vkxs QSykdj muij j[ks            ?kVus dh leL;k ds lkFk gh fn[kkus vkrs gSaA bls   dkxt ij (outstretched  hands) ;g ljyrk ls            apathetic ¼mnklhu½  thyrotoxicosis dgrs gSaA  ns[kh  tk  ldrh  gSA  blls  ekalisf'k;ksa  esa  QM+du           General constitutional symptoms \& BMR ds   (muscular fasciculations) Hkh mRiUu gks ldrs gSaA           c<+us ls ÅtkZ dk mi;ksx c<+ tkrk gSA bldks iwjk djus   Deep tendon reflex dh tkap djus ij ;g brisk           ds ç;kl esa Hkw[k c<+ tkrh gS ,oa blds ckn Hkh otu   jerk (hyperreflexia)  ds :i esa ns[kh tk ldrh gSA           ?kVrk tkrk gSA ¼;kn djsa] vfu;af=r Mk;fcVht esa Hkh   BMR  ,oa  ÅtkZ  dk  mi;ksx  c<+us  ls  tks  çksVhu           ,slk gh gksrk gSA otu ?kVus dk ,d çpfyr dkj.k TB   dSVkckWfyTe esa o`f) gksrh gS og ekalisf'k;ksa dh çksVhu           Hkh gS ijUrq mlesa Hkw[k de gks tkrh gSA½  BMR c<+   ds {kj.k dks c<krh gqbZ  muscular  wasting ,oa           tkus ls 'kjhj dk rkieku lkekU; ls dqN vf/kd jgrk   detksjh (thyrotoxic myopathy)  ds :i esa çdV gks           gS] xehZ vf/kd yxrh gS ,oa FkksM+k Hkh xeZ okrkoj.k   ldrh gSA ;g loZçFke da/ks ,oa dwYgs dh proximal           lgu ugha gksrk gSA ÅtkZ dk mi;ksx c<+ tkus ls 'kjhj   muscles esa ns[kh tk ldrh gS ftlesa O;fä dks Hkwfe           esa Fkdku ,oa detksjh dk vuqHko gksrk jgrk gSA  ij cSB dj mBus ij] lh<+h p<+us ij ,oa gkFkksa dks Åij           Behavioral manifestations \& vR;f/kd :i ls   mBkdj dke djus tSls cky cukus esa detksjh ,oa           c<+s gq, Fkk;jkW;M gkWeksZUl 'kjhj dks vuko';d :i ls   vlqfo/kk gksus yxrh gSA GD ls çHkkfor dqN ¼fo'ks\"krj           mÙksftr djrs gSa ftlls LoHkko esa tYnckth] gM+cM+h]   ,f'k;kbZ ,oa Hkkjrh;½ O;fä;ksa esa ;g vR;f/kd c<+dj           fdlh dk;Z esa /;ku dsafær u dj ikuk] 'kh?kz gh mÙksftr   transient paralysis dk :i ys ysrh gSA blds lkFk           gks tkuk] uhan ?kV tkuk ,oa dHkh\&dHkh Fkdku ,oa   çk;% lhje iksVSf'k;e dh deh feyus ds dkj.k bls           mnklh Hkh çdV gksus yxrh gSA               hypokalemic periodic paralysis dgrs gSaA mipkj                                                      ds lkFk bldh lEHkkouk esa Hkh deh vkrh tkrh gSA           Signs - bu jksfx;ksa ds ijh{k.k esa feyus okys dqN           signs rks vR;ar çpfyr gks ldrs gSa \& mÙkstuk   Cardiovascular  manifestations  \&  CNS  dh           ¼anxiety½ ,oa gM+cM+kgV ¼restless attitude½] Ropk   Hkkafr gh Fkk;jkW;M gkWeksZUl] cardiovascular system                                                     68","¼CVS½ dks Hkh mÙksftr djrs gSaA Fkk;jkW;M gkWeksZUl ds  tkrh  gSA  ekalisf'k;ksa  dh  çksVhu  dh  vR;f/kd           }kjk adrenergic receptors dh catecholamines  dSVkckWfyTe bls vkSj Hkh detksj djrh tkrh gSA bls           ds çfr laosnu'khyrk ¼sensitivity½ c<+ tkus ls blds   thyrotoxic myopathy dgrs gSaA ;g cardiac failure           çHkko vkSj Hkh vf/kd c<+ tkrs gSaA CVS dh mÙkstuk  rd  dk  dkj.k  cu  ldrh  gSA  /;ku  jgs]           çeq[k :i ls /kM+du ¼palpitation½ ds :i esa çdV  Fkk;jksVkWfDldksfll esa high CO] cardiac failure dk           gksrh gSA                                  dkj.k curk gS tcfd vU; ifjfLFkfr;ksa esa cardiac                                                      failure ds dkj.k ls low CO mRiUu gksrk gSA blhfy,]           ân; ij positive  chronotropic  effect ds dkj.k           sinus  tachycardia,  supraventricular  ectopics   bls high cardiac output cardiac failure  dgrs gSaA           vFkok supraventricular tachyarrhythmias mRiUu  xHkkZoLFkk]  vR;f/kd  c<+k  gqvk  ,uhfe;k  ,oa  wet           gks ldrs gSaA cM+h mez ds O;fä;ksa esa ;g  atrial   beriberi esa Hkh ,slk gks ldrk gSA           fibrillation (AF) dk :i rd ys ldrk gSA tc fdlh   Cutaneous manifestations \& ge tku pqds gSa           O;fä esa AF ds vfrfjä ân; jksx dk dksbZ vkSj y{k.k   fd BMR c<+us ls 'kjhj dk rkieku c<+ tkrk gS ftls            u feys rc bls lone  ¼vdsyk½ AF  dgrs gSaA vf/kdk¡'k   ?kVkus ds ç;kl esa ilhuk vkuk ¼sweating½ c<+ tkrk           jksfx;ksa esa dsoy Fkk;jksVkWfDldksfll ds mipkj ls gh ;g   gSA blls Ropk xeZ ,oa ue gks tkrh gS rFkk bldh            Bhd gks tkrk gS vkSj blds fy, fdlh antiarrhythmic   ykfyek Hkh c<+ tkrh gSA dHkh\&dHkh blesa [kqtyh           drug dh vko';drk rd ugha iM+rhA            ¼pruritus½ ,oa urticaria rd mRiUu gks tkrk gSA jä            ân;  ij  positive  inotropic  effect  ds  dkj.k   dk çokg c<+us ls gFksfy;ka yky gks tkrh gSa ¼palmar           ek;ksdkfMZ;e ds ladqpu ¼myocardial contractility½   erythema½  tcfd  'kjhj  dk  jax  xk<+k           ds c<+ tkus ls stroke volume (SV) c<+ tkrk gSA ân;   ¼hyperpigmentation½ gks ldrk gSA GD ds lkFk           xfr ,oa stroke volume ds c<+us ls cardiac output   vU; vkWVksbE;wu jksx ds :i esa vitiligo Hkh fey ldrk           ¼CO½ Hkh c<+ tkrk gSA (SV) c<+us ls flLVksfyd CyM   gSA Fkk;jksVkWfDldksfll esa uk[kwu ,oa cky Hkh çHkkfor           çs'kj ¼systolic blood pressure - SBP½ c<+ tkrk gS   gks ldrs gSaA fcuk fdlh dkj.k ds gh uk[kwu viuh tM+           ,oa  peripheral  vasodilatation  ds  dkj.k   ls m[kM+us yxrs gSa ¼onycholysis;  Greek onyx =                                                      nails, lysis = VwVuk½A cky Øe'k% irys gksrs tkrs gSa           Mk;LVksfyd CyM çs'kj ¼diastolic blood pressure -                                                      ijUrq eqyk;e ,oa pednkj cus jgrs gSaA dqN jksfx;ksa esa           DBP½  ?kV  tkrk  gSA  ;g  nksuksa  high  volume           bounding pulse ,oa widened pulse pressure ds   ;g chp\&chp esa tM+ ls gh m[kM+us yxrs gSa ¼diffuse           :i esa çdV gksrs gSaA                      alopecia½A            Positive  chronotropic ,oa  inotropic  effects ds   Eye signs \& ge tkurs gSa fd Fkk;jkW;M gkWeksZUl]           dkj.k ek;ksdkfMZ;e dks vf/kd dk;Z djuk iM+rk gS ,oa   catecholamines ds fy, sympathetic receptors                                                      dh laosnu'khyrk c<+k nsrs gSaA Åijh iyd dks Åij           mldh vkWDlhtu dh vko';drk c<+ tkrh gSA Mild           asymptomatic atherosclerotic cardio-vascular  mBkus okyh levator palpebrae superioris muscle           disease  esa  ;g  angina  vFkok  myocardial  ds Hkhrjh Hkkx] Muller’s muscle] dk innervation           infarction  rd  mRiUu  dj  ldrh  gSA       sympathetic gksus ds dkj.k Fkk;jksVkWfDldksfll esa           Fkk;jksVkWfDldksfll ij fu;a=.k ds ckn ,sls vf/kdk¡'k  bldk ladqpu c<+ tkrk gSA blls Åijh iyd ladqfpr           O;fä iqu% asymptomatic gks ldrs gSaA       gksdj vkSj Åij f[kap tkrh gS  (lid  retraction)A           yEcs le; rd vfu;af=r jgh Fkk;jksVkWfDldksfll ls   lkekU;r% cornea dk Åijh 2-3 feeh Hkkx Åijh           ek;ksdkfMZ;e vfrfjä dk;Z djrs\&djrs f'kfFky gks   iyd ds }kjk <dk jgrk gSA Lid retraction ls blds                                                      lkFk\&lkFk sclera dk Hkh Åijh Hkkx [kqyk jg tkrk gSA                                                     69","blls vk¡[ksa cM+h\&cM+h ?kwjrh gqbZ lh yxrh gSa (staring   rc GD] ;fn iwjh xzafFk esa fHkUu\&fHkUu vkdkj ds           look)A nksuksa iydksa ds e/; dh nwjh ¼palpebral   vusdksa ukWMîwy ¼xkaB½ gksa rc toxic multinodular           fissure½ c<+ tkrh gSA lkekU;r% flj dks lh/kk j[krs   goiter ¼toxic MNG½ ,oa tc dsoy ,d gh ukWMîwy           gq, tc ge uhps ns[kus dk ç;kl djrs gSa rc Åijh   gks  rc  solitary  toxic  nodule  ¼STN½A           iyd Hkh vk¡[kksa ds lkFk\&lkFk uhps pyrh tkrh gSA   jsfM;ksU;wDykbM LdSu esa viVsd ds ?kVus (iatrogenic           Fkk;jksVkWfDldksfll esa lid  retraction ds dkj.k ;g   ,oa thyroiditis) vFkok c<+us ¼GD] toxic MNG ,oa           ihNs gh NwV tkrh gS ftls lid lag (von Graefe's sign)    STN½ ds ek/;e ls buesa ljyrk ls foHksn fd;k tk           dgrs gSaA                                   ldrk  gSA  jsfM;ksU;wDykbM  LdSu  esa  gh  diffuse             DIAGNOSIS                                 uptake ¼GD½]  patchy  uptake  (toxic  MNG)           Fkk;jksVkWfDldksfll dk lansg mRiUu gksus ds ckn dk   vFkok  single  point  focus  (STN)  ls           vxyk  pj.k  gS]  bldh  igpku  ¼diagnosis½  dks   gkbijFkk;jkW;fMTe ds dkj.kksa dks Hkh vyx\&vyx           lqfuf'pr djukA blds Hkh nks igyw gSaA igyk ;g   igpkuk tk ldrk gSA           lqfuf'pr djuk fd Fkk;jkW;M gkWeksZUl dh ek=k lkekU;   - Doppler study \& gkbijFkk;jkW;fMTe esa xzafFk dks           ls vf/kd gS vFkok ugha ,oa nwljk ;fn ;g vf/kd gS rc   vf/kd dk;Z djus ds fy, vf/kd ek=k esa jä dh Hkh           blds mRiUu gksus ds dkj.k D;k gks ldrk gSA  vko';drk iM+rh gS tcfd iatrogenic toxicosis            CONFIRMATION OF THYROTOXIC STATE            vFkok thyroiditis esa xzafFk dh lfØ;rk ?kV tkus ls           blds fy, jä esa nksuksa Fkk;jkW;M gkWeksZUl ¼T3 ,oa T4½   mlesa jä dk çokg Hkh ?kV tkrk gSA bl çdkj ls                                                       Doppler study bu nksuksa esa foHksn djus esa lgk;d           ds Lrjksa dh tkap djkrs gSa (Serum total T3 ,oa total           T4vFkok serum free T3 ,oa free T4 estimation) A   gks ldrh gSA            bu nksuksa gkWeksZUl ds Lrjksa dk lkekU; ls vf/kd gksuk   - CT/ MRI \& /;ku jgs] TSH secreting pituitary           Fkk;jksVkWfDldksfll dh Mk;Xuksfll dks lqfuf'pr djrk   adenoma esa Hkh T3 ,oa T4 c<+s gq, feyrs gSaA ijUrq           gSA dHkh\&dHkh ¼2-5%½ vk;ksMhu dh deh gksus ij T4   blesa TSH Hkh c<+k gqvk feyrk gS ftlds }kjk blesa           dh ek=k rks lkekU; gh jgrh gS ,oa dsoy T3 gh c<+k   ,oa GD esa foHksn fd;k tk ldrk gSA TSH ds c<+s gksus           feyrk gSA bls T3 toxicosis  dgrs gSaA blds foijhr   ds dkj.k buesa Fkk;jk;M xzafFk dk vkdkj Hkh c<+ tkrk           vk;ksMhu dh vf/kdrk gksus ij T3 dh ek=k lkekU; jg   gSA vr% fiVîwVjh lEcaf/kr fdlh vU; y{k.k ds gksus           ldrh gS ,oa dsoy T4 gh c<+k jg ldrk gSA bls T4   ij CT scan vFkok MRI ds }kjk bl lEHkkouk dks                        A           toxicosis dgrs gSa                          Hkh igpku ysuk pkfg,A           CONFIRMATION  OF  CAUSE  OF  THYRO-        b) DIFFERENTIATION BETWEEN PRIMARY           TOXICOSIS                                  AND SECONDARY HYPERTHYROIDISM           a)  DIFFERENTIATION  BETWEEN  HYPER-        çkbejh gkbijFkk;jkW;fMTe dh fLFkfr esa Fkk;jkW;M xzafFk           THYROIDISM AND THYROTOXICOSIS              ls mRiUu T3 ,oa T4 gkWeksZUl dh vR;f/kd ek=k]           - Radionuclide  scan  -  Fkk;jksVkWfDldksfll  ds   fiVîwVjh ls fuxsfVo QhMcSd ds ek/;e ls TSH dk            çeq[kre dkj.k gSa gkbiksFkk;jkW;fMTe ds mipkj ds   lzko.k ?kVk nsrh gSA ;gh çfØ;k Fkk;jkW;M gkWeksZUl dks            nkSjku Fkk;jkW;M gkWeksZu dh vko';drk ls vf/kd   nok ds :i esa fy, tkus ,oa xHkkZoLFkk ds nkSjku IyklsaVk            ek=k esa ç;ksx ¼iatrogenic½ ,oa vkjafHkd voLFkk esa   ls hCG ds }kjk Fkk;jkW;M xzafFk dks mÙksftr fd;s tkus            Fkk;jkW;MkbfVl  ¼early  thyroiditis½A     ds ckn Hkh gksrh gSA bu fLFkfr;ksa esa T3 ,oa T4 gkWeksZUl            gkbijFkk;jkW;fMTe ds rhu çeq[k dkj.k gks ldrs gSaA   ds Lrj rks c<+s gksrs gSa ijUrq TSH dk Lrj ?kV tkrk gSA            ;fn lEiw.kZ Fkk;jkW;M xzafFk leku :i ls c<+h gqbZ gks                                                      blds foijhr] lsdsaMjh gkbijFkk;jkW;fMTe esa fiVîwVjh                                                    70","ds }kjk TSH ds vf/kd ek=k esa lzkfor fd;s tkus dh   fu;a=.k ugha gksrkA GD esa mRiUu gksus okys fofHkUu           fLFkfr esa T3 ,oa T4 gkWeksZUl ds Lrj rks c<+s gksrs gSa   'kkjhfjd y{k.k] blh vfu;af=r mÙkstuk dk ifj.kke           ijUrq buds lkFk\&lkFk TSH dk Lrj Hkh c<+ tkrk gSA   gksrs gSaA            bl  çdkj]  Fkk;jkW;M  gkWeksZUl  dh  tkapksa  ¼thyroid   CLINICAL MANIFESTATIONS           profile½ dks ns[k dj ;g vuqeku yxk;k tk ldrk gSa   GD esa mRiUu gksus okys lHkh y{k.kksa dks nks lewgksa esa           fd Fkk;jksVkWfDldksfll dk dkj.k D;k gSA çkbejh   ckaVk  tk  ldrk  gSA  çFke]  Fkk;jkW;M  gkWeksZUl  dh           gkbijFkk;jkW;fMTe]  GTT  ,oa  thyrot-oxicosis   vf/kdrk ¼Fkk;jksVkWfDldksfll½ ls mRiUu gksus okys           factitia esa T3/T4 ds Lrj c<+rs gSa tcfd TSH dk   y{k.k  ,oa  f}rh;]  GD  ds  vius  fof'k\"V  y{k.kA           Lrj de gks tkrk gSA ogha TSH secreting pituitary   Fkk;jksVkWfDldksfll ds y{k.kksa dks ge igys gh le>           adenoma  ls  mRiUu  gksus  okys  lsdsaMjh   pqdsa gSA vkb;s GD ds fof”k’V y{k.kksa dks foLrkj ls           gkbijFkk;jkW;fMTe esa T3, T4 ,oa TSH] rhuksa ds Lrj   le>rs gSaA buds feyus ij GD dh igpku lqfuf'pr           c<+s gq, feyrs gSaA                        dh tk ldrh gSA                                                       Graves’  ophthalmopathy  (GO)  \&             GRAVES’ DISEASE           Graves’  Disease  (GD)  Fkk;jksVkWfDldksfll  dk   Fkk;jksVkWfDldksfll esa sympathetic stimulation ds           çeq[kre ¼60-80%½ dkj.k gSA ;g iq#\"kksa dh vis{kk   dkj.k gks jgs lid retraction ds dkj.k vk¡[ksa mHkjh gqbZ           efgykvksa esa 10 xquk vf/kd ik;k tkrk gSA ;|fi ;g   lh yxrh gSa ijUrq okLro esa ,slk gksrk ugha gSA vk¡[kksa           fdlh Hkh mez esa fey ldrk gS ijUrq blls çHkkfor   dk  okLro  esa  vkWfcZV  ds  ckgj  fudy  vkuk           vf/kdka'k jksxh 20-50 o\"kZ dh mez ds gksrs gSaA bldh   exophthalmos  ¼exo  ¾  ckgj]  ophthalmo  ¾           lEHkkouk vk;ksMhu dh i;kZIr miyC/krk okys {ks=   vk¡[k½ vFkok proptosis ¼pro ¾ vkxs] ptosis ¾           ¼iodine sufficient zone½ esa jgus okys O;fä;ksa esa   fxjuk½ dgykrk gSA oSls rks ;g nksuksa 'kCn i;kZ;okph ds           vf/kd gksrh gSA                            :i esa ç;qä gksrs gSa ijUrq dgha\&dgha proptosis dks                                                      dsoy wide palpebral fissure ds fy, ç;qä fd;k           PATHOGENESIS                                                      tkrk gS ,oa exophthalmos dks okLro esa vk¡[kksa ds           GD ,d vkWVks\&bE;wu jksx ¼autoimmune disorder½   vkWfcZV ls ckgj fudy vkus dksA blds fo\"k; esa foLrkj           gS ftlesa TSH fjlsIVlZ ds fo#) ,aVhckWMht cu tkrh   ls ge vkxs i<+sxsaA            gSaA ;g ,aVhckWMht Hkh nks çdkj dh gks ldrh gSaA 1)   T h y r o i d   d e r m o p a t h y   o r   p r e t i b i a l           Blocking antibodies tks TSH fjlsIVlZ dks CykWd   myxedema \& ;wa rks ;g GD ds ek= 5% jksfx;ksa esa           djds TSH }kjk Fkk;jkW;M xzafFk ds mÙksftr gksus dh   GO ds lkFk gh feyrk gS ijUrq GO dh Hkkafr ;g Hkh           çfØ;k dks jksd nsrh gSa ftlls Fkk;jkW;M gkWeksZUl dk   GD dk fof'k\"V y{k.k ¼pathognomonic sign½ ekuk           fuekZ.k  de  gks  tkrk  gS  ¼tSlk  alrophic   tkrk gSA blesa Ropk lwtdj eksVh o yky\&cSaxuh jax dh           hypothyroidism esa gksrk gS½] ,oa 2) Stimulating   gks tkrh gS ftl ij larjs ds fNyds dh Hkkafr NksVs\&NksVs           antibodies tks  TSH  fjlsIVlZ dks mÙksftr djds   xïs iM+ tkrs gSa (peau  d’orange  appearance) A           Fkk;jkW;M gkWeksZUl dk vfu;af=r :i ls mRiknu djk;s   /;ku jgs] czsLV dSalj esa Hkh Lru ds Åij dh Ropk Hkh           ¼tSlk GD esa gksrk gS½A                    blh dh Hkkafr fn[krh gSA dHkh\&dHkh vf/kd c<+rs gq,            GD esa TSH receptor  stimulating  antibodies   ;g iwjs iSj esa QSy dj elephantiasis ¼gkFkh dh Ropk½           (TRAB) dks thyroid stimulating immunoglobulin   ds leku fn[kus yxrh gSA iSjksa esa tibia ds lkeus çdV           ¼TSI½ Hkh dgrs gSaA ;g Fkk;jkW;M xzafFk dks TSH ds   gksus ds dkj.k bls pretibial myxedema  dgrs gSaA           leku gh mÙksftr djrh gSa cl bu ij 'kjhj dk dksbZ   ;gk¡  ;g  myxedema  'kCn  gkbiksFkk;jkW;fMTe  ls                                                    71","lEcaf/kr gksus ds dkj.k gesa Hkzfer dj ldrk gSA okLro   panic  attack  ,oa  pheochromocytoma           esa Ropk dh lwtu rks myxedema ¼gkbiksFkk;jkW;fMTe½   paroxysm ls feyrs tqyrs yxrs gSaA blh çdkj]fcuk           ds  leku  gksrh  gS  ijUrq  ;g  feyrh  GD   fdlh fof'k\"V y{k.k ds otu ?kVus ij vfu;af=r           ¼gkbijFkk;jkW;fMTe½ esa gSA GD ds 1% ls Hkh de   Mk;fcVht ,oa dSalj dh lEHkkouk dks Hkh /;ku esa j[kuk           jksfx;ksa esa gkFk\&iSjksa ds vfxze Hkkx dh Ropk Hkh eksVh gks   vko';d gSA           tkrh gS ftls thyroid acropachy  ¼Greek akro ¾   CLINICAL COURSE           'kh\"kZ] pachy ¾ eksVh½ dgrs gSaA ;g clubbing ds   Without treatment - GD ds jksfx;ksa esa pkj çdkj           leku fn[krh gSA                                                      ds ifj.kke gks ldrs gSaA 1)   Progression \&  jksx                                                      c<+rk tk,] 2) Remission \&  gydk jksx vius vki           LABORATORY DIAGNOSIS                       gh Bhd gks tk;s] 3) Remissions and relapses \&           GD dh Mk;Xuksfll ds rhu çeq[k pj.k gSaA 1) ;g   ;g Bhd gks tk, ijUrq fQj mHkj vk;s ,oa  4)           tkuuk  fd  Fkk;jk;M  gkWeksZu  dh  vf/kdrk   Hypothyroidism \& dqN le; gkbijFkk;jkW;fMTe           ¼Fkk;jksVkWfDldksfll½ gS ;k ugha] 2) Fkk;jk;M gkWeksZu dh   jgus ds ckn ;g Lo;a gh gkbiksFkk;jkW;M voLFkk esa           vf/kdrk dk dkj.k xzafFk }kjk vf/kd ek=k esa fuekZ.k   igq¡p tk;sA           gksuk  ¼gkbijFkk;jkW;fMTe½  gS  vFkok  ugha]  ,oa  3½   After treatment - GD ds jksfx;ksa esa rhu çdkj ds           Fkk;jk;M gkWeksZu ds vf/kd fuekZ.k gksus dk dkj.k   ifj.kke gks ldrs gSaA 1) Persistent remission \&           vkWVksbE;wu ¼GD½ gS vFkok ughaA                                                      yxHkx 1-2 o\"kZ ds mipkj ds ckn og nok,a can gksus ds           Fkk;jksVkWfDldksfll  dh  igpku  ds  fy,  TFT  ,oa   ckn Hkh yEcs le; rd ds remission esa cus jgsa] 2)           gkbijFkk;jkW;fMTe dh igpku ds fy, jsfM;ksU;wDykbM   Lack of remission \& vusd o\"kksaZ ds mipkj ds ckn           LdSu ds fo\"k; esa ge igys gh le> pqds gSaA GD, tks                                                      Hkh  muesa  remission  mRiUu  u  gks]  ,oa  3)           ,d vkWVksbEE;wu jksx gS] mldh iqf\"V ds fy, blds   Hypothyroidism Remission esa vkus ds ckn dqN           rhljs fcanq] vkWVksbEE;wfuVh dh igpku ds fy, TSH   ¼15%½ O;fä;ksa esa 10-15 o\"kksaZ ds i'pkr~ Lor% gh           receptor antibodies (TRAb) dh enn yh tk ldrh   gkbiksFkk;jkW;fMTe mRiUu gks tk,A           gSA ijarq blds eagxs gksus ,oa çR;sd ySc esa miyC/k u           gksus ds dkj.k bldk mi;ksx vf/kdka'kr;% fjlpZ dk;ksaZ   GO - GO ls çHkkfor O;fä;ksa esa mipkj ds ifj.kke           esa gh gks ikrk gSA                        Fkk;jksVkWfDldksfll ,oa vkW¶FkSyeksiSFkh ij fHkUu\&fHkUu                                                      gksrs gSaA Fkk;jksVkWfDldksfll ds lQyrkiwoZd fu;a=.k esa           DIFFERENTIAL DIAGNOSIS                     vkus ds i'pkr~ 1½ vf/kdka'k O;fä;ksa esa GO ds y{k.k           GD dh Dyhfudy Mk;Xuksfll dks pkj çeq[k y{k.kksa ds           lfEefyr :i ls mifLFkr gksus ds vk/kkj ij cuk;k tk   Øe'k% de gksrs tkrs gSa] 2½ dqN O;fä;ksa esa ;g iwoZor           ldrk gS \&1)  biochemical  thyrotoxicosis]   2)   cus jgrs gSa ,oa buesa dksbZ lq/kkj ugha fn[krk] ,oa 3½           diffuse goiter] 3)  ophthalmopathy ,oa 4) jksxh   dqN O;fä;ksa esa ;g igys ls Hkh vf/kd c< tkrs gSaA bl                                                      çdkj ls GO ds y{k.kksa esa lq/kkj ds fo\"k; esa dksbZ           vFkok  mlds  ifjokj  esa  vU;  autoimmune           disorders dh mifLFkfrA ijUrq lHkh jksfx;ksa esa bu   iwokZuqeku yxkuk vR;ar dfBu gksrk gSA mipkj ds           lHkh dk feyuk vko';d ughaA ,sls esa jsfM;ksU;wDykbM   nkSjku nokvksa dh vksojMkst ls Fkk;jkW;M gkWeksZUl ds           LdSu  gh  bldh  iqf\"V  dk  vk/kkj  curk  gSA   vR;f/kd ?kV tkus ls ;fn gkbiksFkk;jkW;fMTe mRiUu gks                                                      tkrh gS rc TSH ds c<+us ls xzafFk ds vkdkj esa o`f)           Fkk;jksVkWfDldksfll ds vusd y{k.k acute anxiety,                                                      ¼xkW;Vj½ ,oa GO esa o`f) dh lEHkkouk c<+ tkrh gSA                                                     72","blhfy, GO ds mipkj ds le; bl rF; dk fo'ks\"k   DEFINITIVE THERAPIES           :i ls /;ku j[kuk pkfg, fd Fkk;jkW;M gkWeksZUl ds Lrj  ftl  çdkj  ,aVhck;ksfVDl  nks  çdkj  dh  gksrh  gSa]           lkekU; lhekvksa ds e/; esa gh jgsa ,oa lhek ls de u   bacteriostatic ,oa bactericidal] Bhd mlh çdkj           gksus ik,aA blh dkj.k ls GO esa RAI fFkjSih fuf\"k)   GD ds mipkj dh Hkh nks çeq[k fof/k;ka gksrh gSa] 1)           ¼contraindicated½  gS  D;ksafd  RAI  ds  i'pkr~   Thyrostatic management \& ftlesa Fkk;jkW;M xzafFk            gkbiksFkk;jkW;fMTe  vo';aHkkoh  gSA  buds  vfrfjä]  ls Fkk;jkW;M gkWeksZUl ds mRiknu dks gh ?kVk;k tkrk gS           /kweziku djus okys O;fä;ksa esa Hkh /kq,a ds laidZ esa vkus   ftlls og dqN le; i'pkr~ Lor% gh bls vf/kd ek=k           ls GO ds c<+us dh lEHkkouk Hkh c<+ tkrh gSA  esa  cukuk  de  dj  ns]  ,oa  2)  Thyroablative                                                       management \& ftlesa Fkk;jkW;M xzafFk dks gh iw.kZ:i                                                      ls vFkok vkaf'kd :i ls u\"V dj fn;k tkrk gS            MANAGEMENT OF HYPERTHYROIDISM                                                      ¼ablation ¾ dkVdj vyx djuk½ ftlls og vf/kd           gkbijFkk;jkW;fMTe ds mipkj ds nks çeq[k vax gSaA i)           Adjuvant therapies - jksxh dks mldh ijs'kkfu;ksa ls   ek=k esa Fkk;jkW;M gkWeksZUl cuk ldus dh fLFkfr esa gh u           vkjke fnykus ds fy, fd;k x;k yk{kf.kd mipkj ,oa   jgsA ;g thyroablation Hkh nks çdkj ls fd;k tk           ii) Definitive therapies - jksx ¼xzsOl fMlht½ dks Bhd   ldrk  gS]  jsfM;ks,fDVo  vk;ksMhu  ds  }kjk           djus ds fy, fd;k x;k leqfpr mipkjA vkb;s bUgsa   (radioablation)  ,oa  ltZjh  (thyroidectomy)  ds           foLrkj esa le>rs gSaA                      }kjkA                                                      buesa igys ltZjh ,oa jsfM;ksvk;ksMhu dh çkFkfedrkvksa           ADJUVANT THERAPIES           Beta blockers \& ge le> pqds gSa fd Fkk;jkW;M   dks le> ysrs gSa ftlds i'pkr~ ATD ds ç;ksx ds fo\"k;           gkWeksZUl] catecholamines ds izfr sensitivity c<+k   esa foLrkj ls ppkZ ge blh v/;k; esa djsaxsaA ltZjh ,oa           nsrs  gSa  ftlds  dkj.k  tachycardia  ,oa   jsfM;ksvk;ksMhu ds fo\"k; esa foLr`r ppkZ ge buls           tachyarrhythmias,  palipitation  rFkk  tremors   lEcaf/kr v/;k;ksa esa vkxs djsaxsaA           mRiUu gks ldrs gSaA Antithyroid drugs ds ç;ksx ls   INDICATIONS FOR THYROIDECTOMY           gkWeksZUl ds Lrj esa deh vkus esa le; yxrk gSA bl  gkbijFkk;jkW;fMTe tk lQyre mipkj gksrs gq, Hkh           varjky esa bu adrenergic symptoms esa ykHk ysus ds   invasive therapy gksus ds dkj.k thyroidectomy dh           fy, beta blockers dk mi;ksx fd;k tk ldrk gSA  lykg dqN fo'ks\"k ifjfLFkfr;ksa esa gh nh tkrh gSA buesa ls           blds  fy,  nonspecific  beta  blockers  tSls  çeq[k gS]            propranolol  ¼20-40  fexzk  çR;sd  6-8  ?kaVksa  esa½   Cosmetic factor \& ;fn xkW;Vj dk vkdkj dkQh           loksZÙke jgrs gSaA CyM çs'kj ds Hkh c<+s jgus ij long   cM+k gksA           acting selective beta blockers tSls atenolol ;k   Pressure symptoms \& ;fn vius cM+s vkdkj ds           metoprolol dk Hkh ç;ksx fd;k tk ldrk gSA                                                      dkj.k xkW;Vj lehiorhZ vaxksa ij ncko Mky jgk gks           Anticoagulants \& /;ku jgs]  atrial  fibrillation   tSls] trachea ds ncus ls dyspnea] esophagus ds           (AF) esa atrial contraction ds lqpk# :i ls u gks ikus   ncus  ls  dysphagia  ,oa  recurrent  laryngeal           ds dkj.k muesa jä ds #dus ls FkDdk ¼thrombus½   nerve ds ncus ls hoarseness of voice bR;kfnA           cuus dh lEHkkouk c<+us yxrh gSA ,sls esa AF ds Bhd   Presence nodule with abnormal cytology \&           gksus rd anticoagulants dk ç;ksx fd;k tkrk gSaA                                                    73",";fn xzafFk ds fdlh Hkkx esa dksbZ ukWMîwy gks ftldh   remission çkIr dj ikrs gSaA blh dkj.k ls dbZ ckj           FNAC esa dSalj dh laHkkouk mRiUu gks jgh gksA   RAI dks gh çFke fodYi ds :i esa ç;ksx esa yk;k tkrk            Moderate to severe ophthalmopathy \& ;fn    gS ftlls ,d ckj nsus ij gh buls jksx dks lnk ds fy,           vkW¶FkSyeksiSFkh  ds  dkj.k  va/ksiu  dh  lEHkkouk  gks   nck fn;k tk,A ijUrq budh Hkh lcls cM+h deh ;g gS           ¼D;ksafd bu jksfx;ksa esa jsfM;ksvk;ksMhu }kjk mipkj   fd buds lQy ç;ksx ls gkbijFkk;jkW;fMTe rks Bhd gks           fd;k tkuk fuf\"k) gksrk gS½A                tkrk gS ijUrq jksxh lnk ds fy, gkbiksFkk;jkW;M gks tkrk                                                      gS vkSj mls vkthou Fkk;jkWfDlu fFkjSih ysuh iM+rh gSA           Nonresponding hyperthyroidism \& ;fn ATD           vFkok jsfM;ksvk;ksMhu vFkok bu nksuksa mipkjksa ds ckn   Second line treatment \& ltZjh dks f}rh; fodYi           Hkh gkbijFkk;jkW;fMTe ij fu;a=.k çkIr u gks ik jgk  ekuus dk eq[; dkj.k ;g gS fd ;g ,d invasive           gksA xHkkZoLFkk ,oa Lruiku ds le; bldh fo'ks\"k :i ls   treatment gS] blds fy, fo'ks\"kK ltZu ,oa vLirky           vko';drk  iM+  ldrh  gS  D;ksafd  bu  le;ksa  esa  dh vko';drk iM+rh gS] ;g eagxk iM+rk gS ,oa blls           jsfM;ksvk;ksMhu }kjk mipkj fd;k tkuk fuf\"k) gksrk  tqM+s gq, vusdksa nq\"çHkko ¼surgical morbidities½ Hkh           gSA                                        gSaA blhfy, TT vFkok NTT dh lykg dsoy mUgha                                                      jksfx;ksa dks nh tkrh gS ftuesa ATD }kjk remission           Relapsing or recurrent disease \& ;fn ATD           vFkok jsfM;ksvk;ksMhu }kjk fu;af=r gks tkus ds ckn   çkIr u gks jgk gks vFkok xkW;Vj dk vkdkj vR;f/kd           ckj\&ckj gkbijFkk;jkW;fMTe mRiUu gks tk jgh gks ,oa   cM+k gksA blds vfrfjä] cPpksa esa remission dh                                                      lEHkkouk de gksus ds dkj.k muesa Hkh TT vFkok NTT           blds remission esa tkus dh lEHkkouk {kh.k gksA                                                      dks ojh;rk nh tk ldrh gSA vxys v/;k; esa buds           INDICATIONS FOR RADIOABLATION              fo\"k; esa foLrkj ls le>rs gSaA           Autonomous  toxic  nodule  \&  ;g  rks           jsfM;ksvk;ksMhu dk absolute indication gS D;ksafd bu           jksfx;ksa esa jsfM;ksvk;ksMhu dsoy VkWfDld ukWMîwy esa gh      ANTI THYROID DRUGS - ATD           igqapdj ,df=r gksrh gS vr% 'ks\"k xzafFk blds }kjk   ;g GD ds mipkj dh çeq[kre fof/k gSA lHkh ATD esa           fcydqy Hkh çHkkfor ugha gksrhA             vktdy dsoy thionamide xzqi dh nok,a gh ç;ksx esa                                                      vkrh gSa ftuesa çeq[k gSa]  carbimazole,  (CMZ),           Persistent or recurrent hyperthyroidism \&                                                       bldh  metabolite  methimazole (MMI)   ,oa           ;fn ATD vFkok ltZjh ds ckn Hkh gkbijFkk;jkW;fMTe   propylthiouracil (PTU)A Thionamides Fkk;jkW;M           esa i;kZIr fu;a=.k u fey ik jgk gks vFkok ,d ckj   gkWeksZUl ds fuekZ.k dh çfØ;k esa ck/kk Mkyrh gSaA fuekZ.k           fu;af=r gksus ds ckn ;g ckj\&ckj vfu;af=r gks tk jgh   ds ?kVus ls xzafFk esa budk Lrj ,oa flØh'ku Øe'k% de           gksA                                       gksrk tkrk gSA jä esa Fkk;jkW;M gkWeksZUl ds Lrj ?kVus ls           CHOICE OF THERAPY                          gkbijFkk;jkW;fMTe ds y{k.k Hkh Øe'k% ?kVus yxrs gSaA           Treatment of first choice \& mijksä rhuksa esa ls   MECHANISMS OF ACTION           ATD ,oa RAI dks çFke fodYi ekuk tkrk gSA ATD ds   Thionamides eq[;r% thyroid peroxidase (TPO)           ykHk gSa fd ;g lLrh gSa ,oa ljyrk iwoZd dgha Hkh ,oa  ,atkbe dh lfØ;rk dks ?kVkrs ¼supress djrs½ gSaA           fdlh ds Hkh }kjk ç;ksx esa yk;h tk ldrh gSaA ijUrq  blds }kjk ;g Fkk;jkW;M gkWeksZUl ds fuekZ.k esa rhu           budh deh ;g gS fd budks dkQh yEcs le; ¼yxHkx  pj.kksa esa ck/kk Mkyrh gSaA i) vk;ksMkbM ds vkWDlhMs'ku           nks o\"kZ½ rd nsus ds ckn Hkh 30%-60% jksxh gh   ls  vk;ksMhu  ds  fuekZ.k  esa]  ii)  vk;ksMhu  ds                                                      Fkk;jksXykWC;qfyu  ds  lkFk  organification  ,oa                                                    74","iodotyrosines (MIT ,oa DIT) ds fuekZ.k esa] rFkk iii)   ij igys ls ç;qä gks jgh ATD dks can dj ds nwljh           iodotyrosines dh coupling ls T3 ¼MIT+DIT½ ,oa   nok dk p;u Hkh djuk iM+ ldrk gSA buds vfrfjä]           T4 ¼DIT+DIT½ ds fuekZ.k esaA               eq[;r% PTU ds lkFk] yhoj ds ,atkbEl Hkh c<+ ldrs                                                      gSaA           PHARMACOLOGY OF ATD           Absorption \& lHkh thionamides] GIT ls 'kh?kz gh   b) MAJOR ADR           ,oa i;kZIr ek=k esa vo'kksf\"kr gks tkrs gSaA   Fulminant hepatitis \& eq[;r%  PTU ds lkFk tqM+k                                                      vR;fèkd xaHkhj nq\"çHkko gSA           Body distribution \& 'kjhj ds vfèkdk¡'k Hkkxksa esa           igq¡prs  gq,  ;g  nok,a  Fkk;jkW;M  QkWfYdYl  dh   Cholestasis  \&  eq[;r%   carbimazole  ;k           dksf'kdkvksa esa laxzfgr gks tkrh gSaA     methimazole ds lkFkA                                                      Agranulocytosis \& bu rhuksa nokvksa ds lkFkA ;g           Plasma  half  life  (T1/2)  and  duration  of   buls tqM+k lcls xaHkhj nq\"çHkko gS tks 500-1000           action \& QkWfydy dh dksf'kdkvksa esa laxzfgr gksus ds           dkj.k] gkQ ykbQ de gksrs gq, Hkh] dksf'kdkvksa esa   jksfx;ksa esa fdlh ,d dks gks ldrk gSA           Fkk;jkW;M gkWekZsUl ds fuekZ.k dks ckfèkr djus dk budk   PECULIARITIES OF PTU           çHkko  yEcs  le;  rd  cuk  jgrk  gSA  vfu;af=r   CMZ/MMI dh vis{kk PTU ,d vU; fof/k }kjk Hkh           Fkk;jksVkWfDldksfll  esa  rks  Fkk;jkW;M  gkWekZsUl  dk   dk;Z djrh gSA ;g deiodinase ,atkbe dh lfØ;rk           VuZvksoj vfèkd gksus ds dkj.k  CMZ/MMI ¼gkQ   dks ?kVkdj çks\&gkWeksZu T4 dh lfØ; gkWeksZu T3 esa           ykbQ 6-8 ?kaVs½ dks fnu esa nks ;k rhu ckj nsuk iM+rk gS   ifjorZu  dks  Hkh  ?kVkrh  gSA  blh  dkj.k  ls  xaHkhj           ijUrq fu;a=.k ds lkFk tSls\&tSls budk VuZvksoj ?kVrk   Fkk;jksVkWfDldksfll  esa  'kh?kz  ykHk  ysus  ds  fy,           tkrk gS] ;g nok,a fnu esa dsoy ,d ckj nsus ij gh   CMZ/MMI dh vis{kk PTU dk p;u djus dh lykg           çHkkoh gks tkrh gSaA PTU dh gkQ ykbQ  vR;ar de   nh tkrh gSA           ¼1-2 ?kaVs½ gksus ds dkj.k bUgsa çkjEHk esa fnu esa rhu ckj   PTU dk ,d ykHk vkSj Hkh gSA xHkkZoLFkk ds nkSjku           ,oa ckn esa Hkh fnu esa de ls de nks ckj nsuk iM+rk gSA   CMZ/MMI dh Hkkafr ;g xHkZLFk Hkzw.k ¼embryo½ ij           Metabolism  -  è;ku  jgs]  carbimazole  ,d   nq\"çHkko ugha MkyrhA blhfy,] xHkkZoLFkk dh çFke           prodrug gS tks 'kjhj esa esVkckWfyTe ds }kjk vius   frekgh esa PTU dk gh p;u fd;k tkrk gSA           lfØ; esVkcksykbV methimazole esa ifjofrZr gks tkrh   mijksä fof'k\"Vrkvksa ds lkFk gh PTU dk ,d voxq.k           gSA Carbimazole 5 fexzk dh esVkckWfyTe ls yxHkx 3   Hkh gS fd ;g ,d hepatotoxic drug  gS ftlds dkj.k           fexzk methimazole dk fuekZ.k gksrk gSA vr% bu   tgk¡ vR;ar vko';d u gks ogka blds ç;ksx ls cpuk           nokvksa  dks  ijLij  vny\&cny  dj  nsus  ij  bl   pkfg,A xaHkhj Fkk;jksVkWfDldksfll ,oa xHkkZoLFkk dh           egRoiw.kZ rF; dks è;ku esa vo'; j[kuk pkfg,A    çFke frekgh gh blds nks çeq[k indications gSa tgk¡            ADVERSE DRUG REACTIONS (ADR)               bldk ç;ksx fd;k tk ldrk gSA Hepatotoxicity ds           a) MINOR ADR                               dkj.k  blds  ç;ksx  ds  le;  fyoj  dh  tkapksa  dh           ATD ds ç;ksx ls tqM+s vfèkdk¡'k nq\"çHkko gyds gh gksrs   ekWuhVfjax vo'; djkrs jguh pkfg,A           gSa tSls cq[kkj ¼fever½]  nkusa (rashes)]  'kjhj ij pdÙks   CLINICAL USES OF ATD           iM+uk (urticaria)  ,oa tksM+ksa esa nnZ mBuk ¼arthralgia½    GD ds mipkj ds fy, ATD dks nks çdkj ls ç;qä           bR;kfn] tks yxHkx 1-5% jksfx;ksa esa fey ldrs gSaA   fd;k tk ldrk gSA           Antihistaminics ;k corticosteroids ds ç;ksx ls           buesa vkjke fey ldrk gSA dHkh\&dHkh vkjke u feyus   High dose regimen \& ftlesa gkbijFkk;jkW;fMTe                                                     75","esa 'kh?kz ykHk ysus ds fy, vkjEHk esa ATD (CMZ/MMI)   b) S. TSH - /;ku jgs] GD esa yEcs le; rd ncs           dh vf/kd ek=k ¼30-60 fexzk izfrfnu½ dk ç;ksx fd;k   (suppressed) jgs TSH dks lkekU; gksus esa 6-8 ekg           tkrk gSA ijUrq blls nokvksa ls mRiUu gksus okyh (drug  ;k dHkh\&dHkh ,d o\"kZ rd yx ldrk gSA blhfy,]           induced) gkbiksFkk;jkW;fMTe dh lEHkkouk Hkh c<+  vkjafHkd ekWuhVfjax T4/F T4 ls djrs gq, tc ;g dbZ           tkrh gSA                                   ekg rd lkekU; cuh jgs] rc gh TSH dh tkap djkuh            Low  dose  regimen  -  ftlesa  CMZ/MMI  dh   pkfg,A  TSH  ds lkekU; gksus ds i'pkr~ blh  dks           vis{kk—r de ek=k ¼10-15 fexzk izfrfnu½ dk ç;ksx   ekWuhVfjax ds fy, ç;qä fd;k tk ldrk gSA            fd;k tkrk gSA blls nokvksa ls mRiUu gksus okyh (drug   Duration  of  therapy  -  /;ku  jgs]  GD  ,d           induced) gkbiksFkk;jkW;fMTe dh lEHkkouk rks de  vkWVks\&bEE;wu  jksx  gS  ftlesa  mÙkstd  ,aVhckWMht           jgrh gS ijUrq vkjEHk esa y{k.kksa esa deh vkus esa le;   (stimulatory  antibodies)  ds  curs  jgus  rd           yxrk gSA vk;ksMhu dh deh okys {ks=ksa esa vf/kdrj de  Fkk;jkW;M gkWeksZUl dk fuekZ.k Hkh vf/kd ek=k esa gksrk           ek=k ls gh fu;a=.k çkIr fd;k tk ldrk gSA   jgrk gSA vr% ,d ckj Fkk;jkW;M gkWeksZUl dk Lrj           Frequency of administration - CMZ/MMI dh   lkekU; gks tkus ds i'pkr~ mipkj can ugha fd;k tk           gkQ ykbQ yxHkx 6 ?kaVs ¼duration of action yxHkx   ldrkA bldh vko';drk rc rd iM+rh jgrh gS tc           4-5x gkQ ykbQ = 24-30 ?kaVs½ gksus ds dkj.k budks   rd vkWVksbE;wfuVh ¼,aVhckWMht dk fuekZ.k½ gh u ?kV           fnu esa ,d ckj ç;ksx esa yk;k tk ldrk gSA ijUrq   tk;sA bls gh remission dgrs gSaA ;g ekuk tkrk gS fd           gkbijFkk;jkW;fMTe esa Fkk;jkW;M xzafFk esa jä çokg   ATD esa dqN u dqN immunosuppressive property           vR;f/kd gks tkus ds dkj.k ;g nok,a xzafFk ls 'kh?kz gh   Hkh jgrh gS ftlds dkj.k buds yEcs le; rd fd;s x,           fudy Hkh ldrh gSa ftlls budk çHkko 'kh?kz gh lekIr   ç;ksx ls dqN O;fä;ksa esa GD esa remission çkIr fd;k           gks ldrk gSA blhfy, bu nokvksa dks çkjEHk esa fnu esa   tk ldrk gSA             ;k           nks   rhu ckj ¼8-12  hourly½ fn;k tkrk gS ,oa   Titration of therapy - mipkj ds vkjEHk esa ATD           gkbijFkk;jkW;fMTe ds fu;a=.k esa vkus ds i'pkr~ bUgsa  dh dqN vf/kd ek=k dh vko';drk iM+rh gS ijUrq           fnu esa ,d ckj Hkh ç;ksx esa yk;k tk ldrk gSA  Fkk;jkW;M gkWeksZUl ds Lrj dks lkekU; dj ysus ds           Monitoring of Therapy                      i'pkr~ budh ek=k Øe'k% ?kVkbZ tk ldrh gSA ATD dh           a) S. T4 - /;ku jgs] Fkk;jkW;M gkWeksZu ¼T4½ dh gkQ  ftl U;wure ek=k ij Fkk;jkW;M gkWeksZUl ds Lrj dks            ykbQ yxHkx 8 fnu gksus ds dkj.k ,d ckj cu tkus ds  lkekU; cuk;s j[kk tk ldrk gS mls maintenance           i'pkr~ bldk çHkko Hkh 32-40 fnuksa rd cuk jgrk gS   dose dgrs gSaA bldk fu/kkZj.k titration  method           ,oa bldk fuekZ.k ?kV tkus ds i'pkr~ Hkh blds Lrj esa  }kjk fd;k tkrk gSA FT4 ds lkekU; lhek ds e/;           visf{kr cnyko vkus esa 32-40 fnu yx tkrs gSaA blh  ¼midnormal range½ esa vkus ds lkFk] CMZ/MMI dh           dkj.k ls mipkj ds çHkko dks tkuus ds fy, T4 dh  ek=k 2.5-5.0 fexzk çR;sd 4-6 lIrkg esa ?kVkrs tkrs gSaA           tkap 30-40 fnu vFkok 4-6 lIrkg i'pkr~ gh djkuh  vf/kdk¡'k O;fä 2-5-10.0 fexzk izfrfnu dh ek=k ij           pkfg,A blds fy, vkjEHk esa   total  T4  ;k  free  fu;af=r j[ks tk ldrs gSaA           (unbound) T4 dh tkap djkuh pkfg,A                                                             76","10        The Art of Managing Hyperthyroidism (Clinical Skill)                                    gkbijFkk;jkW;fMTe ls çHkkfor vf/kdk¡'k O;fä;ksa dk   gksrh gS ftlls mlesa ATD dk VuZvksoj Hkh dkQh c<+k           mipkj ATD ds ek/;e ls gh fd;k tkrk gSA vkb;s   gksrk  gSA  blfy,]  mipkj  vkjEHk  djrs  le;           buds ç;ksx dh O;ogkfjd dyk dks le>rs gSaA  CMZ/MMZ dks de ls de fnu esa nks ckj ,oa PTU            Which  drug?  \& Fkk;jkW;M xzafFk ls gkWeksZUl dk   dks fnu esa rhu ckj dh Mkst esa fn;k tkrk gSA           mRiknu  ?kVkus  okyh  vusd  nokvksa  (ATDs)  esa   gkbijFkk;jkW;fMTe ds fu;a=.k esa vkus ds lkFk\&lkFk           thionamides çeq[k gSaA ;g eq[;r% nks çdkj dh gSa]   ATD dk VuZvksoj Hkh ?kVrk tkrk gS ftlls ;g vf/kd                                                      le; rd xzafFk esa dk;Z dj ikrh gSA vr% fu;a=.k çkIr           carbimazole  (CMZ)  ¼;k  bldh  active           metabolite,  methimazole,  MMZ½  ,oa       gksus ds i'pkr~ bldks fnu esa 1 ;k 2 ckj nsuk gh i;kZIr           propylthiouracil (PTU)A ge igys gh ;g le> pqds   jg ldrk gSA            gSa fd bu nksuksa esa vR;ar VkWfDld gksus ds dkj.k PTU    How  to  initiate?  \&  gkbiksFkk;jkW;fMTe  esa  o`)           dk mi;ksx dsoy xHkkZoLFkk dh çFke frekgh esa  gh fd;k   O;fä;ksa ,oa ân; jksfx;ksa esa Fkk;jkWfDlu fFkjSih dks           tkrk gS tc xHkZLFk f'k'kq ij foijhr çHkko Mky ldus   Øe'k% vkjEHk djus ds foijhr ATD dks lh/ks gh bldh           dh lEHkkouk ds dkj.k CMZ ;k MMZ fuf\"k) ekuh   vuqekfur Mkst ls çkjEHk fd;k tk ldrk gSA okLro esa           tkrh  gSaA  blfy,]  gkbijFkk;jkW;fMTe  ls  çHkkfor   ATD ds }kjk Fkk;jkW;M gkWeksZUl dk mRiknu de djus           xHkkZoLFkk ds vfrfjä fdlh vU; voLFkk  esa O;fä ds   ds ckotwn] igys ls cus gkWeksZUl ds gh vxys 40 fnuksa           mipkj ds fy, ge CMZ ;k MMS  dk gh p;u djsaxsaA   rd dk;Z djrs jgus ds dkj.k ATD dk BMR ij dksbZ                                                      rqjar çHkko ugha iM+rkA           In  what  dosage? \& iwoZ esa çpfyr  high  dose           regimen ds LFkku ij vktdy low dose regimen   Next follow up? \& ge tkurs gSa fd Fkk;jkW;M gkWeksZu           gh  vf/kd  ç;ksx  esa  yk;k  tkrk  gSA  Indian  ,oa   (T4) dh gkQ ykbQ yEch ¼yxHkx 8 fnu½ gksus ds           Europian  Thyroid  Associations  ds  vuqlkj]   dkj.k cuus ds i'pkr~ bldk çHkko yxHkx 40 fnuksa           CMZ dks 15-40 fexzk çfrfnu dh Mkst ls vkjEHk   rd cuk jgrk gSA blhfy,] Fkk;jkW;M gkWeksZUl dh           fd;k tk ldrk gSA D;ksafd 'kjhj esa esVkckWfyTe ds   nksckjk tkap Hkh yxHkx blh varjky ij djkuh pkfg,A           i'pkr~ 10 fexzk CMZ ls yxHkx 6 fexzk MMZ dk   vkjEHk esa mipkj dk ifj.kke 'kh?kz tkuus ds fy, bls           fuekZ.k gksrk gS blfy,] blds LFkku ij MMZ dks Hkh   30 fnuksa esa Hkh djk;k tk ldrk gS ijUrq fu;a=.k çkIr           10-30 fexzk çfrfnu dh Mkst esa vkjEHk fd;k tk   gksus ds lkFk\&lkFk bls c<+kdj 45-60 fnuksa esa djkuk           ldrk gSA                                   mfpr jgrk gSA            At  what  time? \& Hkkstu ATD ds ,CtkWiZ~'ku dks   Which test? \& ;g vR;ar egRoiw.kZ ç'u gSA /;ku           çHkkfor ugha djrkA blfy,] ATD dks Hkkstu ds iwoZ   jgs] yEcs le; rd jgh gkbijFkk;jkW;fMTe ds dkj.k           vFkok blds i'pkr~ dHkh Hkh fn;k tk ldrk gSA   fiVîwVjh ls cuus okyk TSH, suppresion esa pyk           Fkk;jkW;M gkWeksZUl dk mRiknu Hkh fnu ds fdlh le; ls   tkrk gS ftlls mcjus esa bls de ls de 6 ekg ,oa           çHkkfor ugha gksrkA blfy,] ATD dks lqcg] nksigj   dHkh\&dHkh  ,d  o\"kZ  rd  yx  tkrk  gSA  blhfy,]           vFkok 'kke] dHkh Hkh fn;k tk ldrk gS       gkbijFkk;jkW;fMTe ds vkjafHkd mipkj esa TSH dh            At what interval? \& gkbijFkk;jkW;fMTe ds dkj.k   tk¡p  djkus  ls  dksbZ  ykHk  ugha  feyrkA           vkjEHk esa Fkk;jkW;M xzafFk dh esVkckWfyTe vR;f/kd c<+h   gkbijFkk;jkW;fMTe ds dqN ekg rd yxkrkj fu;a=.k esa                                                    77","cus jgus rd dsoy T4 dh tkap gh i;kZIr jgrh gSA gk¡]  }kjk½ regimen dgrs FksA Øe'k% blds vf/kd csgrj           T3 toxicosis dh fLFkfr esa T4 ds Lrj lkekU; gksus ds  ifj.kke u feyus ds dkj.k bldk çpyu de gksrk tk           dkj.k T3 dh tkap djkuh pkfg,A              jgk gSA            Dose titration? \& bl çdkj gkbijFkk;jkW;fMTe dh   Cessation of ATD therapy \& bl çdkj] ATD dh           vkjafHkd voLFkk esa jksx dh xaHkhjrk dk vkdyu T4 ds  Mkst dks Øe'k% ?kVkrs gq, bldh U;wure Mkst dks           Lrj ds vuqlkj fd;k tkuk pkfg,A mipkj ds i'pkr~  vf/kd ls vf/kd le; rd ¼de ls de 12-18 ekg           feyus okys Lrj dh rqyuk vkjfEHkd Lrj ls djrs gSaA  rd½ pykus dk ç;Ru vo'; djuk pkfg,A vkerkSj           buesa visf{kr deh u vkus ij ATD dh Mkst dks 5 fexzk  ij ATD dh U;wure Mkst ij] TSH ds Ng ekg rd           çfrfnu c<+k;k tk ldrk gSA ;fn blij Hkh T4 ds Lrj  fu;a=.k esa jgus ij ATD dks can djus dk fu.kZ; fy;k           esa deh ugha vkrh] rc Mkst dks iqu% 5-10 fexzk c<+k;k  tk ldrk gSA           tk ldrk gSA T4 ds Lrj esa i;kZIr deh feyus ij   Follow up \& ATD dks can djus ds 1-2 ekg i'pkr]           ATD dks iwoZor Mkst esa gh nsrs jguk pkfg, tc rd   GD ds remission vFkok persistent disease dk           T4 viuh e/; jsat esa u vk tk;sA T4 ds Lrj dks   vkdyu vo'; fd;k tkuk pkfg,A vkjEHk esa çR;sd           bldh e/; lhek ls uhps vkus ij ATD dh Mkst dks 5   1-2 ekg] ,oa ckn esa 6-12 ekg ij T4 ,oa TSH dh           fexzk çfrfnu ds vuqlkj ?kVk ysuk pkfg,A    tkapsa djkbZ tk ldrh gSaA ;fn QkWyksvi dh ,d o\"kZ dh           How long? \& mipkj ds vuqlkj dHkh\&dHkh T4 ds  vof/k ds nkSjku Hkh ;g nksckjk fcxM+uk vkjEHk ugha           Lrj vR;f/kd rhozrk ls ?kVrs gq, lkekU; lhek ls Hkh  djrha rc bls remission dk çrhd ekuk tk ldrk           uhps igq¡p tkrs gSaA ,sls esa ç'u ;g mBrk gS fd ATD  gSA           dk D;k djuk pkfg,\\ /;ku jgs] GD dk mipkj   Longterm  outcomes  of  GD  \&  ;g  tkuuk           yxHkx 18 ekg ls iwoZ can djus ij blds remission   vko';d gS fd GD ,d vkWVksbEE;wu jksx gS tks vU;           esa tkus dh lEHkkouk de gks tkrh gSaA blhfy,] T4 ds   vkWVksbEE;wu jksxksa dh Hkkafr gh remission ,oa relapse           Lrj lkekU; lhek ds uhps pys tkus ij Hkh ATD dks   dh çfØ;k ls xqtjrk jgrk gSA vusd v/;;uksa esa ;g           iw.kZ:i ls can ugha djuk pkfg,A bldh Mkst dks   ik;k x;k gS fd 10 o\"kksaZ dh QkWyksvi dh vof/k esa           ?kVkdj ,d ekg i'pkr~ fLFkfr dh iqu% leh{kk djuh   dsoy 40% jksxh gh iw.kZ remission esa ik, tkrs gSaA           pkfg,A                                     10-15%  jksfx;ksa  esa  rks  vkWVksbEE;wu  {kfr  ls            Monitoring with TSH \& T4 ds Lrj dks bldh e/;  gkbiksFkk;jkW;fMTe rd mRiUu gks tkrh gSA 'ks\"k jksfx;ksa           lhek ls uhps vkus ij T4 ds lkFk\&lkFk TSH dh Hkh  esa] chp\&chp ds le; esa] remissions ,oa relapses           tkap djkuh vkjEHk dj nsuh pkfg,A ,d ckj blds  gksrs jgrs gSaA           lkekU; lhek esa vkus ds i'pkr~ ekWfuVfjax ds fy,   Remission \& ATD ds ç;ksx ls yxHkx 30-60%           dsoy TSH dk ç;ksx fd;k tk ldrk gSA         O;fä;ksa esa GD esa remission çkIr fd;k tk ldrk gS            Block and replace regimen \& iwoZ esa ATD ls  ijUrq bl çfØ;k esa de ls de 12-18 ekg dk le;           'kh?kz remission çkIr djus ds mís'; ls high dose  vo'; yx tkrk gSA jksx esa vkjafHkd vkjke feyus ij           ATD  regimen dk çpyu FkkA blls T4 ds Lrj  mipkj dks can dj fn, tkus dh lEHkkouk dks /;ku esa           lkekU; lhek ls Hkh uhps igq¡p tkus ij ATD dks rks  j[krs gq, bl rF; ls jksxh dks mipkj ds iwoZ gh voxr           iwoZor gkbZ Mkst esa gh nsrs jgrs Fks ,oa T4 dks c<+kus ds  djk nsuk pkfg,A ;gk¡ ;g tkuus dh bPNk mBuh           mís'; ls Fkk;jkWfDlu fFkjSih vkjEHk dj nsrs FksA bls gh  LokHkkfod  gh  gS  fd  og  dkSu  ls  jksxh  gSa  ftuesa           block ¼ATD ds }kjk½ and replace ¼Fkk;jkWfDlu ds   remission dh lEHkkouk vf/kd gksxh\\ okLro esa buesa                                                     78","ls dqN dk vuqeku rks Mk;Xuksfll ds le; gh yxk;k  ,d ckj relapse gksus ds i'pkr~ jksxh ds nksckjk           tk ldrk gS ,oa dqN dk mipkj ds nkSjkuA Mk;Xuksfll   remission esa igq¡pus dh lEHkkouk igys ls Hkh de jg            ds le; Fkk;jksVkWfDldksfll dh xaHkhjrk de gksuk] T3  tkrh gSA ,sls esa nks gh LokHkkfod fodYi cprs gSaA 1)           ,oa T4 ds Lrj de c<+s gksuk] TRAb ds Lrj de gksus]   ATD ds }kjk gh gkbijFkk;jkW;fMTe dks fu;a=.k esa           xkW;Vj dk vkdkj NksVk gksus ,oa mipkj ds nkSjku ATD  j[kukA laHko gS fd bldh Mkst dkQh vf/kd gks ,oa bls           dh  de  Mkst  ¼2.5-5.0  fexzk  çfrfnu½  dh  gh  vkthou Hkh nsuk iM+s] 2) ATD ls Hkh i;kZIr fu;a=.k           vko';drk iM+uk] T4 ,oa TSH ds Lrjksa dk 'kh?kz gh  çkIr u gks ikus dh fLFkfr esa ablative therapy  dk           fu;a=.k esa vk tkuk ,oa 18 ekg dh vof/k esa gh ATD  p;u djdsA blds fy, jsfM;ksvk;ksMhu vFkok ltZjh]           can djus ij fopkj djus dh vko';drk iM+uk bR;kfn]  fdlh ,d dks pquk tk ldrk gSA dqN jksfx;ksa esa bu nksuksa           remission dh lEHkkouk vf/kd gksus ds |ksrd gksrs gSaA  esa fdlh ,d ls Hkh i;kZIr fu;a=.k çkIr u gks ldus dh           Relapse \& Remission dh Hkkafr gh relapse ds   fLFkfr esa ,d ds ckn nwljh ablative  therapy dh           fy, Hkh ;g tkuuk vko';d gS fd bldk vuqeku fdl   vko';drk Hkh iM+ ldrh gSA           çdkj yxk;k tk ldrk gSA /;ku jgs] efgykvksa dh   Treatment  of  thyrotoxicosis  without           vis{kk iq#\"kksa esa ,oa vf/kd vk;q dh vis{kk de vk;q ds   hyperthyroidism \& ckgj ls vf/kd ek=k esa fy,           cPpksa esa remission esa igq¡pus dh lEHkkouk de vFkok   x,  ¼exogenous½  vFkok  vanj  laxzfgr           nsj ls gksrh gSA /kweziku Hkh remission dh lEHkkouk dks   ¼endogenous½ Fkk;jkW;M gkWeksZu ds jä esa yhd dj           ?kVk ldrk gSA blds vfrfjä] Mk;Xuksfll ds le;   tkus dh fLFkfr] nksuksa esa] xzafFk esa gkWeksZUl dk mRiknu           Fkk;jksVkWfDldksfll dh vf/kd xaHkhj gksus] T3 ,oa T4   ugha c<+rkA vr%] LokHkkfod :i ls buesa ATD dh           ds Lrj dkQh vf/kd c<+s gksus] TRAb ds Lrj vf/kd   vko';drk Hkh ugha iM+rhA bu nksuksa gh dkj.kksa dk           gksus] xkW;Vj dk vkdkj dkQh cM+k gksus ,oa mipkj ds   le; ds lkFk Lor% gh Bhd gks tkus ds dkj.k buls           nkSjku ATD dh dkQh vf/kd Mkst dh gh vko';drk   çHkkfor  O;fä;ksa  dk  mipkj  dsoy  yk{kf.kd  :i           iM+uk] T4 ,oa TSH ds Lrjksa dk dkQh le; ds ckn Hkh   ¼symptomatic½ ls fd;k tkuk gh i;kZIr jgrk gSA           fu;a=.k esa u vk ikuk ,oa 18 ekg dh vof/k ds ckn Hkh   blesa /kM+du ,oa dEiu ?kVkus ds fy, propranolol]           ATD  dh dkQh vf/kd Mkst dh vko';drk iM+uk    ?kcjkgV de djus ds fy, anxiolytics]  nnZ ,oa cq[kkj           bR;kfn dqN foijhr y{k.k gSa tks remission esa u tkus   ds fy, analgesics  ,oa antipyretics  dk p;u fd;k           ;k blds i'pkr~ relapse gksus dh lEHkkouk vf/kd   tk ldrk gSA dqN yksx xaHkhj :i ls c<+s gq, gkWeksZUl dks           gksus ds |ksrd gks ldrs gSaA Relapse dh lokZf/kd   ?kVkus ds fy, dqN le; ds fy, ATD fn, tkus dk           laHkkouk mipkj can djus ds çFke o\"kZ esa gh gksrh gSA   leFkZu Hkh djrs gSaA bl dk;Z ds fy, PTU dk p;u           blfy,] mipkj can djus ds ckn Fkk;jkW;M gkWeksZUl dh   fd;k tk ldrk gS tks T4 ls T3 cuus dh çfØ;k dks           tkapsa çR;sd rhu ekg ij djrs jguk pkfg,A ,d o\"kZ ds   ?kVkdj Fkk;jksVkWfDldksfll esa 'kh?kz vkjke fnyk ldrk           ckn bl lEHkkouk ds vis{kk—r de gks tkus ds dkj.k   gSA /;ku jgs] ATD dks yEcs le; rd ¼laHkor% ,d           bu tkapksa dks o\"kZ esa ,d ckj djkrs jguk gh i;kZIr   ekg ls vf/kd½ fcydqy u nsa vU;Fkk ;g igys ls gh           jgrk gSA                                   çHkkfor Fkk;jkW;M xzafFk dks vkSj Hkh vf/kd suppress                                                      djds gkbiksFkk;jkW;fMTe mRiUu dj ldrk gSA           Treating a case of relapse in GD \& /;ku jgs]                                                            79","11         Radioactive Iodine                                   vk;ksMhu] Fkk;jkW;M gkWekZsUl ds fuekZ.k ds fy, lokZfèkd  Mk;XuksfLVd ,tsaV ds :i esa ç;ksx ds fy, vkn'kZ ekuk           egRoiw.kZ inkFkZ gSA ç—fr esa ;g vius stable isotope  tkrk gSA           I  ds :i esa feyrh gSA lksfM;e ,oa iksVSf'k;e lkWYV ds   Iodine-131 (I )           127                                                                 131           ioZrh; {ks=ksa ds uhps ds rjkbZ ds {ks=ksa ds Hkwfexr ty esa   bldh  gkQ  ykbQ  8  fnu  gksrh  gS  fdlds  dkj.k           bldh ek=k vis{kkd`r de gksrh gS tcfd leqnzh {ks=ksa esa   Fkk;jk;M xzafFk esa igq¡pus ds i'pkr~ bldk çHkko yxHkx           ;g cgqrk;r esa ik;h tkrh gSA GIT  ls “kh?kzrk ls   40 fnuksa rd pyrk jgrk gSA           vo”kksf’kr gksus ds i”pkr ;g jDr esa igqaprh gS tgka ls           ;g Fkk;jkW;M QkWfydYl dh dksf”kdkvksa ij yxs NIS ds   buls fudyus okys chVk jsfM,'ku]  ok;q esa rks dqN ehVj           ek/;e ls dksf”kdkvksa esa izos”k dj ds Fkk;jkW;M gkWeksZUl   rd py ldrs gSa ijUrq 'kjhj esa budh igq¡p dqN                                                      feyhehVj  ek=  gh  gksrh  gSA  bl  çdkj  Fkk;jkW;M           ds fuekZ.k ds fy;s iz;qDr gks tkrh gSA ;fn blh stable           isotope  ds  LFkku  ij  vk;ksMhu  ds  jsfM;ks,fDVo   QkWfydy dh Y;wesu ls fudyus ds i'pkr~ ;g vfèkd           isotopes ¼eq[;r% I  ,oa I ) ç;ksx esa yk;s tk;sa rc   ÅtkZ;qä jsfM,s'ku ] eq[;r% QkWfydy dh dksf'kdk dks                                131                          123           og Hkh I  dh Hkkafr Fkk;jkW;M gkWekZsUl ds fuekZ.k esa Hkkx   gh çHkkfor dj ikrs gSaA                127           ysus  yx  tkrs  gSaA  vk;ksMhu  ds  bu  jsfM;ks,fDVo  buls xkek jsfM,s'ku  Hkh  fudyrs gSa ftUgsa I  dh Hkkafr                                                                                      123           isotopes (radioactive iodine \& RAI) ls fudyus  xkek dkmaVj ls ukik tk ldrk gSA           okys jsfM,'ku ds ekè;e ls 'kjhj esa vk;ksMhu ;k   gkQ ykbQ ,oa jsfM,'ku yksM vfèkd gksus ds dkj.k I                                                                                             123           Fkk;jkW;M gkWekZsUl dh xfrfofèk;ksa dks igpkuk ,oa ekik   dks therapeutic ,tsaV  ds :i esa ç;ksx ds fy, vkn'kZ           tk ldrk gSA D;ksafd ;g jsfM,'ku 'kjhj dh dksf'kdkvksa   ekuk tkrk gSA lkFk gh buls fudyus okys xkek           dks {kfr igqapk ldrs gSa blfy, Fkk;jkW;M xzafFk esa   jsfM,s'ku ds dkj.k bUgsa Mk;XuksfLVd ,tsaV  ds :i esa Hkh           ,df=r gksus dh {kerk ds dkj.k budk ç;ksx Fkk;jkW;M   iz;ksx esa yk;k x;k tk ldrk gSA           xzafFk dks u\"V djus ds fy, Hkh fd;k tk ldrk gSA vkb;s           buds fo\"k; esa foLrkj ls le>rs gSaA        CLINICAL USES OF RADIOISOTOPES OF                                                      IODINE                      123           Iodine-123 (I )                            nksuksa vkblksVksIl dh ç—fr tkuus ds i'pkr~ buds           bldh gkQ ykbQ  dsoy 13 ?kaVs  gksrh gS ftlds dkj.k   ç;ksx dks ljyrk ls le>k tk ldrk gSA           Fkk;jkW;M xzafFk esa igq¡pus ds i'pkr~ 2 fnuksa esa gh bldk   For thyroid scan \& bl dk;Z ds fy,   dk ç;ksx                                                                                     123           çHkko lekIr gks tkrk gSA                                                  I                                                      fd;k tkrk gSA blds fuEukafdr dkj.k gSaA           buls fudyus okys xkek jsfM,'ku  dh ÅtkZ de gksus ds   - gkQ ykbQ de gksus ds dkj.k ;g Fkk;jkW;M xzafFk esa           dkj.k muls Fkk;jkW;M xzafFk dks cgqr de gkfu igq¡prh   cgqr de le; rd jgrh gSA           gSA                                        - blls fudyus okyh xkek fdj.ksa ls xzafFk dks dksbZ fo'ks\"k            jsfM,s'ku ok;q esa yxHkx 50 ehVj rd ,oa 'kjhj esa dbZ   {kfr ugha igq¡pkrh gSaA           lsaVhehVj rd py ldrs gSaA blds dkj.k og 'kjhj ls   - ;g xkek fdj.ksa 'kjhj ls fudydj dkQh nwj rd tk            fudydj]  blls  nwj  rd  igqapdj]  xkek  dkmaVj   ldrh gSa ftlls xkek dkmaVj ds ekè;e ls budk           ¼gamma counter½ }kjk xzg.k fd;s tk ldrs gSaA gkQ   vkdyu djuk ljy gksrk gSA            ykbQ ,oa jsfM,'ku yksM de gksus ds dkj.k I dks   For radioablation of thyroid gland   \& bl                                               123                                                   80","dk;Z ds fy,   dk ç;ksx fd;k tkrk gSA blds   fofèk dks RAI ablation ¼fdlh ,d Hkkx dks vU; ls                       131                      I           fuEukafdr dkj.k gSaA                       vyx djuk ;k u\"V djuk½ dgrs gSaA           - gkQ ykbQ vfèkd gksus ds dkj.k ;g Fkk;jkW;M xzafFk esa   Fkk;jkW;M xzafFk ds vfrfjä ;fn fdlh vU; dksf'kdk            vfèkd le; rd jgrh gSA                     ¼tSls ectopic thyroid ,oa Fkk;jkW;M dSalj ls mRiUu           - blls fudyus okyh chVk fdj.ksa xzafFk dks dkQh {kfr   gqbZ esVkLVsfll½ esa Hkh vk;ksMhu VSªfiax dh {kerk gS rc            igq¡pkrh gSaA                             mls Hkh RAI LdSu }kjk ns[kk tk ldrk gS ,oa u\"V           - I  ds Fkk;jkW;M xzafFk esa laxzfgr gksus ds i'pkr~ blls   ¼ablate½ fd;k tk ldrk gSA            131            fudyus okyh chVk fdj.ksa dk çHkko dsoy Fkk;jkW;M            xzafFk o blds 2 feeh rd gh lhfer jgrk gS ftlls   INDICATIONS OF RAI THERAPY            xzafFk ds fudV fLFkr vU; vaxksa ij jsfM;ks vk;ksMhu   a) IN DIAGNOSTICS                                                                                  123            dk dksbZ çHkko ugha iM+rkA                ge le> pqds gSa fd bl dk;Z ds fy, I  dks mi;ksx esa                                                      yk;k tkrk gSA lkekU; vk;ksMhu dh Hkkafr xzafFk esa           MECHANISM OF ACTION OF RAI                                                      igqapdj ;g xzafFk dh lfØ;rk ,oa vkdkj ls lEcafèkr           I   ,oa  I   dh  pharmacokinetics]  çk—frd   egRoiw.kZ tkudkjh nsrk gSA                   131           123           vk;ksMhu I  ds leku gh gksrh gSaA ;g nksuksa gh jä ls                   127           gksrs  gq,]  Fkk;jkW;M  QkWfydy  dh  dksf'kdkvksa  esa   Activity level of the thyroid gland - ge tkurs           Fkk;jksXykWC;wfyu ds lkFk feyrs gq,] iodotyrosines   gSa fd ;fn Fkk;jkW;M xzafFk }kjk vfèkd Fkk;jkW;M gkWekZsUl           ,oa iodothyronines ds :i dksykW,M esa laxzfgr gks   dk fuekZ.k gks jgk gS rc og vk;ksMhu Hkh vfèkd ek=k           tkrs gSaA                                  esa xzg.k djsxh tcfd Fkk;jkW;M gkWekZsUl dk fuekZ.k ?kVus                                                      ij xzafFk vk;ksMhu dks de ek=k esa xzg.k djsxhA xzafFk esa           I  ls fudyus okys xkek jsfM,'ku]  de ÅtkZ;qä gksus   igq¡pus okyh vk;ksMhu dh bl ek=k dks RAI ls fudyus           123           ds dkj.k Fkk;jkW;M xzafFk dks vfèkd gkfu ugha igqapkrs   okys jsfM,'ku ds ekè;e ls xkek dkmaVj }kjk  ekik           ijUrq I  ls fudyus okys chVk jsfM,'ku] vis{kkd`r   tk  ldrk  gS  ftls  RAI uptake ¼RAIU½ dgrs gSaA                131           vfèkd ÅtkZ;qä gksus ds dkj.k Fkk;jkW;M xzafFk dks           vR;fèkd gkfu igqapkrs gSaA blls mRiUu y{k.kksa dks   - Hyperthyroidism - gkbijFkk;jkW;fMTe esa xzafFk dh           radiation  thyroiditis dgrs gSaA buds jsfM,'ku dh   lfØ;rk c<+ tkus ij xzafFk vk;ksMhu dh vfèkd ek=k           ÅtkZ  ls  QkWfydy  dh  dksf'kdkvksa  esa  pyknosis   xzg.k djrh gS ftlls RAIU c<+ tkrk gSA RAIU ds                                                       c<+us ij LdSu esa Fkk;jkW;M xzafFk] ykj xzafFk;ksa dh           ¼degeneration  dh  çfØ;k  ftlesa  chromatin           condensation ls U;wfDy;l dk vkdkj NksVk gksus   vis{kk xk<+h ¼darker½ fn[kkbZ nsrh gSA           yxrk gS½ ,oa necrosis  ¼fdlh thfor vax esa fdlh   - Hypothyroidism - gkbijFkk;jkW;fMTe esa xzafFk dh           dksf”kdk dh e`R;q½ gks tkrh gS ftlesa le; ds lkFk   lfØ;rk ?kV tkus ij xzafFk vk;ksMhu dh de ek=k           Qkbczksfll gksrh tkrh gSA                   xzg.k djrh gS ftlls RAIU ?kV tkrk gSA RAIU ds                                                       ?kVus ij LdSu esa Fkk;jkW;M xzafFk] ykj xzafFk;ksa dh           RAI  dk çHkko] ç;ksx ds yxHkx 15 fnuksa i'pkr~   vis{kk gydh ¼lighter½ fn[kkbZ nsrh gSA           vkjEHk gksrk gS ,oa Øe'k% c<+rs gq, yxHkx 3 ekg esa   - Thyroiditis - Fkk;jkW;MkbfVl dh vkjafHkd voLFkk           ;g mPpre Lrj ij igq¡p tkrk gSA              esa Hkh Fkk;jksVkWfDldksfll mRiUu gks ldrh gS ijUrq           jsfM,'ku ds  }kjk mRiUu {kfr ds yxHkx 2 feeh rd gh   xzafFk dks igqaph {kfr ls xzafFk ds fuf\"Ø; gks tkus ds           lhfer jgus ds dkj.k ;g Fkk;jkW;M xazfFk ds lehiorhZ   dkj.k RAIU ?kV tkrk gS ,oa LdSu esa Fkk;jkW;M xzafFk]           vaxksa dks gkfu igqapk, fcuk gh Fkk;jkW;M xzafFk ds dsoy   ykj xzafFk;ksa dh vis{kk gydh ¼lighter½ fn[kkbZ nsrh           lfØ; QkWfydy dks gh fuf\"Ø; djrh gSA blhfy, bl   gSAA  bl  çdkj  RAI  dk  mi;ksx  GD  ,oa                                                     81","Fkk;jksVkWfDldksfll esa foHksn djus ds fy, Hkh fd;k   rc Hkh RAI fFkjSih dh vko';drk iM+rh gSA            tk ldrk gSA                               dHkh\&dHkh  subtotal  /  near  total  thyroidectomy                                                      ¼NTT½ ds i'pkr~ Hkh gkbijFkk;jkW;fMTe cuh jgrh gSA           Size  and  shape  of  the  thyroid  gland  -           Fkk;jkW;M xzafFk ls fudyus okys jsfM,'ku dks xkek dSejk   ,sls esa Hkh RAI fFkjSih dh vko';drk iM+rh gSA           ls ns[kus ls xzafFk ds vkdkj dk vuqeku Hkh gks tkrk gSA   - STN esa çFke fodYi ¼treatment of choice½ ds :i           lkFk gh xzafFk dk dkSu lk Hkkx vfèkd lfØ; gS ,oa dkSu   esaA  ,slk  blfy,  D;ksafd  STN  esa  vfrlfØ;           lk de lfØ;] ;g Hkh tkuk tk ldrk gSA         ¼hyperactive½ ukWMîwy] 'ks\"k xzafFk dks supress dj           gkbijFkk;jkW;fMTe esa xzafFk dh lfØ;rk c<+ tkus ds   nsrk gSA blls RAI dk viVsd dsoy ukWMîwy esa gksrk           dkj.k RAIU c<+ tkrk gS lkFk gh] LdSu ds ekè;e ls   gS ftlls dsoy mlh Hkkx dk ablation gksrk gS ,oa           gkbijFkk;jkW;fMTe ds dkj.kksa esa foHksn Hkh fd;k tk   'ks\"k xzafFk lqjf{kr jg tkrh gS tks dqN le; ckn           ldrk gSA blesa eq[;r% rhu çdkj ds RAIU feyrs gSaA  lkekU; :i ls dk;Z djuk vkjEHk dj nsrh gSA           - GD - lEiw.kZ xzafFk ds leku :i ls RAIU c<+ tkus ij   - Toxic MNG esa vusd ukWMîwy vyx\&vyx :i esa            ;g diffuse toxic goiter ;k Graves' disease  dk   lfØ; gksrs gSaA buesa vfrlfØ; ukWMîwy rks RAI ls            |ksrd gksrk gSA                            u\"V gks tkrs gSa ijUrq de lfØ; ukWMîwy esa RAIU           - STN -  xzafFk esa dsoy ,d LFkku ij RAIU ds c<+s gksus   de gksus ls og blls cp tkrs gSaA ;g dqN le;            ij ;g solitary toxic  nodule  dk |ksrd gksrk gSA  i'pkr~  vR;fèkd  lfØ;  gksrs  gq,  iqu%           - Toxic MNG - xzafFk ds vyx\&vyx LFkkuksa esa RAIU   gkbijFkk;jkW;fMTe mRiUu dj nsrs gSaA blhfy,] toxic            ds vyx\&vyx ¼patchy  uptake½ feyus ij ;g    MNG esa RAI fFkjSih ls dksbZ fo'ks\"k ykHk ugha feyrk            toxic multinodular goiter dk |ksrd gksrk gSA  tgk¡ bls ç;ksx esa u ykuk gh csgrj ekuk tkrk gSA            b) IN THERAPEUTICS                                                      In thyroid cancers           ge le> pqds gSa fd I  ls fudyus okys jsfM,'ku]   Fkk;jkW;M dSalj esa rks RAI fFkjSih dk mís'; gh dSalj                             131           Fkk;jkW;M QkWfydy dh dksf'kdkvksa dks {kfr igqapkrs gSaA   xzLr dksf'kdkvksa dks iw.kZ :i ls u\"V djuk gSA blhfy,           vr% budk mi;ksx nks ifjfLFkfr;ksa esa fd;k tk ldrk   blesa vfèkd ÅtkZ okyh I dh vfèkd ek=k dk ç;ksx                                                                          131           gSA                                        fd;k  tkrk  gSA  Fkk;jkW;M  dSalj  dh  esVkLVsfVd           In hyperthyrodism                          dksf”kdkvksa esa RAIU gksus ds dkj.k og Hkh RAI }kjk           - GD \& GD esa ATD ds fodYi ¼second choice½ ;k   u\"V dh tk ldrh gSaA bl çdkj RAI fdlh y{; Hksnh            dHkh\&dHkh  çFke  mipkj  ¼treatment  of  first   felkby dh Hkk¡fr dk;Z djrh gS tks macroscopic            choice½ ds :i esaA GD esa lEiw.kZ xzafFk ds lfØ; gksus   metastases  ds  lkFk\&lkFk  microscopic            ds dkj.k RAI dk viVsd lEiw.kZ xzafFk esa gksrk gS   metastases dks Hkh <wa<\&<wa< dj u\"V djrh gSA            ftlls lEiw.kZ xzafFk gh Øe'k% fuf\"Ø; gksrh tkrh gSA   PREPARATIONS AND DOSAGE           GD ls çHkkfor dqN O;fä;ksa ¼tSls o`) ,oa ân;   RAI, I  vFkok I  ds lksfM;e lkWYV ¼NaI ] NaI ½                                                           127                                                                   131                                                                                      127                                                                                            131           jksfx;ksa½ esa gkbijFkk;jkW;fMTe vR;ar ?kkrd fl) gks   ds :i esa feyrh gS ftls ty esa feykdj fi;k tk ldrk           ldrh gSA 'kh?kz LokLF; ykHk ds fy, buesa ATD ds   gSA bldh Mkst dk vkdyu blls fy, tkus okys dk;Z ds           LFkku ij RAI fFkjSih dks çkFkfedrk nh tkrh gSA  vkèkkj ij fd;k tkrk gSA           buds vfrfjä] ;fn ATD ds yEcs le; rd ç;ksx ds   - LdSfuax ds fy, \& 25-100 microCurie           i'pkRk Hkh remission çkIr u gks ik jgk gks vFkok ,d   - GD ,oa STN ds fy, 5-15 milliCurie           ckj remission gksus ds i'pkr~ relapse gks x;k gks]                                                      - Fkk;jkW;M dSalj ds fy, 50-150 milliCurie                                                     82","iwoZ esa RAI dks bl mís'; ls nsrs Fks fd blds }kjk xzafFk   vfèkd ek=k dh vko';drk iM+rh gSA           dh dsoy c<+h gqbZ lfØ;rk dks gh de fd;k tk lds   SIDE EFFECTS OF RAI           ftlls  RAI  ds i'pkr~ Fkk;jkW;M gkWekZsUl ds Lrj   Pain \& RAI ds mijkUr jsfM,'ku Fkk;jkW;MkbfVl ds           lkekU; gks tk,a ,oa jksxh dks euthyroid j[kk tk ldsA   dkj.k xzafFk esa FkksM+h ihM+k mRiUu gks ldrh gS ftlds           ijUrq vusd dkj.kksa ls ,slk dj ikuk laHko ugha gks ikrk   fy, analgesics dk ç;ksx fd;k tk ldrk gSA           FkkA  RAI  dh  ek=k  FkksM+h  Hkh  de  jg  tkus  ls           gkbijFkk;jkW;fMTe cuh jgrh Fkh ,oa RAI dh nwljh   Transient toxicosis \& jsfM,'ku Fkk;jkW;MkbfVl ds           Mkst dh vko';drk iM+rh FkhA RAI dh ek=k FkksM+h Hkh   dkj.k yhd gq, gkWekZsUl ls {kf.kd Fkk;jksVkWfDldksfll           vfèkd gks tkus ls gkbiksFkk;jkW;fMTe mRiUu gks tkrh   gks ldrh gS ftlds y{k.kksa ls cpko ds fy, beta           Fkh ftlls Fkk;jkWfDlu fFkjSih dh vko';drk iM+rh FkhA  blockers dk ç;ksx fd;k tk ldrk gSA           bl vfuf'prrk ls cpus ds fy, vktdy RAI dk   Exaccerbation of ophthalmopathy \& RAI ds           ç;ksx bl mís'; ls fd;k tkrk gS fd vis{kk—r vfèkd   mijkUr gkbiksFkk;jkW;fMTe ds mRiUu gksus ls TSH dk           ek=k esa nh x;h ,d gh Mkst ls lEiw.kZ xzafFk dks fuf\"Ø;   Lrj c<+us yxrk gS tks vkW¶FkSyeksiSFkh dks vkSj Hkh           ¼complete ablation½ djds gkbijFkk;jkW;fMTe ¼,d   vfèkd c<+k nsrk gSA blhfy,] active GO esa RAI dk           jksx½ dks lekIr djds gkbiksFkk;jkW;fMTe ¼,d deh½   ç;ksx oftZr gSA           mRiUu dj nh tk;sA blls vkthou Fkk;jkWfDlu fFkjSih    Hypothyroidism - RAI ds mijkUr xzafFk ds Øe'k%           dh vko';drk rks iM+rh gS ijUrq jksx ds nq\"çHkkoksa ls   {kfrxzLr gksrs tkus ls dqN le; esa gkbiksFkk;jkW;fMTe           cpk tk ldrk gSA                            mRiUu gks tkrh gSA yxHkx 20% O;fä;ksa esa ;g çFke            RAI ds mijkUr gkbiksFkk;jkW;fMTe dh lEHkkouk le;   o\"kZ esa gh mRiUu gks tkrh gS tcfd blds ckn bldh           ds lkFk\&lkFk c<+rh tkrh gSA                lEHkkouk yxHkx 5% O;fä çfro\"kZ jgrh gSA blfy,]                                                      RAI ds i'pkr~ çFke o\"kZ esa çR;sd 3 ekg esa ,oa blds           GD ls çHkkfor yxHkx 80% O;fä rks lEiw.kZ xzafFk dks   ckn çR;sd o\"kZ  TSH  dh tkap vo'; djkrs jguk           fuf\"Ø; djus ds mís'; ls nh x;h igyh Mkst ls gh Bhd   pkfg,A           gks tkrs gSa ijUrq yxHkx 20% O;fä;ksa esa igyh Mkst ls           visf{kr  ifj.kke  u  feyus  ij  nwljh  Mkst  dh   Cancer  - ;g ekuk tkrk gS fd ftl çdkj ls           vko';drk Hkh iM+ ldrh gSA                  nuclear fallout ,oa external irradiation ls Hkfo\";                                                      esa Fkk;jkW;M dSalj dh lEHkkouk c<+ tkrh gS] mlh çdkj           LokHkkfod :i ls Fkk;jkW;M xzafFk dk vkdkj NksVk gksus   RAI ls Hkh ,slk gks ldrk gSA ijUrq n'kdksa ds RAI ds           ij bls fuf\"Ø; djus ds fy, RAI dh FkksM+h ek=k dh   ç;ksx ds ckn Hkh bldk gksuk ux.; gh ik;k x;k gSA           vko';drk iM+rh gS ,oa vkdkj ds cM+k gksus ij vfèkd   fQj Hkh bl lEHkkouk dks fopkj esa j[krs gq,] cPpksa esa           ek=k dhA çfr 1 xzke xzafFk ds fy, yxHkx 80-200   RAI dh vis{kk ATD dks gh ojh;rk nh tkrh gSA           microcurie  dh  vko';drk  iM+rh  gSA  Dyhfudy           ijh{k.k ¼palpation½ ds }kjk xzafFk ds vkdkj dk   Xerostomia - (Xero = lw[kk; (stoma ¾ eq[k½ \&           vuqeku ,oa jsfM;ksU;wDykbM LdSu ds }kjk RAIU dh   Fkk;jkW;M dSalj esa RAI dh vfèkd ek=k ds i'pkr~ ykj           x.kuk ds i'pkr~ RAI dh Mkst dk vkdyu fd;k tk   xzafFk;ksa esa Hkh RAIU gksus ds dkj.k bu xzafFk;ksa dks Hkh           ldrk gSA                                   {kfr igqaprh gSA blls ykj dk fuekZ.k Øe'k% ?kVrk                                                      tkrk gS ftlls eqag lw[kk jgrk gS ,oa Hkkstu pckus esa           blh çdkj] RAIU ds vfèkd gksus ij RAI dh de   fnDdr gksrh gSA           ek=k gh xzafFk esa Hkyh\&Hkkafr ,df=r gksdj viuk çHkko           mRiUu dj ysrh gS tcfd RAIU de gksus ij RAI dh   CONTRAINDICATIONS OF RAI                                                    83","Pregnancy  and  lactation \& Fkk;jkW;M xzafFk esa  dh vR;fèkd ek=k laxzfgr gks rc blls Fkk;jksVkWfDld           ,df=r gksus ds iwoZ RAI, jä ds }kjk lEiw.kZ 'kjhj esa  Økbfll tSlh fLFkfr Hkh mRiUu gks ldrh gSA o`) ,oa           çokfgr gksrh gSA xHkkZoLFkk ds nkSjku ;g IyklsaVk ls gksrs  ân; jksfx;ksa ds fy, ;g fo'ks\"k :i ls gkfudkjd gks           gq, xHkZLFk f'k'kq rd igqapdj mldh Fkk;jkW;M xzafFk esa  ldrh gSA blhfy,] ,sls jksfx;ksa esa lhèks gh RAI dh           Hkh ,df=r gksdj mls Hkh {kfr igqapk ldrh gSA blls  vis{kk vkjEHk esa ATD nsuk ,d csgrj fodYi gks ldrk           Hkzw.k esa Hkh gkbiksFkk;jkW;fMTe mRiUu gks ldrk gS tks  gSA ATD ds ç;ksx ds }kjk xzafFk ds fuf\"Ø; gks tkus ls           f'k'kq ds 'kkjhfjd ,oa ekufld fodkl dks vo#) dj  mlesa laxzfgr gkWekZsUl dh ek=k ?kV tkrh gS ftlls           ldrk gSA blh çdkj] Lruiku ds nkSjku nwèk esa fudyus  jsfM,'ku Fkk;jkW;MkbfVl ,oa Fkk;jksVkWfDld Økbfll           okyh RAI] uotkr f'k'kq dks Hkh çHkkfor dj ldrh gSA  dh lEHkkouk de gks tkrh gSA Fkk;jksVkWfDldksfll ds            blhfy,] xHkkZoLFkk ,oa Lruiku ds le; RAI] iw.kZ:i  gYds y{k.k tSls èkM+du ,oa dEiu ds fy, beta           ls fuf\"k) ¼absolutely contraindicated½ gksrh gSA   blockers dk ç;ksx fd;k tk ldrk gSA           RAI ds 6 ekg ckn xHkZ èkkj.k fd;k tk ldrk gSA                                                      ;gk¡ ,d egRoiw.kZ rF; dks è;ku esa vo'; j[kuk           Active GO \& ge tku pqds gSa fd RAI ds }kjk ge  pkfg,A ATD ds ç;ksx ls tc xzafFk fuf\"Ø; gksus yxrh           xzafFk dks fuf\"Ø; djds gkbiksFkk;jkW;fMTe mRiUu djuk  gS rc mlesa vk;ksMhu dk viVsd Hkh ?kV tkrk gSA ,sls           dgrs gSaA ijUrq GO dh fLFkfr esa gkbiksFkk;jkW;fMTe]  esa RAI Hkh xzafFk esa ços'k ugha dj ikrhA blhfy,] ATD           vkW¶FkSyeksiSFkh dks vkSj Hkh vfèkd c<+k ldrh gSA  ysrs gq, dHkh Hkh RAI dk mi;ksx ugha djuk pkfg,A           blhfy,] lfØ; vkW¶FkSyeksiSFkh ds jksfx;ksa esa Hkh RAI   RAI nsus ds iwoZ carbimazole vFkok methimazole           fuf\"k) gksrh gSA                           dks de ls de 3 fnu ,oa PTU dks de ls de 7 fnuksa                                                      ds fy, can dj nsuk pkfg, ftlls RAI dk visf{kr           RADIATION THYROIDITIS                                                      ifj.kke ik;k tk ldsA D;ksafd RAI ds çHkko mRiUu           RAI ls fudyus okys jsfM,'ku ls Fkk;jkW;M QkWfydy   gksus esa yxHkx ,d ls nks ekg dk le; yxrk gS vr%           dh dksf'kdkvksa dks {kfr igq¡prh gS ftlls buesa laxzfgr   bl varjky esa gkWekZsUl dk Lrj de j[kus ds fy, ATD           Fkk;jkW;M gkWekZsUl yhd gksdj jä esa vk ldrs gSaA bls   dks 7 fnuksa ds i'pkr~ nqckjk vkjEHk fd;k tk ldrk gSA           jsfM,'ku Fkk;jkW;MkbfVl dgrs gSaA ;fn xzafFk esa gkWekZsUl                                                                               84","            12 Thyrotoxic Crisis            ;g Fkk;jksVkWfDldksfll ds ,dk,d vfu;af=r gks tkus   (jaundice) Hkh fey ldrh gSA           ls mRiUu gqbZ ,d xaHkhj fLFkfr gS tks le; ij fu;af=r   Marked  tachycardia  and  palpitation \& ;g           u gks ikus ij çk.k?kkrd Hkh gks ldrh gSA mipkj ds   sinus  tachycardia  Hkh  gks  ldrk  gS  ,oa           i'pkr~ Hkh yxHkx 30% jksfx;ksa dks e`R;q ls cpk ikuk   tachyarrhthmia HkhA vfèkd mez ds yksxksa esa ;g atrial            laHko  ugha  gks  ikrkA  bls  thyroid  storm   ;k   fibrillation rd mRiUu dj ldrk gSA           accelerated  hyperthyroidism  Hkh  dgrs  gSaA           vfèkdka'kr;% ;g xzsOl fMlht esa gh gksrh gS ijUrq   Hypotension,  congestive  cardiac  failure                                                      and pulmonary edema \& ân; xfr ds vR;fèkd           dHkh\&dHkh toxic MNG esa Hkh mRiUu gks ldrh gSA   c<+ tkus ds dkj.k ventricular filling time de gksrk           è;ku jgs] bu O;fä;ksa esa Fkk;jkW;M gkWekZsUl dk Lrj   tkrk gSA Venous return ds i;kZIr :i ls vkxs iai u           lnk gh vR;fèkd c<+k gqvk gks] ;g vko';d ughaA           dHkh\&dHkh blls çHkkfor O;fä vis{kk—r de c<+s gq,   fd;s tk ldus ds dkj.k ;g CHF vFkok pulmonary                                                      edema dk :i ys ldrk gSA           Lrj ij Hkh mlds lkFk lkeatL; ugha cSBk ikrs vkSj           Fkk;jksVkWfDld Økbfll dh fLFkfr esa igq¡p tkrs gSaA  vR;fèkd  ?kcjkgV  ¼marked  anxiety½]  dEiu                                                      ¼tremulousness½ ,oa gM+cM+h ¼restlessness½ ds           Precipitating  factors  -  bUQsD'ku]  xgjh  pksV]           ltZjh] xHkkZoLFkk vFkok çlo dqN ,sls çeq[k dkj.k gSa   vfrfjä] dqN O;fä;ksa esa  psychosis]  delirium,                                                      seizures ,oa coma rd mRiUu gks ldrs gSaA           ftuesa ;g fLFkfr mHkj ldrh gSA buds vfrfjä] fcuk           leqfpr rS;kjh o fu;a=.k ds fdlh Fkk;jksVkWfDld jksxh   MANAGEMENT           dks RAI nsus ;k thyroidectomy djus ¼Fkk;jkW;M xzafFk   a) SUPPORTIVE MANAGEMENT           dks fudky nsus½ ls Hkh mlesa laxzfgr Fkk;jkW;M gkWekZsUl   IV fluids - Dehydration ds fy,           ds ,dk,d yhd dj tkus ls Hkh Fkk;jksVkWfDld Økbfll   Cold fomentation and ice packs \& rhoz cq[kkj           mRiUu gks ldrh gSA                         ds  fy,A  è;ku  jgs]  Fkk;jksVkWfDld  Økbfll  esa            CLINICAL MANIFESTATIONS                    salicylates  ds ç;ksx ls cpuk pkfg, D;ksafd ;g           okLro esa Fkk;jksVkWfDld Økbfll] Fkk;jksVkWfDldksfll   Fkk;jkW;M gkWekZsUl dks  TBG ls gVkdj djds Ýh           dh xaHkhjre fLFkfr gh rks gSA vr% blds y{k.k rks   Fkk;jkW;M gkWekZsUl ds Lrj esa o`f) dj ldrs gSaA           lkekU;  Fkk;jksVkWfDldksfll  tSls  gh]  ijUrq  vfèkd   Oxygen and diuretics \& CHF ,oa pulmonary           xaHkhj gksrs gSaA buesa çeq[k y{k.k fuEukafdr gSaA  edema ds fy,A            Hyperthermia \& vR;ar rhoz cq[kkj ,oa vR;fèkd   Propranolol \& Fkk;jkW;M gkWekZsUl dh vR;fèkd ek=k           ek=k esa ilhuk vkuk] yxHkx çR;sd O;fä esa feyrs gSaA  nq\"çHkkoksa ls 'kjhj ¼eq[;r% ân;½ dh j{kk djus ds fy,           Dehydration \& rhoz cq[kkj ,oa vR;fèkd ek=k esa   bldks 'kh?kzrk'kh?kz ?kVkus dh vko';drk gksrh gSA ge           ilhuk vkus ds dkj.k ls ikuh dh deh ¼dehydration½   tkurs gSa fd Fkk;jkW;M gkWekZsUl ds fuekZ.k dks lQyrk           mRiUu gks ldrh gSA                         iwoZd jksd fn, tkus ij Hkh igys ls cuk gqvk gkWekZsu gh                                                      vxys 4-6 lIrkg rd dk;Z djrk jgrk gSA vr% blds           Constitutional features \& dqN O;fä;ksa esa nLr   çHkko dks ?kVkus ds fy, nks fofèk;ka ç;qä dh tkrh gSa \&           (diarrhea)]  myVh  (vomiting)  ,oa  ihfy;k                                                      1½ ân; ij Fkk;jkW;M gkWekZsUl ,oa catecholamines                                                    85","dk çHkko ?kVkus ds fy, IV beta blockers ,oa 2½   SSKI 3 MªkIl fnu esa nks ckj ;k sodium iodide 1           çks\&gkWekZsu T4 ds lfØ; gkWekZsu T3 esa ifjorZu dks  xzke IV \& Fkk;jkW;M xzafFk ls Fkk;jkW;M gkWekZsUl dk           jksddj A rhoz ân; xfr] ?kcjkgV] dEiu] ,oa gM+cM+h  fudyuk ?kVkdj vk;ksMhu Fkk;jksVkWfDld Økbfll esa           ds fy, \& bls 40-80 fexzk eq[k ls] fnu esa pkj ckj ;k  rqjar ykHk çnku djrh gSA okLro esa] Fkk;jksVkWfDld           çR;sd pkj ?kaVs esa 1-2 fexzk IV dh Mkst esa ç;ksx fd;k  Økbfll ds bejtsalh mipkj esa vk;ksMhu gh lokZfèkd           tk ldrk gSA Adrenergic symptoms dks de djus  ykHkdkjh mik; gSA è;ku jgs] vk;ksMhu dks  ATD           ds vfrfjä propranolol, T4 ls T3 cuus dh çfØ;k  vkjEHk djus ds i'pkr~ ;k lkFk gh vkjEHk djrs gSaA           dks Hkh ckfèkr djrh gS ftlds dkj.k bls vU; beta  ,slk blfy, D;ksafd ATD, Fkk;jkW;M xzafFk esa vk;ksMhu           blockers ij ojh;rk nh tkrh gSA             dk viVsd ?kVkrs gSa vU;Fkk ;gh vk;ksMhu dqN le;                                                      i'pkr~ Fkk;jkW;M gkWekZsUl dk mRiknu c<+kus esa Hkh enn           b) DEFINITIVE THERAPY           Fkk;jksVkWfDld Økbfll dk ewy dkj.k rks Fkk;jkW;M   djuk vkjEHk dj ldrh gSA           gkWekZsUl dh vfèkdrk gS vr% bldk okLrfod mipkj   Antithyroid drugs \& T4 ls T3 esa ifjorZu dks           Hkh Fkk;jkW;M gkWekZsUl ?kVkuk gh gSA çkFkfedrk dh –f\"V  jksd ldus ds xq.k ds dkj.k gh PTU  dks fo'ks\"k :i esa           ls ;g dk;Z fuEukafdr Øe esa fd;k tk ldrk gSA   thyrotoxic storm esa ç;ksx esa ykrs gSaA vfèkd ek=k esa           I) Fkk;jk;M xzafFk ls Fkk;jkW;M gkWekZsUl dk fudyuk   (500-1000 fexzk loading  dose nsus ds ckn 250           jksddj] ii) Fkk;jkW;M xzafFk ls fudy pqds Fkk;jkW;M   fexzk çR;sd  4 ?kaVs esa½] Fkk;jksVkWfDld Økbfll esa           gkWekZsUl dks fuf\"Ø; djds \& ;g dk;Z T4 dks T3 esa   fo'ks\"k:i ls ykHknk;d gksrh gS D;ksafd ;g T4 ls T3           cnyus ls jksddj fd;k tk ldrk gS] iii) Fkk;jkW;M   cuus dh çfØ;k ?kVkdj 'kh?kz ykHk çnku djrh gSA blds           gkWekZsUl ds mRiknu dks ?kVkdjA            vfrfjä ;g vk;ksMhu viVsd dks Hkh ckfèkr djrh gSA           bu dk;kZs ds fy, fuEukafdr nok,a ç;ksx esa yk;h tk   PTU, iodine ,oa corticosteroid ds lfEefyr ç;ksx           ldrh gSaA                                  ls T3 dk Lrj 1-2 fnuksa esa gh lkekU; Lrj ij vk                                                      tkrk gSA ijUrq xaHkhj nq\"çHkkoksa ds dkj.k PTU dks cgqr           Corticosteroids - Hydrocortisone 300 mg IV           bolus nsus ds ckn 100-150 fexzk çR;sd 8 ?kaVs esa ;k   yEcs le; rd ç;ksx esa ykuk mfpr ugha gksrkA           dexamethasone 8 fexzk eq[k ls \& ;g Fkk;jkW;M   Økbfll ls mcjus ds i'pkr~ PTU ds LFkku ij bldh           xzafFk ls Fkk;jkW;M gkWekZsUl dk fudyuk ?kVkus ,oa T4 ls   rqyuk esa vfèkd lqjf{kr carbimazole 10-20 fexzk           T3 cuus esa ckèkk Mkydj lgk;d gks ldrs gSaA lkFk gh   çR;sd 6 ?kaVs esa ;k methimazole 10-20 fexzk çR;sd           ;g ruko ls yM+us dh {kerk mRiUu djus esa Hkh enn   8 ?kaVs esa dks vkjEHk dj fy;k tkrk gS tks Fkk;jk;M           djrk gSA                                   gkWekZsUl ds mRiknu dks ?kVkdj yEcs le; rd fu;a=.k                                                      dks cuk;s j[kus esa lgk;d gksrh gSaA           Iodine - Lugol's iodine 5 MªkIl izR;sd 6 ?kaVs esa ;k                                                                    86","13                                 Graves’ Ophthalmopathy            xzsOl fMlht ¼Graves’ disease - GD½ esa vk¡[kksa esa  gkbiksFkk;jkW;M ¼vkVks\&bEE;wu gkbiksFkk;jkW;fMTe½ rd           mRiUu  gksus  okys  ifjorZuksa  dks  xzsOl  vkWIFkSYeksiSFkh  gks ldrs gSaA GD ds Fkk;jkW;M lEcafèkr vfu;ferrkvksa           (Graves’  opthalmopathy  -  GO) dgk tkrk gS  ds fdlh Hkh Qst ¼gkbij] gkbiks vFkok ;wFkk;jk;M½ esa            ftldk vFkZ gS] GD esa vk¡[kksa esa gksus okyk jksxA ijUrq  fey  ldus  dh  lEHkkouk  ds  dkj.k  bls  thyroid           okLro esa GD ds fo'ks\"k çHkko rks eye balls ds ckgj]   associated ophthalmopathy (TAO) ds uke ls Hkh           vkWfcZV  esa  fLFkr  extraoccular  muscles  ,oa  tkuk tkrk gSA           retrobulbar fat esa vkrs gSaA blhfy, ;g çLrko j[kk   EPIDEMIOLOGY           x;k fd bls opthalmopathy u dgdj orbitopathy   GO lkekU;r;% 30 ls 50 o\"kZ dh vk;q oxZ esa ik;h           dguk vfèkd mfpr gksxkA ijUrq GD dh çkjafHkd   tkrh gSA GD esa efgyk\&iq#\"k vuqikr  8:1 ds foijhr           voLFkk esa ,oa mild GO esa rks vkWfcZV ds mijksä nksuksa   GO esa ;g yxHkx 2-3:1 gksrk gSA jksx dh xaHkhjrk           vax Hkh çHkkfor ugha gksrsA blhfy,] blds fy, ,d   iq#\"kksa ,oa o`) O;fä;ksa esa vfèkd gksrh gSA           vkSj uke] thyroid eye disease (TED)  Hkh çLrkfor           fd;k x;kA                                  10% O;fä;ksa esa ;g fdlh ,d rjQ ¼unilateral½ gks                                                      ldrh gS ftlesa vkWfcZV esa vk¡[kksa ds ihNs fdlh Vîwej           GD  esa  TSH  fjlsIVj  ds  fo#)  cuus  okyh   ¼retro-orbital  tumor½ dh lEHkkouk vfèkd çrhr           vkVks\&,aVhckWMht] vkWfcZV ds QSV ,oa ekalisf'k;ksa ls Hkh   gksrh gSA vkWfcZV dh vYVªklksuksxzkQh vFkok CT LdSu esa           cross react djds muesa bU¶yses”ku mRiUu djrh gSaA   extra-occular muscles dh lwtu ds }kjk GO dh           blls mudk vk;ru c<+ tkrk gS ,oa vk¡[ksa ckgj fudy   iqf\"V dh tk ldrh gSA           vkrh gSaA è;ku djsa] nksuksa vka[ksa] fijkfeM ds vkdkj dh           vkWfcZV esa j[kha jgrh gSa ftlesa og vxys Hkkx ds   CLINICAL MANIFESTATIONS           vfrfjä] pkjksa vksj ls gfì;ksa ls f?kjh jgrh gSaA ,sls esa   GD ds Fkk;jkW;M xzafFk ds vfrfjä mRiUu gksus okys           ;fn vk¡[kksa ds ihNs dksbZ soft tissue tSls QSV tek gksrk   y{k.kksa esa GO gh loZçeq[k gSA okLro esa bldk dksbZ ,d           gS rks og vk¡[kksa dks vkWfcZV ls vkxs <dsy nsxkA ;gh   fof'k\"V y{k.k ugha gksrkA ;g vusd :iksa esa çdV gks           okLrfod exophthalmos gSA lkeus ls ns[kus ds LFkku   ldrh gSA vkb;s budks Øeokj le>rs gSaA           ij bls cxy ls ns[kus esa ljyrk ls le>k tk ldrk   Lacrimation - GO  esa vk¡[kksa ds vfèkd [kqys gksus o            gSA Hurthle's exophthalmometer  dh enn ls cksuh  okrkoj.k ds laidZ esa jgus ds dkj.k mlds Åij vkalw           vkWfcZV dh lateral wall ls vk¡[kksa ds lcls vxys Hkkx  dh tear film lw[k tkrh gS ftlls iydksa ds pyus esa           dh nwjh }kjk bldks ekik Hkh tk ldrk gSA    jxM+ ¼grittiness½  yxrh gS ,oa ihM+k ¼pain½  gksrh gSA            GO ds fo\"k; esa ,d fo'ks\"k rF; ;g gS fd ;g lnk   bl jxM+ dks de djus ds ç;kl esa vkalw fudyuk           gkbZijFkk;jkW;fMTe ds lkFk gh feys] ;g vko';d ughaA   ¼lacrimation½ c<+ tkrk gSA çkWIVksfll ds dkj.k bldk           GO ds 90% jksxh rks GD dh gkbijFkk;jkW;M voLFkk   Hkyh\&Hkkafr fudkl u gks ikus ds dkj.k ;g fupyh iyd           esa çdV gksrs gSa ijUrq yxHkx 10% jksxh ;wFkk;jkW;M   ls Vidrk jgrk gSA           voLFkk  esa  Hkh  fey  ldrs  gSaA  bu  jksfx;ksa  esa   Eye  lids  -  Sympathetic  stimulation  ds dkj.k           gkbijFkk;jkW;fMTe] GD ds ,d o\"kZ iwoZ vFkok ,d o\"kZ  Åijh iyd dh Muller's muscle ds ladqpu ls Åijh            ckn] dHkh Hkh fey ldrh gSA GD ds 5% jksxh rks  iyd vkSj Åij f[kap tkrh gS (Lid retraction) A xaHkhj                                                     87",":i ls c<+h gqbZ GD esa Åij o uhps dh iydsa lwth ,oa  vksj ns[kus ¼supero-lateral gaze½ ij çdV gksrk gSA           mHkjh gqbZ fn[kk;h nsrh gSa ,oa buds pkjksa vksj Hkh lwtu   Optic nerve - Orbital contents esa lwtu ls vkWfIVd           (Periorbital edema) vk tkrh gSA            uoZ ij ncko iM+rk gSA ckgj ls iM+us okys bl ncko ls            Palpebral fissure \& ;g vkdkj esa cM+k gks tkrk gSA  vkWfIVd uoZ dk exoplasmic  flow #dus yxrk gS           lkekU;r;% cornea dk Åijh 1/5 Hkkx Åijh iyd ls  ftlls blds vfxze fljs ij lwtu ¼papilledema½  vk           <adk jgrk gSA ,sls esa ;g [kqy tkrk gS ,oa Åijh sclera  tkrh gSA uoZ ds ckgjh QkbclZ ds ncus ls loZçFke –f\"V           fn[kus yxrk gSA dHkh\&dHkh fupyh iyd esa Hkh ,sls gh  {ks= dk ckgjh Hkkx çHkkfor gksrk gS ¼visual  field           ifjorZu vkrs gSaA                          constriction½ tks ncko ds c<+us ls Øe'k% fldqM+rk            Conjunctiva \& xaHkhj :i ls c<+h gqbZ GO esa blesa   gqvk yxHkx 5% O;fä;ksa esa iw.kZ vaèkrk ¼complete            lwtu  (chemosis)]   ykyh  (congestion)   ,oa   loss  of  vision½ rd mRiUu djk ldrk gSA bls                                                      dysthyroid optic neuropathy (DON)  dgrs gSaA           discharge Hkh mRiUu gksus yxrk gSA bu y{k.kksa dks           active GO dk |ksrd ekuk tkrk gSA           MANAGEMENT OF GO           Sclera \& blesa jä çokg c<+ tkus ls ykyh  (scleral   GO dk ewy dkj.k gS vkWVks\&bEE;wfuVhA GD ds mipkj           injection) mRiUu gks ldrk gSA              ds nkSjku tSls\&tSls ;g vkWVks\&bEE;wfuVh ?kVrh tkrh gS]                                                      vfèkdk¡'k jksfx;ksa esa GO esa Hkh lqèkkj gksrk tkrk gSA           Cornea - Palpebral fissure ds c<+ tkus ls lksrs   blhfy,] GD ls çHkkfor vfèkdk¡'k O;fä;ksa esa gydh           le; cornea [kqyh jg tkrh gS ftlls ;g lw[k tkrh gS   GO ds fy, dksbZ vyx ls mipkj dh vko';drk ugha           (corneal xerosis)A xaHkhj :i ls c<+h gqbZ GO esa   gksrhA fdUrq xaHkhj GO ds fy, dqN fof'k\"V mik; fd;s            cornea esa Hkh lwtu] èkqaèkykiu] fMLpktZ (exposure   tkrs gSaA           keratitis)  ,oa  ;gk¡  rd  fd  vYlj   (corneal           ulceration)  Hkh mRiUu gks ldrs gSaA ;g Hkh GO esa   Dark glasses with side frames \& vk¡[kksa dks rst            acivity ds |ksrd ekus tkrs gSaA            gok] èkwy o xnkZ ls cpkus ds fy,A           Orbital fat - GD esa cuus okyh ,aVhckWMht] Fkk;jkW;M   Eye covers - Exophthalmos ds dkj.k tc lksrs           xzafFk ds vfrfjä orbital fat ls Hkh cross react djds   le; iydsa vk¡[kksa dks iwjh rjg <¡d ugha ikrha rc bu           buesa bU¶yses”ku mRiUu dj nsrh gSaA blls buesa lwtu   doj ds ekè;e ls iydksa dks iwjh rjg can djds nck           vk tkrh gS ,oa budk vk;ru c<+ tkrk gSA pkjksa vksj   fn;k tkrk gSA blls corneal xerosis dks ?kVkus esa           ls gfì;ksa ls f?kjh vkWfcZV esa ;g dsoy ckgj dh vksj gh   enn feyrh gSA           QSy ikrk gS ftlls eye balls ckgj mHkj vkrh gSaA ;gh   Beta  blockers  -  Sympathetic  stimulation  ls           okLrfod exophthalmos dgykrk gSA Sympathetic  mRiUu gksus okys y{k.k ¼lid retraction ,oa palpebral           stimulation ls dsoy palpebral fissure ds c<+ tkus   fissure dk c<+uk½ bR;kfn ds fy,A           dks exophthalmos le>uk mfpr ugha gksrkA    Diuretics - Periorbital edema dks de djus ds            Extra-occular muscles (EOM) - Orbital fat dh  fy,A lksrs le; iyax dk fljgkuk Åapk j[kus ls Hkh           gh  Hkkafr  EOM  esa  Hkh  immunological  cross  blesa vkjke feyrk gSA           reactivity  ls  bU¶yses”ku  mRiUu  gks  ldrk  gSA   Artificial tears \& vk¡[kksa esa xM+u ,oa pqHku de djus           ekalisf'k;ksa dh lwtu ls muds ladqpu esa ckèkk mRiUu   ds fy,A           gksrh gS tks diplopia  ds :i esa çdV gks ldrh gSA           çkjEHk esa vfèkdk¡'k jksfx;ksa esa ;g Åij ,oa ckgj dh   Prism in spectacles – Mild diplopia ds fuokj.k                                                      88","ds fy,A                                    ç;ksx ls gkbiksFkk;jkW;M voLFkk esa u igq¡p tk,A ,slk                                                       blfy, D;ksafd gkbiksFkk;jkW;fMTe esa c<+us okyk TSH,           Corticosteroids  \&  xaHkhj  GO  esa  chemosis,           conjunctival congestion] vk¡[kksa ds pkjksa vksj fLFkr   orbital fat dks mÙksftr djrk gqvk GO dks vkSj Hkh           ekalisf'k;ksa ds çHkkfor gksus ij ¼EOM  palsies½]   c<+k ldrk gSA blhfy, bu jksfx;ksa esa jsfM;ks,fDVo           exopthalamos vFkok vkWfIVd uoZ ds çHkkfor gksus   vk;ksMhu fFkjSih fuf’k) (contraindicated) gksrh gS tks           dh fLFkfr esa budk ç;ksx djuk iM+rk gSA gYdk çHkko   dqN le; esa O;fä dks gkbiksFkk;jkW;M cuk nsrh gSA           gksus ij prednisolone  ¼vkjEHk esa 60 fexzk eq[k ls   ATD  ds çHkkoh u gksus ij gkbijFkk;jkW;fMTe ds           çfrfnu nsus ds ckn bls çR;sd 2 lIrkg esa 10 fexzk   fu;a=.k ds fy, thyroidectomy gh çHkkoh fodYi           ?kVkrs gq, Øe'k% can djuk½ gh çHkkoh jgrk gS tcfd   cprk gSA            xaHkhj çHkko gksus ij IV methylprednisololone  dh   GD esa Fkk;jkW;M xzafFk vR;fèkd lfØ; gks tkrh gSA           pulse therapy ¼vkjEHk esa 6 lIrkg rd 500 fexzk IV  blls xzafFk dh oSLdqySfjVh cgqr c<+ tkrh gS ,oa xzafFk           çR;sd lIrkg nsus ds ckn vxys 6 lIrkg rd 250   vR;fèkd eqyk;e gks tkrh gS tks ltjhZ ds nkSjku FkksM+k           fexzk IV çR;sd lIrkg½ vfèkd çHkkoh jgrh gSA  Hkh tksj iM+us ij QV ldrh gSA blds vfrfjä] xzafFk esa                                                      i;kZIr ek=k esa Fkk;jkW;M gkWekZsUl Hkh ,df=r jgrs gSa tks           Immuno suppressive agents and external           beam radiation \& fodYi ¼second line drugs½ ds  xzafFk ds dVus ij yhd gksdj jDr  esa igq¡p dj           :i  esa  prednisone  +/-  cyclosporine  ;k   thyrotoxic crisis mRiUu dj ldrs gSaA bUgha nq\"çHkkoksa           azathioprine,   rituximab vFkok teprotumumab  ls cpus ds fy,  active  GD esa ltZjh ds iwoZ dqN           dks ç;ksx fd;k tk ldrk gSA vfuf'pr çHkkoksa ds  rS;kfj;ka djuh iM+rh gSaA ;g fuEukafdr gSaA           dkj.k vc budk ç;ksx ugha fd;k tkrk gSA     ATD \& yxHkx 6 lIrkg rd ATD ds ç;ksx ls xzafFk dh            Orbital  decompression  -  Optic  nerve    hyperactivity esa deh vkrh gS ,oa jksxh ltZjh ds fy,           compression ds dkj.k ;fn vaèkiu dk ladV mRiUu   csgrj :i ls rS;kj gks tkrk gSA           gks jgk gks rc vkWfcZV dh nhokj dks dkVdj rkRdkfyd                                                      SSKI - 1-2 MªkWi] fnu esa rhu ckj 10 fnukas rd \& ;g           ykHk fy;k tk ldrk gSA blls vkWfcZV esa ,df=r soft                                                      xzafFk dh oSLdqySfjVh de djus ,oa ltZjh ds nkSjku           tissue dk vkWfIVd uoZ ij ncko de gks tkrk gSA ATD           ,oa corticosteroids ds ekè;e ls GO dh lfØ;rk esa   Fkk;jksVkWfDld Økbfll mRiUu gksus ls jksdus esa lgk;d           deh vkus ds i'pkr~ bldks ltZjh ds }kjk nksckjk Bhd   gksrk gSA           fd;k tk ldrk gSA                           Sodium  ipodate  or  iopanoic  acid  \&  ;g                                                      thyrotoxic crisis ds lEHkkouk gksus ij vR;ar mi;ksxh           PRECAUTIONS                                                      jgrs gSaA ;g Fkk;jkW;M gkWekZsUl ds cuus dh çfØ;k esa           GO ls çHkkfor O;fä;ksa ds mipkj esa ,d rF; dks           fo'ks\"k :i ls è;ku esa j[kuk pkfg,A bu O;fä;ksa esa   ckèkk mRiUu djrs gSa] xzafFk ls mudh release dks ?kVkrs           antithyroid drugs (ATD) dks ç;ksx djrs le; fo'ks\"k   gSa ,oa izksgkWeksZu T4 ds lfØ; gkWeksZu T3 esa cnyus dks           :i ls è;ku j[kuk pkfg, fd gkbijFkk;jkW;fMTe dks   jksdrs gSaA bl çdkj ls ;g vR;ar xaHkhj jksxh esa 'kh?kzrk           fu;af=r djrs le; O;fä ATD dh vfèkd ek=k ds   ls euthyroid status ykus esa lgk;d gksrs gSaA                                                              89","[kaM\&4                                             xHkkZoLFkk ,oa ckY;koLFkk esa Fkk;jkW;M xzafFk ds fodkj                   (Thyroid Disorders in Pregnancy and Chidhood)","14                              Thyroid Disorders in Pregnancy            xHkkZoLFkk esa ek¡ ds 'kjhj dh fQft;ksykWth vk'p;Ztud   goitrogenesis dk dkj.k curk gSA           :i ls cny tkrh gSA bu cnykoksa dh i;kZIr tkudkjh   vkjEHk esa TSH ds c<+us ls Fkk;jkW;M xzafFk dh lfØ;rk           u  gksus  ij  ;g  lkekU;  cnyko  (normal   Hkh c<+us yxrh gS ftlls T3 ,oa T4 dk Lrj lkekU;           physiological  adaptations)  Hkh  gesa  fdlh  jksx   cuk;s j[kus esa enn fey tkrh gSA ijUrq vk;ksMhu dh           ¼pathological disorder½ dh Hkkafr çrhr gks ldrs gSaA           fQthf'k;u ,oa xk;usdksykWftLV] nksuksa dks gh] bu   vR;fèkd deh gksus dh n'kk esa T3 ,oa T4 dk Lrj ?kVus           cnykoksa dh i;kZIr tkudkjh gksuk vko';d gS ftlls os   yx tkrk gS ftlls gestational hypothyroidism  Hkh           bl voLFkk esa feyus okys ck;ks dsfedy ifjorZuksa ls   mRiUu gks ldrh gSA           xqejkg u gksdj] fLFkfr dks mfpr çdkj ls le>rs gq,   bl çdkj] vk;ksMhu ds urinary excretion c<+us ds           mlij lgh fu.kZ; ys ldsaA bl fo\"k; esa loZçFke   fuEukafdr çHkko gks ldrs gSa \&            le>rs gSa fd lkekU; xHkkZoLFkk dk Fkk;jkW;M xzafFk dh   - vk;ksMhu ds i;kZIr ek=k esa miyCèk gksus ij \& dksÃ           dk;Zç.kkyh ij D;k çHkko iM+rk gS ,oa mlds ckn   ifjorZu ugÈ vFkok Fkk;jkW;M xzafFk ds vkdkj esa           le>saxsa fd gkbiksFkk;jkW;fMTe ,oa gkbijFkk;jkW;fMTe]   ekewyh o`f) dk gksuk           fdl çdkj ls xHkkZoLFkk esa ek¡ ,oa f'k'kq dks çHkkfor   - vk;ksMhu dh FkksM+h deh gksus ij \& gestational             djrs gSaA                                   goiter                                                        - vk;ksMhu dh dkQh deh gksus ij \& gestational            EFFECTS OF PREGNANCY ON THYROID            HOMEOSTASIS                                hypothyroidism                                                      BY INCREASING TBG LEVELS           xHkkZoLFkk] Fkk;jkW;M gkeksZUl ds larqyu dks 3 çdkj ls           çHkkfor djrh gSA                           xHkkZoLFkk esa TBG vfèkd ek=k esa fuÆer gksrk gS ,oa           - vk;ksMhu dk urinary excretion c<+kdj     bldh esVkckWfyTe ?kV tkrh gSA ÃLVªkstsu ds çHkko esa            - ÃLVªkstsu  ds  }kjk  thyoxine  binding  globulin   bldk sialylation Hkh c<+ tkrk gS ftlls TBG dh            ¼TBG½ dks c<+kdj] ,oa                     gkQ ykbQ Hkh c<+ tkrh gSA bl çdkj TBG  dh c<+h           - IyklsaVk ds hCG ds }kjk Fkk;jkW;M xzafFk dks mÙksftr   ek=k] T3 ,oa T4 dh igys ls vfèkd ek=k dks vius            djdsA                                     lkFk tksM+ ysrh gSA T;ksa gh jä esa mifLFkr Ýh T3 ,oa                                                      Ýh T4] TBG ls tqM+rs gSa] buds jä Lrj esa rkRdkfyd           BY INCREASING URINARY EXCRETION OF           IODINE                                     deh vkus yxrh gSA Fkk;jkW;M xzafFk ds lkekU; gksus dh           vk;ksMhu  dh  miyCèkrk  lkekU;  gksus  dh  n'kk  esa   fLFkfr esa ,slk gksus ij xzafFk ls Fkk;jkW;M gkWeksZUl dk           vk;ksMhu ds excretion c<+us dk dksÃ çHkko Fkk;jkW;M   mRiknu c<+ tkrk gS ftlls ;g iqu% vius iwoZ Lrj ij           xzafFk ij ugÈ iM+rk ijUrq blds vko';drk ls de gksus   igq¡p tkrs gSaA bl çdkj] ;g Ýh T3 ,oa Ýh T4 gkWeksZUl           ij] xHkZorh ek¡ esa vk;ksMhu dh deh gksus yxrh gS   rks nksckjk vius iwoZorÊ Lrj ij igq¡p tkrs gSa ijUrq           ftlls T3 ,oa T4 ds mRiknu esa deh vkus yxrh gS ,oa    TBG ls tqM+s] bound T3  ,oa T4 gkWeksZUl ds Lrj           TSH dk lzko.k c<+ tkrk gSA ;g TSH] Fkk;jkW;M xzafFk   c<+rs tkrs gSaA ;g gesa c<+s gq, total ¼free $ bound½           dks mÙksftr dj] mlds vkdkj esa o`f) djk nsrk gSA   T3 ,oa total T4 ds :i esa fn[kkÃ nsrk gSA           vk;ksMhu dh deh ls çHkkfor {ks=ksa esa ;gh gestational   bl çdkj] TBG ds c<+us ls T3 ,oa T4 gkWeksZUl esa                                                     91","fuEukafdr ifjorZu mRiUu gksrs gSa \&        lajpukRed :i ls TSH tSlk gksus ds dkj.k] TSH           - ukeZy ;k gkÃ ukeZy free T3 ,oa free T4 gkWeksZUl  fjlsIVj ls tqM+dj Fkk;jkW;M xzafFk ls T3 ,oa T4 dk           - c<+s gq, total T3 ,oa total T4 gkWeksZUl \& total T4 rks   lzko.k c<+k nsrk gS tks iqu% TSH dk lzko.k ?kVk nsrs gaSA            vius mPpre Lrj ds 1.5  xqus rd c<+ ldrs gSaA  Fkk;jkW;M gkWeksZUl esa vk;s ;g ifjorZu èkM+du] mÙkstuk                                                      ,oa 'kjhj esa xeÊ mRiUu dj ldrs gSaA           BY SECRETING PLACENTAL hCG           hCG gh gS ;g IyklsaVk ls cuus okyk   hCG] ,d   Multiple  pregnancies,  hyperemesis           XykbdksçksVhu gkWeksZu gS ftldh vYQk\&lc;wfuV TSH   g r a v i d a r u m ,   v e s i c u l a r   m o l e   , o a                                                      choriocarinoma esa IyklsaVk esa cuus okyk hCG Hkh           ds gh leku gksrh gSA blh ds dkj.k hCG]  TSH           fjlsIVlZ ls tqM+dj] TSH dh gh Hkkafr gh Fkk;jkW;M   vR;fèkd  c<  tkrk  gS  ftlls  ,d  Fkk;jksVkWfDld           xzafFk dks mÙksftr dj ldrk gSA xHkkZoLFkk dh çFke   voLFkk mRiUu gks ldrh gSA D;ksafd IyklsaVk esa  hCG           frekgh esa IyklsaVk ds hCG ds dkQh c<+s gq, Lrj]   eq[;r% çFke frekgh esa gh curk gS blhfy, ;g           Fkk;jkW;M xzafFk ls T3 ,oa T4 dk lzko.k c<+k nsrs gSa tks   Fkk;jksVkWfDld voLFkk Hkh çFke frekgh esa jgrh gqÃ]                                                      f}rh; frekgh ls Øe'k% ?kVuh vkjEHk gks tkrh gSA bls           iqu% fuxsfVo QhMcSd ls fiVîwVjh ls TSH dk lzko.k                                                      gestational  thyrotoxicosis]  transient           ?kVk nsrs gSaA okLro esa] xHkkZoLFkk dh çFke frekgh ds   hyperthyroidism  vFkok                                                                            gestational  transient           nkSjku tSls\&tSls hCG ds Lrj c<+rs tkrs gSa] oSls\&oSls   thyrotoicosis ¼GTT½ dgrs gSaA           gh TSH ds Lrj ?kVrs tkrs gSaA nwljh frekgh ds ckn ;g                                                      Placental transfer and metabolism of TH -           nksuksa Øe'k% vius iwoZorÊ Lrjksa ij ykSV vkrs gSaA                                                      è;ku jgs] Fkk;jWk;M xzafFk ds mRiUu gksus ds iwoZ f'k'kq]           bl çdkj] ge le> ldrs gSa fd xHkkZoLFkk] okLro esa   Fkk;jkW;M gkWeksZUl dh vko';drkvksa ds fy, iw.kZ:i ls           Fkk;jkW;M xzafFk ds fy, ,d ruko ds leku gksrh gS   ek¡ ij gh fuHkZj jgrk gSA ijUrq] ek¡ esa cuus okys ;g           ftlesa Fkk;jkW;M xzafFk dk vkdkj c<+ ldrk gS] çFke   gkWeksZUl] IyklsaVk ls gksdj ;w¡ gh ugÈ fudyrs tkrsA           frekgh esa T3 ,oa T4 ds Lrj c<+ tkrs gSa ,oa TSH dk   IyklsaVk bl materno-fetal transport dks vfu;af=r           Lrj ?kV tkrk gSA ,sls esa] tc xHkkZoLFkk Lo;a gh   gksus  ls  Hkh  cpkrk  gSA  IyklsaVk  esa  feyus  okys           esVkckWfyTe ds c<+us ds y{k.k mRiUu djrh gks] rc ;g   deiodinase enzymes ¼D2 tks T4 dks T3 esa cnyrk                                                      gS ,oa D3 tks T3 ,oa T4 dks fuf\"Ø; djrk gS½ Hkh           le>k  tk  ldrk  gS  fd  mijksä  biochemical           adaptations ds dkj.k] xHkkZoLFkk esa mRiUu gksus okys   xHkZLFk f'k'kq esa Fkk;jkW;M gkWeksZUl dh vfrfjä ek=k dks           lkekU; ifjorZu ,oa gkbijFkk;jkW;fMTe tSls fdlh jksx   igq¡pus ls jksdrs gSaA bu ckèkkvksa ds jgrs xHkZLFk f'k'kq dks           esa foHksn djuk fdruk dfBu gks ldrk gSA    Fkk;jkW;M gkWeksZUl dh fu;fer vkiwÆr lqfuf'pr djus                                                      ds fy, gh ek¡ esa Fkk;jkW;M gkWeksZUl ds Lrj 1.5 xquk rd           EFFECTS OF PLACENTA ON TH                  c<+ tkrs gSaA           IyklsaVk] ek¡ ,oa xHkZLFk f'k'kq dks tksM+us okyh dM+h gSA           Maternal ,oa fetal functions dks ;g nks çdkj ls   EFFECTS  OF  THYROID  FUNCTIONS  ON                                                      PLACENTA           çHkkfor dj ldrh gSA           - hCG mRiUu djds] ,oa                      ,slk ugÈ fd dsoy IyklsaVk gh Fkk;jkW;M xzafFk dh           - T3  ,oa  T4  ds  materno\&fetal  transport  dks   xfrfofèk;ksa dks çHkkfor djrk gSA Fkk;jkW;M xzafFk dh            çHkkfor djds                              xfrfofèk;ka Hkh IyklsaVk ds fodkl dks çHkkfor djrh gSaA                                                      Fkk;jkW;M gkWeksZUl ds fodkjksa ls mRiUu gksus okyk           Placental production of hCG - ge le> pqds gSa   IyklsaVk dk vlkekU; fodkl gh vusdksa çlo lEcafèkr           fd çFke frekgh ds le; IyklsaVk ls cuus okyk hCG]   nq\"ifj.kkeksa dk dkj.k curk gSaA                                                     92","TRANSIENT  HYPERTHYROIDISM  OF             GTT rks ,d physiological state gS ftlds y{k.k           PREGNANCY                                  dkQh gyds gksrs gSa ,oa Lor% gh Bhd gks tkrs gSaA           xHkkZoLFkk ds nkSjku gkbijFkk;jkW;fMTe dk lcls vke  blhfy,  ,sls  esa  gkbijFkk;jkW;fMTe  ds  fy,  fdlh           dkj.k Graves’ disease gksrk gS ftlesa TSH fjlsIVj  fof'k\"V  mipkj  dh  vko';drk  ugÈ  iM+rhA  pk;]           ds fo#) cuus okyh stimulatory antibodies }kjk  fepZ\&elkys]  ?kh\&rsy  fpdukÃ  ,oa  rh[ks  O;atuksa  ls           mÙksftr fd;s tkus ls Fkk;jkW;M xzafFk ls Fkk;jkW;M  ijgst rFkk ,d ckj esa Hkkstu dh FkksM+h ek=k ysus ls           gkWeksZUl dk vfu;af=r mRiknu gksrk gSA ¼1½ xHkkZoLFkk ds  myVh\&feryh dh lEHkkouk de dh tk ldrh gSA çksVhu           nkSjku gh gkbijFkk;jkW;fMTe dk ,d vU; dkj.k  ;qä Hkkstu] gastric dysmotility dks Bhd djus esa ,d           transient  hyperthyroidism  of  pregnancy  ¼;k  lhek rd lgk;d gks ldrs gSaA vnjd ds ç;ksx ,oa           gestational transient thyrotoxicosis] GTT½ Hkh gS   accupressure  ls  Hkh  lgk;rk  fey  ldrh  gSA           ftlesa IyklsaVk ls cuus okyk hCG] lajpukRed :i ls  ued\&uhEcw  ;qä  rjy  inkFkZ  dehydration  ,oa           TSH ds tSlk gksus ds dkj.k] TSH fjlsIVj ls tqM+dj   electrolyte imbalance Bhd djus esa lgk;d gksrs           Fkk;jkW;M xzafFk dks mÙksftr djrk gSA xHkkZoLFkk ds  gSaA  mijksä  fofèk;ksa  ls  vkjke  u  feyus  ij           12\&16 lIrkg rd hCG ds fuekZ.k ds ?kVrs tkus ds   pyridoxine-doxylamine]  antiemetics  ¼tSls           dkj.k bldk çHkko Hkh bUgÈ fnuksa rd lhfer jgrk gSA   ondansetron]  phenothiazine]  chlor-           xHkkZoLFkk  esa  yxHkx  1\&3%  xHkZorh  efgykvksa  dks   promazine]  prochlorperazine  ,oa  pro-           çHkkfor djrk gqvk ;g bldh igyh ;k nwljh frekgh   methazine½]  anti-histaminics  ¼tSls  meclizine]           ds var rd Lor% gh Bhd gks tkrk gSA         dimenhyrdinate]  ,oa  diphenhyramine½  rFkk            CINICAL MANITESTATIONS                     prokinetics  ¼tSls  metoclopramide  ;k           çFke frekgh esa gksus okyh vR;fèkd myVh ds dkj.k   domperidone½ dk ç;ksx fd;k tk ldrk gSA            dehydration ¼ikuh ds fudy tkus ls½] electrolyte  lkekU; xHkkZoLFkk dh vis{kk—r] twin pregnancy ,oa           disturbances ¼bysDVªksykbV~l ds fudy tkus ls½]   hyperemesis gravidarum esa hCG ds Lrj vfèkd           metabolic  alkalosis  ¼,flM ds fudy tkus ls½]  gksrs gSa ftlds dkj.k bu fLFkfr;ksa esa gkbijFkk;jkW;fMTe           ketonuria ,oa 5% ls vfèkd otu dk ?kVuk ¼myVh  dh  xaHkhjrk  Hkh  vfèkd  gks  ldrh  gSA  ;g           esa Hkkstu ds fudy tkus ls½ blds çeq[k y{k.k gks ldrs   hypertension]  pre\&eclampsia]  congestive           gSaA                                       cardiac failure ,oa placental abruption rd dk                                                      dkj.k cu ldrs gSaA fLFkfr ds xaHkhj gksus ij buds fy,           ,d tSls y{k.k ,oa feyrs\&tqyrs Fkk;jkW;M gkWeksZUl ds           Lrjksa  ds  dkj.k  mijksä  fodkjksa  ¼disorders½  ,oa   dqN le; rd ATD tSls PTU dh vko';drk Hkh iM+           gkbijFkk;jkW;fMTe tSls jksx esa foHksn djuk dfBu gksrk   ldrh  gSA  H y d a t i d i f o r m   m o l e  ,oa           gSA xHkkZoLFkk ds iwoZ fcydqy LoLFk gksuk ,oa fiNyh   choriocarcinoma esa rks hCG ds Lrj vR;fèkd mPp           xHkkZoLFkk ds nkSjku Hkh blh çdkj ds y{k.k gksus dh   Lrj rd c<+s gks ldrs gSa ftlds dkj.k bu fLFkfr;ksa esa           tkudkjh feyuk] GTT dh lEHkkouk dks c<+k nsrk gS   gkbijFkk;jkW;fMTe dh xaHkhjrk Hkh vR;fèkd gks ldrh                                                      gSA LokHkkfod :i ls budk mipkj rks ltZjh gh gSA           tcfd Fkk;jkW;M xzafFk ls lEcafèkr y{k.k tSls xkW;Vj]           vkW¶FkSyeksiSFkh vFkok vkWVksbE;wu ekdZj tSls anti-TPO                                                       HYPERTHYROIDISM  DURING  PREG-           antibody ,oa thyroid receptor antibody ¼TRAb½]                                                       NANCY           Fkk;jkW;M ds izkbejh jksx  tSls Graves’   disease)                              (           gksus dh lEHkkouk dks c<+k nsrs gSaA       ge tkurs gSa fd xHkkZoLFkk esa esVkckWfyTe Lo;a Hkh c<+                                                      tkrh gS vr% lkekU; xHkkZoLFkk esa feyus okys vusdksa           MANAGEMENT                                                    93","y{k.k Hkh gydh Fkk;jksVWkfDldksfll ls feyrs\&tqyrs  lkekU; ls 1.5 xquk vfèkd rd c<+ ldrs gSaA bl           çrhr gksrs gSaA blds vfrfjä] lkekU; xHkkZoLFkk esa Hkh  çdkj] ;fn fdlh xHkZorh efgyk esa total T4 ds Lrj           T3 ,oa T4 ds Lrj c<+ tkrs gSa rFkk TSH dk Lrj ?kV  lkekU; fey jgs gksa rc okLro esa mUgsa lkekU; ugÈ           tkrk gSA bl çdkj] mÙkstuk;qä y{k.k ,oa Fkk;jkW;M  ekuk tkuk pkfg, D;ksafd xHkkZoLFkk esa rks bls 1.5 xquk           gkWeksZUl ds Lrjksa esa vk;s ifjorZu ;g nqfoèkk mRiUu dj  vfèkd c<+ tkuk pkfg, FkkA blhfy,] xHkkZoLFkk ds           ldrs gSa fd ;g xHkkZoLFkk esa mRiUu gq, lkekU;  nkSjku djk;s x, Fkk;jkW;M gkWeksZUl dh tkapksa dks dHkh           ifjorZu gSa ¼lkekU; xHkZ½] bUgÈ dh c<+h gqÃ voLFkk gS  Hkh  xHkkZoLFkk  ds  vfrfjä  buds  lkekU;  Lrjksa           ¼GTT½ vFkok dksÃ jksx (GD)A vkb;s] le>rs gSa fd  ¼nonpregnant  normal  ranges½ ls feykdj ugÈ           bu esa foHksn fdl çdkj fd;k tk ldrk gSA    ns[kk tkuk pkfg,A buds fy,] xHkkZoLFkk ds nkSjku buds           CLINICAL MANIFESTATIONS                    lkekU;  Lrjksa  ¼pregnancy  specific  normative           è;kuiwoZd iwNus ij ;g tkuk tk ldrk gS fd ;g   data½ dk gh iz;ksx gksuk pkfg,A           y{k.k] xHkZèkkj.k ds igys Hkh Fks ;k ugÈA GD esa   TSH \& blh çdkj] xHkkZoLFkk esa IyklsaVk ds hCG ds           vfèkdka'kr;% ;g y{k.k] xHkZèkkj.k ds iwoZ ls gh vkjEHk  c<+us ds dkj.k  TSH  20-50%  rd ?kV tkrk gSA           gks pqds gksrs gSa tks blds ckn c<+ tkrs gSaA  blhfy, xHkkZoLFkk dh çFke frekgh esa] tc  hCG           gydh èkM+du ,oa dEiu rks lkekU; xHkkZoLFkk esa Hkh   lokZfèkd ek=k esa curk gS rc TSH ds Lrj lcls de           feyrs gSa ijUrq 100 bpm ls vfèkd c<+h gqÃ ân; xfr   gksrs gSaA ,sls esa TSH dh mPpre lhek 2.5 mI U/L gh           gksus ij GD dh lEHkkouk vfèkd gksrh gSA    ekuh tkrh gSA vr% ;fn fdlh xHkZorh efgyk esa] TSH                                                      2.5-5.0 mIU/L ds eè; gks ¼tks xHkkZoLFkk ds vfrfjä           xeÊ vfèkd yxuk ,oa 'kjhj dk xeZ gksuk rks lkekU;   fdlh efgyk ds fy, iw.kZr;% lkekU; gksxk ½ rc mls Hkh           xHkkZoLFkk esa Hkh fey ldrs gSa ijUrq xHkkZoLFkk esa Hkh           otu ds u c<+us vFkok ?kVrs tkus ij  GD dh   xHkZorh efgyk ds fy, c<+k gqvk gh ekuk tkuk pkfg;saA           lEHkkouk c<+ tkrh gSA                      bl rF; dks u le>us ij] çFke frekgh esa TSH ds                                                      Lrj dks ?kVk gqvk ns[kdj] dÃ ckj gkbiksFkk;jkW;M           blh  çdkj]  ifjokj  ds  vU;  lnL;ksa  esa  Fkk;jkW;M   efgyk dh Fkk;jkWfDlu dh Mkst ?kVk nh tkrh gS vFkok           lacafèkr vfu;ferrkvksa tSls xkW;Vj] vkW¶FkSyeksiSFkh   mls ATD rd vkjEHk dj nh tkrh gSaA LokHkkfod gS fd           vFkok  vU;  vkWVks\&bE;wu  fodkj  tSls  vitiligo  ,oa   ;g xHkZorh efgyk ds okLrfod Fkk;jkW;M gkWeksZUl ds           proximal muscular disorders ds feyus ij Hkh GD   Lrj dks vkSj Hkh vfèkd vfLFkj djk nsxhA           dh lEHkkouk c<+ tkrh gSA                                                      Immunological markers \& bl çdkj] tc total           DIAGNOSIS                                  T3 ,oa total T4] free T3 ,oa free T4 ,oa TSH           Free T3 and T4 hormones \& lkekU; xHkkZoLFkk esa   lHkh ds Lrj] lkekU; xHkkZoLFkk ,oa GD esa ,d leku           Hkh IyklsaVk ls cuus okys hCG }kjk mÙksftr gksus ds   gh çrhr gks jgs gksa] rc gesa dqN mu tkapksa dh lgk;rk           dkj.k Ýh T3 ,oa T4] viuh lkekU; lhek ds mPpre   ysuh iM+ ldrh gS tks xHkkZoLFkk }kjk çHkkfor u gksrh           Lrj rd c<+ ldrs gSa ijUrq dqN rduhdh dkj.kksa ls           xHkkZoLFkk esa Ýh gkeksZUl ds assay dks fo”oluh; ugÈ   gksaA ;g gks ldrh gSa] immunological markers tSls                                                      anti–TPO  antibody  vFkok           ekuk tkrk gSA                                                         TSH  receptor                                                      antibody ¼TRAb½ A bu ,aVhckWMht dk c<+k gksuk]           Total T3 and T4 hormones \& xHkkZoLFkk ds nkSjku   Fkk;jkW;M ds çkFkfed fodkj dh lEHkkouk dks bafxr           total T3 ,oa T4 dk assay vfèkd foÜoluh; gksrk gSA   djrk gS tcfd budk lkekU; gksuk] xHkkZoLFkk lEcafèkr           è;ku jgs] xHkkZoLFkk dh çFke frekgh esa] ÃLVªkstsu ds   vfu;ferrkvksa dh lEHkkouk dks c<+krk gSA           çHkko esa TBG ds c<+ tkus ds dkj.k] total T3 ,oa T4]                                                    94","EFFECTS OF PREGNANCY ON CLINICAL           carbimazole / methimazole] (cmz/mmi) nksuksa ds           COURSE OF GD                               lkFk  pruritus ,oa skin rashes Hkh ek¡ dks çHkkfor           ge tku pqds gSa fd xHkkZoLFkk esa esVkckWfyTe Lo;a Hkh   dj ldrs gSaA           c<+ tkrh gSA blhfy,] xHkkZoLFkk dh çFke frekgh esa]           IyklsaVk ds hCG ds çHkko esa] GD ds vfèkdk¡'k y{k.k   Effects  on  pregnancy  - gkbijFkk;jkW;fMTe dk           c<+ tkrs gSaA                              çHkko xHkkZoLFkk ds ifj.kke ij Hkh iM+rk gS ftuesa                                                      lokZfèkd egRoiw.kZ gS]  miscarriage ,oa  stillbirth           xHkZorh efgyk esa f'k'kq ,d allograft ¼,d ckgjh rRo½   Ablds  vfrfjä]  yxHkx  ,d  frgkÃ  efgykvksa  esa           dh  Hkkafr  jgrk  gS  ftls  xHkZ  esa  immunological                                                      preterm  delivery gks ldrh gS ftlls low  birth           rejection ls cpkus ds fy, ek¡ ds immunological   weight okys f'k'kq tUe ys ldrs gSaA           responses  f'kfFky ¼èkhes½ gks tkrs gSaA xHkkZoLFkk esa           c<+k gqvk ÃLVªkstsu] B-cell lymphopoiesis ?kVk dj   izlo  ds  le;  placental  abruption  ,oa  fetal           blesa egRoiw.kZ Hkwfedk fuHkkrk gSA xHkkZoLFkk esa T;ksa\&T;ksa   distress ,oa buds QyLo:i primary  cesarian           ÃLVªkstsu ds Lrj c<+rs tkrs gSa] GD ,oa vusdksa vU;   section dh vko';drk c<+ drh gSA           bE;wu jksx ncus yxrs gSa ,oa dHkh\&dHkh remission   Effects  on  fetus  -    le;  ls  iwoZ  tUesa           rd esa igq¡p tkrs gSaA                     ¼prematurely born½ ,oa low birth weight babies                                                      dk Apgar score vfèkdka'kr;% de gh jgrk gS ftlls           çlo ds mijkar] ÃLVªkstsu Lrj ds ,dk,d ?kV tkus ls           ;g bE;wu jksx nksckjk mHkj ¼exacerbate gks½ ldrs   neonatal ICU admission dh vko';drk Hkh c<+           gSaA                                       ldrh gSA                                                      blds vfrfjä] xHkkZoLFkk ds le; ATD ds vko';drk           bl çdkj] GD ds y{k.k] xHkkZoLFkk dh çFke frekgh esa           c<+ ldrs gSa] f}rh; ,oa r`rh; frekgh esa ?kV ldrs gSa]   ls vfèkd ek=k esa ç;ksx esa ykus ls xHkZLFk ,oa uotkr           tks çlo ds ckn nksckjk mHkj ldrs gSaA      f'k'kqvksa esa goitrogenesis ,oa hypothyroidism dh                                                      lEHkkouk Hkh c<+ tkrh gSA           EFFECTS  OF  THYROTOXICOSIS  ON           OUTCOMES OF PREGNANCY           ftl çdkj] xHkkZoLFkk esa gksus okys ifjorZu Fkk;jkW;M   MANAGEMENT OF HYPERTHYROIDISM           xzafFk dh dk;Z{kerk dks çHkkfor djrs gSa mlh çdkj]   DURING PREGNANCY           Fkk;jkW;M  gkWeksZUl  dh  vfèkdrk  Hkh  xHkkZoLFkk  dks   gkÃijFkk;jkW;fMTe  esa  xHkkZoLFkk  ij  iM+us  okys           çHkkfor djrh gSA vkb;s budks foLrkj ls le>rs gSaA   nq\"ifj.kkeksa dks ns[krs gq, bldh vfu;af=r voLFkk ds                                                      le; xHkZ èkkj.k djus ls cpuk gh loZJs\"B cpko gks           Effects on mother - ge tkurs gSa fd Fkk;jkW;M                                                      ldrk gSA fQj Hkh ;fn ATD ysrs gq, dksÃ efgyk xHkZ           gkWeksZUl] ºn; dks mÙksftr djrs gSa ftlls gestational   èkkj.k dj ys rc xHkkZoLFkk esa gkijFkk;jkW;fMTe ls gks           hypertension ,oa eclampsia rd mRiUu gks ldrs           gSaA gkbijFkk;jkW;fMTe esa bl vR;fèkd mÙkstuk ls left   ldus okys mijksä nq\"çHkkoksa ls cpko ds fy,] bldk           ventricular dysfunction Hkh mRiUu gks ldrk gSA gkÃ   leqfpr mipkj vR;fèkd vko';d gSA lkFk gh ATD           CyM çs'kj] eclampsia] ,uhfe;k vFkok bUQsD'ku   ds ek¡ ;k f'k'kq ij gks ldus okys nq\"ifj.kkeksa ls cpko ds           bR;kfn fdlh vU; mÙkstd dkjd ds gksus ij ;g   fy, ;g Hkh vko';d gS fd ATD dh U;wure Mkst dks           lEHkkouk vkSj Hkh vfèkd c<+ tkrh gSA       gh ç;ksx esa yk;k tk,A è;ku jgs] xHkkZoLFkk ds nkSjku                                                      ÃLVªkstsu ds çHkko esa dHkh\&dHkh GD esa remission Hkh           blds vfrfjä] ATD ds nq\"çHkko tSls PTU ds lkFk   mRiUu gks ldrk gSA ,sls esa f}rh; vFkok r`rh; frekgh           fulminant  hepatic  failure  ,oa  PTU  ,oa   esa ATD can Hkh gks ldrh gSA                                                     95","vfu;af=r ,oa xaHkhj Fkk;jksVkWfDldksfll] tks ATD   fetal goitre ;k fetal hypothyroidism mRiUu dj           }kjk fu;af=r u gks ik jgh gks] mlesa ek¡ ,oa f'k'kq dks  ldrh gSaA f'k'kq dh vis{kk—r ;g nksuksa nok,a] ek¡ ds           Fkk;jksV‚fDldksfll ds nq\"çHkkoksa ls cpkus ds fy,  fy, vfèkd lqjf{kr jgrh gSaA ijUrq bu nokvksa ds ç;ksx           f}rh; frekgh esa ltZjh Hkh vuqeksfnr dh tk ldrh gSA  ls ek¡ esa mild cholestatic jaundice] pruritus ,oa           /;ku jgs] xHkkZoLFkk ds nkSjku jsfM;ksvk;ksMhu fFkjSih   skin rashes Hkh gks ldrs gSaA           iw.kZr;% fuf\"k) (contraindicated)  gksrh gSA                                                      mijksä nksuksa igyqvksa dks è;ku esa j[krs gq, Indian           ATD DURING PREGNANCY \& LACTATION           Thyroid  Society  ,oa   American  Thyroid           CMZ/MMI \& IykTek çksVhu ls tqM+ko ¼binding ½   Association }kjk xHkkZoLFkk ds nkSjku ATD ds ç;ksx           vR;fèkd de gksus ds dkj.k ;g ljyrk ls IyklsaVk  dks  ds fy, fn, x, funsZ'k fuEukafdr gSa\&           ikj djds Hkzw.k esa igq¡p tkrh gSa rFkk Lru ls nwèk esa Hkh   çFke frekgh esa tc CMZ/MMI ls gks ldus okyh           fudyus yxrh gSaA blhfy,] xHkkZoLFkk dh çFke frekgh   embryopathy dk Hk; lokZfèkd gS rc PTU dk ç;ksx           esa  buds  ç;ksx  ls  vusd  tUetkr  fod`fr;ka   fd;k  tk;sA  ;|fi  bl  nkSjku  ek¡  dks  fulminant           (congenital malformations) mRiUu gks ldrh gSaA   hepatitis dh laHkkouk gks ldrh gSA           buesa çeq[k gSa \&           - Aplasia cutis congenita  \& Scalp ij Ropk dk u   f}rh; vFkok r`rh; frekgh esa tc CMZ/MMI ls f'k'kq            cuukA                                     esa gks ldus okys nq\"ifj.kke vis{kk—r de xaHkhj gksrs           - Choanal atresia  \& ukd ds fNæ dk u cuukA   gSa] bl nkSjku ek¡ dh lqj{kk dks çkFkfedrk nsrs gq, PTU            - Exomphalos  \& Anterior abdominal wall dk u   ds ç;ksx ls cpuk pkfg, ,oa CMZ/MMI dks gh budh            cuuk ftlls van:uh vax fcydqy [kqys jgsaA    U;wure Mkst esa lkoèkkuh iwoZd ç;ksx esa ykuk pkfg,A           - Esophageal atresia \&  Esophagus dk u cuuk   PTU dh 15-20 fexzk ds LFkku ij methimazole dh            ;k can gksuk ftlls nwèk uhps ugha tk ikrkA   1 fexzk dk ç;ksx fd;k tk ldrk gSA           - Tracheo-esophageal  fistula  -   Trachea  ,oa   ATD vkjEHk djus ds ckn bldh Mkst esa visf{kr            esophagus dk ,d fNæ ds ekè;e ls ijLij fey  ifjorZu ¼titration½ djus ds fy, çR;sd 4 lIrkg esa            tkukA                                     jä esa free T4 dh tkap djkrs gSaA è;ku jgs] ATD            PTU \&  IykTek çksVhu ls tqM+ko dh {kerk vfèkd   }kjk ;g free  T4 gh lcls 'kh?kz çHkkfor gksrs gSaA           ¼75% ½ gksus ds dkj.k ;g u rks IyklsaVk  dks gh ikj dj   gkbijFkk;jkW;fMTe esa lhje TSH çk;% lkekU; Lrjksa           ikrh gS vkSj u gh Lru ls nwèk esa fudy ikrh gSA   ls Hkh dkQh de ¼supressed½ jgrk gS ,oa bldks           blhfy, bu nksuksa voLFkkvksa esa ;g vkn'kZ fodYi gks   lkekU; Lrj ij vkus esa  rks 6-12 ekg rd dk le;           ldrh  gSA  ijUrq  fyoj  ij  blds  xaHkhj  nq\"çHkko   yx ldrk gSA lhje TSH dks de ns[kdj ATD dh            (Fulminant hepatitis and / or  hepatic failure) ds   Mkst  dks  c<+krs  tkus  ls  vfèkdk¡'k  O;fä;ksa  esa           dkj.k budks de ls de le; ds fy, gh ç;ksx esa yk;k   gkbiksFkk;jkW;fMTe mRiUu gks ldrk gSA blhfy,] ATD           tkuk pkfg;sA                               dks bruh Mkst esa gh ç;ksx esa ykuk pkfg, ftlls lhje                                                      free T4 dks mldh lkekU; jsat dh Åijh lhek ¼upper           PTU dh rqyuk esa CMZ/MMI ljyrk ls IyklsaVk ikj   half of normal range½ esa cuk;s j[kk  tk ldsA           djds f'k'kq esa igq¡p tkrh gSaA çFke frekgh esa ;g f'k'kq           ds fodkl dks çHkkfor djds embryopathy mRiUu   PTU dks 50-100 fexzk fnu esa nks ;k rhu ckj ,oa           dj ldrh gSa tcfd f}rh; vFkok r`rh; frekgh esa ;g   CMZ/MMI dks 5-10 fexzk fnu esa nks ckj dh Mkst esa           f'k'kq esa Fkk;jkW;M gkWeksZUl ds fuekZ.k esa ckèkk Mky dj   vkjEHk djds] çR;sd 4 lIrkg esa lhje free T4 dh                                                      tkap ds vkèkkj ij budh Mkst dks ?kVk;k vFkok c<+k;k                                                    96","tk ldrk gSA è;ku jgs] lhje free  T4  level ds  f'k'kq esa igqapdj Fkk;jkW;M gkWeksZUl ds fuekZ.k dks ?kVk           lkekU; jsat ds eè; ¼mid normal range½ esa vkrs gh  ldsA dHkh\&dHkh bl vfrfjä Mkst ds dkj.k ek¡ esa           ATD dh Mkst dks ?kVkuk vkjEHk dj nsuk pkfg,A lhje  gkbiksFkk;jkW;fMTe ds y{k.k mRiUu gksus yxrs gSaA ,slk           free T4 level dks bldh lkekU; jsat dh Åijh lhek esa  gksus ij ek¡ dks ATD dh vfrfjä Mkst ds lkFk\&lkFk           cuk;s j[k dj f'k'kq dks Fkk;jkW;M gkWeksZUl dh i;kZIr  Fkk;jkWfDlu Hkh ns nh tkrh gSA çR;{k :i ls rks ;g           ek=k dh miyCèkrk lqfuf'pr djkÃ tk ldrh gS ftlls  vthc lk yxrk gS fd fdlh O;fä dks ATD ,oa           f'k'kq dks xkW;Vj cuus ,oa gkbiksFkk;jkW;fMTe ls cpk;k  Fkk;jkWfDlu nksuksa ,d lkFk gh fn;s tk,a ijUrq ;g Hkh           tk ldrk gSA                                dqN  rF;ksa  ij  vkèkkfjr  gSA  okLro  esa]  f'k'kq  esa           ge tkurs gSa fd xHkkZoLFkk ds f}rh; vFkok r`rh;   gkbijFkk;jkW;fMTe dks ?kVkus ds fy, ek¡ dks ATD dh                                                      vfrfjä ek=k nh tkrh gS tks IyklsaVk dks ikj dj ldus           frekgh esa ÃLVªkstsu ds c<+rs tkus ls GD esa remission           vkjEHk gks ldrk gS] ftlls ATD dh Mkst esa dkQh   ds dkj.k f'k'kq rd igq¡pdj Fkk;jkW;M gkWeksZUl ds           deh vk ldrh gSA  GD  ls çHkkfor yxHkx  1/3   fuekZ.k  dks  ?kVk  ldrh  gSA  blds  foijhr]  ek¡  esa           efgykvksa esa rks ;g dqN le; rd ds fy, can Hkh gks   gkbiksFkk;jkW;fMTe dks Bhd djus ds fy, Fkk;jkWfDlu           ldrh gSaA çlo ds i'pkr~ ;fn ;g nksckjk mHkjrh gS   nh tkrh gS ftldh cgqr de ek=k IyklsaVk dks ikj dj           rc ATD dks nksckjk vkjEHk fd;k tk ldrk gS vFkok   ikrh gSA blh dkj.k ls ;g ek¡ ds Fkk;jkW;M gkWeksZUl ds           c<+k;k tk ldrk gSA                         Lrj dks rks c<+k nsrh gS ijUrq f'k'kq esa Fkk;jkW;M gkWeksZUl                                                      ds Lrj dks vfèkd çHkkfor ugÈ dj ikrhA           FETAL  GOITROGENESIS  AND  FETAL           HYPERTHYROIDISM                            f'k'kq esa bu TRAb dk Lrj vfèkdka'kr;% 22 lIrkg ds           è;ku nsa] GD esa Fkk;jkW;M gkWeksZUl ds vfèkd ek=k esa  ckn gh c<+rk gS ftlds dkj.k f'k'kq esa xkW;Vj ,oa           cuus dk dkj.k D;k gksrk gS\\ okLro esa] GD ,d  gkbijFkk;jkW;fMTe Hkh vfèkdka'kr;% 24-30 lIrkg ds           vkWVks\&bE;wu  fodkj  ¼autoimmune  disorder½  gS  ckn gh gksrs gSaA ;fn ek¡ esa TRAb ds Lrj çlo ds le;           ftlesa  TSH fjlsIVj ds fo#) mÙkstd ,aVhckWMht  rd c<+sa jgsa rc og uotkr f'k'kq ¼newborn½ esa Hkh           ¼stimulatory antibodies - TRAb½ cuus yxrh gSa tks   neonatal hyperthyroidism mRiUu djk ldrs gSaA           Fkk;jkW;M xzafFk dks TSH dh gh Hkkafr mÙksftr djrh gSaA  D;ksafd bu TRAb dh gkQ ykbQ ek= 1-2 lIrkg gh           tjk lkspsa] ;fn ;gh ,aVhckWMht] f'k'kq esa igq¡p tk,¡ rc  gksrh gS] vr% tUe ds 2-4 lIrkg ckn gh budk çHkko           og f'k'kq dh Fkk;jkW;M xzafFk dks Hkh mÙkksftr dj nsxhaA  lekIr gks tkrk gSA blhfy,] vfèkdka'kr;% uotkr f'k'kq           blds QyLo:i] f'k'kq dh Fkk;jkW;M xzafFk dk vkdkj Hkh  esa gkbijFkk;jkW;fMTe] tUe ds çFke ekg esa Lor% gh           c<+ tk,xk ¼fetal goitre½ ,oa f'k'kq esa Fkk;jkW;M gkWeksZUl  lekIr gks tkrh gSA blds xaHkhj gksus ij ATD dh FkksM+h           ds  Lrj  Hkh  c<+  tk;saxsa  ¼fetal  or  neonatal  ek=k dks dqN le; ds fy, nsdj uotkr f'k'kq dk           hyperthyroidism½A blhfy,] xHkkZoLFkk ds 22 lIrkg  mipkj fd;k tk ldrk gSA           ds ckn ek¡ dh TRAb titre vo'; djokuh pkfg,A ;fn   xHkkZoLFkk ds nkSjku ÃLVªkstsu ds dkj.k tks vkWVks\&bE;wu           bldk Lrj lkekU; ds rhu xqus ls Hkh vfèkd gksa rc   fodkj Lor% gh remission esa pys tkrs gSa muesa çlo           blds }kjk f'k'kq esa igq¡p dj fetal  goitre]  fetal   ds ckn ÃLVªkstsu ds Lrj esa vk;h ,dk,d deh ls nqckjk           tachycardia ¼fetal heart rate >160 bpm½] IUGR   relapse gks ldrk gSA GD esa ,slk gksus ij ATD dks           ,oa oligohydramnios mRiUu djus dh lEHkkouk c<+   iqu% vkjEHk fd;k tk ldrk gSA ;|fi ek¡ dks nh x;h           tk;sxh A                                                      ATD dh FkksM+h ek=k nwèk esa Hkh fudyrh gS] ijUrq bldh           f'k'kq esa gkbijFkk;jkW;fMTe dh lEHkkouk ?kVkus ds fy,]  ek=k FkksM+h gksus ds dkj.k ;g f'k'kq dks vfèkd çHkkfor           ek¡ dh ATD dh Mkst dks dqN c<+k ldrs gSa ftlls og  ugÈ djrh gSA                                                    97","xHkZèkkj.k dh tkudkjh gksus ds lkFk gh Fkk;jkWfDlu dh            MANAGEMENT OF HYPOTHYROIDISM              Mkst dks yxHkx 25% rd c<+k;k tk ldrk gSA blds            DURING PREGNANCY                                                      i'pkr~ çR;sd 4-6 lIrkg esa Fkk;jk;M gkWeksZUl dh tkap           xHkkZoLFkk esa gkbiksFkk;jkW;fMTe nks çeq[k dkj.kksa ls   ds }kjk bldh Mkst dks vko';drkuqlkj iquÆuèkkZfjr           mRiUu gks ldrh gSaA vk;ksMhu dh deh ls çHkkfor {ks=ksa   fd;k tk ldrk gSA           esa vk;ksMhu dh deh ls ,oa i;kZIr vk;ksMhu okys {ks=ksa           esa vkWVks\&bE;wu Fkk;jkW;MkbfVl ds dkj.k lsA blls   çFke frekgh esa IyklsaVk ds   hCG ds dkj.k ek¡ dk           xHkZorh efgyk ds lkFk\&lkFk xHkZLFk f'k'kq Hkh çHkkfor gks   TSH Lrj ?kV tkrk gSA blhfy,] bl le; TSH dh           ldrk gSA xHkkZoLFkk ds vfrfjä vU; ifjfLFkfr;ksa esa    tkap vfèkd fo”oluh; ugÈ jgrhA ,sls esa bl le;           subclinical hypothyroidism ds dksÃ fo'ks\"k y{k.k   total T4 djkus dh lykg nh tkrh gSA iqu%] xHkZ ds                                                      nkSjku ÃLVªkstsu ds çHkko esa TBG ds Lrj c<+ tkus ls           ,oa nq\"ifj.kke ugÈ gksrs ijUrq ;fn ;gh subclinical           hypothyroidism xHkkZoLFkk ds nkSjku gks rks blls   total T4 ds Lrj Hkh c<+ tkrs gSaA blfy,] Fkk;jkWfDlu           vusdksa  çlo  lEcUèkh  ,oa  uotkr  f'k'kq  lEcUèkh   dh Mkst fuèkkZfjr djrs le; total T4 dks blds Åijh           nq\"ifj.kke mRiUu gks ldrs gSaA vkb;s buls cpko ds   Lrj ls Hkh 1.5 xquk vfèkd ij cuk;s j[kus dk ç;kl           lkèkuksa dks foLrkj ls le>rs gSaA          fd;k tkuk pkfg,A f}rh; frekgh ds ckn hCG ds Lrj                                                      esa deh vkus ds lkFk\&lkFk TSH dk Lrj Hkh c<+us           PRECONCEPTION PLANNING           - ek¡ ,oa f'k'kq dks mijksä nq\"ifj.kkeksa ls cpkus ds fy,   yxrk gSA ,sls esa bls ekWuhVÇjx ds fy, iqu% ç;ksx esa            gkbiksFkk;jkW;fMTe ls çHkkfor efgyk dks xHkZèkkj.k   yk;k tk ldrk gSA            ¼conception½ djus ds iwoZ esa gh ;g lqfuf'pr dj   ;gk¡ ,d vU; egRoiw.kZ rF; dks è;ku esa j[kus dh            ysuk pkfg, fd gkbiksFkk;jkW;fMTe i;kZIr fu;a=.k   fo'ks\"k vko';drk gSA fdlh xHkZorh efgyk esa lhje            ¼TSH <2.5 mIU/L½ esa gSa ;k ugÈA          TSH dk lkekU; Lrj] xHkkZoLFkk ds vfrfjä fdlh           - buds vfrfjä] ;fn ifjokj ds vU; O;fä;ksa esa   efgyk vFkok iq#\"k ls vyx gksrk gSA vr% fjiksVZ ij            Fkk;jkW;M lEcafèkr jksx vFkok vU; vkWVks\&bEE;wu   fy[kh ¼xHkkZoLFkk ds vfrfjä½ lkekU; lhekvksa ds            fodkj mifLFkr gksa rc Hkh xHkZèkkj.k djus ds iwoZ gh   vuqlkj fdlh xHkZorh efgyk dh Fkk;jkWfDlu dh Mkst            Fkk;jkW;M dh tkapsa vo'; djok ysuk pkfg,A  dks ifjoÆrr ugÈ djuk pkfg,A           - lhje TSH 2.5 mIU/L ls de jgus ij gh xHkZèkkj.k   - çFke frekgh esa lhje TSH 2.5 mIU/L ls de gh            dh vuqefr nsuh pkfg,A                      j[kuk pkfg,           - lhje  TSH  3.5  mIU/L  ls  vfèkd  jgus  ij   - f}rh; vFkok r`rh; frekgh esa lhje  TSH  3.5             Fkk;jkWfDlu fFkjSih vkjEHk dj] lhje TSH  2.5   mIU/L ls de gh j[kuk pkfg,            mIU/L ls de ykus ds i'pkr~ gh xHkZèkkj.k dh   Fkk;jkWfDlu dh Mkst dks c<+kus dh vko';drk Hkh blh            vuqefr nsuh pkfg,A                        dkj.k ds vuqlkj fHkUu\&fHkUu gks ldrh gSA           - lhje TSH 2.5 ls 3.5 mIU/L ds eè; jgus ij bl   - Autoimmune thyroiditis - ftlesa Fkk;jkW;M xzafFk esa            tkap dks ,d ekg i'pkr~ nksckjk djok ysuk pkfg,A  dqN lhek rd lfØ; Hkkx cpk gksrk gS] muesa ;g 'ks\"k            D O S A G E   A D J U S T M E N T   D U R I N G   Hkkx  vfèkd  lfØ;  gksdj  Fkk;jk;M  gkWeksZUl  ds           PREGNANCY                                   mRiknu dks ,d lhek rd c<+k ysrk gSA blls]           xHkZèkkj.k ds lkFk gh ek¡ dh Fkk;jkWfDlu dh vko';drk   xHkZèkkj.k ds i'pkr~] Fkk;jkWfDlu dh Mkst vis{kk—r           c<+ tkrh gSA blhfy,] yxHkx 75% gkbiksFkk;jkW;M   de c<+kuh iM+rh gSA           efgykvksa esa Fkk;jkWfDlu dh Mkst dks c<+kuk iM+rk gSA   - Postoperative/ postablative hypothyroidism -                                                     98","jsfM;ks,fDVo vk;ksMhu vFkok ltZjh ds i'pkr gqÃ   antibody½  ,d  çdkj  dh  thyroid  destructing            gkbiksFkk;jkW;fMTe esa fcydqy Hkh lfØ; Hkkx 'ks\"k ugÈ   antibody gSa tks complement ,oa lymphocytic            cprkA  blhfy,]  ,slh  efgykvksa  esa  xHkZèkkj.k  ds   activation ds ekè;e ls Fkk;jkW;M QkWfydYl dks {kfr            i'pkr~] Fkk;jkWfDlu dh Mkst vis{kk—r vfèkd ek=k   igqapkrh  gSaA  blhfy,  PPT  esa  gksus  okyh            esa c<+kuh iM+rh gSA                      Fkk;jksVkWfDldksfll dks destructive thyrotoxicosis                                                      Hkh dgrs gSaA Fkk;jkW;M QkWfydYl esa gqÃ bl {kfr ls           POSTPARTUM DOSAGE ADJUSTMENT                                                      QkWfydy esa laxzfgr Fkk;jkW;M gkWeksZUl yhd gksdj jä           çlo ds mijkar ¼postpartum period esa½ vfèkdka'k   esa igq¡p tkrs gSa ftlls jä esa T3 ,oa T4 ds Lrj c<+           efgykvksa esa Fkk;jk;M gkWeksZUl dh vko';drk] viuh   tkrs gSaA vfèkdk¡'k efgykvksa esa çlo ds dqN le; rd           xHkZèkkj.k ds iwoZ dh vko';drk ij gh ykSV vkrh gSA   cuus ds i'pkr~ ;g destructive antibodies] Lor%           vr% çlo ds mijkar] muesa xHkZèkkj.k ds iwoZ dh Mkst   gh  ?kVus  yx  tkrh  gSa  ftlls  buls  gksus  okyh           dks gh nksckjk vkjEHk fd;k tk ldrk gSA                                                      destructive thyrotoxicosis Hkh dqN le; esa ?kVrh           è;ku jgs] autoimmune Hashimoto’s thyroiditis   tkrh gSA blds nh?kZdkfyd çHkko bl rF; ij fuHkZj           ls  çHkkfor  efgykvksa  esa  çlo  ds  mijkar]  bl   djrs  gSa  fd  çkjfEHkd  immunological  insult  ls           vkWVks\&bE;wfuVh ds ,dne ls c<+ tkus dh lEHkkouk   Fkk;jkW;M QkWfydYl dks fdruh {kfr igqaph ,oa ml {kfr           dkQh vfèkd gksrh gS ftlds dkj.k bu efgykvksa esa   ls ;g QkWfydy fdl lhek rd mcj dj iqu% lkekU;           mudh Fkk;jkWfDlu dh Mkst dks vkSj Hkh vfèkd c<+kuk   gks ldsA           iM+ ldrk gSA                               Transient  thyrotoxicosis  followed  by                                                      euthyroidism -  Fkk;jkW;M QkWfydYl dks gydh {kfr              POSTPARTUM THYROIDITIS                                                      igq¡pus ij ;g lEHkkouk jgrh gS fd Fkk;jkW;M xzafFk           ;fn fdlh efgyk dks iwoZ esa fdlh çdkj dh dksÃ   mlls iw.kZ:i ls mcj tk;s ftlls efgyk dqN le; rd           Fkk;jkW;M xzafFk ls lEcafèkr vfu;ferrk u gks ,oa çlo   Fkk;jksVkWfDld jgus ds i'pkr~ lkekU; gks tk,A           vFkok  miscarriage  ds  ,d  o\"kZ  ds  vanj   Transient  thyrotoxicosis  followed  by           Fkk;jksVkWfDldksfll]  gkbiksFkk;jkW;fMTe  vFkok   hypothyroidism - blds foijhr ;fn ;g {kfr xaHkhj           Fkk;jksVkWfDldksfll  ds  i'pkr~  gksus  okyk   gks vFkok ,aVhckWMht ds yxkrkj curs jgus ls ;g {kfr           gkbiksFkk;jkW;fMTe mRiUu gks] rc ml voLFkk dks   Hkh yxkrkj gksrh tk jgh gks] rc ml fLFkfr esa çkjafHkd           postpartum thyroiditis ¼PPT½ dgrs gSaA     dqN le; rd Fkk;jksVkWfDldksfll dh fLFkfr cus jgus            ETIOPATHOGENESIS                           ds i'pkr~] Fkk;jkW;M QkWfydYl }kjk Fkk;jkW;M gkWeksZUl           ;g ,d vkWVks\&bE;wu fodkj gS ftlesa Fkk;jkW;M xzafFk ds   dk  mRiknu  tkjh  u  j[k  ikus  ds  dkj.k           fo#) cuh ,aVhckWMht] Fkk;jkW;M xzafFk esa bU¶yses”ku   gkbiksFkk;jkW;fMTe  mRiUu  gks  ldrh  gSA  PPT  dh           mRiUu dj ldrh gSaA xHkZ ds nkSjku ÃLVªkstsu ds c<+s   Fkk;jksVkWfDld voLFkk vfèkdka'kr;% çlo ds 8-12           Lrjksa ds çHkko esa vfèkdk¡'k vkWVks\&bE;wu fodkj ncs gq,   lIrkg  i'pkr~  vkjEHk  gksdj  16-18  lIrkg  esa           jgrs gSa tks çlo ds mijkar ÃLVªkstsu ds ,dk,d ?kV   gkbiksFkk;jkW;M voLFkk esa cny tkrh gS           tkus ls nksckjk mHkj vkrs gSaA ,sls esa tc çlo ds   Transient  or  persistent  hypothyroidism  -           yxHkx 6 lIrkg ckn ls ;g ,aVhckWMht c<+uk vkjEHk   vusd efgyk;sa bl çkjfEHkd gydh Fkk;jksVkWfDld           gksrh gSa rc og Fkk;jkW;M xzafFk dks {kfr igqapdj   voLFkk dks eglwl Hkh ugÈ dj ikrh gS ,oa lhèks           Fkk;jkW;MkbfVl mRiUu dj ldrh gSaA          gkbiksFkk;jkW;M voLFkk esa gh mUgsa fdlh y{k.k dh                                                      tkudkjh gks ikrh gSA Immunological insult ls ;fn           PPT esa cuus okyh ,aVhckWMh ¼vfèkdka'kr;% anti-TPO                                                     99","efgyk iw.kZ:i ls mcj tk;s rc ;g gkbiksFkk;jkW;fMTe   antibodies  ds  LFkku  ij  thyroid  stimulating           Hkh dqN le; rd jgus ds i'pkr~ iw.kZ:i ls Bhd gks   antibodies  ¼;k  TSH  receptor  antibodies  -            ldrh  gS  (transient  hypothyroidism) A  blds   TRAb½ ds mHkjus ls gksrh gS tks vfèkdka'kr;% yxkrkj           foijhr {kfr ds iw.kZ:i ls Bhd u gksus dh n'kk esa ;g  curh jgus ds dkj.k nh?kZdkfyd ¼persistent½ gksrh gaSA           gkbiksFkk;jkW;fMTe  nh?kZdkfyd  gks  ldrh  gS  è;ku jgs] bl fLFkfr esa Fkk;jkW;M xzafFk esa laxzfgr           (persistent hypothyroidism)A               Fkk;jkW;M gkWeksZUl dsoy vfèkd ek=k esa fudyrs gh ugÈ            CLINICAL MANIFESTATIONS                   gS  cfYd  mudk  mRiknu  Hkh  c<+  tkrk  gSA  bldks           mijksä o.kZu ds vuqlkj PPT eq[;r% 3 :iksa esa   postpartum Graves’  disease dgrs gSaA tgk¡ PPT           çdV gks ldrh gSA                           esa Fkk;jkW;M QkWfydYl dks gqÃ {kfr ls Fkk;jkW;M                                                      gkWeksZUl dk mRiknu ?kV tkrk gS ftlls radioactive           - Transient thyrotoxicosis - 20%           - Transient  thyrotoxicosis  followed  by   iodine  uptake  ¼RAIU½  Hkh  ?kV  tkrk  gS]  ogha            hypothyroidism - 30%                      postpartum GD esa Fkk;jkW;M xzafFk dh lfØ;rk c<+           - Transient or persistent hypothyroidism - 50%  tkus ds dkj.k RAIU c<+ tkrk gSA vr% U;wfDy;j           bl çdkj PPT ls çHkkfor yxHkx vkèkh efgykvksa esa   LdSu ds }kjk cM+h ljyrk ls buesa foHksn fd;k tk           de ls de dqN le; ds fy, Fkk;jksVkWfDldksfll ds   ldrk gSA           y{k.k vo'; çdV gksrs gSa tks vfèkdka'kr;% dkQh gyds           gh jgrs gSaA çlo ds ckn dh O;Lrrk ds dkj.k gydh   MANAGEMENT           mÙkstuk] ân; xfr dk rhoz gksuk] èkM+du] dEiu ,oa   PPT ds mipkj ds nkSjku è;ku j[kus ;ksX; rF; ;g gS           detksjh çk;% è;ku esa gh ugÈ vkrhA blds foijhr]   fd bldh Fkk;jksVkWfDld voLFkk çk;% vYidkfyd           PPT dh gkbiksFkk;jkW;M voLFkk vfèkd çeq[k gksrh gS   gksrh  gS  ,oa  gkbiksFkk;jkW;M  voLFkk  vfèkdka'kr;%           tks Fkdku] lqLrh] detksjh] iwjs 'kjhj esa vdM+u ,oa nnZ   nh?kZdkfydA blhfy,] Fkk;jksVkWfDld voLFkk esa bu           rFkk vfèkd B.M yxus ds :i esa çdV gks ldrh gSA   efgykvksa dks dksÃ ATD nsus dh vko';drk ugÈ gksrhA                                                      blls lEcafèkr y{k.kksa esa rkRdkfyd :i ls ykHk ysus ds           DIFFERENTIAL DIAGNOSIS                                                      fy, beta blockers dk ç;ksx fd;k tk ldrk gSA           è;ku  jgs]  çlo  ds  mijkar  gksus  okyh  çR;sd   gkbiksFkk;jkW;M voLFkk vkjEHk gksus ds ckn Fkk;jkWfDlu           Fkk;jksVkWfDldksfll ges'kk PPT gh ugÈ gksrhA PPT   fFkjSih vkjEHk djds mldh Mkst dks fdlh Hkh vU;           dh gh Hkkafr ,d vU; vkWVks\&bEE;wu fodkj] GD Hkh   çkbejh gkbiksFkk;jkW;fMTe dh Hkkafr fuèkkZfjr fd;k tk           çlo ds ckn mHkj ldrk gSA  GD esa gksus okyh   ldrk gSA            Fkk;jksVkWfDldksfll]  thyroid  destructive                                                                      100","15                              Hypothyroidism in Newborns, Childhood and Adolescence               CONGENITAL HYPOTHYROIDISM               esa ck/kk Mkyrh gSaA tUe ds i'pkr~ tSls\&tSls budk           'kjhj esa Fkk;jkW;M gkWeksZUl dh deh ls mRiUu gksus okys   çHkko ?kVrk tkrk gS] gkWeksZUl dh deh Hkh Øe'k% Bhd           y{k.kksa dks lfEefyr :i ls gkbiksFkk;jkW;fMTe dgrs gSaA   gksrh tkrh gSA           vk;ksMhu dh deh okys {ks=ksa esa vHkh Hkh vkW;ksMhu dh   b) PERMANENT CH           deh  gh  bldk  loZçeq[k  dkj.k  gSA  ftu  {ks=ksa  esa   Dysgenesis (8-85%) - Fkk;jkW;M xzafFk dh mRifÙk           vkW;ksMhu dh ek=k i;kZIr gS] ogka bldk eq[; dkj.k   dh vfu;ferrk,a gh CH dk loZçeq[k dkj.k gksrk gSA           autoimmune disorder gksrk gSA vkb;s buds fo\"k; esa   bldh lEHkkouk ckfydkvksa esa vf/kd gksrh gSA           foLrkj ls le>rs gSaA                                                      Dyshormonogenesis (10-15%) - dqN f'k'kqvksa           uke ds vuqlkj ;fn Fkk;jkW;M gkWeksZUl dh deh tUe ls   esa ;g Fkk;jkW;M gkWeksZUl ds fuekZ.k esa ç;qä gksus okys           gh  mifLFkr  gks  rc  ml  voLFkk  dks  tUetkr   ,UtkbEl dh deh ls mRiUu gksrk gSA            gkbiksFkk;jkW;fMTe (congenital  hypothyroidism  -   CLINICAL MANIFESTATIONS           CH) dgrs gSaA gkbiksFkk;jkW;fMTe ds lHkh çk:iksa esa   ;|fi uotkr f'k'kqvksa esa bls igpkuuk dfBu gksrk gS           CH lcls xaHkhj leL;k gS D;ksafd ;g 'kkjhfjd fodkl   fQj Hkh dqN y{k.kksa ds feyus ij bldh lEHkkouk ij           ds lkFk\&lkFk ekufld fodkl dks Hkh ckf/kr djrh gSA   fopkj vo'; djuk pkfg,A ;g gSa \&            ETIOLOGIES                                                      Macroglossia - thHk dk lkekU; ls vf/kd cM+h           vf/kdk¡'k f'k'kqvksa esa CH LFkk;h gksrk gS ftlds fy,   gksuk           vkthou  Fkk;jkWfDlu  ds  ç;ksx  ¼thyroxine   Hypotonia - gkFk iSjksa dh ekalisf'k;ksa esa Vksu dk de           replacement/  supplementation½ dh vko';drk   gksuk           iM+rh gSA ijUrq dqN ifjfLFkfr;ksa esa ;g dqN le; esa   Umbilical hernia - dk feyuk           Lor% gh Bhd gks tkrk gSA bls vYidkfyd tUetkr   Neonatal jaundice - dk yEcs le; rd jguk           gkbiksFkk;jkW;fMTe ¼Transient CH½ dgrs gSaA  Dysphagia - f'k'kq dks nw/k ihus esa fnDdr gksuk            a) TRANSIENT CH                            Delayed bone maturation - mez c<+us ds lkFk           TSH-R  blocking  antibodies  -  ek¡  esa   gfì;ksa dk fodkl /khes gksuk           autoimmune thyroid disorder gksus dh fLFkfr esa   Other  congenital  malformations  -  buds           cuus okyh TSH-R  blocking  antibodies] IyklsaVk   vfrfjä] bu f'k'kqvksa esa vU; ¼fo'ks\"k :i ls ân; ds½           ikj djds f'k'kq esa igqapdj mldh Fkk;jkW;M xzafFk esa   congenital malformation  dh lEHkkouk lkeU; ls           Fkk;jkW;M gkWeksZUl ds fuekZ.k esa ck/kk Mky ldrh gSaA   4 xquk rd vf/kd gksrh gSA           tUe ds i'pkr~ budh ek=k Øe'k% ?kVrh tkrh gS ftlls   mez  c<+us  ds  lkFk  o;Ldksa  esa  feyus  okyh           gkWeksZUl dh deh Hkh Øe'k% Bhd gksrh tkrh gSA  gkbiksFkk;jkW;fMTe ds vU; y{k.k Hkh feyus yxrs gSaA            ATD - ek¡ esa gkbijFkk;jkW;fMTe ds mipkj ds fy,   DIAGNOSIS            ç;qä gksus okyh anti-thyroid drugs (ATD) Hkh TSH-  D;ksafd yxHkx 75% uotkr f'k'kqvksa esa tUe ds le;           R blocking antibodie dh Hkkafr gh IyklsaVk ikj djds   blds dksbZ fof'k\"V y{k.k çdV ugha gksrs blhfy, bldh           f'k'kq dh Fkk;jkW;M xzafFk esa Fkk;jkW;M gkWeksZUl ds fuekZ.k   igpku ds fy, universal newborn screening  gh                                                     101","lokZf/kd mi;ksxh fodYi gSA gekjs ns'k esa CH  dh   TSH gh vf/kd çHkko'kkyh jgrk gSA ijUrq] uotkr           prevalence yxHkx 1/1400-1700 gS tks fons'kksa dh  f'k'kqvksa esa gkbiksFkSysel ,oa fiVîwVjh ds iw.kZ:i ls           rqyuk esa dkQh vf/kd gS ijUrq bl ij Hkh gekjs ;gk¡  fodflr u gksus ds dkj.k] nks o\"kZ dh vk;q ds iwoZ lhje           vHkh ek= 2% uotkr f'k'kqvksa dh gh LØhfuax gks ikrh   T4 dh tkap dks ojh;rk nh tkrh gSA rRi'pkr]           gSA                                        ekWuhVfjax ds fy, lhje TSH dk mi;ksx fd;k tk            ;g tkap rhu çdkj ls dh tk ldrh gSA         ldrk gSA                                                      - lhje T4 dk Lrj cPpksa ds fy, LFkkfir jsat ds e/;                                \& tUe ds le; gh cord           Umbilical cord blood \& tUe ds le; gh cord           Umbilical cord blood \&           dkVus ds le; mlhds jä dks ,df=r djdsA       ;k  mlls  FkksM+k  Åij  ¼mid  to  upper  half  of                                                       pediatric reference range½ esa j[kuk pkfg,A           Heel prick \&                                -  lhje TSH dk Lrj cPpksa ds fy, LFkkfir jsat ds                     \& tUe ds rhljs ;k pkSFks fnu needle           Heel prick \& tUe ds rhljs ;k pkSFks fnu needle           }kjk heel  prick djds mlls fudyus okys jä dks           CykWfVax isij ij lks[kdj dsA                e/; ;k mlls FkksM+k uhps ¼mid to lower half of                                                       pediatric reference range) esa j[kuk pkfg,A           Venepuncture    tUe  ds  rhljs  ;k  pkSFks  fnu                         \&  \& tUe  ds  rhljs  ;k  pkSFks  fnu                         \&           Venepuncture           peripheral vein ls jä lSaiy ysdj dsA        HYPOTHYROIDISM  DURING  CHILD-                                                       HOOD AND ADOLESCENCE           MANAGEMENT                                 ckY;koLFkk esa feyus okyh gkbiksFkk;jkW;fMTe ds y{k.k]           Fkk;jkW;M gkWeksZUl] f'k'kq ds ekufld fodkl ds fy,   o;Ldksa esa feyus okys y{k.kksa ds leku gh rks gksrs gSaA           vR;ar vko';d gksrs gSaA blhfy,] ;g vR;ar vko';d   buesa eq[;r% rhu fofHkUurk,a gksrh gSaA           gS fd CH ls çHkkfor f'k'kqvksa esa Fkk;jkWfDlu fFkjSih           ;FkklaHko 'kh?kzrk ls vkjEHk fd;k tk,A blh ds }kjk gh   1) nks o\"kZ dh vk;q ds iwoZ gh gkbiksFkk;jkW;fMTe mRiUu           bu f'k'kqvksa dk IQ lkekU; j[kk tk ldrk gSA  gksus ij ekufld fodkl ,oa 'kkjhfjd fodkl] nksuksa]           - Fkk;jkWfDlu fFkjSih ds 0-3 ekg esa vkjEHk gksus ij   ckf/kr gks ldrs gSaA            vkSlr IQ  89 jgrk gSA                     2) nks o\"kZ dh vk;q ds ckn gkbiksFkk;jkW;fMTe mRiUu           - Fkk;jkWfDlu fFkjSih ds 3-6 ekg esa vkjEHk gksus ij  gksus ij ekufld fodkl rks lkekU; jgrk gS fdUrq            vkSlr IQ 71 jgrk gSA                      'kkjhfjd fodkl çHkkfor gks ldrk gSA           - Fkk;jkWfDlu fFkjSih ds 6 ekg ds i'pkr~ vkjEHk gksus   3)  I;wcVhZ ds le; gkbiksFkk;jkW;fMTe mRiUu gksus ij            ij vkSlr IQ 54 jgrk gSA                   bl le; ds iwoZ dk 'kkjhfjd fodkl rks lkekU; jgrk            /;ku jgs] f'k'kqvksa esa Fkk;jkWfDlu dh Mkst] o;Ldksa dh  gS ijUrq I;wcVhZ ds vkaf'kd vFkok iw.kZ:i ls #d tkus           rqyuk esa yxHkx Ng ls nl xquk rd vf/kd gksrh gSA  ls vafre yEckbZ de jg tkrh gSA bl voLFkk esa           Fkk;jkWfDlu dh 10-15 ekbØksxzke izfr fdxzk@izfrfnu  tuukaxksa dk fodkl eq[; :i ls çHkkfor gksrk gSA           Mkst] 2-3 feyh] ek¡ ds nw/k esa ihl dj feyk dj   4) I;wcVhZ ds ckn gkbiksFkk;jkW;fMTe mRiUu gksus ij           çfrfnu nsuh pkfg,A blds lkFk lks;k] vk;ju vFkok   ekufld] 'kkjhfjd ,oa tuukaxksa dk fodkl] rhuksa]           dSfY'k;e  ugha  nsus  pkfg;saA  f'k'kqvksa  esa  CH  esa   lkekU; jgrs gSaA ,sls esa cPps esa gkbiksFkk;jkW;fMTe ds           Fkk;jkWfDlu dh egÙkk le>rs gq, ;g vko';d gS fd   lHkh y{k.k] fdlh o;Ld O;fä esa feyus okys y{k.kksa ds           Fkk;jkWfDlu fFkjSih nsus esa fdlh çdkj dh f'kfFkyrk u   leku gh jgrs gSaA           vkus nh tk,A FksjSih vkjEHk djus ds ,d ekg i'pkr~           Fkk;jkW;M gkWeksZUl dh tkap ds }kjk bldh Mkst dk   ;gk¡ ,d vU; rF; ij Hkh /;ku nsus dh vko';drk gSA           iqufuZ/kkZj.k  dj  ysuk  pkfg,A  lkekU;r;%]  çkbejh   o;Ldksa esa feyus okys vusd y{k.k tSls] lqLrh] vkyL;]           gkbiksFkk;jkW;fMTe ds mipkj dh ekWuhVfjax esa lhje   Fkdku] 'kjhj esa nnZ] bR;kfn] cPpksa esa mudh papyrk ds                                                     102","dkj.k çeq[krk ls çdV ugha gks ikrsA ckY;koLFkk esa  ukih tkrh gS tcfd arm span esa nksuksa gkFkksa long           gkbiksFkk;jkW;fMTe ds dqN fof'k\"V y{k.k fuEukafdr gks   bones dh yEckbZ nks ckj ukih tkrh gSA bl çdkj ls           ldrs gSaA                                  US:LS dh rqyuk esa arm span esa long bones dh            Short stature - vf/kdka'k cPpksa esa dsoy yEckbZ u   o`f) dk ;ksxnku vf/kd gksrk gSA           c<+us dh f'kdk;r gh fey ldrh gSA           tUe ds le;] /kM+ ds vf/kd yEcs gksus ds dkj.k f'k'kq           Assymmetrical short stature \& ckY;koLFkk esa   dh yEckbZ] mlds arm span ls yxHkx 2.5 lseh vf/kd           gkbiksFkk;jkW;fMTe esa gkFk\&iSjksa dh long  bones dk   gksrh gSA blds ckn long bones ds vf/kd c<+us ds           fodkl vf/kd çHkkfor gksrk gSA ,sls esa çHkkfor cPpksa   dkj.k 10 o\"kZ dh vk;q rd ;g nksuksa cjkcj gks tkrs gSaA           ds /kM+ vis{kk—r cM+s jgus ds dkj.k og ns[kus esa   I;wcVhZ ds le; long bones ds rsth ls c<+us ds dkj.k           vf/kd vk;q ds yxrs gSa ijUrq muds gkFk\&iSj NksVs cPpksa   o;Ldksa esa arm span yEckbZ ls Hkh yxHkx 5 lseh                                                      vf/kd gks tkrh gSA gkbiksFkk;jkW;fMTe esa long bones           tSls yxrs gSaA ,slh fLFkfr dks assymmetrical short           stature dgrs gSaA blds nks ekunaM (criteria) gSaA  dh o`f) ds vf/kd çHkkfor gksus ds dkj.k arm span,                                                      length/height ls de gh jg ldrk gSA /;ku jgs]           a) Higher upper segment to lower segment   blds vk/kkj ij Hkh gkbiksFkk;jkW;fMTe dh Mk;Xuksfll           (US:LS) ratio  Lower segment - cPps dks lh/kk                       -           [kM+k djds Hkwfe ls pubic symphysis ds Åijh ckWMZj   ugha cuk;h tk ldrhA           rd dh yEckbZ \& ;g long bones dh fLFkfr crkrh gSA   Delayed  bone  maturation  - ge tkurs gSa fd           Upper  segment  -  Pubic  symphysis  ds Åijh  Fkk;jkW;M gkWeksZUl dk fo'ks\"k çHkko chondrocytes ds           ckWMZj ls flj ds Åijh Hkkx (vertex) rd dh yEckbZ \&   proliferation, differentiation ,oa maturation ij           ;g /kM+ dh fLFkfr crkrh gSA bls cPps dks lh/kk cSBkdj  iM+rk  gSA  blls  gkbiksFkk;jkW;fMTe  esa  bony           lhV ls flj ds Åijh Hkkx rd dh yEckbZ ds :i esa Hkh   maturation Hkh çHkkfor gksrk gSA Short stature ,oa           ukik tk ldrk gSA bls crown to rump length  Hkh   delayed bone age] nksuksa] ckY;koLFkk esa gksus okyh           dgrs gSaA tUe ds le; gkFk iSj vR;ar NksVs gksrs gSa  gkbiksFkk;jkW;fMTe  ds  çeq[k  y{k.k  gSaA  ,Dljs  esa           ftlds dkj.k US:LS ratio yxHkx 1.7 gksrk gSA vk;q   stippled epiphyses Hkh bldk fof'k\"V y{k.k gSA           c<+us ds lkFk\&lkFk long bones dh o`f) gksus ls ;g   Delayed puberty - I;wcVhZ ds iwoZ gksus okyh çkbejh           Øe'k% ?kVrs gq, 10 o\"kZ dh vk;q rd yxHkx 1.0 jg   gkbiksFkk;jkW;fMTe ls I;wcVhZ le; ij vkjEHk ugha gks           tkrk gSA gkbiksFkk;jkW;fMTe esa long bones dh o`f)   ikrh vFkok vkjEHk gksus ij Hkh iw.kZ voLFkk esa igq¡pus           çHkkfor gksus ls ;g vf/kdka'kr;% 1.0 ls vf/kd gh cuk   esa lkekU; ls vf/kd le; yxkrh gS (prolonged or           jgrk gSA /;ku jgs] fodkl Øe dks le>us ds fy,   arrested  puberty)A  gkbiksFkk;jkW;fMTe  esa           vko';d gksus ij Hkh bls Mk;Xuksfll ds fy, egRoiw.kZ   gonadotropin  inhibiting  hormone  (GnIH)  ds           ugha ekuk tk ldrkA                         c<+us ls gonadotropins (LH ,oa FSH) ds flØh'ku            b) Arm span<height - US:LS ratio dh Hkkafr ,d  ?kV tkrs gSa ftlls bZLVªkstsu o çkstsLVsjkWu ds Lrj Hkh           vU; eki arm span dh Hkh dh tk ldrh gS ftlesa  de jg tkrs gSaA           cPps ds nksuksa gkFkksa dks nksuksa vksj iwjk QSykdj muds   Precocious puberty - blds Bhd foijhr] çkbejh           m¡xfy;ksa ds fljksa ds chp dh vf/kdre nwjh ukih tkrh   gkbiksFkk;jkW;fMTe esa dHkh\&dHkh I;wcVhZ le; ls iwoZ Hkh           gSA ;g eq[; :i ls long bones dh fLFkfr crkrh gSA   vkjEHk gks tkrh gSA okLro esa TSH ds c<+s gq, Lrj]           /;ku jgs] cPps dh yEckbZ esa  Upper  ,oa  lower   lajpukRed :i ls FSH ds leku gksus ds dkj.k FSH           segments ds :i esa long bones ,oa /kM+ dh yEckbZ   fjlsIVlZ ij dk;Z djrs gq, vksosfj;u QkWfydYl dks                                                      103","mÙksftr djds vksosfj;u flLV ,oa bZLVªkstsu mRiUu dj   ij  ekfld  /keZ  iw.kZ:i  ls  can  Hkh  gks  ldrs  gSa           ldrs gSa tks ,aMksesfVª;e dh o`f) djkdj oStkbuy   (amenorrhea)A           CyhfMax  Hkh  mRiUu  dj  ldrs  gSaA  ckydksa  esa  ;g   Disorders  of  ovulation  and  fertility  -           testicular enlargement ds :i esa çdV gks ldrk gSA   gkbiksFkk;jkW;fMTe esa GnRH ,oa gonadotropins ds           bls Van Wyk Grumbach syndrome  dgrs gSaA   Hkh çHkkfor gksus ds dkj.k ovulation esa Hkh ck/kk                                                      igq¡prh gS (oligo or anovulation) tks buQfVZfyVh ds            HYPOTHYROIDISM  IN  YOUNG  ADULT            MALES AND FEMALES                         :i esa çdV gks ldrs gSA           ;qok iq#\"kksa esa rks gkbiksFkk;jkW;fMTe ds lkFk dksbZ   Bad obstetrical history - gkWeksZUl esa gksus okys           fof'k\"V  y{k.k  ugha  feyrsA  buesa  vis{kk—r   vusdksa  cnykoksa  ds  dkj.k  gkbiksFkk;jkW;fMTe  esa           nonspecific  y{k.k  tSls]  hypoactive  sexual   xHkZ/kkj.k djus (conception) esa ck/kk mRiUu gksrh gS           desire  (HSD),  erectile  dysfunction  (ED)  ,oa   (infertility)  rFkk  xHkZ/kkj.k  djus  ds  ckn  Hkh           ejaculatory  disorders  gh  fey  ldrs  gSaA  buds   miscarriage dh laHkkouk vR;f/kd c<+ tkrh gSA           foijhr] ;qofr;ksa esa ekfld /keZ ,oa vksO;qys'ku esa gksus           okyh vfu;ferrk,a fof'k\"V :i ys ldrh gSaA buesa ls   Galactorrhea  -  çkbejh  gkbiksFkk;jkW;fMTe  esa           dqN çeq[k y{k.k fuEukafdr gSaA             fuxsfVo QhMcSd ds dkj.k TRH dk flØh'ku c<+ tkrk                                                      gS tks çksySfDVu cukus okyh lactotropes  ls ØkWl           Menstrual  irregularities  -  gkbiksFkk;jkW;fMTe  esa   fj,DV djds çksySfDVu dk flØh'ku c<+k ldrk gS           fdlh Hkh çdkj dh ekfld /keZ dh vfu;ferrk mRiUu   ftlls galactorrhea rd vkjEHk gks ldrk gSA /;ku           gks ldrh gS ijUrq muesa loZçeq[k gSa] ekfld pØ dk   jgs] bl çdkj vkjEHk gq, galactorrhea ds fy,           yEck ¼>35 fnu½ gksrk tkuk ftlls o\"kZ esa 9 ckj ls   çksySfDVu ?kVkus okyh nokvksa dh vko';drk ugha gksrhA           de CyhfMax gksa (oligomenorrhea; oligo=de) ,oa   gkbiksFkk;jkW;fMTe ds fu;a=.k ,oa TRH ds Lrj lkekU;            ekfld /keZ vkjEHk gksus ij vR;f/kd jälzko dk gksuk   gks tkus ds lkFk gh galactorrhea Lor% gh Bhd gks           (menorrhagia)A gkbiksFkk;jkW;fMTe dh xaHkhjrk c<+us   tkrk gSA                                                                                   104","xHkkZoLFkk ,oa uotkr f'k'kqvksa esa Fkk;jkW;M fodkjksa ds mipkj dh dyk ¼Dyhfudy dkS'ky½            16        xHkkZoLFkk ,oa uotkr f'k'kqvksa esa Fkk;jkW;M fodkjksa ds mipkj dh dyk ¼Dyhfudy dkS'ky½xHkkZoLFkk ,oa uotkr f'k'kqvksa esa Fkk;jkW;M fodkjksa ds mipkj dh dyk ¼Dyhfudy dkS'ky½                      The Art of Managing Hypothyroidism in Pregnancy and Newborns (Clinical Skill)            Fkk;jkW;M lEcaf/kr fodkjksa dh igpku ,oa muds mipkj  vf/kdrk le>uk mfpr ugha gksrkA okLro esa] ;fn T4           ds fo\"k; esa foLr`r ppkZ ge lEcaf/kr v/;k;ksa esa igys  ds Lrj lkekU; lhek (4-12 mcg/dl) esa gh fey jgs gksa           gh dj pqds gSaA çLrqr v/;k; esa ge dsoy xHkkZoLFkk ,oa  ¼tks xHkkZoLFkk ds fy, lkekU; ugha gS½ rc budks           ckY;koLFkk esa buesa gksus okys fof'k\"V ifjorZuksa dk gh  xHkkZoLFkk ds fy, vi;kZIr gh ekuk tkuk pkfg,A           o.kZu djsaxsaA                             TSH during gestation - T4 dh Hkkafr gh  TSH ds            budks mfpr çdkj ls le>us ds fy, vko';d gS fd  Lrj dh rqyuk Hkh fjiksVZ esa fy[kh lkekU; lhek ls ugha           ,d ckj iwoZorhZ Dyhfudy dkS'ky ls lEcaf/kr v/;k;ksa  djuh pkfg, D;ksafd ;g Hkh xHkkZoLFkk esa ifjofrZr gks           dks nksgjk fy;k tk;sA                      tkrs gSaA xHkkZoLFkk esa IyklsaVk ls cuus okys hCG  ds                                                      TSH dh Hkkafr dk;Z djus ds dkj.k  TSH dk flØh'ku           INTERPRETATION  OF  TFT  DURING           GESTATION                                  ?kVrk tk gS ftlls blds Lrj Hkh ?kVrs gq, lkekU;           Dyhfudy dsl\& ,d 30 o\"khZ;k efgyk] tks çkbejh   lhek (0.5 mIU/L)  ds Hkh uhps igq¡p tkrs gSaA xHkkZoLFkk           gkbiksFkk;jkW;fMTe ds fy, 100 ekbØksxzke Fkk;jkWfDlu   esa ;g Hkh lkekU; ekus tkus pkfg;saA iqu%] ;fn xHkkZoLFkk           ys jgh Fkha] xHkZ/kkj.k djus ds i'pkr~ TFT dh mijksä   esa TSH  ds Lrj lkeus lhek (0.5-5.0 mIU/L)  ds           fjiksVZ~l ds lkFk fn[kkus vk;haA Fkk;jkWfDlu dh Mkst   Åijh Hkkx (2.5-5.0 mIU/L)  esa fey jgs gksa rc bUgsa           fu/kkZfjr djus ds fy, vkidk fu.kZ; D;k gksxk ,oa   Fkk;jkW;M gkWeksZUl dh deh gh ekuk tkuk pkfg,A blds           D;ksa\\                                     4.0  mIU/L  ls  vf/kd  gksus  dks  rks  xHkkZoLFkk  esa                                                      gkbiksFkk;jkW;fMTe dk |ksrd ekuk tkrk gSA           ;gk¡ T3/T4 ds Lrj lkekU; lhek ls vf/kd gksus ds           dkj.k ;g /kkj.kk cu ldrh gS fd Fkk;jkWfDlu dh Mkst   Antithyroid  antibody  testing  during           vko';drk ls vf/kd gS ,oa bls ?kVk nsuk pkfg,A blh   gestation - xHkkZoLFkk ds nkSjku ftu efgykvksa esa           çdkj] TSH ds Lrj lkekU; ls de gksus ds dkj.k blh   TSH dh tkap 2.5 mIU/L ls vf/kd gks] muesa anti           vuqeku dh iqf\"V djrs yxrs gSaA ijUrq] ;gk¡ okLrfodrk   TPO antibody dh tkap Hkh djkbZ tkuh pkfg,A ;g           dqN vkSj gh gSA ge ;gk¡ fjiksVZ esa fy[ks ftu lkekU;   bu efgykvksa esa tksf[ke ds fu/kkZj.k esa enn dj ldrh           Lrjksa dks vius fu.kZ; dk vk/kkj cuk jgs gSa og rks   gSA  ,.VhckWMh  ikWftfVo  efgykvksa  esa  xHkkZoLFkk  ds           xHkkZoLFkk esa feyus okys lkekU; Lrj ugha gSaA vr% buls   ifj.kke] vU; dh rqyuk esa de vPNs feyrs gSaA bu           rqyuk djus ij ge xqejkg gh gksaxsaA        efgykvksa esa ,.VhckWMh dks ?kVkus dk mik; rks ugha fd;k                                                      tk ldrk ijUrq blls gkbiksFkk;jkW;fMTe ds c<+us dh           T3/T4 during gestation - ge le> pqds gSa fd   lEHkkouk dks /;ku esa j[krs gq,] Fkk;jkWfDlu fFkjSih           xHkkZoLFkk esa IyklsaVk ls cuus okyk hCG] lajpukRed   vkjEHk djus dk fopkj vo'; fd;k tk ldrk gSA           :i ls TSH dh Hkkafr gh gksus ds dkj.k Fkk;jkW;M xzafFk   UNIVERSAL vs CASE BASED SCREENING           dks mÙksftr djrk gqvk] vf/kd ek=k esa T4 dk mRiknu           djkrk gSA lkFk gh xHkkZoLFkk esa cuus okyk bLVªkstsu]   xHkkZoLFkk esa gkbiksFkk;jkW;fMTe ds mHkj ldus ,oa           TBG ds Lrj dks c<+krk tkrk gSA vf/kd ek=k esa cuus   xHkZLFk f'k'kq ij blds nq\"çHkkoksa dh lEHkkouk c<+ tkus           ,oa TBG ls tqM+rs tkus ds dkj.k T4, vius lkekU;   ds dkj.k ;g fopkj vk ldrk gS fd xHkZ/kkj.k ds iwoZ                                                      vFkok blds Kkr gksus ds ckn] lHkh efgykvksa dks           Lrj (4-12 mcg/dl) dh Åijh lhek ds 1.5 xquk (~18           mcg/dl) rd c<+ tkrs gSaA bUgsa Fkk;jkW;M gkWeksZUl dh   gkbiksFkk;jkW;fMTe ds fy, LØhu fd;k tkuk pkfg,A                                                      ijUrq bldk lkekftd ,oa vkfFkZd cks> vR;ar o`gn                                                    105","gksxkA blhfy,] çR;sd efgyk ls iwoZ esa fdlh Fkk;jkW;M   dkj.k gh blds mipkj ds fy, Hkh vfrfjä lrdZrk dh           lEcaf/kr vfu;ferrk] ltZjh ;k mipkj dh tkudkjh   vko';drk gksrh gSA            vo'; iwNuh pkfg, ,oa buds gksus ij gh TSH +/- T4   Overt  hypothyroidism  (TSH  >10  mIU/L)  -           dh tkap djokuh pkfg, (case-based screening)A   blesa Fkk;jkWfDlu fFkjSih vkjEHk djus ds fo\"k; esa dksbZ           Anti TPO antibody ds ikWftfVo gksus ,oa ART ds   la'k; ugha gS ,oa bls 50 ekbØksxzke çfrfnu dh Mkst ls           }kjk xHkkZ/kku djkus dh fLFkfr esa gh bls çR;sd efgyk   vkjEHk fd;k tk ldrk gSA TSH ds Lrj dk vkSj           esa fd;k tkuk vko';d le>k tkrk gSA         vf/kd gksus ij Fkk;jkWfDlu dh vkSj Hkh vf/kd Mkst dh           gkbZ fjLd efgyk,a] ftudh vk;q 30 o\"kZ ls vf/kd gks]   vko';drk  iM+  ldrh  gS]  ftldk  p;u           ftudks iwoZ esa gkbiks@gkbijFkk;jkW;fMTe jg pqdk gks]   gkbiksFkk;jkW;fMTe ds mijksä fooj.k dh Hkkafr fd;k           xkW;Vj@,aVhckWMh ikWftfVo gksa] Fkk;jkW;M dh ltZjh ;k   tk ldrk gSA ;gk¡ dsoy ,d rF; ij fo'ks\"k:i ls /;ku           xys dk jsfM,'ku gks pqdk gks] Fkk;jkW;M dks çHkkfor   dsafær djuk gS fd xHkkZoLFkk esa Fkk;jkWfDlu dh Mkst]                                                      vU; efgykvksa vFkok iq#\"kksa dh rqyuk esa FkksM+h vf/kd           djus okyh nok,a py jgh gksa ¼tSls amiodarone,           lithium] ;k iodinated radiologic contrast agent   gh jgrh gSA vr% bldks cgqr de Mkst ls vkjEHk           fn;k x;k gks½] Vkbi 1 Mk;fcVht ;k vU; vkWVksbEE;wu   djuk ;k cgqr /khjs /khjs c<+kuk mfpr ughaA           jksx gksa] buQfVZfyVh ;k iwoZ esa ,ckW'kZu ;k le; ls iwoZ   Subclinical  hypothyroidism  (TSH  4-10           fMyhojh (preterm  delivery) gks pqdh gks] ;k og   mIU/L) \& xHkkZoLFkk esa Fkk;jkW;M gkWeksZUl dh vfrfjä           vk;ksMhu dh deh ls çHkkfor {ks= esa jg jgh gks] muesa   vko';drk gksus ds dkj.k rkfdZd :i ls bl voLFkk esa           xHkZ/kkj.k djus ds iwoZ vFkok blds rqjar ckn] Fkk;jkW;M   Hkh Fkk;jkWfDlu fFkjSih dks vkjEHk dj ysuk pkfg,A           QaD'kUl vo'; djkus pkfg;saA                ijUrq vusd v/;;uksa esa blds ifj.kkeksa ds fo\"k; esa                                                      dksbZ Li\"V fu\"d\"kZ u feyus ds dkj.k vHkh blds fy,           CLASSIFICATION  OF  HYPOTHYROIDISM           DURING GESTATION                           Li\"V funsZ'k (recommendation) ugha gSaA ijUrq] ;fn           xHkkZoLFkk ds nkSjku TSH ds Lrj ?kV tkus ds dkj.k gh   efgyk  vkWVksbEE;wfuVh  ls  çHkkfor  gks  (anti-TPO           bl le; gkbiksFkk;jkW;fMTe dh Mk;Xuksfll ds Lrj   antibody ikWftfVo gks½ rc mls Fkk;jkWfDlu fFkjSih           FkksM+k vkSj uhps gh j[ks tkrs gSaA tgk¡ lkekU;r% TSH ds   vo'; vkjEHk dh tkuh pkfg,A blh çdkj] assisted           5 ;k 5.50 mIU/L ls vf/kd gksus ij gh bls vlkekU;   reproductive technique (ART) }kjk xHkkZ/kku fd;s           ekuk tkrk gS ogha xHkkZoLFkk esa bls 4 mIU/L ls vf/kd   tkus ij Hkh bldh lQyrk dks lqfuf'pr djus ds fy,           gksus ij gh vlkekU; ekurs gSaA bl çdkj] xHkkZoLFkk ds   ij Hkh Fkk;jkWfDlu fFkjSih vkjEHk dj nsuh pkfg,A           nkSjku gkbiksFkk;jkW;fMTe ds nks :i gks ldrs gSaA   LokHkkfod :i ls bl voLFkk esa Fkk;jkWfDlu dh Mkst                                                      cgqr FkksM+h ¼12.5-25 ekbØksxzke çfrfnu½ gh gksuh           - Overt hypothyroidism ¼çdV ;k Dyhfudy½ \&   pkfg,A            ;fn lhje TSH 10 mIU/L ls vf/kd gksA           - Subclinical  hypothyroidism  -  ;fn  lhje   TSH 2.5-4.0 mIU/L \& D;ksafd xHkkZoLFkk esa TSH 2.5            TSH 4-10 mIU/L ds e/; gksA                mIU/L ls de gh jguk pkfg,] blfy, rkfdZd :i ls                                                      TSH  ds  2.5-4.0  mIU/L  ds  e/;  gksus  ij  Hkh            MANAGEMENT  OF  HYPOTHYROIDISM            Fkk;jkWfDlu fFkjSih nh tkuh pkfg,A ijUrq LokHkkfod            DURING GESTATION           INDICATIONS  OF  THYROXIN  REPLACE-        :i ls tc TSH 4-10 mIU/L ds e/; gksus ij gh dksbZ           MENT DURING GESTATION                      Li\"V jk; ugha gS rc bl voLFkk ds fy, dSls gksxh\\           xHkkZoLFkk ds nkSjku gkbiksFkk;jkW;fMTe ls ek¡] f'k'kq ,oa   vr%] blds fy, Hkh Li\"V funsZ'k (recommendation)           xHkkZoLFkk ds ifj.kkeksa ij iM+ ldus okys nq\"çHkkoksa ds   ugha gSa ijUrq bl ij Hkh fopkj fd;k tk ldrk gS]                                                      106","fo'ks\"k:i ls vkWVksbEE;wfuVh ls çHkkfor (anti-TPO  xHkZLFk f'k'kq ds Fkk;jkW;M ds çfr vR;f/kd laosnu'khy           antibody ikWftfVo) efgykvksa esaA          gksus ds dkj.k bls de le;kUrjkyksa ij ¼çR;sd 4-6            Role of anti-TPO antibody - bl çdkj] xHkkZoLFkk   lIrkg ij½ djk;k tkuk pkfg,A ,slk fo'ks\"k:i ls           ds nkSjku ftu efgykvksa esa TSH dh tkap 2.5 mIU/L   vkWVksbEE;wfuVh  ls  çHkkfor  ¼anti-TPO  antibody           ls vf/kd gks] muesa anti TPO antibody dh tkap Hkh   ikWftfVo½  efgykvksa  ds  fy,  vko';d  gS  ftuesa           djkbZ tkuh pkfg,A ;g bu efgykvksa esa tksf[ke ds   gkbiksFkk;jkW;fMTe ds rhozrk ls c<+us dh lEHkkouk           fu/kkZj.k esa enn dj ldrh gSA ,.VhckWMh ikWftfVo   vf/kd gksrh gSA xHkkZoLFkk ds mÙkjk/kZ (second half) esa           efgykvksa esa xHkkZoLFkk ds ifj.kke] vU; dh rqyuk esa   bls çR;sd rhu ekg esa ¼fo'ks\"k:i ls 28-30 lIrkg ij½           de vPNs feyrs gSaA bu efgykvksa esa ,.VhckWMh dks   ,d ckj djk;k tk ldrk gSA           ?kVkus dk mik; rks ugha fd;k tk ldrk ijUrq blls   Targets of therapy - iqu% /;ku jgs] Fkk;jkWfDlu           gkbiksFkk;jkW;fMTe ds c<+us dh lEHkkouk dks /;ku esa  fFkjSih dk y{; T4 ,oa TSH dks xHkkZoLFkk ds vuqdwy           j[krs gq,] Fkk;jkWfDlu fFkjSih vkjEHk djus dk fopkj  Lrjksa ij ys tkuk gS] fjiksVZ ij fy[kha lhek esa cuk;s           vo'; fd;k tk ldrk gSA                      j[kuk ughaA blhfy,] xHkkZoLFkk dh çFke frekgh esa                                                      TSH dk y{; 2.5 mIU/L ls de rFkk T4 dk y{;]           USING THYROXIN DURING  GESTATION           Thyroxin  replacement  dose  \&  okLro  esa]   bldh Åijh lhek (12 mcg/dl) ds Ms<+ xqus ls vf/kd           xHkZ/kkj.k ds lkFk gh ek¡ dh BMR rhozrk ls c<+us yxrh   (~18 mcg/dl) gh j[kuk pkfg,A xHkkZoLFkk dh f}rh;           gSA blhfy,] xHkZ/kkj.k ds lkFk gh Fkk;jkWfDlu dh Mkst   ,oa r`rh; frekfg;ksa esa TSH dk y{; 3.0 mIU/L ls           esa yxHkx 20-30% dh c<+ksÙkjh dj nsuh pkfg,A bldh   de j[kuk pkfg,A /;ku jgs] xHkkZoLFkk esa T4 dks free           ,d ljy fof/k ;g gks ldrh gS fd efgyk Fkk;jkWfDlu   T4 ls csgrj ekuk tkrk gSA ;fn fdlh dkj.k ls free           dh ftl Hkh Mkst ij fu;af=r gS] mldh nks fnu dh Mkst   T4 dh tkap djk;h tk jgh gS rc bls bldh lkekU;           çR;sd lIrkg c<+k nh tk,aA vFkkZr] ;fn og  75   Lrj dh Åijh lhek ij j[kuk pkfg,A           ekbØksxzke çfrfnu ys jgh Fkha rc lIrkg ds fdUgha nks   POSTPARTUM  CHANGES  IN  THYROID           fnuksa esa bldks ,d ¼75 ekbØksxzke½ ds LFkku ij nks   FUNCTIONS           xksfy;ka ¼150 ekbØksxzke½ ysus yxsaA  xHkkZoLFkk esa T4   çlo ds mijkUr Fkk;jkW;M xzafFk dh lfØ;rk vusd           dks  c<+k  gqvk  ,oa  TSH  dks  ?kVk  gqvk  ns[kdj   çdkj ls çHkkfor gks ldrh gSA           Fkk;jkWfDlu dh Mkst de dj nsuk mfpr ughaA  Decrease in requirement \& LokHkkfod :i ls ek¡            Monitoring - xHkkZoLFkk dh çFke frekgh esa TSH]   dh esVkckWfyd vko';drk,a ?kVus ls Fkk;jkWfDlu dh           ekWuhVfjax ds fy, mi;qä ugha gksrkA vr% bl le;   Mkst Hkh ?kVuh pkfg,A           ekWuhVfjax ds fy, T4 dk ç;ksx fd;k tkuk pkfg,A   No change in requirement \& ijUrq dHkh\&dHkh           f}rh; ,oa r`rh; frekgh esa] hCG ds de gks tkus ds  xHkkZoLFkk dh vko';drk,a c<+us ds vfrfjä ncko ds           ckn] TSH dks iqu% ekWuhVfjax ds fy, ç;ksx esa yk;k tk  dkj.k xzafFk detksj iM+ tkrh gS ,oa og çlo ds mijkar           ldrk gSA                                   Hkh lqpk# :i ls dk;Z ugha dj ikrhA ,sls esa çlo ds           Frequency  of  monitoring  - gkbiksFkk;jkW;fMTe   ckn Hkh ek¡ dh Fkk;jkWfDlu dh Mkst iwoZor gh cuh jgrh           (overt or subclinical) dh Kkr efgykvksa esa xHkkZoLFkk   gSA           dh çR;sd frekgh esa de ls de ,d tkap vo'; djk   Increase  in  requirement  \&  vkWVksbEE;wu           ysuh pkfg;sA xHkkZoLFkk ds iwokZ/kZ (first half) esa ek¡ dh  Fkk;jkW;MkbfVl dh fLFkfr esa xHkkZoLFkk esa c<+s gq,           esVkckWfyd xfrfof/k;ksa esa vR;f/kd ifjorZu vkus ,oa  bZLVªkstsu ds dkj.k bEE;wu çfØ;k,a nc tkrh gSa tks çlo                                                      107","ds ckn bZLVªkstsu ds ?kV tkus ls iqu% mHkj vkrh gSaA  gkbiksFkk;jkW;fMTe dh igpku xHkkZoLFkk ds nkSjku gh           Postpartum  thyroiditis  dh bl fLFkfr esa ek¡ ds  gqbZ gks ,oa muesa gkbiksFkk;jkW;fMTe vis{kk—r vf/kd           Fkk;jkW;M QaD'kUl iwoZ dh vis{kk vkSj Hkh vf/kd nc  c<+h gqbZ  (moderate  to  severe) jgh gks ftlesa           tkrs gSa ftlls Fkk;jkWfDlu dh vkSj Hkh vf/kd Mkst dh  Fkk;jkWfDlu dh Mkst 50 ekbØksxzke çfrfnu ls vf/kd           vko';drk iM+ ldrh gSA                      ysuh iM+ jgh gks muesa ;g ekuk tk ldrk gS fd xzafFk           Suggestions \& bl çdkj] çlo ds mijkar ek¡ ds   vf/kd ek=k esa çHkkfor gqbZ gS ,oa 'kk;n xHkkZoLFkk dh           Fkk;jkW;M QaD'kUl esa vk ldus okys ifjorZuksa dk   vfrfjä vko';drk ?kV tkus ds ckn Hkh efgyk ds           iwokZuqeku yxkuk vR;ar dfBu gSA blfy,] blds çfr   fy, i;kZIr gkWeksZu dk mRiknu u dj ldsA vr% bls           dksbZ iwokZxzg u j[krs gq,] çlo ds 1.5 ekg ckn   iw.kZ:i ls can u djds] 50 ekbØksxzke çfrfnu ?kVk           Fkk;jkW;M dh tkap vo'; djkrs gq, mlds vk/kkj ij   ysuk pkfg,A           gh vkxkeh mipkj cukuh pkfg,A /;ku jgs] bl le;   Reassessment \& mijksä rhuksa voLFkkvksa esa çlo           ds ckn dh fLFkfr Hkh LFkk;h ugha gksrhA blesa vk ldus  ds 6 lIrkg i'pkr~ TFT ds }kjk ek¡ dh vko';drk           okys ifjorZuksa dks igpkuus ds fy, bu tkapksa dks çlo  ,oa Fkk;jkWfDlu dh Mkst dk iqufuZ/kkZj.k dj ysuk           ds 3 ekg ,oa 6 ekg i'pkr~ iqu% djk ysuk pkfg,A  pkfg,A            MANAGEMENT  OF  HYPOTHYROIDISM             Supplemental iodine \& xHkkZoLFkk ds nkSjku ,oa           AFTER DELIVERY                                                      çlo ds mijkar f'k'kq dks Lruiku djkrs le; Hkh ek¡ dh           çlo ds mijkar ek¡ dh esVkckWfyd vko';drk,a 'kh?kzrk   esVkckWfyd vko';drk,a lkekU; ls c<+h jgrh gSaA           ls ?kVrs gq, xHkkZoLFkk ds iwoZ Lrj ij vkus yxrh gSaA   blhfy, bu nksuksa ifjfLFkfr;ksa esa mls vk;ksMhu dh           vr% çlo ds mijkUr Fkk;jkWfDlu dh Mkst dks iqu% ?kVk   vfrfjä ek=k dh vko';drk gksrh gSA vk;ksMhu dh           ysuk pkfg,A bldh rhu laHkkouk,a gks ldrh gSaA   deh ls çHkkfor {ks=ksa esa] bl vko';drk dks iwjk djus           Prepregnancy hypothyroidism \& xHkkZoLFkk ds   ds fy,] xHkZ/kkj.k djus ds iwoZ ,oa çlo ds mijkar 400           iwoZ ls gh gkbiksFkk;jkW;fMTe ls çHkkfor efgykvksa esa   fexzk vk;ksMhu dks vk;ksMkbTM vkW;y ds :i esa fd;k           mudh xHkkZoLFkk ls iwoZ dh Fkk;jkWfDlu dh Mkst dks iqu%   tk ldrk gSA           vkjEHk fd;k tk ldrk gSA                     MANAGEMENT OF HYPERTHYROIDISM                                                       DURING GESTATION           Gestational onset of mild hypothyroidism \&           ftu  efgykvksa  esa  gkbiksFkk;jkW;fMTe  dh  igpku   Diagnostic  dilemma  \& ge le> pqds gSa fd           xHkkZoLFkk  ds  nkSjku  gh  gqbZ  gks  muesa  ;fn   xHkkZoLFkk ds nkSjku T3 ,oa T4 ds Lrj LokHkkfod :i           gkbiksFkk;jkW;fMTe vis{kk—r gydh (mild) gh jgh gks   ls c<+ tkrs gSa ,oa TSH ds Lrj Hkh LokHkkfod :i ls           ftlesa Fkk;jkWfDlu dh Mkst 50 ekbØksxzke çfrfnu ls   ?kV tkrs gSaA vr% buds }kjk lkekU; xHkkZoLFkk esa feyus           de gks rc bls iw.kZ:i ls can fd;k tk ldrk gSA bu   okys physiological adaptations ,oa xzsOl fMlht           efgykvksa esa ;g ekuk tk ldrk gS fd mudh Fkk;jkW;M   ¼xHkkZoLFkk  ds  nkSjku  feyus  okyh  loZçeq[k           xzafFk lkekU; voLFkk ds fy, gkWeksZu mRiUu djus esa   gkbijFkk;jkW;M voLFkk½ esa foHksn djuk dfBu gksrk gSA           l{ke Fkh ijUrq xHkkZoLFkk dh vfrfjä vko';drk dks   blds  vfrfjä]  xHkkZoLFkk  Lo;a  esa  Hkh  ,d           iw.kZ  u  dj  ldhA  çlo  ds  mijkar  ;g  vfrfjä   gkbijesVkckWfyd voLFkk gS ftlesa mÙkstuk] /kM+du]           vko';drk ?kV tkus ds ckn laHkor% og iqu% i;kZIr   daiu bR;kfn y{k.kksa dk feyuk ,oa Fkk;jkW;M xzafFk dk           ek=k esa gkWeksZu dk mRiknu dj ldsA        vkdkj esa c<+ tkuk Hkh bl foHksn esa vkSj dfBukbZ                                                      mRiUu djrs gSaA vr% gydh (mild) gkbijFkk;jkW;fMTe           Gestational  onset  of  moderate  to  severe   esa ,aVh\&Fkk;jkW;M MªXl dk ç;ksx fd;k tk;s vFkok ugha]           hypothyroidism  \&  ftu  efgykvksa  esa                                                     108",";g ç'u vR;ar egRoiw.kZ gks tkrk gSA bl dk;Z ds fy,   mifLFkr gksa]           lokZf/kd  egRoiw.kZ  tkap]  jsfM;ksU;wDykbM  LdSu]   - ;fn Fkk;jkW;M gkWeksZUl ds Lrj vR;f/kd c<s gq, gksa           xHkkZoLFkk  esa  oftZr  (contraindicated)  gS  rFkk   ftuds lkekU; xHkZ esa feyus dh lEHkkouk de gks]           ,aVhFkk;jkW;M ,aVhckWMht  (anti-TPO  ,oa  anti-TG)   - ;fn dqN le; ds varjky ij djkbZ x;h tkapksa esa ;g           blesa lgk;d ugha gksrha D;ksafd ;g lkekU; efgykvksa esa   Lrj vkSj Hkh vf/kd c<+rs tk jgs gksa]           Hkh fey ldrh gSaA gk¡] TRAb dk feyuk vo';   - ;fn xzsOl vkW¶FkSYeksiSFkh ds y{k.k fey jgs gksa]           Graves' disease dk pathognomonic y{k.k gksrk   - ;fn TRAb ,aVhckWMht ds Lrj c<+s gq, gksa           gS ftlds }kjk bldh Mk;Xuksfll dks lqfuf'pr fd;k   How to treat? \& ge tkurs gSa fd xzsOl fMlht dk           tk ldrk gSA /;ku jgs] gkbijFkk;jkW;fMTe ds lkFk xHkZ                                                      mipkj rhu çdkj ls fd;k tk ldrk gS] ,aVhFkk;jkW;M           Bgjus ij dsoy Fkk;jkW;M gkWeksZUl dh tkapsa (T4/FT4   MªXl ds }kjk] jsfM;ks,fDVo vk;ksMhu ds }kjk ,oa           ,oa TSH) gh i;kZIr jgrh gSaA xzsOl fMlht dh lEHkkouk   Fkk;jkW;MsDVeh ds }kjkA buesa ls jsfM;ks,fDVo vk;ksMhu           gksus ij TRAb dh tkap vo'; djkbZ tk ldrh gSA   dk mi;ksx rks xHkkZoLFkk esa oftZr (contraindicated)           ijUrq] gkbijFkk;jkW;fMTe ds vfrfjä fdlh vU;   gS ,oa Fkk;jkW;MsDVeh dks xaHkhj ekeyksa esa dsoy f}rh;           y{k.k  ds  fcuk  ckj\&ckj  vYVªklkWmUM  djkuk]                                                      frekgh esa gh ç;ksx esa yk;k tk ldrk gSA bl çdkj]           antenatal  testing  vFkok  umbilical  blood   xHkkZoLFkk  ds  nkSjku  dsoy  ,aVhFkk;jkW;M  MªXl  gh           sampling djokuk mfpr ugha gksrkA                                                      loZekU; ,oa çpfyr mipkj cprk gSA           Significance of TRAb \& vius uke ds vuqlkj]                                                      Which drug? \& ge le> pqds gSa fd ,aVhFkk;jkW;M           TRAb  vFkkZr  TSH  receptor  stimulating   MªXl ds nks çeq[k lewg gksrs gSa] CMZ/MMI vFkok           antibodies, ek¡ dh Fkk;jkW;M xzafFk ij fLFkr TSH   PTU A çFke frekgh esa organogenesis ds nkSjku]           fjlsIVlZ ls tqM+dj xzafFk dks mÙksftr djrh gSa ftlls   xHkZLFk f'k'kq dks ojh;rk nsrs gq, PTU dk gh p;u           vko';drk ls vf/kd Fkk;jkW;M gkWeksZUl mRiUu gksus   fd;k tkrk gS D;ksafd IyklsaVk dks ikj ugha dj ldus ds           yxrs gSaA ;g ,UVhckWMht IyklsaVk dks ij djds xHkZLFk   dkj.k ;g Hkzw.k ij nq\"çHkko ugha MkyrhA ijUrq PTU ds           f'k'kq rd Hkh igq¡p ldrh gSa tgk¡ ;g f'k'kq dh Fkk;jkW;M   fyoj ij iM+ ldus okys nq\"çHkkoksa dks /;ku esa j[krs           xzafFk dks Hkh mÙksftr djrs gq, fetal hyperthyroidism   gq,] f}rh; ,oa r`rh; frekgh esa ek¡ ds LokLF; dks           Hkh djok ldrh gSaA                                                      ojh;rk nsrs gq, (CMZ/MMI) dk p;u fd;k tkrk gSA           tks efgyk,a xHkZ/kkj.k ds iwoZ ls gh ATD ys jgh gksa muesa   CMZ/MMI ysrh gqbZa efgykvksa esa xHkZ/kkj.k dh iqf\"V           xHkZ/kkj.k ds i'pkr~ TRAb dh tkap djkuh pkfg,A  gksus ds lkFk gh buds LFkku ij PTU dks vkjEHk dj           blds Lrj c<+s gksus ij bls iqu% 18-22 lIrkg ij ,oa   ysuk pkfg,A blds fy, 5 fexzk MMI ;k 7.5 fexzk           rc Hkh c<+s gksus ij 30-34 lIrkg ij djokuk pkfg,A   CMZ ds LFkku ij 100 fexzk PTU dk mi;ksx fd;k           fdlh Hkh le; blds Lrj rhu xqus ls Hkh vf/kd c<+s  tk ldrk gSA xHkkZoLFkk ds 16 lIrkg gksus ij PTU ds           gksus ij ;g fetal hyperthyroidism dh lEHkkouk dks  LFkku ij iqu% CMZ/MMI dks vkjEHk dj ysuk pkfg,A           O;ä djrh gSaA                                                      Goals  of  therapy  \&  xHkkZoLFkk  ds  nkSjku           Whom to treat? \& xHkkZoLFkk esa xzsOl fMlht dh  ,aVhFkk;jkW;M Mªx fFkjSih dk vkjEHk Hkh vU; efgykvksa           Mk;Xuksfll esa Li\"Vrk u gksus ds dkj.k blds mipkj ds  ,oa iq#\"kksa dh Hkkafr gh fd;k tkrk gSA ;gk¡ ,d rF; dks           fo\"k; esa dqN lq>ko fuEukafdr gks ldrs gSaA   çeq[k :i ls /;ku esa j[kuk gS fd Fkk;jkW;M gkWeksZUl           - ;fn xzsOl fMlht dh Mk;Xuksfll xHkZ ds iwoZ gh cu   (T4/FT4) ds Lrjksa dks budh Åijh lhek ds fudV            pqdh gks vFkok blds y{k.k xHkZ/kkj.k ds iwoZ ls gh   vFkok muls FkksM+k vkSj vf/kd j[kuk pkfg, ftlls ek¡                                                      ,oa f'k'kq dks i;kZIr ek=k esa Fkk;jkW;M gkWeksZUl feyrs                                                     109","jgsA lkFk gh TSH dks Hkh çFke frekgh esa 2.5 mIU/L  Mkst ds vko';drk ls de gksus ij ;g ek¡ dh           rFkk f}rh; ,oa r`rh; frekgh esa 3.0 mIU/L ls de gh  Fkk;jkW;M xzafFk ij i;kZIr :i ls fu;a=.k ugha j[k ikrh           j[kuk pkfg,A                               ftlls ek¡ esa gkbijFkk;jkW;fMTe ds y{k.k cus gh jgrs            Dose requirement \& ;gk¡ ,d vkSj Hkh rF; dks   gSaA vfu;af=r gkbijFkk;jkW;fMTe rks f'k'kq ij çHkko           /;ku esa j[kuk pkfg, fd xHkkZoLFkk esa c<+k gqvk   Mkyrh gS ijUrq ATD dh Mkst de jgus ls f'k'kq lh/ks gh           bZLVªkstsu] vkWVksbEE;wu çfØ;kvksa dks ,d lhek rd nck   çHkkfor ugha gksrkA           nsrk gS ftlls dqN efgyk,a rks Lor% gh remission dh  xzsOl fMlht esa ;fn TRAb dh Lrj lkekU; ds rhu xqus           voLFkk esa igq¡p tkrh gSa ,oa muesa ,aVhFkk;jkW;M MªXl  ls Hkh vf/kd c<+s gksa rc og vo'; IyklsaVk dks ikjdj           dqN le; ds fy, can Hkh gks ldrh gSaA vr% ;fn]  f'k'kq dh Fkk;jkW;M xzafFk dks vuko';d :i ls mÙksftr           xHkZ/kkj.k djrs le;  MMI dh Mkst  5–10 fexzk  dj ldrs gSaA blls fetal hyperthyroidism mRiUu gks           çfrfnu ;k CMZ dh Mkst 10-15 fexzk çfrfnu ;k  ldrh gS tks fetal goiter ,oa fetal tachycardia ds           PTU dh Mkst 100– 200 fexzk çfrfnu gksa rc ATD  :i esa çdV gks ldrh gSA           ds can gks ldus dh lEHkkouk vf/kd gksrh gSA ,sls esa   Management  of  fetal  hyperthyroidism  \&           çkjEHk esa 2 lIrkg ckn FT4 dh tkap djkdj ,oa blds   /;ku jgs] fetal hyperthyroidism] TRAb ds c<+s gq,           Bhd jgus ij 4 lIrkg ckn FT4/TSH  dh tkapsa   Lrj  ds  dkj.k  gksrh  gS]  ek¡  dh  vfu;af=r           djkdj ;g lqfuf'pr dj ysuk pkfg, fd og lkekU;   gkbijFkk;jkW;fMTe ds dkj.k ughaA vr% ATD ds }kjk           lhek esa cuh gSa vFkok ughaA                                                      ek¡ dh gkbijFkk;jkW;fMTe dks fu;af=r djds blij           bl çdkj ls xHkkZoLFkk ds nkSjku ek¡ ,oa f'k'kq dh c<+h  fu;a=.k ugha ik;k tk ldrkA D;ksafd TRAb dks ?kVkus            gqbZ  esVkckWfyd  vko';drkvksa  ds  dkj.k  dh  dksbZ  fof/k  Kkr  ugha  gS  vr%  fetal           gkbiksFkk;jkW;fMTe  esa  Fkk;jkWfDlu  dh  Mkst  dh   hyperthyroidism dks fu;af=r djus ds fy, ATD dh           vko';drk  rks  lkekU;  ls  dqN  vf/kd  ijUrq  gh vf/kd ek=k ¼ek¡ dh vko';drk ls vf/kd½ dk           ,aVhFkk;jkW;M MªXl dh Mkst dh vko';drk lkekU; ls  ç;ksx fd;k tkrk gS tks fd IyklsaVk dks ikj dj ldus ds           dqN de gh iM+rh gSA                        dkj.k f'k'kq rd igqapdj mldh Fkk;jkW;M xzfUFk ls                                                      gkWeksZUl dk mRiknu de dj ldsA           Consequences of overtreatment – ATD dh           Mkst ds vko';drk ls vf/kd gksus ij ;g ek¡ ,oa f'k'kq]  bl çfØ;k esa ck/kk ;g gS fd] ATD dh vf/kd ek=k ls           nksuksa] dks çHkkfor dj ldrh gSA           ek¡ dh Fkk;jkW;M xzafFk ls Fkk;jkW;M gkWeksZUl dk mRiknu                                                      Hkh lkekU; ls vf/kd ?kVdj ek¡ esa gkbiksFkk;jkW;fMTe           ek¡ dh Fkk;jkW;M xzafFk ds vko';drk ls vf/kd ncus ls           ek¡ esa gkbiksFkk;jkW;fMTe mRiUu gks tkrk gS ftlls f'k'kq   mRiUu dj ldrk gSA blls cpus ds fy, ek¡ dks           dk 'kkjhfjd ,oa ekufld fodkl ckf/kr gks ldrk gSA   Fkk;jkWfDlu dh FkksM+h ek=k vyx ls nh tkrh gS tks ek¡ esa                                                      Fkk;jkW;M gkWeksZUl dh deh dks rks iwjk djrh gS ijUrq           ATD IyklsaVk dks ikj dj xHkZLFk f'k'kq rd igq¡p ldrh   IyklsaVk dks i;kZIr :i ls ikj u dj ikus ds dkj.k]           gSaA  f'k'kq  dh  Fkk;jkW;M  xzafFk  ds  ncus  ls  fetal   f'k'kq esa Fkk;jkW;M gkWeksZUl ds Lrjksa dks ugha c<+krhA           hypothyroidism mRiUu gks ldrh gS tks fetal goiter           ,oa fetal bradycardia mRiUu dj ldrh gSA blls   bl çdkj] fetal hyperthyroidism esa ATD dh vf/kd           cpko j[kus ds fy, ATD dh Mkst dks de j[kuk gh   ek=k] fetal hyperthyroidism ds mipkj ds fy, ,oa           mfpr jgrk gS ftl ij T4/FT4  lkekU; lhek ds   Fkk;jkWfDlu  dh  vfrfjä  ek=k]  maternal           Åijh Lrj ij gh jgsaA                       hypothyroidism ls cpko ds fy, nh tkrh gSA bl                                                      çfØ;k  dks  block   (ATD  ds  }kjk½  and  replace           Consequences of undertreatment - ATD dh                                                     110","¼Fkk;jkWfDlu ds }kjk½ regimen  dgrs gSaA    ekalisf'k;ksa  dk  <hykiu  (poor  muscle  tone)]            Management during lactation \& ;wa rks ATD dh   dfCt;r]  neonatal  jaundice  bR;kfn y{k.k fey           dqN ek=k ek¡ ds nw/k esa Hkh flØhV gksrh gS] ijUrq ek¡ ds   ldrs gSA lsdsaMjh CH ¼lsaVªy gkbiksFkk;jkW;fMTe½ ls           LokLF; ds fy, MMI dh 20 fexzk çfrfnu ,oa PTU   çHkkfor f'k'kqvksa esa hypopituitarism ds vU; y{k.k                                                      (hypoglycemia,  micropenis,  cyptorchidism           dh 450 fexzk çfrfnu rd dh ek=k dk ç;ksx fd;s tkus   bR;kfn½ Hkh çdV gks ldrs gSaA ijUrq jksx dh xaHkhjrk           ij ;g f'k'kq dks vf/kd çHkkfor ugha djrhaA  ns[krs gq, y{k.kksa ds vk/kkj ij dksbZ fu.kZ; ysus ds LFkku            ge tkurs gSa fd bl le; ek¡ dh vk;ksMhu dh   ij LØhfuax ij gh Hkjkslk djuk mfpr jgrk gSA           vko';drk yxHkx 250 ekbØksxzke çfrfnu rd c<+   Which test? \& ge tkurs gSa fd gkbiksFkk;jkW;fMTe           tkrh gS ijUrq vk;ksMhu ;qä ued dk lsou djus okyh   dh Mk;Xuksfll ds fy, T4 ,oa TSH dh vko';drk           efgykvksa esa vyx ls vk;ksMhu nsus dh vko';drk ugha   iM+rh gSA buesa ;fn nksuksa dks djk ikuk laHko u gks rc           iM+rhA vU;Fkk] vk;ksMhu dh deh ls çHkkfor {ks=ksa esa   dsoy TSH dh tkap ls gh 95% jksfx;ksa ¼çkbejh           400 fexzk vk;ksMhu dh Mkst] vk;ksMkbTM rsy ds :i   gkbiksFkk;jkW;fMTe½ dks igpkuk tk ldrk gSA 'ks\"k cps           esa nh tk ldrh gSA                         gq,  5%  f'k'kqvksa  esa  lsaVªy  gkbiksFkk;jkW;fMTe  dh            (Ref: Recommendations for the Management   lEHkkouk dks igpkuus ds fy, T4/FT4  dh tkap dh           of Thyroid Dysfunctions in Pregnancy: Jointly   vko';drk iM+rh gSA           by Indian Thyroid Society and FOGSI \& 2019;           American Thyroid Association 2017)         Screening test - CH dh LØhfuax dks le>us ds iwoZ           SCREENING AND MANAGEMENT OF CH             tUe ds i'pkr TSH esa gksus okys ifjorZuksa ds fo\"k; esa           IN A NEWBORN                               tkuuk vko';d gSA tUe ysrs gh f'k'kq] ek¡ ds xHkZ ds           vkb;s le>rs gSa fd çkbejh gkbiksFkk;jkW;fMTe ls   xeZ okrkoj.k ls ckgj ds BUMs okrkoj.k esa igq¡p tkrk           çHkkfor  efgyk  ls  tUe  ysus  okys  f'k'kq  esa   gSA ,sls esa 'kjhj ds rkieku dks fxjus ls cpkus ds fy,           gkbiksFkk;jkW;fMTe dh lEHkkouk tkuus ds fy, gesa D;k   Fkk;jkW;M gkWeksZUl dh vko';drk c<+ tkrh gS ftlds           djuk pkfg,A ge tkurs gSa fd Fkk;jkW;M lEcU/kh fdlh   fy, tUe ds igys ?kaVs esa gh fiVîwVjh }kjk TSH dk           fodkj ds gksus ij fdlh O;fä ds jä lEcfU/k;ksa ¼QlZ~V   flØh'ku c<+ tkrk gSA ,sls esa ;fn tUe ds 2-3 ?kaVksa ds           fMxzh fjysfVo \& ekrk\&firk] HkkbZ\&cgu ,oa cPpksa½ esa Hkh   ckn lSaiy ,df=r fd;k tk;s] rc og dkQh c<+k gqvk           Fkk;jkW;M ds vU; fodkjksa dh lEHkkouk vf/kd gksrh gSA   fey ldrk gSA TSH dks lkekU; Lrjksa ij ykSVus esa 2-           uotkr f'k'kq esa gksus okys Fkk;jkW;M ds lHkh fodkjksa esa   3 fnu yx tkrs gSaA blhfy,] TSH dh tkap ds fy, nks           congenital  hypothyroidism  (CH)  gh  lokZf/kd   le; gh mi;qä gksrs gSa] 1) tUe ds rqjar ckn] heel           egRoiw.kZ gS D;ksafd le; ij mipkj u gksus ij ;g   prick ls jä dks fQYVj isij ij lks[kdj] ,oa 2½ tUe           vkthou  jgus  okyh  ekufld  vYirk  (mental   ds rhljs vFkok pkSFks fnu] venepuncture ds }kjk           retardation) mRiUu dj ldrh gSA vr% ,sls ekrk   jä çkIr djdsA           firk ls mRiUu gksus okys f'k'kq esa CH dh lEHkkouk dks           igpkuus ds fy, Fkk;jkW;M LØhfuax vo'; djkuh   Confirmatory test - TSH ds Lrjksa esa vkus okys bu           pkfg,A                                     ifjorZuksa ds dkj.k ,d gh tkap ij Mk;Xuksfll cuk                                                      ysuk i;kZIr ugha ekuk tkrkA blds fy, Fkk;jkW;M           Clinical features of CH at birth - CH dks cgq/kk   gkWeksZUl dh tkap ,d ckj iqu% djk ysuh pkfg,A nksckjk           tUe ds le; igpkuuk vR;ar dfBu gksrk gSA çkbejh   ,df=r fd;s x, lSaiy esa TSH ds vfrfjä] FT4 dh           CH esa f'k'kq ds psgjs ij lwtu] thHk dk cM+k gksuk  ,oa   tk¡p Hkh djkuh pkfg,A           blds dkj.k nqX/kiku esa dfBukbZ gksuk] gkFk\&iSjksa esa                                                      With prematurity \& le; ls iwoZ tUesa] de otu                                                     111","okys vLoLFk f'k'kqvksa (premature, sick babies with  dks ihl dj] ,d pEep LoPN ty esa feykdj] f'k'kq           low birth weight) esa TSH ds Lrj vf/kd u c<+us ds  dks fn;k tkrk gSA uotkr f'k'kq esa nqX/kiku dk le;           dkj.k vusd ckj ;g tk¡p ukWeZy (false negative)  fu;af=r dj ikuk laHko ugha gksrkA blfy,] nqX/kiku ds           vk tkrh gSA vr% ,sls f'k'kqvksa esa bls tUe ds 10-14  le; dh fpark fd;s fcuk] Fkk;jkWfDlu dks fdlh Hkh           fnuksa ds i'pkr~ nksckjk djk ysuk pkfg,A Down's  fuf'pr le; ij nsrs jguk pkfg,A gka] cM+s cPpksa esa           syndrome esa rks bls tUe ds ,d o\"kZ ckn iqu% djkuk  nok nsus ds pkj ?kaVs rd] lks;k çksVhu] Qy ,oa lfCt;ksa           pkfg,A                                     dks ugha nsuk pkfg,A            Diagnostic criteria                        Monitoring  of  therapy  \&  Fkk;jkWfDlu  fFkjSih           - ;fn tUe ds le; fQYVj isij TSH VsLV esa bldk  vkjEHk djus esa lfØ;rk cjrus dh Hkkafr bldh Mkst            Lrj 40 mIU/L ls vf/kd gksA                dh i;kZIr ek=k dks lqfuf'pr djus ds fy, Hkh lfØ;rk           - ;fn tUe ds nwljs lIrkg esa fd;s x, confirmatory  vR;ar egRoiw.kZ gksrh gSA blds fy, TSH ,oa FT4 dh            VsLV esa TSH Lrj 20 mIU/L ls vf/kd gksA   tkap djkrs gSaA ;gk¡ bl rF; dks /;ku esa j[kus dh           - ;fn tUe ds rhu lIrkg ckn Hkh TSH Lrj 6-20  vko';drk gS fd Fkk;jkWfDlu ¼T4½ dh Mkst ysus ds            mIU/L ls vf/kd gksA                       i'pkr~ vxys 4 ?kaVksa rd jä esa FT4 ds Lrj c<+s gq,           - ;fn fdlh Hkh le; FT4 ds Lrj 5-  10 pmol/L ls  feyrs gSaA vr%] tkap ds fnu lSaiy ;k rks Fkk;jkWfDlu            de gksaA                                  ysus ds iwoZ gh ,df=r dj ysuk pkfg, vFkok nok ysus                                                      ds 4 ?kaVs ckn ysuk pkfg,A TSH ds fy, lSaiy fnu ds           Treatment of CH \& Fkk;jkW;M gkWeksZUl dh deh f'k'kq           esa vkthou ekufld vYirk mRiUu dj ldrh gSA   fdlh Hkh le; ,df=r fd;k tk ldrk gSA           Fkk;jkWfDlu fFkjSih vkjEHk djus esa gksus okyh nsjh   Targets of therapy \& f'k'kq esa Fkk;jkW;M gkWeksZUl dh           bldh  lEHkkouk  dks  c<+krh  tkrh  gSA  blhfy,]  i;kZIrrk lqfuf'pr djus ds fy, FT4 ds Lrj bldh           Mk;Xuksfll ds lkFk gh Fkk;jkWfDlu fFkjSih dks iwjh Mkst  Åijh lhek ij ,oa TSH ds Lrj bldh fupyh lhek           esa vkjEHk dj ysuk pkfg,A /;ku jgs] o;Ld jksfx;ksa dh  ds fudV j[kus dk ç;kl djuk pkfg,A            rqyuk esa ;g Mkst dkQh vf/kd ¼10-15   vs  1.6   Frequency of monitoring \& gkbiksFkk;jkW;fMTe           ekbØksxzke çfr fdxzk½ gksrh gSA            dks 'kh?kzkfr'kh?kz fu;af=r djus ds ç;kl esa vkjEHk esa rks            uotkr f'k'kqvksa esa TSH ds Lrj fLFkj u gksus ds dkj.k  ;g tkapsa] Fkk;jkWfDlu fFkjSih vkjEHk djus ds ,d           bls CH dh Mk;Xuksfll ds fy, rks ç;qä fd;k tkrk gS  lIrkg ckn gh djk yh tkrh gSaA blds ckn nks lIrkg ij           ijUrq CH dh xaHkhjrk dk vuqeku TSH ds LFkku ij  ,oa mlds Hkh ckn bUgsa çR;sd ekg djuk pkfg,A /;ku           FT4 ds vuqlkj yxk;k tkrk gSA               jgs] uotkr f'k'kq dh 'kkjhfjd o`f) dh nj] cM+s cPpksa                                                      dh rqyuk esa vR;f/kd gksrh gS ftlds dkj.k Fkk;jkW;M           - FT4 ds Lrj 5 pmol/L ls de gksus ij Fkk;jkWfDlu            dh vkjafHkd Mkst 15 ekbØksxzke çfr fdxzk j[kuh   gkWeksZUl dh vko';drk Hkh vR;ar rsth ls c<+rh tkrh            pkfg,A                                    gSA bl vko';drk dks le; ij iwjk u djus ij Hkh           - FT4  ds  Lrj  10  pmol/L  ls  vf/kd  gksus  ij   f'k'kq dh 'kkjhfjd ,oa ekufld o`f) çHkkfor gks ldrh            Fkk;jkWfDlu dh vkjafHkd Mkst 10 ekbØksxzke çfr   gSA blhfy,] visf{kr Lrj çkIr gksus ds ckn Hkh bu                                                      tkapksa dks rhu o\"kZ dh vk;q rd çR;sd rhu ekg ij ,oa            fdxzk j[kuh pkfg,A           - FT4  ds  Lrj  lkekU;  gksus  ij  Fkk;jkWfDlu  dh   blds ckn o`f) tkjh jgus rd çR;sd 3-6 ekg ds            vkjafHkd Mkst 5 ekbØksxzke çfr fdxzk j[kuh pkfg,A   varjky ij djkrs jguk pkfg,A Fkk;jkWfDlu dh Mkst esa                                                      fdlh çdkj dk dksbZ ifjorZu djus ij blds i;kZIr           Mode of administration \& Fkk;jkWfDlu dh xksyh   gksus dh iqf\"V 4-6 lIrkg ckn dj ysuh pkfg,A                                                      112","[kaM\&5                                                        Fkk;jkW;M xzafFk ds fodkj \& lftZdy                        (Surgical Disorders of The Thyroid Gland)","Fkk;jkW;M xzafFk dk vkdkj esa c<+uk \& xkW;Vj           17         Fkk;jkW;M xzafFk dk vkdkj esa c<+uk \& xkW;VjFkk;jkW;M xzafFk dk vkdkj esa c<+uk \& xkW;Vj                      Enlargement of The Thyroid Gland - Goiter            Fkk;jkW;M xzafFk ds vkdkj esa c<+ tkus dks xkW;Vj   TSH de gksA           ¼goiter; Latin guttur = throat½ dgrs gSaA lkekU; :i   3. Goiter with hypothyroidism \& ;fn xkW;Vj ds           ls xys dh tkap djus esa Fkk;jkW;M xzafFk dks vyx ls   lkFk\&lkFk jDr esa Fkk;jkW;M gkWeksUl ¼T3 ,oa T4½ ds           Nwdj ¼palpate dj ds½ igpkuk ugha tk ldrk gS   Lrj lkekU; vFkok de gksa ijUrq TSH c<+k gksA           ijUrq vkdkj esa c<+us ij ;g Nwus ls vyx ls igpkuh   ETIOLOGICAL CLASSIFICATION)           tk ldrh gSA vf/kdk¡'k O;fä;ksa esa ,slk TSH ds c<+us   mRifÙk ds dkj.kksas ds vk/kkj ij xkW;Vj vusd çdkj dk           ls gksrk gS tks Fkk;jkW;M QkWfydYl dks mÙksftr dj   gks ldrk gS \&           mudh hypertrophy ,oa hyperplasia djkrk gSA                                                      1. Endemic  goiter \& ;fn ;g fdlh endemic              CLASSIFICATION OF GOITER                  zone esa vk;ksMhu dh deh ls mRiUu gqvk gksA           fdlh xkW;Vj dks mldh lajpuk] dk;Z {kerk ,oa mldh   2. Inflammatory \& ;fn ;g acute ;k chronic           mRifÙk ds vk/kkj ij vusd :iksa esa oxhZ—r fd;k tk   infection vFkok bEE;wu dkj.kksa ls mRiUu gqvk gksA           ldrk gSA                                   3. Neoplastic  \&  ;fn  ;g  benign  vFkok                                                        malignant disorder ls mRiUu gqvk gksA           STRUCTURAL CLASSIFICATION                  4. Infiltrative \& ;fn Fkk;jkW;M xzafFk esa dqN vU;           lajpuk dh –f’V ls xkW;Vj nks çdkj dk gks ldrk gS \&  inkFkksZa ds tek gksus ls bldk vkdkj c<+ x;k gksA           1. Diffuse enlargement \& tc iwjh Fkk;jkW;M xzafFk   5. Physiological  \&  ;fn  ;g  lkekU;  thou  esa            gh vkdkj esa c<+h gksA                      Fkk;jkW;M gkWeksZUl dh c<+h gqbZ vko';drkvksa dks iwjk           2. Nodular enlargement \& tc Fkk;jkW;M xzafFk dk   djus ds fy, c<+k gks tSls I;wcVhZ ,oa xHkkZoLFkk esaA            dksbZ ,d Hkkx vkdkj esa c<+k gqvk gksA ;g iqu% nks   SIMPLE  GOITER  (TSH  DEPENDENT            çdkj dk gks ldrk gS \&                      EUTHYROID GOITER)           - Solitary or isolated nodule \& tc Fkk;jkW;M   dqN immunological,  neoplastic,  inflammatory            xzafFk dk dksbZ ,d Hkkx ukWMîwy ¼nodule] xk¡B½ dh   vFkok infiltrative disorders ds vfrfjDr] vf/kdk¡'k            Hkkafr vyx ls çrhr gks jgk gks ,oa 'ks\"k xzafFk   xkW;Vj] TSH ij fuHkZj (TSH dependent)  gh gksrs gSa            nonpalpable gksA                          vFkkZr muesa TSH dk vf/kd ek=k esa flØh”ku gh           - Dominant nodule \& tc Fkk;jkW;M xzafFk dk dksbZ   Fkk;jkW;M xzafFk ds vkdkj dks c<+krk gSA            ,d Hkkx ukWMîwy dh Hkkafr vyx ls çrhr gks jgk gks            ,oa lkFk gh 'ks\"k xzafFk Hkh lkekU; ls vkdkj esa c<+h   fiVîwVjh ls TSH dk vfFkd ek=k esa flØh”ku Hkh nks            gksdj palpable gksA                       çdkj ls gks ldrk gSA                                                      - ;fn  jDr  esa  Fkk;jkW;M  gkWeksZUl  dh  deh           FUNCTIONAL CLASSIFICATION)                  ¼gkbiksFkk;jkW;fMTe½ gksus ij bldk fuxsfVo QhMcSd]           dk;Z dh –f’V ls xkW;Vj rhu çdkj dk gks ldrk gS \&  fiVîwVjh dks mÙksftr djs] vFkok           1. Euthyroid goiter \& ;fn xkW;Vj ds lkFk\&lkFk   - ;fn fiVîwVjh esa thyrotropes dk Vîwej gks tks fcuk            jDr esa Fkk;jkW;M gkWeksZUl ¼T3 ,oa T4½ ds Lrj   vko';drk ds gh TSH dks vR;fFkd ek=k esa lzkfor            lkekU; gksA                                djrk jgsA           2. Toxic goiter \& ;fn xkW;Vj ds lkFk\&lkFk jDr esa            Fkk;jkW;M gkWeksZUl ¼T3 ,oa T4½ ds Lrj c<+s gksa ,oa   ;g TSH ij fuHkZj xkW;Vj tc rd Fkk;jkW;M gkWeksZUl                                                    114","dks i;kZIr ek=k esa flØhV djrs jgrs gSa rc rd O;fä   ,oa hypertrophy ls Fkk;jkW;M xzafFk dk vkdkj c<+us            euthyroid  cuk  jgrk  gSA  bl  çdkj  ds  TSH   yxrk gSA           dependent  euthyroid  goiter dks flaiy xkW;Vj   - Fkk;jkW;M xzafFk dk vkdkj ,oa lfØ;rk c<+us ls dqN           (simple goiter½ Hkh dgrs gSaA               O;fä;ksa esa Fkk;jkW;M gkWeksZUl ds Lrj lkekU; gks tkrs            ETIOPATHOGENESIS OF SIMPLE GOITER           gSa ftlls dqN le; esa TSH  dk lzko.k Hkh lkekU; gks                                                       tkrk gS ijUrq xkW;Vj c<+k gh jg tkrk gSA blh dks           flaiy xkW;Vj ls çHkkfor vf/kdk¡'k O;fä;ksa esa TSH           c<+us dk vkjEHk] Fkk;jkW;M gkWeksZUl ds ?kVus ls gksrk gSA   simple / euthyroid goiter dgrs gSaA           Fkk;jkW;M gkWekZsUl dh ;g deh eq[;r% rhu çdkj ls gks   - Fkk;jkW;M gkWeksZUl ds mRiknu esa #dkoV vf/kd gksus           ldrh gSA                                    ij TSH  dk lzko.k c<+us ,oa xkW;Vj ds mRiUu gksus                                                       ds i'pkr~ Hkh Fkk;jkW;M gkWeksZUl ds Lrj lkekU; ugha           Iodine deficiency \& Fkk;jkW;M gkWeksZUl ds mRiknu   gks  ikrsA  bu  O;fä;ksa  esa  xkW;Vj  ds  lkFk\&lkFk           ds fy, vk;ksMhu vko';d gksrh gSA Endemic areas   gkbiksFkk;jkW;fMTe ¼elevated TSH  ,oa low T3, T4           esa bldh deh ls Fkk;jkW;M gkWeksZUl ds mRiknu esa deh   - çkbejh gkbiksFkk;jk;fMTe½ dh fLFkfr dks goitrous           vkrh gSA                                    hypothyroidism dgrs gSaA            Dyshormonogenesis  \&  Fkk;jkW;M  gkWeksZUl  ds           mRiknu ds fy, vko';d ,UtkbEl dh deh ls Hkh     IODINE DEFICIENCY GOITER           Fkk;jkW;M gkWeksZUl esa deh vkrh gSA           Goitrogens \& dqN [kk|inkFkZ Fkk;jkW;M gkWeksZUl ds   DEVELOPMENT  OF  DIFFUSE  HYPER-                                                      PLASTIC GOITER           mRiknu ds fofHkUu pj.kksa esa O;o/kku Mkyrs gSaA buesa   TSH }kjk çkjEHk esa lHkh Fkk;jkW;M ykWC;wYl ,d leku           çeq[k  gSa  iÙkkxksHkh  ¼cabbage½]  QwyxksHkh   mÙksftr gksrs gSaA blls iwjh Fkk;jkW;M xzafFk vkdkj esa ,d           ¼cauliflower½]  'kyte  ¼turnip½  bR;kfnA  bu           [kk|inkFkkZsa  esa  mifLFkr  thiocyanates,  vk;ksMkbM   leku  :i  ls  c<+rh  tkrh  gSA  bls  diffuse                                                      hyperplastic goiter dgrs gSaA flaiy xkW;Vj ds fuekZ.k           VSªfiax  esa  #dkoV  Mkyrs  gSaA  gkbijFkk;jkW;fMTe  esa   dk ;g çFke pj.k gSA fdlh vk;ksMhu dh deh ls           Fkk;jkW;M gkWeksZUl ds mRiknu dks ?kVkus okyh vusd   çHkkfor {ks= ds cPpksa esa feyus okyk xkW;Vj blh çdkj           nok,a Hkh ;gh dk;Z djrh gSa ,oa xkW;Vj mRiUu djk   dk  gksrk  gSA  I;wcVhZ  ,oa  xHkkZoLFkk  esa  'kjhj  dh           ldrh gSaA ;wa rks Fkk;jkW;M gkWeksZUl ds mRiknu ds fy,   esVkckWfyd vko';drkvksa ds c<+us ij ;g vkdkj esa           vk;ksMhu vko';d gS ijUrq vk;ksMhu dh vR;f/kd   vkSj vfFkd c<+ tkrk gSA bu ifjfLFkfr;ksa ds chr tkus           ek=k Hkh vk;ksMkbM VSªfiax dks ckf/kr dj xkW;Vj mRiUu   ds i'pkr~ tc esVkckWfyd vko';drk;sa ?kV tkrh gSa rc           djk ldrh gSA                                                      TSH dk mÙkstu Hkh de gks tkrk gS ,oa Fkk;jkW;M xzafFk           vkb;s vc le>rs gSa fd bu ifjfLFkfr;ksa esa xkW;Vj  vkdkj esa fldqM+dj dqN NksVh gks ldrh gSA bl çdkj           fdl çdkj mRiUu gksrk gSA                   dh de lfØ; fdUrq vkdkj esa c<+h gqbZ xzafFk dks           - mijksDr  dkj.k  Fkk;jkW;M  gkWekZsUl  ds  mRiknu  esa   colloid goiter  dgrs gSaA            #dkoV Mkyrs gSaA                          Differential sensitivity of lobules to TSH \&           - Fkk;jkW;M gkWeksZUl dh deh] fuxsfVo QhMcSd ds }kjk   ge tkurs gSa fd Fkk;jkW;M QkWfydYl dk lewg] tks            fiVîwVjh ls TSH dk lzko.k c<+k nsrh gSA   fdlh ,d arteriole }kjk jDr çkIr djrk gS] mls           - TSH  Fkk;jkW;M  xzafFk  dks  vkSj  vfFkd  Fkk;jkW;M   ykWC;wy dgrs gSaA ;g ykWC;wy gh Fkk;jkW;M dh dk;kZRed            gkWeksZUl cukus ds fy, mÙksftr djrk gSA   ¼functional½ ;wfuV gksrh gSaA fdlh ,d ykWC;wy dh lHkh           - TSH, ds }kjk Fkk;jkW;M QkWfydYl dh hyperplasia                                                     115","dksf'kdk,a ,d leku :i ls dk;Z djrh gSa ,oa TSH ds   microscopic  examination  esa NksVs\&NksVs ukWMîwYl            }kjk leku :i ls çHkkfor gksrh gSaA blds foijhr]  iwjh xzafFk esa QSys fey ldrs gSaA fdlh endemic zone           fofHkUu ykWC;wYl ij TSH dk çHkko fHkUu\&fHkUu gks  ds clinically solitary nodules dks ckW;kWIlh esa ns[kus           ldrk gSA blhfy,] yEcs le; rd vk;ksMhu dh deh  ij Kkr gksrk gS fd muesa ls vf/kdk¡'k] okLro esa           esa Fkk;jkW;M gkWeksZUl dk mRiknu ?kVus ij tc TSH dk  eYVh\&ukWMîqyj  xkW;Vj  ¼MNG½  ds  dominant           lzko.k c<+rk gS rc fofHkUu ykWC;wYl mlls fHkUu\&fHkUu   nodule FksA           :iksa  esa  çHkkfor  gksrs  gSaA  ;gh  fHkUurk  muds   DEVELOPMENT OF MNG           vyx\&vyx vkdkj esa c<+us dk dkj.k cu tkrh gSA           Fkk;jkW;M gkWeksZUl ds mRiknu esa iM+us okys O;o/kkuksa ds   yEcs le; ds i'pkr~ vkl\&ikl ds hyperplastic                                                      ykWC;wYl ijLij feyrs tkrs gSaA buds eè; Hkkx esa           ?kVus\&c<+us ds vuqlkj TSH dk lzko.k Hkh ?kVrk\&c<+rk   inactive,  necrosed  follicles  ,oa  colloid inkFkZ           jgrk gSA TSH ds bu mrkj\&p<+ko ls Fkk;jkW;M xzafFk ds   ,df=r gksrk tkrk gSA blds dkj.k igys lfØ; ykWC;wy           dqN ykWC;wYl blls iwoZor mÙksftr gksrs jgrs gSa tcfd   Øe”k% fuf’Ø; gksrs tkrs gSa ,oa buds chp\&chp ds igys           dqN vU; TSH ds çfr mnklhu gksrs tkrs gSa ¼;g Bhd   ls de lfØ; jgs ykWC;wy] vc lfØ; ykWC;wy ds :i esa           mlh çdkj gqvk tSls le; ds lkFk\&lkFk dqN cPps rks   cps jgrs gSaA Activation ,oa involution dh bl çfØ;k           cM+ksa dh MkaV ls iwoZor Mjrs jgrs gSa ijUrq vU; ij   ds pyrs jgus ls le; ds lkFk Fkk;jkW;M xzafFk dh           bldk çHkko de gks tkrk gS½A TSH  ds çfr bl   nodularity c<+rh tkrh gS ftlls igys dk diffuse           vyx\&vyx O;ogkj ls bu ykWC;wy dh lfØ;rk Hkh   hyperplastic goiter, vc MNG cu tkrk gSA fdlh           vyx\&vyx gksrh tkrh gSA                     endemic  zone  esa  ;g  MNG,  ckY;koLFkk  ,oa            DEVELOPMENT OF NODULAR GOITER              ;qokoLFkk esa gh cu ldrk gS tcfd sporadic goiter ls           vf/kd lfØ; ykWC;wy esa follicular hyperplasia gksrs  çHkkfor O;fä;ksa esa ;g vfFkdrj 20-30 o\"kZ dh mez esa           jgus ls og vkdkj esa c<+rk tkrk gS ,oa ,d xk¡B  curk gSA okLro esa vusd O;fä;ksa esa ;g MNG fcuk           ¼ukWMîwy½ dk :i ys ysrk gSA rhozrk ls c<+rs gq, ykWC;wy  mudh tkudkjh ds Hkh iM+k jg ldrk gSA           esa  dksf'kdkvksa  dh  c<+rh  gqbZ  la[;k  ,oa  mldh   STAGES OF GOITER           esVkckWfyd vko';Drkvksa dks iw.kZ djus ds fy, ubZ   Euthyoid goiter \& mijksDr o.kZu ls ge ;g le>           cYM  oslsYl  ds  cuus  ¼angiogenesis½  ds  eè;   ldrs gSa fd Fkk;jkW;M xzafFk esa lfØ; ykWC;wYl ds c<+us           vlarqyu gksus dh lEHkkouk jgrh gSA blh dkj.k ls   ls cuk xkW;Vj] ,d çdkj ls Fkk;jkW;M gkWeksZUl dh deh            vusd ckj bu rsth ls c<+rs hyperplastic ykWC;wYl esa   ls  cpus  dh  gh  ,d  çfØ;k  ¼compensatory           angiogenesis u gks ikus ls blds dsUnzh; Hkkx esa   mechanism½ gSA ;fn xkW;Vj }kjk i;kZIr ek=k esa           ischemia ,oa ischemic necrosis gks tkrh gSA bl   Fkk;jkW;M gkWeksZUl ds fuekZ.k dj fy, tkus dh fLFkfr esa           ischemic zone esa cYM oslsYl friable gks tkrh gSa   jDr esa Fkk;jkW;M gkWeksZUl ds Lrj lkekU; cus jgrs gSa]           ftuds  QVus  ls  blesa  jDrlzko  gksus  yxrk  gSA   rc bl voLFkk dks euthyroid / simple goiter  dgrs           Ischemic  ,oa hemorrhagic  necrosis  ls lfØ;   gSaA           ykWC;wy Øe'k% fuf’Ø; gksrs tkrs gSaA yEcs le; ds           i'pkr~ buesa dSYlhfQds”ku Hkh gks ldrk gSA  Goiter with compensated hypothyroidism                                                      \& ;fn jksx dh xaHkhjrk vf/kd gksus ds dkj.k Fkk;jkW;M           vf/kdk¡'k O;fä;ksa esa ;g ukWMîwy yxHkx leku vkdkj  gkWeksZUl  ds  mRiknu  dks  bl  compensatory           ds ,oa iwjh xzafFk esa QSys gksrs gSa tcfd dqN O;fä;ksa esa   mechanism ds }kjk Hkh larqfyr u fd;k tk lds rc           dsoy ,d ukWMîwy gh vf/kd c<+dj solitary nodule  ml fLFkfr esa xkW;Vj cuus ds ckn Hkh Fkk;jkW;M gkWeksZUl           ds  :i  esa  fn[kkbZ  nsrk  gSA  ,sls  O;fä;ksa  esa  Hkh  dh deh cuh jgrh gSA ,sls esa TSH   vkSj vf/kd c<+dj                                                    116","Fkk;jkW;M gkWeksZUl ds mRiknu dks vkSj c<+kus dk ç;kl   vFkok blds Hkh ckn esa feyrs gSaA            djrk gSA ;fn bl çdkj TSH  ds vkSj vf/kd c<+us ij   SYMPTOMS           Fkk;jkW;M gkWeksZUl ds mRiknu dks lkekU; cuk fy;k   Pressure  symptoms  \& vf/kdk¡'kr% xkW;Vj ds            tk;s rc c<s+ gq, TSH  ds lkFk Fkk;jkW;M gkWeksZUl ds   lkFk] xys esa xk¡B ¼neck  swelling  or  mass½ ds           Lrj lkekU; cus jgrs gSa ,oa gkbiksFkk;jkW;fMTe ds dksbZ                                                      vfrfjDr] fdlh çdkj ds dksbZ vU; y{k.k ugha feyrsA           y{k.k mRiUu ugha gksrsA bl voLFkk dks subclinical   ;wa rks xkW;Vj dk vkdkj xys ds ckgj dh vksj c<+rk gS           hypothyroidism Hkh dgrs gSaA               ijUrq vR;f/kd cM+k gks tkus ij ;g van:uh vaxksa ij           Goiter  with  overt  hypothyroidism-       Hkh ncko Mky ldrk gS ftlls trachea ds ncus ls           Goitrogenesis dh vafre voLFkk ;g gks ldrh gS fd   lk¡l ysus esa :dkoV yxuk ¼shortness of breath½            TSH ds c<+us ,oa blds Fkk;jkW;M xzafFk dks yxkrkj   ,oa lkal ysus esa vf/kd vkokt dk gksuk (stridor),           mÙksftr djrs jgus ds ckn Hkh Fkk;jkW;M xzafFk i;kZIr   esophagus ij ncko ls Hkkstu fuxyus esa #dkoV           ek=k esa Fkk;jkW;M gkWeksZUl mRiUu u dj ldsA bl   yxuk ¼dysphagia½] recurrent laryngeal nerve           fLFkfr esa Fkk;jkW;M gkWeksZUl dk Lrj lkekU; ls Hkh de   ncus ls vkokt esa Hkkjhiu ¼hoarseness½ vFkok xys           gksus ls xkW;Vj ds lkFk\&lkFk gkbiksFkk;jkW;fMTe ds   esa ihM+k tSls y{k.k mRiUu gks ldrs gSaA           y{k.k Hkh mRiUu gksus yxrs gSA bl voLFkk dks clinical           (overt) hypothyroidism dgrs gSaA           Retrosternal goiter \& dHkh\&dHkh Fkk;jkW;M xzafFk                                                      dk fupyk Hkkx vis{kk—r vf/kd c<+rs gq,] thoracic                                                      inlet ls gksrs gq, thoracic cavity rd igq¡p tkrk gSA            CLINICAL MANIFESTATIONS OF GOITER         Anterior  mediastinum  esa igqaps bl xkW;Vj dks           PATIENT’S CHARACTERISTICS                  retro-sternal goiter (retro = ihNs] sternum ds ihNs)           Gender \& lHkh çdkj ds xkW;Vj] iq#\"kksa dh vis{kk   dgrs gSaA Bony thoracic inlet esa QSyus dh xqatkb'k u           efgykvksa esa vf/kd gksrs gSaA bldk çeq[k dkj.k gS]   gksus ds dkj.k] retrosternal goiter ds ncko ls mRiUu           Fkk;jkW;M dh dksf'kdkvksa ij bZLVªkstsu fjlsIVj dk gksuk   gksus okys y{k.k vR;ar xEHkhj gksrs gSa tks çk.k?kkrd rd           tks efgykvksa esa dksf'kdkvksa ds vkdkj esa o`f) djk nsrk   gks ldrs gSaA           gSA                                        Hypothyroidism -  dqN O;fä;ksa esa Fkk;jkW;M xzafFk            Age of presentation \& vk;ksMhu dh deh okys   esa o`f) gksus ds ckn Hkh Fkk;jkW;M gkWeksZUl i;kZIr ek=k esa           {ks=ksa esa thou ds vkjafHkd fnuksa ls gh Fkk;jkW;M xzafFk ij   ugha cu ikrkA buesa gkbiksFkk;jkW;fMTe ds y{k.k mRiUu           Fkk;jkW;M gkWeksZUl dk mRiknu c<+kus ds fy, ncko iM+us   gksus yxrs gSaA buds fo\"k; esa ge foLrkj ls le> pqds           yx tkrk gSA vr% vk;ksMhu dh deh okys {ks=ksa esa   gSA            feyus okys flaiy xkW;Vj ¼diffuse  hyperplastic   SIGNS           endemic goiter½] cpiu esa gh feyus yxrs gSaA blds   Midline  neck  swelling  that  moves  with           foijhr]  i;kZIr  vk;ksMhu  okys  {ks=ksa  esa  gksus  okys   deglutition  - Fkk;jkW;M xzafFk] xys ds vxzHkkx esa]           sporadic goiter, vfFkdka'kr;% I;wcVhZ ,oa xHkkZoLFkk   larynx ds uhps] trachea ds lkeus] chp esa vFkok           ds nkSjku mRiUu gksrs gSa tc 'kjhj dh esVkckWfyd   blds nksuksa vksj fLFkr gksrh gSA           xfrfof/k;ka c<+dj Fkk;jkW;M ij vf/kd gkWeksZUl cukus   Diffuse  goiter dh voLFkk esa rks ;g iwjh xzafFk gh           ds fy, tksj Mkyrh gSaA blh çdkj] MNG Hkh vk;ksMhu   vkdkj esa c<+rh gS ijUrq  MNG  dh voLFkk rd           dh  deh  okys  {ks=ksa  esa  ;qokoLFkk  esa  tcfd  i;kZIr   igq¡prs\&igq¡prs ;g vfku;fer :i ls fdlh Hkh ,d           vk;ksMhu okys {ks=ksa esa 20-30 o\"kZ dh mez ds nkSjku   vksj c<+rs gq,] xys ds fdlh vU; vax dh Hkkafr çrhr                                                      117","gks ldrh gSA                               O;fä ls nksuksa gkFkksa dks Åij mBkdj dqN nsj jksdus dks                                                      dgk tk, rc xys dh veins Qwydj mHkj vkrh gSa           xys ds anterior ¼eè;js[kk esa½ vFkok antero -lateral           part esa fLFkr fdlh xk¡B ds Fkk;jkW;M xzafFk ls mRiUu   (engorgement of neck veins)A ,slk blfy, D;ksafd           gksus dk fo'ks\"k y{k.k gS fd og Hkkstu fuxyus ds nkSjku   venous return dk lkekU; cgko rks retrosternal           igys Åij tkrh gS o fQj uhps dh vksj vkrh gqbZ   goiter ds vxy\&cxy ls gksrk gqvk xqtj tkrk gS ijUrq           fn[kkbZ nsA okLro esa] Fkk;jkW;M xzafFk ftl fascia ls   nksuksa gkFkksa dks Åij mBkus ij buls ykSVus okyk           f?kjh jgrh gS mldk posterior Hkkx eksVk gksdj larynx   vfrfjDr cgko] xkW;Vj ds dkj.k #dus yxrk gS                                                      ftlls xys dh osUl Qwydj mHkj vkrh gSa ,oa psgjs dh           ls tqM+k jgrk gSA bls suspensary  ligament  of           Berry dgrs gSaA ;gh Fkk;jkW;M xzafFk dks blds LFkku ij   ykyh  c<+  tkrh  gS  ¼facial  plethora½A  bls           cuk;s j[kus esa enn djrk gSA blh ds dkj.k Hkkstu   Pemberton's sign dgrs gSaA           fuxyus dh çfØ;k ds nkSjku tSls\&tSls larynx Åij o     DIFFERENTIAL DIAGNOSIS OF GOITER           uhps gksrk gS] mlh çdkj Fkk;jkW;M xzafFk Hkh Åij o uhps   Other swellings of thyroid \& Fkk;jkW;M xzafFk Lo;a           gksrh gSA                                  rks Hkkstu fuxyus ds lkFk Åij o uhps gksrh gh gS fdUrq           Characteristics of a simple goiter - xkW;Vj dh   blls lEcafFkr vU; xkaBsa tSls] ectopic thyroid ,oa                                                      thyroglossal cyst Hkh ,slk gh djrh gSaA ;g nksuksa           vkjafHkd  voLFkk]  flaiy  xkW;Vj  ¼diffuse           hyperplastic goiter½ esa] Fkk;jkW;M xzafFk vius uke ds   Fkk;jkW;M xzafFk dh gh fodkl ds le; gksus okyh           vuq:i] iwjh ,d leku :i ls vkdkj esa c<+h gksrh gSA  vfu;ferrk,a ¼developmental anamoalies½ gSa tks                                                      thHk ds foramen cecum ls ysdj Fkk;jkW;M xzafFk ds           çkjEHk esa ;g eqyk;e gksrh gS ,oa bldh lrg ,dlkj   isthmus rd eè; js[kk esa dgha Hkh fLFkfr gks ldrh gSaA           gksrh gS ijUrq le; ds lkFk\&lkFk] tSls\&tSls blesa   budh ,d vfrfjDr fo'ks\"krk ;g Hkh gS fd xHkkZoLFkk esa           jDrlzko] usØksfll] Qkbczksfll ,oa dSYlhfQds”ku gksrs           tkrs gSa] ;g eqyk;e ¼soft½ ls lkekU; ¼firm½ ,oa fQj   Fkk;jkW;M xzafFk] ftl ekxZ ls gksdj foramen cecum                                                      ls uhps mrjrh gS] mlh dh remnant cord ds thHk ls           lkekU; ls dM+h ¼hard½ gksrh tkrh gSA                                                      tqM+s  jgus  ds  dkj.k  ;g  thHk  ckgj  fudkyus           blh ds lkFk bldh lrg Hkh ,dlkj ls igys nkusnkj   (protrussion of tongue) ij Hkh Åij mBrh gSA           ¼micronodular½ ,oa blds ckn ukWMîqyj gksrh tkrh gS   Swellings other than thyroid \& Hkkstu fuxyus           ftls MNG dgrs gSaA                                                      dh çfØ;k esa okLro esa rks larynx gh Åij mBrk gS]           vf/kdka'kr;% blesa nnZ ugha gksrk ijUrq dHkh\&dHkh  Fkk;jkW;M xzafFk ughaA Fkk;jkW;M xzafFk rks larynx ds           fdlh ukWMîwy esa jDrlzko gksus ij blesa nnZ gks ldrk   fascia ds lkFk tqM+h jgus ds dkj.k gh Åij mBrh gSA           gSA                                        vr% LokHkkfod :i ls 'kjhj ds tks\&tks vax larynx ds           blh çdkj] vkjaHk esa ;g Hkkstu fuxyus ds lkFk Åij   lkFk tqM+s gksaxsa og Hkh Hkkstu fuxyus ds le; Åij           o uhps gksrh gS ijUrq MNG dh fLFkfr esa igqapus rd   mBsaxsaA ;g gSa larynx ds Åij subhyoid  bursa,           bldk fgyuk Øe'k% ?kVrk tkrk gSA            larynx  esa  gh  laryngocele   ,oa  larynx  ds  uhps                                                      pretracheal lymph node A           Characteristics  of  retrosternal  goiter  -           Retrosternal goiter ds çeq[k y{k.k] thoracic inlet  Fkk;jkW;M xzafFk ds l[r gksus ¼hardness½] blesa ihM+k           obstruction  ls  mRiUu  gksrs  gSaA  bldh  çkjafHkd  gksus rFkk blds Ropk vFkok van:uh vaxksa ds lkFk tqM+s           ifjfLFkfr;ksa esa] xkW;Vj ds vkdkj esa NksVk jgus ij]  gksus  ¼fixity½  ij  blesa  Fkk;jkW;M  dSalj  ,oa           O;fä dks Lo;a dksbZ y{k.k çrhr ugha gksrsA ,sls esa ;fn  Fkk;jkW;MkbfVl dh lEHkkouk dks nwj djuk vko”;d gks                                                      118","tkrk gSA                                   esa dSalj dh lEHkkouk dks tkuus ds fy, fd;k tkrk gSA               CLINICAL EVALUATION OF GOITER              COMPLICATIONS           Thyroid function tests - ;g tkuus ds fy, fd  lkekU;r% xkW;Vj esa fdlh çdkj ds xaHkhj nq\"ifj.kke           xkW;Vj ds lkFk Fkk;jkW;M xzafFk dh dk;Z{kerk lkekU; gS  ugha gksrsA buesa gks ldus okys gyds nq\"çHkkoksa dh           ¼euthyroid½] c<+h gqbZ gS ¼Fkk;jksVkWfDldksfll½ vFkok  lEHkkouk Hkh flaiy xkW;Vj esa U;wure] ukWMîqyj xkW;Vj           ?kVh gqbZ gS ¼gkbiksFkk;jkW;fMTe½] lhje   T3, T4 ,oa  esa blls vfFkd ,oa retrosternal goiter esa lokZf/kd gks           TSH dh tkapsa djkrs gSaA ;g xkW;Vj dk dkj.k tkuus  ldrh gSA ;g nq\"çHkko fuEuor gks ldrs gSa \&           ,oa blds mipkj dh fn'kk fu/kkZfjr djus esa enn djrh   Pain vfFkdka'kr;% ;g fdlh ukWMîwy esa jDrlzko ds           gSaA blds vfrfjDr] Fkk;jkW;M gkWeksZUl ds lkekU; jgus   dkj.k  mRiUu  gksrk  gSA  blds  vfrfjDr]           ij Hkh lhje TSH ds Lrj ;g tkuus esa Hkh enn djrs   Fkk;jkW;MkbFkVl Hkh dHkh\&dHkh ihM+k mRiUu dj ldrh           gSa fd Fkk;jkW;M xzafFk ds vkdkj esa gksus okyh o`f) esa   gSA           TSH dk vHkh fdruk ;ksxnku gSA lhje TSH ftruk           vf/kd gksxk] Fkk;jkW;M gkWeksZUl ds }kjk bldks ?kVkdj   Pressure  symptoms  -  ;g  Hkh  vfFkdka'kr;%           xkW;Vj dk vkdkj de djkus esa mruk vf/kd ykHk fey   ukWMîqyj xkW;Vj ds }kjk fudVorhZ vaxksa ij ncko ds           ldsxkA                                     dkj.k mRiUu gksrs gSa tSls trachea esophagus ds                                                      ncus  ls  dyspnea,   esophagus  ds  ncus  ls           Anti-thyroid antibodies - xkW;Vj dk dkj.k tkuus   dysphagia, recurrent laryngeal nerve ds ncus ls           ds lkFk\&lkFk ;g Hkh tkuus esa enn djrh gSa fd Hkfo\";   dysphonia ,oa fdlh Hkh vU; fudVorhZ vaxksa ij           esa Fkk;jkW;M xzafFk dh dk;Z{kerk fdl çdkj jgus dh   ncko iM+us ls nnZ ¼pain½  A Retrosternal goiter esa           lEHkkouk  gksxhA  fdlh  O;fä  esa  ,aVh\&Fkk;jkW;M   ncko ls mRiUu gksus okys ;g y{k.k fdlh çk.k?kkrd           ,aVhckWMht ds feyus dk vFkZ gksrk gS fd og ewy:i ls   :i esa çdV gks ldrs gSa tSls] tracheal ds ncus ls           Fkk;jkW;M xzafFk ds çkbejh fodkjksa ls xzLr gS] vFkkZr                                                      acute respiratory distress  A           xkW;Vj dk dkj.k Fkk;jkW;M xzafFk esa gh gS ¼iodine           deficiency,  dyshormonogenesis  vFkok      Hypothyroidism - vfFkdka'kr;% tks dkj.k xkW;Vj                                                      mRiUu djkrs gSa ogh tc c<+ tk,¡ ;k yEcs le; rd           goitrogen intake½] u fd fiVîwVjh xzafFk esa ¼TSH           producing  adenoma½A  ;g  ,aVhckWMht  (eq[;r%   cus jgsa rc og gkbiksFkk;jkW;fMTe mRiUu djk ldrs           anti-TPO antibodies)] lkekU; Fkk;jkW;M xzafFk dks   gSaA           Hkh Øe'k% {kfrxzLr djrh tkrh gSa ftlls antibody   Transient  thyrotoxicosis  \& flaiy xkW;Vj ls           positive  euthyroid  goiters  esa  Hkfo\";  esa  çHkkfor yxHkx 30% O;fä;ksa esa dqN vKkr dkj.kksa ls           gkbiksFkk;jkW;fMTe dh lEHkkouk Hkh c<+rh tkrh gSA  vYidkfyd Fkk;jksVkWfDldksfll Hkh fey ldrh gS tks            Ultrasonography -  bldh enn ls xkW;Vj flaiy gS   dqN le; i'pkr~ Lor% gh Bhd gks ldrh gSA ,slk           vFkok ukWMîqyj] ;g tkuus ds lkFk\&lkFk blds vkdkj   fo'ks\"k:i ls vkWVks\&bEE;wu Fkk;jkW;MkbfVl esa gksrk gS           dks Hkh ckjhdh ls ukik tk ldrk gSA         ftlesa bE;wu {kfr ls QkWfydYl esa laxzfgr gkWeksZUl jDr                                                      esa yhd gksdj Fkk;jksVkWfDldksfll djk nsrs gSa ijUrq ckn           CT Scan - ;g fo'ks\"k :i ls retrosternal goiter dks   esa QkWfydYl esa gqbZ {kfr ds dkj.k gkbiksFkk;jkW;fMTe           igpkuus esa lgk;d gksrk gSA                mRiUu gks tkrh gSA            Fine  nedle  aspiration  cytolosy  (FNAC)  \&   Cancer  -  ;gh xkW;Vj ds lkFk tqM+k lcls xaHkhj           lkekU;r% fdlh flaiy xkW;Vj esa bldh vko';drk   nq\"ifj.kke gSA vk;ksMhu dh deh okys {ks=ksa esa Fkk;jkW;M           ugha iM+rhA bldk lcls mi;qDr ç;ksx fdlh ukWMîwy                                                    119","QkWfydYl ij fujarj iM+rs ncko ls mlesa follicular   suppressive therapy dks 10 o\"kZ rd nsus ds i'pkr~           adenoma  mRiUu gks ldrs gSa tks le; ds lkFk   Hkh ukWMîwYl dk vkdkj dsoy 50% O;fä;ksa esa gh ?kV           follicular carcinoma esa ifjofrZr gks ldrs gSaA ;g   ikrk gSA           fo'ks\"k:i ls fdlh çeq[k ukWMîwy vFkok rhozrk ls c<+   - lhje TSH ds 5.0 mIU/L ls vf/kd gksus ij gh           jgs ukWMîwy esa fodflr gksrs gaSA           TSH suppressive therapy, xkW;Vj ds vkdkj dks                                                       ?kVk ikus esa l{ke gksrh gS ,oa 2.0 mIU/L ls de gksus                                                       ij fcydqy ughaA            PREVENTION AND MANAGEMENT OF              - è;ku jgs] mipkj dk mís'; c<+s gq, TSH dks ?kVkuk            SIMPLE GOITER                                                       gksrk gS] TSH dks lkekU; ls uhps ys tkuk fcydqy           vk;ksMhu ;qDr ued dk lsou gh vk;ksMhu dh deh ls                                                       ughaA lhje TSH dks 0.5 mIU/L ds fudV gh j[kuk           cpko dk ,dek= mik; gSA Hkkstu esa Kkr goitrogens           dk ijgst djds blls gksus okyh laHkkoukvksa dks jksdk   pkfg,A lhje TSH ds 0.1 mIU/L ls Hkh de gks tkus           tk ldrk gSA mijksDr lko/kkfu;ksa ls u, xkW;Vj mRiUu   ij Fkk;jkWfDlu vksojMkst ds nq\"ifj.kke lkeus vkus           gksus ls jksdk tk ldrk gS rFkk iqjkus flaiy xkW;Vj ds   yxrs gSaA           vkdkj esa Hkh dqN deh yk;h tk ldrh gSA vk;ksMhu   SURGICAL MANAGEMENT OF MNG           fn, tkus ds i'pkr~ Hkh ;fn xkW;Vj dk vkdkj dkQh  D;ksafd xkW;Vj ds mipkj esa esfMdy mipkj dk ;ksxnku           c<+k gks rc mlds fy, nokvksa dh enn yh tk ldrh gSA  lhfer gh gksrk gS vr% dqN fof'k\"V y{k.kksa esa gesa           MNG dh voLFkk rd igq¡pus ds i'pkr~ rks xkW;Vj  lftZdy mipkj dh lgk;rk ysuh iM+rh gSA           vifjorZu'khy  ¼irreversible½  gks  tkrk  gSA   Absolute indications           vf/kdka'kr;% bl voLFkk esa nok,a Hkh lgk;d ugha jg   - Suspicion of malignancy\& ,slh lEHkkouk gksus ij           ikrhaA buesa dqN fof'k’V y{k.kksa ds fy, lftZdy mipkj   rks ltZjh djuh gh iM+rh gSA dSalj ds çdkj ,oa blds           vko';d gks tkrk gSA                         QSyko ds vk/kkj ij gh ltZjh ds çdkj dk Hkh p;u                                                       fd;k tkrk gSA           MEDICAL MANAGEMENT                                                      - Retrosternal goiter with features of thoracic           TSH  suppressive  therapy  - ge tkurs gSa fd   inlet  obstruction  \&  bl  fLFkfr  esa  Hkh  acute           flaiy xkW;Vj dk vkjafHkd dkj.k TSH dk c<+uk gh gSA   respiratory distress ds dkj.k rRdky ltZjh dh           vr% ;fn Fkk;jkWfDlu fFkjSih ds }kjk TSH dks ?kVk   vko';drk iM+ ldrh gSA           fn;k tk;s rc xkW;Vj ds vkdkj esa deh Hkh yk;h tk           ldrh gSA bls TSH suppressive therapy dgrs gSaA   Relative indications                                                      - Pressure  symptoms  \&  Mild  dyspnea,           okLro esa fdlh O;fä dk lhje TSH ftruk vf/kd   dysphagia,  dysphonia  vFkok  compression           gksrk gS] TSH dks ?kVkus ls mlds xkW;Vj ds vkdkj esa   pain dh fLFkfr esa Hkh ltZjh ds fo\"k; esa fopkj fd;k           deh Hkh mruh gh vf/kd vkrh gSA ;gk¡ bl rF; dks Hkh   tk ldrk gSA           è;ku esa j[kuk pkfg, fd lhje TSH ds c<+s u gksus ij   - Cosmetic reasons \& ;g O;fä dh viuh bPNk ij           mlds ?kVkus ls ykHk Hkh ugha feyrkA blfy,] flaiy   vk/kfjr gksrk gSA           xkW;Vj ds fy, Fkk;jkWfDlu fFkjSih nsrs le; fuEukafdr           rF;ksa dks è;ku esa vo'; j[kuk pkfg,A      MNG ds fy, eq[;r% nks çdkj dh lftZdy fofFk;ka                                                      çpfyr gSa\&           - TSH  suppressive  therapy  eq[;r%  diffuse            hyperplastic goiter esa gh ykHknk;d gksrh gSA  a)  Total thyroidectomy (TT)                                                      bl ltZjh dk vFkZ gqvk lEiw.kZ Fkk;jkW;M xzafFk dks           - MNG esa bldk çHkko vis{kk—r de gksrk gSA TSH                                                     120","fudky nsukA bl çfØ;k ds dqN ykHk gSa ,oa dqN   gSa ftlls gkbiksiSjkFkk;jkW;fMTe dh lEHkkouk Hkh ?kV           gkfu;kaA                                    tkrh gSA (iii) ltZjh ls mRiUu gksus okyh vlqfoèkkvksa            - Advantages  –  (I) xkW;Vj ds nksckjk mHkjus dh   dk de gksuk \& STT ds vis{kk—r NksVh ltZjh gksus ds            lEHkkouk (recurrence) dk de gksuk \& TT esa   dkj.k blls lEcafFkr vU; nq\"çHkko Hkh  TT  dh            Fkk;jkW;M xzafFk dks lEiw.kZ :i ls fudky fn, tkus ls]   vis{kk—r de gksrs gSaA            'ks\"k cph xzafFk ls nksckjk xkW;Vj cuus dh lEHkkouk gh   - Disadvantages (I) xkW;Vj ds nksckjk mHkjus dh            lekIr gks tkrh gS ,oa (ii) dSalj dh lEHkkouk dk de   lEHkkouk (recurrence) dk vfèkd gksuk \& mijksDr            gksuk \& MNG ds fdlh Hkkx esa dSalj gksus ij nksckjk   ykHk gksus ij Hkh Fkk;jkW;M xzafFk ds NksM+s x, Hkkx            mHkj vkus dh lEHkkouk Hkh lekIr gks tkrh gSA  ¼remnant thyroid tissue½ esa nksckjk o`f) gksrs tkus           - Disadvantages  -  (I)  gkbiksFkk;jkW;fMTe  dh   ls xkW;Vj ds iqu% c<+ tkus dh lEHkkouk Hkh c<+ tkrh            lEHkkouk dk vfèkd gksuk \& Fkk;jkW;M xzafFk ds lEiw.kZ   gSA            :i ls fudy tkus ls Fkk;jkW;M gkWeksZUl cuuk Hkh can   CHOICE OF SURGERY            gks tkrs gaSA ,sls esa O;fä dks ltZjh ds i'pkr~ vkthou  è;ku jgs] ,d ltZjh gks pqdus ds ckn] mlh LFkku ij            Fkk;jkWfDlu fFkjSih ij fuHkZj jguk iM+rk gS] (ii)  nwljh ltZjh vR;ar dfBu gksrh gSA blhfy,] vf/kdk¡'k            gkbiksiSjkFkk;jkW;fMTe dh lEHkkouk dk vfèkd gksuk \&  ltZu] de mez ds O;fä;ksa esa STT ds LFkku ij TT dks            gkbiksiSjkFkk;jkW;fMTe dh lEHkkouk dk vfèkd gksuk \&             Fkk;jkW;M xzafFk dks lEiw.kZ :i ls fudkys tkus ij  çkFkfedrk nsrs gSa ftlls muesa mez ds lkFk xkW;Vj c<+us            mlds lkFk iSjkFkk;jkW;M xzafFk;ksa ds fudy tkus dh  dh lEHkkouk dks jksdk tk ldsA blds foijhr] vf/kd            lEHkkouk vR;fFkd c<+ tkrh gSA blls vkthou  mez ds O;fä;ksa esa cM+h ltZjh dk cks> de djus ds fy,             dSfY'k;e nsus dh vko';drk iM+ ldrh gSA (iii)   MNG ds vf/kd c<+s gq, yksc dks iwjk fudkydj]            ltZjh ls mRiUu gksus okyh vlqfoèkkvksa dk vfèkd  vis{kk—r de çHkkfor yksc dks vk/kk fudky nsrs gSa            gksuk (Higher surgical morbidities) \& vis{kk—r  vFkok iwjk NksM+ nsrs gSaA bls Dunhill procedure  dgrs            cM+h ltZjh gksus ds dkj.k blls   lEcaf/kr vU;  gSa            nq\"çHkko Hkh c<+ tkrs gSaA           b)  Subtotal thyroidectomy (STT)                                                         RETROSTERNAL GOITER           TT ds nq\"çHkkoksa ls cpus ds fy, gh dqN O;fä;ksa esa   uke ds vuq:i] tc vkdkj esa c<+h gqbZ Fkk;jkW;M xzafFk           STT dh çfØ;k viuk;h tkrh gS ftlesa Fkk;jkW;M xzafFk   ¼fo'ks\"kdj eYVh ukWMîqyj xkW;Vj½] dk fupyk fgLlk           ds nksuksa yksc ds vfFkdk¡'k Hkkx dks fudkydj muesa   /khjs\&/khjs  c<+rs  gq,  sternum  ds  ihNs,  superior           yxHkx 8-8 xzke lkekU; ls yxus okyk Hkkx nksuksa vksj   mediastinum ds vfxze Hkkx esa igq¡p tk, rc mls           NksM+ fn;s tkrs gSA                        retrosternal  goiter  ¼retro  ¾  ihNs;  sternal  ¾           - Advantages (I) gkbiksFkk;jkW;fMTe dh lEHkkouk   sternum ds½ dgrs gSaA            dk de gksuk \& Fkk;jkW;M xzafFk ds NksM+s x, Hkkx esa            Fkk;jkW;M gkWeksZUl dk mRiknu tkjh jgus ds dkj.k   DIAGNOSTIC CRITERIA            STT ds i'pkr~ gkbiksFkk;jkW;fMTe mRiUu gksus dh   blds nks ekunaM gSaA            lEHkkouk ?kV tkrh gS ftlls O;fä dks vkthou   - tc Fkk;jkW;M xzafFk dk fupyk fljk] thoracic inlet            Fkk;jkWfDlu fFkjSih dh vko';drk Hkh de iM+rh gS]   ds 3 lseh vanj rd igq¡p tk;s] vFkok            (ii) gkbiksiSjkFkk;jkW;fMTe dh lEHkkouk dk de gksuk   - tc ;g ,Dljs esa 4th  thoracic  vertebrae rd            \& Fkk;jkW;M xzafFk ds dqN Hkkx dks NksM+ fn, tkus ls   igq¡p tk;s            mlds lkFk gh iSjkFkk;jkW;M xzafFk;ka Hkh NksM+h tk ldrh  viokn :i esa ;g xys esa fLFkr MNG ds QSyko ds                                                    121","LFkku ij anterior vFkok posterior mediastinum esa  tkus ls mHkj vkrh gSaA bls Pemberton sign  dgrs gSaA           fLFkr ectopic ;k aberrant Fkk;jkW;M xzafFk ds c<+us ls   INVESTIGATIONS           Hkh mRiUu gks ldrs gSaA bl fLFkfr esa budks jä igq¡pkus   Retrosternal goiter dk okLrfod vkdkj ,oa bldh            okyh oslsYl Hkh] cervical  ds LFkku ij thoracic   okLrfod fLFkfr lhVh LdSu }kjk gh Kkr gks ldrh gSA           vessels ls mRiUu gksrh gSaA                                                      bl fo\"k; esa ,d rF; dks /;ku esa j[kuk vR;ar           TYPES OF RETROSTERNAL GOITER               vko';d gS fd ;g tkap Hkh O;fä ds nksuksa gkFk da/ks ds           mRifÙk ,oa vkdkj ds vuqlkj retrosternal goiter dks  Åij mBkdj djuh pkfg,A gkFkksa dh bl fLFkfr esa           pkj çeq[k :iksa esa foHkkftr fd;k tk ldrk gSA   retrosternal goiter] thoracic cavity esa T;knk vanj           Type A \& fijkfeM ds vkdkj dk xkW;Vj ftldk  pyk tkrk gS ftlls xkW;Vj ds ncko ls mRiUu gksus okys           uqdhyk Nksj uhps dh vksj gksA              y{k.kksa dk lgh vuqeku yxk;k tk ldrk gSA           Type B \&  fijkfeM ds vkdkj dk xk;Vj ftldk   MANAGEMENT           uqdhyk Nksj Åij dh vksj gksA               fdlh Hkh vU; xkW;Vj dh Hkkafr retrosternal goiter esa           Type C \&  Me: ds vkdkj dk xkW;Vj ftlds nksuksa   Hkh nokvksa ¼medical management½ ls ykHk ugha           yksc ,d irys pedicle ls tqM+s gksaA        feyrkA blhfy,] mipkj dk ,dek= ekxZ ltZjh gh gSA           Type D \&  tks mediastinum esa gh mRiUu gqvk gksA  Retrosternal goiter dh ltZjh nks fof/k;ksa ls dh tk           CLINICAL MANIFESTATIONS                    ldrh gS] xys dh vksj ls ¼transcervical route½ ,oa           Retrosternal  goiter dk Dyhfudy egÙo bldh  Nkrh dh vksj ls ¼transthoracic route½A           fLFkfr ds dkj.k ls gSA Sternum ds ihNs fNis jgus ds   Transcervical surgery \& ;g fof/k mu O;fä;ksa ds           dkj.k ;g ckgj ls fn[kkbZ Hkh ugha iM+rsA vkdkj esa NksVs   fy,  mi;qä  gS  ftuesa  xkW;Vj]  mediastinum  esa           jgus rd ;g çk;% yEcs le; rd dksbZ y{k.k mRiUu   vis{kk—r Åij dh vksj gh gSA viuh lkekU; fLFkfr esa           ugha djrsA ijUrq] vkdkj esa cM+s gks tkus ij ;g   feyus okys cervical goiter dh vis{kk retrosternal           fudVorhZ vaxksa ij ncko Mky dj ncko ds y{k.k   goiter  esa  ltZjh  vis{kk—r  dfBu  gksrh  gSA  blesa           mRiUu dj ldrs gSaA Anterior mediastinum esa fLFkr   lkekU;  ls  vf/kd  yEcs  incision  ,oa           ;g xkW;Vj]                                 sternocleidomastoid  vkfn  muscles  ds  vf/kd            - trachea ij ncko mRiUu djds dyspnea       mobilisation dh vko';drk iM+rh gSA           - esophagus ij ncko mRiUu djds dysphagia  ,oa                                                      Transthoracic  surgery \& vusd O;fä ftuesa           - thoracic  inlet  dks  CykWd  djds  airway                                                      xkW;Vj] 1½ deep  thoracic  cavity ;k posterior            compression ,oa acute  respiratory  distress            mRiUu dj ldrs gSaA                        mediastinum esa igqapk gqvk gks] 2½ bldk vkdkj                                                      bruk cM+k gks ftlls mls cervical  approach ls           Pemberton sign \& vkdkj esa NksVs retrosternal   fudky ikuk laHko u gks vFkok 3½ vU; mediastinal           goiter dh tkap] O;fä ds nksuksa gkFk da/ks ds Åij   structures ds lkFk tqM+k gqvk ¼fixed ,oa immobile½           mBkdj  djuh  pkfg,A  gkFkksa  dh  bl  fLFkfr  esa   gks] rc bls sternotomy ds ek/;e ls fudkyk tkrk gSA           retrosternal goiter] thoracic cavity esa T;knk vanj           pyk tkrk gS ftlls xkW;Vj ds ncko ls mRiUu gksus okys   INDICATIONS FOR SURGERY           y{k.kksa dk lgh vuqeku yxk;k tk ldrk gSA bl fLFkfr   mijksä nksuksa fof/k;ksa esa surgical  morbidities  dh           esa flj ,oa gkFkksa ls vkus okyk venous return ckf/kr   lEHkkouk vR;f/kd gksus ds dkj.k retrosternal goiter           gks tkrk gS ftlls xys ,oa psgjs dh veins] jä Hkj   ls çHkkfor çR;sd O;fä dh ltZjh ugha dh tkrh cfYd                                                      122","mUgsa fo'ks\"k ns[k\&js[k ¼close observation½ esa j[kk   significant airway obstruction A ;g blfy, D;ksafd           tkrk gSA ltZjh dsoy ,d gh fLFkfr esa Li\"V :i ls   fcuk fdlh mipkj ds ;g fLFkfr çk.k?kkrd Hkh gks           funsZf'kr dh tkrh gS ¼clear indication½ vkSj og gS]   ldrh gSA                                                                                                                        123","18                               Thyroid Nodules and Cysts               THYROID NODULES                           xzafFk esa okLro esa dsoy ,d gh ukWMîwy gksA           Fkk;jkW;M xzafFk esa eq[; xzafFk ls vyx fn[kus okyh fdlh   - Dominant  nodule ¼30%½ \& ftuesa USG  esa           çdkj dh xk¡B] Fkk;jkW;M ukWMîwy dgykrh gSA Fkk;jkW;M   vusdksa ekbØks ukWM~;wYl fn[k jgs gksa ijUrq muesa ls           xzafFk dh vU; vfu;ferrkvksa dh Hkkafr ukWMîwy ds   vkdkj esa cM+k gksus ds dkj.k dksbZ ,d gh Nwus esa           feyus dh lEHkkouk Hkh efgykvksa esa 3-4 xquk vf/kd   eglwl gks jgk gksA           gksrh gS ,oa ;g mez ds lkFk c<+rh tkrh gSA  è;ku  jgs]  ukWMîwy  ds  dkj.k  ,oa  ifj.kke]  eYVh             C L A S S I F I C AT I O N   O F   N O D U L A R   ukWMîqyj xkW;Vj ls loZFkk fHkUu gksrh gSA vkblksysVsM            DISEASES  OF  THE  THYROID                vFkok MkWfeusaV ukWMîwYl dh eq[; xaHkhjrk buds dSalj           STRUCTURAL CLASSIFICATION                                                      esa ifjofrZr gks ldus ¼neoplastic  /    malignant           Fkk;jkW;M xzafFk dh lajpuk ,oa ukWMîwYl dh la[;k ds   transformation½ ds dkj.k gksrh gSA okLro esa] buesa           vk/kkj ij ;g eq[;r% rhu çdkj dh gks ldrh gSA  yxHkx 50% ukWMîwYl esa fdlh u fdlh çdkj ds dSalj            - Isolated / solitary nodule - ;fn Nwus ij dsoy   dh Hkkafr ifjorZu fey ldrs gSa] 15% esa malignant            ,d ukWMîwy gh eglwl gks jgk gks ,oa 'ks\"k Fkk;jkW;M   ,oa 'ks\"k 35% esa follicular adenoma A 'ks\"k 50%            xzafFk dks eglwl u fd;k tk ldsA           ukWMîwYl] colloid degeneration, cystic changes           - Dominant  nodule  -  ;fn Fkk;jkW;M xzafFk iwjh   vFkok Fkk;jkW;MkbfVl ds dkj.k gks ldrs gSaA            vFkok fdlh ,d yksc ds :i esa eglwl gks jgh gks ,oa   EVALUATION OF THYROID NODULE            blesa lkFk gh ,d ukWMîwy dks fcydqy vyx ls Hkh   Thyroid  function  tests  -  Fkk;jkW;M  xzafFk  esa            eglwl  fd;k  tk  ldsA  ;gk¡  iwjh  Fkk;jkW;M  xzafFk   ukWMîwYl vFkok vU; vfu;ferrkvksa esa  TFT  dk            ,dlkj  ¼diffuse½  Hkh  gks  ldrk  gS  ,oa  gydh   tkuuk vR;ar vko';d gksrk gS D;ksafd ;g Fkk;jkW;M            ukWMîqyj ds :i esa HkhA                   xzafFk dh dk;Z\&{kerk ¼functional status½ dks n'kkZrk           - Multinodular  goiter  (MNG)  -    ;fn  iwjh   gSA ukWMîwYl ds lUnHkZ esa ;g tkuuk vkSj Hkh vf/kd            Fkk;jkW;M xzafFk gh vkdkj esa c<+h gqbZ gks ,oa blesa   egRoiw.kZ gks tkrk gS D;ksafd gkbiksFkk;jkW;fMTe ¼low            vusd LFkku ij NksVs vFkok cM+s ukWMîwYl eglwl gks   T4 ,oa high TSH½ ds lkFk fdlh ukWMîwy esa dSalj esa            jgs gksaA                                 ifjofrZr gks ldus dh lEHkkouk vf/kd gksrh gS tcfd           ULTRASONOGRAPHIC CLASSIFICATION            gkbijFkk;jkW;fMTe ¼high T4 ,oa low TSH½ ds lkFk           mijksDr oxhZdj.k dsoy 'kkjhfjd ijh{k.k ij vk/kkfjr   yxHkx ux.;A           gSA vYVªklksuksxzkQh ¼USG½ vFkok lhVh LdSu esa Nwdj   Radionuclide  scan  -  TFT  ls  rks  gesa  lEiw.kZ           igpkus tk ldus okys clinically palpable nodules   Fkk;jkW;M xzafFk dh ,dh—r ¼as a whole½ dk;Z\&{kerk           ds vfrfjDr Hkh vusd NksVs] Nwdj u igpkus tkus okys   dh fLFkfr Kkr gksrh gSA blesa ukWMîwy ,oa 'ks\"k xzafFk dh           ¼non-palpable½ ukWMîwYl fey tkrs gSaA bl çdkj ls]   dk;Z\&{kerkvksa dks vyx\&vyx le>us ds fy, gesa           ijh{k.k esa vdsys yxus okys ¼clinically  solitary½   jsfM;ksU;wDykbM LdSu dh enn ysuh iM+rh gS tks okLro           ukWMîwYl Hkh vYVªklksuksxzkQh ds vk/kkj ij nks çdkj ds   esa lEiw.kZ Fkk;jkW;M xzafFk ds vyx\&vyx Hkkxksa dh           gks ldrs gSaA                              dk;Z\&{kerkvksa dks mudh xzafFk esa fLFkfr ds vuqlkj           - Isolated nodule (70%) - ftuesa lEiw.kZ Fkk;jkW;M   n'kkZrk gSA                                                     124","J o i n t   i n t e r p r e t a t i o n   o f   T F T   a n d   ukWMîwy dh dk;Z{kerk dks vyx\&vyx tkuk tk ldrk           radionuclide scan findings - vkb;s] TFT ,oa   gS oSls gh USG ds }kjk budh lajpukvksa dks Hkh           jsfM;ksU;wDykbM LdSu ds vk/kkj ij muls mRiUu gks   vyx\&vyx le>k tk ldrk gSA           ldus okyh ij laHkkoukvksa ij fopkj djrs gSaA                                                      - vkblksysVsM ukWMîwy esa dSalj dh laHkkouk MNG dh           With  hypothyroidism  - vFkkZr Fkk;jkW;M xzafFk   vis{kk vf/kd gksrh gSaA           viuh LokHkkfod {kerk ij dk;Z ugha dj ik jgh gSA   - vkblksysVsM ukWMîwy ds ,dlkj ,oa pkjksa vksj ls           ,sls  esa  xzafFk  dk  jsfM;ksU;wDykbM@  jsfMvks,fDVo   fof/kor  f?kjs  ( h o m o g e n o u s ,   w e l l           vk;ksMhu viVsd ¼RAIU½ lkekU; ls de gksxkA blesa   circumscribed) gksus ij vFkok cystic gksus ij           Hkh ukWMîwy ds RAIU ds vk/kkj ij nks laHkkouk,a gks   mlesa dSalj dh lEHkkouk de gksrh gS tcfd] ukWMîwy           ldrh gSA                                    esa fofo/krk gksus] blesa jDr çokg c<+s gksus] dSIlwy ls           - ukWMîwy ,oa 'ks\"k xzafFk dk RAIU yxHkx ,d leku gksA  ckgj fudys gksus vFkok fyEQ uksM rd igqaps gksus           - ukWMîwy dk RAIU, 'ks\"k xzafFk ls Hkh de gksA bldk   ¼heterogenous,  richly  vascular,  capsular            vFkZ gqvk fd ukWMîwy dh dk;Z{kerk 'ks\"k xzafFk ls Hkh   invasion or lymph node enlagement½ gksus ij            de gSA bldks cold nodule  dgrs gSaA        dSalj dh lEHkkouk c<+ tkrh gSA                                                      - vkblksysVsM  ukWMîwy  esa  ekbØks\&dSfYlfQds”ku  dk           With hyperthyroidism vFkkZr] Fkk;jkW;M xzafFk dh                                                       feyuk Hkh dSalj dh lEHkkouk dks c<+krk gSA           dk;Z{kerk lkekU; ls vf/kd gSA ,sls esa xzafFk dk RAIU           lkekU; ls vf/kd gksxkA blesa Hkh ukWMîwy ds RAIU ds   CT scan - USG esa dSalj dh lEHkkouk feyus ij]           vk/kkj ij nks laHkkouk,a gks ldrh gSA      ltZjh dh ;kstuk cukus esa lhVh LdSu vR;ar ykHkçn                                                      jgrk gSA blds }kjk Fkk;jkW;M xzafFk] ukWMîwy] fyEQ           - ukWMîwy ,oa 'ks\"k xzafFk dk RAIU yxHkx ,d leku gksA            bldk vFkZ gqvk fd ukWMîwy dh dk;Z{kerk 'ks\"k xzafFk   uksM ds vfrfjDr] xys ,oa mediastinum  dh vU;             ds leku gh c<+h gqbZ gSA bldks warm nodule  dgrs   lajpukvksa dh Hkh foLr`r tkudkjh fey tkrh gSA            gSaA                                      Fine  needle  aspiration  cytology  (FNAC)  -           - ukWMîwy dk RAIU, 'ks\"k xzafFk ls Hkh vf/kd gksA bldk   fdlh Hkh Fkk;jkW;M ukWMîwy esa dSalj dh lEHkkouk dks            vFkZ gqvk fd ukWMîwy dh dk;Z{kerk 'ks\"k xzafFk ls Hkh   igpkuus ds fy, FNAC gh lcls egRoiw.kZ tkap gSA                                                      ;g ,d ljy çfØ;k gS tks vksihMh esa Hkh dh tk ldrh            vfFkd c<+h gqbZ gSA bldks hot  nodule ;k toxic            nodule dgrs gSaA                          gSA dsoy ,d lqabZ pqHkus ds vfrfjDr blesa vkSj dksbZ                                                      ijs'kkuh ugha vkrhA gk¡ dHkh\&dHkh tk¡p ds i'pkr~ xzafFk           LokHkkfod :i ls dSalj xzLr dksf'kdkvksa dh dk;Z{kerk   esa jDrlzko vo'; gks ldrk gSA           lkekU; ls de gh gksuh pkfg;sA ;g lkekU; xzafFk ds           leku rd rks gks ldrh gS ijUrq lkekU; ls vfFkd rks   dSalj  dh  igpku  esa  FNAC  dh  sensitivity  ,oa           fcydqy ughaA blhfy, gkbiksFkk;jkW;M voLFkk esa ,oa   specificity  nksuksa  gh  dkQh  vPNh  gSa  ijUrq  blls           cold nodule esa dSalj dh lEHkkouk vfFkd gksrh gSA   Fkk;jkW;M  dSalj  ds  nks  eq[;  dkj.kksa  esa  ls  ,d]           blds foijhr] gkbijFkk;jkW;M voLFkk esa ,oa VkWfDld   papillary carcinoma dh gh igpku fu'p; iwoZd gks           ukWM;wy esa dSalj dh lEHkkouk dks udkjk rd tk ldrk   ikrh gSA FNAC esa follicular neoplasm feyus ij           gSA                                        blls ;g ugha tkuk tk ldrk fd neoplasm benign                                                      gS vFkok malignant A ,slk blfy, D;ksafd fdlh Hkh           Ultrasonography  (USG)  -  ftl  çdkj       gkWeksZu xzafFk esa dSalj dh Mk;Xuksfll dk ,d fu;e gksrk           jsfM;ksU;wDykbM  LdSu  ds  }kjk  Fkk;jkW;M  xzafFk  ,oa   gS ,oa og gS] capsular vFkok vascular invasion A                                                      125","FNAC  esa  follicular  neoplasm  feyus  ij  ;fn   Fkk;jkW;M flLV Hkh Fkk;jkW;M ukWMîwy dh Hkkafr gh çrhr            ck;kWIlh esa  capsular  vFkok  vascular  invasion   gksrh gS ijUrq Nwus ij ¼palpation esa½ bldk ,d           feyrk gS rc og follicular  carcinoma dgyk;sxk   fof'k\"V y{k.k feyrk gS ftls 'fluctuation'  dgrs gSaA           tcfd capsular vFkok vascular invasion u feyus   Fluctuation  dks  tkuus  ¼elicit  djus½  ds  fy,           ij benign follicular neoplasm A            ukWM~;wy@flLV dks vaxwBs vkSj eè;ek ¼nwljh½ maxyh ds            FNAC dks USG ds funsZ'ku esa djus ij blls çkIr   eè; idM+dj mls igyh maxyh ls Åij ls nckrs gSaA           gksus okyh tkudkfj;ka vkSj Hkh vfFkd c<+ tkrh gSaA   blls cystic fluid] Åij ls gVdj uhps vk tkrk gS           fdlh partly cystic, partly solid nodule esa USG dk   ftlls og vaxwBs vkSj eè;ek maxyh dks ckgj dh vksj                                                      <dsyrk gSA è;ku jgs] dsoy  superficial  thyroid           funsZ'ku ;g lqfuf'pr djrk gS fd cellular aspirate,           ukWMîwy ds Bksl Hkkx ls gh fudkyk x;k gSA  cysts esa gh fluctuation mRiUu gks ikrk gS] deeper                                                      cysts esa ughaA blds vfrfjDr] ;fn dksbZ flLV esa           Core biopsy - vkn'kZ :i esa  fdlh Hkh dSalj dh   vR;f/kd æo ¼fluid½ Hkjk gqvk gS ¼tense cyst½ rc rks           fuf'pr :i esa igpku rks ck;kWIlh ds }kjk gh dh tk   Nwus ij og Hkh l[r ukWMîwy tSlh gh yxrh gS tks dSalj           ldrh gS ijUrq Fkk;jkW;M dSalj esa jDr çokg vR;f/kd   dk lansg mRiUu dj ldrh gSA dHkh\&dHkh flLV esa           gksus ds dkj.k blesa jDrlzko dh lEHkkouk vR;f/kd   jDrlzko gks tkus ls mldk vkdkj ,dk,d c<+ tkrk gS           c<+ tkrh gSA                               ftlls og painful ,oa tender Hkh gks tkrh gSA            ukWMîwy ds lkFk fyEQ uksM ds vkdyu esa rks ;g tkap   TYPES OF THYROID NODULES  /  CYSTS           vR;ar egRoiw.kZ jg gh tkrh gSA                                                      bUgha dkj.kksa ls] yxHkx 30% ,dy ukWMîwy esa FNAC           Laryngoscopy - Fkk;jkW;M dSalj ds lkFk dHkh\&dHkh   vFkok USG ds i'pkr~ gh ;g irk py ikrk gS fd og           ipsilateral vocal cords dk infiltration Hkh gks tkrk   l[r ukWMîwy u gksdj okLro esa Fkk;jkW;M flLV gaSA           gSaA Flexible laryngoscopy ds }kjk vocal cords dh   Fkk;jkW;M ukWMîwy@flLV rhu çdkj dh gks ldrh gSaA           mobility bls igpkuus esa lgk;d gks ldrh gSA  1. Pure solid swelling - iw.kZ :i ls Bksl ukWMîwy                                   Fkk;jkW;M ukWMîwy ds           Anti thyroid antibodies -           Anti thyroid antibodies - Fkk;jkW;M ukWMîwy ds   2. Pure cystic swelling - iw.kZ :i ls æo ls Hkjk           vkdyu esa ,aVh\&Fkk;jkW;M ,aVhckWMht dh tkap dk dksbZ   ukWMîwy           fo'ks\"k  egÙo  ugha  gSA  ,aVh\&Fkk;jkW;M  ,aVhckWMht]   3. Partly solid ,oa partly cystic swelling - vkaf'kd           fo'ks\"kr;%  anti  –  TPO  antibodies  dk  feyuk   :i ls Bksl ,oa vkaf'kd :i ls æo ls Hkjk ukWMîwy           chronic lymphocytic thyroiditis dh lEHkkouk dks   ETIOPATHOGENESIS           c<+krk gSA ,sls esa] lymphocytic aggregations ds   vf/kdk¡'k Fkk;jkW;M flLV] okLrfod flLV u gksdj           lymphoma esa ifjofrZr gksus dh lEHkkouk vfFkd gksrh   pseudocysts gksrh gSa D;ksafd buesa epithelial lining           gSA blds vfrfjDr] ;g vkWVks\&bE;wfuVh] Øe'k% lkekU;   ugha feyrhA ;g dsoy æo ls Hkjs fjDr LFkku ¼fluid           fn[kus okyh Fkk;jkW;M xzafFk dks Hkh {kfr igqapkrh tkrh gS   filled cavities½ gh gksrh gSa tks laHkor% rhu çdkj ls           ftlls ,sls O;fä;ksa esa vkxs pydj gkbiksFkk;jkW;fMTe   mRiUu gks ldrh gSaA           dh lEHkkouk c<+ tkrh gSA                                                      - yxHkx  50%  O;fä;ksa  esa  necrotic  lobules  ds                                                        ijLij  feyrs  tkus  ls  ,oa  mlesa  colloid              THYROID CYST                             degeneration lsA            fdlh fluid filled, epithelial lined, membranous   - yxHkx  35% O;fä;ksa esa  follicular adenoma ds           sac dks flLV ¼cyst½ dgrs gSaA ns[kus ¼inspection½ esa   involution lsA                                                     126","- yxHkx  15%  O;fä;ksa  esa  malignant  tissue  esa  dSalj dh lEHkkouk dks nwj djus ds fy, iM+rh gSA            cystic  degeneration  lsA  ;g  vf/kdka'kr;%   blds vfrfjDr] bldk ç;ksx fdlh tense cyst ls æo            papillary carcinoma esa feyrk gSA         fudkydj mlesa nnZ de djus ds fy, Hkh fd;k tk            CLINICAL FEATURES                          ldrk gSA           - Fkk;jkW;M  flLV  vf/kdka'kr;%  20-40  o\"kZ  dh   MANAGEMENT            efgykvksa  esa  feyrh  gSaA  ;|fi  vU;  Fkk;jkW;M   Fkk;jkW;M ukWMîwy dh Hkkafr gh Fkk;jkW;M flLV dk Hkh            vfu;ferrkvksa  dh  gh  Hkkafr  Fkk;jkW;M  flLV  Hkh   dksbZ  fof'k\"V  mipkj  ugha  gksrk  gSA  mipkj  dh            efgykvksa dh vis{kk iq#\"kksa esa de feyrh gS ijUrq   vko';drk nks dkj.kksa ls iM+ ldrh gSA            fdlh flLV esa dSalj dh lEHkkouk efgykvksa dh vis{kk                                                                               \& \& flLV dk vkdkj                                                      For  pressure  symptoms            iq#\"kksa esa vf/kd gksrh gSA              For  pressure  symptoms  \& flLV dk vkdkj           - Fkk;jkW;M flLV vf/kdka'kr% vkblksysVsM ukWMîwy ds   ?kVkus ds fy, fuEukafdr iz;kl fd;s tk ldrs gSaA            :i esa feyrh gSa ijUrq dHkh\&dHkh ,d ls vf/kd   - TSH  supressive  therapy  \& è;ku jgs] Bksl            ukWM;wy ds :i esa Hkh fey ldrh gSaA        Fkk;jkW;M ukWMîwy rks fQj Hkh blds }kjk FkksM+k cgqr           - vfFkdk¡'k Fkk;jkW;M flLV fdlh Bksl ukWMîwy dh Hkkafr   vkdkj esa ?kVk, tk ldrs gSa ijUrq Fkk;jkW;M flLV esa            gh  çrhr  gksrh  gSaA  dsoy  Ropk  ds  fudV  fLFkr   blls dksbZ fo'ks\"k ykHk ugha feyrkA            ¼superficial½ ,oa vkaf'kd :i ls æo ls Hkjh dqN   - Fluid aspiration \& ;g rkRdkfyd :i ls rks flLV            Fkk;jkW;M flLV esa gh fluctuation elicit dj ikuk   dk vkdkj ?kVk nsrk gS ijUrq 'kh?kz gh ;g nksckjk Hkj            laHko gksrk gSA                            tkrh gSA bl çdkj] ;g Hkh yEcs le; rd dkjxj           - vf/kdk¡'k Fkk;jkW;M flLV esa Nwus ij nnZ ugha gksrk   ugha gksrkA            ¼nontender  gksrh gSa½ ijUrq jDrlzko ds i'pkr ;g   - Sclerotherpy - Sclerosant substances ¼tSls            tender Hkh gks ldrh gSaA                   vYdksgy½] fdlh flLV esa Qkbczksfll mRiUu djds            CLINICAL EVALUATION                         mlds fjDr LFkku dks can djus esa enn djrs gSaA ihM+k           fdlh Fkk;jkW;M flLV ds vkdyu ds fy, nks tkapsa   ,oa bUQsD'ku bl çfFk;k ds laHkkfor nq\"çHkko gks           lokZf/kd egRoiw.kZ gSaA ;g gSa] USG ,oa FNAC A  ldrs gSaA            USG - vf/kdk¡'k Fkk;jkW;M flLV rks USG ds ckn gh   For malignancy - dSalj dks dkVdj gVkus ds fy,           Kkr gks ikrs gSaA                          ltZjh dk p;u Bksl ukWMîwy dh Hkkafr gh fd;k tk           - USG ds }kjk gh ;g Hkh Kkr gks ikrk gS fd Fkk;jkW;M   ldrk gSA            ukWMîwy iw.kZ:i ls Bksl gS] iw.kZ:i ls æo ls Hkjk gS   RISK  OF  MALIGNANCY  IN  A  THYROID            vFkok vkaf'kd :i ls Bksl ,oa vkaf'kd :i ls æo ls   NODULE / CYST            Hkjk gSA                                  Fkk;jkW;M xzafFk dh fdlh xk¡B esa dSalj dh lEHkkouk           - Fkk;jkW;M flLV ds Bksl Hkkx esa gh dSalj dh lEHkkouk   fuEukafdr ifjfLFkfr;ksa esa c<+ tkrh gSA            lokZf/kd gksrh gSA blhfy,]  USG  dk ,d vU;   - In advanced ages -   vf/kdka'kr% vk;q c<+us ds            mi;ksx USG guided FNAC esa Hkh gksrk gSA blds   lkFk fdlh xk¡B esa dSalj dh lEHkkouk Hkh c<+rh tkrh            foijhr] iw.kZ:i ls æo ls Hkjh flLV esa dSalj dh   gSA            lEHkkouk vR;ar de gksrh gS ,oa buesa FNAC dks   - In males - è;ku jgs] Fkk;jkW;M xzafFk ds vf/kdk¡'k            Vkyk Hkh tk ldrk gSA                       jksx  efgykvksa  esa  vf/kd  gksrs  gSaA  ;gk¡  rd  fd            FNAC - bldh lokZf/kd vko';drk fdlh flLV esa   Fkk;jkW;M ukWMîwy Hkh iq#\"kksa dh vis{kk efgykvksa esa                                                     127","yxHkx 4 xquk vf/kd gksrs gSaA bl ij Hkh bu ukWMîwy   mlds Åij ljyrk ls fgyk;s tk ldrs gSaA fdlh xk¡B            esa dSalj dh lEHkkouk iq#\"kksa esa efgykvksa dh vis{kk   dk mlds Åij dh Ropk vFkok van:uh vaxksa ds lkFk            iq:’kksa esa 4 xquk vf/kd gksrh gSA        tqM+k gksuk ¼fixaton½] mlesa dSalj dh lEHkkouk dks           - In solitary nodules -   fdlh ,dy ukWMîwy esa   c<+krk gSA            dSalj dh lEHkkouk] MNG  ds çeq[k ukWMîwy dh   - With  recurrent  laryngeal  nerve  palsy  \&            vis{kk yxHkx nksxquk vf/kd gksrh gSA       Benign tumors ,d vksj ls c<+rs gq,] uoZ dks nwljh           - In solid nodules - fdlh Bksl ukWMîwy esa Hkh dSalj   vksj <dsy nsrs gSa tcfd malignant tumors bl uoZ            dh lEHkkouk]  cystic  nodule  dh vis{kk yxHkx   dks pkjksa vksj ls ?ksjdj mls vius chp tdM+ ysrs gSaA            nksxquk vf/kd gksrh gSA fdlh Fkk;jkW;M flLV esa dSalj   ;g vkokt ds Hkkjh gksus ¼hoarseness of voice½            dh lEHkkouk blds Bksl Hkkx esa gh gksrh gSA  ,oa vocal cord paralysis ds :i esa çdV gks ldrk           - In hard nodules -  fdlh xk¡B ds vR;f/kd l[r   gSA lkekU;r% Fkk;jkW;M xzafFk dh fdlh xk¡B ds lkFk            gksus ij mlesa dSalj dh lEHkkouk c<+rh tkrh gSA  lEcafFkr fyEQ uksM~l c<+s gq, ugha feyrsA budk           - If fixed to skin -  Benign tumor dh Åijh Ropk   feyuk Hkh dSalj dh lEHkkouk c<+krk gSA            xk¡B ls vyx jgrh gS ftlls og xk¡B ds Åij   - With recurrent cyst formation \& fdlh flLV            ljyrk ls fgyk;h tk ldrh gSA blh çdkj] benign   dk æo fudkyus ¼aspiration½ ds ckn ckj\&ckj Hkj            tumor Lo;a Hkh van:uh vaxksa ls vyx jgrs gq,   tkuk Hkh dSalj dk |ksrd gks ldrk gSA                                                                                               128","Fkk;jkW;M dSaljFkk;jkW;M dSalj           19         Fkk;jkW;M dSalj                      Thyroid Carcinomas            Fkk;jkW;M dSalj ds fo\"k; esa ,d egRoiw.kZ rF; ;g gS   b) SECONDARY NEOPLASMS           fd ;g lHkh gkWeksZu xzafFk;ksa esa lokZf/kd la[;k esa ik;k   tks fdlh ckgjh dksf'kdkvksa ls mRiUu gksdj Fkk;jkW;M           tkus okyk dSalj gSA xr 30 o\"kksaZ esa dSalj ds çfr   esa igq¡p tkrs gSaA ;g Hkh nks çdkj ds gks ldrs gSaA           tkx:drk c<+us ,oa Fkk;jkW;M ukWMîwYl dh foLr`r   - Nearby spread -   lehiorhZ vaxksa ¼tSls larynx           tkap gksus ds dkj.k bldh Mk;Xuksfll Hkh yxkrkj   ,oa  esophagus½  ds  dSalj  ds  QSyus  (local           c<+rh tk jgh gSA bl ij Hkh bu 30 o\"kksaZ esa Fkk;jkW;M   infiltration) ls           dSalj ls gksus okyh e`R;q nj esa dksbZ c<+ksÙkjh ns[kus dks   - Distant spread - lqnwj fLFkr dSalj ¼fo'ks\"k :i ls           ugha feyhA ,slk blfy, D;ksafd vusd Fkk;jkW;M dSalj]   renal  cell  carcinoma½  dh  esVkLVSfll           dSalj gksrs gq, Hkh jksx dkjd {kerk (morbidity) ,oa   (metastasis) ls           e`R;q dh lEHkkouk (mortality) ds lUnHkZ esa dkQh e`nqy           (benign)  gh jgrs gSaA vr% vc uohu çpyu ds   ON THE BASIS OF NATURE OF GROWTH           vuqlkj]  Fkk;jkW;M  dSalj  ds  lHkh  jksfx;ksa  esa   ç—fr ds vuqlkj follicular neoplasms nks çdkj ds           aggressive  medical  ,oa  surgical  approach   gks ldrs gSa] benign  ,oa malignant  A /;ku jgs] 'kjhj           viukus dh vko';drk ugha gksrhA Low risk patients   ds fdlh vU; vax dh vis{kk fdlh gkWeksZu xzafFk esa dSalj           dks conservative management ds }kjk gh yEcs   dh igpku dsoy cellular vFkok nuclear changes           le; rd Bhd j[kk tk ldrk gSA Fkk;jkW;M dSalj   ds vk/kkj ij ugha dh tkrhA bldh iqf\"V ds fy, ftu           fdl\&fdl çdkj ds gksrs gSa ,oa buds ifj.kke dSls gksrs   fof'k\"V y{k.kksa dk ç;ksx gksrk gS og gSa] a) Capsular           gSa] vkb;s bu rF;ksa dks foLrkj ls le>rs gSaA     invasion  ,oa  b)  Vascular  invasionA dSalj dh                                                      dksf'kdkvksa dk Fkk;jkW;M ds dSIlwy vFkok CyM ;k           CLASSIFICATION  OF  THYROID  NEO-           PLASMS                                     fyEQSfVd oslsYl dks ikj djrs gq,] Fkk;jkW;M xzafFk dh           ON THE BASIS OF CELLS OF ORIGIN            lhekvksa ls ckgj fudy tkuk gh Fkk;jkW;M dSalj dk           mRifÙk ds vk/kkj ij Fkk;jkW;M dSalj nks çdkj ds gks   fof'k\"V y{k.k (pathognomonic feature) dgykrk           ldrs gSaA                                  gSA Histological feature gksus ds dkj.k bUgsa dsoy                                                      ck;kWIlh ds }kjk çkIr fV”kw dh histology ls gh le>k           a) PRIMARY NEOPLASMS                       tk ldrk gS] FNAC ls çkIr cellular aspirate ls           tks Fkk;jkW;M dh viuh dksf'kdkvksa ls mRiUu gksrs gSaA   ughaA           ;g Hkh rhu çdkj dh dksf'kdkvksa ls mRiUu gks ldrs gSaA                                                      - Benign  neoplasm \& tks dSalj] Fkk;jkW;M dh           - Follicular  neoplasms  (adenoma  and            carcinoma)  \&  tks  Fkk;jkW;M  QkWfydYl  dh   QkWfyD;qyj  dksf'kdkvksa  ls  mRiUu  gksrs  gSa]  mUgsa            dksf'kdkvksa ls mRiUu gksrs gSa           lfEefyr :i ls follicular  neoplasms dgrs gSaA           - Medullary  carcinoma  \&  tks  Fkk;jkW;M   buesa ls tks Fkk;jkW;M xzafFk dh lhekvksa esa gh lhfer gksa            QkWfydYl  ds  chp\&chp  esa  fLFkr  iSjkQkWfyD;qyj   ¼ftUgksaus dSIlwy vFkok oSLdqyj lhekvksa dks ikj ugha            dksf'kdkvksa ls mRiUu gksrs gSa           fd;k gks½] mUgsa follicular adenoma  (Greek adeno           - Malignant lymphoma \& tks Fkk;jkW;M xzafFk esa   gland; -oma = benign tumor) dgrs gSaA            fLFkr fyEQkW;M lsYl ls mRiUu gksrs gSa    - Malignant  neoplasms  \&  Fkk;jkW;M  dh                                                      129","QkWfyD;qyj dksf'kdkvksa ls mRiUu gksus okys tks dSalj]   ETIOPATHOGENESIS OF MALIGNANT           dSIlwy vFkok oSLdqyj lhekvksa ds ikj fudy tkrs gSa   NEOPLASMS OF THYROID                                                      fdlh Hkh vU; dSalj dh Hkkafr gh Fkk;jkW;M dSalj ds           mUgsa  follicular  carcinoma   (Greek  karkino  =           cancer; -oma  = tumor) dgrs gSaA           dkj.kksa ds fo\"k; esa Hkh dqN fuf'pr :i ls ugha dgk tk                                                      ldrkA ijUrq dqN dkjd bldh lEHkkouk esa o`f) djk           ON THE BASIS OF SEVERITY OF MALIG-           NANCY                                      ldrs gSaA buesa ls çeq[k fuEukafdr gSaA           dSalj ds fodklØe esa tks dksf'kdk ftruk vf/kd   Radiations - 18 o\"kZ ls de mez esa fdlh dSalj ds            fodflr gksrh tkrh gS og mruk lkekU; dksf'kdk dh  mipkj ds :i esa flj] psgjs vFkok xys esa fn;k x;k           Hkkafr O;ogkj djrh gSA blds foijhr] vU; de  jsfM,'ku (external radiation - jsfM;ksfFkjSih) vFkok           fodflr ;k vfodflr dksf'kdkvksa esa dSalj ds y{k.k  U;wfDy;j ,DlhMsaV ds nkSjku feyk jsfM,'ku] Hkfo\"; esa           vf/kd çdV gksrs gSa ftuds xaHkhj ifj.kke gks ldrs gSaA  Fkk;jkW;M dSalj ¼fo'ks\"k :i ls PTC½ dh lEHkkouk dks           bl vk/kkj ij Fkk;jkW;M dSalj dks rhu Hkkxksa esa  c<+k nsrk gSA okLro esa ;g jsfM,'ku] ØksekslksEl dks           foHkkftr fd;k tk ldrk gSA                  {kfr igqapkdj genetic rearrangement dks c<+kok            - Well  differentiated  carcinoma  -  Hkyh\&Hkkafr   nsrs gSa ftlls tumor suppressor genes  ds ?kV tkus            fodflr gksus ij                           ls dSalj dh lEHkkouk c<+ tkrh gSA           - Poorly  differentiated  carcinoma  -  vkaf'kd   TSH and growth factors \& vk;ksMhu dh deh ls            :i ls fodflr gksus ij                     çHkkfor {ks=ksa (endemic goitrous zone) esa vk;ksMhu           - Undifferentiated  /  anaplastic  thyroid   dh deh ls tSls\&tSls Fkk;jkW;M gkWeksZUl ds mRiknu esa            carcinoma (ATC) -  vfodflr jgus ij        fxjkoV vkrh tkrh gS] TSH dk flØh”ku c<+krs gq,           ON THE BASIS OF DIFFERENTIATION OF         fiVîwVjh bls lkekU; cuk;s j[kus dk ç;kl djrh tkrh           NEOPLASM                                   gSA ge tkurs gSa fd Fkk;jkW;M QkWfydy dh dksf'kdkvksa           Fkk;jkW;M QkWfydy dh dksf'kdk;sa fdl :i esa fodflr   ds fy, TSH] ,d iks\"kd (trophic factor) ds :i esa            gqbZ gSa bl vk/kkj ij buls mRiUu gksus okys  well   dk;Z djrk gSA dkQh yEcs le; rd vk;ksMhu dh deh           differentiated  carcinomas Hkh rhu çdkj ds gks   ls çHkkfor {ks=ksa esa jgus ij TSH }kjk yxkrkj mÙkstu]           ldrs gSaA                                  Fkk;jkW;M QkWfydYl esa o`f) djkrk gqvk xzafFk esa flaiy            - Follicular  thyroid  carcinoma  (FTC) \& tks   (diffuse) vFkok ukWMîqyj xkW;Vj mRiUu djk ldrk            lkekU; Fkk;jkW;M QkWfydYl ds tSls gh nh[krs gSaA   gSA  TSH fjlsIVj vFkok  Gs-alpha  subunit  dk            dSIlwy vFkok oSLdqyj lhekvksa ds ns[ks fcuk buesa ,oa   activating  mutation,  autonomous  thyroid            benign  follicular  adenoma esa foHksn dj ikuk   nodules mRiUu dj ldrk gSA ;gh ukWMîwYl Hkfo\"; esa            dfBu gksrk gSA                            vfu;af=r gksdj dSalj esa ifjofrZr gks ldrs gSaA           - Papillary thyroid carcinoma (PTC) \& FTC   Oncogenes and tumor suppressor genes \&            dh vis{kk ;g vf/kd rhozrk ls c<+us okys dSalj gSa  vf/kdka'k PTC] tyrosine kinase (RET ;k NTRK1)             ftuesa QkWfydy dh dksf'kdk;sa vR;f/kd rhozrk ls  vFkok serine/ threonine kinase (BRAF) genes            c<+rh gqbZ vusd folds (papillae) cuk ysrh gSA ;gh  ds activating mutations  ls mRiUu gksrs gSaA ;g nksuksa            papillary infoldings bu dSalj dk fof'k\"V y{k.k  gh MAP  kinase ds ek/;e ls oncogenesis dks            (pathognomonic feature) gksrh gSaA        c<+krs gSaA blds foijhr FTC] RAS vFkok tyrosine           - Hurthle cell carcinoma \& ;g FTC dk gh ,d   kinase  (PI3K/  AKT)  genes  ds   activating            :i (variant) ekuk tkrk gSA                mutations ls mRiUu gksrs gSa tks MAP kinase ,oa                                                     130","PI3 kinase nksuksa] ds ek/;e ls oncogenesis dks   gksrsA  vf/kdka'kr;%  ;g  ukWMîwy  ljyrk  ls            c<+krs gSaA buds vfrfjä] tumor suppressor gene   fgyk;s\&Mqyk;s tk ldrs gSa ¼freely mobile jgrs gSa½                 dk           PTEN   loss of function mutation Hkh FTC dh   vFkkZr Ropk ,oa van:uh vaxksa ls tqM+s gq, ugha gksrs            lEHkkouk dks c<+krk gSA Germline RET gene  dk   ,oa lkekU; Fkk;jkW;M xzafFk dh Hkkafr gh Hkkstu fuxyus           activating mutation MTC dk dkj.k cu ldrk gSA   ds le; le; Åij Hkh mBrs gSaA                                                      - dHkh\&dHkh] PTC ls çHkkfor dqN O;fä;ksa esa rks           Lymphocytic  infitrafion  -  Autoimmune           thyroiditis esa xzafFk esa gqvk lymphocytic infiltration   Fkk;jkW;M xzafFk esa dksbZ xk¡B gh ugha feyrhA ,sls yksx           Hkfo\"; esa vfu;af=r gksdj lymphoma esa ifjofrZr gks   lh/ks lymph  node  enlargement ds :i esa gh           ldrk gSA                                    fn[kkus vkrs gSaA                                                      - dqN dSalj] eq[;r% ATC] vkl\&ikl ds vaxksa esa QSyrs              SALIENT CLINICAL FEATURES           Gender  predisposition  \&  ge  tkurs  gSa  fd   gq, ¼infiltrate djrs gq,½] hard ,oa fixed swelling           Fkk;jkW;M xzafFk ds vf/kdk¡'k jksx] iq#\"kksa dh vis{kk   (skin  ,oa  deeper  connective  tissues),           efgykvksa esa vf/kd gksrs gSaA bUgha dh Hkkafr Fkk;jkW;M   hoarseness  of  voice  (RLN),  dysphagia                                                       (esophagus), cough ,oa dyspnea (trachea           dSalj Hkh iq#\"kksa dh vis{kk efgykvksa esa 3-4 xquk vf/kd   ,oa larynx) ds lkFk Hkh çdV gks ldrs gSaA           feyrk gSA ;gk¡ ,d vU; rF; dks /;ku esa j[kus dh Hkh           vko';drk gS fd Fkk;jkW;M xzafFk dh fdlh o`f) esa   CLINICAL  FEATURES  SUGGESTIVE  OF                                                      MALIGNANCY IN THYROID SWELLINGS           dSalj feyus dh laHkkouk] efgykvksa dh vis{kk iq#\"kksa esa   ge tku pqds gSa fd vf/kdka'k dSalj] Fkk;jkW;M xzafFk dh           4 xquk vf/kd gksrh gSA ijUrq iq#\"kksa esa bl o`f) dh   fdlh o`f) ¼diffuse vFkok ukWMîqyj xkW;Vj½ ds :i esa           lEHkkouk gh dkQh de gksrh gS blfy, iq#\"kksa esa fdlh   gh çdV gksrs gSaA lkekU;r;%           o`f) esa dSalj dh lEHkkouk vf/kd gksrs gq, Hkh] vafre   - Rapid growth - xk¡B dk rhozrk ls c<+uk           :i esa efgykvksa ls de gh jg tkrh gSA                                                      - Hardness - bldk l[r gksuk           Predisposing  factors \& ge tku pqds gSa fd   - Irregularity - blds fdukjksa dk vfu;fer gksuk           ckY;koLFkk esa xys esa jsfM;ksfFkjSih]  Hkfo\"; esa PCT dh   - Infiltration - lehiorhZ vaxksa esa bldk QSyuk           lEHkkouk c<+k ldrh gSA yEcs le; rd vk;ksMhu dh   - Recurrent laryngeal nerve (RLN) palsy, ,oa           deh ls çHkkfor {ks=ksa esa jguk ,oa TSH ds }kjk   - Lymph  node  enlargement,  bR;kfn  dSalj  ds           yxkrkj mÙkstu] Hkfo\"; esa FCT dh lEHkkouk dks c<+k   y{k.k gks ldrs gSaA           ldrk gSA blh çdkj] ifjokj esa MCT dk feyuk   Fkk;jkW;M  dSalj  esa  Hkh  undifferentiated  vFkok           (positive family history) jksxh ds HkkbZ\&cgu vFkok   anaplastic  carcinomas esa ;gh y{k.k feyrs gSaA           csVk\&csVh (first degree relatives) esa Hkfo\"; esa MCT   buds foijhr] well differentiated, ,oa fo'ks\"k:i ls           dh lEHkkouk c<+k ldrk gSA blhfy, ,sls dSalj ds   PTC esa] vusdksa ckj buesa ls dksbZ Hkh y{k.k ugha feyrk           laHkkfor O;fä;ksa (high risk individuals) esa] dSalj dh   ,oa og fdlh benign growth tSls gh çrhr gks ldrs            'kh?kz igpku ds fy, fu;fer :i ls LØhfuax (periodic   gSaA           screening) dh lykg nh tkrh gSA             Lymph node involvement - Fkk;jkW;M xzafFk dh            Clinical  manifestations  \&  vf/kdka'k  dSalj]   tkap ds lkFk\&lkFk regional ,oa central neck lymph           Fkk;jkW;M xzafFk dh fdlh o`f) ¼diffuse vFkok ukWMîqyj   nodes  dh  foLr`r  tkap  Hkh  vko';d  gksrh  gSA           xkW;Vj½ ds :i esa gh çdV gksrs gSaA        Fkk;jkW;M xzafFk dh fdlh o`f) ds lkFk\&lkFk regional                                                      lymph  node  enlargement dk feyuk] dSalj dk           - vf/kdk¡'k esa buesa ihM+k tSls dksbZ vU; y{k.k Hkh ugha                                                     131","y{k.k gks ldrk gSA ,sls O;fä;ksa esa fyEQ uksM dh   USG - blds }kjk gesa Fkk;jkW;M ukWMîwy dh mifLFkfr]           FNAC ,oa vU; foLr`r tkapksa dh vko';drk vkSj Hkh  mudk vkdkj ,oa mudh la[;k dh tkudkjh feyrh gSA           vf/kd c<+ tkrh gSA Fkk;jkW;M xzafFk dh fdlh o`f) ds  blds }kjk ukWMîwy ds benign,  malignant vFkok            fcuk Hkh] ,d lseh ls vf/kd cM+s cervical lymph   indeterminate gksus dk vuqeku Hkh yxk;k tk ldrk           node dh mis{kk ugha dh tkuh pkfg,A lehiorhZ Ropk  gSA  USG  esa  malignant  vFkok  indeterminate           ;k xys ds bUQsD'ku ds fcuk ,oa ,aVhck;ksfVd ds i'pkr~  fn[kus okys ukWMîwy dks FNAC ds }kjk lqfuf'pr fd;k           Hkh cus jgus okys fyEQ uksM esa FNAC dh tkap] dSalj  tkuk pkfg,A           dh 'kh?kz igpku djus esa vR;ar lgk;d gks ldrh gSA                                                      CT scan or MRI with contrast \& fuf'pr :i ls           Low risk tumors - okLro esa lHkh Fkk;jkW;M dSalj   USG dh vis{kk bu tkapksa ds }kjk Fkk;jkW;M ukWMîwy           esa lokZf/kd (80-85%) feyus okyk dSalj] PTC gh gSA  dh vusd lw{e tkudkfj;ka gesa çkIr gks ldrh gSa tSls           Fkk;jkW;M xzafFk dh çR;sd o`f) esa dSalj dk lansg j[kdj  lehiorhZ vax] lymph  node,  mediastinal vFkok           mldh FNAC tkap djkus dh çofÙk ds dkj.k bldh   thoracic  cavity dk  local  invasion A blhfy,]           prevalance Øe'k% vkSj Hkh c<+rh tk jgh gSA ijUrq   USG esa indeterminate vFkok malignant fn[kus           ;gk¡ ,d vkSj rF; dks Hkh /;ku esa j[kuk vko';d gS  okys ukWMîwy esa ltZjh ls iwoZ ;g tkap vo'; djk ysuh           fd  'kh?kz  igpku  (early  diagnosis)  ,oa  well  pkfg,A           differentiated gksuk ,oa bldk vis{kk—r /kheh xfr ls   Thyroid  function  tests  - ;g] benign vFkok           c<+us  ds  dkj.k  lHkh  Fkk;jkW;M  dSalj  esa  bldh                                                      malignant esa Hksn djus esa rks lgk;d ugha gksrs ijUrq           prognosis  loksZÙke  gSA  bldk  5  ,oa  10  year   jksxh ds lexz mipkj ds fy, budh vko';drk iM+rh           survival rate, 80-90% ls vf/kd gSA         gSA  Fkk;jkW;M  gkWeksZUl  ds  Lrj  c<+s  feyus  ij            Advantages  to  thyroid  cancers \& 'kjhj ds  jsfM;ksU;wDykbM LdSu djuk enndkjh gksrk gSA           vU; LFkkuksa ij mRiUu gksus okys dSalj dh rqyuk esa   Radionuclide  scan  -  Radioisotope  uptake           Fkk;jkW;M dSalj esa dqN fof'k\"V vuqdwyrk,a Hkh gSaA  ¼jsfM;ks,fDVo  vk;ksMhu  ds  mi;ksx  djus  ij            - Easy FNAC - 'kjhj ds ckgjh Hkkx esa fLFkr gksus ds   radioactive iodine uptake - RAIU½ ds vk/kkj ij            dkj.k buesa FNAC  ljyrk iwoZd dh tk ldrh gSA   Fkk;jkW;M ukWMîwy rhu çdkj ds gks ldrs gSaA           - Easy identification and ablation - vk;ksMkbM   (i) Hot nodule \& ftlesa dsoy ukWMîwy gh vR;f/kd            VªSfiax dh fof'k\"Vrk gksus ds dkj.k bUgsa jsfM;ks,fDVo  viVsd ys jgk gks ,oa 'ks\"k xzafFk esa viVsd ux.; gksA            vk;ksMhu ds ek/;e ls jsfM;ksU;wDykbM LdSu (I  ,oa  ;g n'kkZrk gS fd og ukWMîwy Fkk;jkW;M gkWeksZUl dh                                              123            I ) ds }kjk ljyrk ls igpkuk tk ldrk gS ,oa u\"V  vR;f/kd ek=k cuk jgk gSA LokHkkfod :i ls vR;f/kd            131            (ablation - I ) Hkh fd;k tk ldrk gSA      dk;Z djus okyh dksf'kdkvksa esa dSalj dh lEHkkouk                     131           - Known  tumor  markers  -  Fkk;jkW;M  dh  ux.; gh gksrh gSA            dksf'kdkvksa ls mRiUu gksus okys dqN rRoksa ¼tSls PTC   (ii) Warm nodule - ftlesa ukWMîwy ,oa 'ks\"k xzafFk            ,oa  FTC  esa  Fkk;jksXykWC;qfyu   rFkk  MTC  esa   nksuksa esa viVsd lkekU; gksA ;g n'kkZrk gS fd ukWMîwy            dSfYlVksfuu½ dks Vîwej ds serum markers dh rjg   dh dksf'kdk,a lkekU; :i ls dk;Z dj jgh gSaA ,slh            ç;ksx esa ykdj thyroidictomy ds i'pkr~ NwV x,                                                      dksf'kdkvksa esa Hkh dSalj dh lEHkkouk vf/kd ugha gksrhA            residual tumor, metastatic tumor ;k recurrent            tumor dks lQyrk iwoZd igpkuk tk ldrk gSA   (iii) Cold nodule -  ftlesa Fkk;jkW;M xzafFk dk viVsd                                                      rks lkekU; gks ijUrq ukWMîwy esa ;g ux.; gksA ;g           LAB EVALUATION                                                     132","n'kkZrk gS fd ukWMîwy dh dksf'kdk,a lkekU; :i ls Hkh   ablation Hkh fd;k tkrk gSA Thyroidectomy ,oa           dk;Z ugha dj ik jgh gSaA ,sls cold nodules esa dSalj  vU; ltZjh dh fof/k;ks¡ dks ge vU; v/;k; esa foLrkj           dh lEHkkouk lokZf/kd gksrh gS ftudh FNAC vo';  ls le>saxsaA           dh tkuh pkfg,A                             THYROXINE THERAPY                                                       THYROXINE THERAPY           FNAC and Core Biopsy \& budh foLr`r ppkZ ge   Thyroidectomy ds i'pkr~ Fkk;jkWfDlu dks Hkh nks           Fkk;jkW;M ukWMîwYl ds v/;k; esa dj pqds gSaA  mís';ksa ds fy, fn;k tk ldrk gSA             MANAGEMENT                               To  supplement  for  deficient  hormones  -           SURGERY                                    Thyroidectomy ds i'pkr] xzafFk ds fudkys x, Hkkx           fdlh Hkh dSalj esa fpfdRld dk ;gh ç;kl jgrk gS fd   ds vuqlkj] Fkk;jkW;M gkWeksZUl ds mRiknu esa deh vk           ;FkklaHko dSaljxzLr Hkkx dks ltZjh }kjk iw.kZ:i ls   tkrh gSA bl deh dks iwjk djus ds fy, Fkk;jkWfDlu           fudky fn;k tk;sA blh vk/kkj ij Fkk;jkW;M dSalj esa   fFkjSih dh vko';drk iM+rh gSA total thyroidectomy                                                      (TT) ds i'pkr~ tc lEiw.kZ Fkk;jkW;M xzafFk fudy pqdh           Hkh Fkk;jkW;M xzafFk dks iw.kZ:i ls fudky nsus (total           thyroidectomy) dh jk; nh tk ldrh gSA ijUrq]   gksrh gS rc Fkk;jkWfDlu dh yxHkx 1.6 mcg çfrfdxzk           O;ogkfjd :i esa dqN O;fä;ksa esa ,slk djus dh   çfrfnu Mkst dh vko';drk iM+rh gSA bls vkjEHk           vko';drk ugha gksrh tcfd vU; esa ,slk dj ikuk   djus ds 6-8 lIrkg i'pkr~ lhje TSH dh ek=k ds           laHko ugha gksrkA Fkk;jkW;M dSalj esa ltZjh ds rhu çeq[k   vuqlkj] bldh Mkst dks ?kVk vFkok c<+k ysrs gSaA Low                                                      risk cases esa tgk¡ conservative surgery gksus ds           mís'; gks ldrs gSaA 1) Tumor mass dks de djuk 2)           Recurrence dh lEHkkouk dks ?kVkuk ,oa 3) e`R;q nj   i'pkr~  recurrence  dh  lEHkkouk  de  gks]  ogka           dks de djuk                                Fkk;jkWfDlu fFkjSih ds nkSjku lhje TSH dks bldh                                                      lkekU; jsat esa gh j[k ldrs gSaA           Low risk cases, ftuesa dSalj Fkk;jkW;M ds dsoy           ,d yksc esa gh lhfer gks] surgical morbidity dks   To  suppress  postoperative  recurrence  of                                                      carcinoma –   ge tkurs gSa fd TSH] Fkk;jkW;M           ?kVkus ds fy, total  thyroidectomy ds LFkku ij   QkWfydy dh dksf'kdkvksa dks mÙksftr djrk gS ftlls           lobectomy ls Hkh visf{kr ifj.kke çkIr fd;s tk   muds vkdkj ,oa la[;k esa o`f) gksrh gSA bl çdkj ls]           ldrs gSaA blls RLN dks {kfr igq¡pus ,oa iSjkFkk;jkW;M   Fkk;jkW;M dSalj esa ;g dSalj dh dksf'kdkvksa dh o`f) Hkh           xzafFk;ksa ds fudy tkus dh lEHkkouk Hkh ?kV tkrh gSA  djk  ldrk  gSA  blhfy,]  high  risk  patients  esa           High risk cases, ftuesa dSalj] Fkk;jkW;M xzafFk ds   thyroidectomy  ds  i'pkr~  ;fn  dksbZ  dSalj  dh           vfrfjä  regional  lymph  node  vFkok  distant  dksf'kdk] locally vFkok metastatic site ij NwV x;ha           metastases ds :i esa QSy pqdk gksA ,sls esa Fkk;jkW;M  gks] rks og Hkh TSH ds çHkko esa c<+dj recurrence dk           xzafFk ds lkFk\&lkFk xzafFk ds lehi fLFkr Hkkx ,oa  dkj.k cu ldrh gSaA blhfy,] high risk patients esa           lEcaf/kr fyEQ uksM Hkh fudkyus iM+rs gSaA bl foLr`r  Fkk;jkWfDlu fFkjSih ds nkSjku lhje TSH dks bldh           ltZjh dks lateral neck dissection dgrs gSaA ltZjh ls  lkekU; jsat esa gh u j[kdj] blls Hkh de (0.5           gks ldus okyh vlqfo/kkvksa (morbidity) dks ?kVkus ds   mIU/L) (;k suppressed) j[kk tkrk gSA           fy,  lateral  neck  dissection   ds  LFkku  ij   RAI THERAPY           compartment  oriented  neck  dissection ls Hkh   ge tkurs gSa fd çk—frd vk;ksMhu dh gh Hkkafr           i;kZIr lQyrk fey tkrh gSA bUgha high risk cases esa   jsfM;ks,fDVo vk;ksMhu Hkh Fkk;jkW;M dh QkWfydYl esa           recurrence dh lEHkkouk ?kVkus ds fy, ltZjh ds   ,df=r gksrh tkrh gSA Fkk;jkW;M dSalj esa bl çfØ;k dk           mijkUr NwVs gq, remnant tissue dk radioactive                                                     133","mi;ksx nks çdkj ls fd;k tk ldrk gSA        ¼vFkok RAI½ viVsd ds fy, TSH dh vko';drk            RAI scan - 'kjhj esa ços'k djus ds dqN le; esa gh   iM+rh  gSA  vr%  RAI  fFkjSih  ds  iwoZ  O;fä  dk           RAI (I ), iw.kZ:i ls jä ls fudydj] Fkk;jkW;M   gkbiksFkk;jkW;M gksuk vko';d gS ftlls c<+k gqvk                123           QkWfydy dh dksf'kdkvksa esa laxzfgr gks tkrh gSA blds   TSH] RAI viVsd esa lgk;d gks ldsA vr% TT ds           fy, I  isotope dk mi;ksx djrs gSa ftlls eq[;r%   i'pkr~ ;fn Fkk;jkWfDlu fFkjSih vkjEHk gks pqdh gks rc               123           xkek  jsfM,'ku  fudyrs  gSaA  xkek  jsfM,'ku  dh   dqN le; ds fy, bls jksddj lhje TSH dks c<+us dk           penetrating  power  vf/kd  gksus  ds  dkj.k  ;g   volj nsrs gSa ,oa mlds i'pkr~ gh RAI nsrs gSaA bl           dksf'kdkvksa dks vf/kd {kfr igqapk;s fcuk] muls gksdj   çdkj ls ;g RAI] jä esa vf/kd le; rd ugha jgrk           xqtjrs gq, 'kjhj ds ckgj fudy tkrs gSa tgk¡ budh   ,oa 'kh?kz gh dSalj dh lfØ; dksf'kdkvksa esa ços'k dj           x.kuk xkek dkmaVj }kjk dj yh tkrh gSA blds }kjk   mudks lekIr dj nsrk gSA           'kjhj esa functioning thyroid tissue dgk¡\&dgk¡ gS ,oa   Radioiodine refractory disease           fdruh ek=k esa gS] bldk vkdyu fd;k tk ldrk gSA  mijksä fooj.k ls ;g rks le> gh pqds gksaxsa fd RAI           bl çfØ;k dk mi;ksx Fkk;jkW;M dSalj dh  local  fFkjSih ds fy, dSalj dh dksf'kdkvksa dk lfØ; gksuk           spread ,oa distant  metastases dks igpkuus ds  vko';d  gSA  ;g  eq[;r%  well  differentiated           fy, fd;k tkrk gSA                          carcinomas esa gh gksrk gSA dSalj dh dksf'kdk,a ftruh           RAI therapy - tgk¡ I  ds }kjk eq[; :Ik ls xkek   vf/kd undifferentiated gksrh tk;saxha] mudk RAI                            123            jsfM,'ku fudyrs gSa ogha I  ls eq[;r% (90%) chVk   viVsd mruk de gksrs gq,] RAI fFkjSih ls mlesa ykHk                              131            jsfM,'ku fudyrs gSa tks dsoy dqN feeh rd gh tk ikrs   gksus dh lEHkkouk mruh gh de gksrh tk;sxhA mez ds                                                      c<+us ,oa recurrent disease esa Hkh ,slk gks ldrk gSA           gSaA  buls  fudyus  okyh  high  energy  cytotoxic           radiations, body tissues dks dsoy 2 feeh rd gh   ,sls O;fä;ksa esa external beam radiotherapy  dk           Hksn ikrh gSa ,oa mldks iw.kZ:i ls lekIr dj nsrh gSaA   ç;ksx fd;k tk ldrk gSA           bl çdkj] I  fdlh targetted missile dh Hkkafr dk;Z   Indications  of  RAI  therapy  in  thyroid                   131           djrh gSa tks 'kjhj esa functioning thyroid tissue dks   carcinomas           <wa<\&<wa< dj ekjrh gSaA                    mijksä dFku ls ,d nqfo/kk mRiUu gksrh gSA  Well                                                      differentiated carcinomas esa RAI çHkkoh gS ijUrq           PRE-REQUISITES FOR RAI THERAPY             ;g igys ls gh low risk category gS ftlesa 'kk;n           (i) dSalj dks ;FkklaHko ek=k esa fudkyk tk pqdk gks \&   RAI  ls vfrfjä ykHk Hkh u feysA blds foijhr]           loZçFke] TT ,oa neck dissection ds }kjk fn[kkbZ ns   undifferentiate  carcinomas]  tks  high  risk           ldus okyh lEiw.kZ Fkk;jkW;M xzafFk dks fudky fn;k tkrk   category gS] muesa RAI ds çHkkoh gksus dh lEHkkouk           gSA blds i'pkr~ RAI fn, tkus ij ;g mu lHkh LFkkuksa   FkksM+h de gks tkrh gSA bu rF;ksa dks /;ku esa j[krs gq,]           ij  ,df=r  gks  tkrh  gS  tgk¡  vHkh  Hkh  dSalj  ds                                                      Fkk;jkW;M dSalj esa RAI ds indications dks fuEu çdkj           microscopic  deposits ,oa vKkr  metastases   ls le>k tk ldrk gSA           miyC/k gksaA /;ku jgs] ;fn RAI dks ltZjh ds iwoZ gh           fn;k tk, rks vf/kdk¡'k RAI] lkekU; xzafFk ,oa dSalj ds   Primary RAI therapy - lHkh Kkr Fkk;jkW;M ,oa           eq[; Hkkx esa gh laxzfgr gks tk,xh ,oa ltZjh ds mijkar   Fkk;jkW;M  ds  vfrfjä  (extrathyroid)  dSalj  ls           NwVh gqbZ dksf'kdk,a vçHkkfor gh jg tk;saxhaA   çHkkfor Hkkxksa dks fudkyus ds i'pkr~ RAI LdSu esa ik;s                                                      x, microscopic ,oa distant metastases dks u\"V           (ii) çHkkfor O;fä esa gkbiksFkk;jkW;fMTe mRiUu gks pqdh   djus ds fy,A           gks \& Fkk;jkW;M dh dksf'kdkvksa ds }kjk vk;ksMhu                                                     134","Secondary RAI therapy                       mRiUu gksus okys DTC ds fodkl dks TSH de djds           - For  unresectable  tumor  -  ftl Vîwej dks   ckf/kr (suppress) fd;k tk ldrk gSA            fudkyk u tk ldsA                          - bldh dksf'kdk,a] lkekU; QkWfyD;qyj dksf'kdkvksa dh           - For distant metastases - tks Vîwej nwj rd QSy   Hkkafr  vk;ksMhu  dk  lao/kZu  (accumulation)  Hkh            pqdk gksA                                  djrh gSaA blhfy,] blls mRiUu gksus okys DTC dks           - For recurrent disease - tks Vîwej nksckjk mHkj   jsfM;ks,fDVo vk;ksMhu ds ç;ksx ls u\"V Hkh fd;k tk            vk;k gksA                                  ldrk gSA           - For  undetectable  recurrent  tumor  -  tks   - mijksä nksuksa dkj.kksa ls] prqFkZ pj.k (stage IV) rd            Vîwej fn[k u jgk gks ijUrq Fkk;jksXykWC;qfyu ds Lrj   ds vR;ar QSys gq, dSalj esa Hkh çkFkfed ltZjh ds            c<s+ fey jgs gksaA                         mijkar  TSH  suppressive  therapy  ,oa  RAI                                                       ablation therapy ds ç;ksx ls dSalj dks cM+h lhek                                                       rd fu;a=.k esa j[kk tk ldrk gSA            SALIENT  FEATURES  OF  DIFFERENT            THYROID CARCINOMAS                        - bldh dksf'kdk,a] lkekU; QkWfyD;qyj dksf'kdkvksa dh           ge Fkk;jkW;M dSalj ds fofHkUu oxhZdj.k ds fo\"k; esa   Hkkafr Fkk;jksXykWC;qfyu mRiUu djrh gSa ftldk iz;ksx           le> pqds gSaA muesa ls çkbejh Fkk;jkW;M dSalj ¼ftudh   V;wej ekdZj ds :i esa fd;k tk ldrk gSA blhfy,]           mRifÙk Fkk;jkW;M xzafFk esa gqbZ gks½ dks Hkh pkj çeq[k oxksaZ   ltZjh ds i'pkr~ jä esa Fkk;jksXykWC;qfyu ds Lrj ds           esa foHkkftr fd;k tk ldrk gSA               }kjk  dSalj  dh  NwVh  gqbZ  dksf'kdkvksa  (remnant                                                       tissue)  dks  ;k  blds  nksckjk  mRiUu  gksus           - Differentiated thyroid carcinoma (DTC) -            QkWfyD;wyj  dksf'kdkvksa  ls  mRiUu  gksus  okys  iw.kZ   (recurrence) dks igpkuk tk ldrk gSA            fodflr Fkk;jkW;M dSaljA ;g nks çdkj ds gks ldrs   - bldh dksf'kdk,a] lkekU; Fkk;jkW;M QkWfydy dh            gSaA  Papillary  (PTC)  ,oa  follicular  (FTC)   dksf'kdkvksa dh Hkkafr dk;Z djrh gqbZa] cgqr /kheh xfr            Fkk;jkW;M dSalj                            ls fodflr gksrh gSaA blhfy,] ;fn bUgsa 'kh?kz gh            - Undifferentiated/  anaplastic  thyroid    igpku fy;k tk;s rc mfpr mipkj ls bldh e`R;q            carcinoma (ATC) -   QkWfyD;wyj dksf'kdkvksa ls   nj vis{kk—r de ,oa thfor jgus dh lEHkkouk            mRiUu gksus okyk vfodflr Fkk;jkW;M dSalj   (survival rate) dkQh csgrj  (80-90% jksfx;ksa esa                                                             o\"kZ           - Medullary  thyroid  cancer  (MTC)-        10-20  ) gksrh gSA            iSjkQkWfyD;wyj  dksf'kdkvksa  ls  mRiUu  gksus  okyk            esM~;qyjh Fkk;jkW;M dSalj                   Papillary thyroid carcinoma (PTC)           - Thyroid  lymphoma  - fyEQkW;M dksf'kdkvksa ls   Prevalence \& PTC dh mRifÙk Fkk;jkW;M QkWfydYl            mRiUu gksus okyk Fkk;jkW;M dSalj          dh dksf'kdkvksa ls gksrh gSA lHkh Fkk;jkW;M dSalj esa                                                      lokZf/kd O;kid dSalj ¼yxHkx 80%½] PCT gh gksrk gSaA            çLrqr v/;k; esa ge budks foLrkj ls le>rs gSa   ;gk¡ rd fd fdlh Hkh benign dkj.k ds fy, dh x;h              Differentiated thyroid carcinoma (DTC)   thyroidectomy ds i'pkr~ yxHkx 10% Fkk;jkW;M           Fkk;jkW;M xzafFk esa ik;k tkus okyk loZçeq[k dSalj   xzafFk;ksa esa ,oa Fkk;jkW;M ds vfrfjä fdlh Hkh vU;           (90%)  DTC  gh  gS  ftldh  mRifÙk  QkWfydy  dh   dkj.k ls gqbZ e`R;q ds i'pkr~  25-30%  autopsy           dksf'kdkvksa ls gksrh gSA blds vusd xq.k bls vU; dSalj   studies esa Fkk;jkW;M xzafFk esa PTC ds y{k.k fey ldrs           dh rqyuk esa fof'k\"V cukrs gSaA            gSa ftUgksaus O;fä ds thou dky esa dHkh dksbZ y{k.k rd           - bldh dksf'kdk,a] lkekU; QkWfyD;qyj dksf'kdkvksa dh   mRiUu ugha fd;s gksrsA ;g fdlh Hkh mez esa fey ldrs gSa            Hkkafr TSH ds çHkko esa dk;Z djrh gSaA blhfy,] blls   ijUrq 25-50 o\"kZ ds e/; budh lEHkkouk lokZf/kd                                                     135","gksrh  gSA  ftu  O;fä;ksa  dks  dHkh  fdlh  çdkj  dk   vascular  invasion ,oa distant  metastases dh           jsfM,'ku çkIr gqvk gks muesa feyus okys dSalj esa   lEHkkouk vf/kd gksrh gSA           vf/kdk¡'k PTC gh gksrs gSaA                (ii) Diffuse sclerosing variant - tks de mez ds            Gross morphology - PTC eq[; :i ls xzafFk esa   yksxksa esa feyrk gS ,oa blesa squamous metaplasia,           ,d lkFk vusd LFkkuksa ls mRiUu gksrk gS (multifocal),   fibrosis ,oa lymphatic spread dh lEHkkouk vf/kd           blds fdukjs vfu;fer gksrs gSa (irregular margins)   gksrh gSA           ,oa  ;g  fudVorhZ  {ks=ksa  esa  rhozrk  ls  QSyrk  gS   Cytological features - PTC dh dksf'kdkvksa ds           (infiltrative tumor) A dHkh\&dHkh ;g vU; Fkk;jkW;M   U;wfDy;l esa vusd fof'k\"V y{k.k feyrs gSaA           dSalj dh Hkkafr vdsyk (solitary), ,d gh LFkku ij           lhfer (well circumscribed) ,oa iw.kZ:i ls dSIlwy   - budk nucleoli lkekU; ls cM+k gksrk gSA           ls f?kjk gqvk (encapsulated) Hkh gks ldrk gSA fdlh   - budk  chromatin  brus  lw{e  :i  esa  lEiw.kZ           Hkh rhozrk ls c<+rs gq, dSalj dh Hkkafr buesa Hkh   U;wfDy;l  esa  fc[kjk  jgrk  gS  fd  mldk                                                       nucleoplasm ,d ne lkQ yxrk gSA           vascular  growth ds /khes jg tkus ls ischemic           vFkok hemorrhagic necrosis gks ldrh gS tks ckn   - bl çdkj ;g U;wfDy;l fdlh f[kykSus okyh xqfM+;k           esa colloid cyst dk :i ys ldrh gSA yEcs le; ds   dh vk¡[k tSlk fn[krk gS ftls 'orphan Annie eye'           i'pkr~ blesa Qkbczksfll ,oa dSfYlfQds'ku Hkh fey   appearance  (large  round  nucleus  with  a                                                       dense nucleolus and clear nucleoplasm) dgrs           ldrs gSaA                                                       gSA           Variants of PTC - PTC eq[;r% nks :iks esa feyrk   - U;wfDy;l ds e/; esa xsgwa ds nkus dh Hkkafr njkj ;k           gSA                                         xïk (fissure/groove)  gks ldrk gS] ;g ,d nwljs           (i)  Follicular  variant  -  Fkk;jkW;M QkWfydYl ls   ij  p<+s  gks  ldrs  gSa  ,oa  buds  fdukjs  Vs<+s\&es<+s           mRiUu gksus ds i'pkr~ tc rd dSalj dh dksf'kdk,a   (margins  irregular)  gks  ldrs  gSaA  Papillary           la[;k esa c<+rs gq, ,d iafä esa O;ofLFkr cuh jgrh gSa   projections  ds  vHkko  esa  PTC  ds  follicular           rc rd og lkekU; QkWfydy tSlh gh çrhr gksrh gSaA   variant  dks]  bUgha  nuclear  features   ds  }kjk                                                       igpkuk tkrk gSA           (ii) Papillary variant - tc bu dSalj dh dksf'kdkvksa   - Papillae ds e/; esa dSfYlfQds'ku dh vusd ijrsa           dh o`f) vfu;af=r gks tkrh gS rc ;gh dksf'kdk,a vusd   ,d  ds  Åij  ,d  fyiVh  gksrh  gSa  (concentric           folds ;k papillary projections dk :i ys ysrh gSaA   calcification) ftUgsa  Psammoma bodies dgrs           bu papillae ds e/; esa fibrovascular bundle jgrk   gSaA ;g ekuk tkrk gS fd ;g papillae ds e/; fLFkr           gSA bu dSalj dh dksf'kdkvksa esa Fkk;jkW;M gkWeksZUl ds   blood vessels esa thrombosis ds QyLo:i gqbZ           fuekZ.k dh i;kZIr {kerk u gksus ds dkj.k ;g dksf'kdk,a   tissue necrosis ds dystrophic calcification ls           cuboidal gh jgrh gSa ¼tcfd Graves' disease tSls   curh gSaA /;ku jgs]  PTC ds vfrfjä]  renal]           hypersecretory disorders esa ;g columnar gksrh           gSa½A                                       ovarian]  endometrial  ,oa    meningial                                                       carcinomas ds papillary variants esa Hkh ,slh gh           buds vfrfjä] PTC ds nks :ikarj vkSj Hkh fey ldrs   Psammoma bodies fn[krh gSaA           gSaA                                       - mijksä  orpahn  Annie  eye  appearance   o           (i) Tall cell variant - tks vf/kd mez ds yksxksa esa   Psammoma  bodies]   PTC  ds  fof'k\"V  y{k.k                                                       (pathognomonic  features) gSaA buds feyus ds           feyrk  gS  ,oa  blesa  extra  thyroidal  spread,                                                     136","i'pkr~ dSalj dh Mk;Xuksfll ds fy, dSIlwy ,oa  vPNs ifj.kkeksa ¼benign  course½ ds dkj.k buesa            oSLdqyj lhekvksa dks ikj djus dks çekf.kr djus dh  ck;kWIlh  ,oa  ltZjh  fd;s  fcuk  gh,  simple            vko';drk ugha jg tkrhA                    observation]  chemical  ¼ethanol½  vFkok            Peculiar features of PTC - vU; Fkk;jkW;M dSalj   radiofrequency ablation ds ç;kl Hkh py jgs gSaA           ls PTC vusd :iksa esa fHkUu gSA ;g vR;ar rsth ls QSyus     Follicular thyroid carcinoma (FTC)           okyk dSalj gS tks fo'ks\"k:i ls fyEQ uksM~l esa QSyrk gSA   Prevalence \& FTC dh lEHkkouk lHkh Fkk;jkW;M           (i) Intrathyroidal spread - PTC dk ,d çeq[k   dSalj esa dsoy 5-15% gh gksrh gSa ijUrq vk;ksMhu dh           y{k.k gS bldk Fkk;jkW;M xzafFk ds vanj gh vusd LFkkuksa   deh okys {ks=ksa esa ;g 25-40% rd gks ldrh gSaA           ij fc[kjk gksuk (multifocal) ,oa blds dSIlwy dks ikj   Clinical features - FTC vf/kdka'kr;% 40-60 o\"kZ           djds vkl\&ikl ds vaxksa esa QSy tkukA 5 o\"kZ ls de  ds vk;q oxZ esa feyrk gSA vf/kdka'k O;fä;ksa esa ;g           mez esa jsfM,'ku dk lkeuk gksuk bl lEHkkouk dks vkSj  Fkk;jkW;M ukWMîwy ds :i esa gh çdV gksrk gS ij PTC           Hkh c<+k nsrk gSA                          dh rqyuk esa FTC esa dSalj xzLr Hkkx ds cM+s gksus ,oa           (ii) Micrometastases - ;g fyEQSfVDl ls gksdj  vkl\&ikl ds vaxksa esa QSy ldus ¼infitrate djus½ dh           QSyrs gq, jhtuy ,oa lsaVªy fyEQ uksM~l rd igq¡p  lEHkkouk vf/kd gksrh gSA            ldrk gSA PCT dk fo'ks\"k y{k.k gS] 2 feeh ls Hkh NksVh   Histological features and variants           micrometastases] tks yxHkx 40% jksfx;ksa esa fey   - FTC  esa  dSalj  ls  çHkkfor  vf/kdka'k  dksf'kdk,a]           ldrh gSaA vk'p;Ztud :i ls bldh lEHkkouk de   lkekU; QkWfydy dh dksf'kdkvksa dh Hkkafr gh dksykW,M           mez ds O;fä;ksa esa vf/kd gksrh gSA blds fo\"k; esa ,d   ls Hkjh QkWfydy tSlh fn[krh gSaA           jkspd rF; ;g Hkh gS fd fyEQ uksM ds çHkkfor gksus ds   - dgha\&dgha ;g dksf'kdk,a fcuk dksykW,M ds gh] >q.M           i'pkr~ Hkh PCT dh prognosis esa dksbZ fo'ks\"k varj   vFkok ijr ¼nests or sheet½ ds :i esa Hkh O;ofLFkr           ugha vkrkA ijUrq tSls\&tSls vusd fyEQ uksM çHkkfor   fey ldrh gSaA           gksrs tkrs gSa] ;g ltZjh ds ckn nksckjk mHkjus dh   - dHkh\&dHkh dqN fof'k\"V çdkj dh dksf'kdkvksa esa çpqj           lEHkkouk (postoperative  recurrence) dks c<+krs   ek=k  esa  eosinophilic]  granular  cytoplasm           tkrs gSaA                                   ,df=r gks tkrk gSA bUgsa Hurthle cell variant  ;k           (iii)  Microcarcinoma  - fcuk dksbZ y{k.k mRiUu   oncocytic variant dgrs gSaA           fd;s Fkk;jkW;M esa iM+s jguk ,oa fcuk e`R;q nj dks c<+k,           gq, fyEQ uksM~l esa iM+s jguk] bu nksuksa fo'ks\"krkvksa ds   Diagnosis - bl çdkj PTC dh Hkkafr FTC esa fdlh           dkj.k  PCT  ds  mipkj  esa  vkt  dy  dqN   çdkj  ds  fof'k\"V  y{k.k  ugha  gksrs  tks  dSalj  dh           conservative approaches viukus dh jk; Hkh nh   Mk;Xuksfll  esa  lgk;d  gksaA  blls  benign  ,oa           tk jgh gSaA bUgha esa ,d gS fiVîwVjh Vîwej dh gh Hkkafr   malignant follicular carcinoma esa foHksn dj ikuk           PCT dks Hkh  microcarcinoma ¼<10 feeh½ ,oa   laHko ugha gksrkA blhfy, FTC dh Mk;Xuksfll ds fy,           macrocarcinoma ¼>10 feeh½ esa foHkkftr djukA   core  biopsy  dh  vko';drk  iM+rh  gS  ftlls           Microcarcinomas ls çHkkfor 2/3 O;fä;ksa esa ;g   capsular vFkok vascular  invasion dks çekf.kr           vDlj yEcs le; rd leku vkdkj dk gh cuk jgrk   fd;k tk ldsA           gS] buesa ltZjh ds ckn nksckjk mHkjus dh lEHkkouk  ijUrq FTC ds vR;ar oSLdqyj gksus ds dkj.k dksj           yxHkx ux.; gksrh gS ,oa buesa yEcs le; rd thfor  ck;kWIlh esa jälzko gksus dh lEHkkouk ds dkj.k] bl           jgus dh lEHkkouk (long term survival) cgqr vPNh  rduhd dk fopkj flQZ dqN p;fur ekeyksa esa gh fd;k           gksrh gSA fdlh papillary microcarcinoma ds bUgha  tkrk gSA                                                    137","Spread - PTC dh Hkkafr blesa Fkk;jkW;M ds vanj   O;fä;ksa dh e`R;q 6-12 ekg ds vanj gh gks tkrh gSA           ¼intrathyroidal multiple foci½ vFkok fyEQ ds }kjk   Histopathological  features  -  ATC esa vusd           QSyus ¼lymphatic  spread½ dh lEHkkouk yxHkx   çdkj dh vfodflr dksf'kdk,a  (undifferentiated           ux.;  gh  gksrh  gSA  ;g  eq[;r%  jä  ds  }kjk   cells) fey ldrh gSaA           ¼hematogenous spread½ gfì;ksa ¼bones½] QsQM+ksa           ¼lungs½ ,oa CNS esa QSyrk gSA              - ;g osteoclasts  dh Hkkafr large  pleomorphic]                                                       multi-nucleated  giant  cells  gks  ldrh  gSa  ;k           Prognosis - blh jä ds }kjk QSyus dh lEHkkouk   sarcomatous  cells dh Hkkafr spindle  shaped            ¼angioinvasive  character½  ds  dkj.k  FTC  esa   cells, vFkok nksuksaA           vf/kdka'k jksxh bldh prqFkZ voLFkk ¼stage IV½ esa gh   - blds chp\&chp esa gh papillary vFkok follicular           igpkus tk;s ikrs gSa ftlls budh e`R;q nj] PTC dh   differentiation dh Hkh çkIr gks ldrh gSaA           rqyuk esa yxHkx nksxquh gksrh gSA ijUrq blds ckn Hkh ;g   - bu ij epithelial  origin ds cell  markers tSls           vU; dSalj dh rqyuk esa cgqr de jgrh gSA 50 o\"kZ ls                                                       cytokeratin rks fey ldrs gSa ijUrq  thyroidal           vf/kd mez] 4 lseh ls cM+k Vîwej] Hurthle  cell   differentiation ds y{k.k] tSls Fkk;jksXykWC;qfyu] ugha           changes]  vascular  invasion  ,oa  distant   feyrsA           metastases  blls  tqM+s  poor  prognostic   - ATC]  vkjEHk  ls  gh  vfodflr  Lo#I           indicators gksrs gSaA                                                       ¼undifferentiated  form ½ esa mRiUu gks ldrk gS              Hurthle cell carcinoma                   vFkok papillary  ,oa vU; vfodflr dSalj ¼poorly           ;g FTC dk gh ,d :ikarj ¼variant½ ekuk tkrk gSA   differentiated  cancer½  ds  lkekU;  fodkl  ds           budh dksf'kdh; lajpuk ¼histology½ esa acidophilic   foijhr fn'kk esa ifjofrZr gksus ¼dedifferentiation ½           Hurthle vFkok  Askanazy cells dh çpqjrk feyrh   ls mRiUu gks ldrk gSA bl çdkj] blls çHkkfor           gSA ifj.kke ¼prognosis½ ds lUnHkZ esa budh e`R;q nj   yxHkx ,d pkSFkkbZ (1/4)  O;fä;ksa esa iwoZ esa gq, well           FTC ls Hkh vf/kd gksrh gSA                  differentiated  carcinoma  dh  tkudkjh  fey              Anaplastic thyroid carcinoma (ATC)        ldrh gS ,oa vU; ,d pkSFkkbZ (1/4)   O;fä;ksa esa                                                       Fkk;jkW;M ds fdlh vU; Hkkx esa mlh le;  well           vius uke ¼Greek ana = back ward; plasia =           formation½ ds vuqlkj ATC mu dksf'kdkvksa ls cus   differentiated carcinoma feyus dh lEHkkouk Hkh                                                       gks ldrh gSA           gksrs gSa tks viuk fodflr ,oa ifjofrZr ¼mature and           differentiated½ Lo#i [kks pqdh gSaA ;g Fkk;jkW;M   Management  -  Poorly  differentiated gksus ds           dSalj dk lcls vfodflr ¼poorly differentiated½   dkj.k budk RAIU Hkh dkQh de gh jgrk gS ftlls           ,oa  vkØked  ¼aggressive½  Lo:i  gS  tks  lHkh   buesa RAI fFkjSih dk çHkko Hkh lcls de iM+rk gSA           Fkk;jkW;M dSalj dk yxHkx 5% Hkkx cukrk gSA   blhfy, ATC ds ftu jksfx;ksa esa ltZjh dh tk ldrh gS            Clinical  features  - ;g vf/kdka'kr;% 65 o\"kZ ls   ¼operable cases½ muesa dSalj ds vf/kdk¡'k Hkkx dks           vf/kd mez ds O;fä;ksa esa feyrk gSA bldk çeq[k y{k.k   ;FkklaHko fudkyus ¼debulking  surgery djus½ ds           gS vR;ar rhozrk ls c<+rk gqvk Vîwej tks çkFkfed tkap   i'pkr] vFkok ftu jksfx;ksa esa ltZjh ugha dh tk ldrh           ds le; gh gS lehiorhZ {ks=ksa esa local infiltration ;k   gS  ¼inoperable  cases½  esa  ltZjh  ds  fcuk  gh]           lqnwj vaxksa esa (distant metastases) QSy pqdk gksA   chemotherapy ,oa  external beam irradiation dk           blds ifj.kke ¼prognosis½ lcls [kjkc ¼e`R;q nj   ç;ksx fd;k tkrk gSA ijUrq fdlh Hkh fof/k ls blesa           yxHkx  100%½  gksrs  gSA  blls  çHkkfor  vf/kdk¡'k   thou dh lEHkkouk ¼survival½ ugha c<+ ikrk gSA                                                     138","nq%lk/; :i ls QSys gq, ¼intractable½ dSalj esa]   rFkk phaeochromocytoma  ds feyus dh lEHkkouk            trachea rd QSys gksus ls respiratory obstruction   Hkh gks ldrh gSA ,sls yksxksa iSjkFkk;jkW;M gkWeksZu rFkk           gksus ij tracheostomy dh vko';drk Hkh iM+ ldrh   metanephrine ls lEcaf/kr tkapsa djkuh vko';d           gSA                                        gksrh gSaA              Medullary thyroid carcinoma (MTC)        BIOMARKERS           ewy  :i  ls  ;g  dSalj]  Fkk;jkW;M  QkWfydYl  dh   (i) Calcitonin - a biomarker of MTC - MCT dk           dksf'kdkvksa ls mRiUu u gksdj] neural crest ls mRiUu   ,d  fo'ks\"k  xq.k  gS  dSalj  dh  dksf'kdkvksa  ds  }kjk           gksus okyh iSjkQkWfyD;qyj dksf'kdkvksa ¼C  cells½ ls   dSfYlVksfuu dk fuekZ.kA ltZjh ds i'pkr] dSfYlVksfuu           mRiUu gksrs gSaA lHkh Fkk;jkW;M dSalj esa yxHkx 5%   ds  Lrj  ?kV  tkrs  gSa  tcfd  blds  nksckjk  mHkjus           dSalj MCT gh gksrs gSaA                    (recurrence) gksus ij dSfYlVksfuu ds Lrj c<+ tkrs            Type of MTC -  ;g nks çdkj dk gks ldrk gSA   gSaA  blhfy,  MCT  dh  Mk;Xuksfll  ,oa  ifj.kke           (i) Sporadic form (80-90%) \& ftlesa ifjokj ds   (prognosis) ds fu/kkZj.k esa ;g egRoiw.kZ Hkwfedk fuHkk           fdlh ,d O;fä esa] fdlh Hkh mez esa] ;g ,dy Vîwej   ldrk gSA           ds :i esa feyrk gS] ,oa                    (ii)Carcinoembryonic  antigen  (CEA)-           (ii) Familial form (10-20%) \& ftlesa ;g ifjokj   dSfYlVksfuu ds vfrfjä MCT, CEA Hkh mRiUu dj           ds vusd yksxksa esa] vf/kdka'kr;% cPpksa vFkok ;qokvksa   ldrk gSA           esa] ,oa vU; VîwelZ ds lkFk feyrk gSA vU; VîwelZ dk   SALIENT FEATURES           ;g lewg MEN 2A ,oa MEN 2B ds :i esa fey ldrk   - Histology esa amyloid stroma  dk feyuk bldk            gSA Sporadic  form dh vis{kk ;g familial  form   fof'k\"V y{k.k gSA           vf/kd vkØked ¼aggressive½ gksrh gSA        - ;g fyEQ ,oa jä] nksuksa ds }kjk QSy ldrk gSA                                                       yxHkx 50%  O;fä;ksa esa fyEQ uksM~l  çHkkfor fey           Familial MCT ls çHkkfor lHkh O;fä;ksa esa RET           mutations dh tkap vo'; djkuh pkfg,A blds    ldrs gSaA                                                      - Fkk;jkW;M ds vanj gh lhfer jgus (intrathyroidal           feyus  ij  genetic  counselling  ,oa  family           screening Hkh djkuh pkfg,A Familial  MCT esa   disease) esa  total  thyroidectomy  }kjk i;kZIr           dSalj]  de  mez  esa  gh  dkQh  c<+h  gqbZ  voLFkk   lQyrk çkIr dh tk ldrh gSA ltZjh ds i'pkr~           ¼advanced  stage½  esa  igq¡p  ldrk  gSA  blhfy,   fu;fer :i ls lhje dSfYlVksfuu dh tkap djkrs gq,           ifjokj ds lnL;ksa] ,oa ;gk¡ rd fd cPpksa esa Hkh]   bls ekWuhVj fd;k tk ldrk gSA           LØhfuax esa RET mutations ds feyus ij de mez esa   - fyEQ uksM~l ds çHkkfor gksus ij ¼yxHkx  50%           gh total thyroidectomy djk nsuh pkfg,A      O;fä;ksa esa½ blds iw.kZr;% Bhd gksus ¼cure ½ dh                                                       lEHkkouk yxHkx lekIr gks tkrh gSA budk mipkj]           ;g mu nqyZHk dSaljksa esa ls gS ftles prophylactic   total  thyroidectomy]   neck  dissection  ,oa           ltZjh dh Hkwfedk gSA tsusfVd VsfLVax ikWftfVo vkus ij   external radiation }kjk fd;k tkrk gSA           bl Vîwej ds mRiUu gksus dh lEHkkouk 'kr çfr'kr   - Fkk;jkW;M QkWfydYl dh dksf'kdkvksa ls mRiUu u gksus           gksrh gSA ,sls yksxksa esa Vîwej ds y{k.k fn[kus ls igys gh   ds dkj.k ;g Vîwej] vk;ksMhu dks laxzfgr ugha djrsA           ;fn mudh Fkk;jkW;M xzafFk dks iwjk fudky fn;k tk,   blhfy,] budh Mk;Xuksfll ,oa mipkj ds fy, RAI           ¼total  thyroidectomy½  rks  MTC  ds  gksus  dh   dk ç;ksx ugha fd;k tk ldrkA           lEHkkouk ux.; gks tkrh gSA                 - Fkk;jkW;M gkWeksZUl dk fuekZ.k u djus ,oa TSH ds            MTC ds lkFk çkbejh gkbijiSjkFkk;jkW;fMTe  ¼PHPT½                                                    139","}kjk fu;af=r u gksus ds dkj.k TSH suppressive   - bUgha lymphoid cells ls large cell lymphoma            therapy Hkh buesa dk;Z ugha djrhA          fodflr gksrk gS tks ck;kWIlh esa anaplastic thyroid                                                       carcinoma dh Hkkafr gh yxrk gSA             Thyroid lymphoma                                                      - budk ,d fo'ks\"k xq.k gS fd ;g ltZjh ds i'pkr~ cgqr           ;g  vf/kdka'kr;%  Hashimoto's  thyroiditis  ls   rhozrk ls QSyrs gSaA           çHkkfor O;fä;ksa esa mRiUu gksrk gS ftlesa Fkk;jkW;M   - External  radiation  ,oa   dheksfFkjSih  gh  buds           xzafFk esa lymphocytic infiltration c<+ tkrk gSA                                                       loksZÙke mipkj gS tks vk'p;Ztud ifj.kke mRiUu           - ;g vf/kdka'kr;% nonhodgkin lymphoma  gksrs gSaA  dj ldrs gSA                                                                                                              140","20                                Thyroidectomy           Fkk;jkW;M  xzafFk  dks  fudkyus  dh  çfØ;k  dks   - Hemi-thyroidectomy - blesa Fkk;jkW;M xzafFk ds           thyroidectomy (Greek suffix -ectomy = act of   fdlh ,d yksc ,oa isthmus dks fudky fn;k tkrk           cutting out) dgrs gSaA                      gSA STN ,oa dqN çdkj ds lhfer dSalj esa bldk            TYPES OF THYROIDECTOMIES                    p;u fd;k tk ldrk gSA           ;g eq[;r% nks çdkj dh gks ldrh gSaA        - Lobectomy - blesa Fkk;jkW;M xzafFk ds fdlh ,d                                                       yksc dks fudky fn;k tkrk gSA Fkk;jkW;M xzafFk esa fdlh           1. Total thyroidectomy - vFkkZr lEiw.kZ Fkk;jkW;M            xzafFk dks fudky nsukA ;g çk;% Fkk;jkW;M dSalj ds   flLV ;k ukWMîwy ds gksus ij]  cystectomy ;k            gksus ;k bldk lansg gksus ij dh tkrh gSA blds   nodulectomy  ds  LFkku  ij  lobectomy  ;k            vfrfjä] xzsOl fMlht esa Hkh ;fn ATD ;k RAI   hemithyroidectomy dks ojh;rk nh tkrh gSA            fFkjSih ls ykHk u fey jgk gks rc Hkh bldh lykg nh   - Isthumectomy - vFkkZr isthmus dks fudkyukA            tk ldrh gSA                                ;g dksbZ fu.kkZ;d ykHk nsus okyh ¼definitive½ ltZjh           2. Partial thyroidectomy - vFkkZr Fkk;jkW;M xzafFk   u gksdj ,d çdkj dh vlk/; jksx esa rkRdkfyd            ds ,d Hkkx dks fudky nsukA ;g vusd çdkj dh gks   vkjke  nsus  okyh  ¼palliative½  ltZjh  gSA  bldh            ldrh gSA                                   vko';drk  eq[;r%  anapaestic  thyroid           - Near-total  thyroidectomy  (NTT)  -  blesa   carcinoma (ATC) esa iM+rh gS tc rhozrk ls c<+rk            tracheo-esophaegeal groove esa fLFkr Fkk;jkW;M   gqvk Vîwej] trachea ij ncko Mkyrk gqvk lkal ysus            xzafFk ds FkksM+s ls Hkkx dks NksM+dj vU; Hkkxksa dks fudky   esa  ck/kk  mRiUu  djus  yxrk  gSA  Isthmus  dks            fn;k tkrk gSA blls iSjkFkk;jkW;M xzafFk;ksa ds jä çokg   fudkydj blesa rkRdkfyd ykHk çkIr fd;k tk ldrk            dks Hkh cpk;s j[kus esa lQyrk fey tkrh gSA xzsOl   gSA            fMlht ds jksfx;ksa esa vf/kdka'kr;% blh dk p;u fd;k   buds vfrfjä] Fkk;jkW;M xzafFk ls fdlh ukWMîwy dks            tkrk gSA                                  fudkyuk nodulectomy  ,oa fdlh cyst dks fudkyuk           - Sub-total  thyroidectomy  (STT)  -  blesa   cystectomy dgykrk gSA            Fkk;jkW;M xzafFk ds nksuksa yksc ds yxHkx 4 xzke Hkkx   vkb;s bldh çfØ;k dks foLrkj ls le>rs gSaA            NksM+dj 'ks\"k xzafFk dks fudky fn;k tkrk gSA vf/kdk¡'k            euthyroid xkW;Vj ds O;fä;ksa esa eq[;r% blh ltZjh   INFORMED CONSENT            dk p;u fd;k tkrk gSA                      fdlh Hkh ltZjh ds iwoZ esa jksxh vFkok mlds lEcfU/k;ksa           - Hartely-Dunhill procedure - ;g STT dk gh   dks ltZjh ,oa mlds laHkkfor nq\"ifj.kkeksa dh foLr`r                                                      tkudkjh nsus ds i'pkr~ muls fyf[kr vuqefr ysuk            ,d fodYi gS ftlesa Fkk;jkW;M ds nksuksa yksCl esa 4-4            xzke Hkkx u NksM+dj ,d yksc dk gh 8 xzke Hkkx NksM+   vR;ar vko';d gksrk gSA o;Ld gksus ij jksxh Lo;a            fn;k tkrk gS ,oa nwljk iwjk yksc] isthmus ds lkFk   bldh vuqefr ns ldrk gS tcfd vo;Ld gksus ij            fudky fn;k tkrk gSA bldk fo'ks\"k ykHk ;g gS fd ;fn   mlds fof/klEer vfHkHkkod ds gLrk{kj vko';d gksrs            ck;kWIlh  dh  fjiksVZ  ds  i'pkr  TT  djus  dh   gSaA Thyroidectomy ds iwoZ Hkh blds nq\"ifj.kkeksa ds            vko';drk iM+rh gS rks bl cps gq, vk/ks yksc dks   fo\"k; esa igys ls gh foLrkj ls crk nsuk vfrvko';d            fudkyuk ljy gksrk gSA                     gksrk gS D;ksafd ckn esa ;gh jksxh ,oa muds ifjtuksa ds                                                      vlarks\"k dk çeq[k dkj.k cu tkrs gSaA buesa çeq[k gSa]                                                     141","Scar - tks lkeus ls fn[krk jgrk gS ,oa keloid cu   Incision - Fkk;jkW;M ltZjh ds fy, mfpr incision           tkus ij vkSj Hkh vf/kd cqjk yxrk gS]       dk p;u ltZjh ds çdkj ,oa xzafFk ds vkdkj ds vuqlkj            Recurrent laryngeal nerve damage - ftlls   fd;k tkrk gSA vf/kdk¡'kr;% ;g paækdkj (crescent           vkokt [kjkc gks tkrh gS tks gj le; ltZjh dh cqjk;h   shaped)  transverse  incision]  xnZu  ds  fLdu           dk dkj.k curh gS]                          QksYM~l dh fn'kk esa gh yxrk gS ftlls mldk scar] bu            Bleeding - tks ltZjh ds mijkUr gksus okyh rdyhQksa   fLdu QksYM~l ds tSlk gh yxs ,oa blesa fNi tk,A           ¼perioperative morbidity½ dks c<+k nsrh gS]   lkekU;r% bls subcutaneous tissue dh xgjkbZ rd]                                                      suprasternal notch ds 2.5-4.0 lseh Åij] cricoid           Hypocalcemia  -  tks  tetanic  spells  ds dkj.k   cartilage  ds  Lrj  ij]  sternocleidomastoid           d\"Vçn Hkh gksrk gS ,oa ftlds dkj.k yEcs le; rd   muscle ds lateral  borders rd yxk;k tkrk gSA           vFkok vkthou dSfY'k;e dh xksyh ysus dh vko';drk   fdlh efgyk ds cM+s ,oa Hkkjh Lru ¼pendulous           Hkh iM+rh gS] ,oa                          breasts½ gksus dh fLFkfr esa bls FkksM+k vkSj Åij yxkrs           Hypothyroidism - tks vkthou Fkk;jkWfDlu fFkjSih   gSa ftlls Ropk ds uhps f[kapus ls ;g f[kaprs gq,           dks vko';d cuk nsrk gSA                    sternum rd u vk tk, tgk¡ ;g vkSj Hkh vf/kd cqjk                                                      yx ldrk gSA           SURGICAL PROCEDURE           Choice  of  surgery  -  loZçFke] jksx ds foLr`r   Exposing  the  gland  -  Ropk  ds  uhps  fLFkr           vkdyu ds }kjk blds fy, vko';d ltZjh tSls TT]   platysma muscle esa incision] skin incision ds           NTT] STT bR;kfn dk p;u fd;k tkrk gSA       FkksM+k Åij yxk;k tkrk gSA blls  scar] iryk ,oa            Anaesthesia  -  lHkh çdkj dh Fkk;jkW;M ltZjh]   vPNk vkrk gSA           general  anaesthesia  with  endotracheal   Fkk;jkW;M xzafFk dks Hkyh Hkkafr ns[k ikus ds fy, Joll's           intubation and controlled respiration dh fLFkfr esa   thyroid  retractor  dh lgk;rk ls  subplatysmal           gh laiUu dh tkrh gSaA                      flaps  dks Åij Fkk;jkW;M dkfVZyst rd ,oa uhps           Position of the patient - jksxh dks lh/kk fyVkdj   suprasternal notch rd mBkdj jksd ysrs gSaA           vkWijs'ku Vscy ds Åijh fljs (head end) dks 15   blds i'pkr] deep fascia dks nksuksa sternothyroid           fMxzh Åapk dj fn;k tkrk gSA blesa dU/kksa ds uhps ,d   muscles ds chp esa vertical incision ds }kjk [kksyrs           rfd;k (sand bag) o flj ds uhps ,d fjax Hkh yxk nh   gSaA           tkrh gS (erect with neck extended)  ftlls xnZu           dk vxyk Hkkx lkeus mfpr çdkj ls fn[kus yxs ,oa   ekalisf'k;ksa ds fofHkUu Lrjksa ds e/; dissect djrs gq,           ltZjh ds nkSjku cerebral congetion u gksA  sternohyoid dks fdukjs dh vksj ¼laterally½ gVkrs                                                      gq, Fkk;jkW;M xzafFk dks [kksy nsrs ¼expose djrs½ gSaA           Surgical part preparation - Mandible ls ysdj           Nkrh rd fMVtsaZV lkWY;w'ku ls jxM+dj (scrub) mls   Fkk;jkW;M xzafFk dks Hkyh Hkkafr u ns[k ikus dh fLFkfr esa                                                      strap  muscles dks dkVus dh vko';drk Hkh iM+            fLçV ls iqu% lkQ dj ysrs gSa (cleaning) A blds   ldrh gSA           i'pkr~ ml ij 10% povidone iodine dk ysi dj           nsrs gSa (painting) A bl çdkj iw.kZ:i ls ,UVhlsfIll   Cutting and ligating the middle thyroid vein                                                      (MTV) - loZçFke middle thyroid vein dks igpku           gkfly djus ds i'pkr~ Fkk;jkW;M ds FkksM+s ls Hkkx dks   dj] xzafFk ls vyx djrs gq,] 4'0' silk suture ls cka/k           NksM+dj 'ks\"k Hkkx dks LoPN (sterile) diM+ksa ls <¡d nsrs   dj dkV nsrs gSaA /;ku jgs] dHkh\&dHkh ;g osu ,d ds           gSa (draping) A                                                      LFkku ij nks ;k rhu Hkh gks ldrh gSa ;k dHkh\&dHkh                                                     142","vuqifLFkfr Hkh gks ldrh gSA                vein (ITV) -  ITA dks dkVus ds i'pkr~ xzafFk ds fupys            Cutting  and  ligating  the  superior  thyroid   Nksj ij ITV dks Hkh dkVdj ck¡/k fn;k tkrk gSA ;g Hkh           artery (STA) - loZçFke] larynx ds lehi xzafFk ds   çk;% nks ;k rhu gks ldrh gSaA blds i'pkr~ xzafFk dks            Åijh fljs ¼upper  pole½ ij  superior  vascular   mobilize djds uhps ys vkrs gSaA           pedicle dks [kkstrs gSa ,oa Fkk;jkW;M xzafFk esa ços'k djus   Lobectomy  vs  total  thyroidectomy  -  ;fn           okyh bldh çR;sd czkap dks lko/kkuh iwoZd] 3'0' ;k   dsoy ,d yksc dks gh fudkyuk gS rc isthmus dks nks           4'0'  silk  suture ls ck¡/kdj dkVrs tkrs gSa vFkok   clamps ds chp idM+dj] nksuksa vksj ls dldj ck¡/kus           dkVdj blds nksuksa fljksa dks diathermy ds }kjk lhy   ds  ckn  bls  chp  esa  ls  dkV  nsrs  gSaA  Total           djrs tkrs gSaA ;gk¡ ij superior laryngeal nerve ,oa   thyroidectomy ds fy,] mijksä çfØ;k dks nwljh           superior parathyroid gland dks tkus okyh artery   vksj  Hkh  nksgjkrs  gSaA  STT  ,oa  NTT  esa  xzafFk  ds           dk fo'ks\"k /;ku j[kuk gksrk gSA            iwoZfu/kkZfjr Hkkx ¼4 ;k 8 xzke½ dks NksM+ nsrs gSaA            Cutting  and  ligating  the  inferior  thyroid   Reimplantation of the parathyroid glands -           artery (ITA) - Facial plane ds lgkjs dissect djrs   iSjkFkk;jkW;M xzafFk;ksa dh ,d fo'ks\"krk ;g gS fd jä dh           gq, vc Fkk;jkW;M xzafFk ds fupys fljs ¼inferior pole½   lIykbZ ds dV tkus ds ckn Hkh vius NksVs vkdkj ds           rd vkrs gSaA ;gk¡ Hkh Åijh fljs dh Hkkafr inferior   dkj.k ;g lehiorhZ tissues ls diffusion }kjk çkIr           thyroid artery ,oa bldh çR;sd czkap dks 3'0' ;k 4'0'   gq, iks\"k.k ,oa vkWDlhtu ij thfor jg ldrh gSaA           silk  suture  ls  dkVdj  cka/krs  tkrs  gSa  vFkok   blhfy,] total thyroidectomy esa vFkok budks lIykbZ           diathermy ds }kjk lhy djrs tkrs gSaA blds fy,   djus okyh  vessel ds {kfrxzLr gks tkus ij bUgsa           cautery dk ç;ksx ;k rks ugha djuk pkfg, vFkok   sternocleidomastoid muscle dh belly esa ,d dV           dsoy bipolar lead dk gh ç;ksx djuk pkfg,A ;gk¡   yxkdj mlds vanj j[k fn;k tkrk gSA ,slk djus ij           fupyh ¼inferior½ iSjkFkk;jkW;M xzafFk;ksa dh jä dh   vf/kdk¡'k iSjkFkk;jkW;M xzafFk;k¡ dqN le; esa iwoZor dk;Z           lIykbZ dks cpkus ds fy, ;g vko';d gS fd bu   djuk vkjEHk dj nsrh gSaA           arterial  branches dks Fkk;jkW;M xzafFk ds lehi ls           dkVk tk,A                                  Reassuring hemostasis - ltZjh ds i'pkr~ tks                                                      dk;Z  vR;ar  egRoiw.kZ  gS  og  gS]  ltZjh  ds  LFkku           Protecting  the  recurrent  laryngeal  nerve   ¼surgical bed½ dk Hkyh\&Hkkafr fujh{k.k] fd dgha dksbZ           (RLN) - Fkk;jkW;M xzafFk dks Åijh ,oa fupys fljksa ls           eqä  djus  ds  i'pkr~  lokZf/kd  egRoiw.kZ  dk;Z  gS   bleeder NwV rks ugha x;k\\ ;g lqfuf'pr djus ds           recurrent laryngeal nerve dks igpkuuk ,oa mls   i'pkr] ml LFkku dks normal saline ls /kksdj lkQ            cpkukA Fkk;jkW;M xzafFk dks lateral aspect ls dissect   dj fy;k tkrk gSA fQj da/ks ds uhps j[kk rfd;k gVk           out djrs gq, mls medially rotate dj ysrs gSa ftlls   dj nksckjk lqfuf'pr dj ysrs gSa fd dgha ls jälzko rks           tracheo-esophageal grrove esa bl uoZ dks igpkuk   ugha gks jgk\\           tk ldsA /;ku jgs] ;g uoZ] cricothyroid joint ds   Closure  -  loZçFke]  deep  fascia  dks  midline           lehi ls ySafjDl esa ços'k djrh gSA ;gh og LFkku gS   vertically  interrupted  sutures ls can djrs gSaA           tgk¡ bl uoZ ds {kfrxzLr gksus dh lokZf/kd lEHkkouk   blds iwoZ] 14 Tr vaccum drain dk ,d Nksj deep           jgrh gSA RLN dks cpkrs gq, bl LFkku dh CyM oslsYl   fascia ds uhps ,oa nwljk blds Åij NksM+ nsrs gSaA           dks cka/kdj Fkk;jkW;M yksc dks vc iw.kZr;% eqä fd;k   blds ckn] strap muscles dks nksckjk ,d nwljs ds           tk ldrk gSA                                lehi ykdj interrupted sutures ls can dj nsrs gSaA            Cutting  and  ligating  the  inferior  thyroid   /;ku jgs] ;g LFkku trachea ds Bhd lkeus fLFkr gSA                                                     143","bldks cgqr dldj ck¡/kus ;k continuous sutures ls   ds }kjk budh lEHkkouk dks ?kVkus esa vkSj Hkh lgk;rk           can djus ij vFkok ckn esa ;gk¡ adhessions cuus ij   fey ldrh gSA           ;g tracheal compression mRiUu dj ldrs gSaA                                                      RLN palsy - ltZjh ds nkSjku dsoy tissue handling           blds ckn platysma dks continuous sutures ls can   ¼f[kapko] ncko bR;kfn½ ek= ls gh fdlh Hkh uoZ esa           djrs gSaA                                  neuropraxia ¼transient conduction block½ mRiUu                                                      gks ldrk gSA buesa ls vf/kdk¡'k le; ds lkFk Bhd gks           var esa Ropk dks 4'0' nylon suture ls subcuticular           stich ds ek/;e ls can dj ?kko dh Mªsflax dj nh tkrh   tkrh gSa ijUrq] vR;f/kd f[kapko ;k dV tkus ls ;g           gSA                                        deh LFkk;h Hkh gks ldrh gSA ltZjh ds nkSjku RLN esa                                                      vk;h {kfr dks igpkuus ds fy, ltZjh ds ,d ekg ckn           Postoperative care - ltZjh ds i'pkR] gesa eq[;r%   laryngoscopy djds vocal cord ds pyus dh {kerk           mu y{k.kksa ij /;ku dsafær djuk pkfg, tks fdlh   dks ij[krs gSaA ltZjh ds mijkUr rkRdkfyd :i ls ;g           ltZjh  ds  lkFk  fo'ks\"k  :i  ls  tqM+s  gksrs  gSaA   4\&10% O;fä;ksa esa çHkkfor gks ldrh gS tks Lor% gh           Thyroidectomy ds i'pkr~ ftu fcanqvksa ij gusa /;ku   de gksrs gq, 3 ekg esa yxHkx 0-5% O;fä;ksa esa lnk ds           dsafær djuk pkfg, og gSa ltZjh ds LFkku ij nksckjk   fy, çHkkfor jg tkrh gSA ltZjh ds vxys fnu rks           vkjEHk gqbZ CyhfMax] jksxh dh vkokt esa vFkok lkal ysus                                                      bldh lEHkkouk vkSj Hkh vf/kd jgrh gSA vusd           esa vk;k dksbZ ifjorZuA blds fy,] endotracheal   vk/kqfud  fof/k;ksa  ¼tSls  continuous  vFkok           tube fudyus ds ckn] vocal  cords ds pyus dks           lqfuf'pr dj ysuk pkfg,A                    intermittent  nerve  monitoring½  ds  }kjk  RLN                                                      functions dks ltZjh ds le; Hkh tkuk tk ldrk gSA           POSTOPERATIVE COMPLICATIONS                                                      buesa uoZ dks mÙksftr djds mldk çHkko vocal cords           1.  ACUTE COMPLICATIONS                    ij j[ks bysDVªksM dh lgk;rk ls ukik tk ldrk gSA           Hemorrhage - Thyroidectomy ds 1% O;fä;ksa esa   RLN dks {kfr igq¡pus dh fLFkfr esa uoZ ds nksuksa fljs           ltZjh ds 24 ?kaVksa ds vanj gh ltZjh ds LFkku ij   ijLij fly nsrs gSaA blls le; ds lkFk uoZ ds vusd           jälzko  ds  dkj.k  hematoma  cu  ldrk  gSA   dk;Z nksckjk okil vkus yxrs gSaA Speech therapy           Hematoma ds ncko ls ;g jä lapkj esa ck/kk Mkyrk   blesa fo'ks\"k:i ls çHkkoh gksrh gSA           gS ftlds dkj.k venous  pressure ls laryngeal                                                      RLN ds vfrfjä] superior laryngeal nerve dh           edema mRiUu gks ldrk gSA bl çdkj] ;g acute           respiratory obstruction mRiUu djds çk.k?kkrd Hkh   external branch Hkh superior thyroid artery ds           gks ldrk gSA ;kn djsa] ltZjh ds i'pkr] ?kko dks can   lehi gksus ds dkj.k] 0.25-25% O;fä;ksa esa {kfrxzLr                                                      gks  ldrh  gSA  blls  vkokt  dh  loudness  ,oa           djrs le; strap muscles dks interrupted sutures           ls can djus dh lykg D;ksa nh x;h Fkh\\ ;g blfy, Hkh   frequency çHkkfor gks ldrh gSA                                                          Hypocalcemia  and  hypoparathyroidism           fd ;fn strap muscles ds uhps dksbZ hematoma cu   Hypocalcemia  and  hypoparathyroidism  -  -           gh jgk gks rc og buds uhps fNik gh u jg tk, ,oa   iSjkFkk;jkW;M xzafFk dh vfu;ferrkvksa dk eq[; dkj.k]           Vkadksa ds chp ls Åij mHkj vk;s ,oa igpkuk tk ldsA   ltZjh ds nkSjku bldks lIykbZ djus okyh end artery           jälzko dh lEHkkouk çrhr gksrs gh Ropk ds Vkadksa   dk dV tkukA blds vfrfjä] dHkh\&dHkh ;g Fkk;jkW;M           ¼sutures½ dks [kksy nsrs gSa ftlls fupys vaxksa esa ncko   xzafFk ds lkFk fcuk igpku esa vk;s gq, fudy Hkh tkrh           iM+us ls jksdk tk ldsA blds ckn] ?kko dk iqufuZjh{k.k   gSA iSjkFkk;jkW;M gkWeksZu dh deh ls asymptomatic           djds  bleeders  dks  <wa<dj  ck¡/k  fn;k  tkrk  gSA   hypocalcemia vFkok hypocalcemia with tetany           Ultrasonic  shears,  enhanced  bipolar     dh lEHkkouk c<+ tkrh gSA ;g vf/kdrj ltZjh ds           diathermy ,oa harmonic vessel sealing devices   vxys  2-5  fnuksa  esa  mRiUu  gks  ldrs  gSaA  Total                                                    144","thyroidectomy ,oa central neck dissection ds   tkrk gS] bls hypertrophic scar  dgrs gSaA tc ;g            lkFk ;g lEHkkouk lokZf/kd gksrh gS tcfd dsoy total   c<+rs  gq,  viuh  lhekvksa  ls  Hkh  ckgj  fudydj           thyroidectomy ds lkFk mlls deA Lobectomy ds   normal  skin ij QSyus yxrk gS] rc ;g keloid           ckn  nwljh vksj dh iSjkFkk;jkW;M xzafFk;ksa ds lqjf{kr   dgykrk gSA ;g fo'ks\"k :i ls dark skin okys O;fä;ksa           jgus ds dkj.k ;g lEHkkouk ux.; gh gksrh gSA   esa  ,oa  sternum  ij  fLFkr  scars  esa  curk  gSA           Parathyroid artery ds dV tkus ij ;k vupkgs :i   Revision surgery ls ;g Bhd Hkh gks ldrk gS ,oa           ls xzafFk ds fudy tkus ij bls sternocleidomastoid   dqN yksxksa esa nwljk scar vkSj Hkh vf/kd cM+k gksdj           muscle esa nksckjk LFkkfir ¼reimplant½ dj fn;k   igys ls Hkh [kjkc gks ldrk gSA dqN O;fä;ksa esa           tkrk gSA ,sls O;fä;ksa esa] transiet hypocalcemia   intradermal corticosteroid injections bldks nck           jgus ds i'pkr~ jä esa dSfY'k;e ds Lrj Øe'k% lkekU;   ikus esa lQy gks tkrs gSaA           gksrs tkrs gSaA                                                      Stich  granuloma  -  ;g  fo'ks\"k  :i  ls  non-           2. LONG TERM COMPLICATIONS                 absorbable silk suture material ls cu ldrk gSA           Hypothyroidism  - ltZjh esa Fkk;jkW;M xzafFk dk   Thyrotoxic crisis or storm - bldk foLr`r o.kZu           ftruk Hkkx fudkyk x;k gS mlds vuqlkj] ckn esa   vU;= fd;k tk pqdk gSA           Fkk;jkW;M gkWeksZu dh deh mRiUu gksrh tkrh gSA bldh           lEHkkouk ,d lIrkg esa gh vkjEHk gksdj 6 lIrkg esa   Infection                                                      POSTOPERATIVE CARE           vf/kdre gks tkrh gSA blh lEHkkouk dks de djus ds   Thyroidectomy  ds  lkFk  tqMh  mijksä  fof'k\"V           fy, iwoZ esa ;g lykg nh tkrh Fkh fd dSalj u gksus ij           TT ds LFkku ij STT dh tk, ftlls xzafFk dh NksM+h x;h   leL;kvksa ds dkj.k dqN fo'ks\"k ns[kHkky dh vko';drk           ek=k] vko';d ek=k esa Fkk;jkW;M gkWeksZu cukdj 'kjhj   gksrh gSA           dk dke pyk ysA ijUrq xzafFk dh fdruh ek=k ls fdruk   Inspection of surgical site - D;ksafd bl LFkku ij           dke fudy ik;sxk ;g vuqeku yxkuk Hkh cgqr dfBu   cuk hematoma vius ncko ds dkj.k xaHkhj :i           gS ,oa lkFk gh bEE;wu fodkjksa ls ;qä xzafFk dk ;g NksM+k   /kkj.k dj ldrk gSA           x;k Hkkx Hkh le; ds lkFk\&lkFk {kfrxzLr gksdj fuf\"Ø;   Laryngoscopy - blds ek/;e ls vocal cord dk           gksrk tkrk gSA blhfy, vc vf/kdk¡'k O;fä;ksa esa STT   pyuk lqfuf'pr djrs gSa fd dgha RLN dks dksbZ {kfr           ds LFkku ij TT dks gh çkFkfedrk nh tkrh gSA TT esa   rks ugha igqaphA           ltZjh ds ckn ls gh Fkk;jkWfDlu fFkjSih vkjEHk dj yh   Serum calcium estimation - ;g tkuus ds fy,           tkrh gSA blds i'pkr] çkjEHk esa 6-8 lIrkg esa ,oa   fd dgha iSjkFkk;jkW;M xzafFk;ksa ds fudy tkus ;k bldks           lkekU; gksus ds ckn 3-6 eghuksa esa lhje TSH dh tkap   gqbZ {kfr ls dSfY'k;e dk Lrj ?kV rks ugha jgk ftlds           ds vuqlkj bldh Mkst dks ?kVk;k vFkok c<+k;k tk   fy, dSfY'k;e nsus dh vko';drk gksA           ldrk gSA                                                      Thyroid function fests - ;g tkuus ds fy, fd           Hypertrophic scar or keloid - vKkr dkj.kksa ls   xzafFk ds dqN Hkkx ds fudkys tkus ds i'pkr~ 'ks\"k xzafFk ls           dqN O;fä;ksa esa] surgical scar tissue dh vfu;af=r   fdruk Fkk;jkW;M gkWeksZu mRiUu gks ik jgk gS ftlesa           :i ls hypertrophy gksrh tkrh gS ftlls ;g vkdkj   vk;h deh ls gkbiksFkk;jkW;fMTe gksus dh n'kk esa           esa vR;f/kd cM+k ,oa mHkjk gqvk gks ldrk gSA tc rd   Fkk;jkWfDlu fFkjSih vkjEHk djus dh vko';drk gksA           ;g scar tissue vius LFkku ij gh jgrs gq, c<+rk                                                         145","[kaM\&6                                                           Fkk;jkW;M xzafFk ds vU; fodkj                          (Other Disorders of The Thyroid Gland)","21                                                                          Thyroiditis           Fkk;jkW;M xzafFk esa gksus okys bUQsD'ku vFkok bU¶yses'ku   - Tender goiter -   Fkk;jkW;M xazfFk vkdkj esa cM+h]           dks Fkk;jkW;MkbfVl dgrs gSaA ;g vusd çdkj dh gks   tender  ,oa vfu;fer (assymetrical) gks ldrh gSA           ldrh gSA                                    blds Åij dh Ropk esa ykfyek (erythema) gks                                                       ldrh gSA             ACUTE THYROIDITIS                                                      - Dysphagia -  Fkk;jkW;M xzafFk esa ihM+k gksus ds dkj.k           Fkk;jkW;M xzafFk esa gksus okys suppurative infection                                                       Hkkstu fuxyus eas Hkh ihM+k gks ldrh gSA           ¼ftuesa  pus  dk  fuekZ.k  gksrk  gks½  vFkok  acute                                                      - Tender  lymphadenopathy  -  bUQsD'ku  ds           inflammation ls gksus okyh Fkk;jkW;MkbfVl] acute           thyroiditis dgykrh gSA                      draining lymph nodes rd igq¡pus ls mlesa Hkh                                                       ihM+k vkjEHk gks ldrh gSA           ETIOLOGY           ;g eq[;r% rhu dkj.kksa ls gks ldrh gS %\&   DIFFERENTIAL DIAGNOSIS           - B a c t e r i a l   i n f e c t i o n s   -   e q [ ; r %   Acute thyroditis  dks eq[;r% tender thyromegaly            staphylococcus ,oa streptococcus ls]      ds vU; dkj.kksa ls vyx djuk gksrk gSA buesa ls izeq[k           -  Fungal  infections  -  eq[;r% aspergillus ,oa   gSa\&            candida ls] ,oa                           -  Subacute thyroditis - uke ds vuq:i gh blesa            -  Radioactive  iodine  -  RAI  fFkjSih  ds  ckn   y{k.k dqN fnuksa ls u gksdj dqN lIrkg ls gksaxsaA             jsfM,'ku ls gksus okyh {kfr ls Hkh Fkk;jkW;M xzafFk esa   -  Hemorrhage into thyroid nodule or cyst -             bU¶yses”ku mRié gks ldrk gSA               blesa Fkk;jkW;M xzafFk dk vkdkj igys ls gh c<+k gksxk                                                       ftlesa jDrlzko ds dkj.k ,dk,d ihM+k vkjEHk gks           PREDISPOSING FACTORS           vf/kdka'kr;%  lkekU;  Fkk;jkW;M  xzafFk]  cSDVhfj;y   ldrh gSA            bUQsD'ku  }kjk  izHkkfor  ugha  gksrh  ijUrq  xazfFk  dh   -  Thyroid  malignancy  -  vf/kdka'kr;%  blesa           lajpuk esa fdlh izdkj dh fod`fr (abnormality) gksus   Fkk;jkW;M xazfFk dk vkdkj vis{kkd`r vf/kd rhozrk ls           ij blesa bUQsD'ku dh laHkkouk c<+ tkrh gSA tSls\&  c<+rk gS ftlls ihM+k vkjEHk gks tkrh gSA                                                      INVESTIGATIONS           -  fdlh f'k'kq vFkok cPps esa 4th pharyngeal pouch     Features  of  infection  and  inflammation  -            ds 'ks\"k cps Hkkx (remnant piriform sinus)  esa   fdlh acute infection  dh Hkkafr white blood cells           -  fdlh o;Ld esa yacs le; ls xkW;Vj vFkok Fkk;jkW;M   c<+ ldrh gS (leucocytosis) dqN O;fDr;ksa esa ESR            dSalj ds degenerative foci  esa           Hkh c<+k gks ldrk gS           CLINICAL FEATURES                              Thyroid function tests -   oSls rks fdlh acute           fdlh Hkh vU; acute inflammatory disorder  dh   inflammation  dk ,d y{k.k 'loss of function'  Hkh           Hkkafr blds eq[; y{k.k Hkh ihM+k] cq[kkj ,oa lwtu gh   gksrk gS ijUrq ;gk¡ Fkk;jkW;M gkWeksZUl vf/kdrj lkekU;           gksrs gSaA                                 gh jgrs gSaA ,slk blfy, D;ksafd xazfFk esa lax`fgr           - Pain -  Fkk;jkW;M xazfFk ls vkjEHk gksdj xys vFkok   Fkk;jkW;M gkWeksZUl yxHkx 1.5 ekg dk dke pykus ds            dku rd QSy ldrk gSA                       fy, i;kZIr gksrs gSaA blhfy, gky esa gh gq, bUQsD'ku ls           - Fever -  gYdk vFkok e/;e gks ldrk gSA    ;g vf/kd izHkkfor ugha gks ikrsA                                                     147","FNAC  -  Thyroid  parenchyma  esa  polymorph-   feyrs gSA ftuesa multinucleate giant cells Hkh fey           onuclear leucocytic infiltration bldk izeq[k y{k.k   ldrh gSaA dqN le; i'pkr~ ;g granuloma  dk :i           gksrk gSA blds vfrfjDr] fdlh  purulent  foci  ls   Hkh ys ldrs gSa ftlds dkj.k bUgsa granulomatous           purulent aspirate Hkh izkIr gks ldrk gSA   thyroiditis   Hkh dgrs gSaA yEcs le; ds ckn buesa                Pus  culture  and  sensitivity  -  blds  }kjk   Qkbczksfll Hkh gks ldrh gSA           causative organism  dh iqf\"V dh tk ldrh gS ,oa   Phase  of  destructive  thyrotoxicosis  -           mlds fy, izHkkoh ,aVhck;ksfVd dk p;u fd;k tk   Fkk;jkW;M xazfFk eas chp\&chp eas QSys ;g infiltrates,           ldrk gSA ijUrq dYpj ,oa lsaflfVfoVh dh fjiksVZ feyus   Fkk;jkW;M QkWfydYl dks {kfr igq¡pkrs gSa ftlls muesa           rd vuqeku ds vk/kkj ij (emperical) ,aVhck;ksfVDl   laxzfgr Fkk;jksXykWC;qfyu ,oa Fkk;jkW;M gkWeksZUl] jDr esa           vo'; vkjEHk dj ysuh pkfg;saA               yhd gks tkrs gSaA blls jDr esa T3 ,oa T4 c<+ tkrs gSa                                                      ,oa buds fuxsfVo QhMcSd ls lhje TSH ?kV tkrk gSA           MANAGEMENT                                 jDr esa T3 ,oa T4 ds c<+us ls dHkh\&dHkh VkWfDld               Symptomatic management -  nnZ ,oa cq[kkj ds                                                      y{k.k Hkh mRié gksus yxrs gSaA Fkk;jkW;M QkWfydYl esa           fy, antipyretics  ,oa analgesics                                                      gqbZ  {kfr  ds  QyLo:i  vR;f/kd  ek=k  esa  fudys               Definitive  treatment  -  Pus    dh  dYpj  ,oa   Fkk;jkW;M  gkWeksZUl  ls  mRié  gqbZ  bl  fLFkfr  dks           lsaflfVfoVh ds vk/kkj ij mi; qDr ,aVhck;ksfVd  destructive thyrotoxicosis dgrs gSaA                Surgical intervention - Abscess cuus dh n'kk   Phase  of  hypothyroidism  -  tgk¡  ,d  vksj           esa incision ,oa drainage                  Fkk;jkW;M xazfFk esa laxzfgr Fkk;jkW;M gkWeksZUl ds yhd gks           COMPLICATIONS                              tkus ls xzafFk esa gkWeksZUl dk Hk.Mkj lekIr gks tkrk gS           'kjhj ds fdlh Hkh Hkkx esa lhfer bUQsD'ku vfu;af=r   ogha nwljh vksj QkWfydYl dks gqbZ inflammatory           gksdj vkl\&ikl ds {ks=ksa esa vFkok lEiw.kZ 'kjhj esa QSy   insult ds dkj.k muesa gkWeksZUl ds mRiknu dh izfØ;k           ldrk gSA Acute thyroiditis  esa gksus okys bUQsD'ku ds   /kheh iM+ tkrh gS vFkok :d tkrh gSA blls vkjEHk esa           QSyus ls Hkh trachitis, retropharyngeal abscess,   yhd gq;s gkWeksZUl ds Øe”k% lekIr gks tkus ds i”pkr~           jugular venous thrombosis, mediastinitis   ,oa   Fkk;jkW;M gkWeksZUl dh deh gksus yx tkrh gSA /;ku jgs]           septicemia  mRié gks ldrs gSaA                                                      T4   dh gkQ ykbQ yxHkx 8   fnu gksrh gS ftlds             SUBACUTE THYROIDITIS                     vuqlkj bldk izHkko lekIr gksus esa yxHkx 40  fnuksa           bls granulomatous, viral   vFkok de Quervain's   le; yxrk gSA           thyroiditis   Hkh dgrs gSaA  Postpartum thyroiditis           Hkh blh dk ,d izk:i gS ftlesa ihM+k u gksus ds dkj.k   Phase  of  recovery  -  le;  ds  lkFk\&lkFk            bls painless   vFkok silent thyroiditis   Hkh dgk tkrk   inflammatory process  ds ?kVus ls Fkk;jkW;M xazfFk]           gSA vius uke ds vuq:i ;g Øe'k% vkjEHk gksrs gq,   mijksDr {kfr ls Øe”k% mcjus dk iz;kl djrh gSA           /khjs\&/khjs c<+us okyk (gradual  onset  and  slowly   blls gkWeksZUl ds mRiknu ds iqu% vkjEHk gksus ls           progressive)  jksx gSA vU; Fkk;jkW;M lEcaf/kr jksxksa   Fkk;jkW;M gkWeksZUl ds Lrj iqu% lkekU; gksus yxrs gSaA           dh Hkkafr ;g Hkh iq:\"kksa dh vis{kk efgykvksa ¼eq[;r%   CLINICAL MANIFESTATIONS           30-50 o\"kZ dh mez½ esa 3-4 xquk vf/kd la[;k esa ik;k           tkrk gSA                                   Local features - SAT   ls izHkkfor vf/kdk¡”k jksxh                                                      xys ds vxys Hkkx esa nnZ ,oa lwtu ds fy, fn[kkus vkrs           PATHOPHYSIOLOGY                                                      gSa ftlesa Fkk;jkW;M ls vkjEHk gksrk gqvk nnZ] tcM+s ,oa           vf/kdk¡'k ok;jy ,oa V~;wcjD;qyj bUQsD'kUl dh Hkkafr                                                      dku rd tk ldrk gSA dHkh dHkh blds lkFk gYdk           SAT esa Hkh Fkk;jkW;M xzafFk es inflammatory infiltrate                                                    148","cq[kkj Hkh gks ldrk gSA vf/kdka”kr;% ;g y{k.k fdlh  vf/kd  ek=k  esa  fuekZ.k  gksus  ls  ughaA  blhfy,]           upper respiratory infection (URI)  ds ckn vkjEHk  jsfM;ksU;wDykbM LdSu esa Fkk;jkW;M xazfFk dk jsfM;ks,fDVo            gksrs gSa] vkjEHk esa gyds gksrs gSa ,oa Øe”k% dbZ fnuksa rd  vk;ksMhu viVsd  (RAIU)  vFkok  Tc99m  viVsd]           c<+rs tkrs gSaA dHkh dHkh ;g acute thyroditis   dh  lkekU; ls de (<5%)  gh gksrk gSA           Hkkafr gh ,dk,d vkjEHk gksrs gSa ,oa buds iwoZ ds fdlh   Raised ESR  ,oa  low RAIU gh  SAT  ds fof”k’V             URI   dh tkudkjh] gyds gksus ds dkj.k ;kn ugha                                                      y{k.k  (pathognomonic  features)   ekus tkrs gSaA           vkrhA ijh{k.k (palpation)  ds }kjk tender goiter    vU; tkapksa ls SAT   dh Mk;Xuksfll ,oa vU; jksxksa ls           dh iqf’V dh tk ldrh gSA Acute thyroiditis dh Hkkafr                                                      foHksn djus (differential diagnosis)   esa fo”ks’k enn           erythema,  severe  tenderness   vFkok tender   ugha feyrhA fQj Hkh jksx dks le>us dh n`f’V ls budk           lymphadenopathy  buesa ugha feyrsA         o.kZu djuk mfpr gksxkA           Systemic features - SAT dh fofHké voLFkkvksa ds   Thyroid function test - SAT  ds fofHké pj.kksa ds           vuq:i izkjEHk esa gh fn[kkus vk;s O;fDr;ksa esa ?kcjkgV]   vuq:i] izkjEHk esa buesa Fkk;jksVkWfDld y{k.k (raised           gM+cM+h] /kM+du] dEiu ,oa vR;f/kd xehZ yxus tSls   T3, T4   ,oa suppressed TSH)   feyrs gaS] blds           Fkk;jksVkWfDldksfll ds y{k.k fey ldrs gSa tcfd dqN   i”pkr gkbiksFkk;jkW;MfMTe ds y{k.k (low T3, T4  ,oa           fnuksa ds ckn vk;s O;fDr;ksa esa Fkdku] lqLrh] dCt]   elevated  TSH)    feyrs  gaS  tks  varr%  lkekU;           “kjhj esa vdM+u ,oa nnZ] vR;f/kd B.M yxus bR;kfn   (euthyroid)   tkapksa (normal T3, T4   ,oa normal           gkbiksFkk;jkW;fMTe ds y{k.k fey ldrs gSaA                                                      TSH)  esa ifjofrZr gks tkrs gaSA           NATURAL HISTORY OF DISEASE                                                      Anthithyroid  antibodies  -  ;wa  rks  fdlh  Hkh           ok;jy ,oa V~;wcjD;qyj bUQsUD”kUl ds Bhd gksus vFkok   Fkk;jkW;MkbfVl dh Hkkafr SAT  eas Hkh ,aVhFkk;jkW;M           izlo ds i”pkr le; chrrs tkus ls mijksDr y{k.kksa eas   ,aVhckWMht fey ldrh gSa ijUrq ;gk¡ budh lEHkkouk           Øe”k% deh vkrh tkrh gS ,oa vf/kdk¡”k ¼yxHkx 85%½   vis{kkd`r  de  gksrh  gSA  blds  vU;  izk:iksa]  tSls           O;fDr 1-2 ekg esa iw.kZ:i ls LoLFk gks tkrs gSaA vkjEHk   postpartum  thyrodiitis    ,oa  Hashimoto’s           esa gh Fkk;jkW;M xzzafFk dks dkQh {kfr igq¡p pqdh gksus dh   thyroiditis  esa budh lEHkkouk ,oa ek=k vf/kd gkssrh           fLFkfr esa yxHkx 15% O;fDr blls iw.kZ:i ls mcj ugha   gSA           ikrs ftlls os lnk ds fy, gkbiksFkk;jkW;M gh jg tkrs           gSaA dHkh dHkh ;g Fkk;jkW;MbkfVl vusd eghuksa rd   FNAC - SAT   ds vf/kdk¡”k jksfx;ksa esa FNAC   dh           cuh jgrh gS ,oa blesa VkWfDld ,oa gkbiksFkk;jkW;M   vko”;drk ugha iM+rh ijUrq dHkh dHkh jDrlzko vFkok           voLFkkvksa ds vusd mrkj\&p<+ko vkrs jgrs gSaA  dSalj dh lEHkkouk dks nwj djus ds fy, bls fd;k tk                                                      ldrk gSA blesa vkjEHk esa inflammatory infiltration           DIAGNOSIS                                                      ,oa multinucleate giant cells,   dqN fnuksa i”pkr           ESR and blood counts - ESR   dk c<+k gksuk   xzSU;qyksek dk fuekZ.k ,oa yEcs le; ds ckn Qkbczksfll           budk fof”k’V y{k.k gSA lkFk gh WBC counts  dqN   fey ldrh gSA           c<+s gks ldrs gSaA                                                      MANAGEMENT           Radionuclide Scan - /;ku jgs] Fkk;jkW;MkbfVl dh   Symptomatic  management  -   nnZ ,oa gyds           lHkh voLFkkvksa esa Fkk;jkW;M QkWfydYl dh dk;Z{kerk   cq[kkj  ds  fy,  antipyretics     ,oa  analgesics           ?kV tkrh gSA bldh VkWfDld voLFkk eas Hkh jDr esa   (aspirin  600   fexzk fnu esa rhu ckj vFkok vU;           Fkk;jkW;M gkWeksZUl ds Lrj okLro esa bu gkWeksZUl ds   NSAIDs)  dk mi;ksx fd;k tk ldrk gSA           QkWfydYl ls yhd gks tkus ds dkj.k ls c<+rs gSa] muds                                                     149","y{k.kksa ds xaHkhj gksus dh fLFkfr esa dqN le; ds fy,  gSA            LVsjkW;M fFkjSih (prednisolone 15-40  fexzk izfrfnu)      PAINLESS OR SILENT THYRODIITIS           dk Hkh iz;ksx fd;k tk ldrk gS ftls 6-8   lIrkg esa   vkWVks\&bEE;wu  Fkk;jkW;M  fodkjksa  (autoimmune           Øe”k% ?kVkrs gq, can dj nsrs gaSA /;ku jgs] LVsjkW;M dh   thyroid  disorders)    esa  gksus  okyh  immune           enn dsoy y{k.kksa dks ?kVkus ds fy, yh tk ldrh gS]   mediated  thyroditis    cgq/kk  painless    gksrh gS           jksx dh LokHkkfod ifj.kfr  (natural  history)  ,oa   ftlds dkj.k bls silent   thyroiditis   Hkh dgrs gSaA           LokLF; ykHk ij bldk dksbZ izHkko ugha feyrkA   izlo vFkok xHkZikr ds 3-6   eghuksa esa gksus okyh            VkWfDld voLFkk ds nkSjku /kM+du ,oa dEiu esa vkjke   postpartum thyroiditis (PPT)  Hkh SAT  dk gh ,d           ds fy, beta blockers   (propranolol 20-40 fexzk  izk:i gS ijUrq buesa dqN ewy varj gksrs gSa\&           fnu esa rhu ;k pkj ckj)  dk iz;ksx fd;k tk ldrk gSA  - PPT  esa Fkk;jkW;M xazfFk esa nnZ ugha gksrkA                                                      - PPT  esa ESR  lkekU; jgrk gSA           Thyroid specific therapy -  ge tku pqds gSa fd           SAT ds vkjafHkd fnukas esa Fkk;jksVkWfDldksfll ds y{k.k   - PPT  es ,aVh\&Fkk;jkW;M ,aVhckWMht fey ldrh gS                                                      - PPT   esa LVsjkW;M fFkjSih ls dksbZ ykHk ugha feyrk           mRié gks ldrs gSaA ,sls eas ;g fopkj mBuk LokHkkfod gS   ,aVh\&Fkk;jkW;M ,aVhckWMht ds dkj.k PPT  esa Hkfo’; esa           fd  ,sls  esa  ATD  (carabimazole    vFkok   gkbiksFkk;jkW;fMTe dh lEHkkouk vf/kd gksrh gSA PPT           methimazole)  ds iz;ksx ds }kjk bls nck D;ksa u fn;k   dk foLrkj ls fo.kZu ge vkxs djsaxsA           tk,A ;gk¡ ;g /;ku j[kuk vko”;d gS fd ATD  rks           Fkk;jkW;M gkWeksZUl ds mRiknu dks ?kVkrh gSa tks ;gk¡ igys           ls gh QkWfydYl dks gqbZ {kfr ds dkj.k ?kVk gqvk gSA   HASHIMOTO’S THYROIDITIS AND                                                       THYROTOXICOSIS           vr% ,sls jksfx;ksa esa ATD   dk iz;ksx djus ls muesa           fjdojh  ds nkSjku vkjEHk gksus okyk gkWeksZUl dk mRiknu   gkbiksFkk;jkW;fMTe ds nks izeq[k dkj.k gksrs gSaA ftu {ks=ksa           gh nc tk,xk vkSj jksxh gkbiksFkk;jkW;M gh jg tk,xkA   esa vk;ksMhu dh deh gS ogka iodine deficiency, ,oa           vr%  bu  jksfx;ksa  esa  ATD    dk  iz;ksx  fuf’k)   tgk¡  vk;ksMhu  i;kZIr  ek=k  esa  miyC/k  gS]  ogka                                                      Hashimoto’s thyroiditis (HT)A izkjEHk esa xkW;Vj ,oa           (contraindicated)  gksrk  gSA  vr%  SAT    esa                                                      gkbiksFkk;jkW;fMTe dk izeq[k dkj.k vk;ksMhu dh deh           Fkk;jksVkWfDldksfll ds y{k.kksa esa vkjke ds fy, beta   dks gh ekuk tkrk FkkA loZizFke Hashimoto us ;g ik;k           blockers  dk iz;ksx gh mfpr gSA                                                      fd  i;kZIr  vk;ksMhu  okys  {ks=ksa  esa  Hkh  xkW;Vj  ,oa           blh  izdkj  SAT  dh  gkbiksFkk;jkW;M  voLFkk  esa  gkbiksFkk;jkW;fMTe gksrs gSa ftlesa Fkk;jkW;M xzafFk dh           Fkk;jkWfDlu fFkjSih dk fopkj Hkh LokHkkfod gh gSA  ck;kWIlh esa ,d fo”ks’k xq.k] Fkk;jkW;M xzafFk esa izpqj ek=k           okLro esa gkbiksFkk;jkW;fMTe ds y{k.kksa ds lkekU; ls  esa  Iymphocytic  infiltration  feyrk  gSA  blhfy,           vf/kd gksus ij Fkk;jkWfDlu dh FkksM+h ek=k (50-100   Hashimoto us bls struma Iymphomatosa  dgk           mcg izfrfnu)   dk iz;ksx dqN le; rd fd;k tk  ¼struma = mHkkj] vFkkZr goiter ,oa Iymphomatosa           ldrk gS ftls gkWeksZUl ds mRiknu ds vkjEHk gksus ds   =  Iymphocytes   dk lewg½ vFkkZr xkW;Vj ftlesa           lkFk Øe”k% ?kVkdj can dj ldrs gSaA /;ku jgs]   extensive Iymphocytic infiltration feyrk gksA ckn            vf/kdk¡”k jksfx;kas esa ;g gkbikssFkk;jkW;M voLFkk Hkh  esa bls Hashimoto ds gh uke ij Hashimoto’s           {kf.kd gh gksrh gS tks 1-2   ekg esa Lor% gh Bhd gks   thyroiditis dgk tkus yxkA le; ds lkFk\&lkFk ;g           ldrh gSA ;fn bu jksfx;ksa es Fkk;jkWfDlu fFkjSih dks  tkudkjh  gksus  ij  fd  xkW;Vj  esa  gksus  okyk  ;g           tkjh j[kk tk, rks ;g TSH dks nck dj Fkk;jkW;M   Iymphocytic  infiltration  okLro esa /khjs\&/khjs yEcs           QkWfydYl ds regeneration  esa ck/kk mRié dj ldrk  le; rd gks jgs immunological inflammation dk                                                    150","gh  ifj.kke  gS]  bls  vc  chronic  Iymphocytic   }kjk bu ,aVhckWMht ls tqM+dj dksf”kdkvksa dks u’V dj           thyroiditis  (CLT)  ,oa   chronic  autoimmune   nsrh gSaA           thyroiditis ds uke ls tkuk tkrk gSA                                                      bEE;wu fj,D”ku Fkk;jkW;M xzafFk esa fuezkafdr izHkko mRié           PATHOGENESIS                               dj ldrh gS\&           bl izdkj ;g ,d vkWVks\&bEE;wu fodkj gqvk ftlesa   -  EE;wuksykWftdy  {kfr  ds  QyLo:i  Fkk;jkW;M                                                       b           “kjhj] Fkk;jkW;M xzafFk ds gh dqN Hkkxksa dks self antigen                                                       QkWfydYl dh dksf”kdkvksa dh apoptosis ls budh           ds :i esa igpkuuk can djds (breakdown in self   la[;k esa deh vkrh tkrh gSA           tolerance to thyroid auto-antigens) muds fo#)           bEE;wu  fj,D”ku  mRié  djus  yxrk  gS  tks  Øe”k%   -  bEE;wu  fj,D”ku  ds  QyLo:i  Fkk;jkW;M  xzafFk  esa           Fkk;jkW;M  xzafFk  dks  u’V  djrs  gq,  Øe”k%   QkWfydYl  dh  dksf”kdkvksa  ds  LFkku  ij  Øe”k%           gkbiksFkk;jkW;fMTe dh vksj c<+rk tkrk gSA   Iymphocytes ,oa mononuclear cells   ,df=r                                                       gksrh tkrh gSaA           ,slk nks dkj.kksa ls gks ldrk gS \&                                                      -  bEE;wu fj,D”ku ds QyLo:i gh dqN le; i”pkr           -  Sequestered  thyroid  protein  getting   Fkk;jkW;M xzafFk esa Qkbczksfll vkjEHk gks tkrh gSA            exposed -    kk;jkWW;M xzafFk dh  self  protein  tks   -  kk;jkW;M QkWfydYl dh dksf”kdkvksa ds fo#) gksus                      F                                                       F            “kjhj  ds  bEE;wu  ra=  ls  vyx  Nqik  dj   okyk ;g bEE;wu fj,D”ku] Øe”k% bu dksf”kdkvksa dks            (sequestered  self  antigen) j[kh x;h Fkh] og   {kfr igq¡pkrk tkrk gS ftlls Fkk;jkW;M xzafFk dh            fdlh izdkj bl bEE;wu ra= ds lkeus vk tk,] vFkok           - Regulatory  T-cells  itself  getting      dk;Z{kerk Øe”k% {kh.k gksrs gq, gkbiksFkk;jkW;fMTe            unregnated -   bEE;wu ra= dh regulatory T-cells   mRié dj ldrh gSA            tks bu bEE;wu fj,D”ku dks fu;af=r djrh gSa] og Lo;a   HT ds vkajfHkd fnuksa esa QkWfydYl dh dksf”kdkvksa  dh            gh vfu;af=r (functionally abnormal) gks tk;asA  bEE;wuksykWftdy {kfr ls tc Fkk;jkW;M gkWeksZUl dk            Fkk;jkW;M QkWfydYl dh dksf”kdkvksa ds self antigens   mRiknu izHkkfor gksus yxrk gS rc fuxsfVo QhMcSd ls           ds fo:) ;g bEE;wu fj,D”ku rhu izdkj ls mRié gks   fiVîwVjh ds }kjk TSH dk lzko.k c<+ tkrk gSA blds           ldrk gS\&                                   izHkko esa Fkk;jkW;M xzafFk dk vkdkj c<+dj xkW;Vj dk            -  T-cell mediated -   C D 8 +   c e l l s   ds  }kjk   :i ys ysrk gSA dqN O;fDr;ksa esa ;g c<+k gqvk TSH                   cytotoxic T-cell mediated cell death  djkdj]  Fkk;jkW;M gkWeksZUl dks lkekU; Lrj rd ys vkrk gS           -  Cytokine mediated -  CD4+ cells d   } k j k   ftlls og euthyroid gh cus jgrs gSaA ;g fLFkfr            cyto-kine  (interferon-gamma) mediated  cell   euthyroid goiter dgykrh gSA ftu O;fDr;ksa esa TSH            death djkdj \& ;g cytokines, Fkk;jkW;M xzafFk esa   dk lzko.k c<+us ds ckn Hkh Fkk;jkW;M gkWeksZUl lkekU;            mononuclear  cells  dks  vkdf’kZr  djrs  gSa  tks   Lrj ij ugha igq¡p ikrs] muesa xkW;Vj ds lkFk\&lkFk            Fkk;jkW;M QkWfydYl dh dksf”kdkvksa dks u’V djrs gSaA  gkbiksFkk;jkW;fMTe Hkh mRié gks tkrh gSA bl fLFkfr dkss           -  Antibody mediated -  dHkh\&dHkh Fkk;jkW;M self   goiter with hypothyroidism dgrs gSaA ;|fi] HT            antigens ds fo#) cuh ,aVh\&Fkk;jkW;M ,aVhckWMht ds   gksus dk eq[; izHkko gkbiksFkkjkW;fMTe ds :i esa gh gksrk            }kjk antibody dependent, cell mediated, cell   gS  ijUrq  dHkh\&dHkh  Fkk;jkW;M  QkWfydYl    dh            death djkdj \& ;g ,aVhckWMht] Fkk;jkW;M QkWfydYl   bEE;wuksykWftdy {kfr ds le;] QkWfydYl esa laxzfgr            dh dksf”kdkvksa ls tqM+dj natural killer cells dks   Fkk;jkW;M gkWeksZUl] yhd gksdj jDr esa vk tkrs gSaA ;g            vkdf’kZr djrh gSa tks iqu% vius Fc component  ds   dqN le; ds fy, VkWfDld voLFkk mRié dj ldrs gSa                                                      151","ftls Hashitoxicosis  dgrs gSaA             xkW;Vj ,oa gkbiksFkk;jkW;fMTe gh blds izeq[k y{k.k           PATHOLOGY                                  gksrs  gSaA  dsoy  dHkh\&dHkh  gh  ;g  {kf.kd           Gross Morphology - HT esa vf/kdrj lEiw.kZ xzafFk   Fkk;jksVkWfDldksfll ds :i esa izdV gks ldrk gSA           gh vkdkj esa c<+ tkrh gS (diffuse enlargement)   blesa Fkk;jkW;M xzafFk vf/kdrj smooth, symmetric,           ;|fi dHkh\&dHkh blds fdlh ,d Hkkx esa gh o`f) gks   diffusely enlarged ,oa rubbery consistency dh           ldrh gSA                                   gksrh gSA           vkdkj esa c<+us ds ckn Hkh Fkk;jkW;M xzafFk vius dSIlwy   COMORBID DISORDERS           ds vanj gh lhfer jgrh gSA                  ;kn jgs fd fdlh ,d vkWVks\&bEE;wu fodkj ds gksus ij                                                      vU; vkWVks\&bEE;wu fodkjksa ds Hkh lkFk\&lkFk feyus dh           Qkbczksfll ds dkj.k bldh consistency lkekU; xzafFk           dh rqyuk esa vf/kd l[r (firm) gks tkrh gS ftls fo”ks’k   lEHkkouk  c<+  tkrh  gSA  blhfy,  HT  ls  izHkkfor                                                      O;fDr;ksa esa vitiligo, type 1 diabetes, autoimmune           :i ls rubbery consistency  dgk tkrk gSA                                                      adrenal insufficiency, SLE, myasthenia gravis           bl Qkbczksfll ds dkj.k gh dHkh\&dHkh Fkk;jkW;M xzafFk   ,oa Sjogren  syndrome  bR;kfn dh lEHkkouk Hkh           esa dqN ukWMîwy Hkh mRié gks ldrs gSa tks lkekU; :i ls   vf/kd gksrh gSA           ,dlkj c<+h gqbZ xzafFk dks ukWMîwyj cuk nsrs gSaA   ge  tku  pqds  gSa  fd  HT  esa  Fkk;jkW;M  xzafFk  esa            Microscopic  examination  esa  Fkk;jkW;M   Iymphocytic infiltration vR;f/kd c<+ tkrk gS tks           QkWfydYl vkdkj esa vis{kkÑr NksVs gks tkrs gSa ,oa   germinal centers  rd cuk ysrk gSA bUgha germinal           buds chp dk interstitial connective tissue lkekU;   centers dh Iymphocytosis ds vfu;af=r :i ls           ls vf/kd c<+ tkrk gSA                      c<+rs tkus ls extranodal  B-cell  Iymphoma  Hkh                                                      mRié gks ldrs gSaA           Fkk;jkW;M QkWfydYl dh atrophy gksus yxrh gS ,oa                                                      Fkk;jkW;M QkWfydYl dh dksf”kdkvksa ij yxkrkj gks jgh           budh  low  cuboidal  follicular  epithelial  cells           vusd LFkkuksa ij bEE;wuksykWftdy {kfr   ls izHkkfor   bEE;wuksykWftdy  {kfr  ls  dHkh\&dHkh  muesa                                                      mitogenesis  rd mRié gks ldrh gSA blhfy,] HT           gksdj  abundant  eosinophilic,  granular           cytoplasm okyh Hurthle cell  esa ifjofrZr gksus yxrh   esa papillary carcinoma  dh lEHkkouk Hkh vf/kd gksrh           gSaA /;ku jgs] ;gh Hurthle  cells,  HT dh fof”k’V   gSA           (pathognomonic ) cells  gSaA               MANAGEMENT                                                      /;ku jgs] HT dk vius vki esa dksbZ mipkj ugha gSA           Fkk;jkW;M xzafFk dh parenchyma esa cM+h la[;k esa           small  Iymphocytes,  plasma  cells    ,oa   dsoy  vkWVks\&bEE;wu  fodkj  gksus  ds  dkj.k  blesa                                                      immunosuppressive agents fn, tkus ls Hkh dksbZ           mononuclear cells feyrh gSa tks fdlh Iymphoid   ykHk ugh feyrkA okLro esa HT dk Dyhfudy egÙo rks           tissue dh gh Hkkafr iw.kZ fodflr germinal center dk   blds y{k.kksa esa gh gSA D;kasfd ;g eq[;r% rhu :iksa esa           :i Hkh ys ldrh gSaA                                                      izdV gks ldrk gS (euthyroid goiter, goiter with           CLINICAL FEATURES                                                      hypothyroidism  ,oa  dHkh\&dHkh  transient           vU; vkWVks\&bEE;wu fodkjksa dh Hkkafr gh HT Hkh iq#’kksa   thyrotoxicosis)  vr% blds mipkj dks Hkh bu rhuksa           dh vis{kk] 46-65 o’kZ dh efgykvksa esa 10-20 xquk   y{k.kksa ds vk/kkj ij le>k tk ldrk gSA           vf/kd feyrk gSaA                                                      For thyroioxic phase - ;g ge igys Hkh le> pqds                                                     152","gSa fd HT esa feyus okyh ;g VkWfDld voLFkk vf/kdrj   gksus ds dkj.k vkb;s bldks foLrkj ls le>rs gSaA            {kf.kd] gydh ,oa Lor% gh Bhd gks tkus okyh (mild,   AMIODARONE  INDUCED  THYROID  DYS-           transient ,oa self limiting) gksrh gSS ftlds fy, ATD   FUNCTIONS           dh vko”;drk ugha gksrhA y{k.kksa ds mipkj ds fy,   Amiodarone ,d egRoiw.kZ antiarrhythmic drug           ?kcjkgV ds fy, anxiolytics rFkk /kM+du ;k dEiu ds   gS tks cardiac arrhythmias  ds mipkj esa iz;qDr gksrh           fy, beta blockers dk iz;ksx fd;k tk ldrk gSA  gSA ijUrq bldk ,d egRoiw.kZ nq’izHkko Fkk;jkW;M dh           For hypothyroid phase - blds fy, Fkk;jkWfDlu   vfu;ferrk Hkh gSA iz”u ;g mBrk gS fd ân; ij dk;Z           fFkjSih nsrs gSaA /;ku jgs] HT esa Fkk;jkW;M xzafFk ds fo#)   djus okyh nok dk nq’izHkko Fkk;jkW;M ij fdl izdkj ls           cuus okyh ,aVhckWMh ,d lkFk gh iwjh xzafFk dks u’V ugha   iM+rk gS\\ okLro esa ,slk amiodarone esa mifLFkr           dj nsrhaA ;g bEE;wuksykWftdy {kfr dkQh yEcs le;   vk;ksMhu dh dkQh vf/kd ek=k (~39%) ds dkj.k ls           rd  /khes\&/khes  pyrh  jgrh  gSA  blds  dkj.k   gksrk  gSA  Amiodarone  dh  200  fexzk  dh  xksyh           gkbiksFkk;jkW;fMTe Hkh le; ds lkFk\&lkFk Øe”k% c<+rh   (maintenance dose) esa vk;ksMkbM dh yxHkx 75           tkrh gSA blhfy,] HT ls izHkkfor vusdksa O;fDr;ksa esa   fexzk ek=k gksrh gS ftldh esVkckWfyTe ls yxHkx 6                                                      fexzk vk;ksMkbM jkstkuk mRié gksrh gSA ;g WHO }kjk           3-6 ekg ds varjky ij Fkk;jkW;M dh tkapsa djkdj   izLrkfor 0.15-3.0 fexzk izfrfnu ls cgqr vf/kd gS ,oa           bldk vkdyu djrs jguk pkfg, ftlls blds vuqlkj   IykTek ,oa ;wfjujh vk;ksMhu dks 40 xquk rd c<+k           Fkk;jkWfDlu dh Mkst dks iqufuZ/kkZfjr fd;k tk ldsA                                                      ldrh gSA Amiodarone  ds olk (adipose tissues)           For goiter - D;ksafd HT esa xkW;Vj dk dkj.k TSH   esa ,df=r jgus ds dkj.k blds izHkko] nok can djus ds           dk c<+uk gh gS vr% LokHkkfod :i ls ;g vuqeku   6 ekg ckn rd Hkh cus jg ldrs gSaA ;gh vk;ksMkbM]           yxk;k tk ldrk gS fd TSH dks ?kVkdj xkW;Vj ds   Fkk;jkW;M xzafFk esa igq¡p dj Fkk;jkW;M dh vfu;ferrk;sa           vkdkj esa Hkh deh yk;h tk ldrh gSA okLro esa]   mRié djrh gSA vkb;s bls foLrkj ls le>rs gSaA           goiter  with  hypothyroidism esa ,slk gh gksrk gSSA   PATHOPHYSIOLOGY           gkbiksFkk;jkW;fMTe esa c<+k gqvk  TSH,  Fkk;jkWfDlu   Transient hypothyroidism -  Amiodarone  dh           fFkjSih ds mijkar ?kVus yxrk gS ftlls xkW;Vj ds   esVkckWfyTe ls mRié vk;ksMkbM dh fo”kky ek=k]           vkdkj esa deh vkus yxrh gSA vf/kd¡k”k O;fDr;ksa esa   Fkk;jkW;M ds dk;ksZa dks dqN le; ds fy, nck dj           Fkk;jkW;M gkWeksZUl ds Lrj lkekU; gksus ds i”pkr   vYidkfyd gkbiksFkk;jkWfMTe mRié dj ldrh gSA           xkW;Vj Hkh Øe”k% lekIr gks tkrk gSA D;ksafd xkW;Vj ds           vkdkj esa vkus okyh deh TSH ds ?kVus ls vkrh gS   Reduced conversion of T4 into T3 – ;kn djsa]           vr% mipkj ds iwoZ TSH ftruk vf/kd gksxk] xkW;Vj   vk;ksMkbM dh fo”kky ek=k ds suppressive effect  ls           ds vkdkj esa deh vkus dh laHkkouk Hkh mruh gh vf/kd   rks Fkk;jkW;M xzafFk dqN fnuksa esa gh Wolff Chaikoff           gksrh gSA                                  escape phenomenon ds dkj.k  mcj vkrh gS ,oa                                                      blesa Fkk;jkW;M gkWeksZUl dk mRiknu iqu% vkjEHk gks             DRUG INDUCED THYROIDITIS                 tkrk gS] ijUrq amiodarone fFkjSih ds tkjh jgus ij           vkWVks\&bEE;wu Fkk;jkW;M fodkjksa ls izHkkfor O;fDr;ksa   gkbiksFkkjkW;fMTe ds y{k.k ckn esa Hkh cus jgrs gSaA lkspsa]            ¼eq[;r% efgykvksa½ esa dqN nokvksa ds iz;ksx ls Hkh PPT   bldk  D;k  dkj.k  gks  ldrk  gS\\  okLro  esa           dh Hkkafr silent painless thyroditis mRié gks ldrh   amiodarone, type 1 deiodinase enzyme (D1)                                                      dks Hkh ckf/kr djrk gS tks izks\&gkeksZu T4 dks lfØ;           gSaA buesa izeq[k gSa amiodarone, interferone alpha           (IFN-a), interleukin-2 (IL-2) ,oa  tyrosine kinase   gkWeksZu T3 esa cnyrk gSA bl izdkj] amiodarone ds           inhibitors A buesa ls amiodarone ds lokZf/kd iz;qDr   yxkrkj iz;ksx ls Fkk;jkW;M gkWeksZUl dh dk;Z{kerk ckn                                                    153","rd ?kVh jgrh gSA                           amiodarone vkjEHk djus ds iwoZ jksxh ds baseline           Prolonged  hypothyroidism  –  vkWVks\&bEE;wu   serum T3, T4  ,oa TSH dh tkapsa djok ysuh pkfg;sa                                                      ftlls igys ls gh py jgh fdlh vfu;ferrk dks           Fkk;jkW;M fodkjksa ls izHkkfor O;fDR;ksa esa amiodarone           dk iz;ksx nh?kZdkfyd gkbiksFkk;jkW;fMTe Hkh mRié dj   igpkuk tk ldsA mipkj vkjEHk djus ds 3  ekg           ldrk gSA /;ku jgs] vkWVks\&bEE;wfuVh dh lEHkkouk   i”pkr]  blh  tkap  dks  nksckjk  djkdj  xzafFk  ij           vk;ksMhu dh deh okys {ks=ksa dh rqyuk esa i;kZIr   amiodarone ds izHkko dk vkdyu fd;k tk ldrk           vk;ksMhu  okys  {ks=ksa  esa  vf/kd  gksrh  gSA  vr%  gSA blds i”pkr Hkh izR;sd 3 ekg ds varjky ij lhje           amiodarone  ls  gksus  okyh  nh?kZdkfyd    TSH dh tkap ,oa fdlh vfu;ferrk ds feyus ij           gkbiksFkk;jkW;fMTe dh lEHkkouk Hkh vk;ksMhu dh deh  lhje T3  ,oa T4 dh tkapsa djkrs jguh pkfg,A ;aw rks           okys {ks=ksa ¼yxHkx 6% ½ dh rqyuk esa i;kZIr vk;ksMhu  bl izdkj dh vf/kdk¡”k vfu;ferrk,a] amiodarone           okys {ks=ksa esa jgus okys O;fDr;ksa esa vf/kd ¼yxHkx   can djds gh Bhd dh tk ldrh gSa ijUrq arrhythmias           13%½  gksrh gSA                            dh xaHkhjrk dks ns[krs gq, ,slk gksus ij Hkh bldh lykg            Thyrotoxicosis  -  ckn esa tc ;gh vk;ksMkbM]  ugha nh tkrh cfYd amiodarone dks tkjh j[krs gq,           Fkk;jkW;M gkWeksZUl ds mRiknu ds fy, iz;qDr gksus yxrh  Fkk;jkW;M dh vfu;ferrkvksa dk mipkj Hkh lkFk\&lkFk           gS  rc  ;g  Fkk;jksVkWfDldksfll  (amiodarone  vkjEHk dj fy;k tkrk gSA           induced thyrotoxicosis - AIT ) Hkh mRié dj ldrh   Amiodarone  induced  hypothyroidism  -            gSA Fkk;jkW;M xzafFk esa igys ls gh dksbZ fodkj] tSls GD,   LokHkkfod :i ls blesa Fkk;jkWfDlu fFkjSih vkjEHk dh           MNG vFkok AITD gksus dh fLFkfr esa ,slk fo”ks’k :i ls   tkrh gSA ;gk¡ ,d rF; dks /;ku esas j[kuk vko”;d gS           gh ldrk gSA bls type 1 AIT  dgrs gSaA vk;ksMhu dh   fd amiodarone, izks\&gkeksZu T4 ds lfØ; gkeksZu T3           deh okys {ks=ksa esa jgus okys O;fDR;ksa esa bldh lEHkkouk   esa cnyus esa Hkh ck/kk Mkyrh gSA blhfy, bu O;fDr;ksa esa           vf/kd gksrh gSA                                                      Fkk;jkWfDlu dh Mkst lkekU; ls vf/kd gksrh gSA           Transient  thyrotoxicosis  followed  by           transient  hypothyrodism  – dqN O;fDr;ksa esa     Amiodarone induced thyroxicosis - /;ku jgs]           vk;ksMkbM dh fo”kky ek=k] Fkk;jkW;M QkWfydYl dks   amiodarone  induced  thyrotoxicosis  esa  dsoy                                                      type 1 AIT esa gh Fkk;jkW;M gkWeksZUl dk mRiknu c<+           {kfr igq¡pkdj acute vFkok  subacute thyroiditis           mRié  dj  ldrh  gS  ftlls  vYidkfyd        tkrk gS ftlds fy, ATD dks iz;ksx esa yk;k tk ldrk           Fkk;jksVkWfDldksfll  vFkok  vYidkfyd  gkbiks\&   gSA Type 2  AIT esa rks Fkk;jkW;M QkWfydYl dks gqbZ {kfr           Fkk;jkW;fMTe mRié gks ldrh gSA bls type 2   AIT   ds dkj.k Fkk;jk;M gkWeksZUl dk mRiknu igys ls gh ?kVk           dgrs gSaA Type 1  ,oa Type 2 AIT  dk ;g oxhZdj.k   gksrk gSA ,sls esa yk{kf.kd mipkj  (symptomatic           Hkh vf/kd izHkkoh ugha gS D;ksafd vusd O;fDr;ksa esa bu   therapy - beta blockers) ds vfrfjDr dqN le; ds           nksuksaa ds fefJr izHkko ns[kus dks feyrs gSaA  fy, LVsjkW;M fFkjSih dks Hkh iz;ksx esa yk;k tk ldrk gSA                                                      ;gk¡  ;g  Hkh  /;ku  j[kus  dh  vko”;drk  gS  fd           MANAGEMENT                                                      aamiodarone fFkjSih ds tkjh jgus ds dkj.k blls           /;ku jgs] amiodarone fFkjSih ysus okys vf/kdk¡k”k           O;fDr;ksa esa euthyroid goiter ds vfrfjDr Fkk;jkW;M   mRié gksrs jgus okyk vk;ksMkbM vkxs Hkh Fkk;jkW;M                                                      xzafFk dks {kfr igq¡pkrk jgk ldrk gSA ,sls esa xazfFk esa           lEcaf/kr dksbZ y{k.k izdV ugha gksrs ijUrq yxHkx 50%           O;fDr;ksa ds Fkk;jkW;M dh tkapksa esa vusd izdkj dh   vk;ksMkbM  ds  viVsd  dks  CykWd  djus  ds  fy,           vfu;ferrk,a vo”; mRié gks ldrh gSa blhfy,]   potassium perchlorate vFkok iopanoic acid dk                                                       Hkh iz;ksx fd;k tk ldrk gSA                                                   154","22         Nonthyroidal Illness Syndrome - NTIS                                   fofHké “kkjhfjd jksxksa ds lkFk ICU vFkok okMZ esa HkrhZ  mRié gks ldrh gSaA           gksus okys jksfx;ksa esa izk;% fu;fer :i ls gksus okyh   Low T3 syndrome - lhje T3 ds Lrj dk ?kV tkuk           Fkk;jkW;M dh tkapksa (thyroid function tests - TFT) esa   NTIS esa feyus okyh loZizeq[k vfu;ferrk gS tks           vusd vfu;ferrk;sa fey ldrh gSaA buesa ls vusd   NTIS ls izHkkfor yxHkx 70% (40-100%) O;fDr;ksa           jksxh og gksrs gSa ftuesa jksx ds iwoZ djk;s x, TFT   esa fey ldrh gSA lhje T3 ds Lrj ds ?kVus ds lkFk gh           lkekU; gksrs gSa] ,oa dqN og ftuesa jksx ds Bhd gks tkus   lhje reverse T3 (rT3) dk Lrj c<+rk tkrk gS tks           ds i”pkr djk;s x, TFT iqu% lkekU; gks tkrs gSaA ,sls   iqu% NTIS dk ,d izeq[k y{k.k gSA vkjEHk esa bl izdkj           esa  ,d  lEHkkouk  ;g  Hkh  gks  ldrh  gS  fd  ;g   ds vf/kdk¡”k jksfx;ksa esa lhje T4 ,oa TSH lkekU; gh           vfu;ferrk;sa Fkk;jkW;M xzafFk dh viuh u gksdj]   jgrs gSaA           systemic nonthyroidal illness (NTI) ds Fkk;jkW;M           gkWeksZUl (TH) ij iM+us okys izHkkoksa ds dkj.k mRié gqbZ   Low T4 syndrome - “kkjhfjd jksxksa dh vof/k ,oa           gksaA TFT esa feyus okyh bl izdkj dh vfu;ferrk;sa]   xaHkhjrk c<+us ds lkFk\&lkFk lhje T3 ds vfrfjDr           tks Fkk;jkW;M xzafFk dh viuh vfu;ferrk ls mRié u   lhje T4 dk Lrj Hkh ?kVuk izkjEHk gks tkrk gSA okLro           gksdj fdlh vU; chekjh ls mRié gqbZ gks ,oa mlh   esa jksx ds nkSjku lhje T4 dk ?kVuk] jksx dh xaHkhjrk                                                      dk lwpd (poor prognositc factor) ekuk tkrk gSA           chekjh ds nkSjku Kkr gqbZ gksa] mUgsa nonthyroidal           illness syndrome (NTIS)  dgrs gSaA ;g ekurs gq,   Low TSH – okLro esa fdlh acute incident event           fd blesa izHkkfor Fkk;jkW;M xzafFk] NTI ls igys ,oa ckn  tSls major trauma, MI vFkok ltZjh dk rkRdkfyd           esa lkekU; gh jgrh gS] iwoZ esa bls sick euthyroid  izHkko rks transient TSH ds c<+us ds :i esa feyrk gS           syndrome (SES) Hkh dgk tkrk FkkA ijUrq bl uke  ijUrq jksx dh xaHkhjrk c<+us ds lkFk\&lkFk yxHkx 10%           dks vc iz;ksx esa ugha yk;k tkrk D;ksafd fuf”pr :i ls  jksfx;ksa esa TSH ds Lrj ?kVus Hkh vkjEHk gks tkrs gSaA           ;g ugha crk;k tk ldrk fd Fkk;jkW;M xzafFk vkxs   Low T4  dh Hkkafr gh low TSH Hkh jksx dh xaHkhjrk dk           pydj Hkh euthyroid jgsxh vFkok ughaA       lwpd ekuk tkrk gSA            PREVALENCE                                 PATHOGENESIS           vk”p;Ztud :i ls ;g fLFkfr ICU esa HkrhZ yxHkx   NTIS,  Fkk;jkW;M  gkWeksZUl  (TH)  ds  flØh”ku]           70% rd jksfx;ksa esa fey ldrh gSA fdlh Hkh izdkj dk  esVkckWfyTe vFkok dk;Z] fdlh Hkh izfØ;k esa gksus okyh           “kkjhfjd vFkok ekufld ruko]  NTIS mRié dj  vfu;ferrkvksa ls mRié gks ldrh gSA           ldrk gSA buesa ls dqN izeq[k jksx fuEuakfdr gSaA  Reduced production of T3 -   5’-deiodinase           - Severe  critical  illnesses  –  Pneumonia,   type 1 (D1) ds down regulation ds dkj.k]  T4 ls            septicemia, MI, CHF, respiratory failure, IBD,   T3  dk cuuk de gks tkrk gS ftlls lhje T3 ds Lrj            cirrhosis, CRF, DKA ,oa malignancies bR;kfn                                                      ?kV tkrs gSa           - Trauma and major surgeries-  tSls CABG           - Deprivation  of  calorioes  -  Starvation   ,oa   Increased produetion of rT3 - 5’-deiodinase                                                      type 3 (D3) ds up regulation ls            anorexia nervisa                                                    T4 ds inactivation                                                      ls rT3 dk cuuk c<+ tkrk gS ftlls lhje T4 ds Lrj           PATTERNS OF ABNORMALITIES IN TFT                                                      de ,oa lhje rT3 ds Lrj c<+rs tkrs gSaA           NTIS esa TFT esa eq[;r% rhu izdkj dh vfu;ferrk;sa                                                    155","Reduction  in  albumin  bound  T4  - fdlh Hkh   gkbiksFkk;jkW;fMTe ds leku yx ldrk gSA           xaHkhj jksx esa jDr esa ,YC;wfeu ds Lrj ?kV tkrs gSaA   - Midnormal vFkok low normal serum T3  ,oa T4           D;ksafd jDr esa T4 dh lokZf/kd ek=k ,YC;wfeu ls gh   rFkk ckn dh voLFkk esa feyus okyk suppressed           tqM+h jgrh gS] blhfy, ,YC;wfeu ds ?kVus ls  jDr esa T4   serum  TSH  level,  lsaVªy gkbiksFkk;jkW;fMTe ds           ds Lrj vkSj Hkh de gks tkrs gSaA            leku yx ldrk gSA            Role of cytokines on peripheral  - fdlh jksx esa  bUgha dkj.kksa ls fdlh “kkjhfjd jksx ds nkSjku] igyh ckj           mRié  cytokines  u  dsoy  Fkk;jkW;M  gkWeksZUl  dks  ik;h x;ha TFT dh vfu;ferrkvksa ds vk/kkj ij fdlh           dksf”kdkvksa esa izos”k djus ls jksdrs gSa cfYd T3 dks  vafre fu.kZ; ij igq¡puk mfpr ugha gksrkA bl ij Hkh           mlds fjlsIVj ls tqM+us esa Hkh ck/kk mRié djrs gSaA   TFT ds dqN y{k.kksa ds vk/kkj ij ;g vuqeku yxk;k            Role  of  cytokines  on  pituitary  -  “kkjhfjd   tk ldrk gS fd ;g NTIS }kjk mRié fØ;kRed                                                      vfu;ferrk  (functional  disorders)  u  gksdj]           dksf”kdkvksa ds foijhr fiVîwVjh esa ;gh cytokines,           thyrotropes  dks lh/ks  suppress  djds  TSH dk   Fkk;jkW;M xzafFk ds izkFkfed jksx (organic  thyroid           lzko.k ?kVk nsrs gSaA                      disorders) ds Hkkx gksaA ;g y{k.k fuEukafdr gSaA                                                      - lhje T3 dk c<+k gksuk           Enhanced  negative  feedback  on  TSH      - lhje rT3 dk ?kVk gksuk           secretion - blh izdkj tgk¡ “kkjhfjd dksf”kdkvksa esa           T3  dk  cuuk  ?kV  tkrk  gS  ogha  fiVîwVjh  esa   - lhje TSH dk 20 mlU/L ls vf/kd ;k 0.10 mlU/L           deiodinase  type  2  (D2)  ds  upregulation  ls    ls de gksuk           fiVîwVjh esa T4 ls T3 dk cuuk c<+ tkrk gSA blh T3   - ,aVh\&Fkk;jkW;M ,aVhckWMht dk feyuk           ds fuxsfVo QhMcSd ls TSH vkSj Hkh ?kV tkrk gSaA  ,slk  gksus  ij  budk  mipkj  vU;  gkbiksFkk;jkW;M                                                      O;fDr;ksa ds vuqlkj gh djuk pkfg,A            bl izdkj fdlh jksx ds izkjEHk esa T4 dh esVkckWfyTe]           lfØ; T3 ds fuekZ.k ds LFkku ij fuf’Ø; rT3 ds   PROGNOSTIC SIGNIFICANCE           fuekZ.k dh vksj eqM+ tkrh gSA lkFk gh T3 ds vius  vusd v/;;uksa esa ;g ik;k x;k gS fd NTIS esa feyus           fjlsIVj ls u tqM+ ikus ds dkj.k “kjhj ij Fkk;jkW;M  okyh TFT dh xM+cfM+;ka] “kkjhfjd jksxksa dh xaHkhjrk dk           gkWeksZUl ds izHkko vkSj Hkh ?kV tkrs gSaA jksx ds vkSj  ifjpk;d gks ldrh gSaA buls fuEukafdr fu’d’kZ fudy           vf/kd c<+us ij] TSH ,oa T4 dk fuekZ.k gh ?kV tkrk  ldrs gSaA           gSA “kk;n bu lHkh izfØ;kvksa dk mís”; “kjhj dh   Low T3 Level - ;g NTIS esa feyus okyh loZizeq[k           esVkckWfyTe dks ?kVkuk gS ftlls cph gqbZ ÅtkZ dks jksx   vfu;ferrk gSA okLro esa fdlh jksx dh xaHkhjrk           vFkok Hkkstu dh deh (starvation)  ls fucVus esa   tSls\&tSls c<+rh tkrh gS] jDr esa T3 ds Lrj oSls\&oSls           iz;qDr fd;k tk ldsA                        ?kVrs tkrs gSaA bl izdkj T3 dh deh ls jksx dh xaHkhjrk            DIFFERENTIAL DIAGNOSIS                     dk vuqeku Hkh yxk;k tk ldrk gSA ân; jksfx;ksa esa T3           okLro esa NTIS esa feyus okyh TFT dh vfu;ferrk;sa]  dh deh dks c<+h gq;h e`R;q nj ls Hkh lEcaf/kr ik;k x;k           Fkk;jkW;M xzafFk ds fdlh izkbejh fodkj ds leku gh  gSA           izrhr gks ldrh gSaA                        Low T4 Level – NTI ds vkjEHk ls gh jDr esas T3  ds           - Low serum T3, midnormal vFkok low normal  Lrj esa deh vkuh vkjEHk gks tkrh gSA blds foijhr            serum  T4  ,oa izkjafHkd voLFkk esa feyus okyk   T4 ds Lrj esa deh] NTI dh vof/k ,oa xaHkhjrk ds            elevated  serum  TSH  level  –  Hashimoto’s  c<+us ij gh vkjEHk gksrh gSA bl izdkj T4 ds Lrj esa            thyroiditis,  subclinical  vFkok  overt  izkbejh   deh] NTI dh vkSj Hkh vf/kd xaHkhjrk ,oa blds vf/kd                                                     156","xaHkhj ifj.kke gksus dh lEHkkouk dks bafxr djrh gSaA  ;g tkuus ds iz;kl fd;s x, fd Fkk;jkWfDlu fFkjSih bu           lhje T4 ds 4 mcg/dl ls de gksus ij e`R;q nj 50%  jksfx;ksa esa fdl izdkj lgk;d gks ldrh gSA vHkh rd           ,oa 2 mcg/dl ls Hkh de gksus ij 80% rd c<+ ldrh  Fkk;jkWfDlu fFkjSih dk ykHk dsoy ân; jksfx;ksa esa gh           gSA                                        ns[kus dks fey ldk gS ftuesa myocardial ischemia                                                      ,oa vU; cardiac parameters esa Fkk;jkWfDlu fFkjSih           TREATMENT           vkjEHk esa rks NTIS dks fdlh xEHkhj jksx dh izfrfØ;k   ls dqN lq/kkj ik;k x;k gSA ,d v/;;u ds vuqlkj]           (compensatory  adaptation) gh ekuk tkrk FkkA   NTIS ds ftu jksfx;ksa esa T4 ds Lrj 4 mcg/dl ls de           le; ds lkFk ;g tkuk x;k fd ;g izfrfØ;k ges”kk   gksa] de ls de muesa Fkk;jkWfDlu fFkjSih ¼ekSf[kd T4           ykHknk;d ugha gksrhA ,sls esa vusd v/;;uksa ds }kjk   vFkok IV T3½ nsus dk fopkj fd;k tk ldrk gSA                                                                                                            157","REFERENCES                                          REFERENCES                                          REFERENCES                                          REFERENCES                                          REFERENCES                                          REFERENCES             1.    Werner  \&  Ingbar’s  The  Thyroid.  A  Fundamental  and  Clinical  Text  Eds  Lewis  E.                 Braverman, David S. Cooper, Peter Kopp; 11th edition, Wolters Kluwer (India) Pvt Ltd.                 2021            2.    William’s Textbook of Endocrinology, Eds Shlomo Melmed, Richard J. Auchus, Allison B.                 Goldfine, Ronald J. Koenig and Clifford J. Rosen; 14th edition, Elsevier Inc. 2020             3.    Harrison’s Principles  of Internal  Medicine,  Eds Jameson  J Larry, Kasper  Dennis  L,                 Longo Dan L, Fauci Anthony S, Hauser Stephen L and Loscalzo Joseph; 20th edition,                 Mc Graw Hill Education, 2018            4.    Gray’s Anatomy, The Anatomical Basis of Clinical Practice, Ed Standing Susan, 41st                 edition, Elsevier Inc. 2016 5. BD Chaurasia’s Human Anatomy, Regional and Applied,                 Dissection  and  Clinical,  Ed  Garg  Krishna,  Mittal  Pragati  Sheel  and  Chandrupatla                 Mrudula; 7th edition, CBS Publishers \&amp; Distributors Pvt Ltd, 2016            6.    Gyton and Hall Textbook of Medical Physiology, Eds Hall John E, Vaz Mario, Kurpad                 Anura and Raj Tony, 2nd South Asia Edition, Elsevier Inc, 2016            7.    Ganong’s Review of Medical Physiology, Eds Barrett Kim E, Barman Susan M, Boitano                 Scott and Brooks Heddwen L; 25th edition, Mc Graw Hill Education (India) Pvt Ltd, 2016            8.    Textbook of Human Physiology, Khurana Indu, Khurana A, Kowlgi NG, 3rd edition,                 Elsevier Inc. 2020                                                                            158"];